INDRA UUID	Confidence	Citation Source	Citation Reference	Evidence	Subject	Predicate	Object
385d21a1-1878-426f-b80c-1774e33fb5d7	0.65	PubMed	22030330	Acetylated tau promotes AD related memory loss.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
4adb0e52-3e97-41c5-bb1c-49f9267878cd	0.88	PubMed	20237556	Tau can be acetylated by the P300 and CBP acetyltransferase, a 300 kDa CREB binding protein at several Lys residues within its flanking region [XREF_BIBR] or repeat domain.	p(HGNC:CREBBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ac, Lys))
4adb0e52-3e97-41c5-bb1c-49f9267878cd	0.88	Other	sparser:Unknown	CBP acetylates tau at several lysine residues within the microtubule binding repeats and the proline-rich region, whereas auto-acetylation occurs preferentially at lysine residues located in the microtubule binding repeats [ xref ].	p(HGNC:CREBBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ac, Lys))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	Other	sparser:Unknown	While the full complement of enzymes controlling tau acetylation is not well-characterized, in vitro and cell-based experiments showed that CREB-binding protein (CBP) or the highly homologous p300 acetylates tau with high affinity in the MTBR xref  xref  xref .	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	Other	sparser:Unknown	Tau can be found in the nucleus [ xref ], raising the possibility that tau is acetylated by p300 in the nucleus.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	Other	sparser:Unknown	Tau is acetylated by p300 [ xref ], and the expression and acetyltransferase activity of p300 is enhanced in AD brains [ xref , xref ].	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	Other	sparser:Unknown	p300 induced tau acetylation both in vitro and in vivo .	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	PubMed	18785580	Exactly how p300 acetylates tau in vivo remains to be determined.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	PubMed	18785580	Acetylation of Tau by p300 Acetyltransferase.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	Other	sparser:Unknown	Since small amount of tau also may be present in the nucleus in some cell types ( xref ), p300 might acetylate tau directly.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	Other	sparser:Unknown	Mass spectrometry detected p300-induced tau acetylation at 23 lysines.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	Other	sparser:Unknown	Recombinant tau acetylated by p300 was incubated with SIRT1 immunoprecipitated from SIRT1-overexpressing HEK293T cells.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	PubMed	20869593	Acetylation of Tau by p300 Acetyltransferase.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	PubMed	20869593	Exactly how p300 acetylates tau in vivo remains to be determined.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	PubMed	20869593	However, p300 could also induce tau acetylation indirectly by unknown mechanisms.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	PubMed	22030330	Tau can be found in the nucleus [XREF_BIBR], raising the possibility that tau is acetylated by p300 in the nucleus.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	PubMed	18785580	However, p300 could also induce tau acetylation indirectly by unknown mechanisms.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	Other	sparser:Unknown	Exactly how p300 acetylates tau in vivo remains to be determined.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	PubMed	22030330	Tau is acetylated by p300 [XREF_BIBR], and the expression and acetyltransferase activity of p300 is enhanced in AD brains [XREF_BIBR, XREF_BIBR].	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	Other	sparser:Unknown	However, p300 could also induce tau acetylation indirectly by unknown mechanisms.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
1e3c10d5-3078-4032-833e-e2abb25b7f06	1.0	PubMed	23962722	In agreement with our results above, p300 increased acetylation of tau on KIGS motifs, and decreased tau polymerization.	p(HGNC:EP300)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
3825b201-f7ab-4dcf-a5c5-35604126469b	0.65	Other	sparser:Unknown	Like Ab708, antibody 9AB recognized recombinant tau acetylated by GST-p300, but not tau incubated with GST alone, suggesting that 9AB does not cross-react with non-ac-tau.	p(FPLX:GST)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
f1f77206-b0e1-48c8-8b0b-c4c63d993705	0.88	Other	sparser:Unknown	The data show that HDAC6 and acetylated tau are recruited to protein aggregates after proteasomal inhibition.	p(HGNC:HDAC6)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
f1f77206-b0e1-48c8-8b0b-c4c63d993705	0.88	PubMed	23962722	These results demonstrate that HDAC6 directly modulates the acetylation of tau by specifically deacetylating KIGS motifs.	p(HGNC:HDAC6)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
5c52a371-3dce-4357-a483-6d4b7515bd99	0.95	PubMed	17044810	Therefore, inhibition of Abeta induced deficits of histone acetylation and hyperphosphorylation of tau is helpful to treat AD.	p(FPLX:Histone)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
5c52a371-3dce-4357-a483-6d4b7515bd99	0.95	PubMed	22082362	Our data show that the hyperacetylation of Tau by p300 histone acetyltransferase (HAT) disfavors LLPS, inhibits heparin induced aggregation, and impedes access to LLPS initiated microtubule assembly.	p(FPLX:Histone)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
5c52a371-3dce-4357-a483-6d4b7515bd99	0.95	PubMed	PMC17044810	Therefore, inhibition of A β -induced deficits of histone acetylation and hyperphosphorylation of tau is helpful to treat AD.	p(FPLX:Histone)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
29adbc18-164b-4e1b-b713-3b5806694b44	0.65	PubMed	16846010	It is intriguing to speculate that the impact of tau acetylation on its function may be either beneficial or detrimental depending on the target residue and on the relative contributions of enzyme mediated acetylation and auto-acetylation of tau.	p(HGNC:IMPACT)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
6858c521-9def-4c8f-9b92-287a8704bbb8	0.65	Other	sparser:Unknown	Indeed, omitting DTT led to slightly reduced tau auto-acetylation of either full-length 2N4R-tau or tau-K18 proteins, as assessed by pan-[ 14 C]-acetyl-CoA labeling ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:KRT18, pmod(Ac))
48cc2cee-6001-472b-adf5-ea6d9f15e2af	0.65	Other	sparser:Unknown	SIRT1 Deficiency Increases Tau Acetylation and Suppresses Degradation of p-Tau.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:SIRT1, pmod(Ac))
a368f880-c665-4b0c-9c77-a2b53d8b0253	0.65	PubMed	17324007	Earlier studies have shown that an excess of Tau protein increases hyperacetylation of alpha-tubulin, through an inhibitory effect on histone deactylase 6, whose substrates include tubulin XREF_BIBR.	p(HGNC:MAPT)	directlyIncreases	p(UP:Q71G51, pmod(Ac))
d28a0832-bcfe-4986-b408-ef0452568c03	0.86	PubMed	PMC18958247	To examine putative tau substrates, we next determined whether tau directly acetylated microtubules, as described for the tubulin acetyltransferase αTAT-1 (refs.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:WHAMM, pmod(Ac))
d28a0832-bcfe-4986-b408-ef0452568c03	0.86	Other	sparser:Unknown	To examine putative tau substrates, we next determined whether tau directly acetylated microtubules, as described for the tubulin acetyltransferase αTAT-1 (refs.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:WHAMM, pmod(Ac))
1692888a-9b71-4d2d-a8e4-2102116d49ce	0.65	Other	sparser:Unknown	Acetyltransferase p300-induced tau acetylation is inhibited by salsalate and salicylate, which enhance tau turnover and reduce tau levels.	p(HGNC:MAPT)	directlyIncreases	bp(GO:0016407, pmod(Ac))
25851eeb-3652-4d66-8ee4-6fc4219b69c8	0.65	PubMed	27356871	Acetylated tau destabilizes this MT based barrier in the AIS and thus could enter the somatodendritic compartment.	p(HGNC:MCAT)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
7cbc734a-0898-4311-91a1-4183bf23d2c9	0.86	PubMed	22051683	By deacetylating Tau, SIRT1 prevents accumulation of phosphorylated Tau proteins [XREF_BIBR].	p(HGNC:SIRT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
7cbc734a-0898-4311-91a1-4183bf23d2c9	0.86	PubMed	20869593	SIRT1 Reduces Tau Acetylation in Primary Neurons and in Vivo.	p(HGNC:SIRT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
51ad212d-5555-4db8-8509-8fbed6df6e7b	0.65	PubMed	20208154	Salsalate and methylene blue have both been shown to reduce tau acetylation in pre-clinical models, however the exact mechanism has not been fully elucidated and warrants further investigation [XREF_BIBR].	a(PUBCHEM:5161)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
9e1cc12d-a435-4b9f-98f4-8aff15cfc799	0.65	PubMed	23962722	Given that tubulin acetylation and acetylation of tau on KXGS motifs are both controlled by HDAC6, this would allow for tight regulation of microtubule dynamics and axonal transport.	p(FPLX:Tubulin)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
f257dcd8-69d1-436f-be6b-7dd5cf9427dd	0.86	Other	sparser:Unknown	Acetylation of Tau by p300 Acetyltransferase.	bp(GO:0016407)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
f257dcd8-69d1-436f-be6b-7dd5cf9427dd	0.86	Other	sparser:Unknown	Tau can be acetylated by the P300/CBP acetyltransferase, a 300 kDa CREB-binding protein at several Lys residues within its flanking region[ xref ] or repeat domain.[ xref ] Tau can also be deacetylated by sirtuin 1 and histone deacetylase 6.[ xref ] Tau acetylation at certain sites may have distinct effects on tau aggregation and degradation.	bp(GO:0016407)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
04472b42-34c4-4c3e-9637-9439fa3d4d78	0.65	PubMed	25881209	Acetylated tau also transitioned from a predominantly soluble 55 kD species to an insoluble 64 kD species in rTg4510 brain homogenates as the animals aged.	a(PUBCHEM:6426943)	directlyIncreases	p(HGNC:MAPT, pmod(Ac))
fe446253-fa9e-4734-aaa4-c1345162a227	0.65	PubMed	18621244	The observed increase in lag time could indicate that pseudophosphorylation at S422 impedes the ability of ARA to interact with tau, or decreases the ability of tau to adopt a specific filament assembly-competent conformation.	p(HGNC:ABCC6)	directlyIncreases	act(p(HGNC:MAPT))
9d7b2259-0a35-4c5d-b89f-cd3743fa9f56	0.86	PubMed	25384392	We previously demonstrated that lentiviral Abeta1-42 expression leads to p-Tau accumulation and inhibition of both the proteasome and autophagy [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR], while the Abl tyrosine kinase inhibitor Nilotinib increases autophagic Abeta and p-Tau clearance, leading to decreased plaque levels in AD models [XREF_BIBR, XREF_BIBR].	p(HGNC:ABL1)	directlyIncreases	act(p(HGNC:MAPT))
9d7b2259-0a35-4c5d-b89f-cd3743fa9f56	0.86	PubMed	18363490	We previously demonstrated that lentiviral Abeta1-42 expression leads to p-Tau accumulation and inhibition of both the proteasome and autophagy [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR], while the Abl tyrosine kinase inhibitor Nilotinib increases autophagic Abeta and p-Tau clearance, leading to decreased plaque levels in AD models [XREF_BIBR, XREF_BIBR].	p(HGNC:ABL1)	directlyIncreases	act(p(HGNC:MAPT))
6d1f1c44-3414-4735-a737-be281a682620	0.65	PubMed	17586023	Taking into account that increased cellular levels of zink can induce release of tau from microtubules and thereby impair microtubule stability, ADNP replacement therapy that we propose here may be of benefit to prevent microtubule disruption and pathological aggregation of tau.	p(HGNC:ADNP)	directlyIncreases	act(p(HGNC:MAPT))
eec117e8-1d51-4272-bc43-9fb0372f2fed	0.65	PubMed	17587687	AD is diagnosed by clinical mental tests, often combined with the detection of neurobiological markers, mainly brain imaging studies and a decreased amyloid beta (Abeta) level and/or increased total and hyper-phosphorylated Tau protein (tau-P) in cerebral spinal fluid.	p(PFAM:PF09793)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
68ba22e2-6a06-45ff-9514-2e1aa13bbc78	0.92	PubMed	18862851	This hypothesis is supported by results obtained in a triple tg model of AD, which overexpresses human APP, PS1 and tau mutations.	p(PFAM:PF09793)	directlyIncreases	act(p(HGNC:MAPT, var(p.?)))
68ba22e2-6a06-45ff-9514-2e1aa13bbc78	0.92	PubMed	11203785	In this study, we used the same approach to study a triple-transgenic (3xTG) model of AD, which overexpresses human APP, PS1 and tau mutations, and progressively develops amyloid plaques, neurofibrillary tangles, and synaptic dysfunction.	p(PFAM:PF09793)	directlyIncreases	act(p(HGNC:MAPT, var(p.?)))
68ba22e2-6a06-45ff-9514-2e1aa13bbc78	0.92	PubMed	18642958	In this study, we used the same approach to study a triple-transgenic (3xTG) model of AD, which overexpresses human APP, PS1 and tau mutations, and progressively develops amyloid plaques, neurofibrillary tangles, and synaptic dysfunction.	p(PFAM:PF09793)	directlyIncreases	act(p(HGNC:MAPT, var(p.?)))
ad1df8e3-5f2b-46f8-a404-6614123f8654	0.65	PubMed	24464041	Genetic reduction of Ago3 suppressed tau neurotoxicity in Drosophila, and Ago3 and PIWIL1 was overexpressed in tau transgenic Drosophila and mice, and in human AD.	p(HGNC:AGO3)	directlyIncreases	act(p(HGNC:MAPT))
991e6b78-18cf-4356-ba09-868392309d79	0.65	PubMed	17745883	Chronically excessive activation of Akt also caused the development of Tau pathological and Abeta42 generation under insulin resistant situation in db/db and HSFD mouse brains.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:MAPT))
59e0bb51-c900-4cd7-a36d-0167732237dd	0.95	PubMed	21177183	AMPH also increased dialysate concentrations of ASP, GABA, DA and TAU, and decreased dialysate concentrations of the metabolites DOPAC, HVA and 5-HIAA.	p(HGNC:AMPH)	directlyIncreases	act(p(HGNC:MAPT))
59e0bb51-c900-4cd7-a36d-0167732237dd	0.95	PubMed	21177183	</ce:simple-para> </ce:caption> <ce:link locator="gr2"/> </ce:figure> <ce:figure id="FIG3"> <ce:label> Fig. 3 </ce:label> <ce:caption> <ce:simple-para view="all"> Effects of GLU uptake blockers PDC (4 mM) and DK (8 mM) on the increase in extracellular concentrations of ASP, GLU, GABA, TAU and DA produced by AMPH at the highest dose (20 mug and mul) (<ce:italic> n </ce:italic> = 3-6) (open bars).	p(HGNC:AMPH)	directlyIncreases	act(p(HGNC:MAPT))
59e0bb51-c900-4cd7-a36d-0167732237dd	0.95	PubMed	24205320	Chapius et al. showed that Amph, the BIN1 Drosophila ortholog, modulates Tau neurotoxicity in vivo in a Drosophila model system, the loss of Amph was able to suppress Tau induced neurotoxicity [XREF_BIBR].	p(HGNC:AMPH)	directlyIncreases	act(p(HGNC:MAPT))
59e0bb51-c900-4cd7-a36d-0167732237dd	0.95	PubMed	23399914	Variation of Amph expression, that is, the BIN1 Drosophila ortholog modulates Tau neurotoxicity in vivo.	p(HGNC:AMPH)	directlyIncreases	act(p(HGNC:MAPT))
59e0bb51-c900-4cd7-a36d-0167732237dd	0.95	PubMed	23399914	Together, these results are in accordance with the hypothesis that increased BIN1 expression in the brain might be deleterious and indicated that loss of Amph was able to suppress Tau induced neurotoxicity in Drosophila.	p(HGNC:AMPH)	directlyIncreases	act(p(HGNC:MAPT))
dcfb0cb8-4c19-4055-85f6-dc6aef901c38	0.88	PubMed	21892142	Indeed AMPK itself has been shown to target the same sites in Tau under some conditions as well 130.	p(FPLX:AMPK)	directlyIncreases	act(p(HGNC:MAPT))
dcfb0cb8-4c19-4055-85f6-dc6aef901c38	0.88	Other	sparser:Unknown	Here, we investigated the relationship between AMPK activation and phosphorylation of the tau protein in the brain of young (2-month-old) SAMP8 animals and in differentiated SH-SY5Y cells.	p(FPLX:AMPK)	directlyIncreases	act(p(HGNC:MAPT))
0e1402c9-6ce3-4892-b1b7-771366753e38	0.65	PubMed	18358045	To determine whether the Tau cleaving activity is caused by ApN, we fractionated this ApN preparation by hydrophobic chromatography on a TosoHaas butyl-650 column and tested the reactivity of the eluted fractions toward Tau and toward the aminopeptidase substrate Ala-4-MNA.	p(HGNC:ANPEP)	directlyIncreases	act(p(HGNC:MAPT))
290f6e16-c94f-46e7-ba70-2c5006881377	0.94	PubMed	22032791	Aberrant function of tau and Ng protein mediated by APOE epsilon4 may represent a critical event in the pathogenesis of AD.	p(HGNC:APOE)	directlyIncreases	act(p(HGNC:MAPT))
290f6e16-c94f-46e7-ba70-2c5006881377	0.94	PubMed	18112622	The authors of this study suggested that apoE variants could be modulating beta-amyloid 1-42 levels as well as tau pathology.	p(HGNC:APOE)	directlyIncreases	act(p(HGNC:MAPT))
290f6e16-c94f-46e7-ba70-2c5006881377	0.94	PubMed	6605146	In this study, we asked whether APOE promoter -491 (A/T) variants interact with APOE polymorphisms to modulate the degree of beta-amyloid- and tau related pathology in the medial temporal lobe of the non demented elderly.	p(HGNC:APOE)	directlyIncreases	act(p(HGNC:MAPT))
290f6e16-c94f-46e7-ba70-2c5006881377	0.94	PubMed	12471457	In this study, we asked whether APOE promoter -491 (A/T) variants interact with APOE polymorphisms to modulate the degree of beta-amyloid- and tau related pathology in the medial temporal lobe of the non demented elderly.	p(HGNC:APOE)	directlyIncreases	act(p(HGNC:MAPT))
23b9d185-8edd-4c5e-9b3a-a8310290f3fd	0.86	PubMed	11744535	Pretreatment of hippocampal neurons with DEX could up-regulate the increased levels of phosphorylated tau and p25 protein induced by Abeta (25-35) in vitro.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
23b9d185-8edd-4c5e-9b3a-a8310290f3fd	0.86	PubMed	11744535	These results suggest that DEX could potentiate Abeta induced learning and memory impairment and pathological damage in CA1 field of hippocampus in SD rats, which might be related to DEX up-regulating the levels of phosphorylated tau and p25 protein induced by Abeta (25-35).	p(HGNC:APP)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
90860777-286a-4ad9-ae54-59c39024bc35	0.65	PubMed	18663080	Our genetic studies, which allowed us to examine the effect of chronic Fyn inhibition on APP processing in a low level Abeta environment (APP Swedish mutation and tau (P301L) mutation both driven by the Thy1.2 regulatory element in a PS1 (M146V) knock-in mouse), support the hypothesis that Fyn inhibition increases Abeta production in AD 3xTg mice.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:MAPT, var(p.Pro301Leu)))
9a4ec452-f60d-4594-a3a5-b9621718711c	0.65	PubMed	22057290	Dilute Folin-Ciocalteu 's Phenol Reagent 1:1 w/dH 2 O (Sigma-Aldrich, F9252) 4 ARACHIDONIC ACID INDUCED FORMATION OF TAU OLIGOMERS.	a(PUBCHEM:444899)	directlyIncreases	act(p(HGNC:MAPT))
c6524039-4c8c-4bd4-88bf-3bc213697c62	0.65	PubMed	16082466	Increased Arf6 and cell polarity signaling through Par6 and atypical protein kinase Czeta (aPKCzeta) stimulated tau secretion.	p(HGNC:ARF6)	directlyIncreases	act(p(HGNC:MAPT))
bedcd6a3-ad86-4f7b-93bb-f174af6e2a34	0.65	PubMed	26538654	Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy.	p(HGNC:ARG1)	directlyIncreases	act(p(HGNC:MAPT))
5ac455a2-b07c-4826-8e96-a8d94cc87a70	0.92	PubMed	17752022	In MC1 neuroblastoma cells overexpressing the four-repeat Tau isoform with no N-terminal insert, a C-terminal truncated form or the full-length Tau protein was found co-purified with exosomes as well as associated with the exosome fraction obtained from human cerebrospinal fluid.	p(HGNC:ATP7A)	directlyIncreases	act(p(HGNC:MAPT))
5ac455a2-b07c-4826-8e96-a8d94cc87a70	0.92	PubMed	22615831	Our results demonstrating that tau was secreted by an unconventional secretory pathway is consistent with recent studies reporting that tau was found in exosomes in culture medium from MC1 cells overexpressing human tau and that secreted tau by COS-7 and HEK-293 cells was present in microvesicles XREF_BIBR, XREF_BIBR.	p(HGNC:ATP7A)	directlyIncreases	act(p(HGNC:MAPT))
5ac455a2-b07c-4826-8e96-a8d94cc87a70	0.92	PubMed	17327220	Our results demonstrating that tau was secreted by an unconventional secretory pathway is consistent with recent studies reporting that tau was found in exosomes in culture medium from MC1 cells overexpressing human tau and that secreted tau by COS-7 and HEK-293 cells was present in microvesicles XREF_BIBR, XREF_BIBR.	p(HGNC:ATP7A)	directlyIncreases	act(p(HGNC:MAPT))
d98b2e49-d045-4775-87f0-2cc7b8b3196c	0.86	PubMed	9133274	Therefore, the annonacin induced ATP depletion causes the retrograde transport of mitochondria to the cell soma and induces changes in the intracellular distribution of tau in a way that shares characteristics with some neurodegenerative diseases.	a(CHEBI:15422)	directlyIncreases	act(p(HGNC:MAPT))
d98b2e49-d045-4775-87f0-2cc7b8b3196c	0.86	PubMed	18918862	Tau protein was detected in purified exosomes from microglia treated with LPS and ATP but not in purified exosomes from neurons or astrocytes similarly treated (XREF_FIG), confirming the presence of tau protein in exosomes from microglia.	a(CHEBI:15422)	directlyIncreases	act(p(HGNC:MAPT))
10283808-f039-4bdc-8f97-a2ffaf4aac1d	0.86	PubMed	865009	At 0.5 mM, AlCl3 stimulated Tau release to about 170% of basal levels, but did not affect the release of the other compounds.	a(PUBCHEM:24012)	directlyIncreases	act(p(HGNC:MAPT))
10283808-f039-4bdc-8f97-a2ffaf4aac1d	0.86	PubMed	3230743	AlCl3 had no effect on normal adult human CNS tau, while increasing concentrations of AlCl3 (from 0.1 to 1.0 mM) induced PHF tau to aggregate at the top of the stacking gel, and at high concentrations (0.3 and 1.0 mM) of AlCl3, PHF tau completely failed to enter the gel.	a(PUBCHEM:24012)	directlyIncreases	act(p(HGNC:MAPT))
2025cdd5-a4d2-484d-958a-76c7e236a95f	0.65	PubMed	20229411	Furthermore, Al accelerates the aggregation of hyper-phosphorylated Tau protein by inhibiting protein phosphatase 2A activity.	a(PUBCHEM:104727)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
6d55b1d9-caad-4573-88b6-ba9d5bc7c8c3	0.65	PubMed	3284905	Alkaline phosphatase treatment increased the E-2 immunoreactivity of PHF-tau by 120% and normal tau by 38%, but it had no effect on E-3 immunoreactivity.	p(PFAM:PF00245)	directlyIncreases	act(p(HGNC:MAPT))
f46894d0-846b-4d51-9998-8ec5a5f8d4d0	0.65	PubMed	15638326	Aluminum causes the accumulation of tau protein and Abeta protein in the brain of experimental animals.	a(PUBCHEM:104727)	directlyIncreases	act(p(HGNC:MAPT))
24f8ff96-2709-49fe-ae26-db062043e44c	0.86	PubMed	6290214	Ammonia stimulated Tau accumulation in the microdialysates to approximately 250% of the basal value.	a(PUBCHEM:222)	directlyIncreases	act(p(HGNC:MAPT))
24f8ff96-2709-49fe-ae26-db062043e44c	0.86	PubMed	6337085	Ammonia strongly, and HE moderately, increased Tau efflux at 5 mM K+.	a(PUBCHEM:222)	directlyIncreases	act(p(HGNC:MAPT))
16068fb9-fc66-4940-847f-7f22769100d9	0.65	PubMed	3685382	Ammonium chloride stimulated TAU release in a dose dependent manner, a significant stimulation being already observed at 0.5 mM, a concentration that is frequently measured in brain during acute hyperammonemia.	a(PUBCHEM:25517)	directlyIncreases	act(p(HGNC:MAPT))
66b39fca-16a8-418a-ad6c-d52e7ed732d1	0.65	PubMed	16803091	Arachidonic acid, a free fatty acid triggers neurotoxicity through several mechanisms -- by inducing apoptosis, generating oxidative stress, and promoting Tau polymerization.	a(PUBCHEM:444899)	directlyIncreases	act(p(HGNC:MAPT))
473dfc85-c692-42ea-8db6-896dd7d377f1	0.95	PubMed	20678074	BAG-1 has been shown to inhibit degradation of tau by the 20S proteasome without affecting the ubiquitination of tau [XREF_BIBR].	p(HGNC:BAG1)	directlyIncreases	act(p(HGNC:MAPT))
473dfc85-c692-42ea-8db6-896dd7d377f1	0.95	PubMed	9292436	We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.	p(HGNC:BAG1)	directlyIncreases	act(p(HGNC:MAPT))
473dfc85-c692-42ea-8db6-896dd7d377f1	0.95	PubMed	17954934	We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.	p(HGNC:BAG1)	directlyIncreases	act(p(HGNC:MAPT))
473dfc85-c692-42ea-8db6-896dd7d377f1	0.95	PubMed	18585594	In contrast to its role in ubiquitination, Bag-1 also has been shown to inhibit proteosomal degradation of Tau protein, possibly due to enhancement of refolding activity of Hsc70 [XREF_BIBR].	p(HGNC:BAG1)	directlyIncreases	act(p(HGNC:MAPT))
473dfc85-c692-42ea-8db6-896dd7d377f1	0.95	PubMed	18752794	BAG-1 has been shown to inhibit degradation of tau by the 20S proteasome without affecting the ubiquitination of tau [XREF_BIBR].	p(HGNC:BAG1)	directlyIncreases	act(p(HGNC:MAPT))
473dfc85-c692-42ea-8db6-896dd7d377f1	0.95	PubMed	19317853	We have previously shown that the co-chaperone protein BAG-1 can inhibit the degradation of tau by forming a complex with Hsc-70 and tau.	p(HGNC:BAG1)	directlyIncreases	act(p(HGNC:MAPT))
473dfc85-c692-42ea-8db6-896dd7d377f1	0.95	PubMed	10246566	We have previously shown that the co-chaperone protein BAG-1 can inhibit the degradation of tau by forming a complex with Hsc-70 and tau.	p(HGNC:BAG1)	directlyIncreases	act(p(HGNC:MAPT))
10c4a3cc-877b-4264-b05a-3f36e19c10f5	0.65	PubMed	15428505	Transfection of the PUMA gene significantly enhanced the ability of Tau to inhibit proliferation and induce apoptosis of HepG2 cells.	p(HGNC:BBC3)	directlyIncreases	act(p(HGNC:MAPT))
e54fc773-c35b-4b5c-b261-b10bda0306ec	0.86	PubMed	18045303	Although BDNF increased tau act, other kinetic parameters of peak K + current remained unchanged, indicating that the main action of BDNF on suppressing I A are likely through reducing the total expression of Kv4.3, which correlates well with our previous results demonstrating reductions in Kv4.3 expression following Ang II treatment.	p(HGNC:BDNF)	directlyIncreases	act(p(HGNC:MAPT))
e54fc773-c35b-4b5c-b261-b10bda0306ec	0.86	PubMed	17568351	Since BDNF and tau protein are critical factors both engaged in neuronal physiology activity and the development of neurodegenerative disease XREF_BIBR, XREF_BIBR, the meaning of tau protein up-regulation by BDNF should be carefully interpreted.	p(HGNC:BDNF)	directlyIncreases	act(p(HGNC:MAPT))
2ed1a610-a93a-424a-bfd1-0ea0ba7a6537	0.65	PubMed	17636754	Here, we also show that p60TRP, which interacts with PP2A [XREF_BIBR], induces enhanced cleavage of the phosphorylated Mapt protein and increases PP2A activity, consistent with previous reports demonstrating an association between PP2A and Jnk activity in tauopathy [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:BHLHB9)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
4ec9b2e4-9c63-4856-9a46-1e283b2deb5c	0.94	PubMed	13170905	We propose that BIN1 mediates AD risk by modulating Tau pathology.	p(HGNC:BIN1)	directlyIncreases	act(p(HGNC:MAPT))
4ec9b2e4-9c63-4856-9a46-1e283b2deb5c	0.94	PubMed	23399914	We propose that BIN1 mediates AD risk by modulating Tau pathology.	p(HGNC:BIN1)	directlyIncreases	act(p(HGNC:MAPT))
4ec9b2e4-9c63-4856-9a46-1e283b2deb5c	0.94	PubMed	23399914	Taken together, these observations suggest that increased BIN1 expression might modulate Tau pathology in pre-pathological stages.	p(HGNC:BIN1)	directlyIncreases	act(p(HGNC:MAPT))
4ec9b2e4-9c63-4856-9a46-1e283b2deb5c	0.94	PubMed	16851220	We were also able to show that BIN1 and Tau were directly interacting together in vitro and that human Tau toxicity observed in Drosophila melanogaster was partly suppressed by the silencing of the Drosophila BIN1 ortholog [XREF_BIBR].	p(HGNC:BIN1)	directlyIncreases	act(p(HGNC:MAPT))
dfe85d61-18c7-428a-89bf-d0196a8822ce	0.65	PubMed	18650538	However, the reduced fibrosis and LV hypertrophy and preservation of tau in the post-MI hearts of rats treated with C16 raises the question of whether under some conditions ACE2 might adversely affect the heart.	a(PUBCHEM:985)	directlyIncreases	act(p(HGNC:MAPT))
29e86e85-728d-47b7-9c2e-14357eb40c3b	0.92	PubMed	17765006	These qualitative results suggest that CRF induces tau-P in vivo, which accumulates in dendrites and axons, and may cause blockages that are consistent with impaired axon transport.	p(HGNC:C1QL1)	directlyIncreases	act(p(HGNC:MAPT))
29e86e85-728d-47b7-9c2e-14357eb40c3b	0.92	PubMed	17765006	We find that CRF treatment induces tau-P in a manner similar to that reported with stress models in vivo, and demonstrate that the axon transport deficits observed in our model involves CREB phosphorylation and is reliant on tau-P via GSK activation.	p(HGNC:C1QL1)	directlyIncreases	act(p(HGNC:MAPT))
29e86e85-728d-47b7-9c2e-14357eb40c3b	0.92	PubMed	17765006	To probe the functional relevance of CRF induced tau-P, we monitored changes in axon transport of two critical processes, energetics (i.e. mitochondria) and a major neuronal growth factor, BDNF, as a function of CRF treatment.	p(HGNC:C1QL1)	directlyIncreases	act(p(HGNC:MAPT))
3e6e688f-4658-40ce-94c5-1cce8ebb68c8	0.65	PubMed	18439393	These results are indeed in agreement with other experiments showing that activated CaMKII preferentially targets Ser262 of Tau [XREF_BIBR].	p(FPLX:"CAMK2_complex")	directlyIncreases	act(p(HGNC:MAPT))
9da2c937-a7e6-474e-9dbd-5da77a972171	0.65	PubMed	22025902	These findings suggest that enhanced cAMP could mediate the clearance of tau by the UPS [XREF_BIBR].	a(CHEBI:17489)	directlyIncreases	act(p(HGNC:MAPT))
0b1c1484-0d11-4da1-81af-f00bb3d0e4b3	0.98	PubMed	21232757	</sb:maintitle> </sb:title> <sb:volume-nr> 163 </sb:volume-nr> </sb:series> <sb:date> 1989 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 1505 </sb:first-page> <sb:last-page> 1511 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB65"> <ce:label> 65 </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> J. </ce:given-name> <ce:surname> Litersky </ce:surname> </sb:author> <sb:author> <ce:given-name> G. </ce:given-name> <ce:surname> Johnson </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> Phosphorylation by cAMP dependent protein kinase inhibits the degradation of tau by calpain </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> J. Biol.	p(FPLX:CAPN)	directlyIncreases	act(p(HGNC:MAPT))
0b1c1484-0d11-4da1-81af-f00bb3d0e4b3	0.98	PubMed	20181173	In neurons, IU1 surprisingly triggered calpain mediated Tau cleavage, but failed to enhance proteasomal degradation of Tau [XREF_BIBR].	p(FPLX:CAPN)	directlyIncreases	act(p(HGNC:MAPT))
0b1c1484-0d11-4da1-81af-f00bb3d0e4b3	0.98	PubMed	16828627	This calpain inhibitor is highly effective in preventing calpain mediated cleavage of dynamin 1 and tau in cultured hippocampal neurons.	p(FPLX:CAPN)	directlyIncreases	act(p(HGNC:MAPT))
0b1c1484-0d11-4da1-81af-f00bb3d0e4b3	0.98	PubMed	7824677	At 48 h after insult, CSF levels of 14-3-3beta, 14-3-3zeta, and calpain cleavage products of alpha-spectrin and tau were quantified.	p(FPLX:CAPN)	directlyIncreases	act(p(HGNC:MAPT))
0b1c1484-0d11-4da1-81af-f00bb3d0e4b3	0.98	PubMed	17252861	To determine whether calpain promotes tau toxicity by cleaving tau directly, we made specific mutations to alter the putative calpain cleavage sites on tau that are predicted to produce the toxic 17 kD fragment.	p(FPLX:CAPN)	directlyIncreases	act(p(HGNC:MAPT))
0b1c1484-0d11-4da1-81af-f00bb3d0e4b3	0.98	PubMed	17252861	Given that tau toxicity is suppressed under conditions where calpain levels are genetically reduced, we are currently making calpain over-expressing transgenic lines to test whether elevated levels of calpain enhance tau toxicity.	p(FPLX:CAPN)	directlyIncreases	act(p(HGNC:MAPT))
0b1c1484-0d11-4da1-81af-f00bb3d0e4b3	0.98	PubMed	16846010	Abeta treatment of cultured neurons leads to calpain activation and production of Tau 45-230, suggesting that this tau fragment is generated by the action of calpain [XREF_BIBR].	p(FPLX:CAPN)	directlyIncreases	act(p(HGNC:MAPT))
0b1c1484-0d11-4da1-81af-f00bb3d0e4b3	0.98	Other	sparser:Unknown	Aβ treatment of cultured neurons leads to calpain activation and production of Tau 45–230 , suggesting that this tau fragment is generated by the action of calpain [ xref ].	p(FPLX:CAPN)	directlyIncreases	act(p(HGNC:MAPT))
0b1c1484-0d11-4da1-81af-f00bb3d0e4b3	0.98	PubMed	11363471	Recently a " 17 kD " calpain induced Tau fragment, comprising residues 45-230 (molecular weight [MW], 18.7 kD), was proposed to mediate Abeta induced toxicity.	p(FPLX:CAPN)	directlyIncreases	act(p(HGNC:MAPT))
0202f87b-0b63-4f42-8062-192935f06434	0.65	PubMed	17051380	Calpain activation promoted the cleavage of the microtubule associated protein tau, leading to its accumulation [XREF_BIBR].	p(IP:IPR022684)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	5785840	Taken together, these results suggest that the caspase-3 cleavage product of Tau may contribute to the progression of neuronal cell death in Alzheimer 's disease.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	11445954	As expected, induction of caspase-3 activation and cleavage of tau protein at its specific site (aspartic acid 421) was observed by Western blot and immunofluorescence analyses in mice neuronal primary cultures infected with HSV-1.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	Other	sparser:Unknown	As expected, induction of caspase-3 activation and cleavage of tau protein at its specific site (aspartic acid 421) was observed by Western blot and immunofluorescence analyses in mice neuronal primary cultures infected with HSV-1.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	11445954	Therefore, the aim of the present study was to evaluate at the cellular level if another event associated with neurodegeneration, such as caspase-3 induced cleavage of tau, could also be triggered by HSV-1 infection in primary neuronal and astrocyte cultures.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	17713250	In cells, hyperphosphorylation of tau at several residues and cleavage of tau at D421, the preferential cleavage site of caspase-3, enhanced the secretion of tau.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	16163038	Tau proteolysis was completely prevented by caspase-3 inhibition but unaffected by neither the proteasome system nor mu-calpain activity blockade.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	Other	sparser:Unknown	In IGF-1 pretreatment group, the cell morphology was improved, the viability of cells was increased, and caspase-3 activation and hyperphosphorylation of tau (Ser396) were reduced.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	18869506	Caspase-3 activity was also significantly increased (42%) 2 weeks post-injection with lentiviral Abeta 1-42 (XREF_FIG) in the absence of p-Tau, but an 8-fold increase was detected at 4 weeks, when both Abeta 1-42 and p-Tau were detected.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	21098975	Therefore, the aim of the present study was to evaluate at the cellular level if another event associated with neurodegeneration, such as caspase-3 induced cleavage of tau, could also be triggered by HSV-1 infection in primary neuronal and astrocyte cultures.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	21098975	As expected, induction of caspase-3 activation and cleavage of tau protein at its specific site (aspartic acid 421) was observed by Western blot and immunofluorescence analyses in mice neuronal primary cultures infected with HSV-1.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	20152248	Furthermore, caspase-3 cleavage at D421 increases tau release.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
7719d85d-38cc-42c5-93ca-9bcffea86580	0.99	PubMed	11162250	Taken together, these results suggest that the caspase-3 cleavage product of Tau may contribute to the progression of neuronal cell death in Alzheimer 's disease.	p(HGNC:CASP3)	directlyIncreases	act(p(HGNC:MAPT))
c5e41756-b267-4456-9752-8cae6481a929	0.65	PubMed	19572014	Abeta * CaSR signalling in NAHAs also drives exosomal release of toxic hyper-phosphorylated Tau proteins, nitric oxide, and VEGF-A.	p(HGNC:CASR)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
1f342597-a431-40ee-ae5d-faec44d542a4	0.65	PubMed	2634231	Cat increased plasma Tau and Orn.	p(HGNC:CAT)	directlyIncreases	act(p(HGNC:MAPT))
d972711e-108c-4b21-be7e-4b26ce662bcf	0.65	PubMed	14470397	Accordingly, double tg mice expressing mutant Tau under the mThy-1 promoter and GSK3beta (to enhance Tau phosphorylation) were treated with CBL and evaluated neuropathologically.	p(HGNC:CBL)	directlyIncreases	act(p(HGNC:MAPT))
1e22258e-2656-43cb-a6a6-02be4d8c56f4	0.65	PubMed	21980472	Thus, CCI increased tau immunoreactivity in a multifocal fashion in the brains of 3xTg-AD mice.	p(UP:P32954)	directlyIncreases	act(p(HGNC:MAPT))
d190a6db-71aa-4d8b-a882-e9f3ea935dfa	0.65	PubMed	17769158	After administration of CCl 4, the levels of FFA in rats given separate treatments of TAU or SIL were the same as those treated with CCl 4 alone, while FFA levels were restored to almost normal values when rats were given TAU+SIL.	a(PUBCHEM:51039)	directlyIncreases	act(p(HGNC:MAPT))
04829459-41fd-4942-a989-bc5d4aec0840	0.92	PubMed	17568129	PICALM was found to co-localize and immunoprecipitate with hyperphosphorylated and misfolded Tau from brains of AD patients XREF_BIBR, while CD2AP was found to modulate Tau toxicity in Drosophila XREF_BIBR.	p(HGNC:CD2AP)	directlyIncreases	act(p(HGNC:MAPT))
04829459-41fd-4942-a989-bc5d4aec0840	0.92	PubMed	20200537	In addition, RNA interference mediated disruption of cindr, the fly ortholog of CD2AP, enhances Tau toxicity in Drosophila.	p(HGNC:CD2AP)	directlyIncreases	act(p(HGNC:MAPT))
04829459-41fd-4942-a989-bc5d4aec0840	0.92	PubMed	25051234	PICALM was found to co-localize and immunoprecipitate with hyperphosphorylated and misfolded Tau from brains of AD patients XREF_BIBR, while CD2AP was found to modulate Tau toxicity in Drosophila XREF_BIBR.	p(HGNC:CD2AP)	directlyIncreases	act(p(HGNC:MAPT))
032038e9-5313-40f2-9537-e4394e82159d	0.65	PubMed	21085742	In addition, the presence of active cdc2 in the neuronal cytoplasm leads to phosphorylation of high affinity substrates that are unique or abundant in differentiated neurons, i.e. adult isoforms of tau.	p(HGNC:CDK1)	directlyIncreases	act(p(HGNC:MAPT))
060068a0-b28d-42d2-8df4-5831bcc610df	0.95	Other	sparser:Unknown	In this particular study [ xref ], elevated c-Abl activity correlated with downstream Cdk5 activation and phosphorylation of tau at PHF1/AT8, although other studies have revealed that c-Abl, as well as the Abl-related gene (Arg) tyrosine kinase, can phosphorylate tau directly at Tyr 394 [ xref , xref ].	p(HGNC:CDK5)	directlyIncreases	act(p(HGNC:MAPT))
060068a0-b28d-42d2-8df4-5831bcc610df	0.95	PubMed	14674976	In short-term animals, CDK5 knockdown showed reduction of CDK5, reversed Tau aggregation, and improved spatial memory compared to scrambled treated old 3xTg-AD mice.	p(HGNC:CDK5)	directlyIncreases	act(p(HGNC:MAPT))
060068a0-b28d-42d2-8df4-5831bcc610df	0.95	PubMed	17586722	In short-term animals, CDK5 knockdown showed reduction of CDK5, reversed Tau aggregation, and improved spatial memory compared to scrambled treated old 3xTg-AD mice.	p(HGNC:CDK5)	directlyIncreases	act(p(HGNC:MAPT))
b46c94e1-43d0-475f-a129-7ad1491b2c27	0.65	PubMed	20200537	Like FERMT2, RNA interference mediated disruption of aret, the fly ortholog of CELF1, enhances Tau toxicity in a Drosophila model of AD.	p(HGNC:CELF1)	directlyIncreases	act(p(HGNC:MAPT))
1ebb893e-8dc9-4e95-bd1a-41a0de828258	0.86	PubMed	24440524	The involvement of these two families in the mis splicing of Tau is supported by the fact that both CELF2 overexpression and MBNL1 silencing enhance the skipping of Tau exon 2, similar to that observed in the DM1 brain, although the precise mechanisms underlying this reciprocal regulation by MBNL and CELF family members, and in particular, how MBNL1 and MBNL2 precisely contribute to human Tau exon 2 splicing regulation is poorly understood.	p(HGNC:CELF2)	directlyIncreases	act(p(HGNC:MAPT))
1ebb893e-8dc9-4e95-bd1a-41a0de828258	0.86	PubMed	8551318	By using cellular models with a control- or DM1 like splicing pattern of Tau transcripts, we demonstrate that ETR-3 promotes selectively the exclusion of Tau exon 2.	p(HGNC:CELF2)	directlyIncreases	act(p(HGNC:MAPT))
f1072f41-2cbf-4b91-a389-a7aa304f81b6	0.65	PubMed	21439371	Moreover, CELF3 and CELF4 splicing factors promote the inclusion of Tau exon 10.	p(HGNC:CELF3)	directlyIncreases	act(p(HGNC:MAPT))
569a0c89-de42-43f6-8704-2ceea721b563	0.92	PubMed	21439371	CELF4 promotes Tau exon 2 splicing whereas CELF2 represses it.	p(HGNC:CELF4)	directlyIncreases	act(p(HGNC:MAPT))
569a0c89-de42-43f6-8704-2ceea721b563	0.92	PubMed	21439371	CELF4 has also been shown to promote Tau exon 10 inclusion but the potential regulation of Tau exon 10 splicing by CELF2 remains unexplored.	p(HGNC:CELF4)	directlyIncreases	act(p(HGNC:MAPT))
569a0c89-de42-43f6-8704-2ceea721b563	0.92	PubMed	21439371	In this paper, we used HeLa and T98 cells, in which the endogenous expression of CELF4 and CELF2 is lacking, to show that the ectopic expression of CELF4 promotes Tau exon 10 inclusion whereas CELF2 represses it.	p(HGNC:CELF4)	directlyIncreases	act(p(HGNC:MAPT))
47543b11-4ca9-4abb-80dd-986c9385d470	0.65	PubMed	18509022	Second, Cep164 triggers axoneme extension by recruiting Tau tubulin kinase 2 (Ttbk2).	p(HGNC:CEP164)	directlyIncreases	act(p(HGNC:MAPT))
30d82f5b-6dc2-4815-b87f-dbc32262369f	0.65	PubMed	18821413	Immunohistochemical index of phospho-tau (AT8) showed that there was a subtle deposition of AT8-IR in the hippocampal neuronal processes in the brains of non diabetic SAMP8 mice (XREF_FIG, inlet, arrowhead), which was found to increase in the hippocampal neuronal processes of diabetic SAMP8 mice (XREF_FIG, inlet, arrowheads) suggesting that HF induced T2DM in SAMP8 mice promoted increased deposition of phospho-tau, a trend toward Alzheimer like changes.	p(HGNC:CFH)	directlyIncreases	act(p(HGNC:MAPT))
af78100a-916c-4463-b8ab-47bf5775fb67	0.65	PubMed	18780705	To circumvent these problems, we have developed a transgenic mouse model, expressing a tau-EGFP fusion protein driven by the ChAT promoter.	p(HGNC:CHAT)	directlyIncreases	act(p(HGNC:MAPT))
8ffe3646-c413-4eae-927e-941ced00f302	0.65	PubMed	18989761	Therefore, to obtain the intensity of peaks from ChoCC, the intensity of another CH 2 triplet signal of Tau (3.39 - 3.47 ppm) was subtracted from the total intensity of all peaks in the chemical shift region of 3.16 - 3.31 ppm.	p(PFAM:PF00307)	directlyIncreases	act(p(HGNC:MAPT))
8b146ca1-f208-4479-8848-89beb57e75ca	0.65	PubMed	22072916	Smaller studies also found differing levels of brain activation by COMT Val158Met and the MAPT H1/H2 haplotype [XREF_BIBR, XREF_BIBR], though it is unclear whether these can be attributed to sample size issues or differences in disease duration or stages at time of imaging which might have influenced these results.	p(HGNC:COMT, var(p.Val158Met))	directlyIncreases	act(p(HGNC:MAPT))
fd9a3cb7-80f1-4fac-8eeb-6f2204f18386	0.95	PubMed	18357710	Exosomes in CSF from AD patients and control subjects contain Tau and can induce Tau aggregation in cultured N2a cells.	p(HGNC:CSF2)	directlyIncreases	act(p(HGNC:MAPT))
fd9a3cb7-80f1-4fac-8eeb-6f2204f18386	0.95	PubMed	16894195	However, his CSF showed reduced Abeta42 and increased p-tau, strongly suggestive of Alzheimer 's disease.	p(HGNC:CSF2)	directlyIncreases	act(p(HGNC:MAPT))
fd9a3cb7-80f1-4fac-8eeb-6f2204f18386	0.95	PubMed	21994154	CSF QUIN is thus elevated during HIV infection despite antiretroviral therapy and could indirectly contribute to impaired PM by influencing the formation of pTau.	p(HGNC:CSF2)	directlyIncreases	act(p(HGNC:MAPT))
fd9a3cb7-80f1-4fac-8eeb-6f2204f18386	0.95	PubMed	17711239	The typical CSF pattern of AD consists of decreased levels of Abeta 42 and increased values of t-tau or p-tau.	p(HGNC:CSF2)	directlyIncreases	act(p(HGNC:MAPT))
fd9a3cb7-80f1-4fac-8eeb-6f2204f18386	0.95	PubMed	19099842	Experimental, neuropathological and cerebrospinal fluid (CSF) studies support tau and amyloid-beta (Abeta) relevance in Parkinson 's disease (PD) related dementia.	p(HGNC:CSF2)	directlyIncreases	act(p(HGNC:MAPT))
062fb70f-84ff-4c11-b59e-635572fffafd	0.65	PubMed	8274504	RVA pacing reduced dP/dt (max) (-0.8 +/- 8.4%) and prolonged Tau (7.0 +/- 5.6%); RVS pacing enhanced dP/dt (max) (20.7 +/- 15.3%) and shortened Tau (-10.4 +/- 9%); RVOT pacing reduced dP/dt (max) (-8.0 +/- 20.0%) and shortened Tau (-6.0 +/- 12.2%); CS pacing reduced dP/dt (max) (-11.7 +/- 13.0%) and prolonged Tau (10.5 +/- 11.9%).	p(HGNC:CS)	directlyIncreases	act(p(HGNC:MAPT))
ee3a9386-ac01-4588-af17-822d33bba26b	0.92	PubMed	13141114	Previous findings suggest that microglial activation via CX3CL1 promotes p-Tau.	p(HGNC:CX3CL1)	directlyIncreases	act(p(HGNC:MAPT))
ee3a9386-ac01-4588-af17-822d33bba26b	0.92	PubMed	18869506	Previous findings suggest that microglial activation via CX3CL1 promotes p-Tau.	p(HGNC:CX3CL1)	directlyIncreases	act(p(HGNC:MAPT))
ee3a9386-ac01-4588-af17-822d33bba26b	0.92	PubMed	18869506	CX3CL1 signaling and detection of p-Tau.	p(HGNC:CX3CL1)	directlyIncreases	act(p(HGNC:MAPT))
22f8d538-42cb-44a2-b20d-577d10e425bf	0.92	PubMed	15768123	The ablation of the CX3CR1 gene in mice overexpressing human amyloid precursor protein (APP/PS-1) increased cytokine levels, enhanced Tau pathology and worsened behavioural performance in these mice.	p(HGNC:CX3CR1)	directlyIncreases	act(p(HGNC:MAPT))
22f8d538-42cb-44a2-b20d-577d10e425bf	0.92	PubMed	26567742	The ablation of the CX3CR1 gene in mice overexpressing human amyloid precursor protein (APP/PS-1) increased cytokine levels, enhanced Tau pathology and worsened behavioural performance in these mice.	p(HGNC:CX3CR1)	directlyIncreases	act(p(HGNC:MAPT))
22f8d538-42cb-44a2-b20d-577d10e425bf	0.92	PubMed	18640938	Co-cultures of neurons with wild-type microglia significantly induced MAPT phosphorylation at the AT8 site compared to neurons alone, while co-culture of CX3CR1 deficient microglia with neurons further increased the levels of AT8 MAPT epitopes (XREF_FIG).	p(HGNC:CX3CR1)	directlyIncreases	act(p(HGNC:MAPT))
87779e45-e703-4251-b503-3e7ea0cd5378	0.86	PubMed	15552162	The cleaved tau formed varicosities or bead like structures along the neurites, an abnormal distribution of tau induced by CXCL1 that has not been observed previously.	p(HGNC:CXCL1)	directlyIncreases	act(p(HGNC:MAPT))
87779e45-e703-4251-b503-3e7ea0cd5378	0.86	PubMed	15552162	In the present study, we demonstrate that CXCL1 (C-X-C motif ligand 1), a specific ligand for the chemokine receptor CXCR2, induced cleavage of tau at ASP421 in a caspase-3-dependent manner in long-term but not short-term cultured neurons.	p(HGNC:CXCL1)	directlyIncreases	act(p(HGNC:MAPT))
3280519a-bb96-48a5-889a-938e55c1d695	0.86	PubMed	21339331	(e) Chelation of Ca 2+ ions by treatment with BAPTA/AM, which is known to remove annexin from the plasma membrane, increases the mobility of tau in the tip of neurites.	a(CHEBI:29108)	directlyIncreases	act(p(HGNC:MAPT))
3280519a-bb96-48a5-889a-938e55c1d695	0.86	PubMed	17639102	(e) Chelation of Ca 2+ ions by treatment with BAPTA/AM, which is known to remove annexin from the plasma membrane, increases the mobility of tau in the tip of neurites.	a(CHEBI:29108)	directlyIncreases	act(p(HGNC:MAPT))
9212322a-72f6-4bc9-96f2-e539dda0c54d	0.86	PubMed	17628876	It was shown that Cd (II) accelerates heparin induced aggregation of the third repeated (R3) of Tau.	a(CHEBI:22977)	directlyIncreases	act(p(HGNC:MAPT))
9212322a-72f6-4bc9-96f2-e539dda0c54d	0.86	PubMed	20229411	Additionally, Cd could promote the conformational change and self aggregation of tau protein by binding to the third repeat of its microtubule binding domain.	a(CHEBI:22977)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	Furthermore, Congo red has been used to induce abnormal aggregation of human Tau protein in both HEK-293 cells and SH-SY5Y neuroblastoma cells.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	The ultraviolet absorbance spectra of such Tau aggregation induced by Congo red were set up by a mixture of 5muM Tau protein and 50muM Congo red in 10mM HEPES buffer.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	Based on absorbance at 550nm which is representing the amounts of Tau fibrils, we can quantitatively characterize Tau fibrillization induced by Congo red.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	S1A and B displays amyloid fibril formation of Tau and DeltaPHF6 induced by Congo red at 0 and 12h, respectively, and Fig.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	Our Congo red binding data indicate that fibril forming motifs are essential and sufficient for the fibrillization of human Tau induced by Congo red.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	The above data once again demonstrate that fibril forming motifs are essential and sufficient for the fibrillization of human Tau induced by Congo red.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	To further prove Congo red induced Tau aggregation, TEM was employed to study the morphology of Tau incubated with Congo red.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	However, the possibility that changes in structures and/or solubility of Tau result in such distinct kinetics and morphologies can not be excluded.We concluded from the results of TEM and Congo red binding assay that human Tau aggregation induced by Congo red is sequence dependent.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	Then, we applied Western blot to confirm Congo red induced Tau aggregation in Tau over-expressed SH-SY5Y cells.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
a7ef4492-0c54-4192-b9ba-34c994fbe161	0.95	PubMed	25912737	We firstly studied the effect of Congo red on fibril formation of human Tau fragments, and found that human Tau aggregation induced by Congo red is sequence dependent.	a(PUBCHEM:11313)	directlyIncreases	act(p(HGNC:MAPT))
90bb4684-a6bf-4638-bac2-a3a4fdbaf403	0.65	PubMed	4977246	Cycasin and endogenous glutamate may together promote the accumulation of tau protein and neuronal degeneration in Western Pacific ALS and PDC.	a(PUBCHEM:6321404)	directlyIncreases	act(p(HGNC:MAPT))
1d0f5a5a-d83b-4ff6-884b-fcf04851449e	0.65	PubMed	20181324	Nonetheless, in neocortex of AD subjects Cyclin G1 levels are increased in pyramidal neurons lacking Tau aggregates and are undetectable in those pyramidal neurons containing aggregated phospho-Tau.	p(FPLX:Cyclin)	directlyIncreases	act(p(HGNC:MAPT))
45050294-689d-43da-836c-893a150f4dab	0.86	PubMed	17399781	Cycloheximide Treatment Causes a ZVAD Sensitive Protease Dependent Cleavage of Human Tau in Drosophila Cells.	a(PUBCHEM:6197)	directlyIncreases	act(p(HGNC:MAPT))
45050294-689d-43da-836c-893a150f4dab	0.86	PubMed	17399781	Cycloheximide treatment causes truncation of human tau (htau) at C-terminus.	a(PUBCHEM:6197)	directlyIncreases	act(p(HGNC:MAPT))
f23d2dc0-9a9b-4ed7-a301-21b641008299	0.65	PubMed	24853415	Moreover, DAPK1 K42A, a kinase deficient DAPK1 mutant, could not enhance tau protein stability, suggesting that DAPK1 kinase activity is critical for tau protein stability.	p(HGNC:DAPK1, var(p.Lys42Ala))	directlyIncreases	act(p(HGNC:MAPT))
0f5070d6-3fed-4ee8-95eb-f798b95f35ba	0.65	PubMed	17450428	While DAPT treatment somewhat increased the number of Tuj1+ neurons in cultures after overnight treatment (XREF_FIG and XREF_SUPPLEMENTARY) and significantly increased the number of Tau-GFP (a marker of neurons) cells after 48 hours, Y27632 had no effect on the number of Tau+ neurons (XREF_FIG and XREF_SUPPLEMENTARY).	a(PUBCHEM:5311272)	directlyIncreases	act(p(HGNC:MAPT))
02786bd4-7fe4-4595-a650-566b2b1262e7	0.65	PubMed	19620988	Because loss of activity upstream of DDC could reduce suppression of tau by DDC, this suggests the possibility that loss of DDC suppresses tau via the combined accumulation of dopamine precursor levodopa and serotonin precursor 5-hydroxytryptophan.	p(HGNC:DDC)	directlyIncreases	act(p(HGNC:MAPT))
041c2b6a-43fb-4c77-83e8-f96884cf39c4	0.65	PubMed	18628617	Tau pathology, the other neuropathological hallmark of AD, is also increased by DIO in a number of strains of transgenic mice.	a(PUBCHEM:5706734)	directlyIncreases	act(p(HGNC:MAPT))
3351de36-4e34-43db-98d0-ef91a5e8a983	0.86	PubMed	21157558	The increase in extracellular TAU produced by NIP may be due to the release of GABA.	p(HGNC:DUOXA1)	directlyIncreases	act(p(HGNC:MAPT))
3351de36-4e34-43db-98d0-ef91a5e8a983	0.86	PubMed	21157558	</ce:para> <ce:para view="all"> NIP, which in this study has been shown to increase extracellular GABA, also increases extracellular TAU but not the other amino acids such as GLU, GLN and ARG.	p(HGNC:DUOXA1)	directlyIncreases	act(p(HGNC:MAPT))
f0ed8594-4792-4aea-bee5-09e8fd2c8714	0.95	PubMed	17267326	Coexpression of mnb enhanced Tau toxicity and resulted in a more severe phenotype with smaller eyes (GMR> mnb+ Tau in XREF_FIG A and B).	p(HGNC:DYRK1A)	directlyIncreases	act(p(HGNC:MAPT))
f0ed8594-4792-4aea-bee5-09e8fd2c8714	0.95	PubMed	11513682	Dyrk1A itself promoted tau E10 inclusion, whereas 9G8 inhibited E10 inclusion, and these actions were variable depending on the cell types.	p(HGNC:DYRK1A)	directlyIncreases	act(p(HGNC:MAPT))
f0ed8594-4792-4aea-bee5-09e8fd2c8714	0.95	PubMed	21215488	Dyrk1A itself promoted tau E10 inclusion, whereas 9G8 inhibited E10 inclusion, and these actions were variable depending on the cell types.	p(HGNC:DYRK1A)	directlyIncreases	act(p(HGNC:MAPT))
f0ed8594-4792-4aea-bee5-09e8fd2c8714	0.95	PubMed	21215488	However, unlike in COS7 cells, overexpression of active Dyrk1A, but not dead Dyrk1A K188R, promoted tau E10 inclusion.	p(HGNC:DYRK1A)	directlyIncreases	act(p(HGNC:MAPT))
f0ed8594-4792-4aea-bee5-09e8fd2c8714	0.95	PubMed	21215488	Interestingly, we found that Dyrk1A itself, without being co-transfected with 9G8, promoted tau E10 inclusion, and this action was dependent on the kinase activity because no promotion of E10 inclusion was observed with the inactive Dyrk1A K188R.	p(HGNC:DYRK1A)	directlyIncreases	act(p(HGNC:MAPT))
f0ed8594-4792-4aea-bee5-09e8fd2c8714	0.95	PubMed	21215488	Dyrk1A promoted tau E10 inclusion, whereas 9G8 inhibited E10 inclusion, and these actions were variable, depending on the cell types.	p(HGNC:DYRK1A)	directlyIncreases	act(p(HGNC:MAPT))
f0ed8594-4792-4aea-bee5-09e8fd2c8714	0.95	PubMed	12730600	Up-regulation of Dyrk1A as in Down syndrome could lead to neurofibrillary degeneration by shifting the alternative splicing of Tau exon 10 to an increase in the ratio of 3R-tau/4R-tau.	p(HGNC:DYRK1A)	directlyIncreases	act(p(HGNC:MAPT))
f0ed8594-4792-4aea-bee5-09e8fd2c8714	0.95	PubMed	22767602	Up-regulation of Dyrk1A as in Down syndrome could lead to neurofibrillary degeneration by shifting the alternative splicing of Tau exon 10 to an increase in the ratio of 3R-tau/4R-tau.	p(HGNC:DYRK1A)	directlyIncreases	act(p(HGNC:MAPT))
1dfde3a4-e76f-4e6e-9c11-28c41556e80f	0.65	PubMed	15192686	These results suggest that Dbt suppresses expression of activated Dronc to prevent Tau cleavage, and that the circadian clock defects confer sensitivity to expression of activated Dronc in response to prolonged light.	p(UP:Q9XYF4)	directlyIncreases	act(p(HGNC:MAPT))
a63ef29d-8a45-4c20-9f0b-382adc4f0a13	0.65	PubMed	17458231	The tau and GFP reporter was driven by the transgenic E1 promoter, but E4-LI only detected variants expressing the exon 4 sequences.	a(PUBCHEM:5870)	directlyIncreases	act(p(HGNC:MAPT))
ca241801-cdce-4624-a44e-94cad821a9fd	0.65	PubMed	17801564	In medial basal hypothalamic neurons maintained for 4days in vitro (DIV), E2 increased the levels of the 58-kDa Tau isoform but it did not change that of tubulin; by 7 DIV, E2 also increased the content of MAP1 and MAP2.	p(UP:P27958)	directlyIncreases	act(p(HGNC:MAPT))
47280422-1891-48e2-b894-81ca5b5bcfe7	0.65	PubMed	18071024	Eluted tau was then treated with TCEP-HCl and EDTA, and incubated at room temperature (RT) for 1 hr.	a(PUBCHEM:6049)	directlyIncreases	act(p(HGNC:MAPT))
c26c4df6-bcf7-42db-a786-b6535267f857	0.65	PubMed	20927385	We therefore propose that inhibiting eIF4A will reduce the efficiency of APP and tau protein synthesis, but not that of housekeeping proteins.	p(FPLX:EIF4A)	directlyIncreases	act(p(HGNC:MAPT))
33b36a1b-60fa-4dfa-b19f-9ab7d912544b	0.65	PubMed	4823666	EM is therefore able to induce a very rapid change in the posttranslational state of tau.	a(PUBCHEM:6426949)	directlyIncreases	act(p(HGNC:MAPT))
21d1325c-75db-424c-8c2a-8672caa98f36	0.86	PubMed	20869593	In contrast, inhibition of p300 diminished ac-tau and effectively eliminated p-tau, suggesting that interfering with tau acetylation may be a new approach to reduce tauopathy.	p(HGNC:EP300)	directlyIncreases	act(p(HGNC:MAPT))
21d1325c-75db-424c-8c2a-8672caa98f36	0.86	PubMed	18785580	In contrast, inhibition of p300 diminished ac-tau and effectively eliminated p-tau, suggesting that interfering with tau acetylation may be a new approach to reduce tauopathy.	p(HGNC:EP300)	directlyIncreases	act(p(HGNC:MAPT))
b3015137-31c9-4132-a271-11d403c95cf3	0.86	PubMed	21340680	Treatment of either HEK293 or HEK and tau cells overnight (18 h) with PSI, a reversible inhibitor of the chymotrypsinlike activity of the proteasome (XREF_BIBR), causes tau protein to accumulate in a spherical peri-nuclear structure resembling an aggresome (XREF_FIG; XREF_BIBR).	p(HGNC:EPHA3)	directlyIncreases	act(p(HGNC:MAPT))
b3015137-31c9-4132-a271-11d403c95cf3	0.86	PubMed	18666524	Treatment of either HEK293 or HEK and tau cells overnight (18 h) with PSI, a reversible inhibitor of the chymotrypsinlike activity of the proteasome, causes tau protein to accumulate in a spherical peri-nuclear structure resembling an aggresome.	p(HGNC:EPHA3)	directlyIncreases	act(p(HGNC:MAPT))
48df23e7-1192-437e-ba65-34b40e1016ba	0.65	PubMed	18353326	Within an inpatient Veterans Administration hospital setting, 96 patients with a history of high recidivism and current and/or past diagnosis of substance use disorders were randomized to either : 1) treatment as usual (TAU), 2) TAU + DRT + mentorship for addiction problems to enhance engagement to treatment (MAP-engage), or 3) TAU + MAP-engage.	p(HGNC:EPHB2)	directlyIncreases	act(p(HGNC:MAPT))
3cb6dfd0-a086-409b-9b92-8a0b99e0ebcf	0.65	PubMed	18722412	Perhaps, laforin deficiency upregulates Tau protein kinase I/glycogen synthase kinase 3-beta forming Tau, amyloid and polyglucosan bodies.	p(HGNC:EPM2A)	directlyIncreases	act(p(HGNC:MAPT))
37d8c872-e048-4c1d-a97d-95047f418774	0.88	PubMed	21341502	</ce:simple-para> </ce:caption> <ce:link locator="gr9"/> </ce:figure> <ce:figure id="fig10"> <ce:label> Figure 10 </ce:label> <ce:caption> <ce:simple-para id="spara100" view="all"> Hypothetical scheme showing the effects of zinc induced p70 S6 kinase activation by PI3K and MAPK pathways on the accumulation of tau protein.	p(FPLX:ERK)	directlyIncreases	act(p(HGNC:MAPT))
37d8c872-e048-4c1d-a97d-95047f418774	0.88	Other	sparser:Unknown	Taken together, tau −/− mice lack ERK activation upon excitotoxic stimulation.	p(FPLX:ERK)	directlyIncreases	act(p(HGNC:MAPT))
159ed384-2d84-4e37-8b8c-940ca27ab421	0.95	PubMed	18548688	We next tested whether the cells that express Plcbeta4 in the early postnatal cerebellum maintain expression into the adult by double labeling the cerebellum of P2 Pcp2-CreER-IRES-hAP; Tau mGfp /+ mice treated with Tm at E14.5 for mGfp and Plcbeta4.	p(HGNC:"ERVK-18")	directlyIncreases	act(p(HGNC:MAPT))
159ed384-2d84-4e37-8b8c-940ca27ab421	0.95	PubMed	18548688	To confirm that only PCs were marked in Pcp2-CreER-IRES-hAP; Tau mGfp /+ embryos treated with Tm on E14.5, we double labeled tissue sections from E15.5 and E18.5 Cb with antibodies against RORalpha and mGfp.	p(HGNC:"ERVK-18")	directlyIncreases	act(p(HGNC:MAPT))
159ed384-2d84-4e37-8b8c-940ca27ab421	0.95	PubMed	18548688	Our fate mapping experiments demonstrate that at least for the PCs marked in Pcp2-CreER-IRES-hAP; Tau mGfp /+ embryos treated with Tm at E14.5, the embryonic M-L molecular code does indeed carry patterning information forth to the adult M-L molecular code.	p(HGNC:"ERVK-18")	directlyIncreases	act(p(HGNC:MAPT))
159ed384-2d84-4e37-8b8c-940ca27ab421	0.95	PubMed	18548688	To characterize PC axon-target invasion in vivo, we visualized mGfp+ PCs in Pcp2-CreER-IRES-hAP; Tau mGfp /+ embryos treated with Tm on E14.5 and hAP+ PC axons in Pcp2-CreER-IRES-hAP embryos as they projected into their target fields within the DCN and vestibular nuclei.	p(HGNC:"ERVK-18")	directlyIncreases	act(p(HGNC:MAPT))
159ed384-2d84-4e37-8b8c-940ca27ab421	0.95	PubMed	18548688	We followed the three pairs of marked PCs clusters in Pcp2-CreER-IRES-hAP; Tau mGfp /+ embryos treated with Tm at E14.5 into the adult Cb (n = 17), and found that similar to E18.5 these PCs still primarily populated the CZ and PZ of the vermis, which are derived from the central and posterior cardinal lobes (XREF_FIG).	p(HGNC:"ERVK-18")	directlyIncreases	act(p(HGNC:MAPT))
159ed384-2d84-4e37-8b8c-940ca27ab421	0.95	PubMed	18548688	In order to follow single axons into the brainstem we analyzed Pcp2-CreER-IRES-hAP; Tau mGfp /+ embryos treated with Tm at E14.5 for mGfp expression.	p(HGNC:"ERVK-18")	directlyIncreases	act(p(HGNC:MAPT))
159ed384-2d84-4e37-8b8c-940ca27ab421	0.95	PubMed	18548688	Analysis of Pcp2-CreER-IRES-hAP; Tau mGfp /+ embryos treated with Tm at E14.5 and analyzed at E18.5 uncovered that the marked PCs in the vermis were restricted to particular lobes in the A-P axis (n = 23) and most cells populated the PC layer (XREF_FIG).	p(HGNC:"ERVK-18")	directlyIncreases	act(p(HGNC:MAPT))
d5cb3c20-45f2-42c3-b327-c47bc14294d8	0.86	PubMed	17203233	ER stress can also activate Tau kinase, glycogen synthase kinase 3beta (GSK-3beta), which enhances NFT formation [XREF_BIBR].	p(HGNC:ESR1)	directlyIncreases	act(p(HGNC:MAPT))
d5cb3c20-45f2-42c3-b327-c47bc14294d8	0.86	PubMed	23237806	This suggests that ER stress specifically causes an increase in tau protein; in other words, ER stress is specifically involved in tauopathy.We examined whether the increase in tau is due to increased tau production (i.e., increased transcription or translation) or inhibition of tau degradation.	p(HGNC:ESR1)	directlyIncreases	act(p(HGNC:MAPT))
60a0d12e-f6e6-4ac4-850c-856f299b6eec	0.92	PubMed	18519819	Ethanol increases endogenous tau protein.	a(PUBCHEM:702)	directlyIncreases	act(p(HGNC:MAPT))
60a0d12e-f6e6-4ac4-850c-856f299b6eec	0.92	PubMed	18519819	Ethanol enhances tau accumulation in neuroblastoma cells that inducibly express tau.	a(PUBCHEM:702)	directlyIncreases	act(p(HGNC:MAPT))
60a0d12e-f6e6-4ac4-850c-856f299b6eec	0.92	PubMed	18708763	Ethanol induces tau cleavage.	a(PUBCHEM:702)	directlyIncreases	act(p(HGNC:MAPT))
07825afb-3963-4c20-a2ef-1756a11dd4d0	0.65	PubMed	17713250	In transgenic Drosophila, overexpression of the Drosophila homolog Par-1 was associated with increased phosphorylation and enhanced toxicity of human tau.	p(HGNC:F2R)	directlyIncreases	act(p(HGNC:MAPT))
727c9561-3b0d-4cf2-bd90-2cc07d4f28b8	0.65	PubMed	17145378	Their work in flies shows altered expression of both FERMT2 and CELF1 homologs modulates Tau neurotoxicity as measured by a retinal phenotype and suggests biological relevance for these associations.	p(HGNC:FERMT2)	directlyIncreases	act(p(HGNC:MAPT))
07ae5de0-89ad-4e9a-84b0-7f99e4084344	0.86	PubMed	18707150	Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (XREF_FIG).	p(HGNC:FKBP4)	directlyIncreases	act(p(HGNC:MAPT))
07ae5de0-89ad-4e9a-84b0-7f99e4084344	0.86	PubMed	20071522	Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (XREF_FIG).	p(HGNC:FKBP4)	directlyIncreases	act(p(HGNC:MAPT))
2ec91b47-a2ae-4ef5-b7bc-c99f2cb1375a	0.65	PubMed	26903089	The PHF6 and FKBP52 interaction thereby might indeed lead to oligomerization of these more aggregation-prone forms of Tau, while not affecting to the same manner the human wtTau441.Further research is needed to elucidate the molecular details of how FKBP52 promotes the oligomerization of Tau P301L and/or the Tau fragment, but our present results have unambiguously excluded its prolyl / isomerase activity as the underlying molecular mechanism.Expression of Tau, TauP301L, and TauF4 used the same protocols as described in previous reports.	p(HGNC:FKBP4)	directlyIncreases	act(p(HGNC:MAPT, var(p.Pro301Leu)))
642b32cf-9bb6-4689-8435-c507f7242731	0.65	PubMed	17513568	A preliminary study argues that FKBP5 (FKBP51) promotes Tau protein accumulation, while FKBP4 (FKBP52) has a contrasting action by inhibiting the accumulation of Tau proteins [XREF_BIBR].	p(HGNC:FKBP5)	directlyIncreases	act(p(HGNC:MAPT))
de8a7c74-101b-403b-9da5-76b36c7348f6	0.65	PubMed	20460118	Note that the labelings of Paxillin and Transgelin-3 were inconclusive.The ability of Filamin-A and Myosin VI to modulate the Tau induced toxicity in flies, and the colocalization of these two modulators with Tau in neurofibrillary tangles in AD and FTDP-17 raise the possibility that they play a role in the neurodegenerative process.	p(HGNC:FLNA)	directlyIncreases	act(p(HGNC:MAPT))
573c409b-0448-4d24-9ae2-12b893442227	0.65	PubMed	16082466	The activity of cytohesins, interactors of FRMD4A and guanine-nucleotide-exchange factors of Arf6, was necessary for FRMD4A induced tau secretion.	p(HGNC:FRMD4A)	directlyIncreases	act(p(HGNC:MAPT))
fbd41de9-12ea-48bd-9338-927622503c13	0.94	PubMed	12661197	FUS knockdown causes significant growth cone enlargement and disorganization reminiscent of Tau loss of function.	p(HGNC:FUS)	directlyIncreases	act(p(HGNC:MAPT))
fbd41de9-12ea-48bd-9338-927622503c13	0.94	PubMed	22710833	FUS knockdown causes significant growth cone enlargement and disorganization reminiscent of Tau loss of function.	p(HGNC:FUS)	directlyIncreases	act(p(HGNC:MAPT))
fbd41de9-12ea-48bd-9338-927622503c13	0.94	PubMed	18119945	Knockdown of FUS in rat hippocampal neurons promotes Mapt and Tau exon 10 inclusion (Tau 4R isoform), and consequently causes cytoskeleton disorganization, shortened axons and enlarged growth cones that may contribute to neurodegeneration.	p(HGNC:FUS)	directlyIncreases	act(p(HGNC:MAPT))
fbd41de9-12ea-48bd-9338-927622503c13	0.94	PubMed	16774870	FUS is believed to promote skipping of exons 3 and 10 in MAPT, whereas inclusion of exon 10 leads to FTLD and Parkinsonism.	p(HGNC:FUS)	directlyIncreases	act(p(HGNC:MAPT))
39b298c7-8e05-412c-9d47-59779c1b30da	0.92	PubMed	17254830	Formaldehyde can induce misfolding and aggregation of Tau protein and beta amyloid protein, which are characteristic pathological features of Alzheimer 's disease (AD).	a(PUBCHEM:712)	directlyIncreases	act(p(HGNC:MAPT))
39b298c7-8e05-412c-9d47-59779c1b30da	0.92	PubMed	13500473	Formaldehyde can induce misfolding and aggregation of Tau protein and beta amyloid protein, which are characteristic pathological features of Alzheimer 's disease (AD).	a(PUBCHEM:712)	directlyIncreases	act(p(HGNC:MAPT))
39b298c7-8e05-412c-9d47-59779c1b30da	0.92	PubMed	15496074	Formaldehyde induced Tau aggregation is implicated in cytotoxicity and neural cell apoptosis.	a(PUBCHEM:712)	directlyIncreases	act(p(HGNC:MAPT))
6941884a-6543-45be-97dd-e3869f170a82	0.92	PubMed	21157558	In fact, <ce:cross-ref refid="BIB19"> Lerma et al. (1985) </ce:cross-ref> have reported that intracerebral infusion of GABA increases TAU, probably by a counter-transport process.	a(PUBCHEM:119)	directlyIncreases	act(p(HGNC:MAPT))
6941884a-6543-45be-97dd-e3869f170a82	0.92	PubMed	4505807	The elevated GABA levels may also reduce Glu release and enhance Tau release.	a(PUBCHEM:119)	directlyIncreases	act(p(HGNC:MAPT))
6941884a-6543-45be-97dd-e3869f170a82	0.92	PubMed	17237095	It was found that the treatment of GABA A R expressing mouse Neuro-2A cells with BZs or barbiturates appeared to promote the interaction of tau with Pin1 -- a key regulator and facilitator of PP2A mediated tau dephosphorylation [XREF_BIBR].	a(PUBCHEM:119)	directlyIncreases	act(p(HGNC:MAPT))
9ea7bd0d-be7b-4e4b-a0bf-49649bc7c349	0.92	PubMed	9841111	Pulse-chase experiments revealed that GC treatment increased the stability of tau protein rather than its de novo synthesis.	p(HGNC:GC)	directlyIncreases	act(p(HGNC:MAPT))
9ea7bd0d-be7b-4e4b-a0bf-49649bc7c349	0.92	PubMed	15468764	These GC triggered Tau changes were paralleled by reduced levels of synaptic scaffolding proteins such as PSD-95 and Shank proteins as well as reduced dendritic branching and spine loss.	p(HGNC:GC)	directlyIncreases	act(p(HGNC:MAPT))
9ea7bd0d-be7b-4e4b-a0bf-49649bc7c349	0.92	PubMed	18440167	We now also know that GC exposure increases Tau accumulation by affecting turnover of the protein by reducing its degradation [XREF_BIBR]; the latter appears to result from dysregulation of molecular chaperones (e.g., Hsp90 and Hsp70) that are responsible for Tau proteostasis [XREF_BIBR] (see XREF_FIG).	p(HGNC:GC)	directlyIncreases	act(p(HGNC:MAPT))
9eb60e3f-2a63-42f8-937c-827193347df6	0.65	PubMed	7789833	To begin to elucidate the role of glial pathology in tauopathies, we generated a transgenic (Tg) mouse model of astrocytic tau pathology by expressing the human tau protein driven by the glial fibrillary acidic protein (GFAP) promoter.	p(HGNC:GFAP)	directlyIncreases	act(p(HGNC:MAPT))
c8eec55a-7337-4ca2-8946-e98d9582a8e0	0.65	PubMed	18195961	In contrast, GA significantly increased tau and its phosphorylated form, p-tauT181 (XREF_FIG) in the medium.	a(CHEBI:30778)	directlyIncreases	act(p(HGNC:MAPT))
5924e503-94e1-49de-9b1a-eb8ce8280a83	0.65	PubMed	17303772	We found that AMPA receptor stimulation dose dependently increased tau release, with 10 muM and 100 muM (S)-AMPA significantly increasing the amount of tau detected in the culture medium when compared with control cells (XREF_FIG, left).	p(FPLX:GRIA)	directlyIncreases	act(p(HGNC:MAPT))
8572991f-ecbf-4459-a708-e232cd51133d	0.86	PubMed	18273257	The results of the present study show that GRN mutations causing PGRN reduction may accelerate the intracellular accumulation of not only TDP-43 but also tau and alpha-synuclein in the brains of familial FTD patients with GRN mutations.	p(HGNC:GRN, var(p.?))	directlyIncreases	act(p(HGNC:MAPT))
8572991f-ecbf-4459-a708-e232cd51133d	0.86	PubMed	18273257	Hence, GRN mutation may accelerate deposition of tau and alpha-synuclein but the level of abnormal protein deposition seen in routine paraffin embedded sections from GRN cases might not be as strong as that seen than in free floating sections and therefore go unrecognized.	p(HGNC:GRN, var(p.?))	directlyIncreases	act(p(HGNC:MAPT))
9863d840-055f-4526-a6d1-12679d93b85e	0.65	PubMed	27023670	These results suggest that increases in the levels of phosphorylated tau mediated by GSK3beta and Sgg might contribute to Abeta42 induced detachment of tau from microtubules.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
c3193786-4c65-4a29-8b06-2525887d75b7	0.65	PubMed	17565981	Activation of glycogen synthase kinase 3beta promotes the intermolecular association of tau.	p(FPLX:GYS)	directlyIncreases	act(p(HGNC:MAPT))
360f275c-5fe5-4f7a-abbc-89fa77cfbfdc	0.86	PubMed	17636754	In the present study, we show that overexpression of the G-protein-coupled receptor (GPCR)-associated sorting protein p60TRP (transcription regulator protein) in neural stem cells (NSCs) and in a transgenic mouse model modulates the phosphorylation and proteolytic processing of amyloid precursor protein (App), N-cadherin (Cdh2), presenilin (Psen) and tau protein (Mapt).	p(UP:Q18LE5)	directlyIncreases	act(p(HGNC:MAPT))
360f275c-5fe5-4f7a-abbc-89fa77cfbfdc	0.86	PubMed	11502246	In the present study, we show that overexpression of the G-protein-coupled receptor (GPCR)-associated sorting protein p60TRP (transcription regulator protein) in neural stem cells (NSCs) and in a transgenic mouse model modulates the phosphorylation and proteolytic processing of amyloid precursor protein (App), N-cadherin (Cdh2), presenilin (Psen) and tau protein (Mapt).	p(UP:Q18LE5)	directlyIncreases	act(p(HGNC:MAPT))
746452be-ed01-4790-a757-828933fb4310	0.65	PubMed	18364965	They found HAND subjects had significantly increased t-tau and p-tau at concentrations similar to patients with AD, suggesting that ADC may be associated with an AD like process [XREF_BIBR].	p(PFAM:PF09110)	directlyIncreases	act(p(HGNC:MAPT))
3bcdd357-b2eb-4ed4-a4e2-df57bb1d66f7	0.65	PubMed	6897972	Replacement of leucine 272 in S1 of HCN4 by the corresponding phenylalanine present in HCN2 decreased tau act of HCN4 to 149 ms. Conversely, activation of the fast channel HCN2 was decreased 3-fold upon the corresponding mutation of F221L in the S1 segment.	p(HGNC:HCN2)	directlyIncreases	act(p(HGNC:MAPT))
06a8790f-559e-4b0b-8bff-7f1136534ec6	0.94	PubMed	17309736	Further evidence that inhibition of HDAC6 might attenuate TAU pathology in AD stems from a Drosophila model.	p(HGNC:HDAC6)	directlyIncreases	act(p(HGNC:MAPT))
06a8790f-559e-4b0b-8bff-7f1136534ec6	0.94	PubMed	22492994	Overexpression of HDAC6 promotes tau accumulation.	p(HGNC:HDAC6)	directlyIncreases	act(p(HGNC:MAPT))
06a8790f-559e-4b0b-8bff-7f1136534ec6	0.94	PubMed	18395310	On the basis of this pathogenic mechanism, inhibiting HDAC6 selectively could improve acetylation and prevent tau accumulation.	p(HGNC:HDAC6)	directlyIncreases	act(p(HGNC:MAPT))
06a8790f-559e-4b0b-8bff-7f1136534ec6	0.94	PubMed	23962722	We previously demonstrated that overexpression of HDAC6 promotes the accumulation of p-tau, whereas lowering HDAC6 stimulates p-tau clearance (XREF_BIBR).	p(HGNC:HDAC6)	directlyIncreases	act(p(HGNC:MAPT))
cd995ae6-518e-4ae4-8224-cdbe5c04eac0	0.65	PubMed	24813593	Also affecting the brain, systemic overexpression of HO-1 promoted tau accumulation at levels similar to Alzheimer 's disease.	p(HGNC:HMOX1)	directlyIncreases	act(p(HGNC:MAPT))
78eb37da-dfb3-4fd5-a5d5-cd0c2c58b35c	0.65	PubMed	21278472	HNE causes the microtubule associated protein tau to become resistant to dephosphorylation, which may contribute to neurofibrillary degeneration in Alzheimer 's disease <ce:cross-ref refid="BIB28"> [28] </ce:cross-ref>.	a(PUBCHEM:5283344)	directlyIncreases	act(p(HGNC:MAPT))
bd0fd6be-489b-44fe-9992-12990fbbbae3	0.94	PubMed	22026121	In a mouse model, it has been demonstrated that inhibition of HSP90 promotes Tau degradation.	p(FPLX:HSP90)	directlyIncreases	act(p(HGNC:MAPT))
bd0fd6be-489b-44fe-9992-12990fbbbae3	0.94	PubMed	24581495	In this way, Hsp90 can promote both stabilization and degradation of Tau (XREF_BIBR).	p(FPLX:HSP90)	directlyIncreases	act(p(HGNC:MAPT))
bd0fd6be-489b-44fe-9992-12990fbbbae3	0.94	PubMed	18810956	Biophysical measurements by Magnus Kjaergaard from David Klenerman 's and Sophie Jackson 's laboratories (University of Cambridge, Cambridge, UK) revealed that Hsp90 may promote the stability of oligomeric Tau and beta-amyloid, thought to be toxic species involved in the pathology of Alzheimer 's disease.	p(FPLX:HSP90)	directlyIncreases	act(p(HGNC:MAPT))
bd0fd6be-489b-44fe-9992-12990fbbbae3	0.94	PubMed	18362272	In different cellular models, it has been shown that increased HSP70 and HSP90 levels promote Tau solubility and microtubule binding [XREF_BIBR].	p(FPLX:HSP90)	directlyIncreases	act(p(HGNC:MAPT))
48aa18ca-165d-4eca-8e14-c440bf3c4d01	0.92	PubMed	9292436	Hsp70 and Hsc70, a member of the chaperone protein family, interacts with Tau protein and mediates proper folding of Tau and can promote degradation of Tau protein under certain circumstances.	p(HGNC:HSPA8)	directlyIncreases	act(p(HGNC:MAPT))
48aa18ca-165d-4eca-8e14-c440bf3c4d01	0.92	PubMed	17954934	Hsp70 and Hsc70, a member of the chaperone protein family, interacts with Tau protein and mediates proper folding of Tau and can promote degradation of Tau protein under certain circumstances.	p(HGNC:HSPA8)	directlyIncreases	act(p(HGNC:MAPT))
48aa18ca-165d-4eca-8e14-c440bf3c4d01	0.92	PubMed	22041495	In another example, Hsc70 enhances the lifetime of aberrant tau protein in neurons, likely contributing to neurodegenerative disease.	p(HGNC:HSPA8)	directlyIncreases	act(p(HGNC:MAPT))
d7d574eb-4ba2-4fd1-907e-9ec1a01f3f2e	0.65	PubMed	18585594	Tau protein, whose aggregation in neuronal cells leads to neurological disorders, is targeted by Hsp70 and CHIP complex for degradation [XREF_BIBR].	complex(p(FPLX:HSPA), p(HGNC:STUB1))	directlyIncreases	act(p(HGNC:MAPT))
60f73f30-f197-442b-a148-304845c77000	0.86	PubMed	17288854	However, the addition of 5-40 microM Pb 2+ significantly accelerated filament formation of triple mutant H268A/H299A/H329A of Tau 244-372 on the investigated time scale (data not shown).	p(HGNC:HTN3)	directlyIncreases	act(p(HGNC:MAPT, var(p.His268Ala)))
60f73f30-f197-442b-a148-304845c77000	0.86	PubMed	21966400	However, the addition of 5-40 microM Pb 2+ significantly accelerated filament formation of triple mutant H268A/H299A/H329A of Tau 244-372 on the investigated time scale (data not shown).	p(HGNC:HTN3)	directlyIncreases	act(p(HGNC:MAPT, var(p.His268Ala)))
432ea129-0934-48db-8fb0-aa3b814c4081	0.65	PubMed	18872818	In the current article, we provide experimental evidence that diet induced high levels of Hcy in the central nervous system modulate all 3 major pathological aspects of the AD like phenotype in a transgenic mouse model of the disease : behavior, Abeta pathology, and tau pathology.	a(PUBCHEM:778)	directlyIncreases	act(p(HGNC:MAPT))
970d8d78-0703-4211-bfc0-824622b535f4	0.86	PubMed	17198852	Heparin, for instance, has been widely used to induce the aggregation of Tau protein efficiently [XREF_BIBR, XREF_BIBR, XREF_BIBR - XREF_BIBR].	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
970d8d78-0703-4211-bfc0-824622b535f4	0.86	PubMed	17477317	Heparin compacts the repeats and induces the dimerization of Tau, with filaments growing through monomer addition.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
acd90e21-2f49-4d11-885d-df5c293feb7b	0.65	PubMed	17628876	An in vitro study showed that inorganic Hg (50 microg/dL/30 min) increased P-Tau in SH-SY5Y cells by a ROS dependent mechanism, which was reverted by the co-treatment with the antioxidant melatonin.	a(PUBCHEM:101179)	directlyIncreases	act(p(HGNC:MAPT))
7f2d7c87-cdf4-4ba5-8c0f-2f4329c22751	0.65	Other	sparser:Unknown	Activation of tau kinases by β -amyloid.	p(HGNC:IAPP)	directlyIncreases	act(p(HGNC:MAPT))
9b0f7d0f-c241-4541-a916-1530c32ae8a5	0.86	PubMed	18819819	and Kaneko et al., who assessed the percentage of IFN-gamma producing Tau cells in patients with SSNS, did not find significant difference between patients and controls.	p(HGNC:IFNG)	directlyIncreases	act(p(HGNC:MAPT))
9b0f7d0f-c241-4541-a916-1530c32ae8a5	0.86	PubMed	18752627	The MyD88 independent TRIF pathway is also activated resulting in nuclear translocation of Interferon regulatory factor (IRF) -3 and synthesis of Interferon beta (IFN-beta), which then activates its receptor coupled to Signal Transducer and Activator of Transcription 1 / 2 (STAT-1 / 2) and IRF-9 and a secondary wave of transcription of cytokines and chemokines such as Interferon gamma induced protein 10 kDa (IP-10) and Glucocorticoid Attenuated Response Gene 16 (GARG16).	p(HGNC:IFNG)	directlyIncreases	act(p(HGNC:MAPT))
34521c0b-4d84-4de9-876f-4156985dafb9	0.65	PubMed	14946338	Glial activation stimulated generation of interleukin-1 (IL-1), which upregulated GSK3beta, and APP and tau as well, resulting in co-localization of Abeta and phospho-tau with IL-1 receptor.	p(FPLX:IL1)	directlyIncreases	act(p(HGNC:MAPT))
0f2a7826-fe7c-4a2f-950a-108d5b7042c0	0.65	PubMed	18636601	The findings that both Abeta and tau pathologies were accelerated by controlled cortical impact allowed us the opportunity to investigate the interaction between Abeta and tau in the setting of TBI.	p(HGNC:IMPACT)	directlyIncreases	act(p(HGNC:MAPT))
791b4b5b-be31-42ec-b7c4-a05bfc5c083c	0.65	PubMed	22290178	Brain insulin resistance potentiates the deposition of Abeta and hyperphosphorylated tau protein leading to neuronal and synaptic dysfunction and cognitive decline ().	p(HGNC:INS)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
1363aeac-9b3f-4258-80f2-3261f757b9cc	0.86	PubMed	17879122	Under both conditions, protection (which is NMDAR dependent since it is blocked by the concomitant addition of 5,7-dichlorokynurenic acid, DCKA, a selective NMDAR antagonist acting at the glycine site) involves prevention of Akt and ERK1-2 dephosphorylation, JNK phosphorylation, and caspase activation and caspase mediated cleavage of tau protein.	p(FPLX:JNK)	directlyIncreases	act(p(HGNC:MAPT))
1363aeac-9b3f-4258-80f2-3261f757b9cc	0.86	PubMed	19883798	Tau proteolysis was completely prevented by JNK inhibition but not affected by either ERK1/2 or p38 MAPK blockade.	p(FPLX:JNK)	directlyIncreases	act(p(HGNC:MAPT))
8d79b854-4c90-4704-893f-35d2fee4ec2f	0.86	PubMed	25275635	At 10 microM Ca 2+ i, hbeta4 markedly increased tau act : 1.40 +/-0.1 ms in cbv1 vs. 4.25 +/-0.83 ms in cbv1+ hbeta4 (P < 0.05), and exerted a mild effect on tau deact (XREF_FIG).	p(HGNC:KCNMB4)	directlyIncreases	act(p(HGNC:MAPT))
8d79b854-4c90-4704-893f-35d2fee4ec2f	0.86	PubMed	17645158	At 10 microM Ca 2+ i, hbeta4 markedly increased tau act : 1.40 +/-0.1 ms in cbv1 vs. 4.25 +/-0.83 ms in cbv1+ hbeta4 (P < 0.05), and exerted a mild effect on tau deact (XREF_FIG).	p(HGNC:KCNMB4)	directlyIncreases	act(p(HGNC:MAPT))
1072b18a-5a28-4c42-b746-5e457c69f95c	0.95	PubMed	17890370	Surprisingly, Tau was dephosphorylated when neurons were treated with 20 mM KCl.	a(PUBCHEM:4873)	directlyIncreases	act(p(HGNC:MAPT))
1072b18a-5a28-4c42-b746-5e457c69f95c	0.95	PubMed	17890370	At this time point, no change of tau secretion was noted by neurons treated with 10mM KCl indicating that Golgi fragmentation preceded tau secretion (XREF_FIG).	a(PUBCHEM:4873)	directlyIncreases	act(p(HGNC:MAPT))
1072b18a-5a28-4c42-b746-5e457c69f95c	0.95	PubMed	17890370	Tau phosphorylation was not significantly modified when neurons were treated with 10 mM KCl.	a(PUBCHEM:4873)	directlyIncreases	act(p(HGNC:MAPT))
1072b18a-5a28-4c42-b746-5e457c69f95c	0.95	PubMed	3685382	Hypoosmotic media and 65 mM KCl stimulated TAU release, and the release was well correlated with the increase of cell volume.	a(PUBCHEM:4873)	directlyIncreases	act(p(HGNC:MAPT))
1072b18a-5a28-4c42-b746-5e457c69f95c	0.95	PubMed	17303772	3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium (MTS) assay (XREF_FIG, right) showed that tau release induced by KCl occurred in the absence of any changes in cell viability.	a(PUBCHEM:4873)	directlyIncreases	act(p(HGNC:MAPT))
6487dafb-152e-4916-b88f-5eaa547c52c6	0.65	PubMed	22037609	Because pazopanib primarily inhibits VEGFRs, we transfected P301L tau or Abeta cDNA with or without VEGFR2 shRNA into M17 human neuroblastoma cells to ascertain whether inhibition of VEGFR2 could reduce p-tau and/or Abeta 40/42.	p(HGNC:KDR)	directlyIncreases	act(p(HGNC:MAPT))
f7414ebc-4d07-495e-a0fc-1b2a2fbe6f61	0.86	PubMed	22272245	Together these data lead us to suggest that KLC1 can modulate APP and Tau function but this is challenging to test in human neurons.	p(HGNC:KLC1)	directlyIncreases	act(p(HGNC:MAPT))
f7414ebc-4d07-495e-a0fc-1b2a2fbe6f61	0.86	PubMed	22272245	It is unclear why KLC1 disruption in human neural cultures reduces Abeta and Tau while in mouse brain, these proteins are increased.	p(HGNC:KLC1)	directlyIncreases	act(p(HGNC:MAPT))
056c9515-469e-459d-a718-1d1ec1f48969	0.86	PubMed	21320871	Furthermore, endogenous TAU protein abundance in human neuroblastoma SH-SY5Y cells was significantly reduced or augmented by overexpression or knockdown of PSA and NPEPPS, respectively.	p(HGNC:KLK3)	directlyIncreases	act(p(HGNC:MAPT))
056c9515-469e-459d-a718-1d1ec1f48969	0.86	PubMed	18358045	To determine whether PSA, rather than cleave Tau, might activate Tau cleavage by a contaminating protease, we added C-His 6 -PSA, known to have aminopeptidase activity but no Tau cleaving activity, to each of the Tau cleaving untransfected Sf9 derived fractions.	p(HGNC:KLK3)	directlyIncreases	act(p(HGNC:MAPT))
d02f4fe4-7414-4d67-bcd8-ee6565c9c5b3	0.65	PubMed	3239462	Extracellular levels of glutamate (GLU) and taurine (TAU) were not modified by IC stimulation, TTX or 0 Ca2+ although high K+ promoted GABA and TAU release but not that of GLU.	a(PUBCHEM:813)	directlyIncreases	act(p(HGNC:MAPT))
a3581799-2e81-45d1-a318-0af8d0889c4b	0.65	PubMed	5698243	Ketamine anesthesia caused a 2.2% increase of water content of cerebral cortical slices and increased Asp, Glu, and Tau concentration in microdialysates of control rats.	a(PUBCHEM:3821)	directlyIncreases	act(p(HGNC:MAPT))
7b26a930-8df0-4e88-9bdb-57184fb0c75a	0.65	PubMed	10848214	Furthermore, LC stimulated the TAU uptake and TAUT expression in VSMCs.	a(PUBCHEM:10037021)	directlyIncreases	act(p(HGNC:MAPT))
2f2cec17-14b8-4ed9-b3e1-a81e90684e94	0.65	PubMed	18524835	To determine the dose response relationship between leptin and tau phosphorylation, RA-SY5Y cells were treated with leptin for 4 hrs at a range of concentrations (XREF_FIG).	p(HGNC:LEP)	directlyIncreases	act(p(HGNC:MAPT))
920aa148-5a18-4375-97ce-804ea87951f3	0.86	PubMed	16850767	These findings strongly suggest that LFS induced oligomerization of tau.	p(UP:P59082)	directlyIncreases	act(p(HGNC:MAPT))
920aa148-5a18-4375-97ce-804ea87951f3	0.86	PubMed	16850767	Thus, this suggests that LFS induced formation of autophagosomes is critical for LFS induced oligomerization of tau in vivo.	p(UP:P59082)	directlyIncreases	act(p(HGNC:MAPT))
30c10583-deba-4f78-8639-06d0aefea65d	0.94	PubMed	20384540	Coincubation of Abeta peptide with LPS potentiated amyloid fibril formation, and systemic administration of LPS in wild-type and transgenic AD mice induced neuroinflammation, amyloid deposition, and tau pathology.	a(CHEBI:16412)	directlyIncreases	act(p(HGNC:MAPT))
30c10583-deba-4f78-8639-06d0aefea65d	0.94	PubMed	18601476	Because our time course data reliably identified LPS induced tau-P only in the hippocampus among regions examined, analyses were restricted to this region.	a(CHEBI:16412)	directlyIncreases	act(p(HGNC:MAPT))
30c10583-deba-4f78-8639-06d0aefea65d	0.94	PubMed	18601476	Nevertheless, repeated LPS treatment has been shown to increase tau-P at the AT8 and AT180 (T 231 / S 235), but not the PHF-1, sites, and exacerbate tau pathology, in a mouse AD model, with the tau kinase CDK5 (but not GSK-3 or JNKs) implicated as mediating the effect.	a(CHEBI:16412)	directlyIncreases	act(p(HGNC:MAPT))
30c10583-deba-4f78-8639-06d0aefea65d	0.94	PubMed	18365751	RAPA attenuate LPS induced increases in p-S6, p-tau, p-NFkappaB and p-IKKB.	a(CHEBI:16412)	directlyIncreases	act(p(HGNC:MAPT))
11b0b0ea-c3eb-4a56-9a38-233b1e66344e	0.65	PubMed	18417366	The same LRRC37 core duplicons at 17q21.31 are known to have mediated the 970 kbp polymorphic inversions of the MAPT locus that also underlies the syndromes associated with recurrent 17q21.31 microdeletions 27.	p(PFAM:PF15779)	directlyIncreases	act(p(HGNC:MAPT))
de50e1e5-0584-43f1-9c1f-db9b04537c34	0.65	PubMed	18553426	Interestingly, mutant LRRK2 causes tau positive, alpha-Syn-negative inclusions and apoptosis in affected neurons.	p(HGNC:LRRK2, var(p.?))	directlyIncreases	act(p(HGNC:MAPT))
22b6880f-da53-4945-8737-63dfb8de4d70	0.65	PubMed	22764226	We observed that L-dopa increased Tau phoshorylation in mice fed a NF diet, and this effect was augmented in mice on a LF or FD diet.	a(PUBCHEM:6047)	directlyIncreases	act(p(HGNC:MAPT))
7f706d4b-2272-4eb5-9aff-a4c0531af13d	0.65	PubMed	19376616	Liraglutide increased diastolic relaxation (dP/dt; Tau	a(PUBCHEM:16134956)	directlyIncreases	act(p(HGNC:MAPT))
282d85fd-3252-4502-8e62-e88e0e8879db	0.86	PubMed	14928588	Interestingly, MAP2, a microtubule binding protein with mainly dendritic localization that shares Fyn binding motifs with Tau, does not mediate Abeta 's synaptic toxicity in the absence of Tau.	p(HGNC:MAP2)	directlyIncreases	act(p(HGNC:MAPT))
282d85fd-3252-4502-8e62-e88e0e8879db	0.86	PubMed	1190218	Neuroblastoma cells maintained in serum-free medium exhibit a significant induction of MAP-1a and Tau proteins, but not MAP-2; the time course of these inductions is highly correlated with an increase in microtubule mass which parallels neurite growth.	p(HGNC:MAP2)	directlyIncreases	act(p(HGNC:MAPT))
b02455f9-a414-4db9-a8de-f578bfc83100	0.65	PubMed	21987967	Overexpression of both tau and ensconsin still led to an increase in the number of branches and total branch length, consistent with the ability of MAP7 to outcompete tau in vitro.	p(HGNC:MAP7)	directlyIncreases	act(p(HGNC:MAPT))
6005a8cd-36d0-4d1f-b95a-b90e679c4e08	0.94	PubMed	20626350	A large number of cytosolic proteins can be phosphorylated by p38 mapks, including phospholipase a2, the microtubule-associated protein tau, nhe-1, cyclin d1, cdk inhibitors, bcl2 family proteins, growth factor receptors or keratins.	p(HGNC:MAPK14)	directlyIncreases	act(p(HGNC:MAPT))
a013e043-1a8c-451a-a5d4-5ede44fe9a35	0.65	PubMed	19763956	beta-amyloid (Abeta) deposition and the highly phosphorylated Tau protein induced neurofibrillary tangles are some of the common pathological features of AD.	p(HGNC:MAPT, pmod(Ph))	directlyIncreases	act(p(PFAM:PF09793))
f268026a-35f0-4cb7-819f-34b2324d54a2	0.65	PubMed	17709000	Interestingly, growing evidence indicates that hyperphosphorylated tau activates GSK-3beta through an increase in oxidative stress, neuroinflammation, and apoptosis.	p(HGNC:MAPT, pmod(Ph))	directlyIncreases	act(p(HGNC:GSK3B))
2404a1ae-9d0f-447c-be56-a100f45d1d37	0.65	PubMed	17745144	Hyperphosphorylated tau and Abeta induce neuronal death and are responsible for a decrease in the cognitive function and progressive loss of memory.	p(HGNC:MAPT, pmod(Ph))	directlyIncreases	act(bp(GO:"GO:0008219"))
f76ecd3a-9752-47e4-bf7b-2646658c41a9	0.65	PubMed	20146449	Additionally, unlike Abeta42, TAU P301L does not induce the expression of neurodegeneration induced factor Interleukin-4 39, providing further evidence that TAU P301L expression fails to elicit a neurodegeneration regeneration cascade in adult zebrafish brain.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(p(HGNC:IL4))
338da2e7-f6d9-4995-a714-81c5b7f04681	0.65	PubMed	20235173	Messenger RNA analysis of two pro inflammatory markers such as IL-1beta and inducible nitric oxide synthase (iNOS) indicate that TAU P301L expression induce Il-1beta (XREF_FIG D) and iNOS (XREF_FIG D) mRNA expression in both genotypes and DMF treatment decreased this expression only in Nrf2 +/+ mice.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(p(HGNC:NOS2))
48945ad9-e74a-4dcb-a084-71d7be9c912d	0.65	PubMed	20146449	Interestingly, we found that although chronic and abundant expression of TAU P301L starting from early embryonic development led to hyperphosphorylation, TAU P301L did not form oligomers and neurofibrillary tangles, and did not cause elevated apoptosis and microglial activation, which are classical symptoms of tauopathies in mammals.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(bp(GO:"GO:0006915"))
3bad1130-adb4-4fb9-b6d7-2c9f4aa6505c	0.92	PubMed	20146449	These results indicate that TAU P301L expression does not lead to cell death in adult zebrafish brain.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(bp(GO:"GO:0008219"))
3bad1130-adb4-4fb9-b6d7-2c9f4aa6505c	0.92	PubMed	13392099	The overexpression of human WT Tau in pyramidal neurons resulted in NFD, the morphological characteristics and kinetics of which reflected the slow and sporadic neurodegenerative processes observed in sporadic tauopathies, unlike the rapid neurodegenerative processes leading to cell death and ghost tangles triggered by the FTDP-17 mutant Tau P301L.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(bp(GO:"GO:0008219"))
3bad1130-adb4-4fb9-b6d7-2c9f4aa6505c	0.92	PubMed	24929931	Tau mutants P301L and K18DeltaK280 show the greatest tendency to aggregate [XREF_BIBR], and potentiated the highest levels of cell death in the presence of model Hirano bodies.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(bp(GO:"GO:0008219"))
e1966e79-aa21-412e-aa68-77e0cfd236af	0.65	PubMed	20235173	Twenty-one days of TAU P301L -expression did not induce noticeable hippocampal neuronal cell death as measured by Nissl staining, FluoroJade or Bielschowsky staining (data not shown).	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(bp(GO:"GO:0008219"))
a9af090f-8afc-4e12-9821-2b398d261c22	0.86	PubMed	21945393	Wild type and P301L mutant Tau promote neuro inflammation and alpha-Synuclein accumulation in lentiviral gene delivery models.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(bp(GO:"GO:0006954"))
a9af090f-8afc-4e12-9821-2b398d261c22	0.86	PubMed	18362293	A recent study suggests that alpha-syn may be modified by inflammation caused by expression of human wild-type or mutant P301L Tau [XREF_BIBR].	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(bp(GO:"GO:0006954"))
dc829d8c-5367-4f91-87fe-86c756ab290f	0.65	PubMed	20146449	To test if chronic expression of TAU P301L would induce the proliferation of neuronal progenitors, we performed immunostaining for S100beta (a progenitor cell marker) and PCNA (proliferation marker) in sTg and dTg animals.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	act(bp(GO:"GO:0008283"))
f841a8d8-898c-4006-98fc-d227cefea2e6	0.86	PubMed	25406315	Equivalent amounts of recombinant P301S Tau that had aggregated in the presence of heparin failed to induce the aggregation of recombinant P301S Tau (data not shown).	p(HGNC:MAPT, var(p.Pro301Ser))	directlyIncreases	act(p(HGNC:MAPT, var(p.Pro301Ser)))
f841a8d8-898c-4006-98fc-d227cefea2e6	0.86	PubMed	17477317	Equivalent amounts of recombinant P301S Tau that had aggregated in the presence of heparin failed to induce the aggregation of recombinant P301S Tau (data not shown).	p(HGNC:MAPT, var(p.Pro301Ser))	directlyIncreases	act(p(HGNC:MAPT, var(p.Pro301Ser)))
33f9f4dd-9644-47ec-853d-57aef3a8a14f	0.65	PubMed	11006807	We identified several components of the actin network as modifiers of Tau V337M induced neurodegeneration, i.e. Filamin-A, Myosin VI, Paxillin and Transgelin-3.	p(HGNC:MAPT, var(p.Val337Met))	directlyIncreases	act(a(PUBCHEM:7010532))
3827b456-c342-4c71-a95a-a69f79ba94d0	0.86	PubMed	11168206	The expression of R406W Tau pseudophosphorylated at Thr (212), Thr (231), and Ser (262) triggered caspase-3 activation in as much as 85% of the transfected cells, whereas the corresponding value for wild type pseudophosphorylated Tau was 30%.	p(HGNC:MAPT, var(p.Arg406Trp))	directlyIncreases	act(p(HGNC:CASP3))
3827b456-c342-4c71-a95a-a69f79ba94d0	0.86	PubMed	20663882	The expression of R406W Tau pseudophosphorylated at Thr (212), Thr (231), and Ser (262) triggered caspase-3 activation in as much as 85% of the transfected cells, whereas the corresponding value for wild type pseudophosphorylated Tau was 30%.	p(HGNC:MAPT, var(p.Arg406Trp))	directlyIncreases	act(p(HGNC:CASP3))
6dc58ec6-8d1b-45fc-8df3-2c59aad458aa	0.86	PubMed	26751496	Also, tau mutations do not cause AD, but nevertheless relationship exists between chromosomal instability and AD.	p(HGNC:MAPT, var(p.?))	directlyIncreases	act(p(PFAM:PF09793))
6dc58ec6-8d1b-45fc-8df3-2c59aad458aa	0.86	PubMed	17855665	Also, tau mutations do not cause AD, but nevertheless relationship exists between chromosomal instability and AD.	p(HGNC:MAPT, var(p.?))	directlyIncreases	act(p(PFAM:PF09793))
a4e65198-5e84-4e79-b85e-6190fcf19182	0.92	PubMed	22040602	These results suggest that Patient 1 could be referred to as " GGT caused by MAPT mutation " rather than " frontotemporal lobar degeneration (FTLD) with MAPT mutations " [XREF_BIBR].	p(HGNC:MAPT, var(p.?))	directlyIncreases	act(p(HGNC:GGT1))
a4e65198-5e84-4e79-b85e-6190fcf19182	0.92	PubMed	18537383	The major finding of this study is that pathologically confirmed GGT may be caused by MAPT mutations.	p(HGNC:MAPT, var(p.?))	directlyIncreases	act(p(HGNC:GGT1))
a4e65198-5e84-4e79-b85e-6190fcf19182	0.92	PubMed	18537383	Patient 1 shared clinical, genealogical and neuropathologic features with sporadic GGT and is tentatively referred to as " GGT caused by MAPT mutation " rather than FTDP-17T, but we admit that the distinction is largely semantic.	p(HGNC:MAPT, var(p.?))	directlyIncreases	act(p(HGNC:GGT1))
53ff33c8-e3d3-4950-aa1a-8d80902f126c	0.65	PubMed	14251019	In human pedigrees, individual mutations in either hCK1 or hPER2 lead to advanced sleep phase disorders, whereas in rodents, the Tau mutation of CK1 epsilon (CK1epsilon (Tau)) accelerates rest activity cycles and shortens the period of the SCN molecular pacemaker.	p(HGNC:MAPT, var(p.?))	directlyIncreases	act(p(HGNC:REST))
d7e9af28-7452-4fec-a48a-f703591ee1b2	0.65	PubMed	22056947	36 MAPT mutations sometimes produce a PSP phenotype.	p(HGNC:MAPT, var(p.?))	directlyIncreases	act(p(HGNC:STXBP3))
96b5ddf7-5045-42c0-9a33-3c5197edf7d9	0.65	PubMed	13877716	Overexpression of human wild-type or mutant Tau causes age dependent neurodegeneration, axonal transport defects and early death.	p(HGNC:MAPT, var(p.?))	directlyIncreases	act(bp(GO:"GO:0006810"))
a0957664-2b55-4ed5-9a9e-2d8959ad94f6	0.65	PubMed	18359673	In this report, we have demonstrated that GSK-3beta phosphorylation of tau is sufficient to induce the clustering of ARA induced filaments into structures similar to the NFT like aggregates of tau filaments purified from AD brain [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ABCC6))
b1de87e2-a35a-496e-9042-5040fb1786ef	0.92	PubMed	21530001	AChE is increased early in both pathologic structures and may be triggered by either Abeta or P-tau.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ACHE))
b1de87e2-a35a-496e-9042-5040fb1786ef	0.92	PubMed	17147948	Namely, accumulating evidence suggests that both Abeta and p-tau can trigger an AChE increase in the regions around amyloid plaques and NFTs, which can in turn influence presenilin 1 (PSEN1) and thereby modulate Abeta production.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ACHE))
b1de87e2-a35a-496e-9042-5040fb1786ef	0.92	PubMed	11745889	Colocalization of human P-tau and AChE supports the conclusion that P-tau can act to increase AChE.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ACHE))
3f4b89ff-f795-459d-841f-2cb5884c9623	0.65	PubMed	17265414	Tau reportedly has a high capacity as a free radical scavenger and can modulate angiotensin II triggered Na + -Ca 2+ exchange and reduce angiotensin II induced cardiac hypertrophy and arrhythmia [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:AGT))
22eeed91-f0cf-4f0b-8aeb-06f3f8f0db67	0.94	PubMed	17075068	The long N-ter Tau fragment (1-230) is antiapoptotic and promotes the prosurvival effect of the AKT pathway.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:AKT))
22eeed91-f0cf-4f0b-8aeb-06f3f8f0db67	0.94	PubMed	12466300	In conclusion, for the first time, we showed that Tau enhances liver Akt activation and prevents beta-cell compensatory morpho-functional adaptations induced by HFD.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:AKT))
22eeed91-f0cf-4f0b-8aeb-06f3f8f0db67	0.94	PubMed	21596220	TAU induced antiapoptotic effect is PI3K and AKT dependent, which was proved in ACR intoxicated ventral spinal cord 4.1 cells in the presence of AKT inhibitor, MK-2206.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:AKT))
22eeed91-f0cf-4f0b-8aeb-06f3f8f0db67	0.94	PubMed	18362561	XREF_FIG), suggesting that tau phosphorylation was modulated by augmented neurotrophin mediated Trk dependent Akt and GSK3beta signaling in transgenic mice, because GSK3beta is the major kinase phosphorylating tau and its activity is suppressed by Akt mediated phosphorylation at Ser9 [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:AKT))
af9bee62-7719-410a-b11a-39f131ef151a	0.65	PubMed	17546346	Interestingly, it was demonstrated that exposure of mouse cortical neurons to amyloid beta peptide (a.a. 1-42) induced Ca 2+ -CaMKKbeta dependent activation of AMPK and hyperphosphorylation of tau.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:AMPK))
1abd3e3e-055c-44ac-848a-a4455faa418d	0.65	PubMed	15607829	Our results suggest that the MAPT H1 haplotype increases the risk of PD, PSP, and non APOE epsilon4 AD.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:APOE))
0be72d0f-84e6-4fe9-a760-da34a10b15ae	0.65	PubMed	20553310	Recent study has shown that reduction of tau expression prevents the cognitive deficits in the mutant APP without changing the level of Abeta [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:APP, var(p.?)))
5ad69123-bf88-4c99-b7db-67898dca74f3	0.94	PubMed	21453448	Interestingly, the MC1 conformation is induced by hyperphosphorylation of Tau at Ser199, Ser202, Thr205 and the PHF-1 sites [Ser396/404], causing compaction of the paperclip structure [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ATP7A))
5ad69123-bf88-4c99-b7db-67898dca74f3	0.94	PubMed	17244202	Interestingly, the MC1 conformation is induced by hyperphosphorylation of Tau at Ser199, Ser202, Thr205 and the PHF-1 sites [Ser396/404], causing compaction of the paperclip structure XREF_BIBR.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ATP7A))
5ad69123-bf88-4c99-b7db-67898dca74f3	0.94	PubMed	18753600	Interestingly, the MC1 conformation is induced by hyperphosphorylation of Tau at Ser199, Ser202, Thr205 and the PHF-1 sites [Ser396/404], causing compaction of the paperclip structure [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ATP7A))
5ad69123-bf88-4c99-b7db-67898dca74f3	0.94	PubMed	21445308	Interestingly, the MC1 conformation is induced by hyperphosphorylation of Tau at Ser199, Ser202, Thr205 and the PHF-1 sites [Ser396/404], causing compaction of the paperclip structure XREF_BIBR.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ATP7A))
f2ebd779-c21b-4904-bfc5-4d9e522cbd06	0.86	PubMed	17482349	Hence, replenishment of the mitochondrial stores of TAU will restore respiratory chain function and ATP synthesis at the cost of superoxide anion formation [XREF_BIBR], and, more importantly, spare pancreatic cells from death.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:15422))
f2ebd779-c21b-4904-bfc5-4d9e522cbd06	0.86	PubMed	18628614	Likewise, estrogen treatments can reverse deficits in ATP production caused by either Abeta or tau accumulation in SH-SY5Y cells [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:15422))
2ed27726-5f3b-4846-a795-6556aece0e71	0.65	PubMed	17074941	The Role of alpha-synuclein and Tau Hyperphosphorylation Mediated Autophagy and Apoptosis in Lead induced Learning and Memory Injury.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006914"))
2792ac68-e82f-47bd-a1f5-bb90af252af9	0.94	PubMed	22044258	In this study, we show that tau induced BDNF down-regulation is independent of the formation of NFTs.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:BDNF))
2792ac68-e82f-47bd-a1f5-bb90af252af9	0.94	PubMed	22044258	While these findings do not provide a singular mechanism of tau induced BDNF down-regulation alone, they do suggest that Abeta and tau may work both together and independently to down-regulate BDNF.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:BDNF))
2792ac68-e82f-47bd-a1f5-bb90af252af9	0.94	PubMed	22044258	Our current findings also indicate that tau induced BDNF down-regulation is an early event, which takes place prior to the formation of NFTs in hTau mice, consistent with previous reports of neurodegeneration in this model.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:BDNF))
2792ac68-e82f-47bd-a1f5-bb90af252af9	0.94	PubMed	22044258	Lastly, the recent discovery that the pathological accumulation of tau protein is a consequence of protein aggregation in a variety of neurodegenerative diseases suggests that tau induced BDNF down-regulation is a common mechanism of cognitive dysfunction in these disorders, and consequently, our findings have implications beyond the scope of AD.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:BDNF))
4be3cd0c-1301-47a6-bcd2-4d82969d1744	0.65	PubMed	17962560	Because tau is the product of the mutation rate, mu, and speciation time, T (tau = muT), variation in tau across chromosomes can be explained by variability in T and/or mu.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q8R015))
efb68eee-bee9-43e9-a725-6421e95d8bb6	0.65	PubMed	8561414	In our previous studies, taurine (Tau) and L-glutamine protected intestinal epithelial cells from local toxicity caused by sodium laurate (C12), an absorption enhancer, while maintaining sufficient absorption enhancing effect of C12, and it was suggested that one of the mechanisms behind cytoprotection by amino acids was to prevent intracellular Ca2+ concentration ([Ca2+] i) from increasing.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:92136105))
92dbdb9f-f52c-4d83-87e8-8dc89a4415d8	0.65	PubMed	22035381	Activated CaM kinase II causes hyperphosphorylation of the cytoskeletal proteins : MAP-2;, tau, alpha- and beta-tubulin, neurofilament triplet proteins and myelin basic protein.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:CALM))
06e5e32d-dac5-470e-9e08-a753f9f0a15f	0.95	Other	sparser:Unknown	These results suggest that the truncated Tau protein activates proximal caspase-8 through FADD as a necessary step leading to neuronal cell death and neurite regression, contributing to the progression of abnormal Tau-associated neurodegeneracy.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CASP8))
06e5e32d-dac5-470e-9e08-a753f9f0a15f	0.95	PubMed	7110725	These results suggest that the truncated Tau protein activates proximal caspase-8 through FADD as a necessary step leading to neuronal cell death and neurite regression, contributing to the progression of abnormal Tau associated neurodegeneracy.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CASP8))
06e5e32d-dac5-470e-9e08-a753f9f0a15f	0.95	PubMed	PMC7110725	These results suggest that the truncated Tau protein activates proximal caspase-8 through FADD as a necessary step leading to neuronal cell death and neurite regression, contributing to the progression of abnormal Tau-associated neurodegeneracy.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CASP8))
59529e6f-ef54-45be-9027-096487c7a4b2	0.86	PubMed	17273232	Furthermore, TAU inhibited LPO and enhanced the activity of GPx, GR, SOD, and CAT in the renal tissue.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CAT))
59529e6f-ef54-45be-9027-096487c7a4b2	0.86	PubMed	11429275	Besides, Tau also enhanced (p < 0.05) liver antioxidant capacities (GSH, TEAC, SOD, and CAT) and decreased (p < 0.05) lipid peroxidation (MDA), which alleviated liver damage in the high-fat and cholesterol dietary hamsters.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CAT))
229e4f54-061e-423c-ac1a-ba82683c3caf	0.65	PubMed	16948559	Two kinases, Tau tubulin kinase 2 (TTBK2) [XREF_BIBR] and microtubule associated protein and microtubule affinity regulating kinase 4 (MARK4) [XREF_BIBR], are reported to initiate ciliogenesis by excluding CP110 from the mother centriole.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CCP110))
eacb9352-f917-4064-a7ec-d8f5271d1e7b	0.86	PubMed	11972479	Here, we show that phosphorylation of tau at tyrosine 18, which is a fyn phosphorylation site within PAD, prevents inhibition of anterograde FAT induced by both filamentous tau and 6D tau.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CD36))
eacb9352-f917-4064-a7ec-d8f5271d1e7b	0.86	PubMed	18927424	In addition to stabilizing MTs, tau may also modulate FAT (fast axonal transport) along MTs, as overexpression of tau in neuronal culture systems decreased the binding of motor proteins to MTs [XREF_BIBR - XREF_BIBR], thereby affecting FAT.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CD36))
2e503806-9890-42d6-9c42-3d50bc26eb07	0.65	PubMed	18884011	Increased tau expression caused approximately 50% of the CD3d signal to shift from the cytoplasmic to the microsomal fraction (XREF_FIG; * p < 0.05 n = 3 independent experiments).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CD3D))
03366da4-58d8-41a9-aee6-b60c51463f51	0.65	PubMed	20341739	In addition, our current data support that tau triggered CD8 + T cell infiltration in the brain contributes to the development of memory impairments.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:CD8))
f376b7ae-c7c8-473a-ac05-814b1122b38e	0.65	PubMed	16901214	Therefore, we conclude that although IGF-1R signaling can affect the phosphorylation status of tau, perhaps through p25 mediated activation of Cdk5 and/or other non defined mechanisms, the increased transcription of the DYRK1A, GSK3beta, CDK5P35, and CDK5P39 genes observed in p44 +/+ mice was not linked to the hyperactivation of IGF-1R.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CDK5))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	22053992	2 On this basis, the DHA dose in MAPT likely would have increased CSF concentrations by less than 20%.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	18461270	The addition of t-tau or p-tau to Abeta42 (as ratios) significantly increased the diagnostic accuracy of CSF biomarkers (XREF_TABLE).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	18703856	Tau protein fragment of 17 kDa, the alphaII-spectrin breakdown product of 150 kDa (SBDP150) and the collapsing response mediated protein-4 were increased in the CSF after the brain insult.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	18462837	Another mechanism associated with slowing of the EEG is progressive cortical hypoperfusion (), where disturbed connections in autoregulation or regulation from deeper areas on vessels could be a possible contributor.Irrespectively of the specific theory behind increased theta power, all mentioned theories above could be related to neuronal degeneration, which is reflected by tau protein increase in the CSF as suggested by the present study.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	22976236	14 However, it is unknown whether APOE epsilon4 and CSF phospho-tau (p-tau) concurrently modulate the effect of CSF Abeta on longitudinal brain atrophy in preclinical AD.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	22615831	Taken together, our results indicate that hyperphosphorylation and cleavage of tau by favoring its secretion could contribute to the propagation of tau pathology in the brain and its accumulation in the CSF.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	17327220	Taken together, our results indicate that hyperphosphorylation and cleavage of tau by favoring its secretion could contribute to the propagation of tau pathology in the brain and its accumulation in the CSF.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	12601631	Taken together, our results indicate that hyperphosphorylation and cleavage of tau by favoring its secretion could contribute to the propagation of tau pathology in the brain and its accumulation in the CSF.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	11521001	To investigate factors, including cognitive and brain reserve, which may independently predict prevalent and incident dementia of the Alzheimer type (DAT) and to determine whether inclusion of identified factors increases the predictive accuracy of the CSF biomarkers Abeta (42), tau, ptau (181), tau and Abeta (42), and ptau (181)/Abeta (42).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
1bff50e2-1003-4c8f-a11d-dce685289e19	0.95	PubMed	18213497	This finding is consistent with the observation that tau is secreted into the extracellular space XREF_BIBR in an activity dependent fashion XREF_BIBR XREF_BIBR, and supports the concept that soluble oligomeric tau, whether secreted in oligomeric form per se or oligomerized outside the cells, can be detected in CSF.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:CSF2))
a81b934f-3713-4fdf-80c0-d5a8d38ab712	0.92	PubMed	15150256	In N2a cells we observed this even in cells without tangle load, whilst in primary hippocampal neurons transient Tau (RDDelta) expression alone caused similar Ca (++) dysregulation.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:29108))
a81b934f-3713-4fdf-80c0-d5a8d38ab712	0.92	PubMed	16848772	In N2a cells we observed this even in cells without tangle load, whilst in primary hippocampal neurons transient Tau RDDelta expression alone caused similar Ca ++ dysregulation.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:29108))
a81b934f-3713-4fdf-80c0-d5a8d38ab712	0.92	PubMed	18364361	In this paradigm, tau reduction decreased, whereas tau overexpression increased NMDAR dependent Ca 2+ influx.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:29108))
e5e7bcb7-999f-4ddc-b83a-eb05787414a4	0.65	PubMed	12851779	In young rats (8-weeks-old), sevoflurane significantly enhanced MAPT induced DA when administered both intraperitoneally and perfused locally, whereas no significant additive interaction was found in middle aged rats.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:18243))
2a1927e0-01fb-4e05-ba15-88eb04bb1554	0.65	PubMed	26751493	When the heat stress occurs, tau protein binds to DNA and enhances DNA repair [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006281"))
2aa139c3-fa9d-4a54-a510-c4cfe3e17207	0.94	PubMed	18787790	Tau phosphorylation at Thr212, Ser202, and Ser404 is significantly increased in DYRK1A transgenic mice overexpressing human DYRK1A.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:DYRK1A))
2aa139c3-fa9d-4a54-a510-c4cfe3e17207	0.94	PubMed	18787790	This suggests that the contribution of R3 tau to neurofibrillary degeneration is much more significant in the brains of people overexpressing DYRK1A, and that this contribution varies substantially among brain structure (from 1.2 x in sector CA1 to 3.7 x in the frontal cortex).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:DYRK1A))
2aa139c3-fa9d-4a54-a510-c4cfe3e17207	0.94	PubMed	21157379	Tau phosphorylation at Thr212, Ser202, and Ser404 is significantly increased in DYRK1A transgenic mice overexpressing human DYRK1A (XREF_BIBR).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:DYRK1A))
2aa139c3-fa9d-4a54-a510-c4cfe3e17207	0.94	PubMed	21157379	This suggests that the contribution of R3 tau to neurofibrillary degeneration is much more significant in the brains of people overexpressing DYRK1A, and that this contribution varies substantially among brain structure (from 1.2 x in sector CA1 to 3.7 x in the frontal cortex).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:DYRK1A))
33738059-e5d1-402a-93ad-f9227cdb30f6	0.65	PubMed	17292230	Tau Phosphorylation and mu-Calpain Activation Mediate the Dexamethasone Induced Inhibition on the Insulin Stimulated Akt Phosphorylation.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF15198))
026db5cd-8207-4594-b67a-a1e21a310d84	0.65	PubMed	18340930	Taken together, our data support a novel mechanism by which tau directly regulates EB properties at microtubule ends.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF01683))
2592911a-200a-4905-b38c-8a30cea14d96	0.65	PubMed	2288739	With added EDTA, tau increases sigmoidally from tau 0 at 0 EDTA to a maximum (mean tau m = 142 +/- 23 s) at approximately 200 microM EDTA.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:6049))
8627cad3-1fe3-417c-aa64-0877270ebf1f	0.65	PubMed	18557492	On the other hand, stimulation of the MRC biogenesis and functions in neurons of brain by E 2 / ERs offsets the damage on mitochondrial functions caused by Tau and fAbeta and thus, are implicated in protection against AD.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q38846))
795bdf28-4c6a-4b78-9965-aa53e6a45448	0.94	PubMed	20153279	The excessive abnormal phosphorylation of Tau protein will also cause ER stress, which is a pathological feedback loop [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ESR1))
795bdf28-4c6a-4b78-9965-aa53e6a45448	0.94	PubMed	18884011	Our data thus far suggests that tau impedes clearance of ubiquitinated proteins from the ER and causes an ER stress response.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ESR1))
795bdf28-4c6a-4b78-9965-aa53e6a45448	0.94	PubMed	18884011	We tested whether acute up-regulation of tau could activate the ER stress response using this system.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ESR1))
795bdf28-4c6a-4b78-9965-aa53e6a45448	0.94	PubMed	17595337	Thus, an elevated level of tau in differentiated N2a cells causes a retraction of the ER structure in the cell body similar to the effect seen in CHO cells, leading to a decrease of the ER in neurites, presumably by affecting intracellular transport processes.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:ESR1))
bbbf79a2-9029-4d6f-b6ef-045697df6b2e	0.65	PubMed	18836973	Increasing R a would increase tau, which would cause the ETI to charge more slowly, so our results should be interpreted as the maximum possible error.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:1781))
718aca0a-ec34-4290-915c-af5b05f638d5	0.65	PubMed	15724824	Considering that zebrafish is a suitable vertebrate to assess agonistic behaviors using noninvasive protocols, we investigate whether TAU modulates EtOH induced aggression in zebrafish using the mirror induced aggression (MIA) test.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:702))
7fe70362-514e-4203-9c3d-146ab852dbec	0.65	PubMed	18584828	The oocyte polarity and microtubule defects in egg chambers with ectopic Par-1 kinase activity are alleviated when Tau is cooverexpressed, suggesting that Tau is a target of Par-1 in the oocyte to regulate the microtubule polarity.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:F2R))
aa15330e-b48c-4d8f-a721-d9677008b76c	0.94	PubMed	24646911	It was also proposed that phosphorylation of tau drives the association of FKBP51 with tau, suggesting that as tau dissociates from the microtubules, it is recognized by the chaperone machinery and primed for dephosphorylation.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:FKBP4))
aa15330e-b48c-4d8f-a721-d9677008b76c	0.94	PubMed	17200775	It was also proposed that phosphorylation of tau drives the association of FKBP51 with tau, suggesting that as tau dissociates from the microtubules, it is recognized by the chaperone machinery and primed for dephosphorylation.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:FKBP4))
aa15330e-b48c-4d8f-a721-d9677008b76c	0.94	PubMed	18707150	We also show that phosphorylation of tau drives the association of FKBP51 with tau, suggesting that as tau falls from the microtubules, it is recognized by the chaperone machinery and primed for dephosphorylation (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:FKBP4))
aa15330e-b48c-4d8f-a721-d9677008b76c	0.94	PubMed	20071522	We also show that phosphorylation of tau drives the association of FKBP51 with tau, suggesting that as tau falls from the microtubules, it is recognized by the chaperone machinery and primed for dephosphorylation (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:FKBP4))
6cc1ad40-922c-4822-86db-759bc706de59	0.65	PubMed	18461758	The bvFTD clinical syndrome remains the most pathologically heterogenous subtype, caused most frequently by TDP-43 and tau pathologies, less frequently FUS, in addition to other more rare pathologies.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:FUS))
8622d199-7174-4a6e-96be-ac74e2b42dc3	0.65	PubMed	17082211	High Tau Expression Causes Redistribution of Somatodendritic NFs and f-Actin in ABCs.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q2Y2M3))
42d7c0d3-0fb9-4345-8b53-c536f8133fbf	0.92	PubMed	19895707	Tau induced bundling of muscle and platelet F-actin (diameter 54.84 +/- 31.84 nm, n = 30).	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:"F_actin"))
42d7c0d3-0fb9-4345-8b53-c536f8133fbf	0.92	PubMed	19895707	These reports provide evidence that tau may act like polycations to induce F-actin to form bundles.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:"F_actin"))
42d7c0d3-0fb9-4345-8b53-c536f8133fbf	0.92	PubMed	21156460	Panel B outlines the effect of the Ca2+ chelator MAPT on LTD4 induced F-actin reorganisation; the cells were prein cubated in the absence (_) or presence (0) of 10 11M MAPTIAM for 1 h and then stimulated with 40nM LTD4 for 10 or 30s.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:"F_actin"))
97474576-1bc5-4392-961b-293ed20e1cac	0.86	PubMed	17503994	In addition, Tau and lysine can increase both GABA synthesis and effects, while Asp and Glu most likely inhibit GABA effects [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:119))
97474576-1bc5-4392-961b-293ed20e1cac	0.86	PubMed	20551254	In addition, TAU stimulates GABA release in vitro (Leach, 1979) and this is likely to be the case in vivo also.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:119))
7683c606-07bd-4092-aec2-2f97249c87df	0.65	PubMed	15855649	Taken together, the above observations indicate that the fragmentation of the GA induced by tau protein or by mutant FTDP-17-related forms of tau is different from that observed in apoptotic cells.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:30778))
7b2eae68-abef-48de-b54f-56071f5f550c	0.65	PubMed	12449630	The majority of familial FTLD cases are caused by mutations within Microtubule Associated Protein Tau (MAPT) gene, leading to FTLD-TAU, or Progranulin (PGRN) gene, leading to FTLD-TDP.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:GRN))
1394f113-ec78-4485-a4ce-ca02c934ba91	0.65	PubMed	12068258	Both forms of Tau expression increased glycogen synthase kinase-3 (GSK-3) activity, polo like kinase-2 (PLK2) levels and decreased protein phosphatase activity, but had no effects on casein kinase-1 (CK1).	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:GYS))
ec5a2b3a-aeb1-444c-b4fe-26ee77bcbc3a	0.65	PubMed	19895707	This result indicated that tau can both induce polymerization of G-actin to F-actin and to F-actin bundles.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q8JTH0))
86e98127-d952-48ae-81c7-bfa849f8ffbb	0.86	PubMed	8241844	Here we show that overexpression of human tau and of some of its N-terminal fragments in primary neuronal cultures leads to an N-methyl-D-aspartate receptor (NMDAR)-mediated and caspase independent cell death.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q9R1M7))
86e98127-d952-48ae-81c7-bfa849f8ffbb	0.86	PubMed	16477009	Here we show that overexpression of human tau and of some of its N-terminal fragments in primary neuronal cultures leads to an N-methyl-D-aspartate receptor (NMDAR)-mediated and caspase independent cell death.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q9R1M7))
d3a090e8-ac8e-445c-b059-a4ff5d654a86	0.65	PubMed	24581495	The binding of Tau, however, did not modulate the shape of Hsp90.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:HSP90))
4791396c-a2d3-4760-9615-62bbdb9c947e	0.65	PubMed	7606024	Recent work has shown that tau phosphorylation at substrate sites for the kinases Cdk5 and GSK3-beta can trigger the binding of tau to the chaperones Hsc70 and Hsp27.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:HSPA8))
cde06d45-5fc4-42d3-aaf0-22f4d9de9dda	0.65	PubMed	16500040	Smokers with schizophrenia who received COMB-EXT (with or without HV) had greater reductions in cigarettes per day than those treated with TAU (both ps <.01).	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:7021871))
ee7627e7-556d-4481-81eb-3ee53b0eddbb	0.65	PubMed	7056843	During hypoxia, the PSP decreased to 70 +/- 2 mm Hg, while EDP, Tau, and coronary flow increased to 26 +/- 2 mm Hg, 104 +/- 14 ms, and 70 +/- 2 ml/min/g (dry), respectively; palmitate oxidation and oxygen consumption decreased well below baseline.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:101179))
1d05a69c-3595-4b61-8a77-5b8d3fe235d9	0.65	PubMed	17292230	Because tau hyperphosphorylation can occur long before the onset of symptoms and may play a key role in AD pathogenesis and/or progression, it is possible that tau hyperphosphorylation could contribute to the brain IR in AD.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:INSR))
abe32475-1f0a-46fc-9921-b76b48c18f0b	0.95	PubMed	20020422	Insulin secretion of isolated pancreatic islets of OVXH mice was higher than OVXC, and the addition of TAU associated with a HFD did not modulate insulin secretion, suggesting a failure of pancreatic beta cells of OVXHT mice.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:INS))
abe32475-1f0a-46fc-9921-b76b48c18f0b	0.95	PubMed	13191733	TAU supplementation increased insulin secretion in both normal protein and malnourished mice.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:INS))
abe32475-1f0a-46fc-9921-b76b48c18f0b	0.95	PubMed	17584447	We found that CCH caused significant short-term memory deficits and mild long-term spatial memory impairment, as well as decreased level of protein O GlcNAcylation, increased level of tau phosphorylation, dysregulated synaptic proteins and insulin signaling, and selective neurodegeneration in the brain.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:INS))
abe32475-1f0a-46fc-9921-b76b48c18f0b	0.95	PubMed	14117402	We found that CCH caused significant short-term memory deficits and mild long-term spatial memory impairment, as well as decreased level of protein O GlcNAcylation, increased level of tau phosphorylation, dysregulated synaptic proteins and insulin signaling, and selective neurodegeneration in the brain.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:INS))
abe32475-1f0a-46fc-9921-b76b48c18f0b	0.95	PubMed	13191568	TAU promoted increased hypothalamic insulin action only in CH mice which was linked to prevention of overfeeding, obesity, and glucose intolerance.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:INS))
abe32475-1f0a-46fc-9921-b76b48c18f0b	0.95	PubMed	11115953	In conclusion, TAU supplementation increases insulin secretion in response to glucose, favouring both influx and internal mobilisation of Ca2+, and these effects seem to involve the activation of both PLC-inositol-1,4,5-trisphosphate and cAMP-PKA pathways.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:INS))
3f536fa7-26f2-465c-9c93-2932d0b993f5	0.65	PubMed	13149609	Tau reduction decreased Kcna1 (-/-) video-EEG recorded seizure frequency and duration as well as normalized Kcna1 (-/-) hippocampal network hyperexcitability in vitro.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:KCNA1))
1d2a134c-d467-4676-ace5-cd5e161cac77	0.65	PubMed	21193058	Tau, a microtube associated protein, causes a clustering of the stacked micelles in Ca <ce:sup loc="post"> 2+ </ce:sup> and Ba <ce:sup loc="post"> 2+ </ce:sup> but forms shorter, thinner stacks in Mg <ce:sup loc="post"> 2+ </ce:sup> and Ca <ce:sup loc="post"> 2+ </ce:sup> with monovalent salts (KCl or NaCl).	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:4873))
441b51b1-5d6e-44ea-bdbd-1730c5462da2	0.65	PubMed	22072389	Both Tau and RK obstacles did not measurably increase kinesin-1 and kinesin-2 protofilament switch frequencies.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q07970))
5c1f9505-b5e2-484d-b054-57f77c17d47e	0.65	PubMed	15358542	Here, we demonstrate that tau mediates the neurotoxic effects of LPS in Cx3cr1 (-/-) mice.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:16412))
f33c6009-0946-4843-90e0-5125eccab7c6	0.86	PubMed	22658533	The results suggest that polymorphisms of BST1, SNCA, MAPT and PARK16 genes and loci, alone or in combination, can modulate the penetrance of LRRK2-PD to a varying degree.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:LRRK2))
f33c6009-0946-4843-90e0-5125eccab7c6	0.86	PubMed	18791320	Similarly to WT LRRK2, the presence of MTs enhanced the phosphorylation of tau by G2019S LRRK2 at T149, T153, and T205 (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:LRRK2))
240a1a0d-d8a2-450c-809f-5c4da13eebe8	0.65	PubMed	17861066	It has been described that loss of tau prevents LTD and it may result in a deficit in spatial reversal learning [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF00932))
c0affe49-d057-4823-8bc2-f67ec9d1d1f4	0.65	PubMed	11555673	We demonstrate that the absence of tau protein prevents Abeta induced impairment of LTP.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:P80450))
08670199-de1c-4f5a-a6cb-d4ad5604638c	0.86	PubMed	16823354	In comparison with non diabetic controls DiabCo group showed remarkably reduced MAP, LVSP, EF, SW, dP/dt max and impaired dP/dt min values, while LVEDP and Tau increased, indicating LV systolic and diastolic dysfunction.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:6993116))
08670199-de1c-4f5a-a6cb-d4ad5604638c	0.86	PubMed	16162854	NXT resulted in stable compensated CKD and HFpEF [hypertrophied left ventricle, prolonged LV isovolumetric relaxation constant TAU (IVRc TAU), elevated end diastolic pressure (EDP), increased lung weight (pulmonary congestion), and preserved LV systolic function (EF, dP/dt)].	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:6993116))
0b4198b0-57d6-4389-96fc-54ddabc6d13c	0.65	PubMed	4045608	Control tau increased from 18.0 +/- 6 msec to 29.1 +/- 7.5 with 1.5 MAC I and from 20.8 +/- 5.9 to 30.0 +/- 11.3 with 1.5 MAC H (P < 0.05).	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:MAC))
9b866d1e-afd7-4222-a205-a76ac8d0fccd	0.65	PubMed	20553266	</ce:simple-para> </ce:abstract-sec> </ce:abstract> <ce:keywords class="keyword"> <ce:section-title> Keywords </ce:section-title> <ce:keyword> <ce:text> Alzheimer 's disease </ce:text> </ce:keyword> <ce:keyword> <ce:text> Microtubule associated protein tau </ce:text> </ce:keyword> <ce:keyword> <ce:text> Mitogen activated protein kinase </ce:text> </ce:keyword> <ce:keyword> <ce:text> Protein phosphatase 2A </ce:text> </ce:keyword> </ce:keywords> </head> <tail> <ce:bibliography id="R0005" view="all"> <ce:section-title> References </ce:section-title> <ce:bibliography-sec id="RS0005"> <ce:bib-reference id="BIB1"> <ce:label> [1] </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> M. </ce:given-name> <ce:surname> Goedert </ce:surname> </sb:author> <sb:author> <ce:given-name> S.S. </ce:given-name> <ce:surname> Sisodia </ce:surname> </sb:author> <sb:author> <ce:given-name> D.L. </ce:given-name> <ce:surname> Price </ce:surname> </sb:author> </sb:authors> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> Curr.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MAPK1))
31317826-6528-4088-aabd-c8ea64563c76	0.65	PubMed	15033470	Fluorescence recovery after photobleaching assays performed in neuroblastoma cells confirmed that tau modulates EB3 cellular mobility.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MAPRE3))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	18960182	[XREF_BIBR] Instead, upon binding to MTs, tau is found to modulate the diameter of MTs by increasing the MT protofilament number <N pf> (i.e. the average number of protofilaments in MTs) with increasing tau density.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	17533060	Phosphorylation at specific sites detaches Tau from MTs and allows MT depolymerization, while Tau dephosphorylation enables it to bind and stabilize the MT XREF_BIBR - XREF_BIBR.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	24086739	Over-active tau mediated MT nucleation could easily have deleterious effects upon mature neurons.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	17630250	Another means by which tau mediates MT stability is its role in protecting MTs from the enzymatic severing by katanin, a process that is thought to be impacted upon in AD and tauopathies, due to the loss of tau-MT localization when tau is phosphorylated.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	18324451	This work has shown that Tau promotes MT stability and reduces MT dynamics.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	18237242	However, this effect of OKA was reversed by treating the neurons with previously described MT stabilizing agent Peloruside A. Therefore, it can be proposed that OKA induced increases in GSK-3beta activity results in hyper-phosphorylation of tau, which causes MT destabilization.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	17082211	Moreover, since tau has been shown to modulate the activity of MT associated motor proteins that mediate dendritic transport [XREF_BIBR, XREF_BIBR], often in a disease specific [XREF_BIBR] or overexpression induced [XREF_BIBR] manner, it seems likely that toxicity resulting from tau accumulation at localized dendritic loci may have relevance to the pathogenesis of human tauopathies, which typically feature abnormal somatodendritic phosphotau accumulation.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	17712481	The primary function of tau protein is to modulate MT dynamics for maintaining neuronal processes and regulating axonal transport.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	17491119	Over-active tau mediated MT nucleation could easily have deleterious effects upon mature neurons.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	20193846	To define the effects of MT acetylation on MT defects caused by tau overexpression, we expressed human FTDP-17-associated V337M mutant tau in Drosophila and analysed genetic interactions between alpha-tub K40Q and the ectopically expressed tau by quantifying the density of perinuclear MT in larval muscle cells.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	18677332	The analysis of MT gelation with pure tubulin and purified MAPs demonstrated that MAP2 alone and not Tau is able to induce MT gelation, in a cAMP activated manner (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	18539316	Phosphorylation of the serine in these motifs disrupts tau binding to the MT and serves to regulate tau mediated MT assembly [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	12079337	Whereas MAP2 and tau induce thick MT bundling, MAP4 does not (most clearly demonstrated in Barlow.)	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	18422551	SAXS reveals Tau mediated hexagonally ordered MT bundles.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	17309722	Further characterization of representative ATPZ compounds showed they do not interfere with tau mediated MT assembly, and they are significantly more effective at preventing the fibrillization of tau than the Abeta (1-42) peptide which forms AD senile plaques.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	18549180	Further characterization of representative ATPZ compounds showed they do not interfere with tau mediated MT assembly, and they are significantly more effective at preventing the fibrillization of tau than the Abeta (1-42) peptide which forms AD senile plaques.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	18549180	Furthermore, examination of representative active compounds from this class showed that they do not interfere with tau mediated MT assembly.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	10438078	Further characterization of representative ATPZ compounds showed they do not interfere with tau mediated MT assembly, and they are significantly more effective at preventing the fibrillization of tau than the Abeta (1-42) peptide which forms AD senile plaques.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	26165593	Because MT assembly is modulated by the phosphorylation of T231 (), our data indicate that stabilization of the helical conformation is not responsible for the effect of T231 phosphorylation on Tau mediated MT assembly.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	26289831	In the case of tau induced MT bundles, a tau dimer is thought to be responsible for MT bundle formation.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	21242459	Whereas MAP2 and tau induce thick MT bundling, <ce:cross-refs refid="BIB25 BIB26 BIB27 BIB28"> <ce:sup loc="post"> 25-28 </ce:sup> </ce:cross-refs> MAP4 does not <ce:cross-refs refid="BIB7 BIB19"> <ce:sup loc="post"> 7,19 </ce:sup> </ce:cross-refs> (most clearly demonstrated in Barlow <ce:italic> et al </ce:italic>.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	17593424	The increased ability of tau to induce MT polymerization had been previously reported for Q336R and S305N tau mutations, but the effect was small or unclear and not further investigated.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
2143bade-6c95-45e0-963d-3117f9a459fa	0.95	PubMed	26751493	Probably the most important role of tau protein is to promote assembly and stability of MT [XREF_BIBR, XREF_BIBR], although this function is complemented by other MAP (especially by MAP1B), as tau knockout mice are viable, fertile, and relatively normal, with no signs of neurodegeneration.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCAT))
5acc6602-4c03-4ab7-b5d1-d5f64d7131fa	0.92	PubMed	18698372	These include cerebral spinal fluid biomarkers such as increased p-tau and Abeta42 ratios in cognitively normal individuals which enhance the probability of conversion to MCI (mild cognitive impairment) [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCIDAS))
5acc6602-4c03-4ab7-b5d1-d5f64d7131fa	0.92	PubMed	17587713	The analysis of likelihood ratios showed that, in both situations, a CSF test result indicating pathological values of Abeta 42 / p-tau or p-tau significantly increase the probability that the disease is present [in this context progression from MCI to AD or, in other words, MCI due to AD].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCIDAS))
5acc6602-4c03-4ab7-b5d1-d5f64d7131fa	0.92	PubMed	18786283	These include CSF biomarkers such as increased p-tau and Abeta42 ratios in cognitively normal individuals which enhance the probability of conversion to MCI.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MCIDAS))
5deaf291-382f-498a-9618-6c3937da0e53	0.65	PubMed	18892888	Our findings indicate that p.Q336H mutation in exon 12 of MAPT causes hereditary PiD with neuropathologic, biochemical, and clinical phenotype indistinguishable from sporadic PiD.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MTA2))
e7682702-579b-4d4d-aa19-c95193eed0a8	0.65	PubMed	18950918	Together, these data suggest that mTOR hyperactivity, which can be caused by Abeta or tau accumulation, may mediate neurodegeneration as well as Abeta induced cognitive decline.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:MTOR))
53f9c23d-3f84-4b0d-baf1-76c8c69d3d0e	0.95	PubMed	17712524	Remarkably, we found that tau knockdown prevented the redistribution of dynamic MTs toward the far side of the growth cone facing away from the Wnt5a gradient.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05175))
53f9c23d-3f84-4b0d-baf1-76c8c69d3d0e	0.95	PubMed	21130530	On the other hand, tau overexpression causes MTs to bundle and this impedes mitochondrial movement, leading to mitochondrial degeneration, loss of adenosine triphosphate (ATP) and synaptic degeneration ().	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05175))
53f9c23d-3f84-4b0d-baf1-76c8c69d3d0e	0.95	PubMed	23659998	In conclusion, we have identified, by FRET and FRAP, a discrete Tau-MT interaction, in which Tau could induce conformational changes of MTs, favoring recovery of MT self-assembly.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05175))
53f9c23d-3f84-4b0d-baf1-76c8c69d3d0e	0.95	PubMed	17586722	Inappropriate localization of CDK5 can contribute to the formation of NTF by Tau hyperphosphorylation and release from MTs, thereby inducing the breakdown of axonal transport with resulting mitochondrial and lysosomal dysfunction.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05175))
53f9c23d-3f84-4b0d-baf1-76c8c69d3d0e	0.95	PubMed	7425783	Using fluorescence recovery after photobleaching, we find that tau induces Taxol to bind MTs cooperatively depending on the tau concentration.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05175))
53f9c23d-3f84-4b0d-baf1-76c8c69d3d0e	0.95	PubMed	18802461	23 Thus loss of normal function of tau protein induces structural and functional impairments of MTs.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05175))
53f9c23d-3f84-4b0d-baf1-76c8c69d3d0e	0.95	PubMed	13401566	In conclusion, we have identified, by FRET and FRAP, a discrete Tau-MT interaction, in which Tau could induce conformational changes of MTs, favoring recovery of MT self-assembly.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05175))
dbad043b-d85f-4c2a-8c9c-1a5b66f57220	0.65	PubMed	18251824	The initial slope of recovery was greater in hearts before inhibition (XREF_FIG) and tau was shorter (XREF_FIG), demonstrating significantly increased NADH and ATP production rates when contraction is not inhibited.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:928))
c732c74b-902e-479a-bedb-f18f930f6c37	0.65	Other	sparser:Unknown	In a related report from our laboratory, we have shown that netrin-1 preserves mitochondrial Integrity via NO dependent attenuation of NADPH oxidase isoform 4 (NOX4) activation and eNOS uncoupling ex vivo   xref  .	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:"NADPH_oxidase"))
e338b5e8-ed36-4cdb-a1ec-30849618e174	0.65	PubMed	17636789	It is unclear whether tau accumulation or its conformational changes are related to tau induced ND [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:25145403))
54231bc4-9986-4dbd-8e2a-64dbfec50fe8	0.86	PubMed	6545322	These findings suggest that (1) LB pathology can influence the clinical features of familial AD, (2) the E184D mutation of presenilin-1 may be associated with the LB formation through Abeta overproduction, although the process of LB formation is strongly affected by other unknown mechanisms, (3) in neurodegenerative disorders with LBs, there is a common pathophysiological background inducing NAC accumulation in neuritic plaques and astrocytes, and (4) the NAC accumulation in neuritic plaques is modulated by the abnormally aggregated tau protein.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:7421))
54231bc4-9986-4dbd-8e2a-64dbfec50fe8	0.86	PubMed	17405244	Corresponding OPLS-DA loading S-plots showed that Tau, Cho, and GPC were contributing metabolites for the prediction of a pathologic response to NAC (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:7421))
0cd5b34d-9394-41be-80f3-fd61eda334e1	0.92	PubMed	19074461	Tau knockdown impairs autophagy in NPC1 deficient cells.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:NPC1))
0cd5b34d-9394-41be-80f3-fd61eda334e1	0.92	PubMed	19074461	Control and NPC1 deficient cells were treated with MAPT or non targeted siRNAs, and then labeled for 48 hours with 3 H-leucine.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:NPC1))
0cd5b34d-9394-41be-80f3-fd61eda334e1	0.92	PubMed	19074461	NPC1 deficient fibroblasts treated with MAPT siRNAs demonstrated significantly lower levels of long lived protein degradation than cells treated with non targeted siRNAs (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:NPC1))
88f0763c-c1c6-4e94-8480-e055780e6d84	0.65	PubMed	18697348	Pseudophosphorylation of tau at the AT8 epitope (comprised of Ser199, Ser202, and Thr205) reduces the folding of the N terminus into the paperclip conformation, suggesting that phosphorylation of tau at these sites could increase PAD exposure.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF03068))
f6dc3de1-2629-4131-86ba-c610dcd9a73f	0.95	PubMed	26444794	Our results suggest that the MAPT H1 haplotype increases the risk of PD, PSP, and non APOE epsilon4 AD.	p(HGNC:MAPT)	directlyIncreases	act(bp(MESH:D010300))
f6dc3de1-2629-4131-86ba-c610dcd9a73f	0.95	PubMed	21130530	Therefore, our study is in agreement with the fact that hypophosphorylation of tau could also be a cause of PD and this is especially true for populations that are H1-only or with high frequency of H1 ().	p(HGNC:MAPT)	directlyIncreases	act(bp(MESH:D010300))
f6dc3de1-2629-4131-86ba-c610dcd9a73f	0.95	PubMed	24559644	The interaction between the functional promoter SNP and the variant may also imply that the overexpressed tau might potentiate the pathogenic effect of LRRK2 and accelerate the disease onset of the -associated PD.	p(HGNC:MAPT)	directlyIncreases	act(bp(MESH:D010300))
f6dc3de1-2629-4131-86ba-c610dcd9a73f	0.95	PubMed	16486494	The results showed that MPTP decreased the dopaminergic neurons in the substantia nigra and dopamine in the striatum, downregulated the expression of tyrosine hydroxylase (TH), induced the impairment of behavior and hyperphosphorylation of tau, However, 6-hydroxy-1-H-indazole decreased the loss of dopaminergic neurons, increased dopamine concentration and TH expression, alleviated the behavioral damage and level of phosphor-tau in the MPTP induced model of PD in C57BL/6 mice.	p(HGNC:MAPT)	directlyIncreases	act(bp(MESH:D010300))
f6dc3de1-2629-4131-86ba-c610dcd9a73f	0.95	PubMed	18759758	All interaction tests were far from nominal significance : while both SNCA and MAPT SNPs independently increased the risk of PD, their joint effects were not different from that expected under a multiplicative model.	p(HGNC:MAPT)	directlyIncreases	act(bp(MESH:D010300))
f6dc3de1-2629-4131-86ba-c610dcd9a73f	0.95	PubMed	21391235	All interaction tests were far from nominal significance : while both SNCA and MAPT SNPs independently increased the risk of PD, their joint effects were not different from that expected under a multiplicative model.	p(HGNC:MAPT)	directlyIncreases	act(bp(MESH:D010300))
f6dc3de1-2629-4131-86ba-c610dcd9a73f	0.95	PubMed	18509691	The MAPT gene on chromosome 17 has been extensively investigated in FTD 11 and has been recently implicated in AD 14 and PD, 15 suggesting that tau pathology might jointly contribute to FTD, AD and PD.	p(HGNC:MAPT)	directlyIncreases	act(bp(MESH:D010300))
f6dc3de1-2629-4131-86ba-c610dcd9a73f	0.95	PubMed	22013004	MAPT variants associated with FTD also increase the risk of developing PD.	p(HGNC:MAPT)	directlyIncreases	act(bp(MESH:D010300))
46efd7ce-15c8-407a-b10d-08a7b03660ec	0.86	PubMed	13635437	Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer 's disease and other tauopathies.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF06297))
46efd7ce-15c8-407a-b10d-08a7b03660ec	0.86	PubMed	13635437	We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF06297))
193e0bd9-6a04-4874-b209-ff0e6150a57a	0.65	PubMed	12430375	Forty Wistar male albino rats were used in the study and were divided into four groups : group 1, control; group 2, BLM induced PF group; group 3, BLM induced PF and treated with PA group; and group 4, BLM induced PF and treated with Tau group.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:35595))
396f76ba-f37f-4258-9d5b-66a7d3208f50	0.65	PubMed	16697218	Furthermore, abnormal Tau phosphorylation at Thr231 did not allow any change in Pin1 cellular distribution, arguing against the hypothesis of Pin1 nuclear depletion following Tau abnormal phosphorylation.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:PIN1))
e51df018-8e5d-4b8b-9354-55dea2c1053c	0.65	PubMed	11765358	PKA catalytic activity in cell-free extracts was stimulated by Tau and unchanged by Cys, Gly and Met.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:PKA))
f136cd0c-0726-4c17-8ab3-1e8dc5ca8e82	0.65	PubMed	12092206	PLCgamma1 can be activated by receptor tyrosine kinases (i.e. : PDGFR, EGFR, FGFR, Trk), as well as non receptor protein kinases (Src, Syk, Tec) or phosphatidic acid, tau protein and its analogue.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:PLCG1))
5af0b8bd-ece0-413f-aeb1-e40d7bcf2538	0.86	PubMed	16135025	Moreover, both variants of Tau produced extensive PM blebbing associated with cortical redistribution of filamentous actin (F-Actin).	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:1052))
5af0b8bd-ece0-413f-aeb1-e40d7bcf2538	0.86	PubMed	16135025	In addition, when glial cells showing Tau induced PM blebbing were incubated with inhibitors of the Rho associated protein kinase (ROCK) signaling pathway, both formation of abnormal PM blebs and F-Actin remodeling were avoided.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:1052))
56a42c38-068d-4fe0-ae80-a6017bfdaefa	0.65	PubMed	20213248	We achieve direct therapeutic targets such as APP, MAPT (also known as Tau), PPARG 70, MMP9, MMP2 XREF_BIBR, XREF_BIBR, and HTR2A (also known as 5-HT2A), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), and GRIA1 (glutamate ionotropic receptor AMPA type subunit 1) 73 or downstream potential targets such as PTGS2 74 or NOS2 75 that are associated with neuroinflammation or various diseases of nervous system.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:PPARG))
12ca26b8-dc6b-48e7-b3c2-7889c271519a	0.86	PubMed	19036150	Previous work indicated that PP1 is targeted to microtubules by the protein Tau, however, Tau has not been identified by proteomics in flagella from Chlamydomonas or in axonemal fraction from cilia of human cells.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:PPP1))
12ca26b8-dc6b-48e7-b3c2-7889c271519a	0.86	PubMed	18920648	However, recent work identified a signaling cascade by which pathological forms of tau activate axonal PP1.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:PPP1))
a7604866-b1c6-4ea8-8720-91cc059b9440	0.86	PubMed	4952200	Taurine (Tau), a putative inhibitory amino acid neurotransmitter, has been shown to stimulate prolactin (PRL) release.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:PRL))
a7604866-b1c6-4ea8-8720-91cc059b9440	0.86	PubMed	4952200	It is concluded that Tau acts at a central level to increase PRL secretion, most probably by modulating the hypothalamic release of neurotransmitters controlling lactotroph function.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:PRL))
242c2c42-ede7-4734-a59b-dbd3c6f6358b	0.65	PubMed	21261718	Abnormal phosphorylation of the tau protein that leads to NFT formation, BAP deposits, high concentration of amyloid precursor protein (APP), caspase-3, the presenilin 1 and 2 gene and nitric oxide are considered to be important triggers of neuronal and glial apoptosis <ce:cross-refs refid="BIB1 BIB2 BIB3 BIB4 BIB5 BIB6 BIB7 BIB8 BIB9 BIB10 BIB11 BIB12 BIB13 BIB14 BIB15 BIB16 BIB17 BIB18 BIB19 BIB20 BIB21 BIB22 BIB23 BIB24 BIB25"> [1-25] </ce:cross-refs>.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:PSEN1))
260bc1a5-57ac-4634-8dc1-249f317d90e3	0.65	PubMed	23684085	In tau, aminoacids 2-18 activate this pathway, suggesting that disease associated changes in the conformation of tau can increase exposure of the phosphatase activating domain.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Phosphatase))
6304541c-71d1-40a8-ba4e-0be74bd38497	0.92	PubMed	10351088	In addition, we found that an excess of tau protein, as a HDAC6 inhibitor, prevents induction of autophagy by inhibiting proteasome function.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Proteasome))
6304541c-71d1-40a8-ba4e-0be74bd38497	0.92	PubMed	17589397	Recently, Myeku et al. reported that tau can induce dysfunction of the 26S proteasome which can be prevented by activating cAMP-PKA signaling.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Proteasome))
6304541c-71d1-40a8-ba4e-0be74bd38497	0.92	PubMed	9106093	We further show that the phosphorylation of Tau by the LKB1-MARK signaling triggers proteasome mediated degradation of Tau.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Proteasome))
f87e7fae-2625-491f-b8c0-1831f4273cad	0.65	PubMed	17711880	Tau pathology promotes the formation of insoluble RBP aggregates.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:RBP4))
93d2cfcc-fdab-4c7f-bfd5-d723055d6b9c	0.86	PubMed	16849662	Based on the Reelin dependent modulation of several AD-relevant pathways, including APP proteolytic processing [XREF_BIBR, XREF_BIBR] and Tau phosphorylation [XREF_BIBR, XREF_BIBR], we were interested in determining whether these and other disease associated proteins were present in the aging associated Reelin-CAm deposits.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:RELN))
93d2cfcc-fdab-4c7f-bfd5-d723055d6b9c	0.86	PubMed	24252415	Based on the Reelin dependent modulation of several AD-relevant pathways, including APP proteolytic processing [XREF_BIBR, XREF_BIBR] and Tau phosphorylation [XREF_BIBR, XREF_BIBR], we were interested in determining whether these and other disease associated proteins were present in the aging associated Reelin-CAm deposits.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:RELN))
6d07dbfb-025f-4b5d-abd7-313a0d894a93	0.65	PubMed	25930997	POLDIP2 is also known as a regulator of NOX4; in smooth muscle cells, POLDIP2 induces RhoA via NOX4 activation and RhoA - ROCK (Rho kinase) increases Tau mediated neurodegeneration and RhoA and Rock inhibition by Rock inhibitor reduces Tau protein level.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:RHOA))
0ad9a129-f206-4190-bcda-a1ef872f6bcf	0.65	PubMed	21350363	</ce:para> </ce:section> <ce:section id="cesec150" view="all"> <ce:section-title> Okadaic-Acid-Induced Activation of ERK1/2, MEK1/2, and p70 S6 Kinase and Phosphorylation of Tau Are Reversed by PP-2A </ce:section-title> <ce:para id="para250" view="all"> To confirm that the increase in the immunohistochemical staining of the OA treated brain slices with antibodies to phosphorylated (active) kinases and to hyperphosphorylation of tau was specifically due to inhibition of PP-2A activity, and that the antibodies used were specific to the phosphorylated enzymes, we incubated some of the OA treated tissue sections with purified PP-2A before immunostaining.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:RPS6KB1))
0c2dfd01-0a0b-45c5-bbe4-de7402f667ca	0.92	PubMed	26751496	Tau is a product of the microtubule associated protein (MAPT) gene, located on chromosome 17q21.1 [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q9DCV4))
0c2dfd01-0a0b-45c5-bbe4-de7402f667ca	0.92	PubMed	16061179	In the current study, we examined the localization patterns of normal Tau and the potential blast induced accumulation of neurotoxic variants of this microtubule associated protein that are believed to potentiate the neurodegenerative effects associated with synaptic dysfunction in the hippocampus following three successive blast overpressure exposures in nontransgenic rats.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q9DCV4))
0c2dfd01-0a0b-45c5-bbe4-de7402f667ca	0.92	PubMed	17855665	Tau is a product of the microtubule associated protein (MAPT) gene, located on chromosome 17q21.1 [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q9DCV4))
5833391d-abcc-4bda-b474-bf2b44d90e52	0.65	PubMed	14251019	CK1epsilon (Tau) also accelerated in vitro molecular pacemaking in SCN lacking either PER1 or PER2, with a greater effect in PER2 dependent (i.e., Per1-null) SCN than in PER1 dependent slices.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:9322))
6ce45294-b54c-471e-8224-57bc2666d72c	0.86	PubMed	22558197	Tau induces cytoplasmic sequestration of SFPQ.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SFPQ))
6ce45294-b54c-471e-8224-57bc2666d72c	0.86	PubMed	17972626	SFPQ modulates the splicing of Tau, while Tau mediated the nuclear depletion of PSF and SFPQ in Alzheimer 's and Pick 's disease together with a cytoplasmic accumulation [XREF_BIBR - XREF_BIBR], as well as a depletion in the brain of Down syndrome cases [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SFPQ))
63c92296-7a6a-4e60-a8f7-0571a0b1189c	0.94	PubMed	17711880	Emerging evidence from several laboratories demonstrate that tau protein contributes to SG biology by promoting SG aggregation in a process that leads to tau concomitant aggregation.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:56951717))
63c92296-7a6a-4e60-a8f7-0571a0b1189c	0.94	PubMed	18529407	The role of tau in SG biology in neurons also suggests that kinases that regulate tau dynamics might also regulate tau mediated SG formation in neurons.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:56951717))
63c92296-7a6a-4e60-a8f7-0571a0b1189c	0.94	PubMed	18529407	PKR or PERK antagonists strongly inhibited tau mediated SG formation (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:56951717))
63c92296-7a6a-4e60-a8f7-0571a0b1189c	0.94	PubMed	18529407	We investigated whether inhibiting PKR or PERK, two kinases that phosphorylate eIF2alpha, might also inhibit tau mediated SG formation.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:56951717))
212f6c81-888a-4e2a-b7a4-777197c77154	0.86	PubMed	20190868	Moreover, Tau was also shown to stimulate the formation of SGs indicating that its interaction with the mRNA trafficking machinery maybe bi-directional [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05002))
212f6c81-888a-4e2a-b7a4-777197c77154	0.86	PubMed	18529407	Analysis of cells overexpressing tau (4R0N, P301L) showed a decrease in total protein synthesis (measured by SUnSET assay) in response to tau overexpression in a Tet inducible HEK WT tau (4R0N) cell line following addition of doxycycline, which is consistent with the data above suggesting that tau promotes SGs and the translational stress response (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05002))
410deb95-7117-4338-a2f4-dabda72eb881	0.65	PubMed	15795090	Fish were individually treated with TAU (42, 150, and 400mg/L) for 1h and the behaviors were further analyzed for 6min in the novel tank or in the light-dark test.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SH3PXD2A))
b8a8d63b-409e-4d89-bd85-c0816f82a57f	0.65	PubMed	12900789	We found a continuous raised hippocampal glutamate and an up-regulation of GLAST rather than GLT-1, NMDAR1, NMDAR2A/B, AMPAR or tau in hippocampus of aged rats associated with isoflurane induced learning and memory impairment.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SLC1A3))
27b66a5b-fdd7-4282-902e-9715eb5aca02	0.65	PubMed	18271258	Fig. 3A), and meanwhile, Doublecortin (DCX), beta-III tubulin (Tubb3), microtubule associated protein 2 (MAP2), NeuroD1, synapsin 1 (SYN1), neural cell adhesion molecule (NCAM), and microtubule associated protein Tau (MAPT) were all up-regulated (Sup.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNAP25))
37cdb0ca-9ff2-4299-989a-2aa351b25272	0.65	PubMed	14358834	Tau increased the protein content of the alpha1.2 subunit of the Cav channels and the SNARE proteins SNAP-25 and Synt-1 in CHT islets, whereas in RHT, Kir6.2 and Synt-1 proteins were increased.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF05739))
6acc531b-1c37-4e08-ab39-95f8cc7dd8f4	0.95	PubMed	21816655	It has been shown that MAPT induces fibrillization of alpha-synuclein [XREF_BIBR]; such fibrillization is proposed to be an initial step in the generation of PD-pathogenic alpha-synuclein aggregates.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNCA))
6acc531b-1c37-4e08-ab39-95f8cc7dd8f4	0.95	PubMed	17293050	Tau Enhances alpha-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNCA))
6acc531b-1c37-4e08-ab39-95f8cc7dd8f4	0.95	PubMed	17139348	XREF_BIBR Activation of autophagy ameliorates beta-amyloid peptides and MAPT and tau pathology in an Alzheimer disease mouse model, XREF_BIBR enhances autophagic clearance of SNCA and alpha-synuclein oligomers in dopaminergic neurons, XREF_BIBR alleviates behavioral motor abnormalities and neuropathology in Huntington disease models, XREF_BIBR and promotes clearance of mutant SOD1 (superoxide dismutase 1) in models of amyotrophic lateral sclerosis.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNCA))
6acc531b-1c37-4e08-ab39-95f8cc7dd8f4	0.95	PubMed	20346323	MAPT induces fibrillization of alpha-synuclein, such that fibrillization is considered to be an initial step in the generation of PD-pathogenic alpha-synuclein aggregates XREF_BIBR.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNCA))
6acc531b-1c37-4e08-ab39-95f8cc7dd8f4	0.95	PubMed	16846010	Tau expression also enhances the toxicity and secretion of alpha-synuclein and promotes the formation of smaller alpha-synuclein inclusions in human neuroglioma (H4) cells and primary neuronal cultures [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNCA))
6acc531b-1c37-4e08-ab39-95f8cc7dd8f4	0.95	PubMed	18509094	Furthermore, it has been shown that tau promotes the assembly of alpha-synuclein into fibrils, which can further aggregate into Lewy bodies, the pathologic hall-mark of PD.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNCA))
6acc531b-1c37-4e08-ab39-95f8cc7dd8f4	0.95	PubMed	21945393	The change in alpha-Synuclein in Tau models suggests that Tau accumulation, increases the risk of alpha-Synuclein accumulation and may be a risk factor associated with Synucleinopathies and Parkinsonian disorders, including PSP (XREF_BIBR) and CBD (XREF_BIBR).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNCA))
6acc531b-1c37-4e08-ab39-95f8cc7dd8f4	0.95	PubMed	22039514	Tau Enhances alpha-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNCA))
4be3fb06-634a-41fc-85e2-6bfd6524f2a3	0.65	PubMed	18529407	Loss of tau abrogates TIA1 binding to five out of 14 proteins in this core network, RPL6, RPL7, EWSR1, SNRNP70, and RBM17, which points to a role for tau in this translational and transport machinery (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SNRNP70))
4c7400b0-23dc-4b7b-9a00-5fd1aa177847	0.65	PubMed	15659100	CAR, but not TAU, significantly increased low activities of SOD and GSH-Px.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:SOD))
7ae36093-a805-4e22-9927-df59498ab08d	0.97	PubMed	24646911	As a scaffold protein, tau modulates the activity of Src tyrosine kinases, c-Src and Fyn, and facilitates c-Src-mediated actin rearrangements [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SRC))
7ae36093-a805-4e22-9927-df59498ab08d	0.97	PubMed	17200775	As a scaffold protein, tau modulates the activity of Src tyrosine kinases, c-Src and Fyn, and facilitates c-Src-mediated actin rearrangements [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SRC))
7ae36093-a805-4e22-9927-df59498ab08d	0.97	Other	sparser:Unknown	Here we investigated the activation of Src or Fyn by tau, both in vitro and in vivo.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SRC))
7ae36093-a805-4e22-9927-df59498ab08d	0.97	PubMed	27306859	More specifically, it has been found that tau is required to target the Src kinase Fyn to the post-synapse, where it phosphorylates NMDA receptor subunits which then recruit the adaptor protein PSD-95 to facilitate the formation of an excitotoxic protein complex (Ittner etal.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:SRC))
bf65ed95-d972-4040-8d93-ce453678fd1c	0.65	PubMed	17711880	Tau pathology increases somatodendritic localization of TIA1, which is predominantly nuclear in healthy or unstressed cells.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:TIA1))
8ede0b24-1639-43d5-a61c-5d787df77d6e	0.94	PubMed	13141114	Lentiviral Tau or P301L expression significantly increased caspase-3 activity and TNF-alpha, but CX3CL1 was significantly higher in animals expressing Tau compared to P301L.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:TNF))
8ede0b24-1639-43d5-a61c-5d787df77d6e	0.94	PubMed	18869506	Lentiviral Tau or P301L expression significantly increased caspase-3 activity and TNF-alpha, but CX3CL1 was significantly higher in animals expressing Tau compared to P301L.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:TNF))
8ede0b24-1639-43d5-a61c-5d787df77d6e	0.94	PubMed	16872403	Especially, hUCB derived MSCs significantly reduced the levels of Abeta, BACE1, and Tau hyperphosphorylation by regulating neuroinflammatory responses including alternatively elevated microglia and decreased proinflammatory cytokines (IL-1beta and TNFalpha).	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:TNF))
8ede0b24-1639-43d5-a61c-5d787df77d6e	0.94	PubMed	21945393	3.4- Tau P301L and Tau wt differentially increase microglial activation and levels of Interleukin-6 and TNF-alpha in vivo.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:TNF))
6a84bd7c-23a3-48cf-a898-40452f46dbbc	0.86	PubMed	16630784	Furthermore, we observed that exogenous Tau species increase the number of TNTs established between primary neurons, thereby facilitating the intercellular transfer of Tau fibrils.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:TNNT1))
6a84bd7c-23a3-48cf-a898-40452f46dbbc	0.86	PubMed	17709590	For instance, Tau and other prion like proteins promote the formation of TNTs between neurons and thus their own intercellular transfer via TNTs which results in prion like propagation of Tau assemblies and propagation of neurodegenerative pathology.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:TNNT1))
f192a5b5-92fa-4558-8785-7ad5f8403b0b	0.65	PubMed	19933256	gamma and epsilon isoforms but not tau and sigma enhance specific-DNA binding of p53 in vitro.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:TP53))
5f84cdbf-18a6-418d-b1cf-edfad2bcefc3	0.65	PubMed	16603788	To evaluate oligodendrocyte response in neurodegenerative diseases (NDDs) with different extents of oligodendroglial protein deposition we performed immunostaining for tubulin polymerization promoting protein p25alpha (TPPP and p25alpha), alpha-synuclein (alpha-syn), phospho-tau, ubiquitin, myelin basic protein, and the microglial marker HLA-DR.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:TPPP))
d4cad45f-75d7-4d9f-af2c-22fbc8338a5e	0.65	PubMed	17366265	This lowered all-cause mortality rate is consistent with a recent report comparing patients with TRD in the US Medicare system treated with TAU (46.2 per 1,000 person-years) with patients treated with VNS+TAU (19.9 per 1,000 person-years) XREF_BIBR.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:12388))
3ae1ec1e-62e5-4e22-a389-fc016e96c61f	0.65	PubMed	18621244	Pseudophosphorylation of Tau at S422 Enhances SDS-Stable Dimer Formation and Impairs Both Anterograde and Retrograde Fast Axonal Transport.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006810"))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	18891296	The tau protein promotes tubulin polymerization and stabilizes microtubules.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	16906779	Tau promotes microtubule bundling in HeLa cells at elevated tau : tubulin fluorescence ratios while the N-terminal domain responsible for tau mediated cross-bridges clearly antagonizes their formation at lower ratios.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	1430933	However, dramatic quantitative and qualitative differences are observed between NVB and VLB or VCR in TAU induced aggregation of tubulin.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	16906779	On the one hand, in the absence of macromolecular crowding, tau 2N induces the formation of bundles at elevated tau : tubulin molar ratios.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	4887952	This is the first report showing that natural osmolytes, TMAO and betaine, at a near physiological concentration are able to stimulate tau induced tubulin assembly.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	3623629	In a normal mature neuron, microtubule associated protein tau promotes the assembly of tubulin into microtubules and maintains the structure of microtubules.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	3623629	PHF-tau did not promote assembly of bovine tubulin into microtubules whereas tau from the dephosphorylated PHF produced a robust microtubule assembly.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	18742095	In contrast, the addition of unmodified tau greatly stimulated polymerization at all time points, and tau methylated at up to ~ 9 mol and mol promoted tubulin polymerization almost identically (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	17194941	It is well known that tau stimulates the assembly of tubulin into microtubules at tubulin concentrations below the critical concentration for tubulin self-assembly [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	20388155	This level of tau is more than sufficient to promote complete assembly of the tubulin, yet the tau bands are barely visible on stained gels.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	21017277	PHF-tau did not promote assembly of bovine tubulin into microtubules whereas tau from the dephosphorylated PHF produced a robust microtubule assembly.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	21017277	</ce:text> </ce:correspondence> </ce:author-group> <ce:date-received day="10" month="5" year="1994"/> <ce:abstract class="author"> <ce:section-title> Abstract </ce:section-title> <ce:abstract-sec> <ce:simple-para view="all"> In a normal mature neuron, microtubule associated protein tau promotes the assembly of tubulin into microtubules and maintains the structure of microtubules.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	20475017	Ennulat, D.J., Liem, R.K.H., Hashim, G.A. and Shelanski, M.L. (1989) Two separate 18-amino acid domains of tau promote the polymerisation of tubulin.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	20475017	</sb:maintitle> </sb:title> <sb:volume-nr> 76 </sb:volume-nr> </sb:series> <sb:date> 1986 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 173 </sb:first-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB10"> <ce:label> Ennulat et al., 1989 </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> D.J. </ce:given-name> <ce:surname> Ennulat </ce:surname> </sb:author> <sb:author> <ce:given-name> R.K.H. </ce:given-name> <ce:surname> Liem </ce:surname> </sb:author> <sb:author> <ce:given-name> G.A. </ce:given-name> <ce:surname> Hashim </ce:surname> </sb:author> <sb:author> <ce:given-name> M.L. </ce:given-name> <ce:surname> Shelanski </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> Two separate 18-amino acid domains of tau promote the polymerisation of tubulin </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> J. Biol.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	7425783	Both Taxol and tau reduce MT dynamics and promote tubulin polymerization.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	7611101	In the normal brain, tau promotes the assembly of tubulin into microtubules and maintains the structure of microtubules, which are required for axonal transport.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	24869773	In contrast, the addition of unmodified tau greatly stimulated polymerization at all time points, and tau methylated at up to ~ 9 mol and mol promoted tubulin polymerization almost identically (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	2855233	The ability of MAP2 and tau to induce tubulin polymerization in the presence of guanyl-5 '-yl methylene diphosphonate was compared in parallel experiments.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	2648152	Two different proteins, tau and microtubule associated protein 2 (MAP 2), are able to stimulate tubulin polymerization into microtubules in vitro, but it is not certain if both proteins act by the same mechanism.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	21015859	Tau promotes the assembly of tubulin into microtubules and stabilizes their structure.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	18200380	Tau promotes tubulin polymerization and stabilizes microtubules, while hyperphosphorylated tau induces axonal degeneration in Alzeheimer 's disease and leads to central nervous system disorders.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	18898638	Moreover, they demonstrate simultaneous association with multiple tubulin dimers, providing insight into a potential mechanism for tau mediated polymerization of tubulin.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	2561973	Two separate 18-amino acid domains of tau promote the polymerization of tubulin.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	20336839	Tau promotes the polymerization of tubulin into MTs 33 and, when bound to MTs, helps stabilize them in their polymerized state 34.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	18549180	As depicted in XREF_FIG, neither of the ATPZ 's had a meaningful effect on tau mediated tubulin polymerization.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	20045856	The microtubule associated protein Tau promotes the polymerization of tubulin and modulates the function of microtubules.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	7845083	Tubulin polymerization assay was used to assess whether tau modulates binding of paclitaxel to tubulin.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	7713418	Furthermore, they did not inhibit tau induced tubulin assembly.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	5768907	The microtubule associated protein tau was originally identified as a protein that co-purified with tubulin in vitro, stimulated assembly of tubulin into microtubules and strongly stabilized microtubules.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	2484340	Two separate 18-amino acid domains of tau promote the polymerization of tubulin.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	16906201	It was further shown that tau promotes tubulin polymerisation and actin bundling in vitro [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	6457557	Normal tau promotes tubulin polymerization and stabilizes microtubule (MT) structures, whereas hyperphosphorylated tau reduces its affinity for MTs and destabilizes MT-structures.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	16776944	48 Tau promotes the assembly of tubulin into microtubules and stabilizes the microtubule structure that supports axoplasmic transport.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	20895873	Tubulin polymers produced by either the tubulin promoter Tau or by MAP2 disassemble at different rates and efficiencies in the presence of paclitaxel compared with docetaxel.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
2858ac60-f52f-4d7c-bd8a-2766d5150cbc	0.95	PubMed	20973857	Ennnlat, D. J.; Liem, R. K. H.; Hashim, G. A.; Shelanski, M. L. Two separate 18-amino acid domains of tau promote the polymer- ization of tubulin.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Tubulin))
9a93366a-e483-4c0b-a579-df39764bcb2a	0.65	PubMed	17292230	We have previously shown that tau might mediate the GCs induced regulation of cAMP dependent kinase and cAMP response element binding protein in HEK293 cells stably expressing the longest human tau isoform (tau-441; HEK293 and tau441 cells) XREF_BIBR.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:UGCG))
9123a5de-739c-4008-90bf-a0f77ceb943a	0.65	PubMed	2299247	Of the amino acids that are notably enriched in ECF, glutamate (GLU), alanine (ALA), serine (SER), asparagine (ASN), and taurine (TAU) individually enhanced MV production, whereas proline (PRO), glycine (GLY), and aspartate (ASP) had essentially no effect.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:VCL))
743354ef-86e5-4951-8c25-804edba8c7e7	0.65	PubMed	17478107	However, 20%-30% of cases of FTD follow an autosomal dominant pattern of inheritance, and half of them are caused by defects in microtubule associated protein tau (MAPT), multi-vesicular body protein 2B (CHMP2B), and valosin containing protein (VCP) [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:VCP))
57765109-533d-4dff-9538-81d3d2a84875	0.65	PubMed	19497998	However, a single transgene of human mutant tau did not induce the WAVE accumulation in JNPL3 mice.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF07507))
57b240a7-5af1-4f23-aa57-337577308d9e	0.65	PubMed	16087016	Here we report abnormal acetylation of K274 and K281 on tau, identified in AD brains, promotes memory loss and disrupts synaptic plasticity by reducing postsynaptic KIdney and BRAin (KIBRA) protein, a memory associated protein.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:WWC1))
829e89e6-97d5-4752-a4c9-5e7c14b93100	0.65	PubMed	17238529	The Wnt and calcium signaling is mediated by tau, the MTs associated and stabilizing protein, and has emerged to have an important role for MTs reorganization during growth cone remodeling.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:Wnt))
1185e384-e5a2-4c67-9dfa-5ef6a14b1bcb	0.86	PubMed	18752288	Main effect analyses of differences of least square means indicated TAU produced higher rates of any alcohol use than TMC [chi-square (1) = 5.85, p =.016; OR = 1.88, CI = 1.13,3.14].	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:16236))
1185e384-e5a2-4c67-9dfa-5ef6a14b1bcb	0.86	PubMed	18752288	Analyses of differences of least square means indicated TAU produced higher rates of any heavy alcohol use than TMC [chi-square (1) = 4.29, p =.038; OR = 1.74, CI = 1.03,2.94].	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:16236))
b8c3c831-f3b2-4560-a6eb-56ff792fefcb	0.65	PubMed	3230743	In fact, intracerebral injections of PHF tau induce co-deposits of A beta, ACT, and ubiquitin (Shin et al., 1993).	p(HGNC:MAPT)	directlyIncreases	act(p(UP:O73683))
474c65b1-649f-496e-9196-138e69fc5721	0.86	PubMed	22057290	Aggregation of tau is induced using arachidonic acid, and oligomers are purified by centrifugation over a sucrose step gradient.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:444899))
474c65b1-649f-496e-9196-138e69fc5721	0.86	PubMed	19718113	Aggregation of tau is induced using arachidonic acid, and oligomers are purified by centrifugation over a sucrose step gradient.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:444899))
9f55e143-3453-456e-8aa3-da9e2468979b	0.92	PubMed	21281813	For example, acute reduction of tau in a cellular model has been reported to impair autophagy in cells deficient for the gene (Niemann-Pick disease, type C1).	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006914"))
9f55e143-3453-456e-8aa3-da9e2468979b	0.92	PubMed	20219833	Conversely, the increase in tau toxicity provoked by AMPKalpha1-CA is due to the increased phosphorylation and possible reduced degradation of tau, concomitant with the inability of AMPKalpha1-CA to effectively induce autophagy.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006914"))
9f55e143-3453-456e-8aa3-da9e2468979b	0.92	PubMed	18869506	Since alteration of normal autophagy and inflammation are reported in several human diseases, we determined whether autophagic defects are linked to neuro inflammation via CX3CL1 signaling between neurons undergoing Abeta or Tau induced autophagy and microglial activation.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006914"))
232aa59d-c92f-4904-90c4-a726d09736f5	0.86	PubMed	25384392	Tau deletion impairs intracellular beta-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:57339251))
232aa59d-c92f-4904-90c4-a726d09736f5	0.86	PubMed	18363490	Tau deletion impairs intracellular beta-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:57339251))
30502bf3-a335-45e3-b454-5f4215d91774	0.86	PubMed	17712762	Biomarkers for plaques targeted the amyloid beta protein (Abeta) and for tangles, the microtubule associated protein tau.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF14350))
30502bf3-a335-45e3-b454-5f4215d91774	0.86	PubMed	15800503	Biomarkers for plaques targeted the amyloid beta protein (Abeta) and for tangles, the microtubule associated protein tau.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF14350))
8f4b40e3-c876-4144-87a3-407934898eb6	0.92	PubMed	17592813	Tau may be endocytosed, promoting an increase in intracellular calcium that results in neuronal death.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:29108))
8f4b40e3-c876-4144-87a3-407934898eb6	0.92	PubMed	17708666	The increase in intracellular calcium induced by Tau is caused by its interaction with specific cell receptors on neurons.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:29108))
8f4b40e3-c876-4144-87a3-407934898eb6	0.92	PubMed	17711696	Little is known about how an increase of calcium mediated by the interaction of tau with muscarinic receptors could result in cell death.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:29108))
3165cea7-2d3a-4c22-8356-ee05fbc5be4d	0.95	PubMed	9953691	In vivo, over-expression of IL-18 may induce hyperphosphorylation of tau and induce cell cycle activators.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0007049"))
3165cea7-2d3a-4c22-8356-ee05fbc5be4d	0.95	PubMed	22050023	Neuron death in AD is often caused by cell cycle re-entry (CCR) mediated by amyloid-beta oligomers (AbetaOs) and tau, the precursors of plaques and tangles.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0007049"))
3165cea7-2d3a-4c22-8356-ee05fbc5be4d	0.95	PubMed	5917970	These results suggest that overexpression of p25 lead to the activation of cell cycle but not to the direct phosphorylation of tau.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0007049"))
3165cea7-2d3a-4c22-8356-ee05fbc5be4d	0.95	PubMed	20927324	We have previously shown that tau induced cell cycle reentry mediates neuronal apoptosis in the fly tauopathy model XREF_BIBR, a result that has been corroborated in rodent models model of tauopathy XREF_BIBR, XREF_BIBR.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0007049"))
3165cea7-2d3a-4c22-8356-ee05fbc5be4d	0.95	PubMed	18510143	It has been suggested that in neurons, Tau hyperphosphorylation may induce abnormal, incomplete cell cycle re-entry.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0007049"))
3165cea7-2d3a-4c22-8356-ee05fbc5be4d	0.95	PubMed	18510143	Tau hyperphosphorylation may also induce abnormal, incomplete cell cycle re-entry.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0007049"))
3165cea7-2d3a-4c22-8356-ee05fbc5be4d	0.95	PubMed	16589257	Neuron death in AD is often caused by cell cycle reentry (CCR) mediated by amyloid-beta oligomers (AbetaOs) and tau, the precursors of plaques and tangles.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0007049"))
816a6f5b-e328-473b-8013-43f3c8c3fa92	0.65	PubMed	26824039	MAPT overexpression in this cell line significantly accelerates (p < 0.05) cell growth by about 25% (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0016049"))
a615f4cf-3828-4869-ac5f-dd4214bd974c	0.94	PubMed	17646145	Moreover, cell proliferation induced by tau overexpression was at least partially attributed to the decreased expression of Kv channels.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0008283"))
a615f4cf-3828-4869-ac5f-dd4214bd974c	0.94	PubMed	17646145	Certainly, overexpression of tau maybe modulated the cell proliferation through one of its candidate target : Kv channels.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0008283"))
a615f4cf-3828-4869-ac5f-dd4214bd974c	0.94	PubMed	20180362	As shown in Figure XREF_FIG, in the TOV112D cells, cell proliferation was more inhibited by transfection of the MAPT siRNA.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0008283"))
a615f4cf-3828-4869-ac5f-dd4214bd974c	0.94	PubMed	17482349	By analogy to 3-AB and NIC, in nonobese diabetic (NOD) mice TAU was found to promote islet cell proliferation, lower the incidence of pancreatic apoptosis, reduce islet cell insulitis and delay the onset of diabetes when consumed as a diet supplement early in life [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0008283"))
98e54393-20a4-4e9e-b61d-fbf4e9b2b29e	0.65	PubMed	3654079	Our results indicate that GABA, TAU and NMA are involved in the neuroendocrine regulation of GTH-II release in goldfish, and support the idea that testosterone participates in the positive feedback regulation of pituitary gonadotropin release in a non mammalian vertebrate by enhancing GABA- and TAU stimulated GTH release in vivo.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:P47744))
98c2eb83-c058-4591-9b59-b451a522b7fa	0.65	PubMed	20101896	Tau supplementation restored ACh induced vasodilation and collagen content.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:3815))
05da99b8-f0b4-49e1-826c-3e13f10ced0a	0.65	PubMed	18733117	Second, recent animal studies have found stress and cortisol to be associated with neuropathological changes characteristic of Alzheimer 's disease including synapse loss, increases in amyloid beta-peptide (Abeta), tau accumulation, and tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:5754))
57c91a4b-390f-4f27-98c1-9bad60ee3ccc	0.65	PubMed	17644532	Tau and Abeta are both able to increase inflammatory responses and cytokine production.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0001816"))
ba4dcb50-7339-497b-9df9-f0caa96df980	0.65	PubMed	17407301	In the extreme case, ASL will not be reliable in measuring white matter perfusion as no combination of tau and PLD supports adequate SNR dM (for example, the bottom right panel in XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF00751))
1f5d75e1-c805-4859-a508-b3af62a35abd	0.86	PubMed	16042390	The p-tau and tau ratio enabled the differentiation of MV genotype with higher levels in PrP (sc) type 2 (P = 0.04).	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0030154"))
1f5d75e1-c805-4859-a508-b3af62a35abd	0.86	PubMed	7337382	Tau phosphorylated at threonine 231 (p-tau (231)) shows excellent differentiation between AD and FTD, whereas serine 181 (p-tau (181)) enhances accurate differentiation between AD and dementia with Lewy bodies.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0030154"))
998d72a2-a9f1-4bd9-9295-60b47c992fb7	0.65	Other	sparser:Unknown	Structure-derived mutants of Escherichia coli DnaB
that preferentially form one collar state or the other can unwind DNA, but have
markedly altered properties with respect to double-stranded DNA translocation and
their ability to support either priming by DnaG or helicase activation by the
clamp-loader tau subunit.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:P57164))
856fd5bc-dfbf-4526-9486-2650385b6316	0.65	PubMed	3030600	It is suggested that MAPT induced " bizarre stereotypy " of RE-treated rats is mediated by the accelerative effect of RE on MAPT induced dopamine synthesis, while MAPT induced hypermotility of RE-treated rats is partially related to such an acceleration of dopamine synthesis.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:18243))
8f112fc1-612d-417e-a446-10d3bc545c6f	0.86	PubMed	18841380	Effects of Tau Overexpression in MOG Induced EAE.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q03547))
8f112fc1-612d-417e-a446-10d3bc545c6f	0.86	PubMed	18841380	Although our study examined young adult hTau mice and the effect of tau overexpression during MOG induced EAE, by 5 months of age, hTau mice have abnormal tau phosphorylation, with neurofibrillary tangles similar to that observed in AD.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q03547))
3bd53851-dcdd-4fe3-96b8-c17a954d139d	0.86	PubMed	16852815	Conversely, mutations in the MAPT gene encoding tau do not cause fAD, but can lead to neurodegenerative tauopathies which often include Parkinsonian symptoms [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:643975))
3bd53851-dcdd-4fe3-96b8-c17a954d139d	0.86	PubMed	20231021	In all fAD and sAD lines, we observed higher Abeta 1-40 and Abeta 1-42 secretion, increased activation of GSK3B, and hyperphosphorylation of TAU at six different epitopes.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:643975))
0ab67c4f-70c6-465f-89f4-19c85fbdf8d8	0.65	PubMed	21197114	The combination of BBBA and TAU also allowed the escalation of the maximum tolerated dose of FUra from 50 to 200 mg/kg.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:P0A583))
54d6ac8a-e32c-471f-b0d6-5eeb8ea03390	0.95	PubMed	PMC4046129	Activation of PLC-gamma by tau was enhanced in the presence of unsaturated fatty acids such as arachidonic acid, saturated fatty acids being ineffective.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:P03702))
54d6ac8a-e32c-471f-b0d6-5eeb8ea03390	0.95	PubMed	20935653	In the holoenzyme, tau mediates the attachment of gamma complex to core.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:P03702))
54d6ac8a-e32c-471f-b0d6-5eeb8ea03390	0.95	PubMed	PMC5119746	We have recently shown that phospholipase C-gamma (PLC-gamma) is activated by tau, a neuronal cell-specific microtubule-associated protein, in the presence of arachidonic acid.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:P03702))
8069b05b-0741-4011-9fa9-555fb05d7b64	0.65	PubMed	11306713	Compared with the untreated group, the expression of P-tau was significantly decreased (P < 0.01) and the expressions of tau and PP2A proteins were increased (P < 0.01, P < 0.05) in the ginsenoside Rg1 groups, especially in the high-dose ginsenoside Rg1 group.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:441923))
ed50069e-a603-490a-8054-2f57e9c3ec3e	0.65	PubMed	11765358	Tau raised isoproterenol- and dibutyryl-cAMP (Bt2cAMP)-activated glycerol release.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:753))
1d30b7f8-cf09-493c-bf47-4df6694d8931	0.86	PubMed	10606889	Ganciclovir treatment during prenatal development (E11-E13; where E is embryonic day) of mice selectively killed cells with shared S-phase vulnerability and targeted expression of a GPT [golli promoter transgene, linked to HSV-TK (herpes simplex virus-thymidine kinase), tau-eGFP (tau enhanced green fluorescent protein) and lacZ (lacZ galactosidase) reporters] localized in preplate neurons.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF01353))
1d30b7f8-cf09-493c-bf47-4df6694d8931	0.86	PubMed	16911119	Expression of a tau-EGFP (enhanced green fluorescent protein)-myc (TGM) reporter from the ret locus indicates that at embryonic day 11.5 (E11.5) all precursors in the superior cervical ganglion (SCG) and stellate ganglion (STG) express ret.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF01353))
0812a0e4-8b28-4265-8449-269d2fee2035	0.92	PubMed	20141102	The deposition of tau protein was previously shown to be increased in the NH of aged humans, indicating that abnormal tau protein accumulation in magnocellular axons in older individuals may cause a dysfunction in body fluid homeostasis.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0042592"))
0812a0e4-8b28-4265-8449-269d2fee2035	0.92	PubMed	18272392	Indeed, working on SH-SY5Y human neuroblastoma cells, we have found that tau induced pathology involves a deregulation of calcium homeostasis, that takes place in those cells bearing muscarinic receptors ().	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0042592"))
0812a0e4-8b28-4265-8449-269d2fee2035	0.92	PubMed	10567928	Physiologically, Abeta, lipid peroxidation, and tau protein may function to sense changes in activity dependent membrane properties and therefore biochemically modulate membrane lipid homeostasis for more efficient synaptic action.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0042592"))
f69e88b1-c8cc-4932-a097-e28f143ae40e	0.65	PubMed	9017787	Here we report that a fragment of tau protein possesses copper reduction activity and initiates the copper mediated generation of hydrogen peroxide.	p(HGNC:MAPT)	directlyIncreases	act(a(CHEBI:16240))
ea12d6f8-e5bf-4f8b-ba08-ced2c63ee359	0.65	PubMed	20341739	Altogether, these data support that tau triggered innate neuroinflammatory responses may promote CD8 + T cell infiltration into the brain of patients with Alzheimer 's disease.	p(HGNC:MAPT)	directlyIncreases	act(bp(MESH:D009361))
46718412-fedd-48f9-a02e-1a6420d96f4f	0.92	PubMed	17681420	alpha-Synuclein and p-Tau may induce a peripheral inflammatory response in parallel with CNS immune alterations, suggesting that Abl activity and pathogenic proteins (p-Tau and alpha-Synuclein) function within a common loop; involving local communication between microglia and neurons and global crosstalk between body and CNS immunity.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006954"))
46718412-fedd-48f9-a02e-1a6420d96f4f	0.92	PubMed	18636076	Furthermore, the inflammatory response triggered by Tau over-expression may mimic inflammatory reactions that can be initiated by intraneuronal Abeta or alpha-Synuclein, including mechanisms of glial-neuronal communication.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006954"))
46718412-fedd-48f9-a02e-1a6420d96f4f	0.92	PubMed	18876496	alpha-Synuclein and p-Tau may induce a peripheral inflammatory response in parallel with CNS immune alterations, suggesting that Abl activity and pathogenic proteins (p-Tau and alpha-Synuclein) function within a common loop; involving local communication between microglia and neurons and global crosstalk between body and CNS immunity.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006954"))
29155152-9017-4e9e-9a07-f64acb71ae0d	0.92	PubMed	19884810	Interestingly, Tau induced iron overload, lipid peroxidation, and inflammation, which are involved in ferroptosis, were significantly blocked by LA administration.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:23925))
29155152-9017-4e9e-9a07-f64acb71ae0d	0.92	PubMed	22026098	XREF_BIBR, XREF_BIBR Microtubule associated protein tau (MAPT) deficiency induces intracellular iron accumulation, which causes degeneration of dopaminergic neurons, leading to parkinsonism with dementia in mice.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:23925))
29155152-9017-4e9e-9a07-f64acb71ae0d	0.92	PubMed	20182957	In PD nigra, tau mediated iron export is also compromised, XREF_BIBR, XREF_BIBR, XREF_BIBR and ceruloplasmin loading of Tf is disabled, XREF_BIBR, XREF_BIBR which, together with the data presented here, collectively describe fatigue of iron export in the disease.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:23925))
aa7aae3d-2adb-4be4-b24b-5b60e630057a	0.65	PubMed	18906517	Tau removal increases survival in two hAPP transgenic mouse strains as well as kainic acid injection seizure models.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:10255))
d625ac20-c7b9-4e51-8c01-6d663dc85757	0.94	PubMed	24646911	Since tau controls the bidirectionality of axonal motor driven transport in a concentration dependent manner and differentially modulates the kinesin and dynein activity along microtubule tracks [XREF_BIBR], defective intracellular trafficking of cargoes, including neurotrophins, could be due to an increased expression level of this protein [XREF_BIBR - XREF_BIBR] or to its altered intracellular localization [XREF_BIBR] or excessive phosphorylation [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF00225))
d625ac20-c7b9-4e51-8c01-6d663dc85757	0.94	PubMed	16846010	Overexpression and mislocalisation of tau modulates kinesin based transport by directly inhibiting the access of these motors to microtubule tracks [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF00225))
d625ac20-c7b9-4e51-8c01-6d663dc85757	0.94	PubMed	19491104	We recently reported K369I mutant Tau transgenic K3 mice with axonal transport defects that suggested a cargo selective impairment of kinesin driven anterograde transport by Tau.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF00225))
d625ac20-c7b9-4e51-8c01-6d663dc85757	0.94	PubMed	10366055	We recently reported K369I mutant Tau transgenic K3 mice with axonal transport defects that suggested a cargo selective impairment of kinesin driven anterograde transport by Tau.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF00225))
fe901be8-1c93-49cd-8940-64c4bbe5f454	0.65	PubMed	7169308	Following a particular nervous system stimulation in these mice, only neurons, which are functionally activated, will express LacZ, which is targeted to neuronal processes by the tau protein.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:P70753))
3123dd34-b555-4df0-b5b3-157c3f9819fc	0.95	PubMed	20190868	Indeed, Marie Galas and colleagues have recently shown that overexpression of the 0N4R Tau isoform in Tau-knock out (Tau-KO) mouse neurons led to its cytoplasmic localization.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0051179"))
3123dd34-b555-4df0-b5b3-157c3f9819fc	0.95	PubMed	13313407	Both pro aggregant Tau variants cause Alzheimer like features, including synapse loss, mis localization of Tau into the somatodendritic compartment, conformational changes and hyperphosphorylation.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0051179"))
3123dd34-b555-4df0-b5b3-157c3f9819fc	0.95	PubMed	21348938	Pathological forms of tau have repeatedly been shown to cause abnormal somatic localization of mitochondria [XREF_BIBR - XREF_BIBR], which are the main source of energy production and calcium buffering in cells.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0051179"))
3123dd34-b555-4df0-b5b3-157c3f9819fc	0.95	PubMed	16832314	Tau phosphorylation on specific sites modulates function and intracellular localization.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0051179"))
3123dd34-b555-4df0-b5b3-157c3f9819fc	0.95	PubMed	17634135	Pathological forms of tau have repeatedly been shown to cause abnormal somatic localization of mitochondria [XREF_BIBR - XREF_BIBR], which are the main source of energy production and calcium buffering in cells.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0051179"))
3123dd34-b555-4df0-b5b3-157c3f9819fc	0.95	PubMed	17586023	This cellular localization is mediated by tau protein over-expression.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0051179"))
fe25a168-b934-4935-ad6d-26c8c8735629	0.65	PubMed	3497068	It is suggested that in peripubertal female rats, increased preoptic Asp and Glu release rates and decreased GABA and Tau output might enhance luteinizing hormone releasing hormone secretion.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:53481562))
ba58f706-065d-4f71-9cc7-91376b08f34f	0.65	PubMed	20020586	Furthermore, Tau stimulated antioxidant activity of common carp was observed in a dose related manner, where activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were significantly (P < 0.05) higher, but malondialdehyde (MDA) value was significantly (P < 0.05) lower in Tau fed fish groups than those fed the control diet.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:10964))
c2d6a6b4-f138-4059-bca8-f30b9b527c4a	0.86	PubMed	19465218	Protein malnutrition programs beta cells and impairs Tau induced restoration of mitochondrial metabolism and biogenesis.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0008152"))
c2d6a6b4-f138-4059-bca8-f30b9b527c4a	0.86	PubMed	14203043	Moreover, genomic DNA and cytoplasmic and nuclear RNA integrity were altered under HS in hippocampal neurons exhibiting Tau deficiency, which suggests that Tau also modulates RNA metabolism.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0008152"))
8e57a476-a54d-49f9-8686-372f615e2779	0.86	PubMed	16935546	The alternative splicing of the MAPT gene leads to the production of six protein isoforms of tau, differing by the presence of zero, one or two N-terminal repeats (0N, 1N or 2N) and three or four microtubule binding repeats at the C-terminus (3R or 4R) [XREF_BIBR - XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF16796))
8e57a476-a54d-49f9-8686-372f615e2779	0.86	PubMed	8324196	The phosphorylation of the neuronal Tau protein modulates both its physiological role of microtubule binding and its aggregation into paired helical fragments observed in Alzheimer 's diseased neurons.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF16796))
7770ca94-4efb-4fd7-90e2-f7a0107d7e4e	0.65	PubMed	17706948	Although mammalian cells lack the alternative NdhII dehydrogenase, Abeta, Tau and alpha-synuclein induce the generation of ROS by Complex I (NdhI) in neurons and glial cells, with the impairment of transport through membranes and a reduction in ATP generation.	p(HGNC:MAPT)	directlyIncreases	act(p(UP:Q07842))
426674f5-23cf-4aa7-a533-0328c69c7fe3	0.65	PubMed	17052070	Activated p38 MAPK polypeptide phosphorylates tau protein, producing a hyperphosphorylated tau response.	p(HGNC:MAPT)	directlyIncreases	act(p(FPLX:p38))
f15e59df-d92d-456d-a64e-be51a6bb47dd	0.92	PubMed	17307727	Third, experimental studies in rodents suggested that the extracellular injection of fibrils of tau or alpha-synuclein could induce still-healthy neurons to form the respective intracellular lesions, suggesting a physical spread as well as a " prion like " templating of the normal protein by the abnormal (misfolded) protein.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF00377))
f15e59df-d92d-456d-a64e-be51a6bb47dd	0.92	PubMed	16846010	These results suggest that truncation of tau enhances its prion like propagation and likely contributes to neurodegeneration.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF00377))
f15e59df-d92d-456d-a64e-be51a6bb47dd	0.92	PubMed	18359198	Furthermore, cross seeding of misfolded proteins, in which Abeta cross seeding of Tau, induces transition from mild Tau-strains to more aggressive Tau-strains and thereby triggers prion like spreading of Tauopathy along neuronal circuitries, was suggested as a potential mechanism.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF00377))
aca71389-e11e-42c8-95de-fc22998de21e	0.65	PubMed	6253752	In addition, a tau 32-kDa fragment was detected, suggesting that tau was a target of intracellular proteolysis in MK801 treated brains.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006508"))
73ad43a0-2563-4828-80c8-e5da223de68e	0.65	PubMed	19218257	In addition, overexpression of the long form of Protrudin or the short form of Tau promotes protrusion growth of the retinoic acid treated, neuronal differentiated Neuro-2a cells.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:5282379))
ab547c53-24d3-416a-b7ed-80dda07de494	0.65	PubMed	18310726	In our case, tau mediates binding of the VEIDase sensor to the microtubules of neurite like processes while retaining the availability of the sensor to the whole pool of cytosolic enzymes.	p(HGNC:MAPT)	directlyIncreases	act(p(PFAM:PF13796))
91dad407-7a41-479d-a7e6-f64cf7f2618d	0.86	PubMed	20375017	However, recent evidence has indicated that Tau can also interact with various components of intracellular signaling pathways, leading to the possibility that Tau might have a role in signal transduction.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0007165"))
91dad407-7a41-479d-a7e6-f64cf7f2618d	0.86	PubMed	10956959	However, recent evidence has indicated that Tau can also interact with various components of intracellular signaling pathways, leading to the possibility that Tau might have a role in signal transduction.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0007165"))
90a41f24-fe2d-45a8-b4a2-b3b44db28849	0.65	PubMed	25406315	A recent study has shown that the injection of brain homogenates from human tauopathies into the brains of mice transgenic for human wild-type Tau induced the formation of silver positive Tau inclusions (XREF_BIBR).	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:104755))
a251dba3-89eb-43f0-83f0-891deddb9024	0.65	PubMed	2426957	Methionine added to the growth medium of growing TAU not only markedly increased the total production of spermidine, but also increased both the intracellular concentration of spermidine and the accumulation of RNA.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:1102))
b992b77e-864e-43d1-870e-f97a1df6a073	0.65	PubMed	16609769	Counterintuitively, axonal grains of Tau are not targeted for degradation and do not induce a molecular stress response.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006950"))
3ae1c54e-6b7b-4c7d-83cc-0307d6783e66	0.65	PubMed	20579400	The estrogen receptor influences microtubule associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:9548828))
23e10fef-cc09-4787-b1d8-f919bfda3e80	0.92	PubMed	15121914	Rs113986870 is also strongly associated with a MAPT probe that targets transcription of alternatively spliced exon 3 in frontal cortex (P = 9.2 x 10 (-6)) and temporal cortex (P = 2.6 x 10 (-6)).	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006351"))
23e10fef-cc09-4787-b1d8-f919bfda3e80	0.92	PubMed	18364917	Rs113986870 is also strongly associated with a MAPT probe that targets transcription of alternatively spliced exon 3 in frontal cortex (P = 9.2 x10 -6) and temporal cortex (P = 2.6 x10 -6).	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006351"))
23e10fef-cc09-4787-b1d8-f919bfda3e80	0.92	PubMed	18454328	In humans, there are thirteen IFN-alpha subtypes, a single IFN-beta, and the less well characterized IFN-epsilon, -tau, -kappa, -omega, -delta, which activate the transcription of hundreds of IFN stimulated genes (ISGs) [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006351"))
f06f2bc9-e168-4287-8cd6-2e07c37ee0a4	0.65	PubMed	20239126	That tau is recursively specifiable simply means here that tau is specified by a (computable) clause for each atomic expression of L e, and a (computable) clause for each syntactic construction of L e, allowing a computation of the translation tau (s) in L i for each sentence s of L e.	p(HGNC:MAPT)	directlyIncreases	act(bp(GO:"GO:0006412"))
1e0e2342-e38d-472d-8616-477d2f67c101	0.94	PubMed	5632544	Oral administration of 2000 mg/kg TAU increased plasma uridine by over 250-fold with an area under the curve (AUC) of 754 micromol x h/l.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:6029))
1e0e2342-e38d-472d-8616-477d2f67c101	0.94	PubMed	21109946	The acetyl groups of TAU increase the lipo- philicity of uridine, thus enhancing its transport from the gastrointestinal tract to the blood stream and its reabsorp- tion from the renal tubules, while rendering TAU resistant to catabolism by UrdPase [70].	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:6029))
1e0e2342-e38d-472d-8616-477d2f67c101	0.94	PubMed	21109946	Oral TAU produced a plasma uridine C ^ x degreesf 507 | JLM at 0.4 hr, while an equimolar dose of oral uridine resulted in a C ^ ^ of only 20 | JLM at 1 hr.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:6029))
1e0e2342-e38d-472d-8616-477d2f67c101	0.94	PubMed	21109946	Not only did TAU increase the concentration of plasma uridine, but it also reduced the time required to attain the maximum concentration.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:6029))
d75f0afd-4579-4f4b-8556-a2767326be84	0.65	PubMed	10157495	Since TAU conjugated UDCA optimizes fat and fat-soluble vitamin absorption, we asked if TAU deficiency could cause vitamin D malabsorption and lead to metabolic bone disease in captive polar bears.	p(HGNC:MAPT)	directlyIncreases	act(a(PUBCHEM:12895043))
0b68a36d-6913-44ad-b200-7f0c7a535706	0.65	PubMed	17711416	Interactions between tau, fyn, and actin potentiate fyn driven endocytosis of lipid raft markers flotillin-1 and flotillin-2.	complex(p(HGNC:MAPT), p(FPLX:Actin))	directlyIncreases	act(p(HGNC:FYN))
39795b8a-f261-4390-872a-b7280d1678c0	0.65	PubMed	17861066	In the case of AD, it has been proposed that NMDA receptors present at the dendritic spines could favor Abeta toxicity mediated by the presence of the complex Fyn and tau [XREF_BIBR].	complex(p(HGNC:MAPT), p(HGNC:FYN))	directlyIncreases	act(p(HGNC:APP))
0796e273-247e-4982-a0dd-329cb8e61464	0.65	PubMed	13981652	Our findings suggest that interactions between alpha-Syn and Tau at the cellular level cause disruption of cytoskeletal organization, axonal transport defects and aberrant synaptic organization that contribute to neuronal dysfunction and death associated with sporadic PD.	complex(p(HGNC:MAPT))	directlyIncreases	act(bp(GO:"GO:0008219"))
6621fec6-ee01-41f3-9f12-afe341e7049f	0.65	PubMed	17083613	An alternative interpretation of the role of phosphorylated tau protein has been promoted by the group of Mark A. Smith [XREF_BIBR].	p(HGNC:MARK1)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
6bcf3cef-69c3-4f6e-bc7d-f701931023f9	0.94	PubMed	21439371	We previously suggested that a loss of MBNL1 or a gain of CELF2 function could repress Tau exon 2-inclusion as observed in human disease.	p(HGNC:MBNL1)	directlyIncreases	act(p(HGNC:MAPT))
6bcf3cef-69c3-4f6e-bc7d-f701931023f9	0.94	PubMed	24440524	In the present study, when co-transfected with the WT hTau 2Delta3, ectopic MBNL1 expression promoted Tau exon 2 inclusion (i.e. reduced its exclusion, A and B), whereas mutation of the predicted MBNL binding sites attenuated this effect.	p(HGNC:MBNL1)	directlyIncreases	act(p(HGNC:MAPT))
6bcf3cef-69c3-4f6e-bc7d-f701931023f9	0.94	PubMed	24440524	Indeed, as far as Tau exon 2 splicing is concerned, both MBNL2 and MBNL1 are necessary to fully restore the splicing of Tau exon 2, deregulated by the DM1 mutation.	p(HGNC:MBNL1)	directlyIncreases	act(p(HGNC:MAPT))
6bcf3cef-69c3-4f6e-bc7d-f701931023f9	0.94	PubMed	9420104	However, while an overall reduction in the expression of MBNL1 mimics the effect of the DM1 mutation, none of the MBNL1 isoforms tested so far modulates the endogenous splicing of Tau.	p(HGNC:MBNL1)	directlyIncreases	act(p(HGNC:MAPT))
507db89b-808f-48a2-bb02-88205ff0e436	0.65	PubMed	24440524	As seen earlier (C and D), Tau exon 2 inclusion was not significantly enhanced by the ectopic expression of MBNL2 alone.	p(HGNC:MBNL2)	directlyIncreases	act(p(HGNC:MAPT))
410a120c-8d77-4de0-9a04-18a8e72f560e	0.94	PubMed	18233622	It is worth noting that we also detected high molecular weight forms of Tau (HMW Tau) when the cells were treated with high concentrations of MB and AC.	p(HGNC:MB)	directlyIncreases	act(p(HGNC:MAPT))
410a120c-8d77-4de0-9a04-18a8e72f560e	0.94	PubMed	18233622	Another concern raised from the studies of transfected 293T cells is the observation of HWM Tau when cells were treated with high concentrations of MB.	p(HGNC:MB)	directlyIncreases	act(p(HGNC:MAPT))
410a120c-8d77-4de0-9a04-18a8e72f560e	0.94	PubMed	18233622	As shown in XREF_FIG, unphosphorylated Tau also forms HWM bands when treated with MB.	p(HGNC:MB)	directlyIncreases	act(p(HGNC:MAPT))
410a120c-8d77-4de0-9a04-18a8e72f560e	0.94	PubMed	18233622	Therefore, MB and AC seem to cause the formation of HMW Tau irrespective of the phosphorylation state of Tau.	p(HGNC:MB)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	18324451	The observation that the width of the MT induced Tau filaments falls within these values supports the idea that the MT induced and heparin induced filaments are similar structures.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	18324451	Possible relationship of MT induced Tau filaments to Tau NFTs.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	12968123	These observations suggest that the MT induced Tau filaments provide a new model for Alzheimer 's studies and that MTs might play a role in the formation of Alzheimer 's-associated neurofibrillary tangles.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	18324451	The second reason that the formation of MT induced Tau filaments is significant is that it may have relevance to the function of Tau in both health and disease.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	18324451	Moreover, the similarity of the MT induced Tau filaments to those formed in Alzheimer 's disease implies that MT induction of Tau filament assembly might provide an easier way to make Tau filaments and thus open new avenues for studying and perhaps inhibiting filament formation.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	18324451	However, it will be difficult to address this issue in a quantitative way until conditions are found that eliminate MT induced Tau filament formation over a range of Tau concentrations.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	18324451	The formation of MT induced Tau filaments could interfere with MT binding assays in two different ways that would be reflected in the binding data found in XREF_FIG.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	18324451	Given that the heparin induced filaments are recognized as models for Alzheimer 's-induced NFT filaments, the sum of these data suggest that these MT induced Tau filaments provide a new in vitro model for Tau NFT formation.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	23087208	The formation of MT induced Tau filaments could interfere with MT binding assays in two different ways that would be reflected in the binding data found in XREF_FIG.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	23087208	Possible relationship of MT induced Tau filaments to Tau NFTs.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	23087208	The MT induced Tau filaments were most similar in appearance and width to the straight heparin induced Tau filaments (XREF_FIG).	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	23087208	The observation that the width of the MT induced Tau filaments falls within these values supports the idea that the MT induced and heparin induced filaments are similar structures.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	23087208	Given that the heparin induced filaments are recognized as models for Alzheimer 's-induced NFT filaments, the sum of these data suggest that these MT induced Tau filaments provide a new in vitro model for Tau NFT formation.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	23087208	However, it will be difficult to address this issue in a quantitative way until conditions are found that eliminate MT induced Tau filament formation over a range of Tau concentrations.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	23087208	The second reason that the formation of MT induced Tau filaments is significant is that it may have relevance to the function of Tau in both health and disease.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
230ae1db-0609-489d-81c7-35a479a937b1	0.95	PubMed	23087208	Moreover, the similarity of the MT induced Tau filaments to those formed in Alzheimer 's disease implies that MT induction of Tau filament assembly might provide an easier way to make Tau filaments and thus open new avenues for studying and perhaps inhibiting filament formation.	p(HGNC:MCAT)	directlyIncreases	act(p(HGNC:MAPT))
edadcb42-3c2b-457b-9b09-dd1ed9c513a4	0.65	PubMed	25486118	Analysis of AD related biomarkers in CSF (Abeta 1-42, pTau181, and Tau) of AD, MCI and normal control groups confirmed previous findings that decreased Abeta 1-42 and increased Tau and pTau181 which are associated with MCI and AD XREF_BIBR - XREF_BIBR.	complex(p(HGNC:MCIDAS))	directlyIncreases	act(p(HGNC:MAPT))
93036fdb-771d-4e7d-91b9-f54ed39302cf	0.65	PubMed	22015366	The results showed that exposure to METH significantly up-regulated the expression of phosphorylated Tau protein in vivo and in vitro and silencing the expression of CDK5 inhibited the up-regulation of phosphorylated Tau induced by METH exposure.	p(IP:IPR011822)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
03656ccb-fbd2-4fd9-b008-1165fd200371	0.86	PubMed	25384392	MG132 significantly increased p-Tau in Tau expressing cells (p < 0.001).	a(CHEBI:75142)	directlyIncreases	act(p(HGNC:MAPT))
03656ccb-fbd2-4fd9-b008-1165fd200371	0.86	PubMed	18363490	MG132 significantly increased p-Tau in Tau expressing cells (p < 0.001).	a(CHEBI:75142)	directlyIncreases	act(p(HGNC:MAPT))
9ee3c333-e23a-48d6-ba72-798d25df7866	0.65	PubMed	16214366	In this context, Msi-1 not only regulates tau protein expression, but also is able to preferentially induce the expression of a specific splice variant of tau.	p(HGNC:MSI1)	directlyIncreases	act(p(HGNC:MAPT))
d209e4f2-0037-47e2-aae2-b0e060bc9664	0.95	PubMed	26751496	Tang et al. [XREF_BIBR] showed that cells engineered to have upregulated mTor activity also showed tau signals with the endoplasmic reticulum, golgi, and the mitochondria, generally indicating that the enhanced mTor activity caused the trafficking of tau and its subsequent release into the extracellular space.	p(HGNC:MTOR)	directlyIncreases	act(p(HGNC:MAPT))
d209e4f2-0037-47e2-aae2-b0e060bc9664	0.95	PubMed	13348503	In these cellular systems, we not only confirmed the tau phosphorylation sites found in vitro but also found that mTor mediates the synthesis and aggregation of tau, resulting in compromised microtubule stability.	p(HGNC:MTOR)	directlyIncreases	act(p(HGNC:MAPT))
d209e4f2-0037-47e2-aae2-b0e060bc9664	0.95	PubMed	16803091	Tau protein aggregation is also induced by mTOR (mammalian target of rapamycin) signaling via the autophagy process.	p(HGNC:MTOR)	directlyIncreases	act(p(HGNC:MAPT))
d209e4f2-0037-47e2-aae2-b0e060bc9664	0.95	PubMed	18859096	XREF_BIBR, XREF_BIBR Recently, Tang et al demonstrated that mTOR accumulates in tangle bearing neurons at early stages in AD brains and mediates the synthesis and aggregation of tau.	p(HGNC:MTOR)	directlyIncreases	act(p(HGNC:MAPT))
d209e4f2-0037-47e2-aae2-b0e060bc9664	0.95	PubMed	17855665	Tang et al. [XREF_BIBR] showed that cells engineered to have upregulated mTor activity also showed tau signals with the endoplasmic reticulum, golgi, and the mitochondria, generally indicating that the enhanced mTor activity caused the trafficking of tau and its subsequent release into the extracellular space.	p(HGNC:MTOR)	directlyIncreases	act(p(HGNC:MAPT))
d209e4f2-0037-47e2-aae2-b0e060bc9664	0.95	PubMed	23585566	In these cellular systems, we not only confirmed the tau phosphorylation sites found in vitro but also found that mTor mediates the synthesis and aggregation of tau, resulting in compromised microtubule stability.	p(HGNC:MTOR)	directlyIncreases	act(p(HGNC:MAPT))
46b5a5c2-2764-4e7c-b37a-bf449bf51574	0.65	PubMed	18353446	FLEXITau MS analysis also enables the characterization of MAPT splicing and tau PTMs.	p(HGNC:MTR)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	18324451	Our first goal in testing the hypothesis that filaments might be forming in our assays was to reproduce the results of XREF_BIBR), who showed that MTs promote the formation of cross-linkable Tau-Tau complexes that were interpreted as evidence that MTs promote the formation of Tau oligomers.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	18324451	We have found that under the conditions of typical MT binding assays, MTs induce the rapid formation of novel Tau filaments.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	18324451	Investigations of Tau-Tau interactions : MTs induce the formation of Tau filaments.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	18324451	The second section focuses on the observation that MTs induce the formation of Tau filaments.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	18324451	These observations suggested that we should investigate the possibility that MTs induce the formation of Tau filaments.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	18324451	One obvious question is how MTs promote the formation of Tau filament nuclei.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	23087208	The second section focuses on the observation that MTs induce the formation of Tau filaments.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	23087208	Investigations of Tau-Tau interactions : MTs induce the formation of Tau filaments.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	23087208	These observations suggested that we should investigate the possibility that MTs induce the formation of Tau filaments.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	23087208	Our first goal in testing the hypothesis that filaments might be forming in our assays was to reproduce the results of XREF_BIBR), who showed that MTs promote the formation of cross-linkable Tau-Tau complexes that were interpreted as evidence that MTs promote the formation of Tau oligomers.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	23087208	One obvious question is how MTs promote the formation of Tau filament nuclei.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
1e784f52-b1f7-4ce0-9b79-ebf244ce7fa9	0.95	PubMed	23087208	We have found that under the conditions of typical MT binding assays, MTs induce the rapid formation of novel Tau filaments.	p(PFAM:PF05175)	directlyIncreases	act(p(HGNC:MAPT))
f3fb3e79-b99d-4804-a1df-a4a27d97ad64	0.86	PubMed	21319137	A 69% increase in Tau expression was observed in cortical neurons treated with neurobasal media plus NGF and EGF <ce:cross-ref refid="FIG1"> </ce:cross-ref>.	p(HGNC:NGF)	directlyIncreases	act(p(HGNC:MAPT))
f3fb3e79-b99d-4804-a1df-a4a27d97ad64	0.86	PubMed	18851058	These results might partially explain the AD phenotype seen in the AD11 mice, where NGF removal induces both Abeta and tau pathology.	p(HGNC:NGF)	directlyIncreases	act(p(HGNC:MAPT))
1e2e7b51-6709-46ab-a6ec-cd5366210718	0.65	PubMed	3435218	NH4Cl (1 and 5 mM) induced the release of TAU.	a(PUBCHEM:25517)	directlyIncreases	act(p(HGNC:MAPT))
45fa7615-097f-4102-b6bc-e2a8106cb310	0.86	PubMed	18445309	NMDA Induced Tau Regulation Relies on PKC Activation.	a(PUBCHEM:22880)	directlyIncreases	act(p(HGNC:MAPT))
45fa7615-097f-4102-b6bc-e2a8106cb310	0.86	PubMed	18445309	Interestingly, a consistent feature in our experiments was the preferential modulation of Tau isoforms by NMDA, as depicted in XREF_FIG.	a(PUBCHEM:22880)	directlyIncreases	act(p(HGNC:MAPT))
41829397-b2c8-4886-b104-ef8ccde909e8	0.65	PubMed	18955852	Excess NO may also trigger hyperphosphorylation and subsequent accumulation of tau protein.	a(CHEBI:16480)	directlyIncreases	act(p(HGNC:MAPT))
07c491e4-82f1-42a6-bd0f-dd725f535d50	0.65	PubMed	11595108	Furthermore, endogenous TAU protein abundance in human neuroblastoma SH-SY5Y cells was significantly reduced or augmented by overexpression or knockdown of PSA and NPEPPS, respectively.	p(HGNC:NPEPPS)	directlyIncreases	act(p(HGNC:MAPT))
a15a4ace-3cc1-4f2f-a159-38268e76489c	0.65	PubMed	17628876	Silica NPs (siNPs) used in medicine are also able to increase P-Tau at Ser262 and Ser396, two phosphorylation sites characteristic of AD.	p(HGNC:NPS)	directlyIncreases	act(p(HGNC:MAPT))
a01f31ec-8f3d-4280-a058-3eedbc030adb	0.65	PubMed	17778208	Nuak1 phosphorylation stabilizes Tau, and Nuak1 enhances Tau toxicity, both in flies and mice.	p(HGNC:NUAK1)	directlyIncreases	act(p(HGNC:MAPT))
5f45b5d9-08c6-4fad-bccd-b6238a796b4c	0.95	PubMed	25384392	We determined whether introduction of exogenous Tau affects p-Tau clearance in WT and Tau -/- mice treated with Nilotinib.	a(PUBCHEM:644241)	directlyIncreases	act(p(HGNC:MAPT))
5f45b5d9-08c6-4fad-bccd-b6238a796b4c	0.95	PubMed	25384392	Human WT Tau increased p-Tau in WT mice treated with DMSO but Nilotinib eliminated p-Tau (n = 5).	a(PUBCHEM:644241)	directlyIncreases	act(p(HGNC:MAPT))
5f45b5d9-08c6-4fad-bccd-b6238a796b4c	0.95	PubMed	25384392	Tau and Abeta1-42 increased plaque levels in WT mice treated with DMSO and Nilotinib significantly decreased intracellular Abeta1-42 and plaque load compared to Abeta1-42 alone or LacZ.	a(PUBCHEM:644241)	directlyIncreases	act(p(HGNC:MAPT))
5f45b5d9-08c6-4fad-bccd-b6238a796b4c	0.95	PubMed	18363490	Human WT Tau increased p-Tau in WT mice treated with DMSO but Nilotinib eliminated p-Tau (n = 5).	a(PUBCHEM:644241)	directlyIncreases	act(p(HGNC:MAPT))
5f45b5d9-08c6-4fad-bccd-b6238a796b4c	0.95	PubMed	18363490	We determined whether introduction of exogenous Tau affects p-Tau clearance in WT and Tau -/- mice treated with Nilotinib.	a(PUBCHEM:644241)	directlyIncreases	act(p(HGNC:MAPT))
5f45b5d9-08c6-4fad-bccd-b6238a796b4c	0.95	PubMed	18363490	Tau and Abeta1-42 increased plaque levels in WT mice treated with DMSO and Nilotinib significantly decreased intracellular Abeta1-42 and plaque load compared to Abeta1-42 alone or LacZ.	a(PUBCHEM:644241)	directlyIncreases	act(p(HGNC:MAPT))
f09034f0-c9c0-4d9b-a1f5-b0d5dc5f310c	0.65	PubMed	18244520	Phosphorylated tau was also found to be increased in adult rats treated with OA by direct microinjection into the lateral dorsal hippocampus area [XREF_BIBR] or by chronic intraventricular injection into brain [XREF_BIBR].	a(CHEBI:44658)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
45470258-fa42-4c2a-a2ab-d969ce47dada	0.86	PubMed	12807963	However, Abeta (40), Abeta (42), Abeta total, and Tau loads or the level of microglial cell activation were not modulated by the 3 '-UTR OLR1 polymorphisms.	p(HGNC:OLR1)	directlyIncreases	act(p(HGNC:MAPT))
45470258-fa42-4c2a-a2ab-d969ce47dada	0.86	PubMed	6889591	However, Abeta (40), Abeta (42), Abeta total, and Tau loads or the level of microglial cell activation were not modulated by the 3 '-UTR OLR1 polymorphisms.	p(HGNC:OLR1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Otub1 but not Otub1-C91A impairs Tau degradation by removing Lys48 linked polyubiquitin chains from Tau in primary neurons.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Otub1 increases Tau stability and increases Tau aggregation in a well characterized cellular Tau aggregation model.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Finally, we demonstrated that expression of Otub1 but not its catalytically inactive form induced pathological Tau forms after 2months in Tau transgenic mice invivo, including AT8 positive Tau and oligomeric Tau forms.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	19068416	Otub1 strongly increased AT8 positive Tau and oligomeric Tau forms and increased Tau seeded Tau aggregation in primary neurons.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Otub1 expression strikingly enhanced detergent resistant AT8 positive Tau accumulation compared with GFP infected neurons, indicating that Otub1 increased Tau seeded Tau aggregation in primary neurons, corroborating the results obtained in a nonneuronal cell line.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Otub1 strongly increased AT8 positive Tau and oligomeric Tau forms and increased Tau seeded Tau aggregation in primary neurons.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Otub1 enhances Tau oligomerization and Tau seeded Tau aggregation in primary neurons.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	19068416	Finally, we demonstrated that expression of Otub1 but not its catalytically inactive form induced pathological Tau forms after 2months in Tau transgenic mice invivo, including AT8 positive Tau and oligomeric Tau forms.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Consequently, Otub1 dependent deubiquitination inhibits Tau degradation through the proteasome pathway and prolongs its half-life, leading to accumulation of pathological forms of Tau.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Knockdown of Otub1 increased Tau turnover, correlating with the decrease in expression of Otub1 obtained by the different siRNAs.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	In addition, we found robust induction of a (homo- or heterotypic) Tau complex (Tau c), which was strongly detected in AAV-Otub1-infected neurons but absent in AAV-GFP-infected neurons, indicating clearcut Otub1 induced modulation of Tau in neurons.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Taken together, our data demonstrate that Otub1, identified as a Tau interacting protein in the Tau interactome mapping, modulates Tau, by increasing Tau seeded Tau aggregation, by formation of a Otub1 induced Tau complex Tau c, and by increasing the concentration of oligomeric Tau forms in primary neurons.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	Taken together, we conclude that overexpressed Otub1 in primary neurons expressing TauP301S increased total Tau and induced a robust increase in AT8 positive Tau.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
060ca6af-7e2a-4e0a-950c-5eac0eb2a533	0.95	PubMed	16851072	We demonstrate that Otub1 regulates levels of Lys48 linked ubiquitin conjugated Tau and increases pathological forms of Tau invitro and invivo.	p(HGNC:OTUB1)	directlyIncreases	act(p(HGNC:MAPT))
8f46f2e5-3e5b-40d7-a6b1-755d1cb9f86e	0.65	PubMed	7034722	Twelve cases underwent T1WI, T2WI, Gd enhanced T1WI, and Short Tau Inversion Recovery (STIR) images.	p(HGNC:PAEP)	directlyIncreases	act(p(HGNC:MAPT))
7d80256a-016e-48c5-9762-497edf661b43	0.86	PubMed	22954671	However, co-expression of wild type parkin facilitated autophagic clearance and promoted deposition of Abeta (1-42) and p-Tau into the lysosome.	p(UP:O60260)	directlyIncreases	act(p(HGNC:MAPT))
7d80256a-016e-48c5-9762-497edf661b43	0.86	PubMed	23262240	However, wild type parkin expression led to a significant increase of p-Tau in AV-10 (19%) and lysosome (21%) compared to LacZ, alpha-Synuclein and alpha-Synuclein+ T240R (XREF_FIG).	p(UP:O60260)	directlyIncreases	act(p(HGNC:MAPT))
8cfe6b13-32bc-47a5-a0ad-ff391e583f8d	0.65	PubMed	13751356	When transferred into a pro differentiative environment, Pax6 and Foxg1 overexpressing cells activated the neuronal marker Tau-EGFP.	p(HGNC:PAX6)	directlyIncreases	act(p(HGNC:MAPT))
73ee5a80-30ac-4fa9-9159-8c4bbbc238f9	0.65	PubMed	7230032	(d) PDBu also induced rapid proteolysis of two endogenous substrates of calpains, i.e., tau and microtubule associated protein-2 (MAP-2) and the proteolysis was blocked by EGTA and calpain inhibitors.	a(PUBCHEM:37783)	directlyIncreases	act(p(HGNC:MAPT))
3982c3b4-2a18-4b32-9912-b8edb79f2d88	0.65	PubMed	21177183	However, other microdialysis studies have shown that PDC and DK can increase extracellular GABA and TAU (<ce:cross-refs refid="BIB35 BIB23 BIB54"> Massieu et al., 1995; Herrera-Marschitz et al., 1996; Segovia et al., 1997b </ce:cross-refs>), as well as GLU.	p(FPLX:PDC)	directlyIncreases	act(p(HGNC:MAPT))
174539c6-2562-4859-9d1e-05b04f0dbe41	0.65	PubMed	19331814	In particular, KKVAVVR in the PRD enhances the microtubule binding of tau.	p(HGNC:PEPD)	directlyIncreases	act(p(HGNC:MAPT))
a7e7f06f-60c6-45a8-8a7a-6e2efe885969	0.92	PubMed	22027720	It has also been only quite recently that PET ligands that specifically target tau have been developed.	p(PFAM:PF06297)	directlyIncreases	act(p(HGNC:MAPT))
a7e7f06f-60c6-45a8-8a7a-6e2efe885969	0.92	PubMed	14753121	Recently, several positron emission tomography (PET) radiopharmaceuticals targeting abnormal conformations of the tau protein have been developed.	p(PFAM:PF06297)	directlyIncreases	act(p(HGNC:MAPT))
a7e7f06f-60c6-45a8-8a7a-6e2efe885969	0.92	PubMed	16332993	This article will focus on the investigational PET tracers targeting tau and alpha-synuclein as misfolded proteins, and activated microglia and astrocytes as cellular targets for neuroinflammation.	p(PFAM:PF06297)	directlyIncreases	act(p(HGNC:MAPT))
30f4a762-f3d2-4ae6-ac42-2e2c1142cde9	0.65	PubMed	17248140	PGJ 2 induces caspase mediated cleavage of tau, generating Deltatau, an aggregation prone form known to seed tau aggregation prior to neurofibrillary tangle formation XREF_BIBR.	a(PUBCHEM:13588)	directlyIncreases	act(p(HGNC:MAPT))
94b76fe8-d40b-45bc-a62e-9c4c525e4fd6	0.65	PubMed	10330789	We show that prostaglandin (PG) J2, an endogenous product of inflammation, induces caspase mediated cleavage of tau, generating Deltatau, an aggregation prone form known to seed tau aggregation prior to neurofibrillary tangle formation.	a(PUBCHEM:6426709)	directlyIncreases	act(p(HGNC:MAPT))
37af9dc7-41e0-4c65-a871-fc038a6784fc	0.65	PubMed	25912737	Very recently, it has been demonstrated that deletion of PHF6 and PHF6 * does abolish the seeding activity of recombinant full-length Tau, suggesting that its aggregation is necessary for seeding.	p(HGNC:PHF6)	directlyIncreases	act(p(HGNC:MAPT))
d5f8519d-f65b-469c-8d63-ab164ffb6007	0.86	PubMed	6647428	Conversely, Pin1 may restore the tubulin polymerization function of these hyperphosphorylated Tau.	p(HGNC:PIN1)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
d5f8519d-f65b-469c-8d63-ab164ffb6007	0.86	PubMed	12540053	Conversely, Pin1 may restore the tubulin polymerization function of these hyperphosphorylated Tau.	p(HGNC:PIN1)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
d94287b9-2295-4f73-ba0a-b41d78f95f5c	0.65	PubMed	18287129	To solve the MRCMPSP, in accordance with the standard PSO, the combinatorial PSO is used to initialize and update position X l 1 (tau) and velocity V l 1 (tau) (l = 1,2,..., L) in a novel method.	p(HGNC:PIPOX)	directlyIncreases	act(p(HGNC:MAPT))
5eb426fd-1339-4dfa-a94d-5a36b4567c03	0.65	PubMed	21220508	J.r. </ce:given-name> <ce:surname> Lansbury </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> NACP, a protein implicated in Alzheimer 's disease and learning, is natively unfolded </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> Biochemistry </sb:maintitle> </sb:title> <sb:volume-nr> 35 </sb:volume-nr> </sb:series> <sb:date> 1996 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 13709 </sb:first-page> <sb:last-page> 13715 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB31"> <ce:label> [31] </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> M. </ce:given-name> <ce:surname> Yoshimoto </ce:surname> </sb:author> <sb:author> <ce:given-name> A. </ce:given-name> <ce:surname> Iwai </ce:surname> </sb:author> <sb:author> <ce:given-name> D. </ce:given-name> <ce:surname> Kang </ce:surname> </sb:author> <sb:author> <ce:given-name> D.A. </ce:given-name> <ce:surname> Otero </ce:surname> </sb:author> <sb:author> <ce:given-name> Y. </ce:given-name> <ce:surname> Xia </ce:surname> </sb:author> <sb:author> <ce:given-name> T. </ce:given-name> <ce:surname> Saitoh </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> NACP, the precursor protein of the non amyloid beta/A4 protein (Abeta) component of Alzheimer disease amyloid, binds Abeta and stimulates Abeta aggregation </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> Proc Natl Acad Sci USA </sb:maintitle> </sb:title> <sb:volume-nr> 91 </sb:volume-nr> </sb:series> <sb:date> 1995 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 9141 </sb:first-page> <sb:last-page> 9145 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB32"> <ce:label> [32] </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> P.H. </ce:given-name> <ce:surname> Jensen </ce:surname> </sb:author> <sb:author> <ce:given-name> H. </ce:given-name> <ce:surname> Hager </ce:surname> </sb:author> <sb:author> <ce:given-name> M.S. </ce:given-name> <ce:surname> Nielsen </ce:surname> </sb:author> <sb:author> <ce:given-name> P. </ce:given-name> <ce:surname> Hojrup </ce:surname> </sb:author> <sb:author> <ce:given-name> J. </ce:given-name> <ce:surname> Gliemann </ce:surname> </sb:author> <sb:author> <ce:given-name> R. </ce:given-name> <ce:surname> Jakes </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> alpha-Synucle in.binds to tau and stimulates the protein kinase A catalyzed tau phosphorylation of serine residues 262 and 356 </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> J Biol Chem </sb:maintitle> </sb:title> <sb:volume-nr> 274 </sb:volume-nr> </sb:series> <sb:date> 1999 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 25481 </sb:first-page> <sb:last-page> 25489 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB33"> <ce:label> [33] </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> S. </ce:given-name> <ce:surname> Engelender </ce:surname> </sb:author> <sb:author> <ce:given-name> Z. </ce:given-name> <ce:surname> Kaminsky </ce:surname> </sb:author> <sb:author> <ce:given-name> X. </ce:given-name> <ce:surname> Guo </ce:surname> </sb:author> <sb:author> <ce:given-name> A.H. </ce:given-name> <ce:surname> Sharp </ce:surname> </sb:author> <sb:author> <ce:given-name> R.K. </ce:given-name> <ce:surname> Amaravi </ce:surname> </sb:author> <sb:author> <ce:given-name> J.J. </ce:given-name> <ce:surname> Kleiderlein </ce:surname> </sb:author> <sb:author> <ce:given-name> R.L. </ce:given-name> <ce:surname> Margolis </ce:surname> </sb:author> <sb:author> <ce:given-name> J.C. </ce:given-name> <ce:surname> Troncoso </ce:surname> </sb:author> <sb:author> <ce:given-name> A.A. </ce:given-name> <ce:surname> Lanahan </ce:surname> </sb:author> <sb:author> <ce:given-name> P.F. </ce:given-name> <ce:surname> Worley </ce:surname> </sb:author> <sb:author> <ce:given-name> V.L. </ce:given-name> <ce:surname> Dawson </ce:surname> </sb:author> <sb:author> <ce:given-name> T.M. </ce:given-name> <ce:surname> Dawson </ce:surname> </sb:author> <sb:author> <ce:given-name> C.A. </ce:given-name> <ce:surname> Ross </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> Nature Genet </sb:maintitle> </sb:title> <sb:volume-nr> 22 </sb:volume-nr> </sb:series> <sb:date> 1999 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 110 </sb:first-page> <sb:last-page> 114 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB34"> <ce:label> [34] </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> K. </ce:given-name> <ce:surname> Wakabayashi </ce:surname> </sb:author> <sb:author> <ce:given-name> S. </ce:given-name> <ce:surname> Engelender </ce:surname> </sb:author> <sb:author> <ce:given-name> M. </ce:given-name> <ce:surname> Yoshimoto </ce:surname> </sb:author> <sb:author> <ce:given-name> S. </ce:given-name> <ce:surname> Tsuji </ce:surname> </sb:author> <sb:author> <ce:given-name> C.A. </ce:given-name> <ce:surname> Ross </ce:surname> </sb:author> <sb:author> <ce:given-name> H. </ce:given-name> <ce:surname> Takahashi </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> Synphilin-1 is present in Lewy bodies in Parkinson 's disease </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> Ann Neurol </sb:maintitle> </sb:title> <sb:volume-nr> 47 </sb:volume-nr> </sb:series> <sb:date> 2000 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 521 </sb:first-page> <sb:last-page> 523 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB35"> <ce:label> [35] </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> A. </ce:given-name> <ce:surname> Aitken </ce:surname> </sb:author> <sb:author> <ce:given-name> D. </ce:given-name> <ce:surname> Jones </ce:surname> </sb:author> <sb:author> <ce:given-name> Y. </ce:given-name> <ce:surname> Soneji </ce:surname> </sb:author> <sb:author> <ce:given-name> S. </ce:given-name> <ce:surname> Howell </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> 14-3-3 proteins : Biological function and domain structure </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> Biochem Soc Trans </sb:maintitle> </sb:title> <sb:volume-nr> 23 </sb:volume-nr> </sb:series> <sb:date> 1995 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 605 </sb:first-page> <sb:last-page> 611 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB36"> <ce:label> [36] </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> G.W. </ce:given-name> <ce:surname> Reuther </ce:surname> </sb:author> <sb:author> <ce:given-name> M. </ce:given-name> <ce:surname> Pendergast </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> The roles of 14-3-3 proteins in signal transduction </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> Vitam Horm </sb:maintitle> </sb:title> <sb:volume-nr> 52 </sb:volume-nr> </sb:series> <sb:date> 1996 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 149 </sb:first-page> <sb:last-page> 175 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB37"> <ce:label> [37] </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> N. </ce:given-name> <ce:surname> Pstrerova </ce:surname> </sb:author> <sb:author> <ce:given-name> L. </ce:given-name> <ce:surname> Petrucelli </ce:surname> </sb:author> <sb:author> <ce:given-name> M. </ce:given-name> <ce:surname> Farrer </ce:surname> </sb:author> <sb:author> <ce:given-name> N. </ce:given-name> <ce:surname> Mehta </ce:surname> </sb:author> <sb:author> <ce:given-name> P. </ce:given-name> <ce:surname> Choi </ce:surname> </sb:author> <sb:author> <ce:given-name> J. </ce:given-name> <ce:surname> Hardy </ce:surname> </sb:author> <sb:author> <ce:surname> Wolozin </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> B. alpha-Synuclein shares physical and functional homology with 14-3-3 proteins </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> J Neurosci </sb:maintitle> </sb:title> <sb:volume-nr> 19 </sb:volume-nr> </sb:series> <sb:date> 1999 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 5782 </sb:first-page> <sb:last-page> 5791 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> </ce:bibliography-sec> </ce:bibliography> </tail> </converted-article> </xocs:serial-item> </xocs:doc> </originalText> </full-text-retrieval-response>	p(FPLX:PKA)	directlyIncreases	act(p(HGNC:MAPT))
ba54a04e-a5ef-441d-ab4a-1ed3da509dd4	0.65	PubMed	20849811	Track (1) is tau isolated from a control human brain; (2) is recombinant tau 1N4R produced in E. coil, (3) is tau extracted from cells transfected with tan alone; (4) is from cells transfected with tau alone following TPA treatment for 10 min; (5) is from cells co-transfected with both tau and p44 MAP kinase; (6) is from cells co-transfected with tau and p44 MAP kinase and treated with TPA for 10 min; (7) is from cells co-transfected with tan and GSK-3/3; (8) is from ceils co-transfected with tau and GSK- 3or and (9) is a sample of PHF-tau.	a(CHEBI:37537)	directlyIncreases	act(p(HGNC:MAPT))
e363bd4e-7850-41fa-8a25-2e8defa3ee41	0.65	PubMed	26198711	Sex hormone related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-beta or hyperphosphorylated tau protein.	p(HGNC:PLXNA3)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
d1ff3b44-0ac5-40bf-873c-005955f0acc4	0.86	PubMed	15184400	Accordingly, ectopic expression of POLDIP2 enhanced the formation of Tau aggregates without affecting Tau phosphorylation, while down-regulation of POLDIP2 alleviated ROS induced Tau aggregation.	p(HGNC:POLDIP2)	directlyIncreases	act(p(HGNC:MAPT))
d1ff3b44-0ac5-40bf-873c-005955f0acc4	0.86	PubMed	15184400	From a cell based screening using cDNA expression library, we isolated POLDIP2 which increased Tau aggregation.	p(HGNC:POLDIP2)	directlyIncreases	act(p(HGNC:MAPT))
ebca8817-ba24-471b-942c-08ee530aadc2	0.65	PubMed	22050583	In this context, we have shown previously that a nanomagnetic force stimulus 5 - 70 pN, applied over 24 hours, locally modulated Tau distribution in cortical neurons 34 While the translocation of Tau was related to the nanomagnetic force strength, how vesicle transport gets impacted under the application of nanomagnetic forces remains an open question.	p(HGNC:POSTN)	directlyIncreases	act(p(HGNC:MAPT))
ac9efa0e-a457-44e1-b44c-80f1287a3f73	0.86	PubMed	18669011	As shown in XREF_FIG, an increased amount of DARPP-32 caused skipping of the alternative exon in both the tau and tra2-beta1 reporter constructs, that paralleled the increase of DARPP-32 protein caused by the overexpression (XREF_FIG).	p(HGNC:PPP1R1B)	directlyIncreases	act(p(HGNC:MAPT))
ac9efa0e-a457-44e1-b44c-80f1287a3f73	0.86	PubMed	20074680	As shown in XREF_FIG, an increased amount of DARPP-32 caused skipping of the alternative exon in both the tau and tra2-beta1 reporter constructs, that paralleled the increase of DARPP-32 protein caused by the overexpression (XREF_FIG).	p(HGNC:PPP1R1B)	directlyIncreases	act(p(HGNC:MAPT))
9834f401-dc2d-439d-ac51-61d1ffb34f8f	0.86	PubMed	20553266	The proportion of phosphoserine and phosphothreonine in tau that had been incubated for 1 h or 2 h with PP2A, was similar to that of tau which had not been treated with PP2A, indicating that both threonine and serine residues in tau are dephosphorylated by PP2A,.	p(FPLX:PPP2)	directlyIncreases	act(p(HGNC:MAPT))
9834f401-dc2d-439d-ac51-61d1ffb34f8f	0.86	PubMed	16846010	Incubation of misfolded tau isolated from AD brains with PP2A restores tau binding to microtubules to a level similar to that of recombinant 2N4R tau [XREF_BIBR].	p(FPLX:PPP2)	directlyIncreases	act(p(HGNC:MAPT))
db45b064-435c-4d4a-9100-2aba40e0ef42	0.86	PubMed	13819968	PP elevation was associated with increased P-tau (r = 0.23, p = 0.002), reduced Abeta1-42 (r = -0.19, p = 0.01), and increased P-tau to Abeta1-42 ratio (r = 0.27, p < 0.001).	p(HGNC:PPY)	directlyIncreases	act(p(HGNC:MAPT))
db45b064-435c-4d4a-9100-2aba40e0ef42	0.86	PubMed	24225352	PP elevation was associated with increased P-tau (r = 0.23, p = 0.002), reduced Abeta1-42 (r = -0.19, p = 0.01), and increased P-tau to Abeta1-42 ratio (r = 0.27, p < 0.001).	p(HGNC:PPY)	directlyIncreases	act(p(HGNC:MAPT))
8e172ec1-6277-49f5-98ef-8c6aeff28aa3	0.86	PubMed	18518820	To test whether TSA has a similar effect on HDAC6-tau interaction, HEK cells were transfected with tau and HDAC6-HA and treated with TSA followed by co-immunoprecipitation.	a(CHEBI:46024)	directlyIncreases	act(p(HGNC:MAPT))
8e172ec1-6277-49f5-98ef-8c6aeff28aa3	0.86	PubMed	18636984	To test whether TSA has a similar effect on HDAC6-tau interaction, HEK cells were transfected with tau and HDAC6-HA and treated with TSA followed by co-immunoprecipitation.	a(CHEBI:46024)	directlyIncreases	act(p(HGNC:MAPT))
1d7bf733-4f25-463c-85d9-585d586cb9b5	0.65	PubMed	12844409	However, co-expression of wild type parkin facilitated autophagic clearance and promoted deposition of Abeta (1-42) and p-Tau into the lysosome.	p(HGNC:PRKN)	directlyIncreases	act(p(HGNC:MAPT))
3febe082-c5cb-4bef-99ca-a892346a90de	0.65	PubMed	23175838	PrP c -overexpression potentiates oAbeta induced Fyn and tau toxicity in vivo.	p(HGNC:PRNP)	directlyIncreases	act(p(HGNC:MAPT))
2155d793-ad0a-4b3b-a1b1-eb2c9feb2b9e	0.65	PubMed	18206977	Reduced phosphorylation of PTEN can dramatically increase tau phosphorylation and impair the ability of tau to bind to microtubules XREF_BIBR.	p(HGNC:PTEN, pmod(Ph))	directlyIncreases	act(p(HGNC:MAPT))
b0bac7f2-6e58-4426-92ef-deb988f0f146	0.65	PubMed	18360106	Tumor suppressor PTEN affects tau phosphorylation : deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau.	p(HGNC:PTEN)	directlyIncreases	act(p(HGNC:MAPT, var(p.?)))
a6f0435f-e7c8-46b9-9993-3ea59b151ac2	0.65	PubMed	3969903	Step increases of tau fail to elicit a Ca2+ response in cells previously stimulated by a lower shear.	p(HGNC:PTPN5)	directlyIncreases	act(p(HGNC:MAPT))
bbed1852-0f80-49e5-a61f-d7306af9fb42	0.65	PubMed	18361937	Further, in our prior work, PTPRD was considered among other AD candidate genes for studies using a Drosophila model, and knockdown of lar, the fly orthologue of PTPRD, was discovered to enhance Tau induced retinal degeneration, consistent with its association with NFT accumulation in humans 45.	p(HGNC:PTPRD)	directlyIncreases	act(p(HGNC:MAPT))
7e933aae-7e43-4bef-8dc1-55f5a7955689	0.65	PubMed	12068647	In this study, we have investigated the effect of Pb (2+) on fibril formation of recombinant human Tau fragment Tau (244-372) and its mutants at physiological pH. As revealed by thioflavin T and 8-anilino-1-naphthalene sulfonic acid fluorescence, the addition of 5-40 microM Pb (2+) significantly accelerates the exposure of hydrophobic region and filament formation of wild-type Tau (244-372) on the investigated time scale.	a(PUBCHEM:73212)	directlyIncreases	act(p(HGNC:MAPT))
40dea291-d687-4e4a-ba00-40557c8fcc76	0.65	PubMed	17452407	To assess if PINCH interacts with de-phosphorylated Tau, neuronal lysate was treated with lambda protein phosphatase, proteins were immunoprecipitated with anti-Total Tau antibody and reacted with anti-PINCH antibody (XREF_FIG).	p(FPLX:Phosphatase)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
e886d25d-15f1-4921-8336-cbac6f722a91	0.95	PubMed	7849359	Conversely, inhibitors of this protease, but not of caspases, completely prevented tau proteolysis leading to the generation of the 17 kDa fragment and significantly reduced Abeta induced neuronal death.	p(FPLX:Protease)	directlyIncreases	act(p(HGNC:MAPT))
e886d25d-15f1-4921-8336-cbac6f722a91	0.95	PubMed	18358045	Thus, we are forced to conclude that PSA does not cleave Tau and that the Tau cleaving activity we observed in our PSA preparation is caused by an as yet unidentified contaminating protease.	p(FPLX:Protease)	directlyIncreases	act(p(HGNC:MAPT))
e886d25d-15f1-4921-8336-cbac6f722a91	0.95	PubMed	10982846	These data suggest that PSA is a protease that catalyses tau protein predominantly in SH-SY5Y cells.	p(FPLX:Protease)	directlyIncreases	act(p(HGNC:MAPT))
e886d25d-15f1-4921-8336-cbac6f722a91	0.95	PubMed	20377816	These data suggest that PSA is a protease that catalyses tau protein predominantly in SH-SY5Y cells.	p(FPLX:Protease)	directlyIncreases	act(p(HGNC:MAPT))
e886d25d-15f1-4921-8336-cbac6f722a91	0.95	PubMed	17550748	Published data from cellular models indicate that Ubiquitin specific protease 14 (USP14), a deubiquitinating enzyme (DUB), slows the degradation of tau and TDP-43 by the proteasome and that an inhibitor of USP14 increases the degradation of these substrates.	p(FPLX:Protease)	directlyIncreases	act(p(HGNC:MAPT))
633d427f-8dbb-40f8-9f18-bc575db78fcd	0.86	PubMed	18088888	Thus, it is possible that the proteasome dysfunction observed in AD can cause tau, C5L2 and CD88 accumulation.	p(FPLX:Proteasome)	directlyIncreases	act(p(HGNC:MAPT))
633d427f-8dbb-40f8-9f18-bc575db78fcd	0.86	PubMed	23394121	Thus, it is possible that the proteasome dysfunction observed in AD can cause tau, C5L2 and CD88 accumulation.	p(FPLX:Proteasome)	directlyIncreases	act(p(HGNC:MAPT))
10fd2a5d-8b08-41fd-9295-3b061db3c09b	0.65	PubMed	19672249	summarizes some of the complex time dependent changes in wild-type and HPRT deficient NT2 cells in the expression of markers that reflect such DA neuronal functions prior to differentiation (day 0) and at the intermediate day 21 stage of neuronal differentiation, at which time RA induced NT2 cells show a clear neuronal phenotype and express the neuronal marker Tau (data not shown).	a(CHEBI:26536)	directlyIncreases	act(p(HGNC:MAPT))
2287f478-3f32-42ff-a72d-397971271ef7	0.65	PubMed	14564872	We found that the downregulation of the Drosophila REEP1 homolog protein enhanced Tau toxicity with increased formation of insoluble aggregates.	p(HGNC:REEP1)	directlyIncreases	act(p(HGNC:MAPT))
c3f8ea77-81f2-4dba-8e6c-2f74cd6978a4	0.86	PubMed	22049092	By initiating membrane lipid peroxidation, ROS generated by mitochondria may also promote pTau and its aggregation [XREF_BIBR].	p(HGNC:ROS1)	directlyIncreases	act(p(HGNC:MAPT))
c3f8ea77-81f2-4dba-8e6c-2f74cd6978a4	0.86	PubMed	25930997	Interestingly, knockdown of POLDIP2 expression by POLDIP2 siRNA # 1 or 2, but not POLDIP2 siRNA # 3, inhibited ROS induced Tau aggregates (F).	p(HGNC:ROS1)	directlyIncreases	act(p(HGNC:MAPT))
53068cac-64cc-482a-871d-dd1d67a8b2c6	0.92	PubMed	18950918	The authors concluded that the increase in p70S6K in AD brains could mediate an up-regulation of tau.	p(HGNC:RPS6KB1)	directlyIncreases	act(p(HGNC:MAPT))
53068cac-64cc-482a-871d-dd1d67a8b2c6	0.92	PubMed	8154241	Zinc induced p70S6K activation could only upregulate translation of total S6 and tau but not global proteins in SH-SY5Y cells.	p(HGNC:RPS6KB1)	directlyIncreases	act(p(HGNC:MAPT))
53068cac-64cc-482a-871d-dd1d67a8b2c6	0.92	PubMed	16364302	Zinc induced p70S6K activation could only upregulate translation of total S6 and tau but not global proteins in SH-SY5Y cells.	p(HGNC:RPS6KB1)	directlyIncreases	act(p(HGNC:MAPT))
c287cf65-3009-4fd8-9779-2f29c8604502	0.65	PubMed	4691443	The p23 overexpression induced a mobility shift of tau, but most of the phosphorylation sites overlapped the endogenous phosphorylation sites.	p(HGNC:RRAS)	directlyIncreases	act(p(HGNC:MAPT))
7146c97b-3949-45dd-b783-809bb905aae9	0.65	PubMed	22027951	The RV systolic and diastolic function was deteriorated by PAB as measured by decreased contractility index, ejection fraction and increased Tau (time constant).	a(PUBCHEM:6992654)	directlyIncreases	act(p(HGNC:MAPT))
f76921d7-7717-4fdc-9a4f-6f03816f9528	0.65	PubMed	22037607	SAM activation with MAPT sgRNA alone increased total tau as well as p-tau in both lines (XREF_SUPPLEMENTARY).	a(PUBCHEM:34755)	directlyIncreases	act(p(HGNC:MAPT))
e3dfae3d-fe7d-4135-b93f-aa5e74312e90	0.65	PubMed	18857586	But relative to vehicle, infusion of SB increased pTau staining in CA3 neurons and neurites.	a(PUBCHEM:104894)	directlyIncreases	act(p(HGNC:MAPT))
44b95220-bc34-4d44-bc44-efe09bc7c405	0.65	PubMed	5698243	By contrast, the SHE related increase of Tau content was not affected by ketamine anesthesia, indicating that the mechanism (s) underlying SHE evoked accumulation of Tau must be different from the mechanism causing release of excitatory amino acids.	p(HGNC:SHE)	directlyIncreases	act(p(HGNC:MAPT))
0fc92a8e-f442-4498-8945-5b0997025964	0.65	PubMed	12109028	BX 795, an inhibitor of MARK1 and SIK, reduced 12E8 immunolabelling of tau in rat cortical neurons.	p(HGNC:SIK1)	directlyIncreases	act(p(HGNC:MAPT))
f4725e3c-7ea1-4de7-aab3-89806211e08c	0.86	PubMed	20869593	SIRT1 Deficiency Increases Tau Acetylation and Suppresses Degradation of p-Tau.	p(HGNC:SIRT1)	directlyIncreases	act(p(HGNC:MAPT))
f4725e3c-7ea1-4de7-aab3-89806211e08c	0.86	PubMed	18785580	SIRT1 Deficiency Increases Tau Acetylation and Suppresses Degradation of p-Tau.	p(HGNC:SIRT1)	directlyIncreases	act(p(HGNC:MAPT))
e68ec859-b2e2-402e-a9bf-c98ec7560f3d	0.65	PubMed	18561377	On the other hand, overexpression of WT-SIRT6 could rescue Tau (GFP) levels even in irradiated cells, while phosphorylation was still higher after irradiation.	p(HGNC:SIRT6)	directlyIncreases	act(p(HGNC:MAPT))
62c051a0-3527-45c1-afd1-dab9b7536878	0.65	PubMed	20658987	Loss of SUT-2 in C. elegans prevents the accumulation of tau protein.	p(HGNC:SLC26A7)	directlyIncreases	act(p(HGNC:MAPT))
343001bc-061d-4969-bb93-1175a93be455	0.65	PubMed	18704517	In contrast, early stage DAT primarily produced an increase in the Tau component (mean eta p 2 =.06).	p(HGNC:SLC6A3)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	6763462	We demonstrate that alpha-syn induces fibrillization of tau and that coincubation of tau and alpha-syn synergistically promotes fibrillization of both proteins.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	17244202	Although Tau and alpha-Syn have distinct biological functions, in vitro studies have shown that alpha-Syn can induce fibrillization of Tau, and vice versa, with the A53T mutation accelerating and enhancing formation of fibrils as compared to wildtype alpha-Syn XREF_BIBR.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	17244202	Moreover, when incubated together in vitro, alpha-Syn may serve as a seed, accelerating the aggregation of Tau XREF_BIBR.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	17807291	The insoluble and aggregated alpha-synuclein will induce the fibrillization of microtubule associated protein tau [XREF_BIBR] to kill the neuronal cells.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	18971073	Distinct alpha-Synuclein Strains Differentially Promote Tau Inclusions in Neurons.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	26643113	Notably, a cross seeding activity for alpha-synuclein with other aggregating proteins has already been described : alpha-synuclein accelerates the aggregation of tau and amyloid-beta, proteins implicated in Alzheimer 's disease (AD), and huntingtin, a protein involved in Huntington 's disease [XREF_BIBR, XREF_BIBR, XREF_BIBR - XREF_BIBR].	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	27226637	alpha-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	27226637	Furthermore, introduction of alpha-synuclein fibrils into cultured cells overexpressing Tau protein induced Tau aggregation.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	27226637	These results raise the possibility that alpha-synuclein fibrils interact with Tau, inhibit its function to stabilize microtubules, and also promote Tau aggregation, leading to dysfunction of neuronal cells.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	10192349	Oxidative modification of alpha-synuclein has been linked to fibril formation, and alpha-synuclein aggregation may induce the fibrillization of tau.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	17133280	Indeed, recently distinct conformational variants of alpha-synuclein aggregates were shown to differentially promote the aggregation of tau in neurons XREF_BIBR.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	25829335	In addition, studies on dopaminergic neurons treated with MPTP have revealed that this colocalization is primed by alpha-Synuclein triggered tau hyperphosphorylation, therefore this alpha-Synuclein mediated elevation of p-tau and subsequent dissociation form cytoskeleton is implicated in the MPTP mediated neurotoxicity.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	21445308	Moreover, when incubated together in vitro, alpha-Syn may serve as a seed, accelerating the aggregation of Tau XREF_BIBR.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	21445308	Although Tau and alpha-Syn have distinct biological functions, in vitro studies have shown that alpha-Syn can induce fibrillization of Tau, and vice versa, with the A53T mutation accelerating and enhancing formation of fibrils as compared to wildtype alpha-Syn XREF_BIBR.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	18358646	Notably, a cross seeding activity for alpha-synuclein with other aggregating proteins has already been described : alpha-synuclein accelerates the aggregation of tau and amyloid-beta, proteins implicated in Alzheimer 's disease (AD), and huntingtin, a protein involved in Huntington 's disease [XREF_BIBR, XREF_BIBR, XREF_BIBR - XREF_BIBR].	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	20599975	Moreover, we found that upon oxidative stress by MPTP or MPP +, alpha-Syn induced p-Tau formation through specific activation and recruitment of p-GSK-3beta, activated by autophosphorylation at Tyr216 (XREF_BIBR; XREF_BIBR).	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	16205909	These results raise the possibility that alpha-synuclein fibrils interact with Tau, inhibit its function to stabilize microtubules, and also promote Tau aggregation, leading to dysfunction of neuronal cells.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	16205909	Furthermore, introduction of alpha-synuclein fibrils into cultured cells overexpressing Tau protein induced Tau aggregation.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	12714745	We demonstrate that alpha-syn induces fibrillization of tau and that coincubation of tau and alpha-syn synergistically promotes fibrillization of both proteins.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	18443544	So far, mutations or polymorphisms in mitochondrial DNA and at least nine named nuclear genes have been identified as causing PD or affecting PD risk : alpha-synuclein, parkin, ubiquitin C-terminal hydrolase-L1, DJ-1, mitochondrial phosphatase and tensin homologue induced kinase 1, leucine-rich-repeat kinase 2, nuclear receptor NURR1, HTRA2 and tau [XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR].	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	23827677	Distinct alpha-Synuclein Strains Differentially Promote Tau Inclusions in Neurons.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	18359198	Intriguingly, misfolded alpha-synuclein seeds were able to initiate and propagate Tau aggregation, revealing the potential of cross seeding between different types of misfolded proteins [XREF_BIBR].	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	23262240	We previously reported that alpha-Synuclein expression leads to p-Tau (XREF_BIBR).	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	18358196	On the other hand, Parkin, the product of the PARK2 gene, has been reported to inhibit Wnt signaling [XREF_BIBR], whereas alpha-Synuclein, a presynaptic protein causal in PD, contributes to GSK-3beta-catalyzed Tau (a protein linked to tauopathies, such as AD) phosphorylation (pTau) in PD disease models [XREF_BIBR].	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
50b81b9e-a383-4ff4-a941-7fad6a2adfbc	0.95	PubMed	7833961	Affinity chromatography experiments demonstrated a direct binding of the two proteins, and alpha-synuclein was shown to induce fibrillization of tau.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:MAPT))
3c25e1b6-0f06-4af2-af67-aad7e21a386d	0.86	PubMed	25524953	Our results show that hSOD1, and to a higher degree hSOD1 (A4V), can increase tau toxicity in Drosophila and exacerbate the corresponding neurodegeneration phenotype.	p(HGNC:SOD1)	directlyIncreases	act(p(HGNC:MAPT))
3c25e1b6-0f06-4af2-af67-aad7e21a386d	0.86	PubMed	14834521	Our results show that hSOD1, and to a higher degree hSOD1 (A4V), can increase tau toxicity in Drosophila and exacerbate the corresponding neurodegeneration phenotype.	p(HGNC:SOD1)	directlyIncreases	act(p(HGNC:MAPT))
ae7d03fa-3699-4879-93b1-66fb95b1442f	0.65	PubMed	18364549	In addition to its role in IL10 regulation, SP1 is also a co-activator of APP 79, BACE1 80 and MAPT 81, positioning it as an intriguing molecular node at the crossroads of microglial activation, amyloid and tau regulation.	p(HGNC:SP1)	directlyIncreases	act(p(HGNC:MAPT))
7237ea3f-4f5b-45e3-a6aa-bca7380f8c02	0.92	PubMed	13534280	This p62 mediated Tau degradation was significantly impaired in PS1 deficient cells, which can be rescued by ectopic expression of either p62 or wild-type PS1 but not mutant PS1 containing FAD linked mutations.	p(HGNC:SQSTM1)	directlyIncreases	act(p(HGNC:MAPT))
7237ea3f-4f5b-45e3-a6aa-bca7380f8c02	0.92	PubMed	23794287	This p62 mediated Tau degradation was significantly impaired in PS1 deficient cells, which can be rescued by ectopic expression of either p62 or wild-type PS1 but not mutant PS1 containing FAD linked mutations.	p(HGNC:SQSTM1)	directlyIncreases	act(p(HGNC:MAPT))
7237ea3f-4f5b-45e3-a6aa-bca7380f8c02	0.92	PubMed	20166324	In this scenario, synaptic activity could enhance autophagosome formation along nerve terminals to uptake cytoplasmic oligomeric Tau, targeted by p62, within autophagosomes.	p(HGNC:SQSTM1)	directlyIncreases	act(p(HGNC:MAPT))
417202be-c1b8-47d1-b33d-12195fa4caae	0.86	PubMed	26534959	HIV-1-Tat Protein Inhibits SC35 mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.	p(HGNC:SRSF2)	directlyIncreases	act(p(HGNC:MAPT))
417202be-c1b8-47d1-b33d-12195fa4caae	0.86	PubMed	24037441	Cyclic AMP dependent protein kinase enhances SC35 promoted Tau exon 10 inclusion.	p(HGNC:SRSF2)	directlyIncreases	act(p(HGNC:MAPT))
8911aa48-c74e-4270-a442-4525073007ba	0.65	PubMed	18809741	The icv STZ administration further increased the accumulation of tau that was phosphorylated at several of these sites.	p(HGNC:ST3GAL4)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
55ffff1f-98fc-4084-9945-97eff36932a9	0.86	PubMed	20478262	Shimura et al. [XREF_BIBR] concluded that, by ubiquitinylating tau, CHIP could rescue phospho-tau-induced cell death.	p(HGNC:STUB1)	directlyIncreases	act(p(HGNC:MAPT))
55ffff1f-98fc-4084-9945-97eff36932a9	0.86	PubMed	18643199	Shimura et al. [XREF_BIBR] concluded that, by ubiquitinylating tau, CHIP could rescue phospho-tau-induced cell death.	p(HGNC:STUB1)	directlyIncreases	act(p(HGNC:MAPT))
5e1a11e1-6129-4097-8663-7009f74a8009	0.65	PubMed	20117993	In fly and mouse models of Tauopathy, reduction of Synaptogyrin-3 prevents the association of presynaptic Tau with vesicles, alleviates Tau induced defects in vesicle mobility, and restores neurotransmitter release.	p(HGNC:SYNGR3)	directlyIncreases	act(p(HGNC:MAPT))
494e42c3-2201-4ceb-a91f-e30b2442ff45	0.65	PubMed	18273361	Blast induces GSK3beta activation in ApoE4 mice and synj1 knockdown reduces pTau partially through inactivation of GSK3beta.	p(HGNC:SYNJ1)	directlyIncreases	act(p(HGNC:MAPT))
906baf1f-a210-43e6-9633-159bce1f9913	0.65	PubMed	18446111	Interestingly, ISV and Tau were supported by DMN connections to a region of the occipital cortex that spatially overlapped for both measures.	p(HGNC:SYNM)	directlyIncreases	act(p(HGNC:MAPT))
6c13d58d-53e3-4881-959b-830a698fc301	0.65	PubMed	21263780	Lane 2 (<ce:cross-ref refid="FIG4"> Fig. 4 </ce:cross-ref>) shows the result when the fragment produced by <ce:italic> Tau </ce:italic> I digestion was treated with T4 DNA polymerase.	a(PUBCHEM:5819)	directlyIncreases	act(p(HGNC:MAPT))
1ed4394c-4b32-4aed-bb18-6afa33648482	0.95	PubMed	15053964	In this study, we determined whether TG mice overexpressing tau, a key pathogenic protein in AD and other neurodegenerative disorders known as tauopathies, have altered olfactory function, as measured by an odor habituation paradigm.	p(HGNC:TG)	directlyIncreases	act(p(HGNC:MAPT))
1ed4394c-4b32-4aed-bb18-6afa33648482	0.95	PubMed	15053964	The Talpha1-3RT TG mice overexpress human tau in neurons and glia in an age dependent fashion, making them a good model for tauopathies with the clinical features of frontotemporal dementias, AD and other neurodegenerative disorders with neuronal and glial tau pathologies.	p(HGNC:TG)	directlyIncreases	act(p(HGNC:MAPT))
1ed4394c-4b32-4aed-bb18-6afa33648482	0.95	PubMed	11469543	rTg4510 transgenic (TG) mice overexpress mutant (P301L) human tau protein.	p(HGNC:TG)	directlyIncreases	act(p(HGNC:MAPT))
1ed4394c-4b32-4aed-bb18-6afa33648482	0.95	PubMed	16125396	Interestingly, extracellular Abeta deposition precedes tau pathology by several months in this latter Tg line, favoring the amyloid cascade pathogenic hypothesis.In the present study, we have further characterized a new double Tg model that overexpresses APPsw and a triple FTDP-17 tau mutation (APP-tau).	p(HGNC:TG)	directlyIncreases	act(p(HGNC:MAPT))
1ed4394c-4b32-4aed-bb18-6afa33648482	0.95	PubMed	18885012	rTg4510 transgenic (TG) mice overexpress mutant (P301L) human tau protein.	p(HGNC:TG)	directlyIncreases	act(p(HGNC:MAPT))
63ffeb4c-fed9-4a6d-835a-9ea56467732a	0.92	PubMed	17711880	The interaction of TIA1 with tau increases the tendency of tau to form sarkosyl insoluble aggregates, and stabilizes tau dynamics.	p(HGNC:TIA1)	directlyIncreases	act(p(HGNC:MAPT))
63ffeb4c-fed9-4a6d-835a-9ea56467732a	0.92	PubMed	18529407	The ability of TIA1 to promote tau granules led us to hypothesize that TIA1 increased the stability of tau in granules.	p(HGNC:TIA1)	directlyIncreases	act(p(HGNC:MAPT))
63ffeb4c-fed9-4a6d-835a-9ea56467732a	0.92	PubMed	18529407	TIA1 Modulates the Pathophysiology of tau.	p(HGNC:TIA1)	directlyIncreases	act(p(HGNC:MAPT))
87b49cdc-3fec-4c02-bcef-09f5a03469f4	0.65	PubMed	23737459	TKI decreases LC3-II levels and subcellular fractionation show a decrease in Abeta and p-Tau in autophagosomal fractions (AV10 and AV20) and deposition in lysosomes, indicating that TKI facilitates autophagosome clearance.	p(UP:P16223)	directlyIncreases	act(p(HGNC:MAPT))
f788729f-999c-4716-ae8b-1bd24ec1d9e8	0.65	PubMed	26074317	This observation was further supported by the results of Begg 's rank correlation (Kendall 's Tau with continuity correction = -0.39, = 2.12, two tailed -value = 0.034) and Egger 's linear regression (intercept = -2.49, standard error = 0.83; 95% CI = -4.26, -0.71, = 3.01, df = 14.00, two tailed = 0.009) tests.	p(HGNC:TNFRSF11A)	directlyIncreases	act(p(HGNC:MAPT))
10102cf4-bc7f-4469-b44e-8fb584bd6d9a	0.95	PubMed	18075098	We asked whether TRIM28 modulates alpha-Syn and tau by forming a complex with them and found that they did indeed interact, albeit weakly, in human cells (XREF_FIG).	p(HGNC:TRIM28)	directlyIncreases	act(p(HGNC:MAPT))
10102cf4-bc7f-4469-b44e-8fb584bd6d9a	0.95	PubMed	18075098	TRIM28 binds to and promotes the nuclear accumulation of alpha-Syn and tau.	p(HGNC:TRIM28)	directlyIncreases	act(p(HGNC:MAPT))
10102cf4-bc7f-4469-b44e-8fb584bd6d9a	0.95	PubMed	18075098	Our finding that TRIM28 drives the nuclear accumulation of alpha-Syn and tau provides new mechanistic insight into the steps that lead to the pathogenicity of these proteins and highlights a shared pathway for therapeutic targeting.	p(HGNC:TRIM28)	directlyIncreases	act(p(HGNC:MAPT))
10102cf4-bc7f-4469-b44e-8fb584bd6d9a	0.95	PubMed	18075098	Together, these studies suggest that TRIM28 promotes the accumulation of the amyloidogenic proteins alpha-Syn and tau.	p(HGNC:TRIM28)	directlyIncreases	act(p(HGNC:MAPT))
10102cf4-bc7f-4469-b44e-8fb584bd6d9a	0.95	PubMed	18075098	While the Trim28 null mice are embryonic lethal, we found that the Trim28 +/- mice looked and behaved normally and that 50% loss of Trim28 was sufficient to reduce alpha-Syn and tau and ameliorate toxicity.	p(HGNC:TRIM28)	directlyIncreases	act(p(HGNC:MAPT))
10102cf4-bc7f-4469-b44e-8fb584bd6d9a	0.95	PubMed	18075098	If TRIM28 is indeed promoting accumulation of alpha-Syn and tau in a disease context, levels of TRIM28 could also be deregulated.	p(HGNC:TRIM28)	directlyIncreases	act(p(HGNC:MAPT))
161dc78f-1da1-4002-9229-0a44c180ae6c	0.86	PubMed	17125397	TTBK1 has been shown to co-localize with diffuse phospho-Ser422 tau in pre-tangle Alzheimer 's disease neurons XREF_BIBR, and increased levels of TTBK1 have been observed in AD frontal cortex XREF_BIBR and enhance the toxicity of tau in a P301L mouse model XREF_BIBR.	p(HGNC:TTBK1)	directlyIncreases	act(p(HGNC:MAPT))
161dc78f-1da1-4002-9229-0a44c180ae6c	0.86	PubMed	25473830	TTBK1 has been shown to co-localize with diffuse phospho-Ser422 tau in pre-tangle Alzheimer 's disease neurons XREF_BIBR, and increased levels of TTBK1 have been observed in AD frontal cortex XREF_BIBR and enhance the toxicity of tau in a P301L mouse model XREF_BIBR.	p(HGNC:TTBK1)	directlyIncreases	act(p(HGNC:MAPT))
e32c5643-0b24-4992-9bef-225bf0819df7	0.65	PubMed	17475246	Treatment with Abeta oligomers depleted sGluN1 (XREF_FIG, A-F) and sEphB2 (XREF_FIG, A-F) in primary hippocampal neurons from mice lacking tau or PrP C and in wild-type neurons treated with TTX, which blocks action potentials by inhibiting voltage gated sodium channels.	a(PUBCHEM:6324668)	directlyIncreases	act(p(HGNC:MAPT))
16dd4992-3e04-4381-aec3-5ebfbd9a39f2	0.65	PubMed	16639900	Rat models were then randomly divided into four groups including normal control group (Con group), diabetes mellitus group (DM group), Jinmaitong group (JMT group) (treated with JMT similar to the fifteen-fold dose of adult recommended dosage), and taurine group (Tau group) (treated with Taurine similar to the fifteen-fold dose of adult recommended dosage), with 10 rats in each group.	a(PUBCHEM:1123)	directlyIncreases	act(p(HGNC:MAPT))
a68bce0b-57bb-4ca3-924b-8671feac47ed	0.86	PubMed	18752972	Taxane sensitivity of cells overexpressing Tau.	a(PUBCHEM:9548828)	directlyIncreases	act(p(HGNC:MAPT))
a68bce0b-57bb-4ca3-924b-8671feac47ed	0.86	PubMed	21062914	Taxane sensitivity of cells overexpressing Tau.	a(PUBCHEM:9548828)	directlyIncreases	act(p(HGNC:MAPT))
440bab07-6d1d-4177-8e85-46e36313cbd7	0.65	PubMed	12227074	Thapsigargin also induced activation of caspase-3 and cleavage of tau.	a(PUBCHEM:446378)	directlyIncreases	act(p(HGNC:MAPT))
87ee991d-dc7c-4ba7-a4d7-c9d470564c98	0.92	PubMed	20988576	The protein kinase was independent of well-known sec- ond messengers, but tubulin stimulated the phosphoryl- ation of tau by the kinase.	p(FPLX:Tubulin)	directlyIncreases	act(p(HGNC:MAPT))
87ee991d-dc7c-4ba7-a4d7-c9d470564c98	0.92	PubMed	17285286	The phosphorylation of stathmin leads to the inhibition of its ability to form ternary complexes with tubulin dimers preventing their incorporation into growing microtubules and promoting shrinkage of the microtubules XREF_BIBR.	p(FPLX:Tubulin)	directlyIncreases	act(p(HGNC:MAPT))
87ee991d-dc7c-4ba7-a4d7-c9d470564c98	0.92	PubMed	20237556	[XREF_BIBR] Hyper-p-tau in AD could exert pathological effects via several mechanisms : (1) Alterations in microtubule stability : Phosphorylation reduces tau affinity for tubulin causing p-tau to detach from microtubules.	p(FPLX:Tubulin)	directlyIncreases	act(p(HGNC:MAPT))
0316ef96-ea96-44ae-8f72-a5c96a44cb5b	0.65	PubMed	23684085	Conversely, IU1, a small molecule inhibitor of USP14, stimulated the degradation of tau.	p(HGNC:USP14)	directlyIncreases	act(p(HGNC:MAPT))
0f2efc25-81b4-4f8a-bf57-4e64c8b73d91	0.95	PubMed	12077282	For this reason, we sought to determine whether ubiquitin targeting of tau is associated with particular tau modifications that herald specific stages of NFTs maturation in the hippocampus of Alzheimer 's disease cases.	p(FPLX:Ubiquitin)	directlyIncreases	act(p(HGNC:MAPT))
0f2efc25-81b4-4f8a-bf57-4e64c8b73d91	0.95	PubMed	12077282	It would appear, therefore, that ubiquitin targeting of tau protein occurs at NFTs in the early and intermediate stages of the maturation.	p(FPLX:Ubiquitin)	directlyIncreases	act(p(HGNC:MAPT))
0f2efc25-81b4-4f8a-bf57-4e64c8b73d91	0.95	PubMed	17713250	The small molecule IU1, a potent and selective inhibitor of the deubiquitinating enzyme ubiquitin specific peptidase 14 (USP14), enhanced the degradation of tau.	p(FPLX:Ubiquitin)	directlyIncreases	act(p(HGNC:MAPT))
0f2efc25-81b4-4f8a-bf57-4e64c8b73d91	0.95	PubMed	21919991	For this reason, we sought to determine whether ubiquitin targeting of tau is associated with particular tau modifications that herald specific stages of NFTs maturation in the hippocampus of Alzheimer 's disease cases.	p(FPLX:Ubiquitin)	directlyIncreases	act(p(HGNC:MAPT))
0f2efc25-81b4-4f8a-bf57-4e64c8b73d91	0.95	PubMed	21919991	It would appear, therefore, that ubiquitin targeting of tau protein occurs at NFTs in the early and intermediate stages of the maturation.	p(FPLX:Ubiquitin)	directlyIncreases	act(p(HGNC:MAPT))
0f2efc25-81b4-4f8a-bf57-4e64c8b73d91	0.95	PubMed	16125114	Published data from cellular models indicate that Ubiquitin specific protease 14 (USP14), a deubiquitinating enzyme (DUB), slows the degradation of tau and TDP-43 by the proteasome and that an inhibitor of USP14 increases the degradation of these substrates.	p(FPLX:Ubiquitin)	directlyIncreases	act(p(HGNC:MAPT))
d17267af-677b-4623-8f06-46ca73c03827	0.65	PubMed	1704932	Veratrine induced a massive release of neuroactive amino acids such as Glu, Asp, GABA, and Tau into the extracellular fluid, and a delayed increase in PEA.	a(PUBCHEM:6280)	directlyIncreases	act(p(HGNC:MAPT))
9eb2b157-929a-4474-96eb-9e6ab5073a0c	0.65	PubMed	22193544	In conclusion, our data demonstrated that WWOX could restore the ability of Tau to promote microtubule formation by inhibiting GSK3beta activity.	p(HGNC:WWOX)	directlyIncreases	act(p(HGNC:MAPT))
0dc2eecc-44e4-4599-ade1-4e5907e684c6	0.86	PubMed	12362916	Zn2+ can accelerate assembly of the amyloid-beta peptides (Abeta) and tau protein central to the neuropathological changes found in Alzheimer 's disease (AD).	a(PUBCHEM:23994)	directlyIncreases	act(p(HGNC:MAPT))
0dc2eecc-44e4-4599-ade1-4e5907e684c6	0.86	PubMed	22349685	Zn2+ can accelerate assembly of the amyloid-beta peptides (Abeta) and tau protein central to the neuropathological changes found in Alzheimer 's disease (AD).	a(PUBCHEM:23994)	directlyIncreases	act(p(HGNC:MAPT))
21979b59-5a08-4412-81b3-e4472eecda94	0.94	PubMed	19826005	Low micromolar concentrations of Zn (2+) dramatically accelerate fibril formation of wild-type Tau (244-372) under reducing conditions, compared with no Zn (2+).	a(PUBCHEM:32051)	directlyIncreases	act(p(HGNC:MAPT))
21979b59-5a08-4412-81b3-e4472eecda94	0.94	PubMed	19826005	Higher concentrations of Zn (2+), however, induce wild-type Tau (244-372) to form granular aggregates in reducing conditions.	a(PUBCHEM:32051)	directlyIncreases	act(p(HGNC:MAPT))
21979b59-5a08-4412-81b3-e4472eecda94	0.94	PubMed	10620797	Higher concentrations of Zn (2+), however, induce wild-type Tau (244-372) to form granular aggregates in reducing conditions.	a(PUBCHEM:32051)	directlyIncreases	act(p(HGNC:MAPT))
21979b59-5a08-4412-81b3-e4472eecda94	0.94	PubMed	10620797	Low micromolar concentrations of Zn (2+) dramatically accelerate fibril formation of wild-type Tau (244-372) under reducing conditions, compared with no Zn (2+).	a(PUBCHEM:32051)	directlyIncreases	act(p(HGNC:MAPT))
b9c22712-d880-47b3-8032-566de06390b3	0.65	PubMed	17812787	Tau auto-proteolytic cleavage induced by acetyl-CoA maps to within the 2 nd and 4 th MTBR.	a(PUBCHEM:444493)	directlyIncreases	act(p(HGNC:MAPT))
50e2ec11-e352-4208-9a71-aa0ad296d283	0.65	PubMed	20460815	Kinetics of Tau Dephosphorylation MAPs purified from adult mouse brain were treated with E. coli alkaline phosphatase, in the presence of pro- tease inhibitors, for increasing times up to 48 hr.	p(PFAM:PF00245)	directlyIncreases	act(p(HGNC:MAPT))
50381095-898a-440f-bc56-f4cd3501f4a0	0.65	PubMed	4185190	The increase in elipticity was not associated with a change in the general conformation of the protein and was most likely due to an aggregation of the tau protein induced by aluminium.	a(PUBCHEM:5359268)	directlyIncreases	act(p(HGNC:MAPT))
46f9ab48-cf0d-4cff-979b-c2efd1f07316	0.86	PubMed	3832656	We investigated whether aluminum could induce tau protein to form filaments or aggregate.	a(PUBCHEM:104727)	directlyIncreases	act(p(HGNC:MAPT))
46f9ab48-cf0d-4cff-979b-c2efd1f07316	0.86	PubMed	3832656	In conclusion, aluminum appears to induce isolated tau protein to aggregate in a phosphate independent way, without the formation of fibrils.	a(PUBCHEM:104727)	directlyIncreases	act(p(HGNC:MAPT))
1dd6534f-6512-4b25-a085-a90612fb8deb	0.65	PubMed	10689447	Tau and APD90 were compared in cells treated with saline, amiodarone and sotalol (3 x 10 (-5) mmol/L).	a(PUBCHEM:2157)	directlyIncreases	act(p(HGNC:MAPT))
2aa07eb2-955d-47e4-99f5-f3da90b3aa54	0.92	PubMed	6910309	Both short-term and prolonged treatment with ammonia stimulate Tau efflux from C6 glioma cells, which confirms earlier observations with different CNS preparations.	a(PUBCHEM:222)	directlyIncreases	act(p(HGNC:MAPT))
2aa07eb2-955d-47e4-99f5-f3da90b3aa54	0.92	PubMed	6290214	The results are consistent with the assumption that ammonia stimulates Tau efflux mainly via activation of ionotropic Glu receptors.	a(PUBCHEM:222)	directlyIncreases	act(p(HGNC:MAPT))
2aa07eb2-955d-47e4-99f5-f3da90b3aa54	0.92	PubMed	4236839	The results suggest that ammonia induced Tau release is mediated by intracellular accumulation of cAMP and may occur either via an osmoresistant, cAMP controlled channel or a cAMP activated Tau transporter.	a(PUBCHEM:222)	directlyIncreases	act(p(HGNC:MAPT))
a5fa3d1f-919a-49aa-9f29-1014746a1225	0.95	PubMed	5300479	The mechanism through which arachidonic acid induces the polymerization of tau protein into filaments under reducing conditions was characterized through a combination of fluorescence spectroscopy and electron microscopy.	a(PUBCHEM:444899)	directlyIncreases	act(p(HGNC:MAPT))
a5fa3d1f-919a-49aa-9f29-1014746a1225	0.95	PubMed	24086739	Tau aggregation was induced by the addition of arachidonic acid.	a(PUBCHEM:444899)	directlyIncreases	act(p(HGNC:MAPT))
a5fa3d1f-919a-49aa-9f29-1014746a1225	0.95	PubMed	17845553	Tau aggregation was initiated by addition of arachidonic acid (AA) (see XREF_FIG), and tau in a concentration of 5 muM was incubated in absence or presence of the respective peptide in a molar ratio of 1:1 or 1:10.	a(PUBCHEM:444899)	directlyIncreases	act(p(HGNC:MAPT))
a5fa3d1f-919a-49aa-9f29-1014746a1225	0.95	PubMed	17491119	Tau aggregation was induced by the addition of arachidonic acid.	a(PUBCHEM:444899)	directlyIncreases	act(p(HGNC:MAPT))
a5fa3d1f-919a-49aa-9f29-1014746a1225	0.95	PubMed	13648162	Tau oligomers and fibrils were induced by arachidonic acid and then their actions assayed upon addition to microglial cells.	a(PUBCHEM:444899)	directlyIncreases	act(p(HGNC:MAPT))
cd24338e-ca9b-4c6b-bed1-296ce45ef5b9	0.65	PubMed	20159186	A study demonstrated that baicalin administrated before ischemia restrained the increase of extracellular Asp and Glu during brain ischemia and early reperfusion and also increased the concentration of Gly, Tau and GABA in cerebrospinal fluid in MCAO rat [XREF_BIBR].	a(PUBCHEM:64982)	directlyIncreases	act(p(HGNC:MAPT))
80127b6b-d47b-4937-91ca-caafcdb357ea	0.86	PubMed	17241698	Western blot showed that the levels of phosphorylated dopamine- and cyclic adenosine monophosphate regulated phosphoprotein of 32 kDa, extracellular signal regulated kinases 1/2, tau, and DeltafosB in dyskinetic rats treated with LDME and benserazide loaded nanoparticles were 134.6 +/- 14.1, 174.9 +/- 15.1, 134.2 +/- 19.3, and 320.5 +/- 32.8, respectively, which were significantly reduced compared with those of dyskinetic rats treated with LDME plus benserazide (210.3 +/- 19.7, 320.8 +/- 21.9, 340.4 +/- 27.1, and 620.7 +/- 48.3, respectively).	a(PUBCHEM:2327)	directlyIncreases	act(p(HGNC:MAPT))
80127b6b-d47b-4937-91ca-caafcdb357ea	0.86	PubMed	12644649	Western blot showed that the levels of phosphorylated dopamine- and cyclic adenosine monophosphate regulated phosphoprotein of 32 kDa, extracellular signal regulated kinases 1/2, tau, and DeltafosB in dyskinetic rats treated with LDME and benserazide loaded nanoparticles were 134.6 +/- 14.1, 174.9 +/- 15.1, 134.2 +/- 19.3, and 320.5 +/- 32.8, respectively, which were significantly reduced compared with those of dyskinetic rats treated with LDME plus benserazide (210.3 +/- 19.7, 320.8 +/- 21.9, 340.4 +/- 27.1, and 620.7 +/- 48.3, respectively).	a(PUBCHEM:2327)	directlyIncreases	act(p(HGNC:MAPT))
9b5ba773-e4d2-4b47-81d7-00b4b018078a	0.65	PubMed	18357942	Because it blocks proteasome activity, we predicted that bortezomib should significantly increase tau in FLIP-S- and FLIP-L-overexpressing cells.	a(CHEBI:52717)	directlyIncreases	act(p(HGNC:MAPT))
b9a5c2f4-55a2-40fa-91ec-d7bb55e81d38	0.86	PubMed	17681420	We previously demonstrated that nilotinib and bosutinib penetrate the brain, inhibit Abl activity and induce autophagic clearance of alpha-Synuclein and p-Tau in A53T mice and lentiviral gene transfer models [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].	a(PUBCHEM:5328940)	directlyIncreases	act(p(HGNC:MAPT))
b9a5c2f4-55a2-40fa-91ec-d7bb55e81d38	0.86	PubMed	18876496	We previously demonstrated that nilotinib and bosutinib penetrate the brain, inhibit Abl activity and induce autophagic clearance of alpha-Synuclein and p-Tau in A53T mice and lentiviral gene transfer models [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].	a(PUBCHEM:5328940)	directlyIncreases	act(p(HGNC:MAPT))
7a991c26-c0f7-4de8-8ffa-88d3bc2c6230	0.92	PubMed	8704706	Our data demonstrate that an increase in cytosolic calcium concentration induces modifications of neuronal metabolism of APP and tau, similar to those found in Alzheimer disease.	a(CHEBI:29108)	directlyIncreases	act(p(HGNC:MAPT))
7a991c26-c0f7-4de8-8ffa-88d3bc2c6230	0.92	PubMed	17746863	The other surprising observation was that rTg4510 tau transgenic mouse demonstrated normal calcium dynamics despite massive synaptic loss in both sensory and visual cortex, suggesting that tau related synaptic abnormality was induced by a calcium independent mechanism.	a(CHEBI:29108)	directlyIncreases	act(p(HGNC:MAPT))
7a991c26-c0f7-4de8-8ffa-88d3bc2c6230	0.92	PubMed	17707627	Increasing intracellular calcium levels in PC12 cells leads to calpain induced cleavage of tau.	a(CHEBI:29108)	directlyIncreases	act(p(HGNC:MAPT))
de11da78-d2e8-493c-ace1-a56a68b6cb02	0.65	PubMed	4970742	Tau levels increased significantly in denervated muscles treated with chloroquine (a lysosomotrophic agent) and in untreated ones, as compared to levels of similarly treated contralateral, innervated muscles.	a(PUBCHEM:2719)	directlyIncreases	act(p(HGNC:MAPT))
f93b3cca-ac7c-4a7a-89e5-ab8afa3a99d6	0.65	PubMed	7036836	From additional immunofluorescent analysis of the slices, we could demonstrate that the cholesterol imbalance also caused neurodegeneration of hippocampal neural cell processes and the appearance of tau protein pathology in the mossy fibers.	a(CHEBI:16113)	directlyIncreases	act(p(HGNC:MAPT))
22480e28-e2d6-4124-adb3-5db67703aac6	0.92	PubMed	18780705	We describe a mouse model where cholinergic axons are labeled with the tauGFP fusion protein driven by the choline acetyltransferase (ChAT) promoter.	a(PUBCHEM:305)	directlyIncreases	act(p(HGNC:MAPT))
22480e28-e2d6-4124-adb3-5db67703aac6	0.92	PubMed	11732008	We describe a mouse model where cholinergic axons are labeled with the tauGFP fusion protein driven by the choline acetyltransferase promoter.	a(PUBCHEM:305)	directlyIncreases	act(p(HGNC:MAPT))
22480e28-e2d6-4124-adb3-5db67703aac6	0.92	PubMed	17371096	Using a BAC transgenic mouse model where cholinergic neurons are labeled with the tauGFP fusion protein driven by the choline acetyltransferase promoter XREF_BIBR, we first examined whether we could detect cholinergic neurons in the DMH.	a(PUBCHEM:305)	directlyIncreases	act(p(HGNC:MAPT))
b50a403f-ec49-47f8-98fa-2ba3b0677894	0.65	PubMed	20085902	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin.	a(CHEBI:27899)	directlyIncreases	act(p(HGNC:MAPT))
eeb467be-2858-429b-a549-a7670ec81c40	0.65	PubMed	21090062	Hyperphosphorylation of tau was also observed in brain slices treated with OA, CL-A and KN-62 (<ce:cross-ref refid="FIG3"> Fig. 3B, C </ce:cross-ref>).	p(UP:P0CL70)	directlyIncreases	act(p(HGNC:MAPT))
f431bc93-75d9-49c4-9a2b-5b14a9fbc453	0.65	PubMed	16361669	A time series of MR spectra (semi-LASER, TE = 28 msec), localized to the bilateral hypothalamus (~ 1.6 ml) were obtained at 3T in six healthy subjects at baseline (euglycemia) and during a ~ 65-70-minute-long hyperglycemic clamp in 11-minute blocks with interleaved T Spectral quality allowed quantification of [Glc+ Tau] (sum reported due to high negative correlation between these metabolites) with CRLB < 25% in 35/36 timepoints during hyperglycemia.	p(PFAM:PF14769)	directlyIncreases	act(p(HGNC:MAPT))
40407f27-7e96-4aa1-a909-e91f8dec6f5a	0.95	PubMed	25658796	Our data indicate that three-dimensional collagen type I culture conditions, modeling peritoneal extracellular matrix, result in up-regulation of tau, suggesting that interaction with the extracellular matrix at the metastatic sites could lead to up-regulation of tau.	a(CHEBI:3815)	directlyIncreases	act(p(HGNC:MAPT))
40407f27-7e96-4aa1-a909-e91f8dec6f5a	0.95	PubMed	17203094	Three-dimensional collagen I matrix culture conditions resulted in up-regulation of tau protein.	a(CHEBI:3815)	directlyIncreases	act(p(HGNC:MAPT))
40407f27-7e96-4aa1-a909-e91f8dec6f5a	0.95	PubMed	17203094	Our data indicate that three-dimensional collagen type I culture conditions, modeling peritoneal extracellular matrix, result in up-regulation of tau, suggesting that interaction with the extracellular matrix at the metastatic sites could lead to up-regulation of tau.	a(CHEBI:3815)	directlyIncreases	act(p(HGNC:MAPT))
40407f27-7e96-4aa1-a909-e91f8dec6f5a	0.95	PubMed	14979888	Three-dimensional collagen I matrix culture conditions resulted in up-regulation of tau protein.	a(CHEBI:3815)	directlyIncreases	act(p(HGNC:MAPT))
40407f27-7e96-4aa1-a909-e91f8dec6f5a	0.95	PubMed	25658796	Three-dimensional collagen I matrix culture conditions resulted in up-regulation of tau protein.	a(CHEBI:3815)	directlyIncreases	act(p(HGNC:MAPT))
6c5432a9-a4f2-46e1-81de-5d9158b5bba8	0.65	PubMed	22054541	EGCG and curcumin had been tested to target Abeta, tau or transthyretin.	a(CHEBI:3962)	directlyIncreases	act(p(HGNC:MAPT))
8501e4fb-1f9c-40c9-87a4-fbdbd2979165	0.86	PubMed	17082609	Indeed, tau mediated neuronal death, in the absence of tau filaments, is observed in Drosophila and some transgenic mouse models overexpressing human tau [XREF_BIBR - XREF_BIBR].	bp(GO:"GO:0008219")	directlyIncreases	act(p(HGNC:MAPT))
8501e4fb-1f9c-40c9-87a4-fbdbd2979165	0.86	PubMed	17252861	Transgenic flies expressing wild-type and mutant forms of human tau recapitulate many features of the human disease including adult onset, progressive neurodegeneration, early death, enhanced toxicity of mutant tau, and accumulation of abnormal tau XREF_BIBR.	bp(GO:"GO:0008219")	directlyIncreases	act(p(HGNC:MAPT))
a79c24da-8a10-4cc5-8f1e-74116413bec5	0.65	PubMed	5273466	In vitro polyaminated tau was significantly less susceptible to micro-calpain proteolysis; however, tTG mediated polyamination of tau did not significantly alter the microtubule binding capacity of tau.	p(UP:P07650)	directlyIncreases	act(p(HGNC:MAPT))
c6cd6f7a-3aee-4da3-8fb7-224db504980c	0.86	PubMed	19080373	Strong synergetic cytotoxicity was observed when the cells overexpressing tau were simultaneously treated with DHA.	a(CHEBI:207229)	directlyIncreases	act(p(HGNC:MAPT))
c6cd6f7a-3aee-4da3-8fb7-224db504980c	0.86	PubMed	17548540	Strong synergetic cytotoxicity was observed when the cells overexpressing tau were simultaneously treated with DHA.	a(CHEBI:207229)	directlyIncreases	act(p(HGNC:MAPT))
9313cd31-f7c6-433b-82bd-886a57d7fafd	0.65	PubMed	1052526	Negative dp/dt (p less than 0.05), but not Tau, computed by the logarithmic or derivative methods, was reduced by diatrizoate.	a(PUBCHEM:2140)	directlyIncreases	act(p(HGNC:MAPT))
3e0abd36-f569-4a48-ae23-47245c160fac	0.65	PubMed	22890115	Tau aggregation was induced by the organic solvent dimethyl sulfoxide (DMSO), as previously demonstrated for both tau and alpha-synuclein ().	a(PUBCHEM:679)	directlyIncreases	act(p(HGNC:MAPT))
b3cd9169-16fb-41b5-bbf6-f56aeba27584	0.65	PubMed	18509032	Densitometry analysis shows a significant increase in the ratio of pGSK-3beta (Ser9) to total GSK-3beta and decrease in phosphorylated tau (p-tau) to total tau for HeLa and tau cells treated with 10 muM diosmetin compared with control (0 muM) below each figure panel.	a(CHEBI:4630)	directlyIncreases	act(p(HGNC:MAPT))
3fecc03c-636f-4e16-9dcd-06bf71b5a05e	0.65	PubMed	18728768	In aged monkey brain, dynein accumulates at the nerve endings and less dynein interacts with dynactin, causing accumulation of endogenous Tau and amyloid precursor proteins.	complex(p(PFAM:PF12455))	directlyIncreases	act(p(HGNC:MAPT))
3653efd0-101f-40a3-94b7-d899901baaec	0.65	PubMed	16902136	In summary, we report that chronic Dyrk1 inhibition synergistically reduces Abeta and tau pathology.	p(UP:Q76NV1)	directlyIncreases	act(p(HGNC:MAPT))
4496414b-49e5-4661-b409-f130e4f3fa06	0.65	PubMed	11016901	The metal ion magnesium (a co-factor for endonuclease) enhanced the Tau DNA nicking ability, while an endonuclease specific inhibitor, aurinetricarboxylic acid (ATA) inhibited the Tau DNA nicking ability.	p(UP:O00370)	directlyIncreases	act(p(HGNC:MAPT))
5215ce2e-a954-4ede-9f15-fbe1bf4ea901	0.65	PubMed	21213161	</ce:para> <ce:para view="all"> We and others have shown that in neurons, tau protein is induced by estradiol <ce:cross-refs refid="BIB17 BIB18"> [17,18] </ce:cross-refs> and that, in vitro, estradiol decreases tau phosphorylation and induced hyperphosphorylation (Alvarez de la Rosa et al., unpublished).	a(CHEBI:23965)	directlyIncreases	act(p(HGNC:MAPT))
d8f4a588-ebb1-4637-a61f-6c8b8b8634bc	0.65	PubMed	20579400	Jonna et al. found that estrogen stimulation upregulated MAPT mRNA in MCF-7 cells in microarray analysis [XREF_BIBR], and the MAPT gene is considered to contain an imperfect ER response element upstream of its promoter.	a(CHEBI:50114)	directlyIncreases	act(p(HGNC:MAPT))
44eeeede-abcb-4cb6-b623-4bbc7890d7c1	0.65	PubMed	18539088	Compared with deactivation after 4-s application of maximal GABA, addition of 3.2 microM etomidate significantly increased tau w to 221.9 +/- 41.1 ms for 0.6 (p < 0.01), 240.9 +/- 50.2 ms for 2.0 (p < 0.01) and 218.2 +/- 50.2 ms for 6.0 mug cDNA (p < 0.05) (XREF_FIG).	a(PUBCHEM:667484)	directlyIncreases	act(p(HGNC:MAPT))
2a9d1712-6b65-4787-89f8-9d7163d0ac08	0.86	PubMed	20183469	We reported previously that an fAD APP mutation elevates the Abeta42 :40 ratio and the total TAU and phospho-TAU levels in rostral, forebrain neuronal cultures.	a(PUBCHEM:643975)	directlyIncreases	act(p(HGNC:MAPT))
2a9d1712-6b65-4787-89f8-9d7163d0ac08	0.86	PubMed	20183469	Importantly, the increases in total TAU and phospho-TAU levels caused by the fAD mutation in rostral, forebrain neurons were not observed in parallel cultures directed to caudal fates (XREF_FIG A and 5B, teal bars).	a(PUBCHEM:643975)	directlyIncreases	act(p(HGNC:MAPT))
cd9b88d3-7962-458c-849f-925c7fb2fb3a	0.65	PubMed	13680205	As we showed in this study, tau hyperphosphorylation and DNA damage co-occurred under formaldehyde treatment in N2a cells, indicating that phosphorylated tau (p-Tau) induced by formaldehyde may be involved in DNA impairment.	a(PUBCHEM:712)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
654b964e-cf88-49ea-a1a2-a33d7b898852	0.86	PubMed	18673582	Similarly, PHF tau was increased by 867% in formic acid extracts of parietal cortex homogenates (XREF_TABLE).	a(PUBCHEM:284)	directlyIncreases	act(p(HGNC:MAPT))
654b964e-cf88-49ea-a1a2-a33d7b898852	0.86	PubMed	19104446	Similarly, PHF tau was increased by 867% in formic acid extracts of parietal cortex homogenates (XREF_TABLE).	a(PUBCHEM:284)	directlyIncreases	act(p(HGNC:MAPT))
ee0775b4-4bea-49c9-ad3b-069cbaa1b2bd	0.86	PubMed	3266716	Tau protein was proteolyzed to a significantly lesser extent in cells treated with forskolin and rolipram, okadaic acid, or both than in cells in which phosphorylation was not increased.	a(PUBCHEM:47936)	directlyIncreases	act(p(HGNC:MAPT))
ee0775b4-4bea-49c9-ad3b-069cbaa1b2bd	0.86	PubMed	3266716	Partially purified tau protein from cells treated with a combination of forskolin, rolipram, and okadaic acid was also more resistant to proteolysis by calpain in vitro compared with tau isolated from control cells.	a(PUBCHEM:47936)	directlyIncreases	act(p(HGNC:MAPT))
3cdf6c5b-697d-4203-bb24-8ed27d707488	0.65	PubMed	1014520	Using whole cell patch-clamp recording in hippocampal slices, halothane and pentobarbital were found to prolong the decay time constant (TAU (D)) of GABAA mediated spontaneous inhibitory postsynaptic currents (sIPSCs).	a(PUBCHEM:3562)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	18324451	The MT induced Tau filaments were most similar in appearance and width to the straight heparin induced Tau filaments (XREF_FIG).	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	18324451	More significantly, these filaments form in regular MT binding buffers, are induced by MTs, and are seen by electron microscopy (EM) to be similar to the well established Alzheimer 's-like Tau filaments induced by heparin.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	5017424	Heparin stimulation of tau phosphorylation by NCLK showed dependence on time of heparin exposure and correlated with the heparin induced conformational change of tau.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	26177386	The existence of a similar barrier for RNA- (this study) and heparin induced Tau fibrils 36 indicates that the lateral associations between beta-sheets in these fibrils are similar.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	22055905	EGCG was on the other hand unable to prevent fibril formation by beta2m, the prion protein, or heparin induced fibril formation of tau.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	23087208	More significantly, these filaments form in regular MT binding buffers, are induced by MTs, and are seen by electron microscopy (EM) to be similar to the well established Alzheimer 's-like Tau filaments induced by heparin.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	17738809	The existence of a similar barrier for RNA- (this study) and heparin induced Tau fibrils 36 indicates that the lateral associations between beta-sheets in these fibrils are similar.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	17288854	The kinetics for heparin mediated Tau filament formation can be characterized by a lag period, followed by a period of exponential growth and an asymptotic approach to equilibrium XREF_BIBR.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	25406315	Sequences in the second (amino acids 275-280, VQIINK) and third (amino acids 306-311, VQIVYK) repeats are essential for the heparin induced assembly of Tau into filaments (XREF_BIBR, XREF_BIBR).	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	19864981	In addition, we found that heparin efficiently induced TAU fibrillization 48 hours post-incubation, as evidenced by ThT assay.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	17477317	Sequences in the second (amino acids 275-280, VQIINK) and third (amino acids 306-311, VQIVYK) repeats are essential for the heparin induced assembly of Tau into filaments.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0c6883d1-cd8f-438a-b69c-9f743c0b7c4f	0.95	PubMed	21966400	The kinetics for heparin mediated Tau filament formation can be characterized by a lag period, followed by a period of exponential growth and an asymptotic approach to equilibrium XREF_BIBR.	a(PUBCHEM:22833565)	directlyIncreases	act(p(HGNC:MAPT))
0f34d4bb-8a7d-47c4-a216-c4a82d6a107c	0.65	PubMed	20016918	The aim of this study was to investigate the effects of taurine (Tau) on primary cultured neonatal myocardial cells treated with hydrogen peroxide (H	a(CHEBI:16240)	directlyIncreases	act(p(HGNC:MAPT))
88873fde-f495-465a-bd0c-c03e3b3bebdf	0.65	PubMed	6512033	Herein we report that iron (III) can also induce aggregation of soluble PHFtau.	a(PUBCHEM:23925)	directlyIncreases	act(p(HGNC:MAPT))
178add2d-4499-4a21-aa70-b14582de13e9	0.65	PubMed	3231550	The altered tau immunostaining is not the direct result of excitotoxic insult, as intrahippocampal injection of kainic acid did not cause the somal accumulation of tau, but did cause disruption of MAP2 immunostaining.	a(PUBCHEM:10255)	directlyIncreases	act(p(HGNC:MAPT))
3ff42fff-755d-411b-8ac6-9565f13e679b	0.65	PubMed	1599783	Ketamine modified postrest recovery : the first beat (B1) after a 1-min rest period was decreased by ketamine 10 (-4) M but not ketamine 10 (-5) M. Moreover, the beat-to-beat postrest recovery has been demonstrated to be exponential, and tau, the time constant of the decay was increased by ketamine 10 (-4) M (5.4 +/- 0.3 vs. 3.9 +/- 0.2 beats) but not by ketamine 10 (-5) M (3.4 +/- 0.4 vs. 3.7 +/- 0.2 beats).	a(PUBCHEM:3821)	directlyIncreases	act(p(HGNC:MAPT))
541bd254-19ee-43d4-b885-2df56c3f79e8	0.92	PubMed	22046776	Several lines of evidence support the neuroprotective effect of lithium and its potential to modulate amyloid-beta and tau protein metabolism, and to reduce the incidence of Alzheimer 's disease among bipolar patients.	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:MAPT))
541bd254-19ee-43d4-b885-2df56c3f79e8	0.92	PubMed	17591188	These results raise the question of whether or not the increased phosphorylation of tau may result in altering the activity of proteins downstream of tau, which may be rescued by lithium treatment.	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:MAPT))
541bd254-19ee-43d4-b885-2df56c3f79e8	0.92	PubMed	17373186	Lithium is able to reduce the amount of phosphorylated Tau in cell culture XREF_BIBR, so it is conceivable that lithium may activate too much Tau by inhibiting the activity of GSK-3 after fertilization and randomize the vegetal paralleled microtubule arrays.	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:MAPT))
682dfb86-4b43-4be7-a1bc-85a6870803c9	0.65	PubMed	12312632	To analyze how lithium is therapeutically beneficial in tauopathies, transgenic mice overexpressing human mutant tau (P301L) were treated with oral lithium chloride (LiCl) for 4 months starting at the age of 5 months.	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:MAPT, var(p.Pro301Leu)))
63610b95-3cba-42c3-a0e2-61a5eef26fb1	0.65	PubMed	17149141	Also, we measured the amount of phosphorylated levels of tau in N1E-115 cells treated with okadaic acid and melatonin.	a(CHEBI:16796)	directlyIncreases	act(p(HGNC:MAPT))
d1837a98-0698-4e10-8d2f-96716f2f7fff	0.65	PubMed	3395038	Injection of morphine sulphate (3 mg kg-1, s.c.) had no effect on resting release, but produced a significant suppression of the formalin evoked behaviour and release of Glu, Asp, Tau, Gly, Cit and PGE2.	a(PUBCHEM:23253564)	directlyIncreases	act(p(HGNC:MAPT))
1731d90b-a543-4ec0-946a-f7d029ae460d	0.65	PubMed	18640938	Finally, a growing number of studies suggest that pro inflammatory cytokines, such as interleukin 1 (IL1), interleukin 6 and nitric oxide released from astrocytes can accelerate MAPT pathology and formation of neurofibrillary tangles (NFTs) in vitro.	a(PUBCHEM:145068)	directlyIncreases	act(p(HGNC:MAPT))
83b0bc80-40fe-4116-9cb8-e4ffd80440ac	0.65	PubMed	17568351	Also in accord with previous results, hippocampal neurons with shorter dendrites showed less somatic accumulation of tau following nocodazole+ BDNF treatment compared to neurons treated with nocodazole alone (XREF_FIG).	a(PUBCHEM:4122)	directlyIncreases	act(p(HGNC:MAPT))
6bec8041-959b-42bd-bb63-8808ec20ca60	0.65	PubMed	16723659	We will also explain how new 3D culture technologies were applied to accelerate Abeta and p-tau pathologies in human neural cell cultures, as compared the standard two-dimensional (2D) culture conditions.	p(PFAM:PF06725)	directlyIncreases	act(p(HGNC:MAPT))
c9909ee3-4071-4fb8-9231-82d14d42d048	0.65	PubMed	16896550	XREF_FIG E, 0.2 mum Abeta1-42 monomers after 3h induced Tau protein conformational change as revealed by the significant increase of the corresponding band (3.5-fold increase).	p(PFAM:PF02829)	directlyIncreases	act(p(HGNC:MAPT))
60bdb10b-5ffe-4dd3-b44f-78e571f7b5a1	0.65	PubMed	17650583	Analysis of AD related biomarkers in CSF (Abeta 1-42, pTau181, and Tau) of AD, MCI and normal control groups confirmed previous findings that decreased Abeta 1-42 and increased Tau and pTau181 which are associated with MCI and AD XREF_BIBR - XREF_BIBR.	complex(p(HGNC:MCIDAS))	directlyIncreases	act(p(HGNC:MAPT))
51a8cd20-693c-4543-9d62-edb1a60d969f	0.65	PubMed	21352012	<ce:bold> B : </ce:bold> Tau is nitrated in cultured OLN-Tau40 cells treated with peroxynitrite.	a(PUBCHEM:104806)	directlyIncreases	act(p(HGNC:MAPT))
182ccc44-6fa2-4eca-ad99-487dd3138d95	0.65	PubMed	3282262	In patients with congestive heart failure, intracoronary phentolamine caused a significant increase in + dP/dt and the rate of isovolumic LV relaxation (-dP/dt and Tau).	a(PUBCHEM:5775)	directlyIncreases	act(p(HGNC:MAPT))
76ed35b3-8acc-4561-ad06-2f485a86758f	0.65	PubMed	18773197	XREF_BIBR, XREF_BIBR In most patients with PPA, the underlying neurodegenerative disease arises sporadically; however, in a few cases, PPA has been reported in families with disease causing mutations in the MAPT, GRN, C9orf72 or PSEN1 genes, which encode tau, granulin, protein C9orf72 and presenilin 1, respectively.	p(UP:P57190)	directlyIncreases	act(p(HGNC:MAPT))
4b05293d-383b-4583-b8fb-d5d5effecc5f	0.65	PubMed	18396574	Other studies demonstrated that pathological forms of tau replicate conformation and spread among cells, thus suggesting that prion like mechanisms underlie the stereotyped propagation of tau XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR.	p(PFAM:PF00377)	directlyIncreases	act(p(HGNC:MAPT))
b9060e04-2063-40cd-8b4a-4555ffd0f539	0.65	PubMed	20236152	The P301S mice (PS19 line) expressing human mutant microtubule associated protein tau, MAPT, driven by the mouse prion protein (Prnp) promoter were used in this study (Yoshiyama etal.	p(IP:IPR000817)	directlyIncreases	act(p(HGNC:MAPT, var(p.?)))
1099f7e1-ffdd-4adb-a7ce-deb0e2ed8088	0.65	PubMed	18831055	Furthermore, studies from human, transgenic mice and cells showed that progesterone also modulates Tau, another pathological molecule in AD and frontotemporal dementia [XREF_BIBR].	a(CHEBI:17026)	directlyIncreases	act(p(HGNC:MAPT))
722cf652-ae2a-4335-bb0a-9ba1112f348e	0.65	PubMed	22054541	EGCG, curcumin, and rifampicin also targeted tau protein, and these compounds led to reduced phosphorylated tau.	a(PUBCHEM:70680287)	directlyIncreases	act(p(HGNC:MAPT))
598f1bda-250c-4f82-b989-eaeb838a64a0	0.86	PubMed	16163038	In this work we show that sorbitol induced hyperosmotic stress promotes Tau proteolysis in SH-SY5Y neuroblastoma cells.	a(PUBCHEM:5780)	directlyIncreases	act(p(HGNC:MAPT))
598f1bda-250c-4f82-b989-eaeb838a64a0	0.86	PubMed	19883798	We have previously described that hyperosmotic stress induced by sorbitol promotes Tau proteolysis and apoptosis in SH-SY5Y cells via caspase-3 activation.	a(PUBCHEM:5780)	directlyIncreases	act(p(HGNC:MAPT))
29acdb75-1043-4a57-a36a-48dd87acc516	0.86	PubMed	17640395	As positive control, we treated cells with the pro apoptotic agent staurosporine, which efficiently induces Tau processing by caspase-3 during neuronal apoptosis [XREF_BIBR].	a(PUBCHEM:44259)	directlyIncreases	act(p(HGNC:MAPT))
29acdb75-1043-4a57-a36a-48dd87acc516	0.86	PubMed	17640395	As showed in immunoblot reported in XREF_FIG, this analysis revealed that Tau was not cleaved during DADS treatment, whereas a strong Tau cleaved immunoreactive band was observed in cells treated with staurosporine.	a(PUBCHEM:44259)	directlyIncreases	act(p(HGNC:MAPT))
e8a46735-6949-479f-b36f-ab43b66ada96	0.65	PubMed	22019084	Here, we investigated whether sulforaphane modulates the production of amyloid-beta (Abeta) and tau, the two main pathological factors in Alzheimer 's disease (AD).	a(CHEBI:47807)	directlyIncreases	act(p(HGNC:MAPT))
d4763cfe-9b41-47b8-92ac-e512e4c3cf3d	0.65	PubMed	8937912	We used gene expression data from 209 untreated patients to assess the pure prognostic value of tau, data from 267 patients treated with adjuvant tamoxifen to assess predictive value for endocrine therapy, and data from 82 patients treated with preoperative paclitaxel followed by 5-fluorouracil, doxorubicin, and cyclophosphamide (paclitaxel and FAC) to assess predictive value for chemotherapy response.	a(CHEBI:41774)	directlyIncreases	act(p(HGNC:MAPT))
fb2cc755-a10c-4b28-94c1-209052fb6b6a	0.86	PubMed	26534959	Here, we utilized clinical samples, an animal model, and neuronal cell cultures and found that Tat promotes TAU 3R up-regulation through increased levels of phosphorylated SC35, which is retained in nuclear speckles.	p(UP:P04608)	directlyIncreases	act(p(HGNC:MAPT))
fb2cc755-a10c-4b28-94c1-209052fb6b6a	0.86	PubMed	15666836	Here, we utilized clinical samples, an animal model, and neuronal cell cultures and found that Tat promotes TAU 3R up-regulation through increased levels of phosphorylated SC35, which is retained in nuclear speckles.	p(UP:P04608)	directlyIncreases	act(p(HGNC:MAPT))
4a3172be-6796-424d-9e52-f0299fcd26b3	0.95	PubMed	25773385	Predictive value of microtubule associated protein Tau in patients with recurrent and metastatic breast cancer treated with taxane containing palliative chemotherapy.	a(PUBCHEM:9548828)	directlyIncreases	act(p(HGNC:MAPT))
4a3172be-6796-424d-9e52-f0299fcd26b3	0.95	PubMed	18752972	We also measured the kinetics of taxane driven tubulin polymerization in MCF-7 cells knocked down in Tau, demonstrating no difference in comparison to parental or luciferase shRNA controls (data not shown).	a(PUBCHEM:9548828)	directlyIncreases	act(p(HGNC:MAPT))
4a3172be-6796-424d-9e52-f0299fcd26b3	0.95	PubMed	18752972	The probe sets used in gene expression studies that originally identified Tau as a potential modulator of taxane response targeted Tau domains shared by all isoforms.	a(PUBCHEM:9548828)	directlyIncreases	act(p(HGNC:MAPT))
4a3172be-6796-424d-9e52-f0299fcd26b3	0.95	PubMed	21062914	The probe sets used in gene expression studies that originally identified Tau as a potential modulator of taxane response targeted Tau domains shared by all isoforms.	a(PUBCHEM:9548828)	directlyIncreases	act(p(HGNC:MAPT))
4a3172be-6796-424d-9e52-f0299fcd26b3	0.95	PubMed	21062914	We also measured the kinetics of taxane driven tubulin polymerization in MCF-7 cells knocked down in Tau, demonstrating no difference in comparison to parental or luciferase shRNA controls (data not shown).	a(PUBCHEM:9548828)	directlyIncreases	act(p(HGNC:MAPT))
4e8b7485-7fd5-42f0-ac59-c3ba1a36ea0d	0.65	PubMed	12321641	Furthermore, tau protein accumulated in the distal region of the neurite when treated with taxol or taxol plus BDNF.	a(PUBCHEM:36314)	directlyIncreases	act(p(HGNC:MAPT))
84b2a7d2-91b6-4102-801e-4401f9c22a9e	0.86	PubMed	25406315	Cells were exposed to the Sarkosyl-insoluble fraction from the brains of TgP301S Tau mice 24 h after the induction of Tau expression and treated with 0.0125% trypsin to remove extracellular Tau.	a(CHEBI:9765)	directlyIncreases	act(p(HGNC:MAPT))
84b2a7d2-91b6-4102-801e-4401f9c22a9e	0.86	PubMed	17477317	Cells were exposed to the Sarkosyl-insoluble fraction from the brains of TgP301S Tau mice 24 h after the induction of Tau expression and treated with 0.0125% trypsin to remove extracellular Tau.	a(CHEBI:9765)	directlyIncreases	act(p(HGNC:MAPT))
1e80dadc-728e-453c-97b7-081b412c21f2	0.65	PubMed	22054838	As shown in XREF_FIG, tunicamycin induced aggregates of tau and tau pS214 immunoreactivity in cell bodies (arrowheads).	a(CHEBI:29699)	directlyIncreases	act(p(HGNC:MAPT))
4f63a07c-c1b6-4bf6-8385-8750aa4772ac	0.65	PubMed	17250920	Given its ability to raise and sustain supraphysiologic uridine levels, TAU may be useful in the management of disorders previously treated with uridine.	a(PUBCHEM:6029)	directlyIncreases	act(p(HGNC:MAPT))
94adefd1-5356-4e53-ae2a-746917618bc7	0.86	PubMed	21341502	Pretreatment of the primary cultures with rapamycin for 1 hour resulted in decreased levels of phosphorylated p70 S6 kinase and tau induced by zinc sulfate treatment (<ce:bold> G </ce:bold> and <ce:bold> H </ce:bold>).	a(PUBCHEM:24424)	directlyIncreases	act(p(HGNC:MAPT))
94adefd1-5356-4e53-ae2a-746917618bc7	0.86	PubMed	21341502	<ce:cross-refs refid="bib27 bib28 bib29"> <ce:sup loc="post"> 27-29 </ce:sup> </ce:cross-refs> To clarify the relationship between p70 S6 kinase and tau, p70 S6 kinase activity was modulated by zinc sulfate, and the effects on tau synthesis and phosphorylation were investigated in SH-SY5Y neuroblastoma cells.	a(PUBCHEM:24424)	directlyIncreases	act(p(HGNC:MAPT))
148b4986-79ac-49e5-b793-967da6d8d364	0.95	PubMed	16452634	No evidence text.	p(HGNC:MAPT, pmod(Ph, Ser, 396), pmod(Ph, Ser, 721))	directlyIncreases	act(p(HGNC:MAPT))
148b4986-79ac-49e5-b793-967da6d8d364	0.95	PubMed	10601262	No evidence text.	p(HGNC:MAPT, pmod(Ph, Ser, 396), pmod(Ph, Ser, 721))	directlyIncreases	act(p(HGNC:MAPT))
8dec9e93-5af8-4467-84a1-17e151121112	0.86	PubMed	17309736	It was furthermore shown that HDAC6 mediated loss of Tau acetylation renders the protein vulnerable to toxic phosphorylation events.	p(HGNC:HDAC6)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
8dec9e93-5af8-4467-84a1-17e151121112	0.86	PubMed	23962722	Furthermore, addition of the HDAC6 selective inhibitor ACY-738 prevented HDAC6 mediated deacetylation of tau on the KIGS motifs, and also blocked the increase in tau polymerization.	p(HGNC:HDAC6)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	18817541	A separate study in AD mice deficient for SIRT1 demonstrated that SIRT1 deacetylates tau, promoting its ubiquitin mediated degradation to suppress its pathogenic accumulation [XREF_BIBR, XREF_BIBR].	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	16905775	These observations are supported by in vitro and neuronal culture data indicating that SIRT1 can directly deacetylate tau protein at multiple residues.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	16905775	An example of this mechanism is observed in AD where direct deacetylation of tau protein by SIRT1 may promote protein clearance by removing acetyl groups from lysine residues that are subsequently marked by ubiquitination to signal for protein degradation by the proteasome system 62.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	18436588	Additionally, SIRT1 can directly deacetylate Tau protein, the main constituent of neurofibrillary tangles and primary marker of AD.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	18075196	Tau protein is deacetylated by SIRT1, affecting the stability of the protein and implying that SIRT1 activators may have therapeutic implications by reducing taumediated neurodegeneration [XREF_BIBR].	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	18539316	Acetyl-transferases p300, pCAF, and CBP (CREB binding protein) have all been reported to acetylate tau, and deacetylases SIRT1 and HDAC6 have been shown to modulate deacetylation of tau at specific residues [XREF_BIBR, XREF_BIBR].	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	18785580	Using gene silencing and pharmacological approaches, we show that p300 acetylates and SIRT1 deacetylates tau.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	18785580	SIRT1 Reduces Tau Acetylation in Primary Neurons and in Vivo.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	18785580	Deacetylation of Tau by SIRT1 in Cultures.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	20869593	Using gene silencing and pharmacological approaches, we show that p300 acetylates and SIRT1 deacetylates tau.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	20869593	Deacetylation of Tau by SIRT1 in Cultures.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	20869593	Deleting SIRT1 significantly enhanced levels of ac-tau in the brain, providing direct evidence that SIRT1 deacetylates tau in vivo (XREF_FIG).	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	20869593	Moreover, we demonstrated that SIRT1 deacetylates tau and that acetyltransferase p300 mediates its acetylation.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	24877878	A separate study in AD mice deficient for SIRT1 demonstrated that SIRT1 deacetylates tau, promoting its ubiquitin mediated degradation to suppress its pathogenic accumulation [XREF_BIBR, XREF_BIBR].	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	18785580	Deleting SIRT1 significantly enhanced levels of ac-tau in the brain, providing direct evidence that SIRT1 deacetylates tau in vivo (XREF_FIG).	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	18785580	Moreover, we demonstrated that SIRT1 deacetylates tau and that acetyltransferase p300 mediates its acetylation.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
d99420f7-454a-43bc-9aed-96f1dd1eac98	0.95	PubMed	17051743	Additionally in vitro observations indicated that SIRT1 can directly deacetylate Tau protein at multiple residues.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
21b054bc-34cd-4da7-addc-06911cff9332	0.65	PubMed	15613629	Acetyltransferase p300 induced tau acetylation is inhibited by salsalate and salicylate, which enhance tau turnover and reduce tau levels.	a(PUBCHEM:5161)	directlyDecreases	p(HGNC:MAPT, pmod(Ac))
fda87f0b-75c1-4ecc-b655-064932e47262	0.86	PubMed	17398399	Studies have shown that AD patients have decreased levels of Abeta 42 and increased levels of T-tau and P-tau in CSF compared with controls [XREF_BIBR].	p(PFAM:PF09793)	directlyDecreases	p(HGNC:MAPT)
fda87f0b-75c1-4ecc-b655-064932e47262	0.86	PubMed	22699906	Numerous studies have shown that AD and MCI patients have reduced CSF levels of Abeta 1-42 and increased levels of p-tau and total tau (XREF_BIBR).	p(PFAM:PF09793)	directlyDecreases	p(HGNC:MAPT)
41c89029-affa-406b-a5b4-85bbfbd2c53c	0.65	PubMed	17268123	In any case, it will be very difficult to evaluate, whether potential beneficial effects of sGC-1061 are due to changes in the level of tau, caused by decreased levels of Abeta, or due to other neuroprotective activities.	p(HGNC:APP)	directlyDecreases	p(HGNC:MAPT)
390ac077-0f6e-4622-b12e-4378d2c4c0d1	0.65	PubMed	13729299	In neuroblast SH-SY5Y cells, ASI dose-dependently reduced cellular ROS level and phosphorylation of tau in response to hydrogen peroxide challenge by modulation of Bcl-2 and Bax ratio.	p(HGNC:ARSI)	directlyDecreases	p(HGNC:MAPT)
1b4f519f-719f-437a-915c-69ba996c56a0	0.86	PubMed	18049691	Intermittent intranasal NAP administration at 2 mug and mouse per day, 5 days a week, for 24 weeks, starting at 4 weeks of age, significantly decreased the ratio of p-tau and tau levels in the subcortical region while a higher dose of 15 mug and mouse per day induced a decrease in p-tau and tau levels in the cerebellum.	p(HGNC:BASP1)	directlyDecreases	p(HGNC:MAPT)
1b4f519f-719f-437a-915c-69ba996c56a0	0.86	PubMed	14875420	Intermittent intranasal NAP administration at 2 mug and mouse per day, 5 days a week, for 24 weeks, starting at 4 weeks of age, significantly decreased the ratio of p-tau and tau levels in the subcortical region while a higher dose of 15 mug and mouse per day induced a decrease in p-tau and tau levels in the cerebellum.	p(HGNC:BASP1)	directlyDecreases	p(HGNC:MAPT)
e36e8eaa-8053-44a5-9d4b-bc59c39651c2	0.65	PubMed	26997278	Moreover, BIX treatment completely abolishes the increase in Tau expression during differentiation (F).	a(PUBCHEM:16656807)	directlyDecreases	p(HGNC:MAPT)
217cf614-f857-4331-9e25-c0af35fe72b5	0.65	PubMed	12940917	Oral administration of CP extract (150 mg/kg) to scopolamine treated rats reduced the increased protein and mRNA levels of tau and AbetaPP levels followed by reduction in Abeta levels compared with scopolamine treated group.	p(HGNC:CP)	directlyDecreases	p(HGNC:MAPT)
3dcf334f-e0f0-4a79-a17c-2ea70e683aa6	0.65	PubMed	15023486	Overexpression of CREB or activation of PKA significantly suppressed the expression of tau at mRNA and protein levels.	p(FPLX:CREB)	directlyDecreases	p(HGNC:MAPT)
91607238-1d75-403d-9944-90ac0c67e74a	0.65	PubMed	24853415	These findings suggest that DAPK1 KO downregulates tau protein expression in an age dependent manner in the mouse brain.	p(HGNC:DAPK1)	directlyDecreases	p(HGNC:MAPT)
0d0b7797-c1bc-4899-b4d3-2513f2702904	0.65	PubMed	17750514	DR dose-dependently decreased the levels of PHF-tau in the cortex, and a decreasing trend in PHF-tau was observed in the hippocampus after DR treatment.	a(PUBCHEM:16122509)	directlyDecreases	p(HGNC:MAPT)
640ddea8-e05e-4746-8bb6-d808cd3b4d73	0.65	PubMed	18358524	E1.4 reduces MAPT mRNA levels by 50-55 percent and tau protein synthesized (XREF_FIG).	a(PUBCHEM:5870)	directlyDecreases	p(HGNC:MAPT)
2e09fd62-eee8-4221-8557-d79e12e6008c	0.65	PubMed	18358524	However, in SH-SY5Y cultures, consistent with decrease in MAPT transcripts, E7.3 oligonucleotide also decreased tau protein levels by 67%.	p(UP:P03129)	directlyDecreases	p(HGNC:MAPT)
079a72f7-2f59-43ca-840b-d37c53949131	0.86	PubMed	19909395	These findings suggest that erythropoietin combined with hypothermia reduces serum tau protein levels and improves neonatal behavioral neurology outcome but does not affect long-term neurodevelopmental outcome.	p(HGNC:EPO)	directlyDecreases	p(HGNC:MAPT)
079a72f7-2f59-43ca-840b-d37c53949131	0.86	PubMed	20193528	As far as our clinical observations are concerned, a low dose of EPO used in the early stages of neonatal HIE can decrease serum tau levels and prevent disease development, as well as improve neonatal early behavioral neurology outcome.	p(HGNC:EPO)	directlyDecreases	p(HGNC:MAPT)
a53f404f-58e1-4820-8dab-58956eb1dc83	0.65	PubMed	15059108	We found that the Accell (TM) SMART pool siRNA against MAPT can effectively suppress tau expression in vitro and in vivo without a specific delivery agent.	p(HGNC:"ERVK-18")	directlyDecreases	p(HGNC:MAPT)
8dfb304f-5287-424d-b7de-2481c13d0f56	0.65	PubMed	11123930	MAPT protein expression was increased by stimulation with 17-beta-estradiol or tamoxifen, but decreased by ER downregulation and by fulvestrant, an ER inhibitor.	p(HGNC:ESR1)	directlyDecreases	p(HGNC:MAPT)
65c6114c-59db-47b5-b90e-6ee23c348de1	0.65	PubMed	11353659	Estrogen can up-regulate ChAT and NGF and down-regulate tau protein expression, thus producing obvious therapeutic effect on AD in rats.	a(PUBCHEM:5991)	directlyDecreases	p(HGNC:MAPT)
7b897747-636e-4617-b7fb-0dde7b2778f0	0.65	PubMed	18785314	To circumvent developmental toxicity of tau we utilized a ubiquitously expressed, temperature sensitive allele of the GAL4 repressor, GAL80 to restrict tau expression to adult glia.	p(UP:P04387)	directlyDecreases	p(HGNC:MAPT)
9aef6a27-091a-4499-8db5-6d009731cc7a	0.92	PubMed	22193544	This indicates that SH-SY5Y cell differentiation requires WWOX protein expression and lower pTau S396 and pTau S404 levels, possibly caused by the inhibition of GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MAPT)
9aef6a27-091a-4499-8db5-6d009731cc7a	0.92	PubMed	17583891	It was observed that the model was sensitive to dramatic changes in GSK3beta, which decreased pTau levels to 40.5%, and changes in PP2A, which increased pTau levels to 56%.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MAPT)
9aef6a27-091a-4499-8db5-6d009731cc7a	0.92	PubMed	13649359	However, GSK-3beta inhibition also unexpectedly increases tau protein levels, and produces insoluble granular tau oligomers.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MAPT)
05b03e0d-b172-4bfe-b15b-bc562fcd34ae	0.65	PubMed	11637055	Inhibition of tau kinases casein kinase 1 (CK1) or glycogen synthase kinase-3 decreased tau phosphorylation and significantly increased amounts of tau in the membrane fraction.	p(FPLX:GYS)	directlyDecreases	p(HGNC:MAPT)
7fd02aa1-bb4a-4a45-a861-03c17e401ffe	0.86	PubMed	16911717	Finally, gamma-secretase modulation also reduced tau protein levels in healthy controls, indicating that the link between APP metabolism and tau proteostasis is a feature of neuronal biology in health and disease.	p(FPLX:"Gamma_secretase")	directlyDecreases	p(HGNC:MAPT)
7fd02aa1-bb4a-4a45-a861-03c17e401ffe	0.86	PubMed	16911717	In support of a role for APP metabolism and APP-C83/99 in regulating tau levels, we found that gamma-secretase inhibition increased intracellular tau protein levels, whereas beta-secretase inhibition reduced intracellular tau protein.	p(FPLX:"Gamma_secretase")	directlyDecreases	p(HGNC:MAPT)
f660dc26-4fa4-47d7-afda-7a5a75b627ab	0.65	PubMed	11022883	Ginsenoside Rg1 could inhibit the expression of P-Tau to slow the formation of neurofibrillary tangles and could inhibit the expression of caspase-3 to inhibit neuronal apoptosis to protect the nerve cells, so as to play the role of anti-dementia.	a(PUBCHEM:441923)	directlyDecreases	p(HGNC:MAPT)
bf12b266-b410-47eb-b651-dfa19b0d69e1	0.65	PubMed	22272245	Here we find that human KLC1 depletion in hESC derived neural cultures reduces endogenous levels of Tau and Abeta.	p(HGNC:KLC1)	directlyDecreases	p(HGNC:MAPT)
d7a1c646-3b73-4ca5-85da-118675df4745	0.65	PubMed	16846010	In Drosophila expressing human tau, PSA expression reduced the amount of tau and protected against tau induced neurodegeneration, whereas flies expressing a PSA loss-of-function mutant exhibited exacerbated neurodegeneration [XREF_BIBR].	p(HGNC:KLK3)	directlyDecreases	p(HGNC:MAPT)
3244f4c8-7571-469c-99eb-f8a4d0d6e417	0.65	PubMed	18648555	Work from our laboratory in organotypic slices from rabbit hippocampus recently demonstrated that leptin decreases both basal and 27-hydroxycholesterol-induced phosphorylated tau and Abeta levels.	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT)
03d1f975-b357-4bd3-8459-cef18e0e2f58	0.86	PubMed	18358091	MAPT hypermethylation leads to decreased Tau expression, suggesting that the hypomethylation observed in AD is associated with an increase in Tau protein expression and thus could participate in aggregation seeding and pathological propagation through the brain via a prion like mechanism [XREF_BIBR].	p(HGNC:MAPT, pmod(Me))	directlyDecreases	p(HGNC:MAPT)
03d1f975-b357-4bd3-8459-cef18e0e2f58	0.86	PubMed	26170022	MAPT hypermethylation leads to decreased Tau expression, suggesting that the hypomethylation observed in AD is associated with an increase in Tau protein expression and thus could participate in aggregation seeding and pathological propagation through the brain via a prion like mechanism [XREF_BIBR].	p(HGNC:MAPT, pmod(Me))	directlyDecreases	p(HGNC:MAPT)
d1f8bffd-64ee-46a2-845c-d4fdc03428ea	0.86	PubMed	20235173	We observed that in Nrf2 +/+ mice, TAU P301L expression decreased Bdnf mRNA expression in concordance with impaired Ca 2+ signaling and synaptic activity and that DMF restored Bdnf levels.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyDecreases	p(HGNC:BDNF)
d1f8bffd-64ee-46a2-845c-d4fdc03428ea	0.86	PubMed	20235173	We observed that mRNA levels of Bdnf were significantly reduced by TAU P301L -expression in Nrf2 +/+ mice treated with vehicle (XREF_FIG C), indicating that TAU induced alterations in calcium homeostasis, according to the results observed above with calbindin-D28K.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyDecreases	p(HGNC:BDNF)
71ed8ae4-9623-40ee-ae6a-4d0d5e2bc755	0.65	PubMed	17646145	Collectively, the present study demonstrates for the first time that overexpression of tau inhibited the expression of Kv channels and related macroscopic currents in N2A cells and the heterologous expression system.	p(HGNC:MAPT)	directlyDecreases	a(PUBCHEM:6992341)
ff192168-7e82-429a-bf0a-68d9eda91c2d	0.65	PubMed	18234489	Neuroinflammation XREF_BIBR XREF_BIBR, Abeta accumulation XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR, and Tau phosphorylation XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR have been reported to induce mitochondrial dysfunction, leading to energy deficit, e.g., reduction in ATP level.	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	a(CHEBI:15422)
9d6e8755-77af-4219-9614-4a92282988d8	0.65	PubMed	18730557	Increased tau phosphorylation reduces the amount of tau that binds to microtubules, and 3R tau isoforms also bind less tightly than 4R tau to microtubules [XREF_BIBR].	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	p(HGNC:MAPT)
e899cc54-3536-436b-9508-120f0d306341	0.65	PubMed	18704498	In AD brain, for example, abnormal hyperphosphorylation of NF and tau is accompanied by significantly decreased mRNA expression, protein levels, and methylation (Sontag, et al. 2004) of protein phosphatase 2A (PP2A) and lowered protein levels of protein phosphatase 1 (PP1).	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	p(FPLX:Phosphatase)
9d3497bf-6b79-45c3-bfaf-a4b99b81f8a8	0.65	PubMed	19371649	Evidence suggests that Abeta and Tau oligomers contribute to synaptic loss in AD.	p(HGNC:MAPT)	directlyDecreases	p(PFAM:PF09793)
6fdd6cf7-76ce-464a-8a49-314ec5b54e51	0.65	PubMed	14760374	In vivo, neutralizing human tau in 2 human tau transgenic models also reduced Abeta levels.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:APP)
502b2a03-0c2a-4441-87c0-8cbb374d0c01	0.65	PubMed	14809799	Further studies showed that Tau promoted apoptosis in human breast cancer cells and inhibited the growth of tumor in nude mice by inducing the expression of PUMA, which further up- and downregulated the expression of Bax and Bcl-2 protein, giving rise to increased activation of caspase-3.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:BBC3)
7371b1f8-9867-47f9-b218-09fe27d1d764	0.65	PubMed	19677836	The results of RT-PCR and WB showed that Tau treatment significantly reversed the disturbance of Bax and Bcl-2 expression.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:BCL2)
0d68eea0-bad7-4361-a916-c0ca04803318	0.65	PubMed	14705068	Both PD98059 and Tau could inhibit the up-regulated expressions of PCNA, Cyclin A and p-ERK1/2.	p(HGNC:MAPT)	directlyDecreases	p(FPLX:ERK, pmod(Ph))
5a0e71a8-4834-42de-ba7e-be342104d77a	0.65	PubMed	17051958	To investigate this hypothesis, we employed genetic and biochemical studies and found that Tau RNAi failed to suppress the expression of Hpo pathway responsive genes (XREF_SUPPLEMENTARY).	p(HGNC:MAPT)	directlyDecreases	p(HGNC:GFER)
489ec6a8-873c-4300-b1d9-917d33a1230c	0.65	PubMed	13554366	Both CAR and TAU reduced MDA and PC levels and elevated GSH levels, SOD and GSH-Px (non significant in TAU+GAL group) activities.	p(HGNC:MAPT)	directlyDecreases	a(CHEBI:16856)
2340ab5a-560c-41af-83a4-19315c211f40	0.65	PubMed	15659100	CAR and TAU significantly reduced brain AChE activities, MDA and PC levels and elevated GSH levels in GAL treated rats.	p(HGNC:MAPT)	directlyDecreases	a(PUBCHEM:10964)
7366d9aa-c51f-4365-a659-ce6943d09d5b	0.65	PubMed	17022592	XREF_BIBR Tau ablation markedly reduced or fully reversed abnormalities in NPY and calbindin expression in all hippocampal subfields examined.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:NPY)
a6b22063-f904-49a5-a538-f10b5b6b547c	0.65	PubMed	22058634	Further studies are needed to explore the mechanism by which tau deficiency reduces the expression of OTX2 and how it may at least in part contribute to neurodegeneration in Parkinson 's disease.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:OTX2)
a64b3f39-a0a2-47de-bd34-33713826a38f	0.65	PubMed	15360622	Tau supplementation decreased whole body fat accumulation and serum TG levels, without altering IR.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:TG)
04b421ab-9967-4f46-816d-336d0b6bbc48	0.86	PubMed	19155101	Matching with the SN, tau vectors reduced TH immunoreactivity levels on the side of the tau vector injections in the striatum (XREF_FIG), and greater effects on TH were associated with the high dose and long interval, at both ages.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:TH)
04b421ab-9967-4f46-816d-336d0b6bbc48	0.86	PubMed	18648614	Matching with the SN, tau vectors reduced TH immunoreactivity levels on the side of the tau vector injections in the striatum (XREF_FIG), and greater effects on TH were associated with the high dose and long interval, at both ages.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:TH)
b1635c2b-4245-4547-8edc-920e5f2148f3	0.65	PubMed	19666594	Tau may decrease the expression levels of VCAM-1 and ICAM-1 in endothelial cells induced by hypoxia through MAPK p38 pathway.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:VCAM1)
9b04ecc3-5320-4186-81af-9e33f881e10e	0.65	PubMed	3182233	Nef + Tau iv in 30 min significantly decreased the level of total cholesterin in serum.	p(HGNC:MAPT)	directlyDecreases	a(PUBCHEM:11025495)
05f3fb57-0071-40a2-90fa-c369853f771f	0.65	PubMed	12430375	PA and Tau effectively inhibited inflammation, edema, severity of fibrosis, fibrosis extension, inflammatory cell accumulation, iNOS staining, and hydroxyproline level as well (p < 0.05).	p(HGNC:MAPT)	directlyDecreases	a(PUBCHEM:5810)
7b751659-7464-4426-869b-2eb25239c761	0.65	PubMed	13284325	Tau treatment significantly decreased serum amylase activity (p < 0.001), total injury score (p < 0.001), malondialdehyde levels (p < 0.001) and myeloperoxidase (MPO) activity (p < 0.001).	p(HGNC:MAPT)	directlyDecreases	a(PUBCHEM:10964)
41d3d4e8-1c64-404b-bd91-fa7aec40b35c	0.65	PubMed	6743699	On the other hand, tau also associates to erythrocyte ghosts in which the tetrameric state of spectrin is predominant [33], and the experiments of inhibi- tion of F-actin cross linkking indicate that tau decreases the amount of active spectrin in the gelation phenomenon, without changing the rate of the tetramer -+ dimer conversion.	p(HGNC:MAPT)	directlyDecreases	p(PFAM:PF00435)
3f9f6608-5597-4b1e-83d3-89f736bc114f	0.86	PubMed	18366179	Only 1 mM MB reduced tau levels.	p(HGNC:MB)	directlyDecreases	p(HGNC:MAPT)
3f9f6608-5597-4b1e-83d3-89f736bc114f	0.86	PubMed	18366179	This shows that MB does not reduce tau pathology, but reduces soluble tau levels.	p(HGNC:MB)	directlyDecreases	p(HGNC:MAPT)
90e98d20-110d-4899-a9d9-3a8f342ad922	0.95	PubMed	16643877	Memantine, a selective antagonist of E-NMDARs, reversed E-NMDARs-induced tau overexpression.	a(PUBCHEM:4054)	directlyDecreases	p(HGNC:MAPT)
90e98d20-110d-4899-a9d9-3a8f342ad922	0.95	PubMed	17319640	Memantine inhibits expression of tau and stathmin mRNA in breast cancer cells.	a(PUBCHEM:4054)	directlyDecreases	p(HGNC:MAPT)
90e98d20-110d-4899-a9d9-3a8f342ad922	0.95	PubMed	17319640	Memantine can inhibit the level of amyloid precursor protein (APP) and the expression of tau protein by cap independent translational initiation mechanism in Alzheimer 's disease.	a(PUBCHEM:4054)	directlyDecreases	p(HGNC:MAPT)
90e98d20-110d-4899-a9d9-3a8f342ad922	0.95	PubMed	10585485	Memantine may reduce the expression of amyloid precursor protein and tau protein, as well as acting as an antagonist of N-methyl-D-aspartate receptors in the brain.	a(PUBCHEM:4054)	directlyDecreases	p(HGNC:MAPT)
90e98d20-110d-4899-a9d9-3a8f342ad922	0.95	PubMed	10585485	Memantine may function not only as an antagonist of N-methyl-D-aspartate receptors, but also as an inhibitor of the internal ribosome entry site to block the expression of amyloid precursor protein and tau, and so ameliorate the symptoms of AD.	a(PUBCHEM:4054)	directlyDecreases	p(HGNC:MAPT)
b579b69a-a90f-4d5a-955a-79b375376417	0.65	PubMed	18695431	Metformin treated db/db mice had reduced total tau protein levels and phosphorylated tau at Ser396 when compared to the control db/db mice [P = 0.017 and t (18) = -2.618 for total tau and P = 0.01 and t (14) = -2.976 for Ser396].	a(PUBCHEM:4091)	directlyDecreases	p(HGNC:MAPT)
24c778d2-8cf5-447f-880f-b4198ba9c9d6	0.65	PubMed	17260343	Early NDEA exposure alone was sufficient to significantly reduce the mean mRNA levels of AbetaPP (P < 0.05), Tau (P < 0.01), insulin receptor (P < 0.001), IGF-2 receptor (P < 0.01), and IRS-2 (P < 0.05) relative to control (LFD+VEH).	a(PUBCHEM:5921)	directlyDecreases	p(HGNC:MAPT)
148aac1d-3fe5-456b-849d-2feac6f89ba8	0.95	PubMed	20214306	Further studies showed that NNK and ethanol + NNK similarly reduced tau, p-tau, ubiquitin, ASPH-A85G6 and ASPH-A85E6 protein expression relative to control and ethanol exposures.	a(PUBCHEM:47289)	directlyDecreases	p(HGNC:MAPT)
148aac1d-3fe5-456b-849d-2feac6f89ba8	0.95	PubMed	20214306	The finding that the relative levels of pTau (pTau and Tau) were not significantly reduced vis-a-vis significant reductions Tau and pTau following NNK exposure indicates that the main effect of NNK was to inhibit Tau expression.	a(PUBCHEM:47289)	directlyDecreases	p(HGNC:MAPT)
148aac1d-3fe5-456b-849d-2feac6f89ba8	0.95	PubMed	20190143	NNK selectively inhibited Tau expression, and NNK and ethanol+ NNK had greater inhibitory effects pTau than did ethanol.	a(PUBCHEM:47289)	directlyDecreases	p(HGNC:MAPT)
148aac1d-3fe5-456b-849d-2feac6f89ba8	0.95	PubMed	20190143	Tau expression was selectively reduced by NNK relative to all other groups (XREF_FIG), whereas pTau (phosphorylated on S396 and T205) expression was progressively reduced by ethanol, followed by NNK, and then further by ethanol+ NNK exposures (XREF_FIG).	a(PUBCHEM:47289)	directlyDecreases	p(HGNC:MAPT)
148aac1d-3fe5-456b-849d-2feac6f89ba8	0.95	PubMed	18003097	NNK and ethanol+ NNK inhibited expression of MAG-1 (XREF_FIG), GFAP (XREF_FIG), ChAT (XREF_FIG), AChE (XREF_FIG), Tau (XREF_FIG), pTau (XREF_FIG), ubiquitin (XREF_FIG), ASPH-A85G6 (XREF_FIG), and ASPH-A85E6 (XREF_FIG) relative to control.	a(PUBCHEM:47289)	directlyDecreases	p(HGNC:MAPT)
b4a0ccd1-9375-4aca-8295-889e07bd595c	0.94	PubMed	25384392	Nilotinib reduced p-Tau in Tau over-expressing WT mice and when Tau and Abeta1-42 were expressed together (p < 0.015), which led to more p-Tau than Tau alone (p < 0.02).	a(PUBCHEM:644241)	directlyDecreases	p(HGNC:MAPT)
b4a0ccd1-9375-4aca-8295-889e07bd595c	0.94	PubMed	17681420	Nilotinib and bosutinib reversed p-Tau levels (p < 0.05) in young as well as older (p < 0.001) A53T mice, which remained higher than WT.	a(PUBCHEM:644241)	directlyDecreases	p(HGNC:MAPT)
b4a0ccd1-9375-4aca-8295-889e07bd595c	0.94	PubMed	18363490	Nilotinib reduced p-Tau in Tau over-expressing WT mice and when Tau and Abeta1-42 were expressed together (p < 0.015), which led to more p-Tau than Tau alone (p < 0.02).	a(PUBCHEM:644241)	directlyDecreases	p(HGNC:MAPT)
b4a0ccd1-9375-4aca-8295-889e07bd595c	0.94	PubMed	18876496	Nilotinib and bosutinib reversed p-Tau levels (p < 0.05) in young as well as older (p < 0.001) A53T mice, which remained higher than WT.	a(PUBCHEM:644241)	directlyDecreases	p(HGNC:MAPT)
94e868a8-b9b4-422b-a3d1-5bea1286d3d2	0.86	PubMed	17485366	Furthermore, we found that the a-domain of human PDI (20 microM) not only inhibited both steps of seed induced Tau 244-372 fibrillization more strongly than full-length human PDI, but also significantly decreased the amount of Tau 244-372 filaments represented by the maximum ThT intensity (XREF_SUPPLEMENTARY).	p(HGNC:P4HB)	directlyDecreases	p(HGNC:MAPT)
94e868a8-b9b4-422b-a3d1-5bea1286d3d2	0.86	PubMed	24098548	Furthermore, we found that the a-domain of human PDI (20 microM) not only inhibited both steps of seed induced Tau 244-372 fibrillization more strongly than full-length human PDI, but also significantly decreased the amount of Tau 244-372 filaments represented by the maximum ThT intensity (XREF_SUPPLEMENTARY).	p(HGNC:P4HB)	directlyDecreases	p(HGNC:MAPT)
d2fa69f3-b998-4a04-8c2a-e0eade71d4e2	0.65	PubMed	10746844	PiB PET amyloid imaging was negative at age 88 (1/2) years, but at age 89 (1/2) years there was reduced amyloid beta 42 and elevated levels of tau in the CSF.	p(PFAM:PF06297)	directlyDecreases	p(HGNC:MAPT)
0568f138-f69e-4dd1-b14a-7b9d5dfd01eb	0.65	PubMed	17711323	In addition to potentially affecting APP processing, it has been suggested that PrP C downregulates transcription of microtubule associated protein tau by activating Fyn kinase signalling.	p(HGNC:PRNP)	directlyDecreases	p(HGNC:MAPT)
960f7296-886a-406e-956e-76037fe2d5b5	0.65	PubMed	23428800	Overexpression of PTPA reduced significantly the phosphorylation levels of tau at Ser262 (pS262), Ser396 (pS396), Ser404 (pS404), Ser422 (pS422) and Ser198/199/202 (tau-1) sites (tau-1 antibody is specific for tau dephosphorylated at this specific site and its increase suggests the increased dephosphorylation at this site) (E and F).	p(HGNC:PTPRA)	directlyDecreases	p(HGNC:MAPT)
c7add225-1683-4e46-9750-5fba1538b7b1	0.65	PubMed	17725405	Rapamycin inhibits the trans-synaptic spread of human tau expression to dentate gyrus, likely by reducing transfer of the AAV vector.	a(CHEBI:9168)	directlyDecreases	p(HGNC:MAPT)
42b50642-4eec-4716-849f-27217131c5ab	0.65	PubMed	10794864	Testing the vulnerability of Rin-5F clones by MTT assay, we revealed that high TAU levels going along with highest TAU aggregates could not be antagonized by high levels of SCGN protein.	p(HGNC:SCGN)	directlyDecreases	p(HGNC:MAPT)
daea5b52-96e7-4bbb-8b9e-0c881b04539f	0.65	PubMed	17585269	Conversely, SIRT1 inhibition leads to the opposite effect, increasing levels of tau, and exacerbating the accumulation of pathogenic forms of phosphorylated tau.	p(HGNC:SIRT1)	directlyDecreases	p(HGNC:MAPT)
1d5b3a6c-1756-4a9c-9faa-39f378a6677b	0.92	PubMed	14792905	We find that co-expressing CHIP with full-length tau, tau truncated at D421 mimicking caspase cleavage, or the short tauRDDeltaK280 tau construct containing only the tau repeat domain with a tauopathy mutation, decreases tau protein levels in human H4 neuroglioma cells in a manner dependent on the Hsp70 binding TPR domain of CHIP.	p(HGNC:STUB1)	directlyDecreases	p(HGNC:MAPT)
1d5b3a6c-1756-4a9c-9faa-39f378a6677b	0.92	PubMed	18785580	Deletion of CHIP significantly increased p-tau levels in the brain.	p(HGNC:STUB1)	directlyDecreases	p(HGNC:MAPT)
1d5b3a6c-1756-4a9c-9faa-39f378a6677b	0.92	PubMed	20869593	Deletion of CHIP significantly increased p-tau levels in the brain (XREF_BIBR).	p(HGNC:STUB1)	directlyDecreases	p(HGNC:MAPT)
f3916138-3062-446f-9779-e5f028140835	0.65	PubMed	18273361	Down-regulation of synj1 prevents elevation of pTau levels in ApoE4 mice in response to blast TBI exposure.	p(HGNC:SYNJ1)	directlyDecreases	p(HGNC:MAPT)
81f9715a-be7b-4740-89fd-7da990acfd9b	0.92	PubMed	17591419	We recently found that TDP-43 suppressed tau expression and tau exon 10 exclusion.	p(HGNC:TARDBP)	directlyDecreases	p(HGNC:MAPT)
81f9715a-be7b-4740-89fd-7da990acfd9b	0.92	PubMed	19258550	We found that TDP-43 suppressed tau expression by promoting its mRNA instability through the UG repeats of its 3 '-untranslated region (3 '-UTR).	p(HGNC:TARDBP)	directlyDecreases	p(HGNC:MAPT)
81f9715a-be7b-4740-89fd-7da990acfd9b	0.92	PubMed	19258550	Our findings indicate that TDP-43 suppresses tau expression by promoting the instability of its mRNA.	p(HGNC:TARDBP)	directlyDecreases	p(HGNC:MAPT)
1bb2cca6-c69b-4c0a-9e66-ee1fd2eb869e	0.65	PubMed	16240751	These data suggest that the overexpression of TFEB can reliably enhance autophagy in vivo, reduce levels of PHF-tau, and thereby reverse the deposition of lipofuscin granules and memory deficits.	p(HGNC:TFEB)	directlyDecreases	p(HGNC:MAPT)
eaab11a1-a3ca-411a-aae6-68dece4a0374	0.65	PubMed	19388492	TST rehabilitation greatly improved motor function, but not memory, and suppressed p-tau expression and neuroinflammation.	p(HGNC:TST)	directlyDecreases	p(HGNC:MAPT)
33d45b6e-7390-48c3-9653-6167e47e9322	0.92	PubMed	18785314	Since GAL80 TS produced moderate repression of tau expression at the lower temperature (25degreesC; XREF_SUPPLEMENTARY), the effect of tau on decreasing lifespan was more modest than that seen in XREF_FIG.	p(HGNC:TYMS)	directlyDecreases	p(HGNC:MAPT)
33d45b6e-7390-48c3-9653-6167e47e9322	0.92	PubMed	21123557	To circumvent developmental toxicity of tau we utilized a ubiquitously expressed, temperature sensitive allele of the GAL4 repressor, GAL80 (tub-GAL80 TS; XREF_BIBR) to restrict tau expression to adult glia.	p(HGNC:TYMS)	directlyDecreases	p(HGNC:MAPT)
33d45b6e-7390-48c3-9653-6167e47e9322	0.92	PubMed	21123557	Since GAL80 TS produced moderate repression of tau expression at the lower temperature (25degreesC; XREF_SUPPLEMENTARY), the effect of tau on decreasing lifespan was more modest than that seen in XREF_FIG.	p(HGNC:TYMS)	directlyDecreases	p(HGNC:MAPT)
f4fa00d2-00be-44b6-8bbd-e63b05cac5ba	0.65	PubMed	18876931	Tolfenamic Acid Reduces Tau and CDK5 Levels : Implications for Dementia and Tauopathies.	a(PUBCHEM:610479)	directlyDecreases	p(HGNC:MAPT)
ed7a524e-6464-41ae-8fec-50b9acd6fcf7	0.86	PubMed	14715354	Tolfenamic acid lowers the levels of tau, which forms pathological aggregates in Alzheimer 's disease and other tauopathies, by promoting the degradation of the transcription factor specificity protein 1 which regulates tau transcription.	a(PUBCHEM:610479)	directlyDecreases	p(HGNC:MAPT)
ed7a524e-6464-41ae-8fec-50b9acd6fcf7	0.86	PubMed	17414241	Tolfenamic acid lowers the levels of tau, which forms pathological aggregates in Alzheimer 's disease and other tauopathies, by promoting the degradation of the transcription factor specificity protein 1 which regulates tau transcription [XREF_BIBR].	a(PUBCHEM:610479)	directlyDecreases	p(HGNC:MAPT)
17047ae7-5be0-4d64-b735-8bfe5954d988	0.65	PubMed	16779191	In contrast, both AEBSF and apocynin significantly reduced the expression of Tau and MAP2 by 60% and 30%, respectively (XREF_FIG).	a(CHEBI:2781)	directlyDecreases	p(HGNC:MAPT)
99be2e54-fa61-47db-9435-b593c17cd4ff	0.65	PubMed	18669337	Promising are two drugs, aziridinylbenzoquinone and albendazole, which can reduce tau expression by 38% and 52%, respectively, without detectable cytotoxicity.	a(PUBCHEM:42616)	directlyDecreases	p(HGNC:MAPT)
5ee70da2-ef10-4264-9f55-047b49f72c24	0.92	PubMed	17681420	In conclusion, these studies demonstrate that nilotinib and bosutinib can reduce the levels of alpha-Synuclein and p-Tau in peripheral tissues and inside the CNS, and are therapeutic candidates to treat gastrointestinal complications in alpha-Synucleinopathies and other neurodegenerative diseases.	a(PUBCHEM:5328940)	directlyDecreases	p(HGNC:MAPT)
5ee70da2-ef10-4264-9f55-047b49f72c24	0.92	PubMed	18876496	Both nilotinib and bosutinib significantly reduced p-Tau levels, which remained higher than control.	a(PUBCHEM:5328940)	directlyDecreases	p(HGNC:MAPT)
5ee70da2-ef10-4264-9f55-047b49f72c24	0.92	PubMed	18876496	In conclusion, these studies demonstrate that nilotinib and bosutinib can reduce the levels of alpha-Synuclein and p-Tau in peripheral tissues and inside the CNS, and are therapeutic candidates to treat gastrointestinal complications in alpha-Synucleinopathies and other neurodegenerative diseases.	a(PUBCHEM:5328940)	directlyDecreases	p(HGNC:MAPT)
93417f3e-0924-4db6-9f79-f5dd1f3b2235	0.65	PubMed	4466589	Western blot analysis showed that estrogen increased and bromocriptine decreased the expression of PKC alpha, beta 1, beta 2, CaM kinase alpha, beta, MAP-2, and Tau protein.	a(PUBCHEM:31101)	directlyDecreases	p(HGNC:MAPT)
f901e1dc-40b2-4982-a236-77452fd3c3a3	0.86	PubMed	17610121	However, the observation that doxycycline appears to preferentially reduce human tau levels in a particular cortical layer and this is the same layer that shows the greatest reduction in GFAP staining suggests that at least some of the reduced inflammation observed with doxycycline treatment was a result of tau reduction.	a(CHEBI:50845)	directlyDecreases	p(HGNC:MAPT)
f901e1dc-40b2-4982-a236-77452fd3c3a3	0.86	PubMed	16939203	Nonetheless, the fact that only a partial suppression of tau expression by doxycycline was able to modulate subsequent progression of tau pathology and normalise behaviour provides encouraging support that potential clinical therapies do not necessarily have to be maximally effective to exhibit functionally beneficial effects.	a(CHEBI:50845)	directlyDecreases	p(HGNC:MAPT)
e6789396-86ee-4af2-8ddb-4b152e01bdad	0.86	PubMed	20579400	MAPT protein expression was increased by stimulation with 17-beta-estradiol or tamoxifen, but decreased by ER downregulation and by fulvestrant, an ER inhibitor.	a(PUBCHEM:104741)	directlyDecreases	p(HGNC:MAPT)
e6789396-86ee-4af2-8ddb-4b152e01bdad	0.86	PubMed	20579400	Tamoxifen stimulates the ER in the presence of 17-beta estradiol, and significantly increases MAPT expression at low concentration, whereas fulvestrant decreases ER and MAPT expression at all concentrations.	a(PUBCHEM:104741)	directlyDecreases	p(HGNC:MAPT)
b1986507-3195-456f-8c25-7def624a3945	0.65	PubMed	17550056	The results suggest that GSPA is able to decrease APP and Tau protein expression levels in the hippocampi of APP and PS1 double transgenic mice.	p(UP:P25148)	directlyDecreases	p(HGNC:MAPT)
16a0c145-066b-4fe1-891f-ad740a52d26a	0.65	PubMed	13753588	We have previously reported that chronic ibuprofen treatment improves cognition and decreases intracellular Abeta and phosphorylated-tau levels in 3xTg-AD mice.	a(PUBCHEM:3672)	directlyDecreases	p(HGNC:MAPT)
81e5dd49-4782-4c7e-826c-99f3580b73f3	0.65	PubMed	18697105	Furthermore, it was recently shown that lithium downregulates tau transcription in cultured cortical neurons.	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:MAPT)
74a3764e-c190-47ee-bd57-7f8752529895	0.65	PubMed	20155224	Also, melatonin significantly reduced the phosphorylation level of tau in KA treated primary hippocampal neurons.	a(CHEBI:16796)	directlyDecreases	p(HGNC:MAPT)
e9d965b4-7984-494a-906e-a1513d677dab	0.65	PubMed	17319640	We showed that memantine reduced mRNA levels of tau and stathmin and also estrogen positive breast cancer cell line migration in vitro.	a(PUBCHEM:4054)	directlyDecreases	p(HGNC:MAPT)
0e695719-6f5d-48d2-a958-2d45f563e452	0.65	PubMed	18695431	Interestingly, metformin also attenuated the increase of total tau expression in the db/db mice, further supporting that increased total tau as a mechanism for the increased phospho-tau in the db/db mouse brains.	a(CHEBI:6801)	directlyDecreases	p(HGNC:MAPT)
98afd8d1-1208-40f2-90ce-727c6b149c81	0.65	PubMed	18751847	XREF_BIBR We have shown here that both myricetin and its " pro drug " myricitrin reduce tau levels.	a(PUBCHEM:5281672)	directlyDecreases	p(HGNC:MAPT)
faf297e4-5c11-4c0c-aac7-0ea1b2d859e8	0.65	PubMed	17750514	The PHF-tau expression in the hippocampus (associated with the plaques) was significantly decreased by naringenin (100 mg kg -1 per day) treatment.	a(PUBCHEM:439246)	directlyDecreases	p(HGNC:MAPT)
0a5c50ee-8d7c-45de-9ff0-69634cd6b1a5	0.92	PubMed	17681420	However, nilotinib and bosutinib reduced the levels of both alpha-Synuclein and p-Tau back to WT levels, suggesting TKI effects on peripheral tissue.	a(PUBCHEM:644241)	directlyDecreases	p(HGNC:MAPT)
0a5c50ee-8d7c-45de-9ff0-69634cd6b1a5	0.92	PubMed	17681420	Both nilotinib and bosutinib significantly reduced p-Tau levels, which remained higher than control.	a(PUBCHEM:644241)	directlyDecreases	p(HGNC:MAPT)
0a5c50ee-8d7c-45de-9ff0-69634cd6b1a5	0.92	PubMed	18876496	However, nilotinib and bosutinib reduced the levels of both alpha-Synuclein and p-Tau back to WT levels, suggesting TKI effects on peripheral tissue.	a(PUBCHEM:644241)	directlyDecreases	p(HGNC:MAPT)
07df56e7-80ca-4b4d-8420-f61d62689b34	0.86	PubMed	12960585	The hsp90 inhibitors 17-AAG and radicicol nevertheless caused a dose dependent reduction in total human tau levels in transgenic larvae without specifically altering tau hyperphosphorylated at S396 and S404.	a(PUBCHEM:6505803)	directlyDecreases	p(HGNC:MAPT)
07df56e7-80ca-4b4d-8420-f61d62689b34	0.86	PubMed	23114515	The hsp90 inhibitors 17-AAG and radicicol nevertheless caused a dose dependent reduction in total human tau levels in transgenic larvae without specifically altering tau hyperphosphorylated at S396 and S404.	a(PUBCHEM:6505803)	directlyDecreases	p(HGNC:MAPT)
887107dc-7811-4a53-a851-fad25d17f652	0.94	PubMed	15678849	Finally, rapamycin inhibited trans-synaptic transfer of human tau expression to the dentate granule neuron targets for the perforant pathway, likely by preventing the synaptic spread of the AAV vector in response to pathway degeneration.	a(CHEBI:9168)	directlyDecreases	p(HGNC:MAPT)
887107dc-7811-4a53-a851-fad25d17f652	0.94	PubMed	17725405	Finally, rapamycin inhibited trans-synaptic transfer of human tau expression to the dentate granule neuron targets for the perforant pathway, likely by preventing the synaptic spread of the AAV vector in response to pathway degeneration.	a(CHEBI:9168)	directlyDecreases	p(HGNC:MAPT)
887107dc-7811-4a53-a851-fad25d17f652	0.94	PubMed	17725405	Finally, the human tau expression spreads over time from the lateral perforant pathway to include the dentate granule neuron targets of the pathway, and rapamycin partially blocks this trans-synaptic expansion of human tau expression (XREF_FIG).	a(CHEBI:9168)	directlyDecreases	p(HGNC:MAPT)
887107dc-7811-4a53-a851-fad25d17f652	0.94	PubMed	19539012	In Drosophila models, rapamycin treatment decreases tau levels, reducing toxicity caused by tau [XREF_BIBR].	a(CHEBI:9168)	directlyDecreases	p(HGNC:MAPT)
bff06a9e-3704-4e12-a1e3-e463c99ff59f	0.65	PubMed	9773223	We show forced expression of EWS-FLI1 causes absence of retinoic acid induced neural morphology, and decreases expression of neural specific proteins MAPT and NCAM.	a(PUBCHEM:5282379)	directlyDecreases	p(HGNC:MAPT)
597a1ce7-1eb1-4ef0-9605-b75936ed581e	0.65	PubMed	18692268	For example, sodium selenate decreases the Tau protein phosphorylation levels in mice and is currently is under intense study [XREF_BIBR].	a(PUBCHEM:26473)	directlyDecreases	p(HGNC:MAPT)
a17b540b-474c-47a1-a052-6e57633161cf	0.65	PubMed	17144169	Although the effect of selenium on AD has been investigated in a number of studies, moreover, selenomethionine (Se-Met) treatment reduced the levels of tau.	a(PUBCHEM:15103)	directlyDecreases	p(HGNC:MAPT)
162db902-80ef-41d0-aa12-77578a53aff6	0.65	PubMed	17076666	Overall Tau levels were also slightly reduced by staurosporine, with the most extensive loss of the slowest migrating isoforms.Treatment with Z-VAD-fmk did not significantly increase Tau levels but prevented the depletion of slowest migrating isoforms, indicating that their depletion was the result of caspase mediated truncation of one or both termini.	a(PUBCHEM:44259)	directlyDecreases	p(HGNC:MAPT)
80a8d13a-e50d-4e36-bd9f-c20b22b6d30e	0.86	PubMed	18876931	Data presented within this manuscript demonstrate that tolfenamic acid lowers tau and CDK5 levels by inhibiting their transcription.	a(PUBCHEM:610479)	directlyDecreases	p(HGNC:MAPT)
80a8d13a-e50d-4e36-bd9f-c20b22b6d30e	0.86	PubMed	18876931	Furthermore, tolfenamic acid decreased total tau protein levels by 46% with both doses as measured by Western blot analysis (XREF_FIG).	a(PUBCHEM:610479)	directlyDecreases	p(HGNC:MAPT)
33d80135-bbdd-4f5c-97bb-43ecb5d9a221	0.65	PubMed	22764226	Methotrexate, a folate antagonist, promotes PP2A demethylation and Tau hyperphosphorylation in rat primary cortical neurons (XREF_BIBR), an effect probably mediated through inhibition of folate metabolism and altered SAM and Hcy metabolism.	a(PUBCHEM:126941)	directlyDecreases	p(HGNC:MAPT, pmod(Me))
78649ea5-79b3-45e2-ba61-dfbc2cd206c1	0.65	PubMed	18233622	AC also inhibited Tau phosphorylation at S262, but to a lesser extent while OS had no effect, even at 100muM.	p(HGNC:ADCY1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
da8f344f-0566-4fe7-a3f7-5c5b2cb5f3d8	0.65	PubMed	16872090	By using RAGE antibody to block the receptor, we found that blockage of RAGE almost abolished the Abeta-AGE-induced reduction of cell viability (XREF_FIG), elevation of apoptotic rate (XREF_FIG), tau hyperphosphorylation (XREF_FIG) and deficits of synaptic proteins (XREF_FIG).	p(HGNC:AGER)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3c2c800b-9a2d-4722-b45c-0ffd95e92f1e	0.65	PubMed	10041170	Vice versa, stereotactic inhibition of AT2 oligomers by RNA interference prevented the impairment of Galphaq/11 and delayed Tau phosphorylation.	p(HGNC:AGTR2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
066c4fc3-e7b7-4034-9c15-b159a13af7f7	0.65	PubMed	9909619	A central role for AMP dependent kinase as a mediator of leptin 's action is demonstrated by the ability of 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) to decrease tau phosphorylation, and by blocking leptin in the presence of Compound C. Thus, leptin, which ameliorates both amyloid beta and tau related pathological pathways, holds promise as a novel therapeutic for Alzheimer 's disease.	a(CHEBI:18406)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
074f7c47-453b-4725-adf0-fee7fdc39ba0	0.65	PubMed	11005189	In cultured bovine adrenal chromaffin cells expressing Nav1.7 sodium channel isoform, we previously showed that veratridine induced Na+ influx via Nav1.7 and the subsequent Ca2+ influx via voltage dependent calcium channels activated protein kinase C-alpha and Akt, which converged on increasing inhibitory Ser9 phosphorylation of glycogen synthase kinase-3beta, decreasing constitutive Ser396 phosphorylation of tau.	p(FPLX:AKT)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
b7263aca-9864-48bd-8b93-e54ef810b959	0.65	PubMed	11884553	We also found that ALCAR arrested microtubule associated protein tau hyperphosphorylation at multiple Alzheimer 's disease sites in vivo and in vitro.	a(PUBCHEM:7045767)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9d8f34b8-9165-407e-89f8-af2f9f6e511b	0.92	PubMed	PMC17200775	TNAP dephosphorylates overphosphorylated tau once it is released upon neuronal death.	p(HGNC:ALPL)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9d8f34b8-9165-407e-89f8-af2f9f6e511b	0.92	Other	sparser:Unknown	TNAP dephosphorylates the hyperphosphorylated tau protein once it is released upon neuronal death.	p(HGNC:ALPL)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9d8f34b8-9165-407e-89f8-af2f9f6e511b	0.92	Other	sparser:Unknown	TNAP dephosphorylates overphosphorylated tau once it is released upon neuronal death.	p(HGNC:ALPL)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7562f218-93b8-4836-b5b4-985b816b4358	0.95	PubMed	22051683	However, AMPK is also reported to inhibit Tau phosphorylation in vitro in the rat cortical neuron model [XREF_BIBR, XREF_BIBR].	p(FPLX:AMPK)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7562f218-93b8-4836-b5b4-985b816b4358	0.95	PubMed	18733650	In summary, the findings of the present study suggest that Leptin and its downstream signaling protein, AMPK (stimulated by AICAR) [XREF_BIBR, XREF_BIBR], reduce phosphorylation of tau by inhibiting GSK-3beta; thereby supporting a putative signaling cascade whereby Leptin modulates tau phosphorylation via AMPK [XREF_BIBR, XREF_BIBR].	p(FPLX:AMPK)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7562f218-93b8-4836-b5b4-985b816b4358	0.95	PubMed	16897463	AMPK induced inhibition of mTOR in CR fed ApoE-/- mice reduced Tau phosphorylation and improved their cognition performance.	p(FPLX:AMPK)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7562f218-93b8-4836-b5b4-985b816b4358	0.95	PubMed	15357761	AMPK activation also triggered Tau dephosphorylation.	p(FPLX:AMPK)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7562f218-93b8-4836-b5b4-985b816b4358	0.95	PubMed	15999628	These studies showed that justicidin A inhibited activity of glycogen synthase kinase-3beta (GSK-3beta), which is an important kinase in up-stream signaling pathways; inhibited hyperphosphorylation of tau in AD; and enhanced activity of AMP activated protein kinase (AMPK), which is the key molecule for both hyperphosphorylation of tau and induction of autophagy.	p(FPLX:AMPK)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
44d67f4c-8516-4077-85c4-a126632264c7	0.65	PubMed	18358072	Knockdown ANP32A reverses tau phosphorylation by activating PP2A.	p(HGNC:ANP32A)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
bbb902a0-8eff-4555-975c-8c225fd3a7c1	0.65	PubMed	16897463	ApoE deficient mice (ApoE-/-), serving as a model of neurodegeneration, showed upon CR vs. ad libitum feeding increased Fgf21 levels in both, plasma and brain as well as higher phosphorylation of fibroblastic growth factor receptor 1c (Fgfr1c), extracellular signal regulated kinases 1/2 (ERK1/2) and AMPK in brain, lower activity of mTOR and decreased Tau phosphorylation.	p(HGNC:APOE)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1aca2064-41ea-40a3-a09e-0637a26caafc	0.94	PubMed	22051749	LLI suppressed Abeta induced reactive gliosis, proinflammatory cytokines production, and tau hyperphosphorylation.	p(HGNC:APP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1aca2064-41ea-40a3-a09e-0637a26caafc	0.94	PubMed	18892139	Having shown that sAPPalpha can reduce GSK3beta activity we next set out to determine if sAPPalpha can also reduce tau phosphorylation.	p(HGNC:APP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1aca2064-41ea-40a3-a09e-0637a26caafc	0.94	PubMed	18892139	In SH-SY5Y cells overexpressing BACE1 (SH-SY5Y and BACE1) and HeLa cells overexpressing human tau (HeLa and tau), sAPPalpha additionally reduced tau phosphorylation, as shown by phospho-tau (Thr231) and PHF1 tau (Ser396 and Ser404) immunodetection.	p(HGNC:APP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1aca2064-41ea-40a3-a09e-0637a26caafc	0.94	PubMed	15728903	In this study, we found that IGF-Iota suppressed tau phosphorylation induced by Abeta, although IGFBP-3 inhibited this property of IGF-Iota.	p(HGNC:APP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1bfdfbbe-74fa-4da0-854d-ec6fb37e9bf3	0.86	PubMed	18439393	These data are consistent with the notion that inhibition of acid ceramidase may induce Tau hyperphosphorylation by activating GluN2B containing NMDA receptors.	p(HGNC:ASAH1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1bfdfbbe-74fa-4da0-854d-ec6fb37e9bf3	0.86	PubMed	18439393	Blockade of Lysosomal Acid Ceramidase Induces GluN2B Dependent Tau Phosphorylation in Rat Hippocampal Slices.	p(HGNC:ASAH1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
19901b8f-ca50-4932-a54b-78f7050a39e1	0.86	PubMed	4120637	The resulting decrease in ATP triggers the hyperphosphorylation of tau protein by activating protein kinase 40erk.	a(CHEBI:15422)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
19901b8f-ca50-4932-a54b-78f7050a39e1	0.86	PubMed	3430431	These results demonstrated depletion of ATP alone was not sufficient to stimulate the dephosphorylation of tau in this experimental paradigm.	a(CHEBI:15422)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1f52745f-a8ae-4a35-ac30-22fd0133d2e7	0.65	PubMed	22032472	In addition, sAPPalpha, acting through unknown receptors, inhibited BACE1 and GSK3beta activity, which reduced tau phosphorylation.	p(HGNC:BACE1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1f9835b4-8355-4ef7-8e4b-8a8c91561f21	0.65	PubMed	18460259	Strikingly, the elevated phosphorylation of tau protein was inhibited by the application of beta-secretase but not gamma-secretase inhibitors, suggesting that in this human neuronal system, aberrant phosphorylation of tau protein is driven, at least in part, by the beta-C-terminal fragment fragment of APP.	p(UP:W8W138)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c6c1a26d-1206-456a-8b2b-dd6d99886330	0.92	PubMed	18737146	NAP is also reported to reduce hyperphosphorylation of tau in in vivo models of tauopathy and Alzheimer 's disease [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:BASP1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c6c1a26d-1206-456a-8b2b-dd6d99886330	0.92	PubMed	17309722	Tau hyperphosphorylation occurs in these ADNP deficient mice and is reduced by NAP (davunetide) treatment [XREF_BIBR].	p(HGNC:BASP1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c6c1a26d-1206-456a-8b2b-dd6d99886330	0.92	PubMed	13320287	Tau hyperphosphorylation, associated with MT dysfunction and defective axonal transport, was discovered in the brains of the ALS mice and was significantly reduced by chronic NAP treatment.	p(HGNC:BASP1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d0dafb70-f805-4e52-b78d-977eb168842c	0.65	PubMed	12495439	We also found that BBR significantly decreased the levels of C-terminal fragments of APP and the hyperphosphorylation of APP and tau via the Akt and glycogen synthase kinase 3 signaling pathway in N2a mouse neuroblastoma cells stably expressing human Swedish mutant APP695 (N2a-SwedAPP).	p(UP:Q9LT17)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
42eb3e66-5506-4a6d-a296-9f52f898a42e	0.99	PubMed	23831349	The activation of BDNF and TrkB signaling pathway can also induce the dephosphorylation of tau protein, possibly through phosphatidylinositide 3-kinases (PI3K) signaling pathway.	p(HGNC:BDNF)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
42eb3e66-5506-4a6d-a296-9f52f898a42e	0.99	Other	sparser:Unknown	But there are more interactions of AD and BDNF: a specific loss of BDNF was found in tangle-bearing neurons ( xref ; xref ), and BDNF dephosphorylates Tau including the most crucial sites for microtubule binding through TrkB activation and a PI3-kinase/Akt-dependent mechanism in a cellular model ( xref ), implicating a direct Tau–BDNF interaction.	p(HGNC:BDNF)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
42eb3e66-5506-4a6d-a296-9f52f898a42e	0.99	Other	sparser:Unknown	Moreover, BDNF induces rapid tau dephosphorylation in neuronal cells through TrkB activation and PI3K/Akt signalling, [ xref ] and, therefore, this decrease in BDNF might also contribute to tau hyperphosphorylation ( xref b), a pathological hallmark of AD.	p(HGNC:BDNF)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
42eb3e66-5506-4a6d-a296-9f52f898a42e	0.99	PubMed	22212405	Directly correlated to AD pathology, BDNF also induces a rapid dephosphorylation of tau protein through phosphatidylinositol 3-kinase signaling pathway ().	p(HGNC:BDNF)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
42eb3e66-5506-4a6d-a296-9f52f898a42e	0.99	PubMed	17448817	Interestingly, BDNF induces rapid dephosphorylation of tau protein via the PI3K and Akt signaling pathways XREF_BIBR.	p(HGNC:BDNF)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1a45f134-09d4-4abc-99b4-12c80b0dcec7	0.65	PubMed	13075400	To find the relation between CacyBP and SIP and tau we examined dephosphorylation of tau by CacyBP and SIP.	p(HGNC:CACYBP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1431836f-8ec3-4d37-8ee1-b091ade42489	0.65	PubMed	18436588	Tau pathophysiological phosphorylation is also limited by activation of calcium/calmodulin dependent protein kinase kinase-beta (CamKKbeta) promoted by RV through the increase of intracellular calcium levels and activation of AMP protein kinase (AMPK).	p(HGNC:CAMKK2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c67e9e1b-5dae-4dd1-87d3-9f86bd1e0ae1	0.65	PubMed	16678793	Treatment with calcium ionophore A23187 generates the calpain cleaved p25 fragment but only in conditions that are toxic and result in dephosphorylation and loss of tau.	p(FPLX:CAPN)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7ebc242b-4b8c-42e8-baec-6d3b9164c154	0.65	PubMed	20153279	In contrast, the overexpression of CAV-1 could reduce the phosphorylation of Tau at Thr231 and Ser396 sites.	p(HGNC:CAV1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
ebaaba88-7493-404b-8a6a-543dd242fd12	0.86	PubMed	14470397	CBL treatment reduced the levels of Tau phosphorylation in the dentate gyrus and the degeneration of pyramidal neurons in the temporal cortex and hippocampus of the Tau and GSK3beta double tg mice.	p(HGNC:CBL)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
ebaaba88-7493-404b-8a6a-543dd242fd12	0.86	PubMed	18667160	We have previously shown that in APP tg mice CBL reduces Abeta production by modulating APP phosphorylation and maturation and that this involves the regulation of CDK5 and GSK3beta; CBL also reduces TAU phosphorylation and related neurodegenerative pathology through this pathway.	p(HGNC:CBL)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
53472332-b8da-4665-9842-033c37f8a608	0.65	PubMed	16897463	CR inhibited mTOR and Tau phosphorylation in ApoE-/- mice.	p(HGNC:CD55)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
cfb4e1cc-0526-421b-9fa5-d525acdc0803	0.65	PubMed	11245315	Previously, we identified a 125-residue truncated fragment of p35 called CIP that effectively and specifically inhibited Cdk5-p25 activity and Tau hyperphosphorylation induced by Abeta peptides in vitro, in HEK293 cells, and in neuronal cells.	p(HGNC:CD59)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
480f8964-31eb-4201-8758-77c0cfe78f43	0.65	PubMed	18591665	In previous studies, we proposed CDK5 RNAi mediated silencing as a novel strategy against the tau pathology associated with AD because the knock down of CDK5 decreased tau phosphorylation, reduced the number of neurofibrillary tangles, and blocked the rapid neuronal loss in the hippocampi of older triple transgenic Alzheimer 's mice.	p(HGNC:CDK5)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
03fca324-0e11-42f0-aa6e-18e61d75ca03	0.65	PubMed	13872674	We hypothesized that CK2 coupled SIRT1 activation stimulated by cilostazol suppresses tau acetylation (Ac-tau) and tau phosphorylation (P-tau) by inhibiting activation of P300 and GSK3beta.	p(FPLX:CK2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d94dbea3-0c9c-4283-b1e0-8e245c8aa169	0.65	PubMed	18093249	Notably, the effect of microglial CM on tau phosphorylation was partially reversed with the anti-IL-10 antibody, suggesting involvement of IL-10 in the regulation of tau phosphorylation.	a(PUBCHEM:23979)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
f085d5be-b72c-448d-8250-488297ba99f8	0.65	PubMed	13266695	Tau hyper-phosphorylation and high activities of tau kinases were also reduced by CS.	p(HGNC:CS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
16acaa7b-cd3e-4fc2-ba31-0a92259be504	0.65	PubMed	18234450	We found that DUSP1 overexpression decreased tau phosphorylation whereas DUSP1 knockdown increased tau phosphorylation.	p(HGNC:DUSP1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
5256e202-b9a7-483d-b4f7-d6951a6c38ea	0.65	PubMed	17242732	DUSP6 knockdown can increase the level of phospho-ERK to promote high levels of tau phosphorylation.	p(HGNC:DUSP6)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
a7a11d46-b5a3-4426-bf4d-97da07d09256	0.94	PubMed	18557492	E2 also attenuates Tau hyperphosphorylation.	p(UP:P27958)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
a7a11d46-b5a3-4426-bf4d-97da07d09256	0.94	PubMed	9822590	Tau hyperphosphorylation has been implicated to have a prodeath role in Alzheimer 's disease and cerebral ischemia, and E2 attenuates tau hyperphosphorylation.	p(UP:P27958)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
a7a11d46-b5a3-4426-bf4d-97da07d09256	0.94	PubMed	18734048	Tau hyperphosphorylation has been implicated to have a prodeath role in Alzheimer 's disease and cerebral ischemia, and E2 attenuates tau hyperphosphorylation.	p(UP:P27958)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
a7a11d46-b5a3-4426-bf4d-97da07d09256	0.94	PubMed	18734048	In Alzheimer 's disease, E2 also suppresses hyperphosphorylation of tau, a principal component in neurofibrillary tangle formation.	p(UP:P27958)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
766a3a46-c2c7-4b76-b499-1cc19d8322ea	0.65	PubMed	17304424	PERK activation reduces tau phosphorylation in the overexpression model.	p(HGNC:EIF2AK3)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
2bba0acf-98e8-4d01-9e63-ed8ea65e0e34	0.98	Other	sparser:Unknown	To further confirm the role of GSK-3β inhibition in EphB2-induced tau dephosphorylation, we simultaneously transfected GSK-3β with EphB2 plasmids into HEK293-tau cells before ephrinB1/Fc treatment.	p(HGNC:EPHB2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
2bba0acf-98e8-4d01-9e63-ed8ea65e0e34	0.98	PubMed	18189986	These in vitro and in vivo data demonstrate that stimulation of EphB2 can attenuate tau phosphorylation.	p(HGNC:EPHB2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
2bba0acf-98e8-4d01-9e63-ed8ea65e0e34	0.98	Other	sparser:Unknown	To explore the mechanisms underlying the EphB2-induced tau dephosphorylation, we measured the alterations of GSK-3β, the most implicated kinase in regulating tau phosphorylation xref .	p(HGNC:EPHB2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
2bba0acf-98e8-4d01-9e63-ed8ea65e0e34	0.98	Other	sparser:Unknown	EphrinB1/Fc stimulates EphB2 tyrosine phosphorylation and deletion of the kinase domain eliminates EphB2-induced tau dephosphorylation.	p(HGNC:EPHB2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
2bba0acf-98e8-4d01-9e63-ed8ea65e0e34	0.98	Other	sparser:Unknown	These in vitro and in vivo data together confirm the role of PI3K/Akt-mediated GSK-3β inactivation in EphB2-induced tau dephosphorylation.	p(HGNC:EPHB2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c069fa32-98cf-4ab2-aadd-10a153bb796d	0.65	PubMed	10415388	Finally, our in vitro and in vivo assays demonstrate that laforin dephosphorylates Tau, and therefore laforin is a novel Tau phosphatase.	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
5d3123eb-d720-4724-8dfb-8163ab951ee2	0.65	PubMed	18909716	Tau hyperphosphorylation increased in response to gp120, whereas EPO and/or IGF-I decreased tau hyperphosphorylation, as revealed by immunoblotting (see XREF_FIG).	p(HGNC:EPO)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d0241855-016d-4e39-a7c1-d5a3e3c8d0e3	0.65	PubMed	16930356	Escitalopram (80 muM) significantly decreased tau phosphorylation at Thr231 and Ser396, while increased Tau1 that indicates the unphosphorylated tau protein.	a(PUBCHEM:146570)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
eb5c3916-b204-4554-8820-8ea7fbd70c2a	0.65	PubMed	18574032	Estradiol is also able to inhibit the pathological hyperphosphorylation of Tau characteristic of Alzhemier 's disease brains.	a(PUBCHEM:5757)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
2f5711b6-b12c-4384-a9d6-4fd018ea854a	0.86	PubMed	16213384	bFGF down-regulated the phosphorylation of tau by increasing the phosphorylation of GSK3beta via the PI3K and Akt signaling pathway.	p(HGNC:FGF2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
2f5711b6-b12c-4384-a9d6-4fd018ea854a	0.86	PubMed	16213384	bFGF reduced the phosphorylation of tau and GSK3beta and increased the phosphorylation of PI3K and Akt.	p(HGNC:FGF2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3d829cbd-c0d6-4154-be05-8ed7135bcb5a	0.65	PubMed	18775899	Follow-up studies on this observation, reported that Se supplemented rats overexpressing SelM exhibited diminished beta and gamma-secretase activity, reduced tau phosphorylation, and increased activation of the ERK signaling pathway relative to Se supplemented controls [XREF_BIBR].	p(HGNC:FUT2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
cdc75293-dfcb-4519-9e80-1df22ba18a3f	0.65	PubMed	18663080	We found that knock-down of Fyn resulted in both increased Abeta levels and decreased tau phosphorylation accompanied by deficits in spatial learning on the Morris water maze.	p(HGNC:FYN)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
186b7d50-8d8d-4865-8b41-4797efc5e16d	0.65	PubMed	17236136	Folate supplementation inhibited tau phosphorylation only in the hippocampal DG region.	a(PUBCHEM:6037)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
5facc461-4455-4adf-9920-1571b4a4caf7	0.65	PubMed	17236136	Folic Acid Reduces Tau Phosphorylation by Regulating PP2A Methylation in Streptozotocin Induced Diabetic Mice.	a(PUBCHEM:6037)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3464dc3c-f5e9-48de-8cb8-e2fa7316388e	0.86	PubMed	17236136	Folic acid supplementation inhibited tau phosphorylation only in the CA3 region.	a(PUBCHEM:6037)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3464dc3c-f5e9-48de-8cb8-e2fa7316388e	0.86	PubMed	17236136	Folic acid reduced phosphorylation of tau by regulating metPP2A expression.	a(PUBCHEM:6037)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
625cba81-09cb-4bdc-b68e-8ced955206b7	0.65	PubMed	18801472	The normally functioning GAB2 protein suppresses the phosphorylation of tau protein, whose accumulation results in neurofibrillary tangles promoting AD.	p(HGNC:GAB2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
dc8a33ba-a5a2-41e6-be77-0aa21ea510da	0.65	PubMed	19509395	GAPT could attenuate abnormal hyperphosphorylation of tau protein in hippocampal neurons of APPV717I transgenic mice via inhibiting the expression of CDK5 and activating the expression of PP2A.	p(HGNC:GAPT)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8601324e-4120-4163-b4f0-01def4072928	0.65	PubMed	18437544	Taken together, the above findings indicate that blockade of NR2A containing NMDA receptors promotes Tau phosphorylation at Ser199 residue, implicating both calcium and the Cdk5 signalling pathway.	p(HGNC:GRIN2A)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
b53aa64d-e8db-4154-8df7-e83b0fadffd9	0.65	PubMed	18643563	Leptin treatment markedly increased levels of inactive Ser 9 phosphorylated GSK-3beta, thus potentially reducing the phosphorylation of tau.	p(HGNC:GSK3B, pmod(Ph))	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7544079c-70c6-401e-8489-21c707eaf994	0.65	PubMed	17083164	Downregulation of either GSK3 or MARK2 by siRNAs suppresses the level of phosphorylation of tau on Ser262 suggesting that GSK3 regulates Ser262 of tau indirectly through phosphorylation and activation of MARK2 [XREF_BIBR]; however, this has recently been disputed [XREF_BIBR].	p(FPLX:GSK3)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
e31080be-6f66-4547-b238-dde19f0a2595	0.86	PubMed	18909716	In the mouse brain following transnasal treatment with EPO+IGF-I, in addition to neuroprotection we observed increased phosphorylation and activation of Akt (protein kinase B) and increased phosphorylation and inhibition of glycogen synthase kinase (GSK)-3beta, dramatically decreasing downstream hyperphosphorylation of tau.	p(FPLX:GYS, pmod(Ph))	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
e31080be-6f66-4547-b238-dde19f0a2595	0.86	PubMed	11253142	In the mouse brain following transnasal treatment with EPO+IGF-I, in addition to neuroprotection we observed increased phosphorylation and activation of Akt (protein kinase B) and increased phosphorylation and inhibition of glycogen synthase kinase (GSK)-3beta, dramatically decreasing downstream hyperphosphorylation of tau.	p(FPLX:GYS, pmod(Ph))	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3ed8fdea-b222-46f8-b404-0bab9bd9b0f7	0.65	PubMed	17075068	Genistein may also decrease the hyperphosphorylation of Tau protein by inactivating GSK3beta, the kinase involved in Tau phosphorylation in homocysteine mediated neurodegeneration in SH-SY5Y human neuroblastoma cells [XREF_BIBR].	a(PUBCHEM:5280961)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
36f325fe-a758-4e08-91a7-07547b018d81	0.65	PubMed	9301764	Ginsenoside Rb1 can attenuate Abeta (25-35) -induced hyperphosphorylation of tau protein through CDK5 signal pathway.	a(PUBCHEM:9898279)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
98c8c95b-89f9-46fc-9d43-8d5ae143bcfc	0.65	PubMed	11306713	Ginsenoside Rg1 can promote dephosphorylation of P-tau by increasing the expression of PP2A in Alzheimer 's disease like tau phosphorylation rat brain slices, so as to inhibit tau phosphorylation.	a(PUBCHEM:441923)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
5322aae0-ad33-454c-b129-fb8fafbd8ef7	0.65	PubMed	18846100	Excitingly, it has been reported that treatment with nicotinamide prevents cognition in AD transgenic mice via a mechanism involving sirtuin inhibition and reduction of tau phosphorylation.	p(FPLX:"HDAC_III")	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
76d56e53-8a54-491a-bc07-789da0cb89c0	0.65	PubMed	17124901	Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.	p(HGNC:HSF1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
966354c6-9819-43f1-b660-6b8ce3ebe73e	0.65	PubMed	17149155	Subsequent experiments in human neuronal like cells revealed that both Hsp27 and its phosphorylated form, pHsp27, participated in the dephosphorylation of tau and perhaps facilitated tau degradation [XREF_BIBR].	p(HGNC:HSPB1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c5ded08b-333d-43d6-b0dd-1a735e504511	0.65	PubMed	12443004	Pb exposure increased the expression and activity of PP1 and decreased phosphorylation of tau at threonine 231 in hippocampus at both PND21 and PND30.	p(HGNC:HTN3)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
4b166697-0c84-421a-be53-f6623db3af7d	0.86	PubMed	21210956	In particular, the AD-characteristic phosphorylation of tau is completely inhibited by HD <ce:italic> in vivo </ce:italic>.	p(HGNC:HTT)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4b166697-0c84-421a-be53-f6623db3af7d	0.86	PubMed	18237242	In vivo studies in cerebellar granule cells revealed that Hd inhibits phosphorylation of tau at sites that are hyper-phosphorylated by GSK-3beta and cyclin dependent kinase 5 (CDK5).	p(HGNC:HTT)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
10acd3a0-4fb9-4a3a-91cf-bf7aa588f03a	0.65	PubMed	17746991	IGF-1 genetic deletion specifically increased tau phosphorylation at two specific residues, Ser 293 and Ser 202, both GSK-3beta targeted sites.	p(HGNC:IGF1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
d8c61b47-70dc-44eb-aa6b-43932fa9a056	0.86	PubMed	18093249	LPS induced expression of SAA proteins in the brain leads to the activation of microglia and release of IL-10, which in turn suppresses tau hyperphosphorylation in a mouse model of systemic inflammation.	p(HGNC:IL10)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d8c61b47-70dc-44eb-aa6b-43932fa9a056	0.86	PubMed	15863530	LPS induced expression of SAA proteins in the brain leads to the activation of microglia and release of IL-10, which in turn suppresses tau hyperphosphorylation in a mouse model of systemic inflammation.	p(HGNC:IL10)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
98b91581-75f8-4ffd-bc0c-b1ea7658f358	0.65	PubMed	17152488	It has been suggested that besides its increases in Tau phosphorylation, IL-1beta may increase the levels of TAU mRNA [XREF_BIBR] and that blocking IL-1 signalling lead to decreased Tau phosphorylation [XREF_BIBR].	p(FPLX:IL1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
042b50fe-f04b-41fb-93f0-5558a6f67014	0.65	PubMed	5010273	Glutamate but not IL-6 induced a dephosphorylation of tau.	p(HGNC:IL6)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	17292230	Nevertheless, our study suggests that i) the GCs induced tau phosphorylation may not be mediated by inhibition of insulin signaling, and ii) the GCs induced tau phosphorylation could function upstream as a mediator of IR.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	17245783	In the first study, our data shows diet induced insulin resistance reduces tau phosphorylation at 3 epitopes, independent of APOE genotype.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	12761289	The mechanism underlying the Abeta induced Tau hyperphosphorylation is mediated by the impaired insulin signal transduction because we demonstrated that the phosphorylation of Akt and GSK3beta upon insulin stimulation is less activated under this condition.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	12301843	Considering that insulin mitigates hippocampal synapse vulnerability to amyloid beta and inhibits the phosphorylation of tau, pharmacological strategies bolstering brain insulin signaling, such as intranasal insulin, could have significant therapeutic potential to deter AD pathogenesis.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	19373099	Increased tau phosphorylation resulting from insulin depletion is reversed by insulin treatment in a murine model.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	20224726	A second limitation that may have further affected our estimates of the association between CSF insulin and CSF p-Tau concerns the use of an antibody for p-Tau that was specific for phosphorylation at threonine 181, while deficient insulin signaling leads to a widespread phosphorylation of tau at multiple sites.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	7182904	Additionally, both disturbed insulin signaling and reduced ATP forward the hyperphosphorylation of tau protein.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	18930745	Insulin can inhibit phosphorylation of tau, the protein that forms NFTs.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	17587502	Intranasal insulin prevents anesthesia induced hyperphosphorylation of tau in 3xTg-AD mice.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	17499166	Finally, both disturbed insulin signaling and reduced ATP induce the hyperphosphorylation of tau.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	18566691	In addition to insulin 's role in Abeta clearance and degradation, insulin also inhibits phosphorylation of tau, the protein the forms neurofibrillary tangles, a neuropathological hallmark of Alzheimer 's disease and other dementing processes.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	18651770	Impaired insulin signaling has been shown to enhance hyperphosphorylation of tau, which mediates dissociation of the protein from microtubules in the axons and association into tangles [XREF_BIBR, XREF_BIBR].	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	17590201	We found that daily intranasal administration of insulin for 7 days attenuated anesthesia induced hyperphosphorylation of tau in both 3xTg-AD mice and aged WT mice.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3753658a-16f9-4bce-a56e-47a907f553ce	0.95	PubMed	20188014	Insulin also inhibits phosphorylation of tau protein, possibly through its regulation of glycogen synthase kinase 3beta, a downstream target in the insulin signaling pathway.	p(HGNC:INS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8cd00f1e-a169-451a-a259-3979b0168fda	0.65	PubMed	14469989	Although both pS404 antibodies had a similar affinity, they differed in isotype, and only passive immunization with the IgG2a and kappa pS404 specific antibody resulted in a lower tangle burden and reduced phosphorylation of tau at the PHF1 epitope in K3 mice.	p(UP:P20760)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
5426cbb9-166e-4a6d-8c58-7b470aa85a8e	0.65	PubMed	19884810	Here, we found that LA supplementation effectively inhibited the hyperphosphorylation of Tau at several AD related sites, accompanied by reduced cognitive decline in P301S Tau transgenic mice.	a(CHEBI:30314)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	18524835	Leptin Reduces Alzheimer 's Disease Related Tau Phosphorylation in Neuronal Cells.	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	18733650	Leptin Inhibits Glycogen Synthase Kinase-3beta to Prevent Tau Phosphorylation in Neuronal Cells.	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	18643563	In studies by Greco and colleagues, leptin reduced tau phosphorylation through inhibition of GSK-3beta and AMPK in rat primary neurons and in human neuroblastoma cells [XREF_BIBR].	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	16502899	Leptin decreased tau phosphorylation, an effect was dependent on the activation of JAK2.	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	17434621	Likewise, LEP activation has been shown to reduce enzymatic activity of beta-secretase 1 (BACE1) and phosphorylation of MAPT [XREF_BIBR].	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	18986033	The ability of leptin to reduce both Abeta accumulation and hyperphosphorylation of tau, independently and directly, implicates a leptin target upstream of both pathological cascades.	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	17497011	Inefficient leptin signaling in fa/fa rats could contribute to Tau hyperphosphorylation because leptin has been reported to prevent Tau phosphorylation in neuronal cells via the activation of AMP dependent kinase [XREF_BIBR].	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	22039489	Leptin reduces the hyper-phosphorylation of tau by activating PI3K and Akt and AMPK signaling pathways [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	18648555	Treatment with leptin completely reversed the decrease in p- Ser 473 Akt and p-Ser 9 GSK-3beta induced by Abeta, suggesting that inhibition of GSK-3beta underlies the mechanism by which leptin reduces tau phosphorylation.	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d11d6ae0-d42f-4cbc-b494-0bb32506c76f	0.95	PubMed	18648555	Tau phosphorylation, increased levels of which is a hallmark of AD, is also reduced by leptin in SH-SY5Y cells, differentiated human NT2 cells and rat primary cortical neurons.	p(HGNC:LEP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
463afede-b954-46a7-81c6-6261d5a80af4	0.65	PubMed	13626197	The activated asparaginyl endopeptidase cleaves inhibitor-2 of protein phosphatase-2A, I2 (PP2A), into I (2NTF) and I (2CTF) which translocate to the neuronal cytoplasm and inhibit the protein phosphatase activity and consequently the abnormal hyperphosphorylation of tau.	p(HGNC:LGMN)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
60ad6145-71f4-4a31-b75c-715986c4bbe1	0.65	PubMed	21288824	Moreover, disorganization of the actin cytoskeleton by agents such as Cytochalasin D, not only blocks LPA induced neurite retraction but also inhibits the GSK-3 activation and the hyperphosphorylation of Tau triggered by this bioactive lipid.	p(HGNC:LPA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8d8d6e84-244c-4b36-bb31-45e167c858a0	0.86	PubMed	17292230	We have shown that LiCl prevented the DEX induced increase in tau phosphorylation and insulin did not affect tau phosphorylation.	a(PUBCHEM:433294)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8d8d6e84-244c-4b36-bb31-45e167c858a0	0.86	PubMed	12755074	LiCl attenuated the cellular apoptosis by inhibition the level of tau phosphorylation.	a(PUBCHEM:433294)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9c47c614-584f-4f30-8ee3-5163026f7859	0.65	PubMed	19314806	Liraglutide can reduce hyperphosphorylation of tau and NFs and reduce neuronal degeneration, apparently through alterations in JNK and ERK signaling, which may be related to its positive effects on AD like learning and memory impairment.	a(PUBCHEM:16134956)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4d4af559-88d7-4d31-9ea1-57e1c9e26671	0.95	PubMed	18701130	Lithium, a dual action GSK3 inhibitor, and a second GSK3 inhibitor, AR-A014418, reduced tau phosphorylation, tau accumulation, and axonal degeneration in tau mice.	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4d4af559-88d7-4d31-9ea1-57e1c9e26671	0.95	PubMed	9261022	Lithium, a widely used drug for affective disorders, inhibits GSK-3 at therapeutically relevant concentrations and has been demonstrated to prevent tau phosphorylation.	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4d4af559-88d7-4d31-9ea1-57e1c9e26671	0.95	PubMed	9333250	Lithium and CHIR98014 reduced tau phosphorylation (Ser (396)) in the cortex and hippocampus of postnatal rats, while Alsterpaullone and SB216763 were effective only in hippocampus.	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4d4af559-88d7-4d31-9ea1-57e1c9e26671	0.95	PubMed	21251653	Lithium inhibits tau phosphorylation through inhibition of GSK-3beta, as shown in vitro and in vivo <ce:cross-refs refid="BIB105 BIB111 BIB125 BIB156 BIB185 BIB245"> (Hedgepeth et al., 1997; Hong et al., 1997; Klein &amp; Melton, 1996; Lovestone et al., 1999; Munoz-Montano et al., 1997; Stambolic et al., 1996) </ce:cross-refs>.	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4d4af559-88d7-4d31-9ea1-57e1c9e26671	0.95	PubMed	4514874	Lithium also blocks the Alzheimer 's disease like proline directed hyperphosphorylation of tau protein which is observed in neurons treated with a phosphatase inhibitor.	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4d4af559-88d7-4d31-9ea1-57e1c9e26671	0.95	PubMed	21192078	</sb:maintitle> </sb:title> <sb:volume-nr> 315 </sb:volume-nr> </sb:series> <sb:date> 1996 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 111 </sb:first-page> <sb:last-page> 114 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB9"> <ce:label> Hong et al., 1997 </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> M. </ce:given-name> <ce:surname> Hong </ce:surname> </sb:author> <sb:author> <ce:given-name> D.C.R. </ce:given-name> <ce:surname> Chen </ce:surname> </sb:author> <sb:author> <ce:given-name> P.S. </ce:given-name> <ce:surname> Klein </ce:surname> </sb:author> <sb:author> <ce:given-name> V.M.Y. </ce:given-name> <ce:surname> Lee </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> Lithium reduces Tau phosphorylation by inhibition of glycogen synthase kinase-3 </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> J. Biol.	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4d4af559-88d7-4d31-9ea1-57e1c9e26671	0.95	PubMed	20991506	Lithium also blocks the Alzheimer 's disease like proline directed hyperphosphorylation of tau protein which is observed in neurons treated with a phosphatase inhibitor.	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
a2df8a27-c70f-4338-80cf-47767c9b1e49	0.65	PubMed	9858117	Lithium chloride, a specific inhibitor of GSK-3, completely abolished the anisomycin induced elevation of tau phosphorylation without any effect on the activity of MAPK.	a(PUBCHEM:433294)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
71ded4bd-44b6-4291-9c63-e2fad1683085	0.92	PubMed	5754705	These M1 agonists promote the nonamyloidogenic APP processing pathways and decrease tau protein phosphorylation.	a(PUBCHEM:13019211)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
71ded4bd-44b6-4291-9c63-e2fad1683085	0.92	PubMed	9454830	The M1 selective muscarinic agonists AF102B [Cevimeline], AF150 (S) and AF267B - i) elevated alphaAPPs, decreased Abeta levels and tau hyperphosphorylation, and blocked Abeta induced neurotoxicity, in vitro, via M1 mAChR modulation of kinases (e.g. PKC, MAPK and GSK3beta); ii) restored cognitive deficits, cholinergic markers, and decreased tau hyperphosphorylation in relevant models with a wide safety margin.	a(PUBCHEM:13019211)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
71ded4bd-44b6-4291-9c63-e2fad1683085	0.92	PubMed	6581319	The M1 muscarinic agonists AF102B, AF150 (S) & AF267B -- i) restored cognitive impairments in several animal models for AD with an excellent safety margin; ii) elevated alpha-APPs levels; iii) attenuated vicious cycles induced by A beta, and inhibited A beta- and oxidative stress induced apoptosis; and iv) decreased tau hyperphosphorylation.	a(PUBCHEM:13019211)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d35d63c3-a97c-49e5-aa75-8a2b4725e0ff	0.65	PubMed	17795528	MAPK1 (ERK2) can reduce phosphorylation of tau at S396.	p(HGNC:MAPK1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
f22e7341-5bb4-4047-aee4-cd95a931cdd1	0.65	PubMed	17247926	Previous studies have demonstrated that competitive glycosylation of Tau prevents Tau hyperphosphorylation XREF_BIBR.	p(HGNC:MAPT, pmod(Glyco))	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1e9ee8c5-24fd-44c3-ac8d-9aec2e3a10b5	0.65	PubMed	8104537	The aim of this study was to determine if the dephosphorylation or inhibition of tau and GSK3beta phosphorylation induces the Pin1 phosphorylation.	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	p(HGNC:PIN1, pmod(Ph))
e914c570-a0f9-40ba-b6a6-39f8da862f2f	0.65	PubMed	6960725	Tau phosphorylation status diminished during in vitro maturation, suggesting that healthy OLG processes require regulated phosphorylation of tau at specific sites.	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
63578c44-6f92-4b08-854f-f4f1cdc6fe0c	0.65	PubMed	20153279	On the other hand, the serum containing SRBFL could rescue the expression of CAV-1 in the presence of CAV1-shRNA and cause the reduced and enhanced phosphorylation of GSK-3beta at the sites of Ser9 and Tyr216, respectively, as well as leading to the increased phosphorylation of Tau at the sites of Thr231 and Ser396.	p(HGNC:MAPT, pmod(Ph, Thr, 548))	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
0f1201ae-6d69-4f22-8fc3-715c34bfe285	0.95	Other	sparser:Unknown	EphB2 activation inhibits glycogen synthase kinase-3β (GSK-3β), a crucial tau kinase, and activates phosphatidylinositol-3-kinase (PI3K)/Akt both in vitro and in vivo, whereas simultaneous inhibition of PI3K or upregulation of GSK-3β abolishes the EphB2 stimulation-induced tau dephosphorylation.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:EPHB2, pmod(Ph))
0f1201ae-6d69-4f22-8fc3-715c34bfe285	0.95	Other	sparser:Unknown	To further verify the role of PI3K/Akt-mediated GSK-3β inhibition in EphB2 stimulation-induced tau dephosphorylation, we first used wortmannin, a PI3K inhibitor, in SK-N-SH cells.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:EPHB2, pmod(Ph))
0f1201ae-6d69-4f22-8fc3-715c34bfe285	0.95	Other	sparser:Unknown	PI3K/Akt-mediated GSK-3β inhibition is required for the EphB2 stimulation-induced tau dephosphorylation.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:EPHB2, pmod(Ph))
0f1201ae-6d69-4f22-8fc3-715c34bfe285	0.95	Other	sparser:Unknown	EphB2 activation inhibits glycogen synthase kinase-3β (GSK-3β), a crucial tau kinase, and activates phosphatidylinositol-3-kinase (PI3K)/Akt both in vitro and in vivo , whereas simultaneous inhibition of PI3K or upregulation of GSK-3β abolishes the EphB2 stimulation-induced tau dephosphorylation.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:EPHB2, pmod(Ph))
0f1201ae-6d69-4f22-8fc3-715c34bfe285	0.95	Other	sparser:Unknown	We observed that simultaneous upregulation of GSK-3β abolished EphB2 stimulation-induced tau dephosphorylation at Ser396, Thr231 and Thr205 sites ( xref ), which confirm the role of GSK-3β inhibition in EphB-induced tau dephosphorylation.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:EPHB2, pmod(Ph))
0f1201ae-6d69-4f22-8fc3-715c34bfe285	0.95	Other	sparser:Unknown	The results show that simultaneous activation of GSK-3β abolishes the EphB2 stimulation-induced tau dephosphorylation.	p(HGNC:MAPT)	directlyDecreases	p(HGNC:EPHB2, pmod(Ph))
79edfc29-95e3-4043-9a14-bd249af1f2d3	0.65	Other	sparser:Unknown	Protein phosphatase PP1 and PP2B are phosphatases of tau dephosphorylating tau at S199, S202, T205, T212, S214, S235, S262, S396, S404, and S409 and total phosphatase activity and the activity of PP2B toward tau were increased in AD brain (Liu et al., xref ).	p(HGNC:MAPT)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
bc59eab4-8d7a-40df-91ec-d39713b3e36d	0.65	PubMed	18233622	Attenuation of synaptic toxicity and MARK4 and PAR1 mediated Tau phosphorylation by methylene blue for Alzheimer 's disease treatment.	p(HGNC:MARK4)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
12e8ff00-0db3-4b42-b9ad-1dc3e6a677e0	0.65	PubMed	18233622	Interestingly, MB inhibited Tau phosphorylation at S396 and S214 but with reduced potency compared to the inhibition of pS262.	p(HGNC:MB)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
90c4e077-2790-4086-ae67-3560e8324e13	0.65	PubMed	18233622	Similar results were observed as shown in XREF_FIG where Tau phosphorylation at S262 by endogenous MARK4 was inhibited by MB in a dose dependent manner.	p(HGNC:MB)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
2358ee20-9e69-420b-8398-40fe3abdd5e2	0.65	PubMed	12575678	A recent placebo controlled clinical trial in patients with amnestic mild cognitive impairment (MCI) showed that long-term lithium treatment may actually slow the progression of cognitive and functional deficits, and also attenuate Tau hyperphosphorylation in the MCI-AD continuum.	p(HGNC:MCIDAS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
5d8d2c35-ef36-49cf-aa9f-219d97fc8053	0.65	PubMed	15349934	ME significantly attenuated Abeta induced cell damage, enhanced Akt and GSK-3beta phosphorylation, and reduced tau phosphorylation.	p(HGNC:MMP12)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1fc26625-4e79-49fe-8770-f24d28992417	0.65	PubMed	20300289	Mechanism study demonstrated that FTO activated the phosphorylation of Tau in a mTOR dependent manner because FTO activated mTOR and its downstream signaling and rapamycin blocked FTO mediated phosphorylation of Tau.	p(HGNC:MTOR)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3f8f997c-d10c-40c3-bf8b-ca976626fa0c	0.86	PubMed	17606647	Magnesium sulfate treatment also decreased tau hyperphosphorylation by increasing the inhibitory phosphorylation of GSK-3beta at serine 9, thereby increasing the activity of Akt at Ser473 and PI3K at Tyr458/199, and improving insulin sensitivity.	a(PUBCHEM:24083)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3f8f997c-d10c-40c3-bf8b-ca976626fa0c	0.86	PubMed	14702715	Magnesium sulfate treatment also decreased tau hyperphosphorylation by increasing the inhibitory phosphorylation of GSK-3beta at serine 9, thereby increasing the activity of Akt at Ser473 and PI3K at Tyr458/199, and improving insulin sensitivity.	a(PUBCHEM:24083)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1493a8ce-de7c-4e26-a895-c5a2162cac8b	0.86	PubMed	17151017	Melatonin has been shown to prevent the hyperphosphorylation of the tau protein in rats [XREF_BIBR].	a(PUBCHEM:896)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1493a8ce-de7c-4e26-a895-c5a2162cac8b	0.86	PubMed	17149141	Melatonin added before, simultaneously or after okadaic acid treatment decreased tau hyperphosphorylation caused by this compound respectively.	a(PUBCHEM:896)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
09160512-f809-4133-bf2a-9ba2f7729c05	0.86	PubMed	18365645	Metformin reduces tau phosphorylation through activation of PP2A via AMPK and mTOR in vitro.	a(PUBCHEM:4091)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
09160512-f809-4133-bf2a-9ba2f7729c05	0.86	PubMed	18365645	Metformin reduces tau phosphorylation in the brain of P301S mice.	a(PUBCHEM:4091)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
713ad45d-641b-4924-a9f2-2fa2f5e52826	0.86	PubMed	18233622	Methylene blue reduces Tau phosphorylation in mammalian cell cultures.	a(PUBCHEM:6099)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
713ad45d-641b-4924-a9f2-2fa2f5e52826	0.86	PubMed	18802461	103 Methylene blue failed to inhibit abnormal phosphorylation of tau, neuronal cell loss or a swimming defect in a tauopathy zebrafish model.	a(PUBCHEM:6099)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c09d3756-5b15-4926-9cd5-bd88e08f1334	0.65	PubMed	17087465	Milton knockdown increased the levels of active PAR-1 and tau phosphorylation at Ser262, and promoted detachment of tau from microtubules.	p(PFAM:PF12448)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
28a78a43-c996-4cea-9331-fb6010ad6692	0.86	PubMed	16986024	Minocycline decreases the hyperphosphorylation of tau and Abeta production by inhibiting the process of neuroinflammation.	a(PUBCHEM:51537604)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
28a78a43-c996-4cea-9331-fb6010ad6692	0.86	PubMed	16986024	Minocycline decreased phosphorylation of tau.	a(PUBCHEM:51537604)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4e2d873a-7367-46b1-a6a1-eac486740b65	0.65	PubMed	14329482	Our previous study showed that ginsenoside Rd (Rd), one of the main active ingredients in Panax ginseng, decreased tau phosphorylation in Alzheimer model.	p(HGNC:NELFE)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
273e87a7-a34c-4972-8476-ed9613e130f0	0.65	PubMed	14529703	Both western blotting and immunostaining results displayed intranasal pretreatment of NGF significantly reduced tau phosphorylation.	p(HGNC:NGF)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9df8560c-5a55-4366-a225-fb78904a1805	0.95	PubMed	3261170	Determine the involvement of the Ca2 +/calmodulin-dependent phosphatase, calcineurin, in the KCl+ NMDA induced dephosphorylation of tau, slices were pretreated with the calcineurin inhibitor Cyclosporin A. Pretreatment of the rat brain slices with Cyclosporin A completely abolished the dephosphorylation of tau induced by the addition of KCl+ NMDA.	a(PUBCHEM:22880)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9df8560c-5a55-4366-a225-fb78904a1805	0.95	PubMed	18445309	In contrast, we noticed that the capacity of NMDA to reduce Tau phosphorylation was totally prevented in hippocampal slices preincubated with the PKC inhibitor Chelerythrine chloride (1muM), indicating that NMDA induced regulation of Tau phosphorylation probably involves GSK3betablockade by the PKC system (XREF_FIG).	a(PUBCHEM:22880)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9df8560c-5a55-4366-a225-fb78904a1805	0.95	PubMed	18445309	XREF_FIG shows that the ability of NMDA to downregulate Tau phosphorylation at Ser199-202 residues was not affected by these inhibitors.	a(PUBCHEM:22880)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9df8560c-5a55-4366-a225-fb78904a1805	0.95	PubMed	18445309	NMDA Reduces Tau Phosphorylation in Rat Hippocampal Slices by Targeting NR2A Receptors, GSK3beta, and PKC Activities.	a(PUBCHEM:22880)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9df8560c-5a55-4366-a225-fb78904a1805	0.95	PubMed	18445309	We observed that preexposure of hippocampal slices to the cell-impermeable form of BAPTA completely blocked the NMDA induced reduction of Tau phosphorylation at Ser199-202 epitopes (XREF_FIG), indicating that Tau hypophosphorylation after NMDA receptor activation mainly relies on calcium entrance from the extracellular space.	a(PUBCHEM:22880)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9df8560c-5a55-4366-a225-fb78904a1805	0.95	PubMed	18445309	XREF_FIG illustrates that the ability of NMDA to reduce Tau phosphorylation was further enhanced in slices preexposed to the NR2B antagonist.	a(PUBCHEM:22880)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9df8560c-5a55-4366-a225-fb78904a1805	0.95	PubMed	18445309	Tau Phosphorylation at Ser199-202 is Reduced by NMDA Treatment : Role of NR2A Containing Receptors.	a(PUBCHEM:22880)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8389e6c4-2064-4f7b-8533-fca92c6eeb0d	0.86	PubMed	21011048	</ce:para> <ce:para id="para260" view="all"> In the present study, the inhibition of the PP-2A and PP-1 activities in SY5Y cells, which have minimal PP-2B activity, produced hyperphosphorylation of tau at specific sites and upregulation of the activities of cdc2 kinase, cdk5 and MAPK but not of GSK-3.	p(HGNC:NPY4R)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8389e6c4-2064-4f7b-8533-fca92c6eeb0d	0.86	PubMed	21090062	Tau <ce:inf loc="post"> 410 </ce:inf> phosphorylated at Ser 262/356 by CaMKII could be dephosphorylated in vitro both by PP-2A and PP-1.	p(HGNC:NPY4R)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
ad850220-a7a2-4483-b04b-f980d8feee6b	0.65	PubMed	8092648	Okadaic acid (OA), a protein phosphatase inhibitor, induces neuronal death and hyperphosphorylation of tau.	a(CHEBI:44658)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
a13a15b7-ce02-4d94-9e2c-57de34479c15	0.86	Other	sparser:Unknown	In neonatal forebrain slices, tau became rapidly dephosphorylated at the AT8 and Tau1 sites during incubation at 34 degrees C, but was incompletely dephosphorylated at the PHF1 site.	p(UP:Q9SI18)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
a13a15b7-ce02-4d94-9e2c-57de34479c15	0.86	PubMed	PMC4051449	In neonatal forebrain slices, tau became rapidly dephosphorylated at the AT8 and Tau1 sites during incubation at 34 degrees C, but was incompletely dephosphorylated at the PHF1 site.	p(UP:Q9SI18)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9236004e-65ff-4566-8590-7872468a3cff	0.65	PubMed	11245315	Furthermore, we have demonstrated that p5 reduced Abeta (1-42)-induced Tau hyperphosphorylation and apoptosis in cortical neurons.	p(HGNC:PDIA6)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
20996bb2-e285-45f7-92b0-b9aba489d279	0.65	PubMed	7917706	In addition, it has been documented that PS1 positively regulates, whereas PS1 familial Alzheimer disease mutations suppress, phosphatidylinositol 3-kinase (PI3K)/Akt activation, a pathway known to inactivate glycogen synthase kinase-3 and reduce tau phosphorylation.	p(FPLX:PI3K)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
ccd835e4-6d58-4ede-a02f-4b97fe2334a6	0.65	PubMed	18669640	Further studies by Lu et al., showed that overexpression of Pin1 leads to decreased phosphorylation of Tau protein [XREF_BIBR], and suggests that Pin1 might be a promising therapeutic target to delay or combat this devastating disorder.	p(HGNC:PIN1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
faba845e-63a9-4373-884e-73fadd4784d6	0.88	PubMed	8438185	In both cases, juglone, a Pin1 pharmacological inhibitor, partially prevented dephosphorylation of Tau at Thr 231 among a set of phosphoepitopes tested.	p(HGNC:PIN1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
faba845e-63a9-4373-884e-73fadd4784d6	0.88	Other	sparser:Unknown	Likewise, we showed in cellular model that Pin1 allowed for specific Tau dephosphorylation at Thr231, whereas other phosphorylation sites were unchanged.	p(HGNC:PIN1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
f70448da-fc3a-47d2-ac10-a69d6492b0b9	0.65	PubMed	7479839	Infusion of forskolin together with PKA inhibitor or glycogen synthase kinase-3 (GSK-3) inhibitor revealed that the phosphorylation of tau at Ser 214 was catalyzed by PKA and that the phosphorylation at both the Tau-1 and the PHF-1 sites is induced by basal level of GSK-3, because forskolin activated PKA and not GSK-3 and inhibition of the latter inhibited the phosphorylation at Tau-1 and PHF-1 sites.	p(FPLX:PKA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
03a877e1-c4a8-46f6-92d9-5ab9fccf429f	0.65	PubMed	21063753	In the presence of GF-109203X, an inhibitor of PKC, wortmannin induced activation of GSK-3 without consequential inactivation and also phosphorylation of tau without dephosphorylation.	p(FPLX:PKC)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
5527a6d5-55c7-4d80-b89c-b850b4f358f3	0.65	PubMed	11228625	A recent paper reported that the phospholipid transfer protein (PLTP) reduces phosphorylation of tau in human neuronal cells.	p(HGNC:PLTP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
6702ceda-cffc-4da9-908f-a07b1f1b7493	0.65	PubMed	18802461	For example, it is known that the levels of homocysteine are increased in AD patients, that folate deprivation, which is also observed in AD patients, 82 is a major factor contributing to increased homocysteine levels 83 and that folate and methyl-folate promote methylation of PP2Ac and subsequent formation of an active Balpha containing PPA2 complex that should lead to increased dephosphorylation of tau.	p(HGNC:PPA2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
47467957-211d-4b51-9e6f-d2cec9f6f88c	0.86	PubMed	17245783	PPARgamma activation has also been shown to reduce the phosphorylation of tau in vitro XREF_BIBR, whilst the overexpression of PPARgamma reduces the accumulation of Abeta XREF_BIBR, XREF_BIBR.	p(HGNC:PPARG)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
47467957-211d-4b51-9e6f-d2cec9f6f88c	0.86	PubMed	18463245	XREF_BIBR Furthermore, PPAR-gamma agonists could reduce Tau protein phosphorylation, thereby inhibiting the accumulation of NFT in AD.	p(HGNC:PPARG)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
473ff0e5-fab2-4a3d-b2e2-f56d80b310fe	0.88	PubMed	17504051	The active ingredient of Radix Ginseng Rg1 could significantly reduce phosphorylation of tau protein [XREF_BIBR].	p(HGNC:PPP1R3A)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
473ff0e5-fab2-4a3d-b2e2-f56d80b310fe	0.88	Other	sparser:Unknown	Ginsenoside Rg1 can promote dephosphorylation of P-tau by increasing the expression of PP2A in Alzheimer's disease-like tau phosphorylation rat brain slices, so as to inhibit tau phosphorylation.	p(HGNC:PPP1R3A)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
476a85fe-ec6f-42ca-bee4-e44bd88f9584	0.65	PubMed	17082609	Tau is dephosphorylated by protein phosphatases 2A (PP2A) and, to a lesser extent, by PP1, PP2B, and PP5 [XREF_BIBR, XREF_BIBR - XREF_BIBR].	p(FPLX:PPP1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
4ecc6a3c-2e74-4158-948e-edbc17cd9f84	0.99	PubMed	6958404	We investigated whether a decrease in PP-2A activity could underlie the activation of these kinases and the abnormal hyperphosphorylation of tau.	p(HGNC:PPP2CA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4ecc6a3c-2e74-4158-948e-edbc17cd9f84	0.99	PubMed	21350363	We investigated whether a decrease in PP-2A activity could underlie the activation of these kinases and the abnormal hyperphosphorylation of tau.	p(HGNC:PPP2CA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4ecc6a3c-2e74-4158-948e-edbc17cd9f84	0.99	PubMed	21350363	We found that the inhibition of PP-2A by okadaic acid (OA) induced a dramatic increase in the phosphorylation and activation of ERK1/2, MEK1/2, and p70 S6 kinase as well as the phosphorylation of tau at several of the sites seen in PHF-tau.	p(HGNC:PPP2CA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4ecc6a3c-2e74-4158-948e-edbc17cd9f84	0.99	PubMed	12875979	Thus, it is likely that reduced PP-2A activity might not only induce a compromised PHF-tau dephosphorylation, but may also cause PHF-tau accumulation as a result of up-regulated p70 S6 kinase activation.As hypothesized in, the production and phosphorylation of tau protein is regulated by p70 S6 kinase.	p(HGNC:PPP2CA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4ecc6a3c-2e74-4158-948e-edbc17cd9f84	0.99	PubMed	17331704	The down-regulation of PPP2CA which can dephosphorylate tau may also be part of this self killing strategy.	p(HGNC:PPP2CA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4ecc6a3c-2e74-4158-948e-edbc17cd9f84	0.99	Other	sparser:Unknown	The down-regulation of PPP2CA which can dephosphorylate tau may also be part of this self-killing strategy.	p(HGNC:PPP2CA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4ecc6a3c-2e74-4158-948e-edbc17cd9f84	0.99	Other	sparser:Unknown	Additionally, PPP2CA can dephosphorylate tau and was significantly correlated with AD progression.	p(HGNC:PPP2CA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c8e8fe5b-cf39-4fa7-923b-9eb69f114cf3	0.65	PubMed	14291634	Down-regulation of PPP2R5D expression decreased tau phosphorylation at Ser-202 and Thr-205, Thr 231, and Ser 422, which indicates activation of the tau kinase glycogen synthase kinase 3 beta (GSK3beta) by PP2A with PPP2R5D subunit.	p(HGNC:PPP2R5D)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
6f67f21d-b170-4554-8568-4e16703d7d1e	0.92	PubMed	18437330	Also, decreased activity of phosphatases such as protein phosphatase 2A (PP2A), that can dephosphorylate tau, have been associated with the development of AD in people who have DS.	p(FPLX:PPP2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
6f67f21d-b170-4554-8568-4e16703d7d1e	0.92	PubMed	1330687	Of the major serine/threonine protein phosphatases found in mammalian tissues only protein phosphatase 2A (PP2A) could dephosphorylate tau phosphorylated in this manner, with PP2A1 being the most effective form of the enzyme.	p(FPLX:PPP2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
6f67f21d-b170-4554-8568-4e16703d7d1e	0.92	PubMed	595691	Of the major serine/threonine protein phosphatases found in mammalian tissues only protein phosphatase 2A (PP2A) could dephosphorylate tau phosphorylated in this manner, with PP2A1 being the most effective form of the enzyme.	p(FPLX:PPP2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
0d3de806-4d19-475b-8202-9c5e02a2ee43	0.65	Other	sparser:Unknown	In terms of phosphatase deregulation, it has been shown that protein phosphatases PP1, PP2A, PP2B, and PP5 dephosphorylate tau in vitro at sites Ser199, Ser202, Thr205, Thr212, Ser214, Ser235, Ser262, Ser396, Ser404, and Ser409 [ xref ].	p(FPLX:PPP2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
48765b85-5829-4332-ac75-ce00d658d5bb	0.65	PubMed	14291634	We showed that the PP2A B subunit PPP2R2A mediated dephosphorylation of tau protein at Ser 199, Ser-202 and Thr-205, Thr 231, Ser 262, and Ser 422.	p(FPLX:PPP2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
7ae44784-5667-4662-9c7e-f60ac2c12ff3	0.65	PubMed	7932668	Tyrosine phosphorylation of tau was inhibited by PP2 (4-amino-5-(4-chlorophenyl-7-(t-butyl) pyrazolo [3,4-d] pyrimidine), which is known to inhibit Src family kinases and c-Abl.	p(FPLX:PPP2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Tyr))
14e3dcf1-1191-42af-a58b-c5a42bf9bf79	0.86	Other	sparser:Unknown	Protein phosphatase 2B (PP2B) is one of the major brain phosphatases and can dephosphorylate tau at several phosphorylation sites in vitro.	p(HGNC:PPP3CA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
14e3dcf1-1191-42af-a58b-c5a42bf9bf79	0.86	Other	sparser:Unknown	Protein phosphatase 2B (PP2B) is one of the major brain phosphatases and can dephosphorylate tau at several phosphorylation sites in vitro .	p(HGNC:PPP3CA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
05425b13-a8dd-4c3f-b6de-1ec00e3c2cf3	0.65	Other	sparser:Unknown	Compared with the full-length PP2B, the truncated PP2B induced dephosphorylation of tau at Ser199, Ser202, Thr205, Thr212, and Ser404 to larger degrees ( xref ), despite the fact that expression of the truncated PP2B was similar or even less than that of the full-length PP2B ( xref ).	p(FPLX:PPP3)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
c1ef9320-9517-45a9-a62b-7e1cb8110c93	0.86	Other	sparser:Unknown	Protein phosphatase 5 (PP5), mainly localized in human brain, can dephosphorylate tau protein whose high level of phosphorylation is related to Alzheimer's disease.	p(HGNC:PPP5C)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c1ef9320-9517-45a9-a62b-7e1cb8110c93	0.86	Other	sparser:Unknown	Inversely, protein phosphatase 5 (PP5), which dephosphorylates tau to restore microtubule-binding function, is repressed with aging and activity is further repressed in AD.	p(HGNC:PPP5C)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1c7480ad-ac8a-4519-8517-c2e008c929a5	0.98	Other	sparser:Unknown	Dephosphorylation of PKA-phosphorylated tau by PP-1, PP-2B  and PP-2C.	p(HGNC:PPY)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1c7480ad-ac8a-4519-8517-c2e008c929a5	0.98	Other	sparser:Unknown	We have recently found that PP-2A  and PP-2B rapidly dephosphorylate AD P-tau in vitro  ([22] and Gong et al. manuscript submitted for publica-  tion).	p(HGNC:PPY)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1c7480ad-ac8a-4519-8517-c2e008c929a5	0.98	Other	sparser:Unknown	These two neuroleptics inhibit tau dephosphorylation by PP-2B through antagonizing calmodulin as well as directly interacting with PP-2B. The inhibition of the dephosphorylation of abnormally hyperphosphorylated tau by neuroleptics raises an intriguing possibility that the chronic use of these drugs might contribute to neurofibrillary degeneration in schizophrenic and AD patients.	p(HGNC:PPY)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1c7480ad-ac8a-4519-8517-c2e008c929a5	0.98	Other	sparser:Unknown	Using phosphorylation-dependent monoclonal antibodies, tau-1, AT8 and PHF-1, we have found that the dephosphorylation of the abnormal tau by PP-2B is inhibited at all the sites recognized by these antibodies.	p(HGNC:PPY)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1c7480ad-ac8a-4519-8517-c2e008c929a5	0.98	PubMed	18253332	Biochemical studies have previously demonstrated that all these PP can dephosphorylate tau in vitro XREF_BIBR.	p(HGNC:PPY)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
dc30f07f-4568-43c0-ba80-9b7790c7a92f	0.65	PubMed	7345123	By activating PI3K and Akt signaling, PS1 promotes phosphorylation and inactivation of glycogen synthase kinase-3 (GSK-3), suppresses GSK-3-dependent phosphorylation of tau at residues overphosphorylated in AD and prevents apoptosis of confluent cells.	p(HGNC:PSEN1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
55e31603-9694-4cc1-9d35-1c4ec882fed8	0.65	PubMed	18340162	However, contrary to expectations, phosphatase-null PTEN increased tau phosphorylation and its aggregation and impaired tau binding to microtubules, whereas PTEN overexpression in neuronal cells decreased tau phosphorylation, followed by increased tau-microtubule association and decreased formation of tau aggregates.	p(HGNC:PTEN)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3d9d26fb-f635-40fe-b4fa-ac21d692c357	0.65	PubMed	18340162	Mutation of PTEN was believed to decrease tau phosphorylation by increasing Akt activity and subsequently decreasing the activity of GSK3beta, a well established tau kinase.	p(HGNC:PTEN, var(p.?))	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1ddee5eb-5d42-4d05-9555-66f444895448	0.86	Other	sparser:Unknown	Since PTPN13 is a tyrosine phosphatase, we assessed whether PTPN13 could dephosphorylate phospho-tyrosine tau after its phosphorylation with c-Abl.	p(HGNC:PTPN13)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1ddee5eb-5d42-4d05-9555-66f444895448	0.86	Other	sparser:Unknown	While these data suggested that PTPN13 could dephosphorylate phospho-tyrosine tau after its phosphorylation with c-Abl, the results could be interpreted differently, as for example it could be the case that PTPN13 dephosphorylates and inactivates phospho-tyrosine-c-Abl, since c-Abl has 2 tyrosine residues, whose phosphorylation is required for kinase activity, tyrosine 245 and tyrosine 412  xref  .	p(HGNC:PTPN13)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
0165f478-03dd-43f9-882e-992f85389361	0.65	Other	sparser:Unknown	However, it is not known how various FTDP-17 mutations affect tau dephosphorylation by phosphoprotein phosphatases.	p(UP:Q8JTH2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
967d9210-232b-479c-9db3-7450f2ce1a8d	0.65	PubMed	6762115	Phosphatase 2B, calcineurin can dephosphorylate the tau protein and, therefore, might prevent the assembly of paired helical filaments and even Alzheimer 's disease.	p(PFAM:PF15698)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
56e77ca2-952e-49fc-9ccd-eca44f132e8d	0.95	PubMed	3412286	Tau factor phosphorylated by cdc2 kinase and tau protein kinase II was dephosphorylated by the holoenzyme of protein phosphatase 2A and calcineurin, while either the catalytic subunit of protein phosphatase 2A or protein phosphatase 2C could not catalyze the dephosphorylation.	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
56e77ca2-952e-49fc-9ccd-eca44f132e8d	0.95	PubMed	18359445	Tau is dephosphorylated by protein phosphatase 2A (PP2A) and, to a lesser extend, by PP1, PP2B and PP5 [XREF_BIBR, XREF_BIBR - XREF_BIBR].	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
56e77ca2-952e-49fc-9ccd-eca44f132e8d	0.95	PubMed	17366836	Moreover, betaIII-tubulin isoform and Tau (axonal microtubule associated protein) are preferentially dephosphorylated by protein phosphatase 2A, in neuron microtubules XREF_BIBR.	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
56e77ca2-952e-49fc-9ccd-eca44f132e8d	0.95	PubMed	18388516	A number of kinases contribute to tau hyperphosphorylation, including glycogen synthase kinase-3 (GSK-3), cyclin dependent kinase 5, and microtubule affinity regulating kinase; conversely, protein phosphatase 2A dephosphorylates tau.	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
56e77ca2-952e-49fc-9ccd-eca44f132e8d	0.95	PubMed	20553266	Of the major serine/threonine protein phosphatases found in mammalian tissues only protein phosphatase 2A (PP2A) could dephosphorylate tau phosphorylated in this manner, with PP2A <ce:inf loc="post"> 1 </ce:inf> being the most effective form of the enzyme.	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
56e77ca2-952e-49fc-9ccd-eca44f132e8d	0.95	PubMed	10899436	Of the major phosphatase activities in brain, tau is dephosphorylated predominantly by the trimeric form of phosphatase 2A.	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
56e77ca2-952e-49fc-9ccd-eca44f132e8d	0.95	PubMed	20553266	Of the major serine/threonine protein phosphatases found in mammalian tissues only protein phosphatase 2A (PP2A) could dephosphorylate tau phosphorylated in this manner, with PP2A1 being the most effective form of the enzyme.	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
01d951a8-c582-448a-b2b2-237398b97368	0.86	PubMed	17200775	Protein phosphatase PP2A also dephosphorylates tau protein at Ser202 and Thr205 in response to microtubule depolymerization [XREF_BIBR].	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
01d951a8-c582-448a-b2b2-237398b97368	0.86	PubMed	24646911	Protein phosphatase PP2A also dephosphorylates tau protein at Ser202 and Thr205 in response to microtubule depolymerization [XREF_BIBR].	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
402839f5-8356-4d6e-babf-8b91e0b19a6f	0.65	PubMed	13313664	Pioglitazone can ameliorate intracerebral insulin resistance and decrease tau protein hyperphosphorylation, but can not increase intracerebral insulin levels.	a(PUBCHEM:4829)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
357547d0-73ce-41a4-ae98-98c26e452394	0.94	PubMed	7634179	Thus, to investigate if proteasome inhibition leads to accumulation, hyperphosphorylation and aggregation of Tau, we used neuroblastoma cells overexpressing Tau proteins.	p(FPLX:Proteasome)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
357547d0-73ce-41a4-ae98-98c26e452394	0.94	PubMed	14306830	Our results indicated that proteasome inhibition led to degradation obstacles and abnormal phosphorylation of tau protein.	p(FPLX:Proteasome)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
357547d0-73ce-41a4-ae98-98c26e452394	0.94	PubMed	14306830	Proteasome inhibition can induce abnormal accumulation and phosphorylation of microtubule associated protein tau.	p(FPLX:Proteasome)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
357547d0-73ce-41a4-ae98-98c26e452394	0.94	PubMed	13917152	Restoration of the microtubule transport was achieved by inhibiting ERK 1/2 activation, and simultaneous inhibition of both ERK 1/2 and c-Jun reversed the proteasome inhibition induced tau phosphorylation.	p(FPLX:Proteasome)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
42574850-2e24-421b-830c-eb6b7d6bc4ee	0.65	PubMed	14934445	Coff or Caff, plus Mel inhibited GSK3beta, Akt, PI3K p55, and Tau phosphorylation but enhanced PI3K p85 and Erk1/2 phosphorylation in N2a and APP cells.	p(HGNC:RAB8A)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
58ae74be-e7a9-4307-bb14-52aec3f6953b	0.65	PubMed	13206560	In addition, RARalpha signalling prevents tau phosphorylation.	p(HGNC:RARA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
34d14eae-7454-4e5b-be1e-8186f8f8bcc3	0.65	PubMed	7783142	Rb1 pretreatment also attenuated Thr (231) and Ser (396) hyperphosphorylations of Tau protein, and restored PP2A activity compared to the OA group (P < 0.01).	p(HGNC:RB1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
909dbe2f-63b9-4f82-a5b4-7190df882f0d	0.65	PubMed	21876249	RCAN1 overexpression could be expected to cause calcineurin inhibition and, therefore, decreased tau dephosphorylation.	p(HGNC:RCAN1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
b3e72f59-319c-4177-931a-3e9093c56763	0.92	PubMed	17759691	The activation of reelin signaling may inhibit excitotoxic neurotransmission and Tau phosphorylation, and may activate neurogenesis.	p(HGNC:RELN)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
b3e72f59-319c-4177-931a-3e9093c56763	0.92	PubMed	18236197	Previously we demonstrated that Reelin obtained from SH-SY5Y cells treated with Abeta42 fails to reduce tau phosphorylation XREF_BIBR.	p(HGNC:RELN)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
b3e72f59-319c-4177-931a-3e9093c56763	0.92	PubMed	17878579	The reelin pathway that inhibits Tau protein phosphorylation, proposed as a protective mechanism against AD [XREF_BIBR], has been found to be overexpressed in CM-R mice together with other genes involved in neurogenesis, suggesting that CM-S mice are less efficient in repairing neuronal damage [XREF_BIBR].	p(HGNC:RELN)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
09277415-2c97-42a7-9db0-839131aea1e4	0.65	PubMed	18206977	Decreased ROCK1 protein levels reduced PTEN phosphorylation at Ser380/Thr382/Thr383, and increased tau phosphorylation at Ser396 (XREF_FIG).	p(HGNC:ROCK1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
2c30fe75-2f51-47f3-86df-2c9e490fe62d	0.65	PubMed	17079908	The model shows that reducing the burden of Abeta reduces levels of ROS, which leads to less DNA damage, lower p53 activity, lower GSK3beta activity, and reduced tau phosphorylation.	p(HGNC:ROS1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
bff4700b-29f1-4c20-9d39-3d0c4fe575ab	0.65	PubMed	17051677	Rapamycin has been reported to decrease tau phosphorylation at Ser214 in vitro and reduce tau tangles and insoluble tau in vivo [XREF_BIBR, XREF_BIBR].	a(CHEBI:9168)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
2751205e-f84b-45c8-8380-894856e91158	0.65	PubMed	9552694	Ginsenoside Rbl markedly attenuated tau protein hyperphosphorylation through JNK and p38 MAPK pathway.	p(UP:Q9PVW8)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7297b595-51d6-46f9-9204-b929456dfd82	0.65	PubMed	20155224	To assay the requirement of GSK-3 and CDK5 in KA induced tau hyperphosphorylation, we deployed SB216763 (SB, a GSK-3 specific inhibitor) and roscovitine (Ros, a CDK5 specific inhibitor) in KA treated primary hippocampal neurons, and found that both SB and Ros inhibited tau hyperphosphorylation.	a(CHEBI:26523)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
62e516cf-cf10-4a6a-a424-e8f4c0814f9a	0.86	PubMed	12442764	Overexpression of S100A1 in COS-7 cells induced dephosphorylation of Tau.	p(HGNC:S100A1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
62e516cf-cf10-4a6a-a424-e8f4c0814f9a	0.86	PubMed	22399290	Overexpression of S100A1 in COS-7 cells induced dephosphorylation of Tau.	p(HGNC:S100A1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
43ccd6f5-1a35-4510-b953-144228c9ab7c	0.65	PubMed	13412801	In cells, a CagA peptide specifically and significantly inhibited tau phosphorylation at Ser (2) 6 (2) mediated by MARK4 but not other MARK isoforms.	p(HGNC:S100A8)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser))
7224d084-f48f-4bad-a163-e033110c0921	0.65	PubMed	18093249	Transgenic expression of Saa3 attenuates tau hyperphosphorylation.	p(UP:P19453)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
5c630ee6-0069-4b5d-a0d0-0ea274a83ebc	0.65	PubMed	22054838	We investigated whether loss of SelS expression would promote phosphorylation of tau under various conditions of ER stress.	p(HGNC:SELENOS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
079fbbda-488e-4b62-a34d-6301a0d433d1	0.92	PubMed	16872759	In addition, LP treatment significantly reduced tau phosphorylation (p-tau (Ser 396)), as determined by IHC (XREF_FIG) and tau phosphorylation (p-tau (Ser 396, Ser 404, Thr 181 and Thr 231)), as determined by WB (XREF_FIG).	p(HGNC:SEPSECS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
079fbbda-488e-4b62-a34d-6301a0d433d1	0.92	PubMed	16872759	In 3XTg-AD mice, 28-week LP treatment significantly reduced tau phosphorylation (p-tau (Thr 231)) in CA1 as determined by IHC (XREF_FIG).	p(HGNC:SEPSECS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
079fbbda-488e-4b62-a34d-6301a0d433d1	0.92	PubMed	16872759	Chronic LP treatment reduces tau phosphorylation through inhibition of GSK3beta in Tg2576 and 3XTg-AD mice.	p(HGNC:SEPSECS)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
f60c0498-9b7c-445f-9748-3cc6b2659739	0.65	PubMed	PMC18518820	It is noteworthy that in a mouse model of AD, treatment with nicotinamide, an inhibitor of Sir2, a class III HDAC member, also caused tau dephosphorylation at T231, which was partially responsible for cognitive improvements following the treatment ( xref ).	p(PFAM:PF02146)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
054491c7-6f0e-47a6-b59a-48e999d05feb	0.65	PubMed	14574429	Moreover, AST inhibited production of p53 and phosphorylation of tau by modulation of the Bcl-2 and Bax ratio.	p(HGNC:SLC17A5)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
72c759d1-148f-4b83-aa70-2fbba646e318	0.65	PubMed	11440755	In mouse brain, ablation of alpha-synuclein function significantly suppresses Tau phosphorylation at Ser (262).	p(HGNC:SNCA)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser))
c2561315-e135-4a55-98fa-a02b9ba031a5	0.65	PubMed	12179092	The Sod1 deletion also caused Tau phosphorylation and the lower levels of synaptophysin.	p(HGNC:SOD1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
ae5d0c8d-8240-4529-8d63-ef0ba9a9e4f8	0.65	PubMed	18734048	As shown in XREF_FIG, intravenous administration of the JNK inhibitor SP600125 significantly attenuated cerebral ischemia induced hyperphosphorylation of tau in CA1 region at 24 hr after cerebral ischemia, suggesting that JNK and c-Jun activation, which is important for induction of Dkk1, is critical for hyperphosphorylation of tau following cerebral ischemia.	a(CHEBI:90695)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
348a6cc6-4e23-4ca5-8666-da2bc558748b	0.65	PubMed	11191375	Both SPRED1 and SPRED2 inhibit the ability of DYRK1A to phosphorylate its substrates, Tau and STAT3.	p(HGNC:SPRED1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
81f94b86-7ec3-45ef-a732-4afd0d0a673a	0.65	PubMed	13045617	Depletion of SRPK2 in dentate gyrus inhibits tau phosphorylation in APP and PS1 mouse and alleviates the impaired cognitive behaviors.	p(HGNC:SRPK2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
44b36740-8e06-4519-99c0-adfe550f795e	0.86	PubMed	18496725	The ascending order of control < LSP < MSP and SSP potentiated the phosphorylation of CREB and GSK and inhibited Tau phosphorylation in the hippocampus which in turn inhibited beta-amyloid accumulation.	a(PUBCHEM:7848)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
44b36740-8e06-4519-99c0-adfe550f795e	0.86	PubMed	15035222	The ascending order of control < LSP < MSP and SSP potentiated the phosphorylation of CREB and GSK and inhibited Tau phosphorylation in the hippocampus which in turn inhibited beta-amyloid accumulation.	a(PUBCHEM:7848)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
fa3c6a34-3fe4-4ede-a6e0-fe36eb196fdf	0.65	PubMed	13905167	Our result showed that a single injection of geniposide (50muM, 10muL) to the lateral ventricle prevented STZ induced spatial learning deficit by about 40% and reduced tau phosphorylation by about 30% with Morris water maze test and quantitative immunohistochemical analysis, respectively.	p(HGNC:ST3GAL4)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7e208c01-9b87-4519-a87b-097a11e3cf39	0.65	PubMed	17285176	Knocking-down Stk25 expression reduces Tau phosphorylation, and as we have recently shown, Stk25 regulates neuronal polarization and Golgi morphology in a competitive manner with Reelin-Dab1 signaling XREF_BIBR.	p(HGNC:STK25)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
99eaf4c6-9e8b-4fc3-b4e3-7c5a2731a1e8	0.65	PubMed	PMC3443418	Protein phosphatase-2A was able to dephosphorylate the abnormally phosphorylated tau at Ser-46, Ser-199, Ser-202, Ser-396 and Ser-404, but not at Ser-235 (the amino acids are numbered according to the largest isoform of human tau, tau441).	p(HGNC:SULT2A1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 46))
3cb3af00-f8a0-4842-8da9-05ed72145d67	0.92	PubMed	18273361	To determine the causal relationship between changes in pTau and PIP 2 / synj1 levels after TBI, we tested if down-regulation of synj1 prevented blast induced Tau hyper-phosphorylation.	p(HGNC:SYNJ1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3cb3af00-f8a0-4842-8da9-05ed72145d67	0.92	PubMed	18273361	We next investigated if synj1 down-regulation reduces Tau phosphorylation through inhibition of either of these two Tau kinases (GSK3beta and CDK5).	p(HGNC:SYNJ1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3cb3af00-f8a0-4842-8da9-05ed72145d67	0.92	PubMed	18273361	Together, our results suggest that synj1 down-regulation abolishes dysregulation of PIP 2 levels and hyper-phosphorylation of Tau in response to blast injury exposure in ApoE4 mice.	p(HGNC:SYNJ1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
53549c8e-fa68-4da5-8084-d7e7e716e1d4	0.86	PubMed	18087198	For in vivo studies, SCM-198 significantly enhanced cognitive performances of rats 12days after intrahippocampal injections of aged Abeta 1-40 peptides in the Morris water maze (MWM), accompanied by less hippocampal microglial activation, decreased synaptophysin loss and phosphorylation of ERK and tau.	p(HGNC:SYP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
53549c8e-fa68-4da5-8084-d7e7e716e1d4	0.86	PubMed	14588159	For in vivo studies, SCM-198 significantly enhanced cognitive performances of rats 12 days after intrahippocampal injections of aged Abeta (1-40) peptides in the Morris water maze (MWM), accompanied by less hippocampal microglial activation, decreased synaptophysin loss and phosphorylation of ERK and tau.	p(HGNC:SYP)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
6855bc95-a188-454f-bfbc-04da2b957068	0.65	PubMed	12279113	We found that S-adenosylmethionine reduced amyloid production, increased spatial memory in TgCRND8 mice and inhibited the upregulation of B vitamin deficiency induced PSEN1 and BACE1 expression and Tau phosphorylation in TgCRND8 and wild-type mice.	a(PUBCHEM:16757548)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
182ef432-77f9-4163-be15-97736fdfe086	0.65	PubMed	18895604	S-nitrosoglutathione Reduces Tau Hyper-phosphorylation and Provides Neuroprotection in Rat Model of Chronic Cerebral Hypoperfusion.	a(PUBCHEM:104858)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
a7c60579-00b3-469a-a12e-27fe03550348	0.65	PubMed	14756136	In K5, T4 suppressed tau phosphorylation at two developmentally regulated sites as well as phosphorylation of c-jun N-terminal kinase (JNK) necessary for its activation and localization to axons.	a(PUBCHEM:5819)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
218bac72-1a41-45eb-a038-15f55162d608	0.65	PubMed	17859095	Hyperphosphorylated tau can also be dephosphorylated by PP5 and other PPP family members [XREF_BIBR, XREF_BIBR], preventing the misfolded state [XREF_BIBR - XREF_BIBR] that is relevant for the development of neurofibrillar tangles in tauopathies such as Alzheimer 's disease (AD) [XREF_BIBR - XREF_BIBR].	p(HGNC:TFPI2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph), pmod(Ph))
c8bfeb79-40da-4db7-a668-b9994d291924	0.65	PubMed	18942477	Tau is dephosphorylated by protein phsophatase 2A (PP2A), and to lesser effect by PP1, PP2B and PP5.	p(HGNC:TFPI2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ala, 2))
d1b8032a-99b4-4e0f-acdf-3e5e39671399	0.65	PubMed	18640938	Furthermore, either TLR4 or IL1R1 deficiency blocked the enhanced MAPT phosphorylation observed upon LPS administration, demonstrating that LPS induced MAPT phosphorylation is acting through a canonical inflammatory pathway mediated in part by IL1.	p(HGNC:TLR4)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
ae841ab7-5903-4f91-89ab-bd7585ee423f	0.65	PubMed	17824030	However, TREM2 deficiency not only ameliorated amyloid pathology but also reduced reactive astrocyte accumulation and MAPT hyperphosphorylation.	p(HGNC:TREM2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1b852031-3644-4222-8604-2fddbaed48f3	0.65	PubMed	18813146	In contrast, over-expression of either TS2 or TS3 inhibited tau phosphorylation under stimulation by SEMA3A (XREF_FIG).	p(UP:Q8SRG2)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8b700e9c-4f7f-4e90-a475-79a2e3b6df8f	0.65	PubMed	8201962	Tungstate reduces tau phosphorylation only in primed sequences, namely, those prephosphorylated by other kinases before GSK3beta modification, which are serines 198, 199, or 202 and threonine 231.	a(PUBCHEM:24465)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
0fcaa89a-7bdf-436c-96ea-2c3d9725c541	0.65	PubMed	15609599	All the results presented that both inhibition of the activity and expression of UCH-L1 induced the decreased microtubule binding ability and increased phosphorylation of tau protein.	p(HGNC:UCHL1)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
6b904484-6ba9-4766-87a0-1eba67cb7d08	0.65	PubMed	21251653	However, it is our view that the effects of VPA on Wnt dependent gene expression are unlikely to be due to inhibition of GSK-3beta since VPA does not inhibit phosphorylation of beta-catenin (or tau protein or a peptide derived from glycogen synthase) in vitro and does not stabilize beta-catenin protein in vivo (<ce:cross-ref refid="BIB204"> Phiel et al., 2001 </ce:cross-ref>; unpublished data).	a(CHEBI:39867)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
b4bfd882-d199-431d-bab3-af5a7f953f22	0.65	PubMed	12901373	Furthermore, we found that the novel HDACI W2 decreased tau phosphorylation at Thr181, an effect previously unknown for HDACIs.	p(PFAM:PF02020)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
8f424fef-fcb9-4968-8e79-1a666eba888d	0.65	PubMed	17209226	Suppression of WOX1 expression by small interfering RNA spontaneously induces Tau phosphorylation in neuroblastoma cells XREF_BIBR, suggesting a role of WOX1 in controlling Tau tangle formation.	p(HGNC:WWOX)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
19d9ffa5-43f0-4a70-935c-4c39a38cae00	0.65	PubMed	9652153	We found that a variety of Wnt and PI3K inhibitors, significantly increased tau phosphorylation at the PHF-1 site, induced the disarrangement of the microtubule network and the accumulation of tau within cell bodies.	p(FPLX:Wnt)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
14a22200-2e7e-46d9-8a7c-9ee350e9920c	0.65	PubMed	20105492	These findings indicated that 14-3-3zeta combing with tau can prevent the over phosphorylation of tau and can be disturbed by Al-exposure due to Al3+ binding to 14-3-3zeta, which could account for the mechanisms underlying Al-neurotoxicity related to AD.	p(HGNC:YWHAZ)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
eabee242-89a7-4b93-bc82-12b98b06ca85	0.95	Other	sparser:Unknown	Treatment of isolated PHF with alkaline phosphatase dephosphorylated PHF-tau at Ser&quot;9/Sere 2 as determined by Western blots of the phosphatase-treated and untreated PHF with antibody Tau-1 (Fig. 1).	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
eabee242-89a7-4b93-bc82-12b98b06ca85	0.95	Other	sparser:Unknown	Dephosphorylation of PHF-tau by alkaline phosphatase on Western blots has also been observed previously [12].	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
eabee242-89a7-4b93-bc82-12b98b06ca85	0.95	Other	sparser:Unknown	Immunocytochemical and Western blot analyses using phosphorylation-sensitive tau antibodies showed that HNE treatment causes a moderate increase in basal levels of tau phosphorylation, and prevents tau dephosphorylation by alkaline phosphatase in neurons pretreated with the phosphatase inhibitor okadaic acid.	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
eabee242-89a7-4b93-bc82-12b98b06ca85	0.95	Other	sparser:Unknown	Interestingly, the dephosphorylation of secreted tau by tissue-non-specific alkaline phosphatase could potentiate its high-affinity binding to muscarinic receptors of nearby neurons ( xref ), thus accounting for the “clustering” lesion spread patterns characteristically seen in tauopathies ( xref , xref , xref ).	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
eabee242-89a7-4b93-bc82-12b98b06ca85	0.95	PubMed	PMC4478555	Immunocytochemical and Western blot analyses using phosphorylation-sensitive tau antibodies showed that HNE treatment causes a moderate increase in basal levels of tau phosphorylation, and prevents tau dephosphorylation by alkaline phosphatase in neurons pretreated with the phosphatase inhibitor okadaic acid.	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
eabee242-89a7-4b93-bc82-12b98b06ca85	0.95	Other	sparser:Unknown	Tau dephosphorylated by alkaline phosphatase migrated more rapidly on sodium dodecyl sulfate-polyacrylamide gels and also showed an altered two-dimensional NEPHGE pattern.	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
eabee242-89a7-4b93-bc82-12b98b06ca85	0.95	Other	sparser:Unknown	When tau is dephosphorylated by alkaline phosphatase, it becomes shorter and more elastic; when it is phosphorylated by Ca++/calmodulin-dependent kinase, it becomes longer and stiffer.	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8b288ca9-25bb-4519-a7e9-0f920f7c6f6f	0.94	PubMed	21017277	Dephosphorylation of PHF-tau by alkaline phosphatase on Western blots has also been observed previously [12].	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8b288ca9-25bb-4519-a7e9-0f920f7c6f6f	0.94	PubMed	21015859	PHF-tau and in vitro phosphorylated tau have lower activity to stimulate mi- crotubule assembly as compared to normal tau, while dephosphorylation of PHF-tau by alkaline phosphatase can recover this activity [5,6].	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8b288ca9-25bb-4519-a7e9-0f920f7c6f6f	0.94	PubMed	820490	Tau dephosphorylated by alkaline phosphatase migrated more rapidly on sodium dodecyl sulfate-polyacrylamide gels and also showed an altered two-dimensional NEPHGE pattern.	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8b288ca9-25bb-4519-a7e9-0f920f7c6f6f	0.94	PubMed	1422371	When tau is dephosphorylated by alkaline phosphatase, it becomes shorter and more elastic; when it is phosphorylated by Ca+ +/calmodulin-dependent kinase, it becomes longer and stiffer.	p(PFAM:PF00245)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
e0ccdb30-483b-418a-9022-cebefee21b42	0.65	Other	sparser:Unknown	The most important phosphatase that is capable of dephosphorylating Tau at AD specific phospho-sites is protein phosphatase 2 A (PP2A).	p(UP:B6EMS7)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
57455b53-48b4-4b90-8b78-f3cbfcabffde	0.65	PubMed	16232265	Long-term oral administration of baicalein inhibited 12/15LO and GSK3beta activity, reduced beta-secretase enzyme (BACE1), decreased the concentration of total Abeta, and prevented phosphorylation of tau in APP and PS1 mice.	a(PUBCHEM:5281605)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
6c57e5f7-5a95-47b2-b934-bad15a12d329	0.65	PubMed	18461377	In consideration that degradation of hyperphosphorylated tau by the proteasome is inhibited by the actions of Abeta, berberine may decrease the hyperphosphorylation of tau by limiting the actions of Abeta.	a(CHEBI:16118)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
b95378f5-f192-4ce6-a404-db96e7f11967	0.65	PubMed	10063688	In addition, the neuroprotective mechanisms of caffeic acid against Abeta attenuated intracellular calcium influx and decreased tau phosphorylation by the reduction of GSK-3beta activation.	a(PUBCHEM:1549111)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4b60f511-f2c3-4674-a1d9-1f0ef51a09eb	0.65	PubMed	16023405	We also found that calycosin treatment significantly stimulated Akt phosphorylation and decreased GSK-3beta and tau phosphorylation, and that these changes could be restored by the PI3K and Akt inhibitor LY294002.	a(PUBCHEM:86289448)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9f4e651a-4631-47c9-bc75-8d08cc2fe7c4	0.65	PubMed	5714647	In neurons a nonspecific muscarinic agonist, carbachol, reduced tau phosphorylation.	a(PUBCHEM:5831)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
b1c8b9e8-6d5a-4531-9893-a9be983612cb	0.95	Other	sparser:Unknown	The results have shown that CN directly dephosphorylates all of those sites of tau protein.	p(UP:A1Z746)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
b1c8b9e8-6d5a-4531-9893-a9be983612cb	0.95	PubMed	6359315	The results have shown that CN directly dephosphorylates all of those sites of tau protein.	p(UP:A1Z746)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
b1c8b9e8-6d5a-4531-9893-a9be983612cb	0.95	PubMed	PMC6359315	The results have shown that CN directly dephosphorylates all of those sites of tau protein.	p(UP:A1Z746)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
b59c35d4-4ff1-4cba-87e7-5d308af9589c	0.65	PubMed	18386601	In human neuroblastoma cells, excess copper promoted tau phosphorylation and a copper complexing agent, tetrathiomolybdate, attenuated tau phosphorylation.	a(CHEBI:29036)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
84f29f31-922d-4753-a81a-beba0cf90185	0.65	PubMed	12511428	While total tau protein levels were unaltered between the two groups, we found that dexamethasone significantly reduced tau phosphorylation at specific sites that were mediated by decreases in glycogen synthase kinase-3beta protein level activity.	a(CHEBI:41879)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
974d9437-38d2-4d1e-a223-31fe3dde7e7f	0.65	PubMed	18438111	The potential ability of DHA to reduce caspase activation [XREF_BIBR, XREF_BIBR], Abeta peptide accumulation, and Tau hyperphosphorylation [XREF_BIBR, XREF_BIBR] also strongly supports the notion that DHA deficiency, as a result of iPLA 2 deficiency, could represent a precursor event that could initiate the cellular manifestations of AD pathology.	a(CHEBI:207229)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
073615dd-d700-4968-9aa6-d4d40929c216	0.65	PubMed	18509032	As expected, diosmetin also enhanced the level of inhibitory phospho-GSK-3beta (Ser9) and reduced tau phosphorylation in HeLa and tau cells, as determined by WB.	a(CHEBI:4630)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
38b0bb0f-05ce-42b5-89f0-1b3c6fa79adf	0.65	PubMed	15621424	The data showed that docosahexaenoic acid administration substantially reduced tau hyperphosphorylation (t = 4.111, p < 0.05), improved cognition (t = 6.532, p < 0.001), and inhibited C/EBP homology protein activation (t = 5.631, p < 0.01).	a(PUBCHEM:445580)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
ce5b9365-3290-43bd-a7ae-7a1a4ac30e27	0.65	PubMed	13581236	Moreover, hyperphosphorylation of tau resulting from intracerebroventricular streptozotocin (ICV-STZ) injection was decreased by the administration of edaravone.	a(PUBCHEM:70335)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
0f40a840-3ee4-41de-849b-0efa7270f350	0.86	PubMed	18213726	Similarly controversial, while estrogen decreases the hyperphosphorylation of tau in a ER dependent manner XREF_BIBR supporting the observation that females have more affected brain regions with NFTs than males XREF_BIBR and show more severe early tau alterations in the nucleus basalis of Meynert XREF_BIBR, a recent study demonstrated that overexpression of ERalpha caused tau hyperphosphorylation and aggregation XREF_BIBR.	a(CHEBI:50114)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
0f40a840-3ee4-41de-849b-0efa7270f350	0.86	PubMed	18766842	XREF_BIBR In the laboratory, estrogen reduces beta-amyloid formation, diminishes hyperphosphorylation of tau protein, and increases apolipoprotein expression.	a(CHEBI:50114)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d17e8c9b-dc1a-4865-8ce3-84075892a14a	0.86	PubMed	7783142	These results indicate that OA induced hyperphosphorylation of Tau protein in rat hippocampal neurons can be attenuated by the pretreatment of ginsenoside Rb1.	a(PUBCHEM:9898279)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d17e8c9b-dc1a-4865-8ce3-84075892a14a	0.86	PubMed	18444756	In addition, pretreatment of ginsenoside Rb1 can attenuate amyloid beta induced phosphorylation of tau protein (Li et al., 2005; Xie et al., 2007; Chen et al., 2008; Jia et al., 2011).	a(PUBCHEM:9898279)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
6dee5cd9-eb09-4195-8683-0c3c6c3ad303	0.65	PubMed	13107021	In this study, we showed that ginsenoside Rd pretreatment inhibited tau phosphorylation at multiple sites in beta-amyloid (Abeta)-treated cultured cortical neurons, and in vivo in both a rat and transgenic mouse model.	a(PUBCHEM:11679800)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7e6a801c-ed8b-4646-ba5c-c517c6f9f1e9	0.65	PubMed	14685182	These results suggest that ginsenoside Rg1 upregulates brain derived neurotrophic factor expression and inhibits Tau protein phosphorylation in brain slices from a rat model of Alzheimer 's disease.	a(PUBCHEM:441923)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
675b67f3-45a4-4f19-977e-436354c069ce	0.95	PubMed	PMC3318329	These findings demonstrate that glutamate and colchicine induce tau dephosphorylation, as opposed to increased tau phosphorylation, which would be more indicative of Alzheimer-type neurodegeneration.	a(CHEBI:29987)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
675b67f3-45a4-4f19-977e-436354c069ce	0.95	PubMed	PMC5010273	Glutamate but not IL-6 induced a dephosphorylation of tau.	a(CHEBI:29987)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
675b67f3-45a4-4f19-977e-436354c069ce	0.95	Other	sparser:Unknown	Glutamate but not IL-6 induced a dephosphorylation of tau.	a(CHEBI:29987)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
675b67f3-45a4-4f19-977e-436354c069ce	0.95	Other	sparser:Unknown	Both glutamate and colchicine caused the dephosphorylation of tau. ss-amyloid peptide appeared to increase tau degradation rather than affect phosphorylation.	a(CHEBI:29987)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
675b67f3-45a4-4f19-977e-436354c069ce	0.95	Other	sparser:Unknown	These findings demonstrate that glutamate and colchicine induce tau dephosphorylation, as opposed to increased tau phosphorylation, which would be more indicative of Alzheimer-type neurodegeneration.	a(CHEBI:29987)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
6e519b6a-7f11-4c2a-a45e-1396ff9af9d9	0.65	PubMed	19807812	Additionally, the pretreatment of glycyrrhizin reduced the postoperative neuroinflammation (production of pro inflammatory cytokines including IL-1beta, TNF-alpha, and IL-6 as well as NF-kappaB nuclear expression) and Alzheimer 's-related pathology (Tau phosphorylation at the site of AT-8 and Ser396 as well as Abeta40 and 42 concentrations) in the hippocampus of the aged mice undergoing splenectomy surgery.	a(PUBCHEM:5460305)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
9a60f785-a0ba-412c-8f8e-46984f563d73	0.65	PubMed	18922607	Our present studies have shown that GSPE treatment significantly reduced tau phosphorylation at the epitopes known to be substrates for specific tau kinases.	p(UP:P45759)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
bcd9b391-32b8-4eeb-9456-823524b27abe	0.65	PubMed	8880508	hAPP tg mice that were treated with lithium or that were crossed with DN-GSK3beta tg mice displayed improved performance in the water maze, preservation of the dendritic structure in the frontal cortex and hippocampus, and decreased tau phosphorylation.	p(UP:P14163)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
d661bf1b-369b-4a54-a504-08e98ef2b600	0.65	PubMed	17152488	Later, a study carried out by McKee et al. [XREF_BIBR] showed that ibuprofen treatment decreased TAU phosphorylation in 3xtg AD mice.	a(PUBCHEM:3672)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
20644e2e-3297-442c-b4e8-3a81b66940a2	0.65	PubMed	18173238	Nevertheless, LBM could totally prevent the increased phosphorylation of tau at ser396 while reducing the development of dyskinesia.	p(UP:Q24188)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
64a20193-0066-4877-897e-180d049a87a1	0.65	PubMed	16587672	Moreover, linagliptin also improves brain incretin levels and attenuates amyloid beta, tau phosphorylation as well as neuroinflammation.	a(PUBCHEM:10096344)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
cb4ec5b1-338e-4d08-904a-eb4a0d076887	0.65	PubMed	18039702	The use of a GSK3beta inhibitor (lithium) caused a similar reduction of TAU Thr231 phosphorylation in both DUSP22 shRNA depleted (0.7 +/- 0.12) and transfected SK-N-BE (2) (0.5 +/- 0.13) cells (XREF_FIG d).	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
08ecec3d-0727-42c9-bebd-7966d8ce7c73	0.65	PubMed	17606647	In addition, magnesium sulfate markedly decreased tau hyperphosphorylation at multiple AD sites in sAD rats by improving insulin sensitivity, and increasing the inhibitory phosphorylated GSK-3beta (ser 9) through the activation of PI3K and Akt.	a(PUBCHEM:24083)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
f8c3053c-13a1-451e-b797-d60029b4a350	0.65	PubMed	15148126	Chronic melatonin treatment attenuated the hyperphosphorylation of tau protein via PI3K/Akt/GSK3beta signaling by activating the p-PI3K, p-Akt (Ser 473) and p-GSK3beta (Ser9) in the Abeta1-42-treated mice.	a(CHEBI:16796)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
713ac4b6-29c9-4879-a4e8-17a171037bdf	0.65	PubMed	18045856	Consistent with this, more recent studies showed that in primary mouse cortical neurons, Ca 2+ / calmodulin dependent protein kinase beta (CaMKKbeta) activation of AMPK in response to Abeta 1-42 led to increased phosphorylation of tau at Ser262 and Ser356 and Ser396, which was blocked by memantine [XREF_BIBR].	a(PUBCHEM:4054)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
ecea7dad-7623-4e10-a9b1-3e75fd66975d	0.65	PubMed	18695431	However, metformin attenuated tau phosphorylation at Ser396 and Thr231 but did not attenuate the decrease of PP2A C subunit expression in the hippocampus of db/db mice.	a(CHEBI:6801)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
f2dbe244-5109-415d-b932-21f93e38205c	0.65	PubMed	17087465	In the PAR-1 knockdown background, milton knockdown did not increase tau phosphorylation levels at Ser262 (XREF_FIG), indicating that PAR-1 mediates the increase in tau phosphorylation at Ser262 caused by milton knockdown.	p(PFAM:PF12448)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
0267c45b-61ba-4caa-b5d6-27a887d69de5	0.94	PubMed	13721816	These results showed that minocycline decreased expression of Abeta protein and lowered the phosphorylation of tau protein, and retarded the proinflammatory cytokines, but not amyloid precursor protein.	a(PUBCHEM:51537604)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
0267c45b-61ba-4caa-b5d6-27a887d69de5	0.94	PubMed	16986024	XREF_BIBR, XREF_BIBR The results from this research found that minocycline strongly limited the phosphorylation of tau protein, including TG3 (pT231), pS214, and PHF-1 (pS396 and pS404), but not total tau.	a(PUBCHEM:51537604)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
0267c45b-61ba-4caa-b5d6-27a887d69de5	0.94	PubMed	16986024	These results showed that minocycline decreased expression of Abeta protein and lowered the phosphorylation of tau protein, and retarded the proinflammatory cytokines, but not amyloid precursor protein.	a(PUBCHEM:51537604)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
0267c45b-61ba-4caa-b5d6-27a887d69de5	0.94	PubMed	16986024	These results noted that minocycline decreased the levels of the inflammatory markers and Abeta, and inhibited the hyperphosphorylation of tau in the hippocampus of rats with DM.	a(PUBCHEM:51537604)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
7b1e6c24-4c68-4ac4-bf37-387a2b56b662	0.65	PubMed	15871522	Upregulation of O GlcNAcylation in metabolically active rat brain slices by O-(2-acetamido-2-deoxy-d-glucopyranosylidenamino) N-phenylcarbamate (PUGNAc), an inhibitor of N-acetylglucosaminidase, increased the phosphorylation of tau at the PKA site, Ser214, but not at the non PKA site, Thr205.	p(UP:P40406)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
96f28f51-5031-44db-b19b-349ccdfa2a8d	0.65	PubMed	19690584	These results indicate that oxygen deprivation causes dephosphorylation of tau, while GD and OD differentially affect distribution of total tau and tau phosphorylation variants in neuronal compartments by activating different mechanisms.	a(CHEBI:25806)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3a996360-d1df-41d6-91a6-3e0724d5795b	0.65	PubMed	18734048	17beta-Estradiol attenuates hyperphosphorylation of tau following cerebral ischemia by attenuating JNK-c-Jun-Dkk1 signaling.	a(PUBCHEM:5757)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
4dc5ee9c-bcc2-40e4-8511-99a3ccbe6405	0.65	PubMed	18365645	At this concentration, phenformin significantly reduced tau phosphorylation in primary cortical neurons, while buformin did not have any effect on tau phosphorylation levels.	a(CHEBI:8064)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
07bb3164-9b4a-4b94-9fbc-d4b2ab0ce327	0.65	PubMed	17245783	The lowering of tau phosphorylation by pioglitazone treatment in insulin resistant animals indicates that human APOEepsilon3 is the isoform most responsive to treatment.	a(PUBCHEM:4829)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
19515779-766f-44e1-9f50-e60a30189caf	0.65	PubMed	15715085	Herein, we demonstrate that curcumin encapsulated poly (lactide-co-glycolide) (PLGA) 50:50 nanoparticles (NPs-Cur 50:50) are able to prevent the phosphorylation of Akt and Tau proteins in SK-N-SH cells induced by H2O2 and display higher anti-inflammatory and antioxidant activities than free curcumin.	a(PUBCHEM:23111554)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1389737c-c890-4160-a688-4d1743c604aa	0.65	PubMed	12837191	Both propofol and MK-801 could protect against the impairment of learning-memory and reduce the hyperphosphorylation of Tau protein induced by ECT in depressed rats.	a(PUBCHEM:4943)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
3299f2bf-6a48-4bc2-b8bc-75a3b5815876	0.65	PubMed	18861114	For example, it has been reported that rapamycin could decrease tau phosphorylation at Serine 214 via the regulation of cAMP dependent kinase, leading to less build-up of hyper-phosphorylated tau [XREF_BIBR].	a(CHEBI:9168)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
d3a79cfa-89a8-49f5-9b23-686860e8752a	0.65	PubMed	19849177	Here we show that resveratrol, a polyphenol, significantly induces PP2A activity and reduces Tau phosphorylation at PP2A dependent epitopes.	a(CHEBI:27881)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
415c6ea2-02ec-48ab-b48a-2bd0c2965f4d	0.65	PubMed	11185296	Interestingly, rosiglitazone reduced tau phosphorylation only in the hippocampus of OLETF type 2 diabetes rats, and not in that of STZ injected type 1 diabetes mice.	a(CHEBI:50122)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
8236cd9f-78c6-4be2-a645-38e5b5a53141	0.65	PubMed	18276240	It is of worth mentioning that as compared to vanillin, rutin inhibits the phosphorylation of tau to a greater extent (as shown by histogram 2 in Fig.	a(CHEBI:28527)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1b5e73b4-1784-4068-80d5-2af81aa11200	0.94	PubMed	18441440	Experimental studies have shown that sodium selenate reduces Tau phosphorylation, both in cell culture and in mouse models of the disease [XREF_BIBR - XREF_BIBR].	a(PUBCHEM:26473)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1b5e73b4-1784-4068-80d5-2af81aa11200	0.94	PubMed	16256053	Sodium selenate treatment increased PP2A and PR55, and decreased tau phosphorylation, brain damage, and cognitive and motor impairments in rats given repeated mild traumatic brain injuries.	a(PUBCHEM:26473)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1b5e73b4-1784-4068-80d5-2af81aa11200	0.94	PubMed	12240798	In vitro, sodium selenate reduced tau phosphorylation in human neuroblastoma cells and reversed the increase in tau phosphorylation induced by the PP2A inhibitor, okadaic acid.	a(PUBCHEM:26473)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
1b5e73b4-1784-4068-80d5-2af81aa11200	0.94	PubMed	22054838	We examined if SelS might have a role in the selenate induced reduction of tau phosphorylation.	a(PUBCHEM:26473)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
c53a143c-b566-4c81-9ea8-bc1cc8e57405	0.65	PubMed	10391890	Therefore, these results provide strong evidence that selenium treatment and SelM activate the ERK pathway to attenuate alpha and gamma-secretase-mediated proteolysis and Tau phosphorylation to protect brain function.	a(PUBCHEM:6326970)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
beb90517-d6fc-46f1-8581-0afb3b26eae1	0.65	PubMed	19094874	Our previous studies demonstrated that selenomethionine (Se-Met) was able to reduce beta-amyloid peptide (Abeta) deposition, decrease Tau protein hyperphosphorylation and markedly improve cognitive functions in triple transgenic (3xTg) AD mice.	a(PUBCHEM:15103)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
cf6a9109-c0a0-495d-a6d2-8ccd3acfd096	0.65	PubMed	18971445	The HDACi sodium 4-phenylbutyrate reduced tau phosphorylation and ameliorated spatial learning and memory deficits in the Tg2576 mouse model of AD.	a(PUBCHEM:5258)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
641e5e4c-06af-42d8-b911-e085c5ef5f0b	0.65	PubMed	19083482	Moreover, in these animals, sunitinib reduced the hyperactivation of CDK5, tau hyperphosphorylation, and p35 cleavage to p25.	a(PUBCHEM:5329102)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
dbebcb5e-7a92-46f1-9976-edc230a2d2f0	0.65	PubMed	17640395	Actually, we found that in SH-SY5Y cells Tau can be dephosphorylated by H 2 O 2 treatment but not by the superoxide generating agents paraquat and rotenone (data not shown).	a(CHEBI:18421)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
0c9634d8-f97f-42db-ba37-d9562735264f	0.86	PubMed	17409694	In addition, taxol reduced tau phosphorylation at Ser 262 by 2.1-fold in Ln-14-3-3zeta infected neurons (lane 4).	a(PUBCHEM:36314)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
0c9634d8-f97f-42db-ba37-d9562735264f	0.86	PubMed	17409694	Thus, taxol treatment reduced tau phosphorylation at Ser 262 and provided significant protection against downregulation of synaptophysin induced by 14-3-3zeta overexpression.	a(PUBCHEM:36314)	directlyDecreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
b83facaf-1cb6-4c2c-ac17-eaf8f028b7f6	0.65	PubMed	6180314	These findings demonstrate that testosterone prevents the hyperphosphorylation of tau by inhibiting the heat shock induced overactivation of GSK-3 beta and suggest that androgens given to aging men or, in combination with estrogens, to postmenopausal women could prevent or delay Alzheimer 's disease.	a(PUBCHEM:6013)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
90d5cf66-e0fe-4650-9bbc-5d496fa9518d	0.65	PubMed	18276240	These results are clearly suggesting that rutin and vanillin inhibits the phosphorylation of tau.	a(PUBCHEM:1183)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
54e63e3d-c606-49bf-a91a-037167931ff2	0.86	PubMed	17513150	Our findings demonstrated that wogonin inhibited amyloid precursor protein (APP) processing in the beta-secretase pathway, the phosphorylation of Tau protein, and Abeta aggregation in human neuroblastoma cells and exhibited protective effects on learning and memory impairments in the Morris water maze test, Y-maze, and the novel object recognition test of 3xTg-AD mice.	a(CHEBI:10043)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
54e63e3d-c606-49bf-a91a-037167931ff2	0.86	PubMed	14972794	In conclusion, our study identified a small molecule, wogonin, which could effectively promote Abeta clearance and decrease tau phosphorylation, and highlighted its therapeutic potential for AD treatment.	a(CHEBI:10043)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
f97aec61-7f16-4f4c-b72f-db9263f3abd8	0.65	PubMed	18656656	This observation was further corroborated by in vitro studies, in which by using primary neuronal cells we showed that zileuton decreased tau phosphorylation at the same epitopes and via a cdk-5-dependent mechanism.	a(PUBCHEM:60490)	directlyDecreases	p(HGNC:MAPT, pmod(Ph))
23e4c116-ee9a-4b45-a2f7-82a0621ba8cd	0.65	PubMed	16851072	We demonstrate here for the first time that Tau is deubiquitinated by Otub1.	p(HGNC:OTUB1)	directlyDecreases	p(HGNC:MAPT, pmod(Ub))
ceab3a61-aa85-4ea4-a03e-b6d4aea32497	0.95	PubMed	PMC6648356	The present study demonstrates that a balance exists between phosphorylation and O-GlcNAc glycosylation of Tau proteins, and furthermore that a dysfunction of this balance correlates with reduced nuclear localization.	p(HGNC:OGT)	directlyIncreases	p(HGNC:MAPT, pmod(Glyco))
ceab3a61-aa85-4ea4-a03e-b6d4aea32497	0.95	Other	sparser:Unknown	To study the effects of Xixin decoction (XXD) on O-GlcNAc transferase (OGT) and O-GlcNAc glycosidase in O-GlcNAc glycosylation of tau proteins in the brain of rats with sporadic Alzheimer's disease (SAD) and explore the possible mechanism.	p(HGNC:OGT)	directlyIncreases	p(HGNC:MAPT, pmod(Glyco))
ceab3a61-aa85-4ea4-a03e-b6d4aea32497	0.95	Other	sparser:Unknown	XXD can regulate the expression of OGT and O-GlcNAc glycosidase to enhance O-GlcNAc glycosylation of tau proteins in the hippocampus of SAD rats.	p(HGNC:OGT)	directlyIncreases	p(HGNC:MAPT, pmod(Glyco))
ceab3a61-aa85-4ea4-a03e-b6d4aea32497	0.95	Other	sparser:Unknown	O-GlcNAc glycosylation and expression of tau proteins were detected by O-GlcNAc-specific antibodies RL2 and CTD110.6.	p(HGNC:OGT)	directlyIncreases	p(HGNC:MAPT, pmod(Glyco))
ceab3a61-aa85-4ea4-a03e-b6d4aea32497	0.95	Other	sparser:Unknown	The present study demonstrates that a balance exists between phosphorylation and O-GlcNAc glycosylation of Tau proteins, and furthermore that a dysfunction of this balance correlates with reduced nuclear localization.	p(HGNC:OGT)	directlyIncreases	p(HGNC:MAPT, pmod(Glyco))
4c6ad8f3-d486-418f-83ea-36a9c24ca367	0.65	PubMed	16546302	Also CSF changes characteristic for AD e.g. decreased Abeta42, and increased Tau and phospho-Tau levels can be found in those MCI patients who will later develop AD.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT)
0c5b7157-6d19-4066-9d3f-caaaa5fe6319	0.65	PubMed	4292304	We thus conclude that increased levels of Abeta do not seem to increase the levels of tau in human fibroblasts.	p(HGNC:APP)	directlyIncreases	p(HGNC:MAPT)
00bf279f-eccd-4e29-bc82-b936935a7cd8	0.65	PubMed	16911717	Increased APP Gene Dosage and APP V717I Specifically Increase Neuronal Tau Protein Levels.	p(HGNC:APP, var(p.Val717Ile))	directlyIncreases	p(HGNC:MAPT)
64ae844b-d39b-4919-b522-cbff41649435	0.79	PubMed	21298039	No evidence text.	act(p(HGNC:APP), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
f2a1a821-3dc2-4656-aa84-902bb237a6c5	0.86	PubMed	9292436	Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.	p(HGNC:BAG1)	directlyIncreases	p(HGNC:MAPT)
f2a1a821-3dc2-4656-aa84-902bb237a6c5	0.86	PubMed	17954934	Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.	p(HGNC:BAG1)	directlyIncreases	p(HGNC:MAPT)
6c4ab239-037c-4c51-82b5-c2baaa9dd52a	0.86	PubMed	15436145	Overexpression of BAG2 in cold exposed undifferentiated cells restored levels of p-tau to those of 37degreesC undifferentiated control.	p(HGNC:BAG2)	directlyIncreases	p(HGNC:MAPT)
6c4ab239-037c-4c51-82b5-c2baaa9dd52a	0.86	PubMed	26208804	Overexpression of BAG2 in cold exposed undifferentiated cells restored levels of p-tau to those of 37degreesC undifferentiated control.	p(HGNC:BAG2)	directlyIncreases	p(HGNC:MAPT)
40b932fb-4145-44c7-9dbc-67a8fde5e6c2	0.92	PubMed	12321641	Moreover, BDNF promoted spine growth as well as tau protein over-expression.	p(HGNC:BDNF)	directlyIncreases	p(HGNC:MAPT)
40b932fb-4145-44c7-9dbc-67a8fde5e6c2	0.92	PubMed	17568351	In this study, we report that BDNF can increase tau protein expression in RA differentiated SH-SY5Y cells (XREF_FIG, XREF_FIG) as well as primary cultured E18 hippocampal neurons XREF_BIBR and shift the subcellular distribution away from the soma and toward the dendrites.	p(HGNC:BDNF)	directlyIncreases	p(HGNC:MAPT)
40b932fb-4145-44c7-9dbc-67a8fde5e6c2	0.92	PubMed	17568351	As revealed by immonocytochemistry, tau protein levels were elevated in RA treated cells compared to untreated controls (XREF_FIG), while subsequent application of BDNF further increased tau expression.	p(HGNC:BDNF)	directlyIncreases	p(HGNC:MAPT)
20652a61-373d-4b31-8e90-b7d9a1daa856	0.65	PubMed	23737459	Nilotinib and Bosutinib increased p-Tau levels in the lysosomes (142 and 136ng/mL, respectively) compared to DMSO (104ng/mL).	a(PUBCHEM:5328940)	directlyIncreases	p(HGNC:MAPT)
3d602e80-0d6e-40ba-824b-3e05670fc03e	0.65	PubMed	17458231	This possibility is supported by the expression of the tau and LacZ reporter driven by the transgenic E11 promoter in the CA1 and CA2 regions.	p(HGNC:CA1)	directlyIncreases	p(HGNC:MAPT)
88a5376e-a3f1-4f9c-908c-23e7df25714a	0.65	PubMed	20005921	Therefore, we hypothesized that CALHM1 P86L may modulate Abeta or tau levels in cerebrospinal fluid (CSF).	p(HGNC:CALHM1, var(p.Pro86Leu))	directlyIncreases	p(HGNC:MAPT)
c812d3ea-270f-4dcd-8450-af19f35359dc	0.65	PubMed	21319137	CD40L plus PN-MDM-conditioned media caused a significant <ce:italic> decrease </ce:italic> in Tau expression compared to neurobasal media and growth factor supplemented neurobasal media.	p(HGNC:CD40LG)	directlyIncreases	p(HGNC:MAPT)
a489d637-d95e-43aa-b33f-9eaf40847fdc	0.65	PubMed	18780705	In this model, the expression of a tauGFP fusion protein driven by the ChAT promoter, allows for the resolution of single cholinergic axons in order to examine responses to focal electrical stimulation.	p(HGNC:CHAT)	directlyIncreases	p(HGNC:MAPT)
982bbbae-d36d-41e2-a745-f3eeaf7763b2	0.65	PubMed	16623965	The result also suggest that the CNS can contribute to blood levels of tau, raising the possibility that, as suggested for other misfolded proteins, blood levels of tau proteins could be used as a biomarker of CNS disease.	a(PUBCHEM:11006)	directlyIncreases	p(HGNC:MAPT)
155504a9-3fea-49c8-8c0b-f49ff2a2b15c	0.86	PubMed	24116116	To address these limitations, RP-HPLC was utilized to enrich and concentrate tau from a large volume of pooled, denatured CSF thereby enabling analysis of the relatively low levels of tau by western blotting.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT)
155504a9-3fea-49c8-8c0b-f49ff2a2b15c	0.86	PubMed	11288988	A significant altered CSF biomarkers profile in a pure VD supports the use of CSF Abeta42, t-tau, and p-tau levels in the differential diagnosis of VD and AD.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT)
d30789dd-a21a-4b9d-9da1-0f1efd495c1a	0.94	PubMed	24853415	DAPK1 increases tau protein expression and stability in cells.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT)
d30789dd-a21a-4b9d-9da1-0f1efd495c1a	0.94	PubMed	24853415	We found that the DAPK1 significantly enhanced tau protein expression and stability in cell culture and mouse brain models.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT)
d30789dd-a21a-4b9d-9da1-0f1efd495c1a	0.94	PubMed	24853415	DAPK1 significantly increased exogenous tau protein levels compared with the vector control (XREF_FIG).	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT)
d30789dd-a21a-4b9d-9da1-0f1efd495c1a	0.94	PubMed	24853415	Given that DAPK1 increased tau protein levels but not transcription, the next question was whether DAPK1 might affect tau protein stability.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT)
5044e0de-e94d-499e-9a9f-114e9e646e8d	0.65	PubMed	19693268	Lentiviral shRNA knockdown of DDR1 and DDR2 reduces the levels of alpha-synuclein, tau, and beta-amyloid and prevents cell loss in vivo and in vitro.	p(HGNC:DDR2)	directlyIncreases	p(HGNC:MAPT)
ad5ecbe2-5d21-4a20-aa36-ec434454fdda	0.65	PubMed	21157558	</ce:para> <ce:para view="all"> NIP (8 mM) significantly increased basal levels of TAU but not those of GLU, glutamine (GLN) or arginine (ARG) (<ce:cross-ref refid="TBL1"> Table 1 </ce:cross-ref> <ce:float-anchor refid="TBL1"/>).	p(HGNC:DUOXA1)	directlyIncreases	p(HGNC:MAPT)
00cb5e32-ad65-414b-8462-38545fc3b453	0.94	PubMed	23948904	We found that Dyrk1A enhanced tau expression in a dose dependent manner.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT)
00cb5e32-ad65-414b-8462-38545fc3b453	0.94	PubMed	23948904	These results suggest that Dyrk1A enhances tau expression by stabilizing its mRNA and provides a novel insight into the regulation of tau expression and a molecular mechanism of tauopathies.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT)
00cb5e32-ad65-414b-8462-38545fc3b453	0.94	PubMed	13633121	These results suggest that Dyrk1A enhances tau expression by stabilizing its mRNA and provides a novel insight into the regulation of tau expression and a molecular mechanism of tauopathies.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT)
00cb5e32-ad65-414b-8462-38545fc3b453	0.94	PubMed	13633121	We found that Dyrk1A enhanced tau expression in a dose dependent manner.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT)
145308b1-18f6-4479-a0b4-d18e3ba3b0eb	0.65	PubMed	21262904	Not surprisingly, E2 increases the expression of tau and class II-beta-tubulin, both of which are involved in process growth <ce:cross-refs refid="BIB14 BIB43"> (Ferreira and Caceres, 1991; Rogers et al., 1993) </ce:cross-refs>.	p(UP:P27958)	directlyIncreases	p(HGNC:MAPT)
c5ac3c65-1d6a-497b-a4a7-7200c11d52af	0.65	PubMed	20927385	Our model predicts that the specific reduction of APP and tau protein levels following eIF4A inhibition depends on features in the 5 ' UTRs of these mRNAs.	p(FPLX:EIF4A)	directlyIncreases	p(HGNC:MAPT)
06e00619-39d2-45ae-8eda-ca50ed958575	0.65	PubMed	16845823	So far several groups have reported that Eph and ephrin signaling up-regulates tau expression and phosphorylation [XREF_BIBR, XREF_BIBR].	p(HGNC:EPHA1)	directlyIncreases	p(HGNC:MAPT)
79fe432d-c093-4fa6-b579-f4f9e95f7a92	0.86	PubMed	20579400	The ER plays a key role in the development and progression of breast cancer, but it is unknown if ER stimulation induces MAPT expression in breast cancer cells.	p(HGNC:ESR1)	directlyIncreases	p(HGNC:MAPT)
79fe432d-c093-4fa6-b579-f4f9e95f7a92	0.86	PubMed	20579400	These findings suggest that the ER modulates MAPT expression, especially for MAPT isoforms of less than 70 kDa.	p(HGNC:ESR1)	directlyIncreases	p(HGNC:MAPT)
2f13361f-108e-4c39-82ec-05639cf809c7	0.86	PubMed	17030664	On the other hand, GC appear to increase tau levels.	p(HGNC:GC)	directlyIncreases	p(HGNC:MAPT)
2f13361f-108e-4c39-82ec-05639cf809c7	0.86	PubMed	15468764	In addition, we show, for the first time, that chronic GC administration also increased Tau levels in synaptic compartment; however, at the synapse, there was an increase in phosphorylation of Ser396/404, but a decrease of Thr231.	p(HGNC:GC)	directlyIncreases	p(HGNC:MAPT)
7166f91a-83dd-4fc9-9223-4b72753e6618	0.65	PubMed	8943799	GSK-3 overexpression did not potentiate apoptotic stimulus induced cell apoptosis in the presence of high levels of tau.	p(FPLX:GSK3)	directlyIncreases	p(HGNC:MAPT)
1aa487a3-f195-46cb-8380-d09ca7262261	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_c3680fe1119c12414e76689dbffe3d74	No evidence text.	act(p(HGNC:GTF3A), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
7372ac86-1214-4b46-91a5-0c6cbd20e7d9	0.65	PubMed	23962722	Inhibition of HDAC6 decreases p-tau levels in vivo.	p(HGNC:HDAC6)	directlyIncreases	p(HGNC:MAPT)
a04771b1-38bb-44f4-a06f-4107af7236aa	0.65	PubMed	6917335	This low level of p25 expression did not seem to result in hyperphosphorylation of tau, but increased the phosphorylation of neurofilament M and enhanced the expression of tau protein.	p(HGNC:HRES1)	directlyIncreases	p(HGNC:MAPT)
9d836759-89f1-4f74-b7c6-6c43f629de14	0.65	PubMed	19747809	Meanwhile, both RanBP9 and tau levels are simultaneously reduced by Hsp90 or Hsc70 inhibitors, whereas overexpression or knockdown of RanBP9 significantly diminishes the anti-tau potency of Hsp90 and Hsc70 inhibitors as well as Hsc70 variants (WT & E175S).	p(FPLX:HSP90)	directlyIncreases	p(HGNC:MAPT)
c4f923b7-e793-4cf4-9c10-6d0bc1791382	0.92	PubMed	9292436	Induction of Hsp70 by heat shock enhanced the increase of Tau levels in cells overexpressing BAG-1 but induced a decrease of Tau levels in cells that were depleted of BAG-1.	p(FPLX:HSPA)	directlyIncreases	p(HGNC:MAPT)
c4f923b7-e793-4cf4-9c10-6d0bc1791382	0.92	PubMed	17954934	Induction of Hsp70 by heat shock enhanced the increase of Tau levels in cells overexpressing BAG-1 but induced a decrease of Tau levels in cells that were depleted of BAG-1.	p(FPLX:HSPA)	directlyIncreases	p(HGNC:MAPT)
c4f923b7-e793-4cf4-9c10-6d0bc1791382	0.92	PubMed	19793966	When all 4 tau variants were analyzed in aggregate, only Hsp70 inhibition significantly reduced tau levels (XREF_FIG).	p(FPLX:HSPA)	directlyIncreases	p(HGNC:MAPT)
4f95a87c-be24-45e4-97fd-662428c3f151	0.65	PubMed	17006145	Bjorkdahl and colleagues [XREF_BIBR] showed that overexpression of the chaperonin proteins Hsp27 or alphaB-crystallin in N2a cells could increase or decrease phosphorylation level of tau and NF.	p(HGNC:HSPB1)	directlyIncreases	p(HGNC:MAPT)
888c1007-0cea-4565-ab59-9d4bec47e571	0.92	PubMed	18934289	Here we report that developmental Pb exposure results in elevation of protein and mRNA levels of tau in aged mice.	p(HGNC:HTN3)	directlyIncreases	p(HGNC:MAPT)
888c1007-0cea-4565-ab59-9d4bec47e571	0.92	PubMed	14412971	Here we report that developmental Pb exposure results in elevation of protein and mRNA levels of tau in aged mice.	p(HGNC:HTN3)	directlyIncreases	p(HGNC:MAPT)
888c1007-0cea-4565-ab59-9d4bec47e571	0.92	PubMed	13716381	Here we report that infantile Pb exposure elevated the mRNA and protein levels of tau as well as its transcriptional regulators namely specificity protein 1 and 3 (Sp1 and Sp3) in aged primates.	p(HGNC:HTN3)	directlyIncreases	p(HGNC:MAPT)
2e2b3a0b-639d-401b-8115-13070aa125fb	0.65	PubMed	18561377	Importantly, irradiation (IR) increased the levels of Tau and Tau-p (exogenous and endogenous) in both WT and KO cells (XREF_FIG, XREF_SUPPLEMENTARY).	p(HGNC:INSR)	directlyIncreases	p(HGNC:MAPT)
65ef24ef-fb4d-41f1-9db0-3160ff498f8a	0.86	PubMed	26824039	We observed that a MAPT overexpressing cell line demonstrates altered insulin transcription, translation, and insulin secretion rates.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT)
65ef24ef-fb4d-41f1-9db0-3160ff498f8a	0.86	PubMed	15874122	We observed that a MAPT overexpressing cell line demonstrates altered insulin transcription, translation, and insulin secretion rates.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT)
7432267d-cf4f-42ea-b6bd-28871e27e1e3	0.65	PubMed	18101916	For this reason, the effect of media supplementation with 0.2% glucose prior to IPTG induction of tau expression was investigated.	a(PUBCHEM:656894)	directlyIncreases	p(HGNC:MAPT)
ce1e9d45-d7b0-4123-9ef6-64df23b55542	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_e0e3454153fa2075f80b7f7e3d5f2bd1	No evidence text.	act(p(HGNC:KLF12), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
b44ed39f-4faa-4c07-81ab-27009a6c5494	0.65	PubMed	8758591	These results are consistent with observations that PSA modulates tau levels in vivo and suggest that this enzyme may be involved in tau degradation in human brain.	p(HGNC:KLK3)	directlyIncreases	p(HGNC:MAPT)
dc932685-5b39-4c59-92b3-f6d50866e4da	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_8db1e932977d65c8ce93bb741d5240c2	No evidence text.	act(p(HGNC:LEF1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
77acc934-c791-46d8-a120-c16f253408d2	0.65	PubMed	20146449	The best characterized zebrafish TAU model so far is Gal4 and UAS mediated expression of human TAU P301L under the control of HuC/D promoter 37.	p(HGNC:LGALS4)	directlyIncreases	p(HGNC:MAPT, var(p.Pro301Leu))
00902cdc-04e0-4244-a012-b4da20322857	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_33f90adf72ee4e83cc2258134b75faea	No evidence text.	act(p(HGNC:LMO2), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
6f567b06-baa6-4e43-8a10-efb65d036a08	0.65	PubMed	16279506	In addition, 7days of LPS induced inflammation and Abeta production also leads to elevated total tau protein expression.	a(CHEBI:16412)	directlyIncreases	p(HGNC:MAPT)
3a895493-2578-4261-8463-d65fba7a57c1	0.65	PubMed	20235173	Nqo1 and Osgin-1 mRNA levels were also increased by TAU P301L expression even in the absence of DMF, suggesting that TAU P301L expression induces antioxidant response.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	p(HGNC:NQO1)
f0732656-988a-4746-adbb-f3d9e0afa586	0.65	PubMed	21945393	Expression of Tau wt and Tau P301L causes changes in microglial morphology and increases the levels of IL-6 and TNF-alpha.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IL6)
d7709b37-274e-4269-bd74-94f51b596e18	0.65	PubMed	17646145	Our results suggested that the modulation of Kv channel expression by tau overexpression also resulted in an increase of cell proliferation.	p(HGNC:MAPT)	directlyIncreases	a(PUBCHEM:6992341)
f1cc6ec9-89b2-41d2-9c98-f27fbd2d6aa9	0.94	PubMed	18359445	It should be kept in mind that, although modifications in tau may lead to its accumulation in tauopathies, the overexpression of tau in this model may increase tau levels beyond what is observed in disease.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT)
f1cc6ec9-89b2-41d2-9c98-f27fbd2d6aa9	0.94	PubMed	20214306	The calculated pTau and Tau ratios did not differ among the groups (XREF_TABLE) because the pTau levels were mainly driven by Tau protein expression rather than differential alterations in pTau.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT)
f1cc6ec9-89b2-41d2-9c98-f27fbd2d6aa9	0.94	PubMed	25687773	Across all cases and controls, we found a strong association between the T allele of rs422112 and decreased MAPT transcript expression levels (standardized beta-coefficient = -0.27, t-statistic = -6.61, p-value = 1.45 x 10 -10) which corresponds to presence of the A allele of rs393152 and increased MAPT transcript expression (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT)
f1cc6ec9-89b2-41d2-9c98-f27fbd2d6aa9	0.94	PubMed	18358156	Across all cases and controls, we found a strong association between the T allele of rs422112 and decreased MAPT transcript expression levels (standardized beta-coefficient = -0.27, t-statistic = -6.61, p-value = 1.45 x 10 -10) which corresponds to presence of the A allele of rs393152 and increased MAPT transcript expression (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT)
d038ac94-6bc9-4fa5-8710-caa094990c1e	0.65	PubMed	20286478	We found that wfs1 expression was induced by tau expression (XREF_FIG) concomitant with a significant upregulation of the mRNA expression of oxidative stress related genes (XREF_FIG).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:WFS1)
e7f78e4e-bf22-44e4-b18f-98b256b7e3cc	0.86	PubMed	15975834	Expression of tau-GFP was observed to cause high levels of neuronal death.	p(HGNC:MAPT)	directlyIncreases	bp(GO:"GO:0008219")
e7f78e4e-bf22-44e4-b18f-98b256b7e3cc	0.86	PubMed	26852117	Expression of tau-GFP was observed to cause high levels of neuronal death.	p(HGNC:MAPT)	directlyIncreases	bp(GO:"GO:0008219")
031b14bf-a9be-4317-9959-e57828a5313a	0.65	PubMed	17397695	Thus, restoring insulin levels and/or its receptor mediated signaling cascades (without affecting blood glucose levels) constitute a potentially interesting therapeutic strategy against AD, due to the inhibition of Abeta production (and its increased clearance) and tau protein hyperphosphorylation, two well-known hallmarks of the pathology.	p(HGNC:MAPT, pmod(Ph))	directlyIncreases	p(HGNC:INS)
09c5043a-c2df-4b8c-b40f-0594ddd6cc66	0.65	PubMed	18979907	These show : the increase in IL-1 and S100B expression in DS prior to the detection of either Abeta plaques or neurofibrillary tangles; XREF_BIBR, XREF_BIBR the capacity of both IL-1 86 and S100B to elevate neuronal betaAPP; 87 the induction of tau phosphorylation through IL-1-induced activation of mitogen activated protine kinase p-38; 65 and the relation of overexpression of IL-1 and S100B to both Abeta plaque XREF_BIBR, XREF_BIBR, XREF_BIBR and neurofibrillary tangle XREF_BIBR, XREF_BIBR development.	p(HGNC:MAPT, pmod(Ph))	directlyIncreases	p(HGNC:S100B)
695673a3-7720-482e-9380-cda569da2876	0.65	PubMed	20235173	TAU P301L did not significantly increase the levels of phospho-CRMP2 in agreement with lack of this modification in frontotemporal lobar degeneration associated with mutations in MAPT or with Pick bodies XREF_BIBR.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	p(HGNC:DPYSL2)
021ecad7-dc33-43eb-8788-0dda47fcda55	0.65	PubMed	20146449	Additionally, TAU P301L neither increased neural stem cell proliferation nor activated the expression of regenerative factor Interleukin-4, indicating that TAU P301L toxicity is prevented in the adult zebrafish brain.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	p(HGNC:IL4)
dc7f61e1-29f8-47ee-bbe4-36d51a6d8d0c	0.65	PubMed	21945393	Tau wt and Tau P301L increased the levels of endogenous alpha-Synuclein, but not beta-amyloid precursor protein (betaAPP) or Tar-DNA binding protein (TDP-43).	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	p(HGNC:SNCA)
212e718b-652d-47d6-9114-7e4b79abb010	0.65	PubMed	21945393	Tau P301L also induced a significant increase (74%) in TNF-alpha levels (XREF_FIG), but no change in iNOS levels compared to LacZ control (P < 0.05).	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	p(HGNC:TNF)
bf796622-5843-43dc-b6d4-7a240e29313d	0.86	PubMed	25406315	Approximately 50 times more synthetic P301S Tau seed than TgP301S Tau seed was needed to produce equivalent amounts of Sarkosyl-insoluble Tau from expressed protein (XREF_FIG, B and C).	p(HGNC:MAPT, var(p.Pro301Ser))	directlyIncreases	p(HGNC:MAPT)
bf796622-5843-43dc-b6d4-7a240e29313d	0.86	PubMed	17477317	Approximately 50 times more synthetic P301S Tau seed than TgP301S Tau seed was needed to produce equivalent amounts of Sarkosyl-insoluble Tau from expressed protein (XREF_FIG, B and C).	p(HGNC:MAPT, var(p.Pro301Ser))	directlyIncreases	p(HGNC:MAPT)
fe45cf64-d242-4075-bb8c-9858abc45e02	0.94	PubMed	17710715	Recently, we showed for the first time that P-tau can trigger an increase in AChE expression.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ACHE)
fe45cf64-d242-4075-bb8c-9858abc45e02	0.94	PubMed	21530001	Here, we have shown for the first time that P-tau can trigger an increase in AChE expression in vivo and in vitro.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ACHE)
fe45cf64-d242-4075-bb8c-9858abc45e02	0.94	PubMed	21530001	Finally, although the present study examines whether P-tau modulates AChE levels, the possibility that AChE inhibitors or cholinergic agonists may influence the phosphorylation of tau also need to be considered.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ACHE)
fe45cf64-d242-4075-bb8c-9858abc45e02	0.94	PubMed	20216920	As presented by Gracia-Allon et al. several authors have suggested that P-tau can trigger an increase in AChE expression.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ACHE)
040839f2-1a4c-4f87-9f61-6aa0c4f81666	0.65	PubMed	14760374	Here, we confirm that human tau increases Abeta levels.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:APP)
9d1e2742-58ef-4fd3-afbf-8d465d9abbb1	0.86	PubMed	17711755	This anatomical segregation was confirmed in Drd2-Cre BAC transgenic mice crossed with the Tau mGFP reporter line, which leads to the expression of nuclear beta-galactosidase and membrane targeted GFP (mGFP).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GLB1)
9d1e2742-58ef-4fd3-afbf-8d465d9abbb1	0.86	PubMed	23908605	This anatomical segregation was confirmed in Drd2-Cre BAC transgenic mice crossed with the Tau mGFP reporter line, which leads to the expression of nuclear beta-galactosidase and membrane targeted GFP (mGFP) (Hippenmeyer et al., XREF_BIBR).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GLB1)
5ff65a1e-da61-4b5c-b770-4410b1f07f83	0.65	PubMed	25772164	This experimental design mimics the influence of extracellular tau (released from neurons accumulating pathological tau) on astrocytes, and suggests that extracellular forms of tau may induce the expression of Hsp27 in astrocytes observed in TG animals.To further characterize the relation of SIT and glial cells activation, we performed transcriptomic analysis of selected glial cell specific markers and key proteins of immune system in the brainstem tissue samples.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:HSPB1)
32a26d91-c071-4748-b440-3710f903a4a4	0.86	PubMed	12960585	Tau pathology in tau expressing larvae, therefore, induces weak de novo HSP expression relative to other neurodegenerative disease models, and unlike these disease models, pharmacological manipulation of the hsp90 pathway does not lead to further induction of the heat shock response.	p(HGNC:MAPT)	directlyIncreases	a(PUBCHEM:16654923)
32a26d91-c071-4748-b440-3710f903a4a4	0.86	PubMed	23114515	Tau pathology in tau expressing larvae, therefore, induces weak de novo HSP expression relative to other neurodegenerative disease models, and unlike these disease models, pharmacological manipulation of the hsp90 pathway does not lead to further induction of the heat shock response.	p(HGNC:MAPT)	directlyIncreases	a(PUBCHEM:16654923)
307a633e-01de-4ecc-94a4-0a542176d0c5	0.65	PubMed	15289074	These findings show that Oys or Tau may increase growth plate thickness by elevating IGF-1 levels and by promoting the phosphorylations of JAK2-STAT5, and suggest that Oys or Tau are growth promoting substances of potential use in the food and pharmaceutical industries.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IGF1)
8a06d09e-c799-4172-8402-81cd2f57baee	0.65	PubMed	18203888	However LTP in CA1 was decreased in a different animal model with the overexpression of Mecp2 driven by Tau promoter in neurons (Tau-Mecp2) [XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MECP2)
01563aaf-abf3-4e9c-8990-ecd16ccf3f55	0.65	PubMed	17503994	Compared with the ischemia group, the levels of Lac, Ala, Cho, and Pcho in the treatment group were significantly reduced and the levels of NAA, Cre, Myo, and Tau remarkably increased.	p(HGNC:MAPT)	directlyIncreases	a(PUBCHEM:6862)
0ec18613-d32d-4966-9c4b-b946ef6eec3c	0.65	PubMed	15181729	Tau also enhanced MafA, Ngn3 and NeuroD mRNA levels in obT islets.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:NEUROG3)
751d2bd9-7c8f-427c-9544-288397fceeb4	0.65	PubMed	21981837	Administration of both MgAT and TAU restored the altered levels of NOS isoforms expression, reduced retinal nitrosative stress and retinal cell apoptosis.	p(HGNC:MAPT)	directlyIncreases	p(FPLX:NOS)
03502688-cd00-4f00-a035-e489115dcb39	0.65	PubMed	22058634	Together, these observations indicated that tau loss would lower the expression level of OTX2.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:OTX2)
878f4291-3c84-4e2a-942a-daaa14c4d2c9	0.65	PubMed	17915068	The temporal region is one of the most vulnerable to damage produced by the accumulation of the beta-amyloid protein as well as of the tau protein, which may increase NRSF expression.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:REST)
341559f3-3354-45ac-8c51-54a6cf6b0d9e	0.65	PubMed	18561377	One possibility is that SIRT6 directly represses Tau transcription through its histone deacetylation activity.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:SIRT6)
6cfa29d3-984c-42e7-9cde-2af290c45af0	0.86	PubMed	11600090	SC35 did not affect tau transcription, but stabilized tau mRNA by binding to the SC35 like element of exon 10.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:SRSF2)
6cfa29d3-984c-42e7-9cde-2af290c45af0	0.86	PubMed	21333649	SC35 did not affect tau transcription, but stabilized tau mRNA by binding to the SC35 like element of exon 10.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:SRSF2)
52d36670-9eb9-477c-9ea2-058b7bc96843	0.65	PubMed	17711696	Once tau is bound to the cell receptor, it could be endocytosed in a vesicle, a mechanism that occurs with ligands of M1/M3 receptors, or simply, tau could promote the increase of intracellular calcium level and the appearance of second messengers or toxic compounds that will result in neuron death without being internalized.	p(HGNC:MAPT)	directlyIncreases	a(CHEBI:29108)
08b18d64-c48a-411e-8e5e-9d3a1d637a1a	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_2d60230a1d55421534ae6df724713d89	No evidence text.	act(p(HGNC:MAZ), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
b9fccddd-487f-4624-978a-55ea7b516b0e	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_2d66c7fba2bd5cf9a9d17b7f12cdf16c	No evidence text.	act(p(HGNC:MEIS1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
ae4b4c89-dc7e-4260-8638-fb56b366a91a	0.86	PubMed	25384392	MG132 increased p-Tau levels (p < 0.03) even in the presence of Nilotinib when Tau was expressed alone or together with Abeta1-42.	a(CHEBI:75142)	directlyIncreases	p(HGNC:MAPT)
ae4b4c89-dc7e-4260-8638-fb56b366a91a	0.86	PubMed	18363490	MG132 increased p-Tau levels (p < 0.03) even in the presence of Nilotinib when Tau was expressed alone or together with Abeta1-42.	a(CHEBI:75142)	directlyIncreases	p(HGNC:MAPT)
0b1dad88-a380-4768-a738-b4d70aaa6a3f	0.65	PubMed	19611031	While MMP9 levels were not significantly altered in mice or newborns, reduced gelsolin levels and increased ubiquitin carboxy-terminal hydrolase L1 and tau levels were detected in GMH-IVH patients at birth.	p(HGNC:MMP9)	directlyIncreases	p(HGNC:MAPT)
e20b448f-7aaf-4d7a-8e0e-f62929755d67	0.65	PubMed	6376118	Our results show that msi-1 mediates the posttranscriptional regulation of tau expression by T3.	p(HGNC:MSI1)	directlyIncreases	p(HGNC:MAPT)
1a95552e-5c26-40cf-bad1-b2e3436094f8	0.86	PubMed	18647126	ELISA studies demonstrated that NDEA treatment chronically increased the levels of tau, phospho-tau and AbetaPP-Abeta.	a(PUBCHEM:5921)	directlyIncreases	p(HGNC:MAPT)
1a95552e-5c26-40cf-bad1-b2e3436094f8	0.86	PubMed	18647126	The NDEA mediated persistent oxidative stress, lipid peroxidation, and increased levels of phospho-tau and AbetaPP-Abeta, correspond with our recent in vitro experimental results where, neurons treated with NDEA had virtually the same responses, in addition to increased DNA damage and mitochondrial dysfunction [XREF_BIBR].	a(PUBCHEM:5921)	directlyIncreases	p(HGNC:MAPT)
6b7d473c-2c03-4c48-a59d-5f727b3a3257	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_a401028b69ab6ae1cfd7a291cab12847	No evidence text.	act(p(HGNC:NF1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
bd4ef8c7-3110-4f86-80ea-fb003f2754de	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_0b404d00c3717c819fa90a63b96d5adb	No evidence text.	act(p(HGNC:NFE2L1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
829bd0eb-b5ea-4245-bf70-83cb94322627	0.65	PubMed	16166566	Induction of MAPT transcription by NRF2 was confirmed using a human neuroblastoma cell line and a Nrf2 deficient mouse model.	p(HGNC:NFE2L2)	directlyIncreases	p(HGNC:MAPT)
c7cb46c2-a045-41f6-9e4d-1fca3f3086a0	0.92	PubMed	4433353	We find that BDNF but not NGF rapidly (within 2 h) upregulates levels of synaptophysin, tau and c-Fos correlating with expression of the neurotrophin receptor TrkB.	p(HGNC:NGF)	directlyIncreases	p(HGNC:MAPT)
c7cb46c2-a045-41f6-9e4d-1fca3f3086a0	0.92	PubMed	17878407	The interaction between NGF and Tau in AD or tauopathies is less clear : NGF induced neuronal differentiation of the neuroblastoma cell line pheochromocytoma celline-12 (PC-12) exhibits an increase in Tau promoter activity and subsequently elevated Tau protein levels.	p(HGNC:NGF)	directlyIncreases	p(HGNC:MAPT)
c7cb46c2-a045-41f6-9e4d-1fca3f3086a0	0.92	PubMed	3808361	In particular, while NGF increases the total specific levels of tau in both cell types to similar extents (by about twofold), the proportion comprising HMW tau is threefold higher in the PC12-C41 clone than in PC12 cells.	p(HGNC:NGF)	directlyIncreases	p(HGNC:MAPT)
a707b847-c5a2-40b6-bd2a-b3335b43df7c	0.79	PubMed	27188386	No evidence text.	act(p(HGNC:NOG), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
5b163422-e989-458a-b6f2-44706a97cdd9	0.86	PubMed	16779191	Also, antioxidants and NADPH-oxidases (NOX) inhibitors reduced the expression of Tau and MAP2.	p(HGNC:NOX1)	directlyIncreases	p(HGNC:MAPT)
5b163422-e989-458a-b6f2-44706a97cdd9	0.86	PubMed	15215400	Also, antioxidants and NADPH-oxidases (NOX) inhibitors reduced the expression of Tau and MAP2.	p(HGNC:NOX1)	directlyIncreases	p(HGNC:MAPT)
a3151a0b-b0bd-4a47-b531-a71d5278489f	0.95	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_99e23ab802682b44dc645054279a7574	No evidence text.	act(p(HGNC:NRF1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
a3151a0b-b0bd-4a47-b531-a71d5278489f	0.95	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_34d0953c3832e2cc739c4950f717abcc	No evidence text.	act(p(HGNC:NRF1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
aa231d73-c5f3-47d4-b56a-ddc0cf1321f4	0.65	PubMed	5927680	Here, we report that the neuregulin neu differentiation factor (NDF) increases the expression of tau mRNA and tau protein in OLGs.	p(HGNC:NRG1)	directlyIncreases	p(HGNC:MAPT)
35de24d7-fe49-4b85-8ce7-8b8c465bfa9a	0.65	PubMed	17178508	In a different approach, we also examined the reporter mouse line OMPCre-eRosa26tauGFP in which OMP expression drives the continuous expression of tau : green fluorescent protein fusion (tauGFP).	p(HGNC:OMP)	directlyIncreases	p(HGNC:MAPT)
85ebe74b-dce2-4316-9405-8bfe2d4dd24c	0.65	PubMed	18932714	Mild primary BOP induces early occurring and persistently elevated phospho-tau levels.	p(HGNC:OPN1SW)	directlyIncreases	p(HGNC:MAPT)
064fde02-91d4-43b9-b2e4-db8bf4e6618c	0.65	PubMed	16851072	Otub1 also significantly increased total Tau protein level compared with GFP control.	p(HGNC:OTUB1)	directlyIncreases	p(HGNC:MAPT)
33a10e2f-586a-4d64-ae3b-374bed3aa1ed	0.65	PubMed	21376022	Lentiviral parkin expression did not cause any changes to GSK-3beta activity (XREF_FIG) nor to the hyper-phosphorylation levels of Tau, suggesting that beta-amyloid triggers TDP-43 modification independent of Tau.	p(UP:O60260)	directlyIncreases	p(HGNC:MAPT)
411a3401-39d6-482d-a32b-016ffcc08224	0.95	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_6906dfd8886605a9078756e22e6d27d4	No evidence text.	act(p(HGNC:PAX4), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
411a3401-39d6-482d-a32b-016ffcc08224	0.95	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_aa2db86d099bb99114ed2022243b41dd	No evidence text.	act(p(HGNC:PAX4), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
f0c80f2d-b7b1-4ece-8f58-b75579243d92	0.65	PubMed	10138499	Both compounds significantly increased the levels of synaptophysin and tau in cerebral cortex, and PFOA also increased the levels of tau in hippocampus.	a(PUBCHEM:9554)	directlyIncreases	p(HGNC:MAPT)
60e5ac0d-cc21-46e0-8bbc-cf412975c228	0.65	PubMed	18753019	Lentiviral parkin expression did not cause any changes to GSK-3beta activity (XREF_FIG) nor to the hyper-phosphorylation levels of Tau, suggesting that beta-amyloid triggers TDP-43 modification independent of Tau.	p(HGNC:PRKN)	directlyIncreases	p(HGNC:MAPT)
7e3f09df-9edf-451e-a879-66bbd132f9f4	0.65	PubMed	9307604	Moreover, Abeta 1-40 and PrP 106-126 increased the levels of tau protein phosphorylated at Ser202 and Thr205.	p(HGNC:PRNP)	directlyIncreases	p(HGNC:MAPT)
6a30f5e0-f3e6-4708-b837-bd662256fec8	0.65	PubMed	5707383	In cultures that were treated with amyloid beta (Abeta), PS1 mutations significantly increased neuritic dystrophy and AD like changes in tau such as hyperphosphorylation, release from MT, and increased tau protein levels.	p(HGNC:PSEN1, var(p.?))	directlyIncreases	p(HGNC:MAPT)
6fbae7fe-cf83-4608-bfdf-a6b0c79df1be	0.65	PubMed	3409535	Potassium stimulation led to increased Asp, Glu, Gly, and Tau levels, whereas Gln content decreased and Ser remained unaltered.	a(PUBCHEM:813)	directlyIncreases	p(HGNC:MAPT)
368d4a16-a1a6-485d-9fad-91e2764c6d5d	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_b57de0c2e11853d3c096a0a79020ea92	No evidence text.	act(p(HGNC:RB1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
8aa093dd-1701-4066-90d0-ba435c3e0f05	0.65	PubMed	17285286	Myogenic HET isolated cultured cells had elongated cell shape (XREF_FIG, arrow), in contrast to the MUT cells with a smaller rounder appearance and increased Tau levels (XREF_FIG, arrow).	p(HGNC:SAFB)	directlyIncreases	p(HGNC:MAPT)
ea8846d9-e9b5-4bd7-9c03-891367105efd	0.65	PubMed	22037607	We therefore used SAM technology to induce endogenous expression of tau, alone or together with APP and BACE1.	a(PUBCHEM:34755)	directlyIncreases	p(HGNC:MAPT)
6f8524d1-249c-440b-92f8-1f16ef555c89	0.65	PubMed	8850269	It can be concluded that the SOD1 G93A mutation causes early alterations of tau expression in cns, which are not exclusively restricted to the upper and lower motor neuron.	p(HGNC:SOD1, var(p.Gly93Ala))	directlyIncreases	p(HGNC:MAPT)
9095f381-34a6-4514-ac2a-eb63c2c9a11a	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_a8af827bb56a4af677e3088b90e24b9f	No evidence text.	act(p(HGNC:SP1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
0a44d29e-f982-4a81-ba9e-d1a38eeabdc5	0.79	PubMed	25402454	No evidence text.	act(p(HGNC:SRSF2), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
23d7a67c-0698-4139-b222-3bd9186697f8	0.86	PubMed	18273361	Consistently, treatment with synj1 knockdown (62.2 +/-18.4% of controls; N = 10-18/group, one-way ANOVA F (3,54) = 11.84, p = 0.0012; Tukey 's multiple comparison test adjusted p < 0.0001), or GSK3 inhibitors (66.0 +/-22.9% of controls; adjusted p = 0.0006) reduced pTau levels, but the combination of synj1 knockdown and GSK3beta inhibitors failed to further reduce pTau levels, suggesting that the effects of synj1 reduction on Tau phosphorylation are mediated, at least partially, through inactivation of GSK3beta.	p(HGNC:SYNJ1)	directlyIncreases	p(HGNC:MAPT)
23d7a67c-0698-4139-b222-3bd9186697f8	0.86	PubMed	18273361	Reduction of synj1 decreases pTau levels in N2a cells.	p(HGNC:SYNJ1)	directlyIncreases	p(HGNC:MAPT)
6e74a7bb-8d7c-4d0f-bf65-09971c287eec	0.65	PubMed	19758268	Recent studies suggested that AD pathogenesis could cause the accumulation of TDP-43, while abnormal TDP-43 accumulation could also lead to abnormal tau expression.	p(HGNC:TARDBP)	directlyIncreases	p(HGNC:MAPT)
a1a9179f-ba18-42f8-808e-0cf37607fdfd	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_d9ad21549e027f294074c0c49d26d812	No evidence text.	act(p(HGNC:TCF3), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
4c611c8d-9539-4477-acf1-067b725558c4	0.95	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_436c3700244da748aa6860a2f643dadb	No evidence text.	act(p(HGNC:TFDP1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
4c611c8d-9539-4477-acf1-067b725558c4	0.95	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_44c343e9850713d96013f8811046a1d9	No evidence text.	act(p(HGNC:TFDP1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
6f4757e8-48dd-47ad-9bbf-24e4317c3765	0.95	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_fbac17a0b0047bff95cb6a2320bbec00	No evidence text.	act(p(HGNC:TFDP2), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
6f4757e8-48dd-47ad-9bbf-24e4317c3765	0.95	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_f0ff117403809088796db352eb3bafb9	No evidence text.	act(p(HGNC:TFDP2), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
e7bf4837-6f1b-4028-852d-c6d7184e6b8f	0.65	PubMed	18072244	Compared to nTg mice treated with vehicle, Tg mice treated with vehicle or ISRIB had increased levels of p-tau (Bonferroni 's MCT, p < 0.01) throughout the hippocampus.	p(HGNC:TG)	directlyIncreases	p(HGNC:MAPT)
4a1ede29-b3fd-4609-bfc0-eec24d6c1803	0.65	PubMed	18839051	In the 3xTg-AD mouse model, both APP and tau expressions are driven by Thy1.2 promoter, but only the steady-state levels of APP, but not tau, were significantly increased after 3- and 9-month copper exposures.	p(HGNC:THY1)	directlyIncreases	p(HGNC:MAPT)
bc3e28dc-50d3-4f5f-b553-deaffac211fb	0.65	PubMed	18438155	Therefore, TMX alone demonstrated to increase Tau-1 and total tau expression without an effect on 12E8Site epitope.	p(HGNC:TMX1)	directlyIncreases	p(HGNC:MAPT)
b3d5f8a3-54b9-4374-9e80-c62e40bf6633	0.65	PubMed	18959325	In addition, TRH gene depletion can enhance tau and GSK-3beta expression in cultured rat hippocampal neurons; while in contrast, TRH administration can effect a 75% decrease in GSK-3beta and a 90% decrease in tau phosphorylation.	p(HGNC:TRH)	directlyIncreases	p(HGNC:MAPT)
a2f3db3e-7d5b-4484-9fb7-d06521e0cbc0	0.65	PubMed	18075098	To ensure that this effect was mediated through tau levels, we tested the effect of TRIM28 loss of function on transgenic tau levels and found indeed that reduction of TRIM28 could effectively decrease tau levels in this heterologous system (XREF_FIG).	p(HGNC:TRIM28)	directlyIncreases	p(HGNC:MAPT)
d991526b-d366-4aff-917f-ece2dca6b874	0.65	PubMed	16752739	After observing a high positive correlation between the expression of USP9 and MAPT in the public transcriptomics data, we show that USP9 knockdown results in significantly decreased MAPT expression in a DU145 cell culture model and a concentration dependent decrease for the MAPT orthologs mapta and maptb in a zebrafish model.	p(HGNC:USP9X)	directlyIncreases	p(HGNC:MAPT)
e7abfe1e-6a4e-4052-bc40-5d0e77d81d0f	0.86	PubMed	18111365	HE4 modulates tubulin levels and MAPT gene expression.	p(HGNC:WFDC2)	directlyIncreases	p(HGNC:MAPT)
e7abfe1e-6a4e-4052-bc40-5d0e77d81d0f	0.86	PubMed	27184254	HE4 modulates tubulin levels and MAPT gene expression.	p(HGNC:WFDC2)	directlyIncreases	p(HGNC:MAPT)
c1900628-4b12-4dcf-b61d-844aaf396a7d	0.79	Other	biopax:http://pathwaycommons.org/pc2/TemplateReactionRegulation_ca340ff3c5f5f6ee1f8fbdf4621faf8c	No evidence text.	act(p(HGNC:YY1), ma(tscript))	directlyIncreases	p(HGNC:MAPT)
25d1ee58-e384-4e54-8f33-f17243282db1	0.65	PubMed	10325073	Results showed that in the prefrontal cortex, coumarin at the lowest dose increased the levels of GLU and TAU, while GABA increased with both doses studied and GLY had its levels increased only at the dose of 40 mg/kg.	a(PUBCHEM:323)	directlyIncreases	p(HGNC:MAPT)
fd900a7e-e863-4a5e-a140-8168b861524c	0.86	PubMed	16939203	Performance in these assays was shown to worsen progressively with age, to correlate well with developing tau pathology, and to be responsive to experimental modulation of tau expression by doxycycline treatment.	a(CHEBI:50845)	directlyIncreases	p(HGNC:MAPT)
fd900a7e-e863-4a5e-a140-8168b861524c	0.86	PubMed	16848772	Induction of pro aggregant Tau RDDelta expression by doxycycline led to stable expression of the construct, tested via bioluminescence (data not shown).	a(CHEBI:50845)	directlyIncreases	p(HGNC:MAPT)
715a06e1-26f7-434c-8815-dbbbf60b6ddc	0.65	PubMed	24464041	The pan-neuronal elav-GAL4 driver was used to drive tau and RNAi transgene expression.	p(UP:P16914)	directlyIncreases	p(HGNC:MAPT)
7cac0d8a-d04c-4417-89c2-4292e9d9857f	0.65	PubMed	20579400	In MCF7 cells, MAPT expression was increased by 17-beta estradiol.	a(CHEBI:23965)	directlyIncreases	p(HGNC:MAPT)
6a3d8b81-7e71-4af2-8f07-419b2d0174b2	0.86	PubMed	20579400	Previous experimental studies have shown that MAPT expression is increased by estrogen in vitro and in vivo [XREF_BIBR, XREF_BIBR], and clinical studies have shown a positive correlation of MAPT levels with estrogen receptors (ER) expression [XREF_BIBR, XREF_BIBR].	a(CHEBI:50114)	directlyIncreases	p(HGNC:MAPT)
6a3d8b81-7e71-4af2-8f07-419b2d0174b2	0.86	PubMed	17646145	Enhanced levels of tau protein induced by estrogen can increase the growth of ER positive breast cancer tissues by reducing their sensitivity to taxane [XREF_BIBR] and paclitaxel [XREF_BIBR], which are important chemotherapy drugs for cancer.	a(CHEBI:50114)	directlyIncreases	p(HGNC:MAPT)
1bd10165-9aff-488e-a2fc-c6acf5060566	0.95	PubMed	9845791	During tau induction, ethanol exposure (1.25-5mg/ml) dose-dependently increased tau protein levels and reduced cell viability.	a(CHEBI:16236)	directlyIncreases	p(HGNC:MAPT)
1bd10165-9aff-488e-a2fc-c6acf5060566	0.95	PubMed	18519819	During tau induction, ethanol exposure (1.25-5 mg/ml) dose-dependently increased tau protein levels and reduced cell viability.	a(CHEBI:16236)	directlyIncreases	p(HGNC:MAPT)
1bd10165-9aff-488e-a2fc-c6acf5060566	0.95	PubMed	18519819	Additionally, ethanol increased endogenous tau protein levels in neuroblastoma cells lacking the tetracycline-off induction system for tau.	a(CHEBI:16236)	directlyIncreases	p(HGNC:MAPT)
1bd10165-9aff-488e-a2fc-c6acf5060566	0.95	PubMed	9845791	Additionally, ethanol increased endogenous tau protein levels in neuroblastoma cells lacking the tetracycline-off induction system for tau.	a(CHEBI:16236)	directlyIncreases	p(HGNC:MAPT)
1bd10165-9aff-488e-a2fc-c6acf5060566	0.95	PubMed	18519819	Nonetheless, it is expected that longer durations of ethanol exposure would further increase tau expression such that tau levels would exceed the acceptable range for normal tau activity.	a(CHEBI:16236)	directlyIncreases	p(HGNC:MAPT)
0befd7c3-4678-4ed1-8ab0-ac6f8f2a8510	0.65	PubMed	17241698	In general, levodopa treatment produced increased levels of p-tau in dyskinetic rats treated with levodopa when compared with 6-OHDA-lesioned rats treated with the vehicle.	a(PUBCHEM:6047)	directlyIncreases	p(HGNC:MAPT)
598bef71-917c-4bbe-af9e-23a6f3828ad0	0.65	PubMed	17051210	Consistent with these findings, treatment of PDAPP or 3xTg-AD mice with rapamycin, an mTOR inhibitor, reduced amyloid-beta and tau levels and restored cognitive function [XREF_BIBR, XREF_BIBR].	a(CHEBI:68481)	directlyIncreases	p(HGNC:MAPT)
2dfec4bc-c843-438d-bbfc-a92682d25876	0.65	PubMed	17319640	Memantine significantly decreased tau and stathmin mRNA expression (by RT-PCR), so that 100 micromol/l of memantine decreased tau and stathmin expression by 46% (P = 0.0341) and 33% (P = 0.043), respectively.	a(PUBCHEM:4054)	directlyIncreases	p(HGNC:MAPT)
1e97fa2e-32b4-4026-8a69-4dd9e63d3a0e	0.65	PubMed	11628973	We previously demonstrated that treatment of cultured neurons with a dual cPLA (2) and iPLA (2) inhibitor, methyl arachidonyl fluorophosphonate (MAFP), decreased total Tau levels and increased Tau phosphorylation at Ser (214) site.	a(PUBCHEM:3034819)	directlyIncreases	p(HGNC:MAPT)
9d9c5d44-c1de-4ebd-816f-5c6b55f88151	0.65	PubMed	17324007	In mice striata, paraquat treatment caused increased levels of soluble total Tau to be present in cholate-soluble extracts, along with increased levels of hyperacetylated alpha-tubulin in cytoskeleton-free fractions and reduced levels of hyperacetylated alpha-tubulin in cytoskeleton associated fractions, suggesting remodeling of the microtubule cytoskeleton.	a(PUBCHEM:15939)	directlyIncreases	p(HGNC:MAPT)
0f8c2c48-dd2a-45b1-a1b1-1630e1b9db5a	0.86	PubMed	13013308	Thus, pilocarpine induced chronic epilepsy was associated with accelerated and enhanced neuritic plaque formation and altered intraneuronal p-tau expression in temporal lobe structures in 3xTg-AD mice, with these pathologies occurring in regions showing neuronal death and axonal dystrophy.	a(PUBCHEM:5910)	directlyIncreases	p(HGNC:MAPT)
0f8c2c48-dd2a-45b1-a1b1-1630e1b9db5a	0.86	PubMed	17368486	Thus, pilocarpine induced chronic epilepsy was associated with accelerated and enhanced neuritic plaque formation and altered intraneuronal p-tau expression in temporal lobe structures in 3xTg-AD mice, with these pathologies occurring in regions showing neuronal death and axonal dystrophy.	a(PUBCHEM:5910)	directlyIncreases	p(HGNC:MAPT)
310e4d4a-1055-43dd-843c-e5f91435f01d	0.65	PubMed	23798570	We then examined whether exogenous PROG could modulate the levels of TDP-43 and Tau in an in vitro model using a human neuroblastoma cell line.	p(UP:Q00777)	directlyIncreases	p(HGNC:MAPT)
02361cd8-a6f9-4307-9efa-b928f5d7c2b4	0.86	PubMed	18582004	Estrogen can reduce GSK-3beta activity [XREF_BIBR], and progesterone can decrease expression of both tau and GSK-3beta.	a(CHEBI:17026)	directlyIncreases	p(HGNC:MAPT)
02361cd8-a6f9-4307-9efa-b928f5d7c2b4	0.86	PubMed	9014833	The regulation of Tau expression and phosphorylation by progesterone may contribute to the hormonal regulation of cerebellar function by the modification of neuronal cytoskeleton.	a(CHEBI:17026)	directlyIncreases	p(HGNC:MAPT)
e3e0e11e-ff0c-4c13-a910-80d1ca4ee012	0.65	PubMed	18914611	The binding of PrPc to amyloid oligomers present in the AD brain increases tau expression to help shuttle more APP to the cell surface; decreasing neuronal iron while increasing Abeta production.	p(UP:Q937N9)	directlyIncreases	p(HGNC:MAPT)
283ff127-0961-41e1-814a-1f9b896a25a6	0.65	PubMed	22047573	Moreover, salicylate stimulation of p300 has recently been shown to prevent tau acetylation on lysine 174 and lower total levels of tau in a mouse model of Alzheimer 's disease, resulting in functional improvement.	a(PUBCHEM:338)	directlyIncreases	p(HGNC:MAPT)
13bc1877-88b1-497b-abb8-a49ed759737e	0.65	PubMed	27023670	In addition, knockdown of Sgg significantly decreased phosphorylation levels of tau at SP/TP sites and shifted all tau species to lower-molecular weight regions (XREF_FIG); therefore, Abeta is capable of promoting tau toxicity under conditions in which the levels of tau upper species are diminished.	p(UP:P18431)	directlyIncreases	p(HGNC:MAPT)
3e585681-e20c-4391-971d-b34b830d26cb	0.92	PubMed	3806655	Two major findings are described : a) staurosporine rapidly induces outgrowth of neurites that are resistant to colchicine treatment; and b) staurosporine treatment causes a rapid increase in tau protein levels, with a time course similar to the initiation of its neurotropic effects.	a(PUBCHEM:44259)	directlyIncreases	p(HGNC:MAPT)
3e585681-e20c-4391-971d-b34b830d26cb	0.92	PubMed	3806655	On the other hand, staurosporine treatment causes a transient, dose dependent increase in tau protein levels.	a(PUBCHEM:44259)	directlyIncreases	p(HGNC:MAPT)
3e585681-e20c-4391-971d-b34b830d26cb	0.92	PubMed	3806655	The rapid, transient increase of tau protein levels induced by staurosporine is reminiscent of its neurotropic properties.	a(PUBCHEM:44259)	directlyIncreases	p(HGNC:MAPT)
31c7f989-40b2-44b0-8076-48e31ba941f5	0.86	PubMed	23631819	Function of Tau gene is regulated by estrogens and expression of Tau protein in vitro might be induced by these hormones as well as tamoxifen.	a(CHEBI:41774)	directlyIncreases	p(HGNC:MAPT)
31c7f989-40b2-44b0-8076-48e31ba941f5	0.86	PubMed	20579400	With 17-beta estradiol, MAPT expression was decreased by tamoxifen at low concentrations, but increased by tamoxifen at 500 nM.	a(CHEBI:41774)	directlyIncreases	p(HGNC:MAPT)
fffd7cf1-8213-4571-aaa5-c29c29cb0b88	0.92	PubMed	18654482	The commercial tetracycline regulated T-REx expression system (Invitrogen) was used to allow control of tau expression.	a(PUBCHEM:51580080)	directlyIncreases	p(HGNC:MAPT)
fffd7cf1-8213-4571-aaa5-c29c29cb0b88	0.92	PubMed	20143409	The commercial tetracycline regulated T-REx expression system (Invitrogen) was used to allow control of tau expression.	a(PUBCHEM:51580080)	directlyIncreases	p(HGNC:MAPT)
fffd7cf1-8213-4571-aaa5-c29c29cb0b88	0.92	PubMed	18519819	The ability to conditionally control the expression of tau in response to tetracycline makes this system ideal to study the involvement of tau in ethanol induced cell death.	a(PUBCHEM:51580080)	directlyIncreases	p(HGNC:MAPT)
ac170c9d-2a80-47d8-9e34-a5e4536f630e	0.92	PubMed	4796788	Tau phosphatase activity is decreased by approximately 30% in AD brain.	p(PFAM:PF09793)	directlyDecreases	act(p(HGNC:MAPT))
ac170c9d-2a80-47d8-9e34-a5e4536f630e	0.92	PubMed	17592833	Administration of the prototype AD drug clioquinol can cause a reduction of tau and Abeta, as well as an improvement in cognitive performance.	p(PFAM:PF09793)	directlyDecreases	act(p(HGNC:MAPT))
ac170c9d-2a80-47d8-9e34-a5e4536f630e	0.92	PubMed	9015209	Here we show that dietary supplementation with docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, in the 3xTg-AD mouse model of AD reduced the intraneuronal accumulation of both amyloid-beta (Abeta) and tau.	p(PFAM:PF09793)	directlyDecreases	act(p(HGNC:MAPT))
0c0404fb-924e-4ad8-895f-d638450219f5	0.86	PubMed	13170905	Interestingly, decreased expression of the Drosophila BIN1 ortholog Amph suppressed Tau mediated neurotoxicity in three different assays.	p(HGNC:AMPH)	directlyDecreases	act(p(HGNC:MAPT))
0c0404fb-924e-4ad8-895f-d638450219f5	0.86	PubMed	23399914	Interestingly, decreased expression of the Drosophila BIN1 ortholog Amph suppressed Tau mediated neurotoxicity in three different assays.	p(HGNC:AMPH)	directlyDecreases	act(p(HGNC:MAPT))
57daf8f5-9ad6-4c71-b0a2-74306335f62f	0.65	PubMed	17255996	In early pupation between +13 h to +20 h aHE, when control muscle decreased in size, AMPKalpha RNAi caused a loss of tubular morphology and decrease of tau-GFP fluorescence.	p(FPLX:"AMPK_alpha")	directlyDecreases	act(p(HGNC:MAPT))
f6e1eea8-89de-4eca-af6a-0ea852e570aa	0.95	PubMed	18207314	Previous studies have shown that Abeta immunotherapy decreases Abeta and tau pathology in 3xTg-AD mice XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR, which is consistent with the results presented here.	p(HGNC:APP)	directlyDecreases	act(p(HGNC:MAPT))
f6e1eea8-89de-4eca-af6a-0ea852e570aa	0.95	PubMed	18855261	In fact, recent research points to tau as a requisite mechanistic factor in Abeta induced pathology - lowering of tau can prevent neurotoxicity in Abeta treated cultures and AD mouse models [XREF_BIBR - XREF_BIBR].	p(HGNC:APP)	directlyDecreases	act(p(HGNC:MAPT))
f6e1eea8-89de-4eca-af6a-0ea852e570aa	0.95	PubMed	20615469	As shown in, under the same condition in which Abeta reduced the tau 4R content in SH-SY5Y cells () an increase in GSK-3beta activity was noted.To establish the causal role of GSK-3beta in mediating Abeta alteration of tau exon 10 splicing, we studied the effect of lithium, a GSK-3beta inhibitor ().	p(HGNC:APP)	directlyDecreases	act(p(HGNC:MAPT))
f6e1eea8-89de-4eca-af6a-0ea852e570aa	0.95	PubMed	20615469	To examine whether SC35 is involved in Abeta alteration of tau exon 10 splicing, we applied siRNA of SC35 to study the effect of SC35 knockdown on Abeta suppression of tau 4R mRNA expression.	p(HGNC:APP)	directlyDecreases	act(p(HGNC:MAPT))
f6e1eea8-89de-4eca-af6a-0ea852e570aa	0.95	PubMed	27343974	Immunochemistry experiments added that Abeta exposure triggered a significant decrease of the pTau and Tau -5 in the cytoplasmic fraction (-60%, P < 0.05) paralleled with the marked increase observed in the nucleus after 8h of Abeta exposure (C).	p(HGNC:APP)	directlyDecreases	act(p(HGNC:MAPT))
f6e1eea8-89de-4eca-af6a-0ea852e570aa	0.95	PubMed	18648555	Because Abeta is known to cause tau phsophorylation and leptin to reduce phsophorylation of tau, we determined the extent to which mTORC1 is involved in tau phosphorylation.	p(HGNC:APP)	directlyDecreases	act(p(HGNC:MAPT))
6509d897-15cd-4067-8d36-3fc5fa7c987d	0.86	PubMed	19864981	Our collective results show, for the first time, that the chaperone Artemin could significantly inhibit aggregation of the TAU proteins in a dose dependent manner, and support Artemin as a potential potent blocker of TAU aggregation in people with AD.	p(HGNC:ARTN)	directlyDecreases	act(p(HGNC:MAPT))
6509d897-15cd-4067-8d36-3fc5fa7c987d	0.86	PubMed	19864981	Importantly, Artemin was observed to effectively block the aggregation of both physiologic- and supraphysiologic TAU concentrations in a dose dependent manner, as judged by ThT and CD spectroscopy analyses.	p(HGNC:ARTN)	directlyDecreases	act(p(HGNC:MAPT))
d239c08e-cd40-4f17-88f7-23fef993161f	0.86	PubMed	10076645	At 100 microM zinc induced a tau dephosphorylation on the PHF-1 epitope, and at higher zinc concentrations induced the appearance of the abnormal tau conformational epitope MC1 and reduced the electrophoretic mobility of tau, known to be associated to increased tau phosphorylation.	p(HGNC:ATP7A)	directlyDecreases	act(p(HGNC:MAPT))
d239c08e-cd40-4f17-88f7-23fef993161f	0.86	PubMed	17367947	MC1 Significantly Reduces Total Tau and Insoluble Tau in Forebrains of P301L Mice Treated from 3 to 7 Months of Age, Whereas DA31 does not.	p(HGNC:ATP7A)	directlyDecreases	act(p(HGNC:MAPT))
ce7f684e-e629-4f31-a088-de3427dfae59	0.94	PubMed	3615578	Supply of excess ATP alone was sufficient to reduce migration of tau on SDS gels, diminish Tau-1 immunostaining, and induce the expression of epitopes recognized by the PHF-1 antibody, suggesting that Alzheimer-type phosphorylation may have occurred.	a(CHEBI:15422)	directlyDecreases	act(p(HGNC:MAPT))
ce7f684e-e629-4f31-a088-de3427dfae59	0.94	PubMed	10389225	To investigate whether GSK-3 inhibition can reduce amyloid and tau pathologies, neuronal cell death and memory deficits in vivo, double transgenic mice coexpressing human mutant APP and tau were treated with a novel non ATP competitive GSK-3beta inhibitor, NP12.	a(CHEBI:15422)	directlyDecreases	act(p(HGNC:MAPT))
ce7f684e-e629-4f31-a088-de3427dfae59	0.94	PubMed	18643199	Tau protein degradation is catalyzed by the ATP and ubiquitin independent 20S proteasome under normal cell conditions.	a(CHEBI:15422)	directlyDecreases	act(p(HGNC:MAPT))
ce7f684e-e629-4f31-a088-de3427dfae59	0.94	PubMed	2576998	Application of ATP (10 (-3) M) caused a decrease of tau and IJC amplitude, while apamine reduced the amplitude of IJC without any changes in their time course.	a(CHEBI:15422)	directlyDecreases	act(p(HGNC:MAPT))
74aea06e-3f00-4c2b-bc7f-11b94571849b	0.65	PubMed	18873443	Aspirin Triggered LXA 4 Reduces Tau Pathology.	a(PUBCHEM:2244)	directlyDecreases	act(p(HGNC:MAPT))
370ddc39-8f6f-4d72-9fff-0f1c50781cf8	0.65	PubMed	5605565	BAF treatment also decreased tau proteolysis.	p(HGNC:BANF1)	directlyDecreases	act(p(HGNC:MAPT))
2ca527e4-5ea3-47d7-8f9b-fe8606aa071e	0.65	PubMed	8976365	Our results indicate that NAP treatment of transgenic mice initiated at an early stage reduced both Abeta and tau pathology, suggesting that NAP might be a potential therapeutic agent for AD.	p(HGNC:BASP1)	directlyDecreases	act(p(HGNC:MAPT))
7d349a06-73d2-42ff-a4c2-5bfcb16bc774	0.65	PubMed	12888575	The data showing that tau pathology was significantly reduced by BBS1 antibodies suggest a close interaction between tau and Abeta in the development of AD, and may serve as an efficient novel immunotherapy against both hallmarks of this disease.	p(HGNC:BBS1)	directlyDecreases	act(p(HGNC:MAPT))
f7c7d468-df39-4197-9588-5c6092784b04	0.65	PubMed	17713609	In addition, co-chaperone BCL2 associated athanogene 2 (BAG2) could preferentially and efficiently degrade insoluble and phosphorylated Tau, primarily through forming a complex with Hsp70 on microtubules by capturing and delivering Tau protein to the non-ubiquitin-independent proteasomal pathway for degradation.	p(HGNC:BCL2)	directlyDecreases	act(p(HGNC:MAPT, pmod(Ph)))
97a5fecd-46c7-4cbe-8a92-4770ea066f38	0.92	PubMed	19989757	Neonatal bilirubin induced neurotoxicity was validated by significantly decreased serum BDNF, brain BDNF, and serum S100B, along with significantly increased serum tau protein (p < 0.05).	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:MAPT))
97a5fecd-46c7-4cbe-8a92-4770ea066f38	0.92	PubMed	18661772	Therefore, one possibility is that reduction of BDNF protein increases P-tau, while P-tau does not directly reduce BDNF.	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:MAPT))
97a5fecd-46c7-4cbe-8a92-4770ea066f38	0.92	PubMed	20061629	Therefore, one possibility is that reduction of BDNF protein increases P-tau, while P-tau does not directly reduce BDNF.	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:MAPT))
b17b5e38-0511-4071-8d37-f193c489fb70	0.65	PubMed	23399914	First, we obtained evidence that a deregulation of BIN1 expression is likely pathological : (i) BIN1 is over-expressed in the brain of AD cases; (ii) a functional variant, rs59335482, associated with increased transcriptional activity in vitro could mediate AD risk by increasing BIN1 cerebral expression in vivo; (iii) loss of the Drosophila BIN1 ortholog Amph was able to suppress Tau induced neurotoxicity in line with a deleterious role of increased BIN1 expression in the AD brain.	p(HGNC:BIN1)	directlyDecreases	act(p(HGNC:MAPT))
b47267c3-1bf0-422c-a1ab-da4607328cce	0.65	PubMed	702699	PCP (1.0 mM) decreased tau protein (50 kD) in the cytoplasmic (supernatant) fraction as well as in the membrane (pellet) fraction.	p(HGNC:BMP1)	directlyDecreases	act(p(HGNC:MAPT))
d3a577c3-f4af-43c4-a10a-3cd7d8f46ccd	0.65	PubMed	23737459	Similarly, Bosutinib decreased p-Tau in AV10 (62ng/mL) and increased it in lysosomes (24ng/mL) compared to DMSO.	a(PUBCHEM:5328940)	directlyDecreases	act(p(HGNC:MAPT))
f6bb27a8-b2ce-4669-8b6b-a0571cb33c61	0.86	PubMed	27079381	One possible explanation might be that the observed C9orf72 decrease in GRN and MAPT cases is a consequence of the neurodegeneration process.	p(HGNC:C9orf72)	directlyDecreases	act(p(HGNC:MAPT))
f6bb27a8-b2ce-4669-8b6b-a0571cb33c61	0.86	PubMed	27079381	Taken together these results suggest that the risk haplotype affects C9orf72 expression in brain tissue, but it does not fully explain the observed C9orf72 reduction in MAPT and GRN patients as it was also detected in cases not carrying the risk allele.	p(HGNC:C9orf72)	directlyDecreases	act(p(HGNC:MAPT))
14d98fe9-25c3-489f-a446-d06e127643a0	0.65	PubMed	593091	The effects of cyclic AMP dependent protein kinase (cAMP-PK) or Ca2 +/calmodulin-dependent protein kinase II (CaMKII) phosphorylation on the binding of bovine tau to tubulin and calpain mediated degradation of tau were studied.	p(HGNC:CA2)	directlyDecreases	act(p(HGNC:MAPT))
0928fdb8-b241-4397-8130-a0f9ad330a6a	0.99	PubMed	10090741	We found that when tau was first phosphorylated by A-kinase, C-kinase, cdk5, or CaM kinase II and then by GSK-3, its binding to microtubules was inhibited by 45, 61, 78, and 79%, respectively. Further, the kinase combinations cdk5/GSK-3 and CaM kinase II/GSK-3 rapidly phosphorylated the sites Thr 231 and Ser 235. When these sites were individually replaced by Ala and the phosphorylation experiments repeated, tau binding to microtubules was inhibited by 54 and 71%, respectively. By comparison, when Ser 262 was replaced by Ala, tau binding to microtubules was inhibited by only 8% after phosphorylation by CaM kinase II.	p(HGNC:CAMK2A)	directlyDecreases	act(p(HGNC:MAPT))
0928fdb8-b241-4397-8130-a0f9ad330a6a	0.99	PubMed	10090741	We found that when tau was first phosphorylated by A-kinase, C-kinase, cdk5, or CaM kinase II and then by GSK-3, its binding to microtubules was inhibited by 45, 61, 78, and 79%, respectively. Further, the kinase combinations cdk5/GSK-3 and CaM kinase II/GSK-3 rapidly phosphorylated the sites Thr 231 and Ser 235. When these sites were individually replaced by Ala and the phosphorylation experiments repeated, tau binding to microtubules was inhibited by 54 and 71%, respectively. By comparison, when Ser 262 was replaced by Ala, tau binding to microtubules was inhibited by only 8% after phosphorylation by CaM kinase II.	p(HGNC:CAMK2A)	directlyDecreases	act(p(HGNC:MAPT))
0928fdb8-b241-4397-8130-a0f9ad330a6a	0.99	PubMed	10090741	We found that when tau was first phosphorylated by A-kinase, C-kinase, cdk5, or CaM kinase II and then by GSK-3, its binding to microtubules was inhibited by 45, 61, 78, and 79%, respectively. Further, the kinase combinations cdk5/GSK-3 and CaM kinase II/GSK-3 rapidly phosphorylated the sites Thr 231 and Ser 235. When these sites were individually replaced by Ala and the phosphorylation experiments repeated, tau binding to microtubules was inhibited by 54 and 71%, respectively. By comparison, when Ser 262 was replaced by Ala, tau binding to microtubules was inhibited by only 8% after phosphorylation by CaM kinase II.	p(HGNC:CAMK2A)	directlyDecreases	act(p(HGNC:MAPT))
b06ebc5a-aed9-41c4-968e-e5c30894c2ed	0.94	PubMed	25969760	Besides tau phosphorylation, calpain activation might play a role in tau-mediated neurodegeneration by inducing tau cleavage. In vitro studies have shown that both fetal and adult tau isoforms are rapidly proteolyzed by calpains	p(HGNC:CAPN1)	directlyDecreases	act(p(HGNC:MAPT))
e21cf1c5-5d68-40e0-a475-6bac3809cc1e	0.94	PubMed	25969760	Besides tau phosphorylation, calpain activation might play a role in tau-mediated neurodegeneration by inducing tau cleavage. In vitro studies have shown that both fetal and adult tau isoforms are rapidly proteolyzed by calpains	p(HGNC:CAPN2)	directlyDecreases	act(p(HGNC:MAPT))
e72db8e6-9f67-4760-a0b3-8833b159bb7c	0.94	PubMed	25969760	Besides tau phosphorylation, calpain activation might play a role in tau-mediated neurodegeneration by inducing tau cleavage. In vitro studies have shown that both fetal and adult tau isoforms are rapidly proteolyzed by calpains	p(HGNC:CAPN3)	directlyDecreases	act(p(HGNC:MAPT))
6ef1c389-67d0-40ed-8302-db48a39e2d4d	0.65	PubMed	18894782	On the other hand, in vitro studies reported that Cat D degrades tau and that autophagic-lysosomal systems play a role in tau clearance, suggesting that higher levels of hippocampal Cat D might represent lysosomal activation in response to tau accumulation.	p(HGNC:CAT)	directlyDecreases	act(p(HGNC:MAPT))
8dd27f34-1da5-417b-8fd2-172025ceefd1	0.65	PubMed	18793405	CAST is known to prevent oligomerization of Tau and alpha-synuclein and inhibit reactive gliosis.	p(HGNC:CD3EAP)	directlyDecreases	act(p(HGNC:MAPT))
e24059d0-8d99-4f1b-9458-f17e0b3d21fe	0.65	PubMed	18849422	Cdc37 siRNA reduced phospho-tau to a greater extent than total tau.	p(HGNC:CDC37)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12226093	Phosphopeptide mapping revealed enhanced phosphorylation of ser(202)/thr(205) residues by p25-cdk5  considering the fact that phosphorylation of ser(202)/thr(205) antagonizes the tau-mediated nucleation of tubulin, p25-cdk5 may play a pivotal role in neuronal cell death in alzheimer's disease.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	21215781	However, other kinases, such as cdk5, p38 and pka, also phosphorylate tau at t231tau phosphorylation at t231, s235 and s262 also contributes to the dissociation of tau from microtubules	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	12226093	Phosphopeptide mapping revealed enhanced phosphorylation of ser(202)/thr(205) residues by p25-cdk5  considering the fact that phosphorylation of ser(202)/thr(205) antagonizes the tau-mediated nucleation of tubulin, p25-cdk5 may play a pivotal role in neuronal cell death in alzheimer's disease.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
811f5022-da1e-4df5-89e1-ccb20cad0390	0.99	PubMed	21215781	Cdk5 regulates app (amyloid precursor protein) processing and tau hyperphosphorylationtau phosphorylation at t231, s235 and s262 also contributes to the dissociation of tau from microtubules	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:MAPT))
353fe3c7-7cbd-4e62-ada9-349aa648ff85	0.86	PubMed	21439371	In contrast, CELF2 and CELF4 significantly reduced Tau exon 2-inclusion by 17% (= 0.0001) and by 12% (= 0.0012), respectively (B and C).	p(HGNC:CELF2)	directlyDecreases	act(p(HGNC:MAPT))
353fe3c7-7cbd-4e62-ada9-349aa648ff85	0.86	PubMed	21439371	Finally, Tau exon-10 inclusion was promoted by CELF4 and repressed by CELF2 but neither by CELF1 nor DN-CELF in both T98 and HeLa cells ().	p(HGNC:CELF2)	directlyDecreases	act(p(HGNC:MAPT))
e05c1f62-e9f6-4ec8-91de-97e933596d1c	0.94	PubMed	21215781	Tau pseudophosphorylation at specific sites such as s262, s293, s324 and s356 was reported to induce tau conformational change and attenuate tau binding to microtubules (fischer et al., 2009). Then, newly soluble tau proteins are targeted by post-translational modifications that directly or indirectly alter tau conformation, promoting tau dimerization in an anti-parallel manner. Stable tau dimers form tau oligomers, which continue in the aggregation process	p(HGNC:CHEK2)	directlyDecreases	act(p(HGNC:MAPT))
c2d4ac14-01f8-4687-b518-2ba7cd698058	0.65	PubMed	16935445	Khalid Iqbal (New York State Institute for Basic Research, New York City, NY, USA) discussed peptide-6, a peptide fragment of the ciliary neurotrophic factor that decreased Abeta and phospho-tau in a mouse model of AD.	p(HGNC:CNTF)	directlyDecreases	act(p(HGNC:MAPT))
1f1063f0-ce59-49d0-ae33-577b5305f4d7	0.65	PubMed	17434144	Evidence has shown that levels of CSF Abeta decrease prior to elevated levels of tau and p-tau, supporting the hypothesis that abnormal Abeta metabolism precedes tau related pathology and subsequent neuronal degeneration [XREF_BIBR].	p(HGNC:CSF2)	directlyDecreases	act(p(HGNC:MAPT))
bbe48dc8-1ef8-4d1c-a408-886792a7102e	0.99	PubMed	14761950	Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.Here we characterized the contribution of one ck1 isoform, ckidelta, to the phosphorylation of tau at residues ser202/thr205 and ser396/ser404 in human embryonic kidney 293 cells.	p(HGNC:CSNK1D)	directlyDecreases	act(p(HGNC:MAPT))
bbe48dc8-1ef8-4d1c-a408-886792a7102e	0.99	PubMed	14761950	Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.Here we characterized the contribution of one ck1 isoform, ckidelta, to the phosphorylation of tau at residues ser202/thr205 and ser396/ser404 in human embryonic kidney 293 cells.	p(HGNC:CSNK1D)	directlyDecreases	act(p(HGNC:MAPT))
bbe48dc8-1ef8-4d1c-a408-886792a7102e	0.99	PubMed	14761950	Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.Here we characterized the contribution of one ck1 isoform, ckidelta, to the phosphorylation of tau at residues ser202/thr205 and ser396/ser404 in human embryonic kidney 293 cells.	p(HGNC:CSNK1D)	directlyDecreases	act(p(HGNC:MAPT))
bbe48dc8-1ef8-4d1c-a408-886792a7102e	0.99	PubMed	14761950	Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.Here we characterized the contribution of one ck1 isoform, ckidelta, to the phosphorylation of tau at residues ser202/thr205 and ser396/ser404 in human embryonic kidney 293 cells.	p(HGNC:CSNK1D)	directlyDecreases	act(p(HGNC:MAPT))
5dfbcd28-65ca-42ee-9054-205ef3674d0e	0.86	PubMed	22042832	Tau aggregates can be degraded by cathepsin D in autophagosomes-lysosomes.	p(HGNC:CTSD)	directlyDecreases	act(p(HGNC:MAPT))
5dfbcd28-65ca-42ee-9054-205ef3674d0e	0.86	PubMed	17483337	Indeed, reduction of lysosomal proteolysis results in an Alzheimer like axonal dystrophy, knockout of cathepsin D promotes Tau neurotoxicity, and an age related reduction in the activity of cathepsin B and D is associated with the production of amyloidogenic fragments of amyloid precursor protein.	p(HGNC:CTSD)	directlyDecreases	act(p(HGNC:MAPT))
99c4b3ee-1354-4f5b-8e90-19e63f01a5b0	0.86	PubMed	20461814	In our preparations, baclofen 10 fiM selectively inhibited Asp and Glu total and Ca ^-independent evoked release and at a higher (100 ^ M) concentration, inhibition of Tau and Ala total release (which is completely Ca2 ^ dependent) was also observed.	a(CHEBI:29108)	directlyDecreases	act(p(HGNC:MAPT))
99c4b3ee-1354-4f5b-8e90-19e63f01a5b0	0.86	PubMed	6908339	In addition, when the extracts containing 1 mmol/L CaCl (2) were treated with mu-calpain inhibitor (0.05 micromol/L of calpastatin) or m-calpain inhibitor (100 micromol/L calpain inhibitor IV) or both, the Ca (2+)-induced degradation of tau protein was blocked to about 8.6% 92.5% and 97.8% compared with the group with 1 mmol/L CaCl (2), respectively.	a(CHEBI:29108)	directlyDecreases	act(p(HGNC:MAPT))
e72e7e6b-4e24-47d0-aa90-3ee7987d1275	0.95	PubMed	7215287	Finally, in apoptotic conditions, Tau proteins were degraded at their carboxy terminus by caspase, leading to an apparent decrease in Tau phosphorylation in this region.	p(FPLX:Caspase)	directlyDecreases	act(p(HGNC:MAPT))
e72e7e6b-4e24-47d0-aa90-3ee7987d1275	0.95	PubMed	18519819	There is evidence that tau is degraded by the autophagic-lysosomal system [XREF_BIBR], the proteasome [XREF_BIBR], and by caspases and calpains [XREF_BIBR].	p(FPLX:Caspase)	directlyDecreases	act(p(HGNC:MAPT))
e72e7e6b-4e24-47d0-aa90-3ee7987d1275	0.95	PubMed	15221002	Atorvastatin prevents AbetaO induced neurotoxicity in cultured rat hippocampal neurons by inhibiting calpain- and caspase mediated Tau cleavage.	p(FPLX:Caspase)	directlyDecreases	act(p(HGNC:MAPT))
e72e7e6b-4e24-47d0-aa90-3ee7987d1275	0.95	PubMed	25891085	Atorvastatin prevents AbetaO induced neurotoxicity in cultured rat hippocampal neurons by inhibiting calpain- and caspase mediated Tau cleavage.	p(FPLX:Caspase)	directlyDecreases	act(p(HGNC:MAPT))
e72e7e6b-4e24-47d0-aa90-3ee7987d1275	0.95	PubMed	16457803	In addition, PIO decreased cleaved caspase3 and C-terminal truncated tau species by caspase, which is expected to decrease tau aggregation.	p(FPLX:Caspase)	directlyDecreases	act(p(HGNC:MAPT))
20ae498a-6ae1-4988-858a-8a408dc7b8ba	0.86	PubMed	17319954	Crocin inhibited tau aggregation with IC 50 of 100 microg/ml.	a(PUBCHEM:5281233)	directlyDecreases	act(p(HGNC:MAPT))
20ae498a-6ae1-4988-858a-8a408dc7b8ba	0.86	PubMed	15323738	Crocin inhibited tau aggregation with IC50 of 100 microg/ml.	a(PUBCHEM:5281233)	directlyDecreases	act(p(HGNC:MAPT))
d3d4f05c-fdb3-42bc-ab2b-e4c113ffab64	0.86	PubMed	24853415	Altogether, these results suggest that DAPK1 overexpression inhibits tau protein turnover in cells.	p(HGNC:DAPK1)	directlyDecreases	act(p(HGNC:MAPT))
d3d4f05c-fdb3-42bc-ab2b-e4c113ffab64	0.86	PubMed	24853415	Overall, our data suggest a model in which DAPK1 inhibits tau function via aberrant tau phosphorylation and accumulation followed by impaired tau-MT interactions and promote pathological tau aggregation through inhibitory phosphorylation of Pin1 (XREF_SUPPLEMENTARY).	p(HGNC:DAPK1)	directlyDecreases	act(p(HGNC:MAPT))
287f1305-3a78-42be-b065-07716959e9c0	0.65	PubMed	17507479	The results of PCA, HCA, and heat map suggested that the improvement of cardiac function and elimination of edema in model should be attributed to fat oil fraction (DS-A5), which promoted Phe metabolism, increased plasma level of DA, decreased excretion of Tau, and accelerated excretion of renal and cardiac toxin.	a(CHEBI:18243)	directlyDecreases	act(p(HGNC:MAPT))
86b80beb-335b-47f1-97ab-10a4c0c0146d	0.65	PubMed	24440524	In agreement with previous experiments (), the co-expression of DT with MBNL1 did not significantly reduce the skipping of Tau exon 2 whereas ectopic MBNL2 expression did (A).	p(HGNC:DCT)	directlyDecreases	act(p(HGNC:MAPT))
3a456130-4b9a-49ca-a904-868c9314b39b	0.86	PubMed	21177183	PDC and DK also attenuated increases in extracellular concentrations of ASP, GABA and TAU, but not DA, produced by AMPH (20 mug and mul) (<ce:cross-ref refid="FIG3"> Fig. 3 </ce:cross-ref> <ce:float-anchor refid="FIG3"/>).	a(PUBCHEM:6427003)	directlyDecreases	act(p(HGNC:MAPT))
3a456130-4b9a-49ca-a904-868c9314b39b	0.86	PubMed	21177183	</ce:para> <ce:para view="all"> As shown in the results section, the specific GLU uptake inhibitors PDC and DK not only attenuated the increase in GLU produced by AMPH but also the increase in GABA and TAU.	a(PUBCHEM:6427003)	directlyDecreases	act(p(HGNC:MAPT))
87e0d128-b93a-4dea-b76c-93de30ec09d1	1.0	PubMed	18696092	DYRK1A induced tau phosphorylation inhibits tau activity to stimulate microtubule assembly and promotes its self-assembly into filaments [XREF_BIBR].	p(HGNC:DYRK1A)	directlyDecreases	act(p(HGNC:MAPT))
87e0d128-b93a-4dea-b76c-93de30ec09d1	1.0	PubMed	18787790	DYRK1A induced tau phosphorylation inhibits tau activity to stimulate microtubule assembly and promotes its self-assembly into filaments.	p(HGNC:DYRK1A)	directlyDecreases	act(p(HGNC:MAPT))
87e0d128-b93a-4dea-b76c-93de30ec09d1	1.0	PubMed	18735407	DYRK1A induced tau phosphorylation inhibits tau activity to stimulate microtubule assembly and promotes its self-assembly into filaments [XREF_BIBR].	p(HGNC:DYRK1A)	directlyDecreases	act(p(HGNC:MAPT))
87e0d128-b93a-4dea-b76c-93de30ec09d1	1.0	PubMed	21215488	In neuronal N2a cells, we found that over-expression of Dyrk1A suppressed tau E10 inclusion, whereas inhibition of Dyrk1A led to increased E10 inclusion.	p(HGNC:DYRK1A)	directlyDecreases	act(p(HGNC:MAPT))
87e0d128-b93a-4dea-b76c-93de30ec09d1	1.0	PubMed	21215488	In the neuronal cells, Dyrk1A suppressed tau E10 inclusion.	p(HGNC:DYRK1A)	directlyDecreases	act(p(HGNC:MAPT))
87e0d128-b93a-4dea-b76c-93de30ec09d1	1.0	PubMed	21157379	DYRK1A induced tau phosphorylation inhibits tau activity to stimulate microtubule assembly and promotes its self-assembly into filaments (XREF_BIBR, XREF_BIBR).	p(HGNC:DYRK1A)	directlyDecreases	act(p(HGNC:MAPT))
87e0d128-b93a-4dea-b76c-93de30ec09d1	1.0	PubMed	21215781	Dyrk1a phosphorylates tau at least at s202, t212 and s404, but t212 phosphorylation is known to initiate tau hyperphosphorylation by gsk3b (ryoo et al., 2007;woods et al., 2001) and has been demonstrated to have a role in alternative splicing of taumrna	p(HGNC:DYRK1A)	directlyDecreases	act(p(HGNC:MAPT))
87e0d128-b93a-4dea-b76c-93de30ec09d1	1.0	PubMed	21215781	Dyrk1a phosphorylates tau at least at s202, t212 and s404, but t212 phosphorylation is known to initiate tau hyperphosphorylation by gsk3b (ryoo et al., 2007;woods et al., 2001) and has been demonstrated to have a role in alternative splicing of taumrna	p(HGNC:DYRK1A)	directlyDecreases	act(p(HGNC:MAPT))
87e0d128-b93a-4dea-b76c-93de30ec09d1	1.0	PubMed	21215781	Dyrk1a phosphorylates tau at least at s202, t212 and s404, but t212 phosphorylation is known to initiate tau hyperphosphorylation by gsk3b (ryoo et al., 2007;woods et al., 2001) and has been demonstrated to have a role in alternative splicing of taumrna	p(HGNC:DYRK1A)	directlyDecreases	act(p(HGNC:MAPT))
31f19c23-e5fc-4879-87c4-4e3c1aa87ed0	0.94	PubMed	18653404	Since EGCG inhibited tau aggregation at highly substoichiometric concentrations, stable, quantitative binding to the tau monomer can not explain its effect.	a(CHEBI:4806)	directlyDecreases	act(p(HGNC:MAPT))
31f19c23-e5fc-4879-87c4-4e3c1aa87ed0	0.94	PubMed	22055905	EGCG treatment reduced cytotoxicity of Abeta [see also XREF_TABLE], Htt, alpha-Syn, IAPP and tau in cellular models.	a(CHEBI:4806)	directlyDecreases	act(p(HGNC:MAPT))
31f19c23-e5fc-4879-87c4-4e3c1aa87ed0	0.94	PubMed	22055905	In XREF_FIG, we see that EGCG prevents the large-scale formation of SDS-stable dimers (D), oligomers (O) and high-molecular-weight species (HMW) of tau, likely by sequestering a rate limiting but non SDS-stable aggregation nucleus, leaving most of the protein in its monomeric state.	a(CHEBI:4806)	directlyDecreases	act(p(HGNC:MAPT))
31f19c23-e5fc-4879-87c4-4e3c1aa87ed0	0.94	PubMed	25436420	Since EGCG inhibited tau aggregation at highly substoichiometric concentrations, stable, quantitative binding to the tau monomer can not explain its effect.	a(CHEBI:4806)	directlyDecreases	act(p(HGNC:MAPT))
747ed53f-0ba5-4a68-9c01-9fbd34e16e5c	0.65	PubMed	17304424	PERK overexpression reversed the annonacin induced increase in 4R MAPT mRNA (Fig XREF_FIG B) and protected LUHMES neurons against toxicity induced by annonacin (Fig XREF_FIG C and D) and 4R tau overexpression in a similar fashion to PERK activator treatment (Fig XREF_FIG E and F).	p(HGNC:EIF2AK3)	directlyDecreases	act(p(HGNC:MAPT))
9af91e3d-58a4-40e1-8ae4-03d37012601e	0.65	PubMed	21350363	</ce:label> <ce:caption> <ce:simple-para id="spara20" view="all"> Inhibition of PPs, activation of protein kinases, and phosphorylation of tau in rat brain slices treated with OA or CsA.	a(CHEBI:4031)	directlyDecreases	act(p(HGNC:MAPT))
45a64838-8407-411f-bca9-34a25337f0cc	0.65	PubMed	17268123	LMTX (TM) inhibited tau aggregation in a cellular assay and reduced tau aggregates and rescued learning impairment in two tau aggregation prone mouse models, which expressed either a truncated tau fusion protein or a full-length tau protein with FTDP-17 mutations [XREF_BIBR].	p(HGNC:"ERVK-18")	directlyDecreases	act(p(HGNC:MAPT))
53f85306-f55b-43a7-9b41-4972be22c2a4	0.65	PubMed	20200537	RNA interference mediated disruption of FERMT2 homologs enhances Tau toxicity in Drosophila indicates these associations.	p(HGNC:FERMT2)	directlyDecreases	act(p(HGNC:MAPT))
1b3f07e7-df7a-43e6-94ab-05d5bc62d1bd	0.86	PubMed	17508809	FKBP52 (FK506 binding protein 52) has been found to inhibit Tau protein aggregation.	complex(a(PUBCHEM:445643), p(HGNC:FKBP4))	directlyDecreases	act(p(HGNC:MAPT))
1b3f07e7-df7a-43e6-94ab-05d5bc62d1bd	0.86	PubMed	14385990	FKBP52 (FK506 binding protein 52) has been found to inhibit Tau protein aggregation.	complex(a(PUBCHEM:445643), p(HGNC:FKBP4))	directlyDecreases	act(p(HGNC:MAPT))
896947ca-2313-42ee-80a3-a250271e8696	0.95	PubMed	24581495	As recently described, Hsp90 and the co-chaperone FKBP51 can prevent Tau from forming dense amyloids, and rather promote the formation of more toxic Tau intermediates (XREF_BIBR).	p(HGNC:FKBP4)	directlyDecreases	act(p(HGNC:MAPT))
896947ca-2313-42ee-80a3-a250271e8696	0.95	PubMed	10846148	Overexpression of FKBP52 in differentiated PC12 cells prevented the accumulation of Tau and resulted in reduced neurite length.	p(HGNC:FKBP4)	directlyDecreases	act(p(HGNC:MAPT))
896947ca-2313-42ee-80a3-a250271e8696	0.95	PubMed	20133804	Overexpression of FKBP52 in differentiated PC12 cells prevented the accumulation of Tau and resulted in reduced neurite length.	p(HGNC:FKBP4)	directlyDecreases	act(p(HGNC:MAPT))
896947ca-2313-42ee-80a3-a250271e8696	0.95	PubMed	14385990	The FKBP52 structure variation may induce FKBP52 activation and inhibit Tau protein aggregation.	p(HGNC:FKBP4)	directlyDecreases	act(p(HGNC:MAPT))
896947ca-2313-42ee-80a3-a250271e8696	0.95	PubMed	17508809	The FKBP52 structure variation may induce FKBP52 activation and inhibit Tau protein aggregation.	p(HGNC:FKBP4)	directlyDecreases	act(p(HGNC:MAPT))
896947ca-2313-42ee-80a3-a250271e8696	0.95	PubMed	26655856	Tau degradation is modulated by FKBP51, an immunophilin with a prolyl / isomerisation domain, leading to the hypothesis that specific prolyl bonds of Tau would be necessary for microtubule stabilization.	p(HGNC:FKBP4)	directlyDecreases	act(p(HGNC:MAPT))
b11bc4a4-51c7-4983-955c-ee40cdf13e39	0.65	PubMed	16426137	Foxp2 mRNA and protein are also reduced with disease progression in the somatosensory cortex in transgenic mice bearing the P301S mutation in MAPT when compared with wild-type littermates.	p(HGNC:FOXP2)	directlyDecreases	act(p(HGNC:MAPT))
5d18ff85-db20-4b3a-a05a-672bd861c44b	0.86	PubMed	18573239	Identification that FUS and TLS suppresses splicing of MAPT exon 10 is of particular relevance for disease pathogenesis, as mutations that increase the inclusion of exon 10 are linked to frontotemporal dementia 31.	p(HGNC:FUS)	directlyDecreases	act(p(HGNC:MAPT))
5d18ff85-db20-4b3a-a05a-672bd861c44b	0.86	PubMed	23023293	Identification that FUS and TLS suppresses splicing of MAPT exon 10 is of particular relevance for disease pathogenesis, as mutations that increase the inclusion of exon 10 are linked to frontotemporal dementia 31.	p(HGNC:FUS)	directlyDecreases	act(p(HGNC:MAPT))
947dfe47-6623-4108-91ac-7f47718a4951	0.94	PubMed	14999081	In this study we determined that human tau tyr18 was phosphorylated by the src family tyrosine kinase fyn.	p(HGNC:FYN)	directlyDecreases	act(p(HGNC:MAPT))
44d44113-3d8a-4b1d-ab32-9e92b5398954	0.65	PubMed	16420965	In our study GF 109203X reversed GSK-3beta-mediated Tau hyperphosporylation with the IC values of 1.1 +/-0.2 and 4.6 +/-0.4 muM at Ser396 and Ser202 sites, respectively.	a(PUBCHEM:92953)	directlyDecreases	act(p(HGNC:MAPT))
21f96979-48d2-4c75-8908-ff607b520812	0.86	PubMed	15788569	GP could improve the memory ability and reduce the content of Abeta1-42 and p-tau in AD rats.	a(PUBCHEM:3013625)	directlyDecreases	act(p(HGNC:MAPT))
21f96979-48d2-4c75-8908-ff607b520812	0.86	PubMed	15788569	GP also reduced the content of Abeta1-42 and p-tau and improved the mRNA and protein expression of PI3K, p-Akt and Akt, and Bcl-2 and Bax in the hippocampus.	a(PUBCHEM:3013625)	directlyDecreases	act(p(HGNC:MAPT))
8ec57d9b-f31b-43cf-a1c7-f269faa3151b	0.65	PubMed	18437544	The present data show that blockade of NR2A subunits with NVP significantly increased the phosphorylation of Ser199 epitope located in the proline rich domain of Tau.	p(HGNC:GRIN2A)	directlyDecreases	act(p(HGNC:MAPT))
c79d5a0a-5f1b-479d-9d60-e3aac2163b9b	0.99	PubMed	9771888	Tau is phosphorylated by gsk-3 at several sites found in alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by a-kinase.	p(HGNC:GSK3A)	directlyDecreases	act(p(HGNC:MAPT))
c79d5a0a-5f1b-479d-9d60-e3aac2163b9b	0.99	PubMed	7706316	Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.	p(HGNC:GSK3A)	directlyDecreases	act(p(HGNC:MAPT))
c79d5a0a-5f1b-479d-9d60-e3aac2163b9b	0.99	PubMed	7566348	The ability of p42 map and p44 map kinases, glycogen synthase kinases 3 alpha and 3 beta (gsk-3 alpha and gsk-3 beta) to phosphorylate tau in transfected cos cells was investigated. Both gsk-3 alpha and gsk-3 beta phosphorylated tau to produce a phf-like state of phosphorylation but the map kinases failed to induce such a transformation in tau.	p(HGNC:GSK3A)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	21949350	We also demonstrate that GSK-3beta (shaggy) is a common suppressor of tau, Abeta42 and TDP-43 toxicity, and that GSK-3beta activity is strongly upregulated due to mutant TDP-43 expression.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	21443865	GSK3B might modulate tau mRNA splicing and then reduce the ability of tau to bind to microtubules ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	9771888	Sequencing of 32P-labeled trypsin phosphopeptides from tau prephosphorylated by A-kinase (using unlabeled ATP) and further phosphorylated by GSK-3 in the presence of [gamma-32P]ATP revealed that Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356 and Ser-404 are phosphorylated, whereas if tau is not prephosphorylated by A-kinase, GSK-3 phosphorylates it at Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400. These data suggest that (i) prephosphorylation of tau by A-kinase makes additional and different sites accessible for phosphorylation by GSK-3; (ii) phosphorylation of tau at these additional sites further inhibits the biological activity of tau in its ability to bind to microtubules and promote microtubule assembly.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	Sequencing of 32P-labeled trypsin phosphopeptides from tau prephosphorylated by A-kinase (using unlabeled ATP) and further phosphorylated by GSK-3 in the presence of [gamma-32P]ATP revealed that Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356 and Ser-404 are phosphorylated, whereas if tau is not prephosphorylated by A-kinase, GSK-3 phosphorylates it at Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400. These data suggest that (i) prephosphorylation of tau by A-kinase makes additional and different sites accessible for phosphorylation by GSK-3; (ii) phosphorylation of tau at these additional sites further inhibits the biological activity of tau in its ability to bind to microtubules and promote microtubule assembly.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	9832145	Sequencing of 32P-labeled trypsin phosphopeptides from tau prephosphorylated by A-kinase (using unlabeled ATP) and further phosphorylated by GSK-3 in the presence of [gamma-32P]ATP revealed that Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356 and Ser-404 are phosphorylated, whereas if tau is not prephosphorylated by A-kinase, GSK-3 phosphorylates it at Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400. These data suggest that (i) prephosphorylation of tau by A-kinase makes additional and different sites accessible for phosphorylation by GSK-3; (ii) phosphorylation of tau at these additional sites further inhibits the biological activity of tau in its ability to bind to microtubules and promote microtubule assembly.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	9771888	Tau is phosphorylated by gsk-3 at several sites found in alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by a-kinase.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	17078951	Here, we found that prephosphorylation by pka promotes gsk-3beta-catalyzed tau phosphorylation at thr181, ser199, ser202, thr205, thr217, thr231, ser396 and ser422	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	21215781	Tau pseudophosphorylation at specific sites such as s262, s293, s324 and s356 was reported to induce tau conformational change and attenuate tau binding to microtubules (fischer et al., 2009). Then, newly soluble tau proteins are targeted by post-translational modifications that directly or indirectly alter tau conformation, promoting tau dimerization in an anti-parallel manner. Stable tau dimers form tau oligomers, which continue in the aggregation process	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	17078951	Here, we found that prephosphorylation by pka promotes gsk-3beta-catalyzed tau phosphorylation at thr181, ser199, ser202, thr205, thr217, thr231, ser396 and ser422	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20679343	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-? Peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated tau protein. Tau is mostly found in a hyperphosphorylated form in these tangleswe find that three residues can be phosphorylated (ser-396, ser-400, and ser-404) by gsk3?	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20679343	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-? Peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated tau protein. Tau is mostly found in a hyperphosphorylated form in these tangleswe find that three residues can be phosphorylated (ser-396, ser-400, and ser-404) by gsk3?	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20308788	Abnormal hyperphosphorylation of tau appears to be crucial in neurofibrillary degeneration in alzheimer's disease (ad). Gsk-3beta phosphorylated tau at many sites, with ser199, thr205, and ser396 being the most favorable sites in cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20679343	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-? Peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated tau protein. Tau is mostly found in a hyperphosphorylated form in these tangleswe find that three residues can be phosphorylated (ser-396, ser-400, and ser-404) by gsk3?	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20308788	Abnormal hyperphosphorylation of tau appears to be crucial in neurofibrillary degeneration in alzheimer's disease (ad). Gsk-3beta phosphorylated tau at many sites, with ser199, thr205, and ser396 being the most favorable sites in cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	21215781	Gsk3b phosphorylates tau at t231tau phosphorylation at t231, s235 and s262 also contributes to the dissociation of tau from microtubules	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
9f22bcdb-105d-4feb-9722-aeeb071e262f	0.65	PubMed	14098780	At low temperature, tau is limited by a spin quantum tunneling, whereas at high temperature a thermally activated relaxation prevails with U (eff) = ~ 48 cm (-1).	p(HGNC:GTF2I)	directlyDecreases	act(p(HGNC:MAPT))
275ada1e-e641-4514-bbd4-bf1f2fa68788	0.86	PubMed	594643	Glycogen synthase kinase-3 (GSK-3) reduced the mobility of human tau on SDS-PAGE, prevented binding of the monoclonal antibody (mAb), Tau.1, and induced binding of the mAb 8D8.	p(FPLX:GYS)	directlyDecreases	act(p(HGNC:MAPT))
275ada1e-e641-4514-bbd4-bf1f2fa68788	0.86	PubMed	14833631	Remarkably, inhibition of glycogen synthase kinase-3beta rescues BDNF transport defects independent of tau.	p(FPLX:GYS)	directlyDecreases	act(p(HGNC:MAPT))
3d1e443a-8f8f-4363-b6f2-14cdf1cdc22a	0.86	PubMed	22492994	HDAC6 deficiency promotes tau degradation.	p(HGNC:HDAC6)	directlyDecreases	act(p(HGNC:MAPT))
3d1e443a-8f8f-4363-b6f2-14cdf1cdc22a	0.86	PubMed	22492994	Since loss of HDAC6 activity has been shown to increase the affinity of Hsp90 for Hsp90 inhibitors, such as 17AAG, as well as enhance 17AAG mediated degradation of Hsp90 client proteins (XREF_BIBR, XREF_BIBR), we sought to evaluate whether HDAC6 depletion would likewise enhance the degradation of tau induced by Hsp90 inhibition.	p(HGNC:HDAC6)	directlyDecreases	act(p(HGNC:MAPT))
af991071-f553-4ec3-b251-7c7ced94ffe9	0.92	PubMed	17513568	UPS pathways have been identified to degrade misfolded Tau proteins [XREF_BIBR, XREF_BIBR - XREF_BIBR].	p(HGNC:HMBS)	directlyDecreases	act(p(HGNC:MAPT))
af991071-f553-4ec3-b251-7c7ced94ffe9	0.92	PubMed	16937836	On the other hand, tau is inefficiently degraded by the UPS, although the non canonical 20S proteasomal degradation rather than the ubiquitin dependent 26S proteasomal degradation seems to have a predominant role [XREF_BIBR].	p(HGNC:HMBS)	directlyDecreases	act(p(HGNC:MAPT))
af991071-f553-4ec3-b251-7c7ced94ffe9	0.92	PubMed	17308218	Tau protein is degraded by the UPS in vitro and in vivo.	p(HGNC:HMBS)	directlyDecreases	act(p(HGNC:MAPT))
944a4b3b-3fc6-4879-9c4b-0bfe9796147b	0.65	PubMed	21949350	This suggests that Tom34 and Tom70 function more as chaperone proteins which would help to explain why increased expression of Tom34 suppresses tau toxicity.	p(UP:P38922)	directlyDecreases	act(p(HGNC:MAPT))
2d081e2d-eeaa-4f6d-93fb-57fd42e9b7c7	0.65	PubMed	17266184	In cells, the HSF-1 activator HSF1A reduced tau aggregation by increasing proteasomal degradation of tau.	p(HGNC:HSF1)	directlyDecreases	act(p(HGNC:MAPT))
b5609ae2-e202-4f1f-ae71-18212263a5cb	0.86	PubMed	17513568	It has been suggested that HSP90 promotes the degradation of Tau proteins by recruiting the C-terminus of the HSP70 interacting protein (CHIP) E3 ligase and the promotion of Tau protein clearance [XREF_BIBR].	p(FPLX:HSP90)	directlyDecreases	act(p(HGNC:MAPT))
b5609ae2-e202-4f1f-ae71-18212263a5cb	0.86	PubMed	16905971	XREF_BIBR, XREF_BIBR Indeed, elevated levels of intracellular Hsp70 and Hsp90 diminish Tau deposits and enhance microtubule binding.	p(FPLX:HSP90)	directlyDecreases	act(p(HGNC:MAPT))
85de1ece-25c0-4ff6-b192-c05caa56aa71	0.65	PubMed	18627313	Accordingly, Hsc70 might interfere with the ability of Hsp70-CHIP to degrade tau, leading to the observed increase in microtubule binding.	p(HGNC:HSPA8)	directlyDecreases	act(p(HGNC:MAPT))
486d1c4b-e489-4b24-b0b6-698c05f70754	0.92	PubMed	18784093	However, after incubation for 5 days, both wt- and 3xS/D Hsp27 reduced tau aggregation at sub-stoichiometric ratios (35:1) compared to tau incubated with buffer alone (XREF_FIG).	p(HGNC:HSPB1)	directlyDecreases	act(p(HGNC:MAPT))
486d1c4b-e489-4b24-b0b6-698c05f70754	0.92	PubMed	21084594	However, after incubation for 5 days, both wt- and 3xS/D Hsp27 reduced tau aggregation at sub-stoichiometric ratios (35:1) compared to tau incubated with buffer alone (XREF_FIG).	p(HGNC:HSPB1)	directlyDecreases	act(p(HGNC:MAPT))
486d1c4b-e489-4b24-b0b6-698c05f70754	0.92	PubMed	17591855	In vitro, HSP27 and its constitutively phosphorylated mutant form both interacted with and prevented tau accumulation.	p(HGNC:HSPB1)	directlyDecreases	act(p(HGNC:MAPT))
baf53340-b4eb-452b-838a-2e091225c3d1	0.65	PubMed	18514061	Without ApoE present, HtrA1 degraded Tau leading to a steady decrease in full-length Tau levels over time.	p(HGNC:HTRA1)	directlyDecreases	act(p(HGNC:MAPT))
e200a51e-6071-468c-8d10-7c096601523d	0.65	PubMed	18906517	Tau reduction by MR22 significantly decreased bang sensitivity in eas Drosophila by over 13% in eas; MR22/+ and 15% in eas; MR22 and tau EP3203 flies (XREF_FIG, eas; +/+ : 97% BS, eas; MR22/+ : 84% BS, eas; MR22 and tau EP3203 : 82% BS, p < 0.001, n> = 98).	p(UP:P35365)	directlyDecreases	act(p(HGNC:MAPT))
6bba3999-97df-46ce-828d-4e930e70cf3e	0.65	PubMed	18654952	Brain insulin and IGF deficiency and resistance directly contribute to oxidative stress, neuroinflammation, impaired function and survival of neurons and oligodendrocytes, reduced neurotransmitter functions required for plasticity, learning, and memory, deficient myelin integrity, and disrupted processing and function of tau and AbetaPP-Abeta.	p(UP:P22618)	directlyDecreases	act(p(HGNC:MAPT))
92a4493e-e752-4080-97a3-99fcc39a8450	0.65	PubMed	9666166	Minor alterations were seen in protein content with IFN; Il-1beta decreased alpha-synuclein and tau at 18 and 96 h; TNFalpha inversely reduced alpha-synuclein and increased ubiquitin content.	p(HGNC:IL1B)	directlyDecreases	act(p(HGNC:MAPT))
99fa8987-c700-444e-acdb-ddc1aaef36f1	0.92	PubMed	17412100	Additionally, insulin inhibits phophorylation of tau, which leads to an increase in neurofibrillary tangles XREF_BIBR.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:MAPT))
99fa8987-c700-444e-acdb-ddc1aaef36f1	0.92	PubMed	17872252	Thus, it is possible that the hyperinsulinemia seen in AD patients may lead to brain insulin resistance or reduced insulin transport, which can modulate both Abeta and p-tau to contribute to AD in a causal way.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:MAPT))
99fa8987-c700-444e-acdb-ddc1aaef36f1	0.92	PubMed	18253332	However, insulin injection significantly decreased tau hyperhosphorylation only at one phosphoepitope compared to STZ injected mice without insulin injection 30minutes before sacrifice.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:MAPT))
87395d0b-a200-482f-9ba8-d48be987739d	0.65	PubMed	23028730	Expression of Q377E G380E Tip60 (mTip60) significantly reduced both tau independent (APP and c31) and tau dependent (APP/c31/352PHPtau) cell death by at least 50% as shown in XREF_FIG (*** p < 0.005).	p(HGNC:KAT5, var(p.Gly380Glu))	directlyDecreases	act(p(HGNC:MAPT))
12ca2bac-6d92-4e46-b9c6-153a8ec7b41f	0.86	PubMed	17890370	The protein levels of Tau were also significantly decreased in neurons treated with 20mM KCl.	a(PUBCHEM:4873)	directlyDecreases	act(p(HGNC:MAPT))
12ca2bac-6d92-4e46-b9c6-153a8ec7b41f	0.86	PubMed	17890370	Unexpectedly, we noted a decrease of total Tau in the cell lysate of neurons treated with 20mM KCl (XREF_FIG).	a(PUBCHEM:4873)	directlyDecreases	act(p(HGNC:MAPT))
71eae6b9-8b69-40cc-bd15-648e248e7298	0.65	PubMed	17777005	However, recent data suggests that tau is not directly degraded by PSA XREF_BIBR.	p(HGNC:KLK3)	directlyDecreases	act(p(HGNC:MAPT))
411c17a5-018a-4647-b033-61c65875ba43	0.65	PubMed	18697348	Pathogenic Forms of Tau Inhibit Kinesin Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases.	p(PFAM:PF00225)	directlyDecreases	act(p(HGNC:MAPT))
0741558f-51da-4610-88a7-7afe7c8a54eb	0.86	Other	sparser:Unknown	One may then wonder how cue integration is affected by partial inactivation of MSTd.	p(HGNC:LGI1)	directlyDecreases	act(p(HGNC:MAPT))
0741558f-51da-4610-88a7-7afe7c8a54eb	0.86	Other	sparser:Unknown	At one extreme, if optimal cue integration involves complex dynamics and precise balancing of network activity across populations of neurons, then one might expect partial inactivation of MSTd to largely destroy the ability to combine cues optimally.	p(HGNC:LGI1)	directlyDecreases	act(p(HGNC:MAPT))
a376e8cb-bf7d-4a58-9016-ae3a619838fc	0.65	PubMed	17069969	By electrophoretic analysis it was shown that LPS prevents MAP-1, MAP-2 and tau from interaction with tubulin.	a(CHEBI:16412)	directlyDecreases	act(p(HGNC:MAPT))
3a33de86-f7cc-4a19-95da-17cd506b3e36	0.94	PubMed	22303461	Lrrk2 directly phosphorylates tubulin-associated tau, but not free tau;(iii) lrrk2 phosphorylates tau at thr181 as one of the target sites;. furthermore, we revealed that lrrk2-mediated phosphorylation of tau reduces its tubulin-binding ability.	p(HGNC:LRRK2)	directlyDecreases	act(p(HGNC:MAPT))
27e8994b-acf7-4490-9e66-bcc006f45ec5	0.86	PubMed	4841363	Lithium treatment also significantly decreased tau and tyrosinated alpha-tubulin levels.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:MAPT))
27e8994b-acf7-4490-9e66-bcc006f45ec5	0.86	PubMed	18708763	Lithium treatment effectively blocked tau cleavage as well as caspase-3 cleavage (XREF_FIG).	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:MAPT))
e64e6fef-de6e-483a-b7fa-5c24c9de7bea	0.65	PubMed	5102191	Collectively, these results indicate that MAP2b could impair the ability of MAP2c and tau to redistribute F-actin in Sf9 cells, thereby decreasing their capacity to induce process formation.	p(UP:Q56Y85)	directlyDecreases	act(p(HGNC:MAPT))
83d4b698-9a19-4fd5-b732-5d2cb6ac27ca	0.65	PubMed	5458532	Within 1 to 6 hours following SCI, there is rapid loss of MAP2, tau, and nonphosphorylated neurofilament proteins at the injury site.	p(HGNC:MAP2)	directlyDecreases	act(p(HGNC:MAPT))
7632e3e8-a7f0-45db-af66-e15b8865b9d4	0.99	PubMed	9199504	Phosphorylation of tau by SAPK3 and SAPK4 markedly reduced the ability of tau to promote microtubule assembly. SAPK3 (also called ERK6 and p38) and SAPK4 phosphorylate recombinant tau protein at multiple Ser/Thr-Pro sites that are hyperphosphorylated in PHF-tau, with SAPK4 and SAPK3 being the most effective.	p(HGNC:MAPK12)	directlyDecreases	act(p(HGNC:MAPT))
7632e3e8-a7f0-45db-af66-e15b8865b9d4	0.99	PubMed	9199504	Phosphorylation of tau by SAPK3 and SAPK4 markedly reduced the ability of tau to promote microtubule assembly. SAPK3 (also called ERK6 and p38) and SAPK4 phosphorylate recombinant tau protein at multiple Ser/Thr-Pro sites that are hyperphosphorylated in PHF-tau, with SAPK4 and SAPK3 being the most effective.	p(HGNC:MAPK12)	directlyDecreases	act(p(HGNC:MAPT))
7632e3e8-a7f0-45db-af66-e15b8865b9d4	0.99	PubMed	9199504	Phosphorylation of tau by SAPK3 and SAPK4 markedly reduced the ability of tau to promote microtubule assembly. SAPK3 (also called ERK6 and p38) and SAPK4 phosphorylate recombinant tau protein at multiple Ser/Thr-Pro sites that are hyperphosphorylated in PHF-tau, with SAPK4 and SAPK3 being the most effective.	p(HGNC:MAPK12)	directlyDecreases	act(p(HGNC:MAPT))
7632e3e8-a7f0-45db-af66-e15b8865b9d4	0.99	PubMed	9199504	Phosphorylation of tau by SAPK3 and SAPK4 markedly reduced the ability of tau to promote microtubule assembly. SAPK3 (also called ERK6 and p38) and SAPK4 phosphorylate recombinant tau protein at multiple Ser/Thr-Pro sites that are hyperphosphorylated in PHF-tau, with SAPK4 and SAPK3 being the most effective.	p(HGNC:MAPK12)	directlyDecreases	act(p(HGNC:MAPT))
7632e3e8-a7f0-45db-af66-e15b8865b9d4	0.99	PubMed	9199504	Phosphorylation of tau by SAPK3 and SAPK4 markedly reduced the ability of tau to promote microtubule assembly. SAPK3 (also called ERK6 and p38) and SAPK4 phosphorylate recombinant tau protein at multiple Ser/Thr-Pro sites that are hyperphosphorylated in PHF-tau, with SAPK4 and SAPK3 being the most effective.	p(HGNC:MAPK12)	directlyDecreases	act(p(HGNC:MAPT))
4f06c1a1-b232-44af-ac89-b3a505be5d05	0.99	PubMed	10737616	Using nanoelectrospray mass spectrometry, we have undertaken an extensive comparison of phosphorylation in vitro by several candidate tau kinases, namely, JNK, p38, ERK2, and glycogen synthase kinase 3beta (GSK3beta). Between 10 and 15 sites were identified for each kinase. The three MAP kinases phosphorylated Ser202 and Thr205 but not detectably Ser199, whereas conversely GSK3beta phosphorylated Ser199 but not detectably Ser202 or Thr205. Phosphorylated Ser404 was found with all of these kinases except JNK. The MAP kinases may not be strictly proline specific: p38 phosphorylated the nonproline sites Ser185, Thr245, Ser305, and Ser356, whereas ERK2 was the most strict. All of the sites detected except Thr245 and Ser305 are known or suspected phosphorylation sites in paired helical filament-tau extracted from Alzheimer brains. Thus, the three MAP kinases and GSK3beta are importantly all strong candidates as tau kinases that may be involved in the pathogenic hyperphosphorylation of tau in Alzheimer's disease.	p(HGNC:MAPK1)	directlyDecreases	act(p(HGNC:MAPT))
4f06c1a1-b232-44af-ac89-b3a505be5d05	0.99	PubMed	10737616	Using nanoelectrospray mass spectrometry, we have undertaken an extensive comparison of phosphorylation in vitro by several candidate tau kinases, namely, JNK, p38, ERK2, and glycogen synthase kinase 3beta (GSK3beta). Between 10 and 15 sites were identified for each kinase. The three MAP kinases phosphorylated Ser202 and Thr205 but not detectably Ser199, whereas conversely GSK3beta phosphorylated Ser199 but not detectably Ser202 or Thr205. Phosphorylated Ser404 was found with all of these kinases except JNK. The MAP kinases may not be strictly proline specific: p38 phosphorylated the nonproline sites Ser185, Thr245, Ser305, and Ser356, whereas ERK2 was the most strict. All of the sites detected except Thr245 and Ser305 are known or suspected phosphorylation sites in paired helical filament-tau extracted from Alzheimer brains. Thus, the three MAP kinases and GSK3beta are importantly all strong candidates as tau kinases that may be involved in the pathogenic hyperphosphorylation of tau in Alzheimer's disease.	p(HGNC:MAPK1)	directlyDecreases	act(p(HGNC:MAPT))
4f06c1a1-b232-44af-ac89-b3a505be5d05	0.99	PubMed	10737616	Using nanoelectrospray mass spectrometry, we have undertaken an extensive comparison of phosphorylation in vitro by several candidate tau kinases, namely, JNK, p38, ERK2, and glycogen synthase kinase 3beta (GSK3beta). Between 10 and 15 sites were identified for each kinase. The three MAP kinases phosphorylated Ser202 and Thr205 but not detectably Ser199, whereas conversely GSK3beta phosphorylated Ser199 but not detectably Ser202 or Thr205. Phosphorylated Ser404 was found with all of these kinases except JNK. The MAP kinases may not be strictly proline specific: p38 phosphorylated the nonproline sites Ser185, Thr245, Ser305, and Ser356, whereas ERK2 was the most strict. All of the sites detected except Thr245 and Ser305 are known or suspected phosphorylation sites in paired helical filament-tau extracted from Alzheimer brains. Thus, the three MAP kinases and GSK3beta are importantly all strong candidates as tau kinases that may be involved in the pathogenic hyperphosphorylation of tau in Alzheimer's disease.	p(HGNC:MAPK1)	directlyDecreases	act(p(HGNC:MAPT))
07da9653-3813-4987-ad81-fd2ad99ecb75	0.65	PubMed	16905924	This possibly occurs as a consequence of BAG2 inhibition of ERK1/2 via association with Hsp90 and/or via BAG2 mediated degradation of phosphorylated-tau as a consequence of BAG2 phosphorylation by p38 and MAPKAPK2 [XREF_BIBR].	p(HGNC:MAPKAPK2)	directlyDecreases	act(p(HGNC:MAPT))
3c6f9d23-1de4-4be2-8cf1-5ace4de08b79	0.65	PubMed	17078356	Recently, Wang and colleagues [XREF_BIBR] found that overexpression of human tau, in vivo in transgenic mice and in vitro in N2a cells, decreased p53 levels, decreased mitochondrial cytochrome c release, and decreased caspase-9 and caspase-3 activation.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CASP3))
5c1dd3fa-4687-41d6-8b64-679642302b5e	0.65	PubMed	18591611	Decreased CSF amyloid-beta (ABeta) 1-42 levels are thought to reflect amyloid deposition in the brain, and increased tau or phosphorylated tau (p-tau) CSF levels, increased neuronal death.	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	act(p(HGNC:CSF2))
6be5329a-77cb-42d6-9231-3edb9e978c29	0.86	PubMed	17629755	Hyperphosphorylated tau sequesters normal tau, and the other two major MAPs (MAP1 and MAP2), causing disruption of microtubules and misfolding of tau.	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	act(p(HGNC:METAP1))
6be5329a-77cb-42d6-9231-3edb9e978c29	0.86	PubMed	9445701	While normal tau promotes assembly and stabilizes microtubules, the abnormally hyperphosphorylated tau sequesters normal tau, MAP1 and MAP2, and disrupts microtubules.	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	act(p(HGNC:METAP1))
913d2e33-7cb3-48f5-a2fb-fe9dcfa27aaa	0.65	PubMed	17144893	Hyperphosphorylated Tau Disruption of Axonal Transport.	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	act(bp(GO:"GO:0006810"))
2941e93b-3da7-4f5a-afb5-0b586a9c898c	0.65	PubMed	18873619	Streptozotocin treated animals also displayed several classical features of AD including elevated amyloid precursor protein (APP), beta-amyloid (Abeta) and phosphorylated tau protein, neuronal cell loss, diminished acetylcholine, and cerebral atrophy.	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	act(a(PUBCHEM:187))
aecfaad1-c390-4c0f-8e2e-02b4c7b81f55	0.65	PubMed	18360789	And in turn, the phosphorylated Tau can inhibit the death promoting effect of DAPK1 [XREF_BIBR].	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	act(bp(GO:"GO:0008219"))
06896649-eaa0-4836-86fd-dbf889ceb8df	0.65	PubMed	16796925	Hyperphosphorylated tau and Abeta cooperatively impair mitochondrial membrane potential and further increase in accumulation of intracellular reactive oxygen species (ROS), which ultimately result in neurodegeneration 11.	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	act(bp(MESH:D053078))
04a41217-1910-4601-94b1-4b2057f48dd5	0.65	PubMed	18569751	Hyperphosphorylated tau is also known to destabilize microtubules and cause impairment in microtubule function and axonal transport, leading to the idea that microtubule stabilizing agents may help compensate for these losses [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT, pmod(Ph))	directlyDecreases	act(bp(GO:"GO:0006810"))
0a61aeab-8edb-4d38-baa5-fdd98ab843db	0.65	PubMed	20235173	These results suggest again that calcium homeostasis, which leads to changes in BDNF levels, is deregulated by TAU P301L expression, but can be restored by DMF through targeting of NRF2.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyDecreases	act(a(CHEBI:29108))
e5d44af5-cddf-4043-8a2c-986c92e1e662	0.65	PubMed	20193846	Muscle specific overexpression of tau V337M (C57-Gal4/+, tau V337M) led to significantly reduced perinuclear MT density, with sparser and shorter fibres compared with the genetic control (C57-Gal4/+; XREF_FIG A, A ', B, B ').	p(HGNC:MAPT, var(p.Val337Met))	directlyDecreases	act(p(HGNC:MCAT))
647fc387-9581-4520-bbf4-db7f24c85e81	0.65	PubMed	18666246	Tau mutation based deficits could thus disrupt the routine maintenance of axons and synapses (anterograde FAT) and neurons (retrograde FAT) (XREF_FIG) as well as non neuronal cells with high transport needs and thus precipitate FTLD syndromes.	p(HGNC:MAPT, var(p.?))	directlyDecreases	act(p(HGNC:CD36))
14663e6e-1daf-443e-8a9c-538b13833538	0.65	PubMed	22338605	MAPT mutations reduce the ability of tau to interact with microtubules leading to the accumulation of pathogenic tau aggregates (XREF_BIBR).	p(HGNC:MAPT, var(p.?))	directlyDecreases	act(p(HGNC:MAPT))
eea5017d-c3ed-4260-93a8-f4169524cba7	0.65	PubMed	5397199	These results suggest that mutations of tau might cause FTDP-17 by these pro apoptotic functions by disrupting the intracellular calcium homeostasis.	p(HGNC:MAPT, var(p.?))	directlyDecreases	act(bp(GO:"GO:0042592"))
c362aa3d-f2b7-4475-8425-7805dab946ab	0.65	PubMed	19705011	Part dose of Kaixin San of Yixin Fang, Kaixin Wan of Yimen Fang, Dingzhi Xiaowan of Beji Qianjin Yaofang and Dingzhi Wan of Guji Luyan could improve the learning and memory ability evaluation indicators, significantly increased BDNF and Ach in the hippocampus of AD model mice, reduced the Abeta, Tau protein, p-Tau protein in hippocampus of AD model mice, decreased the NT-proBNP and AchE in serum of AD mice, the effect is more significant.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:ACHE))
43084c1f-302a-4cb9-b37b-6ad27a39d1bc	0.65	PubMed	9701461	In mesenteric rings, the potency for ACh was significantly decreased from animals treated with TAU (about 4.2-fold) or PLA2 (about 6.9-fold) compared to saline group without changes in the maximal responses.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:187))
365e8ed0-f437-475d-9d83-3dbf0fb9cc25	0.95	PubMed	18906517	Genetic removal of tau decreases interictal spiking and spontaneous seizures in the J20 human amyloid precursor protein (hAPP) AD mouse, which overexpresses amyloid-beta (Abeta).	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF09793))
365e8ed0-f437-475d-9d83-3dbf0fb9cc25	0.95	PubMed	17815993	Tau phosphorylation reduces its affinity for microtubules and tau is hyperphosphorylated in AD.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF09793))
365e8ed0-f437-475d-9d83-3dbf0fb9cc25	0.95	PubMed	15148705	Immunotherapy for AD has demonstrated that targeting beta-amyloid (Abeta) or tau protein with vaccines or antibodies can reduce AD pathologies.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF09793))
365e8ed0-f437-475d-9d83-3dbf0fb9cc25	0.95	PubMed	19395567	Whether overexpression of human tau (htau40) in EC disrupts cognitive function and synaptic plasticity in AD has not been fully elucidated.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF09793))
365e8ed0-f437-475d-9d83-3dbf0fb9cc25	0.95	PubMed	23748737	We found that knocking out caspase-2 in the J20 mice, completely prevented many of the age dependent AD like changes, including the memory deficits in performing the radial arm water maze and the increase in phosphorylated tau protein (pTau).	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF09793))
365e8ed0-f437-475d-9d83-3dbf0fb9cc25	0.95	PubMed	13482699	Abeta and paired helical filament-tau were reduced (61.0% and 44.1% respectively) in BMT-recipient AD mice, which had 20.8% more retinal ganglion cell layer neurons than non transplanted AD controls.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF09793))
1e741fe3-38ec-4aa2-be49-bc2ee7d60ff8	0.65	PubMed	18514061	Tau degradation in the presence of ApoE.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APOE))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	18636601	However, if tau and Abeta are independently affected by trauma, blocking Abeta production should have no effects on tau pathology observed following TBI in these mice.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	17532755	Similarly, RNS60 treatment suppressed neuronal apoptosis, attenuated Tau phosphorylation, inhibited glial activation, and reduced the burden of Abeta in the hippocampus and protected memory and learning in 5XFAD transgenic mouse model of AD.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	6249309	In particular, tau inhibits transport of amyloid precursor protein (APP) into axons and dendrites, causing its accumulation in the cell body.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	18782127	Tau Reduction Prevents Abeta Induced Defects in Axonal Transport.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	18366133	Another study showed that tau itself had blocked transport of amyloid precursor protein from the neuron body into axons and dendrites, causing amyloid precursor protein accumulation in the neuronal body [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	11113575	Pin1 is a unique prolyl isomerase that has been shown to protect against age dependent neurodegeneration by acting on phosphorylated tau and APP to suppress tangle formation and amyloidogenic APP processing.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	16844413	Although our current data clearly suggests that tau pathology can reduce the accumulation of Abeta, these prior reports that in many cases corroborate our findings but in others contrast our findings clearly suggest that this remains a highly complex question that will need additional examination.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	16935005	Furthermore, expression of H1 MAPT in Tau -/- mice was shown to restore Abeta mediated inhibition of hippocampal long-term potentiation, whereas expression of mutant N296H showed no effect.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	18444244	This was consistent with earlier studies showing that the removal of tau could relieve Abeta induced neurotoxicity in cultured neurons [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	20140051	Tau immunization reduces Abeta plaque burden.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	18546398	These data suggest that tau deficiency prevents APP from being trafficked to the neuronal surface where it matures and interacts with ferroportin to govern iron export.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	16700252	In contrast, we found that, at least in early disease, site specific phosphorylation of tau inhibited Abeta toxicity.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	20829454	Tau Reduction Prevents Abeta Induced Defects in Axonal Transport.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	20385508	As shown in Figure XREF_FIG, depletion of tau in J20 mice failed to reverse APP induced memory impairments when the same test paradigm as that described by Roberson et al..	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	20580132	Pin1 is a unique prolyl isomerase that has been shown to protect against age dependent neurodegeneration by acting on phosphorylated tau and APP to suppress tangle formation and amyloidogenic APP processing.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	17751238	Over-expression of tau inhibits trafficking of APP to the cells surface; and ATP7A traffics to the cell surface along the microtubule network.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
376c8460-af91-4412-b521-0b3ad0428aca	0.95	PubMed	17317113	In these cases, isomerization rate of pThr231-Pro of Tau and pT668-Pro of APP may be reduced, which may lead to accumulation of phosphorylated Tau and promote the amyloidogenic pathway of APP.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:APP))
f2b8df94-91a5-4f47-8e26-57869bd27c06	0.86	PubMed	17482349	Since TAU is required for the formation of mitochondrial TAU conjugated tRNAs which mediate the normal translation of mitochondrial encoded proteins, including protein components of the respiratory chain, a deficiency of TAU will impair the flow of electrons through the respiratory chain, promote the accumulation of electron donors, reduce ATP production, and divert electrons from the respiratory chain to oxygen to generate superoxide anion.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:15422))
f2b8df94-91a5-4f47-8e26-57869bd27c06	0.86	PubMed	16609769	Proaggregant Tau induces a reduction of neuronal ATP, concomitant with loss of dendritic spines.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:15422))
b0298184-48b9-49b3-857a-b1b85e018837	0.65	PubMed	16911717	Tau levels were decreased by beta-secretase inhibition (XREF_FIG B), a treatment that reduces APP-C99 generation.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P12023))
5f1ba254-b117-4991-be1d-81d80680fc39	0.65	PubMed	9618587	Furthermore, inhibition of signaling via the fibroblast growth factor receptor, Src family nonreceptor tyrosine kinases, protein kinase C, or GSK3beta, and expression of constructs of the cytoskeletal proteins spectrin and tau inhibited NCAM- but not BASP1 induced neurite outgrowth.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:BASP1))
562d3779-51ff-4f9f-afbf-365686ba925a	0.86	PubMed	22044258	Furthermore, we determine that tau down-regulates BDNF transcript IV in vitro.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:BDNF))
562d3779-51ff-4f9f-afbf-365686ba925a	0.86	PubMed	22044258	While too few animals were available to obtain statistically significant differences in BDNF expression at each age examined, the lack of correlation between BDNF expression and age within each mouse genotype, and the overall reduction in BDNF expression when ages were averaged within each genotype (XREF_FIG), suggest that tau induced BDNF loss is independent of age and occurs early in development.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:BDNF))
d41d150a-a865-4a79-a0ac-cc344df9b3f9	0.86	PubMed	25384392	Tau expression decreased Beclin-1 compared to LacZ relative to actin (n = 5) but Nilotinib and parkin increased Beclin-1 (35% and 59%, respectively, p < 0.05) relative to actin levels when Abeta1-42 was expressed alone or together with Tau.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:BECN1))
d41d150a-a865-4a79-a0ac-cc344df9b3f9	0.86	PubMed	18363490	Tau expression decreased Beclin-1 compared to LacZ relative to actin (n = 5) but Nilotinib and parkin increased Beclin-1 (35% and 59%, respectively, p < 0.05) relative to actin levels when Abeta1-42 was expressed alone or together with Tau.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:BECN1))
c5429307-759a-4db7-ae2c-af1155008cdf	0.92	PubMed	22026601	Using live-brain imaging of individual clock neurons expressing both tau and the cAMP sensor Epac1-camps, we found that tau disrupted cAMP signaling.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:17489))
c5429307-759a-4db7-ae2c-af1155008cdf	0.92	PubMed	22026601	Expressing tau in pdf-GAL4> UAS-Epac-camps expressing neurons substantially reduced the increase in cAMP usually seen following the administration of Dopamine (DA; XREF_FIG, red).	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:17489))
c5429307-759a-4db7-ae2c-af1155008cdf	0.92	PubMed	19879466	Using live-brain imaging of individual clock neurons expressing both tau and the cAMP sensor Epac1-camps, we found that tau disrupted cAMP signaling.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:17489))
fdee5c3d-4da1-4f1d-b481-85cfc4c7b7fa	0.65	PubMed	6908339	These data suggest that both mu-calpain and m-calpain in brain cortex extracts are activated by Ca (2+) and both of them degraded tau protein, although, m-calpain plays a more important role in proteolysis of the tau protein.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CAPN2))
07b0a4cb-bdb6-475b-81e9-a71976f8c7d1	0.65	PubMed	19686522	The results showed that Tau treatment induced the decrease of TUNEL positive cells, prohibited the disturbance of Bcl-2 and Bax expression, and inhibited Cyt C release and caspase-8 and caspase-3 activation significantly.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CASP8))
807f4268-9aeb-426e-93f8-252a92abd087	0.65	PubMed	18744543	The neuronal microtubule stabilizer Tau also increases v g and decreases f cat [XREF_BIBR - XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CAT))
ad7f26bf-d40c-453a-8b71-ec4ab1f17bea	0.65	PubMed	17140311	Tau tubulin kinase 2 (TTBK2) is also known to promote CP110 loss from the mother centriole in addition to the recruitment of IFTs, although the relationship between EHD proteins and TTBK2 is unclear XREF_BIBR.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CCP110))
37767b33-c4d9-4777-a02e-266b94cea507	0.65	PubMed	8051814	Thus, amyloid burden, gliosis and hyperphosphorylation of tau are all reduced in transgenic models of AD lacking functional CD40L.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CD40LG))
ed257d5b-510b-47df-bc1c-643baeb72f2f	0.65	PubMed	22037276	The neuroprotective effects of sunitinib in Tat models were associated with induction of autophagy, reduced activation of CDK5, and normalization of the levels EndoB1 and pTau.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CDK5))
053f1930-5143-424f-95fd-57c4dece889c	0.86	PubMed	18340930	Tau inhibits EB1 tracking at microtubule plus ends.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:COX7A2L))
053f1930-5143-424f-95fd-57c4dece889c	0.86	PubMed	18340930	Thus tau inhibits the binding of EB1 along the microtubule wall in vitro.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:COX7A2L))
6f046852-a643-45c1-a276-71cf13e31b49	0.65	PubMed	13722853	Accordingly, eye movement desensitization and reprocessing (EMDR), originally developed as a treatment approach for posttraumatic stress disorders, is a promising approach for treating CBP in patients who have experienced psychological trauma.Thus, the aim of this study is to determine whether a standardized, short-term EMDR intervention added to treatment as usual (TAU) reduces pain intensity in CBP patients with psychological trauma vs. TAU alone.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CREBBP))
106c06aa-a9b3-425e-adcf-2a60cd470609	0.65	PubMed	18070127	A recent study has also shown that Tau accumulation reduces CREB activity by increasing calcineurin levels.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:CREB))
1c1cf6ac-79a2-42a7-b8c3-4a66394c72a3	0.86	PubMed	18617109	[XREF_BIBR, XREF_BIBR] Neurons with NFTs have significantly lower 8-OHG levels despite obvious oxidative damage (i.e., the presence of advanced glycation endproducts or lipid peroxidation), [XREF_BIBR] and phosphorylation of tau has been demonstrated to antagonize apoptosis by stabilizing beta-catenin.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CTNNB1))
1c1cf6ac-79a2-42a7-b8c3-4a66394c72a3	0.86	PubMed	17078356	Transient transfection of tau decreased beta-catenin levels by 25%, and co-expression of tau and GSK3betaDeltaexon9 +11 reversed the GSK3 mediated decrease in beta-catenin signaling.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CTNNB1))
272194da-3d6f-400e-84c6-fd7356983b52	0.65	PubMed	5370493	Tau-Cl, but not Tau, inhibited cytokine triggered synthesis of IL-6 (50% inhibitory concentration [IC50] approximately 225 microM) and IL-8 (IC50 approximately 450 microM) when added simultaneously with the stimuli.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CXCL8))
2e205a99-9e5e-469a-8609-a27397957752	0.65	PubMed	24063855	Cytochrome oxidase activity was significantly increased (P = 0.03) in the SiRNA-Tau cells relative to cytochrome oxidase activity in the SHSY5Y cells (XREF_FIG), indicating that reduced Tau may enhance cytochrome c oxidase activity.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:CYCS))
e32d0106-8fcb-4d5d-8241-bb2e17798e14	0.65	PubMed	18378624	3 In particular, aggregating Abeta and Tau can impair mitochondrial function and perturb neuronal Ca 2+ handling, thereby rendering synapses and neurons vulnerable to degeneration.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:29108))
b32498bf-21b9-4e8d-8a07-3d0a0328f7ab	0.65	PubMed	4952200	However, during stimulation with KCl (50 mM), Tau (10 (-3) M) significantly lowered DA release, and increased GABA output.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:18243))
888df161-a110-4d23-908c-4c18976488b0	0.65	PubMed	18918862	Tau propagation reduces excitability in the DG.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:151148))
241b5c97-d127-49c4-8167-edc93dc66c7f	0.65	PubMed	10348349	Large dosage of Tau can increase ATPase activity on cardiocyte membrane, improve [Ca2+] i in cardiocyte and antagonise calcium overload of DHF rats.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:54678503))
807ef33d-bd0e-4642-ac1e-649cd0bf7fb9	0.65	PubMed	11853273	Our findings support the notion that either Abeta or tau can induce reduction of PSD-95 in excitatory synapses in hippocampus.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:DLG4))
3acc80be-be5a-466b-aeab-8a6da0435a14	0.65	PubMed	14203043	The formation of phosphorylated histone H2AX foci, a double-strand break marker, was observed in KO-Tau neurons only after HS, indicating that Tau deletion did not trigger similar DNA damage under physiological or HS conditions.	p(HGNC:MAPT)	directlyDecreases	act(bp(MESH:D004249))
774d3ee8-f2ac-4921-b42e-bcfb5b839f71	0.65	PubMed	4977246	Elevated Tau gene expression in vitro is coincident with increased cycasin related DNA adducts and reduced DNA repair.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006281"))
230559d5-d3db-46fc-8adb-ae3f0aace816	0.86	PubMed	18474248	XREF_BIBR Tau, as well as other microtubule associated proteins, interact with DNA and repress DNA replication.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006260"))
230559d5-d3db-46fc-8adb-ae3f0aace816	0.86	PubMed	18474248	Interesting, this domain of APC has similarity to the microtubule associated protein Tau, known to repress DNA replication.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006260"))
d2c518d1-26f9-486b-892b-93f50100d352	0.92	PubMed	23582339	Increased F-actin in human TAU transgenic mice and flies disrupts the physical association of mitochondria and DRP1, leading to mitochondrial elongation (D).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:DNM1L))
d2c518d1-26f9-486b-892b-93f50100d352	0.92	PubMed	22920254	Tau expression blocks mitochondrial localization of DRP1.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:DNM1L))
d2c518d1-26f9-486b-892b-93f50100d352	0.92	PubMed	18946808	Tau expression blocks mitochondrial localization of DRP1.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:DNM1L))
b8d74e9a-e39f-4d0f-9157-5e6957ce466c	0.86	PubMed	18213726	Overexpression of the tau protein in M17 cells (i.e., ERalpha+ tau) significantly decreased E2 stimulated reporter activity by 30% compared with the ERalpha only cells (p < 0.01) (XREF_FIG).	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P27958))
b8d74e9a-e39f-4d0f-9157-5e6957ce466c	0.86	PubMed	26837465	Overexpression of the tau protein in M17 cells (i.e., ERalpha+ tau) significantly decreased E2 stimulated reporter activity by 30% compared with the ERalpha only cells (p < 0.01) (XREF_FIG).	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P27958))
4b436df9-5f5f-4166-8921-70c4aab4f408	0.92	PubMed	16476638	We find that tau inhibits EB tracking at microtubule ends.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF01683))
4b436df9-5f5f-4166-8921-70c4aab4f408	0.92	PubMed	16476638	Overall our results demonstrate that tau directly antagonizes EB function through a phosphorylation dependent mechanism.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF01683))
4b436df9-5f5f-4166-8921-70c4aab4f408	0.92	PubMed	18340930	In conclusion, our work shows that tau directly antagonizes EB proteins through a phosphorylation dependent mechanism, providing a new model for the regulation of EB end tracking properties.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF01683))
a860157a-c6f8-4802-83d0-6b445c487f3c	0.65	Other	sparser:Unknown	Inhibition of lysosomal proteases by tau misprocessing causes the accumulation of amphisome-resembling vacuoles in cultured neurons that are morphologically similar to those seen in AD brains.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:"ERVK-9"))
37fc9331-b37c-45b6-8536-a2d97b8ca916	0.95	PubMed	18884011	Similarly, we observed concomitant decreases of pPERK, BiP, and ubiquitin, thus confirming the in vivo results : Tau induced ER stress is reversible.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:ESR1))
37fc9331-b37c-45b6-8536-a2d97b8ca916	0.95	PubMed	18213726	To pursue the functional consequence of increased ERalpha and tau interaction in AD, we further explored the effects of tau expression on ERalpha signaling in M17 cells and found that tau overexpression inhibits the transcriptional activity of ERalpha.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:ESR1))
37fc9331-b37c-45b6-8536-a2d97b8ca916	0.95	PubMed	18213726	Tau overexpression inhibits transcriptional activity of ERalpha.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:ESR1))
37fc9331-b37c-45b6-8536-a2d97b8ca916	0.95	PubMed	26837465	Tau overexpression inhibits transcriptional activity of ERalpha.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:ESR1))
37fc9331-b37c-45b6-8536-a2d97b8ca916	0.95	PubMed	26837465	To pursue the functional consequence of increased ERalpha and tau interaction in AD, we further explored the effects of tau expression on ERalpha signaling in M17 cells and found that tau overexpression inhibits the transcriptional activity of ERalpha.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:ESR1))
2f7f10b9-5384-4f1f-bfc0-93195cb49da2	0.65	PubMed	11774527	With levosimendan, basal E (ES) increased 27% (6.2 mmHg/ml), tau decreased 11% (40.8 ms), E (ES)/E (A) increased 34% (0.75), and SW/PVA improved by 15% (0.60).	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:6995653))
2af0ee70-e9c3-4a96-b58f-3e2b328132ea	0.65	PubMed	23582339	By as-yet unknown mechanisms, TAU mainly impairs (either directly or indirectly) complex I activity of the ETC, whereas Abeta disrupts complex IV function.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P32940))
31a4a778-f148-4599-bbdf-29429fc5eb35	0.86	PubMed	16846010	Thus, thrombin cleavage of tau at Arg209, Arg230, Lys257 and Lys340 is suppressed by GSK3 mediated phosphorylation of tau at Thr212, Thr231 and Ser396 and Ser404 and dephosphorylation of insoluble aggregated tau from AD brain causes it to become more susceptible to thrombin degradation [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:F2))
31a4a778-f148-4599-bbdf-29429fc5eb35	0.86	PubMed	17707627	Interestingly, phosphorylation of tau also appears to disrupt some thrombin cleavage sites, changing the pattern of cleavage without impeding the thrombin mediated proteolysis.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:F2))
ae6e1dba-94c4-467b-a904-cd023593a749	0.86	PubMed	2826818	Evidence for an interaction between these two proteins is provided by spectrin affinity chromatography of brain MAPs, gel overlay of electrophoresed MAPs with 125I labelled spectrin, incorporation of tau factor in human erythrocyte ghosts, and demonstration that tau inhibits the F-actin cross linking activity of tetrameric spectrin.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:"F_actin"))
ae6e1dba-94c4-467b-a904-cd023593a749	0.86	PubMed	6743699	Evidence for an interaction between these two proteins is provided by spectrin affinity chromatography of brain MAPs, gel overlay of electrophoresed MAPs with; 25I labelled spectrin, incorporation of tau factor in human erythrocyte ghosts, and demonstration that tau inhibits the F-actin cross linking activity of tetrameric spectrin.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:"F_actin"))
2dd5288c-0520-4700-a957-4b947bd394d7	0.65	PubMed	11689437	ELISA studies showed that si-InR increased cerebellar levels of tau, phospho-tau and beta-actin, and inhibited GAPDH.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:GAPDH))
eb750ca3-c840-46eb-b4c9-ad302c86acc2	0.65	PubMed	18868634	Tau expression antagonized the action of Gem GTPase, a negative regulator of Rho 37.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:GEM))
18b65670-2a3b-4014-8b0e-c1ad79780e67	0.65	Other	sparser:Unknown	Tau inhibits katanin in neurons [ xref , xref – xref ] and we have observed in fibroblasts that the Alzheimer's disease-related pseudo-hyperphosphorylated (PHP)-tau and FTDP-17-derived mutant tau have a reduced capacity for this inhibition [ xref ].	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:0008568))
24da88fd-ab6a-4196-a42c-640f649f9b59	0.65	Other	sparser:Unknown	By binding to HDAC6, tau inhibited the deacetylase activity and led to an increase in tubulin acetylation.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:0019213))
1c116b71-e69e-4b9f-abd8-5b70af1f8aeb	0.65	PubMed	13422958	Small molecules in the diaminothiazole class are potent Tau kinase inhibitors that target CDK5 and GSK3beta.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:GSK3B))
7c579a64-d03a-4644-b271-63b775bf9133	0.65	PubMed	18554520	GSK3beta phosphorylates tau and inhibits glycogen synthase.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:GYS))
78f7b9b5-5d3b-43b7-a66c-05a5930e6aac	0.99	PubMed	17293050	A possible explanation for the increase in the insoluble syn-T fraction is the ability of tau to inhibit histone deacetylase 6 (HDAC6), a key component of the aggresome complex XREF_BIBR.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HDAC6))
78f7b9b5-5d3b-43b7-a66c-05a5930e6aac	0.99	PubMed	18188192	Given that Tau can interact with and inhibit the function of HDAC6, the main tubulin deacetylase XREF_BIBR, we investigated whether the increase in tubulin acetylation in cells expressing Gln124-Tau was related to a stronger inhibition of HDAC6 activity.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HDAC6))
78f7b9b5-5d3b-43b7-a66c-05a5930e6aac	0.99	PubMed	25974414	Given that Tau can interact with and inhibit the function of HDAC6, the main tubulin deacetylase XREF_BIBR, we investigated whether the increase in tubulin acetylation in cells expressing Gln124-Tau was related to a stronger inhibition of HDAC6 activity.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HDAC6))
78f7b9b5-5d3b-43b7-a66c-05a5930e6aac	0.99	Other	sparser:Unknown	Also, there was a strong evidence that HDAC6 was inhibited by tau in AD [ xref ].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HDAC6))
78f7b9b5-5d3b-43b7-a66c-05a5930e6aac	0.99	Other	sparser:Unknown	Thus, while HDAC6 seems to be necessary for aggregate elimination by autophagy, an induction could also fail to countervail AD pathological conditions, since overexpressed HDAC6 would be eventually inhibited by tau (Figure xref ).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HDAC6))
78f7b9b5-5d3b-43b7-a66c-05a5930e6aac	0.99	PubMed	22492994	It has been demonstrated that tau overexpression inhibits HDAC6 in a cell culture model (XREF_BIBR).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HDAC6))
78f7b9b5-5d3b-43b7-a66c-05a5930e6aac	0.99	PubMed	22039514	A possible explanation for the increase in the insoluble syn-T fraction is the ability of tau to inhibit histone deacetylase 6 (HDAC6), a key component of the aggresome complex XREF_BIBR.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HDAC6))
c956086f-e120-4f15-a988-4394fdbafb5d	0.95	PubMed	21340680	Aggregated proteins are not efficient substrates for the proteasome, and PHF tau actually drives UPS dysfunction and decreased UPS activity (XREF_BIBR; XREF_BIBR).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HMBS))
c956086f-e120-4f15-a988-4394fdbafb5d	0.95	PubMed	18666524	Aggregated proteins are not efficient substrates for the proteasome, and PHF tau actually drives UPS dysfunction and decreased UPS activity.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HMBS))
c956086f-e120-4f15-a988-4394fdbafb5d	0.95	Other	sparser:Unknown	Accumulation of tau oligomers could exceed the capacity of the UPS to clear them from neurons or the UPS could be directly inhibited by disease-associated tau aggregates [ xref ].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:HMBS))
608fe3e1-a5d5-4a02-8c2b-55ca8edce3ef	0.65	PubMed	18798235	In an Alzheimer 's mouse model, a protein restricted diet was shown to reduce IGF-1 and phosphorylated Tau, resulting in a decline in cognitive impairment and AD related pathologies.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:IGF1))
5458ac93-4c7d-4a6a-82f8-306fbeb06d38	0.65	PubMed	20289770	TAU decreased the IL-1beta and IL-1ra ratio (p < 0.05).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:IL1R1))
43b0ce39-e214-419e-871a-34d9772e3c00	0.65	PubMed	17239271	Decreased cerebral insulin signaling activities promotes Abeta production and Tau phosphorylation, causing neuroinflammation and neurodegeneration.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:INS))
b1221ebb-b2ba-4124-b223-12f1dc012a6c	0.65	PubMed	11270089	Tau kinase activity analysis demonstrated significantly suppressed c-Jun N-terminal kinase (JNK) in the brains of DZ treated PS19 mice.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:JNK))
5f88ccdd-a8f8-4c4f-a935-a5d7e959d731	0.65	PubMed	18317047	Tau binds along the surface of the microtubule and suppresses the capacity of P60-katanin (and spastin, to a much lesser extent) to access the microtubule lattice.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:KATNA1))
cbf77c3c-1eb2-4ebf-9444-b46647c28539	0.86	PubMed	16934508	Tau vaccination increased the time the mice were able to stay on the accelerating rotarod and reduced the number of foot slips in the traverse beam task [XREF_BIBR] or improved short-term memory in the Y maze [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:KCNK3))
cbf77c3c-1eb2-4ebf-9444-b46647c28539	0.86	PubMed	20385508	Tau Depletion in APP Transgenic Mice Attenuates Task Related Hyperactivation of the Hippocampus and Differentially Influences Locomotor Activity and Spatial Memory.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:KCNK3))
7d81f153-5254-4b3c-aff6-8cf1ec5a377d	0.92	PubMed	8804248	Tau was proposed to inhibit attachment of kinesin-1 to MTs by competing for the kinesin-1 binding site.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q07970))
7d81f153-5254-4b3c-aff6-8cf1ec5a377d	0.92	PubMed	22072389	Much of the previous work of the regulation of cargo transport by Tau has focused on kinesin-1, where in vitro single-molecule experiments showed that Tau attenuates kinesin-1 motility in a concentration dependent manner XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q07970))
7d81f153-5254-4b3c-aff6-8cf1ec5a377d	0.92	PubMed	21987967	Previous studies have shown that tau inhibits kinesin-1 without markedly affecting dynein XREF_BIBR, XREF_BIBR, posing a transport problem within the axons of neuronal cells.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q07970))
c5019b18-5ac5-46fe-b48e-a3dba79ef765	1.0	Other	sparser:Unknown	Both MAP7 and tau strongly inhibit kinesin-3 and have no effect on cytoplasmic dynein, demonstrating that MAPs differentially control distinct classes of motors.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P46875))
c5019b18-5ac5-46fe-b48e-a3dba79ef765	1.0	Other	sparser:Unknown	We further show that both MAP7 and tau inhibit kinesin-3, which transports cargo into both dendrites and axons (Fig.  xref ).	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P46875))
c5019b18-5ac5-46fe-b48e-a3dba79ef765	1.0	Other	sparser:Unknown	In addition, we find that MAP7 and tau strongly inhibit kinesin-3, but have no effect on dynein motility, suggesting that individual MAPs may provide differential control over distinct classes of microtubule motors.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P46875))
c5019b18-5ac5-46fe-b48e-a3dba79ef765	1.0	Other	sparser:Unknown	Tau also strongly inhibited kinesin-3 landing rate (0.24 ± 0.24 motors/μm/min) and motility similarly to its effects on kinesin-1 (Fig.  xref , Supplementary Figure  xref ).	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P46875))
c5019b18-5ac5-46fe-b48e-a3dba79ef765	1.0	PubMed	21987967	In addition, we find that MAP7 and tau strongly inhibit kinesin-3, but have no effect on dynein motility, suggesting that individual MAPs may provide differential control over distinct classes of microtubule motors.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P46875))
c5019b18-5ac5-46fe-b48e-a3dba79ef765	1.0	PubMed	21987967	Tau also strongly inhibited kinesin-3 landing rate (0.24 +/-0.24 motors/mum/min) and motility similarly to its effects on kinesin-1.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P46875))
c5019b18-5ac5-46fe-b48e-a3dba79ef765	1.0	PubMed	21987967	We further show that both MAP7 and tau inhibit kinesin-3, which transports cargo into both dendrites and axons.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P46875))
88faf07d-5750-457f-9817-188f82e85405	0.65	PubMed	17595337	Overexpression of Tau Protein Inhibits Kinesin dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum : Implications for Alzheimer 's Disease.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
efe395e5-df53-449f-a452-43c5af89a3cc	0.65	PubMed	17646145	In the current study here, we found that overexpression of tau in N2A cells significantly reduced the mRNA levels of Kv channels, including Kv2.1, Kv3.1, Kv4.1, Kv9.1, and KCNH4.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:6992341))
0e30ebff-43cd-4a8e-8aac-98aa7e591c75	0.86	PubMed	13636730	We propose that alterations in the membrane localization of PP2A and Tau following down-regulation of LCMT1 may lead to PP2A and Tau dysfunction in AD.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:LCMT1))
0e30ebff-43cd-4a8e-8aac-98aa7e591c75	0.86	PubMed	23943618	We propose that alterations in the membrane localization of PP2A and Tau following down-regulation of LCMT1 may lead to PP2A and Tau dysfunction in AD.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:LCMT1))
71e112b6-584f-45cb-b2fe-d30ce00b75fb	0.86	PubMed	15532542	Kinetic studies show tau can prevent LDH from self aggregation monitored by light scattering during thermal denaturation.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:LDH))
71e112b6-584f-45cb-b2fe-d30ce00b75fb	0.86	PubMed	7550501	Kinetic studies show tau can prevent LDH from self aggregation monitored by light scattering during thermal denaturation.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:LDH))
0aa8e7a3-2876-42cc-beef-e6bbaad65fa7	0.65	PubMed	15326572	Additionally, RH and CH mice developed hypothalamic leptin resistance, which was prevented by Tau.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:LEP))
62d31a98-3200-4bdb-ba21-9cb86e922051	0.65	PubMed	3598409	Taurine (Tau), a putative inhibitory amino acid neurotransmitter, has been shown to inhibit luteinizing hormone (LH) release in vivo.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:LH))
9bfb9fbe-0a0c-4079-bbf8-28753ffcedeb	0.65	Other	sparser:Unknown	Furthermore, TAU inhibited LPO and enhanced the activity of GPx, GR, SOD, and CAT in the renal tissue.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:LPO))
0fd115f9-552c-4b45-a441-3e8c83514b53	0.65	PubMed	16848772	We found that aggregating Tau causes pre- and postsynaptic morphological changes at the mossy fiber-CA3 synapse and an impairment of LTD in pro aggregant Tau RDDelta.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00932))
fe4180cf-997d-433e-910f-75f51e9be308	0.65	PubMed	18310726	Tau Anchoring Prevents Nuclear Localization of FRET Sensors.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0051179"))
4c5cd354-a4b1-43ef-8d21-76123ef44ec5	0.86	PubMed	18340930	Increasing concentrations of tau strongly decreased the comet intensity of GFP-EB3 (XREF_FIG, and Supplemental Movie S2), as observed earlier for GFP-EB1 (XREF_FIG).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:MAPRE3))
4c5cd354-a4b1-43ef-8d21-76123ef44ec5	0.86	PubMed	18340930	Moreover, microtubules assembled with both GFP-EB3 and tau elongated with few catastrophes and some rescue events, showing that tau impeded the microtubule destabilizing activity of EB3 (XREF_TABLE).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:MAPRE3))
d2e8c3e0-2906-40ca-becd-6bcb9db3baef	0.86	PubMed	26083267	Downregulation of tau impairs process outgrowth and the transport of myelin basic protein (MBP) mRNA to the cell periphery.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:MBP))
d2e8c3e0-2906-40ca-becd-6bcb9db3baef	0.86	PubMed	25847153	Downregulation of the microtubule associated protein tau impairs process outgrowth and myelin basic protein mRNA transport in oligodendrocytes.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:MBP))
28bfe2c0-06e4-489a-9f4a-f9a2d0dbc19d	0.92	PubMed	10191430	In Tau preventive group (Mn + Tau), Tau increased the activity of SOD and decreased the production of the MDA, with the significant difference level compared to the Mn treated group (P < 0.05).	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:10964))
28bfe2c0-06e4-489a-9f4a-f9a2d0dbc19d	0.92	PubMed	15304686	Tau administration, however, significantly reduced the MDA content, and increased the activities of aforementioned enzymes (P < 0.05).	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:10964))
28bfe2c0-06e4-489a-9f4a-f9a2d0dbc19d	0.92	PubMed	15304686	The MDA content was higher and the activities of GSH-Px, Ca (2+)-ATPase and Mg (2+)-ATPase lower in the blood of the Al treated group ' (P < 0.05), while Tau markedly decreased MDA content and improved the activities of GSH-Px and Ca (2+)-ATPase (P < 0.05).	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:10964))
ae277b50-ed8a-4f92-a279-baa8c8eb5bc6	0.86	PubMed	17480355	Recent epidemiological studies and animal experiments have shown that a high-fish diet, or intake of Tau, prevents MS risks including obesity, hypertension and hypercholesterolemia.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:MTR))
ae277b50-ed8a-4f92-a279-baa8c8eb5bc6	0.86	PubMed	16819761	These data support the hypothesis that diet rich in Mg and Tau may help to prevent MS risks.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:MTR))
a9799513-17dd-4895-8618-72cc2060c6bb	0.65	PubMed	27356871	Tau acetylated at K274 and K281 reduced the stability of MTs in the AIS, as measured with site specific FRAP to monitor tubulin dynamics.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF05175))
5d43720d-f3ed-41e1-98e5-ef5c1c4399b0	0.65	Other	sparser:Unknown	To clarify whether tau inhibits KL1, we performed RFL6-based MT sensitivity tests as described previously [ xref , xref ].	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q9QYW3))
dbd1eba3-bf70-43a8-b58b-b4832a9fb6b6	0.65	Other	sparser:Unknown	After naloxone, Tau also inhibited  NMDA, kainic acid as well as substance P-induced biting and scratching behaviors,  suggesting that inhibition of substance P activity alone is insufficient to cause anti-  nociception.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:31882))
51e83463-2f4f-4071-bce4-8186e990e848	0.92	PubMed	18340930	We provide biochemical and cell-biological evidence that tau inhibits the microtubule-end tracking properties of EBs.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:NAT9))
51e83463-2f4f-4071-bce4-8186e990e848	0.92	PubMed	18340930	Here we show that tau inhibits the microtubule end tracking properties of EBs and that this inhibition is regulated by tau phosphorylation.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:NAT9))
51e83463-2f4f-4071-bce4-8186e990e848	0.92	PubMed	18340930	Tau could thus sequester EBs and/or affect EB conformation upon binding, thereby hampering + TIP localization to microtubule ends (XREF_FIG).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:NAT9))
8b060dd1-b15c-4dd0-ad7b-3096a3346c88	0.65	PubMed	18704719	The presence of tau in the complex has also been shown to prevent premature removal of beta 2 by exogenous DnaX complex.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:NEUROD1))
1164dccb-afdc-4a78-942e-8d4acc50cf42	0.65	PubMed	15729444	TAU supplementation decreased the ratio of pIkappa-Balpha and Ikappa-Balpha protein, possibly contributing to the increased Ikappa-Balpha content in MTAU adipose tissue.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:NFKBIA))
7a37ec20-ee12-4009-8454-a4ebda32ef52	0.65	PubMed	18003097	Similarly, the mean expression levels of GFAP, AChE, Tau, pTau, ubiquitin, ASPH-A85G6 and ASPH-A85E6 were significantly reduced the ethanol+ NNK relative to the ethanol-only group.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:47289))
6cfb658e-dd96-45ef-9c50-b8856d661143	0.65	Other	sparser:Unknown	In healthy rats, nNOS inhibition by L-VNIO worsened dP/dt-min and tau, but it did not affect these parameters in rats with HF due to previous myocardial infarction [ xref ].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:NOS1))
c2cfed46-5cf4-400b-8549-c266f021228e	0.65	PubMed	12500671	A change in tau was also prevented in eNOS (-/-) myocytes or by inhibition of eNOS suggesting an NO mediated regulation of SERCA activity.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:16480))
9264e2b9-b8df-4838-a0b2-64dd096a4fd0	0.65	PubMed	17785178	Tau removal effectively prevented kainate induced NPY increases in the dentate gyrus and mossy fibers (B).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:NPY))
523b927d-8d98-4fc5-937a-2c563511a706	0.65	PubMed	18357710	In addition, we checked if dephosphorylation of neuronal Tau can reduce the Mr difference between neuronal and exosomal Tau.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:NR3C2))
fc777830-36d3-439c-8e7f-3068bc4d8f9c	0.65	PubMed	21949350	Hence, tau may block neurensin-1 from microtubule binding, leading to impaired lysosomal trafficking when tau is over-abundant.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:NRSN1))
bbaccc09-d8d9-4da2-b629-d8d350018bc7	0.86	PubMed	18249585	To evaluate whether tau acetylation reduced AT8 immunoreactivity in neurons, we generated GFP tagged versions of WT tau-T40 (WT-tau-GFP) or the 4KQ acetylation-mimic (4KQ-tau-GFP).	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q9SI18))
bbaccc09-d8d9-4da2-b629-d8d350018bc7	0.86	PubMed	22035011	Tau ASO Treatment Prevents AT8 positive Tau Deposition.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q9SI18))
400beaa9-9210-40ac-88de-f86dd6744dac	0.98	PubMed	17482349	3-AB, NIC and TAU were able to inhibit PARP, with the inhibitory potency order being 3-AB> NIC>> TAU.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:PARP1))
400beaa9-9210-40ac-88de-f86dd6744dac	0.98	Other	sparser:Unknown	3-AB, NIC and TAU were able to inhibit PARP, with the inhibitory potency order being 3-AB>NIC>>TAU.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:PARP1))
400beaa9-9210-40ac-88de-f86dd6744dac	0.98	PubMed	11249472	3-AB, NIC and TAU were able to inhibit PARP, with the inhibitory potency order being 3-AB> NIC> or = TAU.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:PARP1))
400beaa9-9210-40ac-88de-f86dd6744dac	0.98	Other	sparser:Unknown	3-AB, NIC and TAU were able to inhibit PARP, with the inhibitory potency order being 3-AB&gt;NIC&gt; or =TAU.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:PARP1))
72b1ea98-a43f-470f-89b4-bb5c797d9a88	0.65	PubMed	17970011	These data indicate that downregulation of MAPT and upregulation of GBA, CCDC62, HIP1R, and perhaps BDNF and DRD2 may reduce PD risk, reflected in XREF_TABLE, whereas the effects of transcription regulation of the other genes on PD risk are more tentative.	p(HGNC:MAPT)	directlyDecreases	act(bp(MESH:D010300))
1f3c4920-984c-4311-9d63-a6c3a0d15e62	0.95	PubMed	4422983	PP1 was predominantly inhibited in MCF7 cells treated with TAU but even at 10 microM TAU PP1 inhibition was much slower than that observed with 10 nM CA.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:PPP1))
1f3c4920-984c-4311-9d63-a6c3a0d15e62	0.95	PubMed	PMC4422983	PP1 was predominantly inhibited in MCF7 cells treated with TAU but even at 10 microM TAU PP1 inhibition was much slower than that observed with 10 nM CA. Furthermore, binding of inhibitors to PP2Ac and/or PP1c in MCF7 cells led to differential posttranslational modifications of the carboxyl termini of the proteins as demonstrated by Western blotting.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:PPP1))
1f3c4920-984c-4311-9d63-a6c3a0d15e62	0.95	Other	sparser:Unknown	PP1 was predominantly inhibited in MCF7 cells treated with TAU but even at 10 microM TAU PP1 inhibition was much slower than that observed with 10 nM CA. Furthermore, binding of inhibitors to PP2Ac and/or PP1c in MCF7 cells led to differential posttranslational modifications of the carboxyl termini of the proteins as demonstrated by Western blotting.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:PPP1))
c8eb0e19-1695-4355-a88d-735f9e34e540	0.65	PubMed	17433504	Negative correlation between PP-2A activity and the level of tau phosphorylation at most of the phosphorylation sites in human brains further supports the dominant role of PP-2A in regulation of tau phosphorylation as compared with other protein phosphatases ().	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:PPP2CA))
ba4887d8-4304-4cf1-a912-3f0277bb208b	0.65	PubMed	8613015	Tau phosphorylation was increased in HT22 cells by OA [okadaic acid; which inhibits PP (protein phosphatase) 1 and PP2A] or CsA [cyclosporin A; which inhibits PP2B (calcineurin)], and in PC12 cells by induction of a tet-off dependent RCAN1 transgene (which also inhibits PP2B).	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:PPP3))
c6dc73ff-f52b-424e-9587-89cf8aeb020f	0.65	PubMed	22049092	Another possibility is that pTau inserts into the mitochondrial membrane and impairs Parkin mediated mitophagy [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:PRKN))
04e6926f-3f23-4213-98ef-6cdaaee2160d	0.86	PubMed	21763357	Treatment with PP2A increased the electrophoretic mobility of Tau (Western blot in, compare lanes marked "-" and "+ ") accompanied by a substantial restoration of the ability to decrease the PrP induced oligomerization of tubulin ().	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:PRNP))
04e6926f-3f23-4213-98ef-6cdaaee2160d	0.86	PubMed	11924730	Tau protein, a major neuronal member of the MAPs family, reduces the effect of PrP.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:PRNP))
52827da2-c609-4ca0-bf91-e174d37def52	0.65	PubMed	20190868	Second, Marininak 's study demonstrates that Tau levels tend to reduce the ability of PTEN lipidphosphatase to dephosphorylate PIP3 into PIP2, an important step in downstream insulin signaling.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:PTEN))
c921007a-3686-4f3f-baf0-87ee734c3ccf	0.86	PubMed	21322811	Membrane-permeant phosphatase antagonists were therefore used to determine the PEA-15 dephosphorylation pathway : okadaic acid (OK) that inhibits phosphatase 2A (PP2A) and, with a lesser efficacy, phosphatase 1 (PP1), Calyculin A (CalA) which is equipotent to inhibit PP1 and PP2A, and Tautomycin (Tau) that preferentially inhibits PP1 <ce:cross-ref refid="BIB6"> [6] </ce:cross-ref>.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Phosphatase))
c921007a-3686-4f3f-baf0-87ee734c3ccf	0.86	PubMed	21945393	Both forms of Tau expression increased glycogen synthase kinase-3 (GSK-3) activity, polo like kinase-2 (PLK2) levels and decreased protein phosphatase activity, but had no effects on casein kinase-1 (CK1).	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Phosphatase))
e7d6a996-baa3-47b2-bbdd-08e44b38cc60	0.86	PubMed	8907432	Here we found that a moderate tau phosphorylation activated the trypsin like activity of proteasome, whereas further phosphorylation of tau inhibited the activity of the protease in HEK293 cells stably expressing tau441.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Protease))
e7d6a996-baa3-47b2-bbdd-08e44b38cc60	0.86	PubMed	17376439	Here we found that a moderate tau phosphorylation activated the trypsin like activity of proteasome, whereas further phosphorylation of tau inhibited the activity of the protease in HEK293 cells stably expressing tau441.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Protease))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	25384392	Tau did not affect proteasomal function, but Tau and Abeta1-42 together significantly reduced proteasome activity (p < 0.04) compared to Tau or LacZ.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	17635892	Tau accumulation also inhibits the proteasome and reduces protein degradation 18, 133.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	18362272	In addition, in vitro studies show that Tau aggregates isolated from human AD brain directly inhibit the proteasome.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	18363490	Tau did not affect proteasomal function, but Tau and Abeta1-42 together significantly reduced proteasome activity (p < 0.04) compared to Tau or LacZ.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	18119229	In fact, it has been reported that the proteasome activity is impaired in AD brains XREF_BIBR and that TAU containing paired helical filaments inhibit the proteasome XREF_BIBR.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	18810817	Furthermore, it has been demonstrated that Abeta and MAPT inhibit proteasome activity [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	17970011	alphaSyn, Abeta, and tau each inhibit the proteasome, impair mitochondrial function, produce free radicals, and promote apoptosis.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	16904690	A direct block of proteasome degradation by tau has been observed [XREF_BIBR], which may presumably increase an autophagosomal reaction [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	19630439	Furthermore, we tested whether expression of tau protein which is also an effective substrate for proteasome (XREF_BIBR), inhibits intracellular proteasome activity in SH-SY5Y cells.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
f43bb208-52ed-4fc4-af7f-146fad612abe	0.95	PubMed	18357704	Similarly, it has been shown that paired helical filaments of tau inhibit the proteasome [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Proteasome))
28fb146a-d5a2-4995-bb39-f106d38ce019	0.65	PubMed	16295510	Tau also inhibit the generation of ROS and autophagy.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:ROS1))
31f372b4-10f6-45ae-9dec-0179c35cea5c	0.86	PubMed	17022592	Tau ablation reduced the percentage of Scn1a RX/+ mice with seizures 2.7-fold to 16% without affecting seizure severity or duration in those mice that did develop seizures.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:SCN1A))
31f372b4-10f6-45ae-9dec-0179c35cea5c	0.86	PubMed	17022592	Tau Reduction Lowers Epileptic Activity and Network Hyperexcitability in Scn1a RX/+ Mice.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:SCN1A))
d4ba47d1-6c71-4ebd-9afe-0a92dc6fefd9	0.86	PubMed	22558197	Tau Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer 's and Pick 's Disease.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:SFPQ))
d4ba47d1-6c71-4ebd-9afe-0a92dc6fefd9	0.86	PubMed	17365400	Correction : Tau Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer 's and Pick 's Disease.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:SFPQ))
c1e175ca-8fe4-4d70-9dc2-99d3cfaaaee0	0.65	PubMed	22093191	TAU (150mg/L) also prevented oxidative stress in PTZ challenged fish by decreasing lipid peroxidation and protein carbonylation and preventing changes on nonprotein thiol levels.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:SH3PXD2A))
00f4ba85-a026-4937-8c13-0354bf1f382f	0.65	PubMed	18785580	To directly test if enhancing acetylation can block ubiquitination, we transfected HEK293T cells with expression plasmids encoding tau and hemagglutinin (HA)-tagged ubiquitin and then treated with EX527 to inhibit SIRT1 and with MG132 to block the proteasome mediated degradation.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:SIRT1))
bd92fb00-3c14-4b78-833d-096b328f1f29	0.65	PubMed	17238882	Like the Abeta model, tau overexpression produced strong neurodegeneration that provoked ommatidia malformation [XREF_BIBR], brain tissue degeneration and reduced lifespan [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:SQSTM1))
cf2ff138-f8c1-47d0-b31a-2f72eb5eeacf	0.65	PubMed	8508155	Collectively, these results indicate that tau overexpression and Taxol treatment induced a calpain dependent degradation of the microtubule destabilizing protein SCG10.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:STMN2))
d9d1fb3e-60e9-4492-9fdf-5622b5c69418	0.86	PubMed	17409694	Overexpression of 14-3-3zeta Promotes Tau Phosphorylation at Ser 262 and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:SYP))
d9d1fb3e-60e9-4492-9fdf-5622b5c69418	0.86	PubMed	24367683	Overexpression of 14-3-3zeta Promotes Tau Phosphorylation at Ser 262 and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:SYP))
02deb776-cf0e-4880-9a48-285cd3471938	0.65	Other	sparser:Unknown	The potentiation of substance P and kainic acid after pretreatment with Tau  differed from our previous results (7), which showed that Tau inhibited substance P-  induced biting and scratching when Tau was coadministered with substance P. We  confirmed the inhibitory effect of Tau on substance P when coadministered and also    1930       Antlnociceptive Effect of Taurine, Calcium        Vol.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:TAC1))
ec9f2bfc-2377-4536-825f-e2b5a63899dd	0.65	PubMed	17480355	The fact that administration of omega-3 fatty acids including DHA and EPA, rich in fish products, was effective to dyslipidemia is consistent with our present result that the high Tau group showed elevated DHA and suppressed TC and non-HDL-C level [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:23957))
08614718-38cb-4581-8cee-e49cdd68d2c9	0.86	PubMed	15360622	Tau supplementation prevented obesity and hepatic TG deposition by upregulating MTP mRNA, ameliorating hepatic lipid efflux, and consequently enhancing PPAR-alpha which increases lipid oxidation through ACO and CPT-1a gene expressions.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:TG))
08614718-38cb-4581-8cee-e49cdd68d2c9	0.86	PubMed	11374230	TAU decreased liver TG content in both supplemented groups, but fat content only in MTAU rats.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:TG))
47484aee-e757-4640-b50f-b88679a0d9e7	0.94	PubMed	19155101	Tau vector gene transfer caused a loss of TH immunoreactivity in the SN and the striatum in young rats (XREF_FIG, XREF_FIG), as expected (XREF_BIBR).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:TH))
47484aee-e757-4640-b50f-b88679a0d9e7	0.94	PubMed	19155101	While tau expression clearly reduced TH immunoreactivity in the SN and the striatum in a specific manner relative to a GFP control, the aging difference was subtle, underscored by the lack of an aging effect on TH fiber density in the striatum.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:TH))
47484aee-e757-4640-b50f-b88679a0d9e7	0.94	PubMed	18648614	Tau vector gene transfer caused a loss of TH immunoreactivity in the SN and the striatum in young rats (XREF_FIG, XREF_FIG), as expected.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:TH))
47484aee-e757-4640-b50f-b88679a0d9e7	0.94	PubMed	18648614	While tau expression clearly reduced TH immunoreactivity in the SN and the striatum in a specific manner relative to a GFP control, the aging difference was subtle, underscored by the lack of an aging effect on TH fiber density in the striatum.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:TH))
9882933a-a552-46c3-a8e7-86e7d8c07298	0.65	PubMed	18529407	Tau inhibited net displacement and velocity of TIA1 granules, with retrograde (-) movement inhibited more than anterograde (+) movement (XREF_FIG).	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:TIA1))
6538804c-2f6b-414b-9c3d-0a2c8b51c2cb	0.65	PubMed	17044810	Nicotinamide selectively reduces phosphorylation of tau at Thr231 site and increases the acetylated alpha-tubulin [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q71G51, pmod(Ac)))
98c80f90-33f6-4323-98e9-f1b1a80e4fda	0.65	PubMed	17479151	As shown in Fig XREF_FIG and XREF_FIG, Tau, AZ and combination of Tau and AZ effectively inhibited tyrosinase activities as compared to the alpha-MSH or LPS treated groups.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:TYR))
5f555ac2-28a1-466c-8240-36494f67e820	0.94	PubMed	18669337	In vitro polymerization assays reveal that tau decreases the tubulin critical concentration required for microtubule assembly; thus, the microtubule growth rate increases as the tau concentration increases.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Tubulin))
5f555ac2-28a1-466c-8240-36494f67e820	0.94	PubMed	24559475	Notably, phosphorylation at Ser Pro and Thr Pro sites within the proline rich domain inhibits the ability of tau to promote tubulin polymerization.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Tubulin))
5f555ac2-28a1-466c-8240-36494f67e820	0.94	PubMed	21763357	In this study we have found that Tau protein may substantially decrease the PrP induced oligomerization of tubulin.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Tubulin))
5f555ac2-28a1-466c-8240-36494f67e820	0.94	PubMed	18537383	Many pathogenic MAPT missense mutations lead to decreased ability of tau protein to promote tubulin polymerization into microtubules.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Tubulin))
763c8514-0da5-4fba-b95b-81b9e1f78290	0.65	PubMed	11324153	show that acetylation of the amino acid lysine in the microtubule associated protein tau prevents its ubiquitin mediated degradation, resulting in " tau tangles " similar to those of dementias.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:Ubiquitin))
28b1a0b5-04b3-4939-b1a0-fa338b8078e7	0.65	PubMed	10778506	Uric acid (UA) concentration was decreased by NAC, ALA and TAU at 24 h rest compared with CON.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:1175))
5068683e-b3ec-4aaf-919c-76fb66f5fc03	0.65	PubMed	17574198	The TAU group reduced their alcohol use severity with a small effect size (SMD = 0.14, ns) at 3months and at 9months (SMD = 0.22.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:16236))
e1fc4f01-0f97-4fb5-bccc-138343a1fb0e	0.65	PubMed	21333929	The ability of Tau to attenuate ammonia produced cell swelling is consistent with the contribution of free radicals to this response, and compatible with a role for the NMDA receptor mediated generation of NO, as suggested above.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:222))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	18436885	Tau reduces oxidative stress in nerve cells (Maier et al., 2008; Violet et al., 2014), and also resists cell apoptosis (Duan et al., 2013).	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	27099072	Tau phosphorylation can antagonize cell apoptosis with the mechanisms involving Bcl-2 and caspase-3 in mitochondria XREF_BIBR XREF_BIBR, while expression of fusion proteins attenuates apoptosis XREF_BIBR.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	27099072	These observations suggest that intracellular accumulation of tau may antagonize acute apoptosis via modulating mitochondria fission and fusion and cause neurodegeneration through disrupting mitochondrial functions.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	10912197	Recently, we have reported that phosphorylation of tau can antagonize apoptosis induced by exogenous apoptotic inducers.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	22115752	It has been reported that 14-3-3 theta and tau inhibits apoptosis via interaction with p21 (WAF1 and CIP1), when induced by drugs such as tamoxifen in breast cancer cells.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	15428505	Silencing the PUMA gene with specific siRNA was demonstrated to significantly reduce the ability of Tau to inhibit proliferation and induce the apoptosis of HHCC HepG2 cells (P < 0.01).	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	21596220	TAU attenuated apoptosis caused by ACR through observing terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL)-positive cells, measure of protein expression of Bcl-2, Bax, and caspase 3 activity.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	18811826	Mechanistically, phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin 92.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	12716760	Our data suggest that tau hyperphosphorylation could attenuate the ER stress induced apoptosis with the mechanism involving upregulation of UPR system.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	16925239	Tau phosphorylation can antagonize cell apoptosis with the mechanisms involving Bcl-2 and caspase-3 in mitochondria [XREF_BIBR - XREF_BIBR], while expression of fusion proteins attenuates apoptosis [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	21981837	MgAT and TAU prevent ET1 induced retinal cell apoptosis by reducing retinal nitrosative stress in Sprague Dawley rats.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	15659100	Both CAR and TAU diminished apoptosis and ameliorated histopathological findings in the brain of GAL treated rats.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	15659100	Our results indicate that CAR and TAU may be effective to prevent the development of oxidative stress, apoptosis and histopathological deterioration in the brain of GAL treated rats.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	18206454	Tau phosphorylation can antagonize cell apoptosis with the mechanisms involving Bcl-2 and caspase-3 in mitochondria XREF_BIBR XREF_BIBR, while expression of fusion proteins attenuates apoptosis XREF_BIBR.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	18206454	These observations suggest that intracellular accumulation of tau may antagonize acute apoptosis via modulating mitochondria fission and fusion and cause neurodegeneration through disrupting mitochondrial functions.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
3069a82f-e65e-4a59-a890-1f5d1cd6536c	0.95	PubMed	18548765	In this regard it is interesting to note that a recent study demonstrated that phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006915"))
a536fccd-abfa-4a40-9638-ae12f4f9ead5	0.86	PubMed	24086678	Thus, tau has been shown to not only directly inhibit the deacetylase activity of HDAC6, but also impair HDAC6 dependent autophagy XREF_BIBR.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006914"))
a536fccd-abfa-4a40-9638-ae12f4f9ead5	0.86	PubMed	18530720	Accumulations of Abeta and p-Tau, as well as mutations in presenilin1 (PS1) that cause early-onset inherited AD, inhibit autophagy flux and lysosomal function.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006914"))
147d4d0a-15c0-43c0-ac24-67a664d520c8	0.65	PubMed	19570921	These prospects include agents acting on Abeta, its receptors and tau protein, such as small molecules, vaccines and antibodies against Abeta; inhibitors or modulators of beta- and gamma-secretase; Abeta degrading proteases; tau protein inhibitors and vaccines; amyloid dyes and microRNAs.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:B7I895))
51d47779-9188-40a4-a8d9-90f4264ff1d0	0.65	PubMed	10848214	LC and TAU synergistically inhibited the proliferation and beta-glycerophosphate (beta-GP)-induced osteoblastic differentiation of VSMCs as evidenced by the decreased [(3) H] thymidine incorporation, ALP activity and calcium deposition.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:2526))
273a470f-7c70-4255-abf9-a32163c02c11	0.65	PubMed	18561598	However, the exact molecular mechanism by which p-tau disrupts ATP synthesis and cell bioenergetics is unknown.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006091"))
8ca71a66-e338-4fc7-a6a9-b8904088bc14	0.65	Other	sparser:Unknown	The inhibition in oxidative stress and the elevation of the total antioxidant capacity as well as the inhibition of the inflammatory biomarkers by NAC or TAU after CP administration may play a central role in modulation of nephrotoxicity induced by CP.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:59163))
a2db8e47-58b4-4215-ba63-9b3e59bdfdfc	0.94	PubMed	23948915	Overexpression of DAPK1 in HEK293 and N2a cells decreased cell viability with activation of caspase-3, whereas simultaneous expression of tau antagonized DAPK1 induced apoptotic cell death.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008219"))
a2db8e47-58b4-4215-ba63-9b3e59bdfdfc	0.94	PubMed	18884011	Thus, tau could directly impair ERAD, leading to UPR stress and the associated cell death that occurs when this pathway is activated.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008219"))
a2db8e47-58b4-4215-ba63-9b3e59bdfdfc	0.94	PubMed	18762450	tau and GSK-3beta copurify with YWHAZ, and the association of phosphorylated GSK-3beta with 14-3-3 in vitro prevents cell death.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008219"))
a2db8e47-58b4-4215-ba63-9b3e59bdfdfc	0.94	PubMed	13634691	Overexpression of DAPK1 in HEK293 and N2a cells decreased cell viability with activation of caspase-3, whereas simultaneous expression of tau antagonized DAPK1 induced apoptotic cell death.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008219"))
5e1c8df2-3213-4b89-b1b1-fa60928b6dd9	0.86	PubMed	22193544	We therefore suspected that the reduced GSK3beta mediated Tau phosphorylation and increased WWOX expression are indispensable for RA induced SH-SY5Y cell differentiation.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0030154"))
5e1c8df2-3213-4b89-b1b1-fa60928b6dd9	0.86	PubMed	18352476	Downregulation of tau impairs cell differentiation and the process of early myelination.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0030154"))
99f9e618-cf79-4d3e-b127-e5b96aca5086	0.86	PubMed	18934289	In vitro investigations have also indicated that overexpression of tau leads to altered cell shapes and reduced cell growth which eventually results in a dramatically redistribution of various organelles transported by microtubule dependent motor proteins.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0016049"))
99f9e618-cf79-4d3e-b127-e5b96aca5086	0.86	PubMed	22029871	Furthermore, PHF-tau disrupts intracellular compartments that would be essential for normal metabolism and cell culture studies show that the over-expression of tau causes a change in cell shape, retards cell growth, and dramatically alters the distribution of various organelles transported via microtubule dependent motor proteins.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0016049"))
d98a2f5d-4f88-4561-b56b-1df16755da5a	0.92	PubMed	19420078	In vitro, inactivation of tau by gene knockdown suppressed cell proliferation and sensitized docetaxel cytotoxicity.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008283"))
d98a2f5d-4f88-4561-b56b-1df16755da5a	0.92	PubMed	20180362	Note here that MAPT DNA transfection or MAPT siRNA transfection significantly inhibited the cell proliferation of TOV112D without the administration of paclitaxel.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008283"))
d98a2f5d-4f88-4561-b56b-1df16755da5a	0.92	PubMed	11352189	Strikingly, both AT tau and Tau 40 reduced the metabolic activity of the cells in a time dependent manner (p < 0.0001) suggesting that tau overexpression slows down cell proliferation.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008283"))
bcd74f8e-bde1-485f-a381-6a8aad783ea2	0.94	PubMed	12948995	Our findings suggest that oligomeric Tau aggregation intermediates are the most toxic compounds of Tau fibrillogenesis, which effectively decrease cell viability and increase phospholipid vesicle leakage.	p(HGNC:MAPT)	directlyDecreases	act(bp(MESH:D002470))
bcd74f8e-bde1-485f-a381-6a8aad783ea2	0.94	PubMed	23129775	Our findings suggest that oligomeric Tau aggregation intermediates are the most toxic compounds of Tau fibrillogenesis, which effectively decrease cell viability and increase phospholipid vesicle leakage.	p(HGNC:MAPT)	directlyDecreases	act(bp(MESH:D002470))
bcd74f8e-bde1-485f-a381-6a8aad783ea2	0.94	PubMed	9845791	The increase in cell death likely resulted from tau accumulation since increased levels of tau were sufficient to reduce cell viability and ethanol was toxic to cells expressing tau but not to non induced controls.	p(HGNC:MAPT)	directlyDecreases	act(bp(MESH:D002470))
bcd74f8e-bde1-485f-a381-6a8aad783ea2	0.94	PubMed	18519819	The increase in cell death likely resulted from tau accumulation since increased levels of tau were sufficient to reduce cell viability and ethanol was toxic to cells expressing tau but not to non induced controls.	p(HGNC:MAPT)	directlyDecreases	act(bp(MESH:D002470))
78e27020-b3d4-4e59-8d3a-c573d4324d0e	0.65	PubMed	14792905	Changes in tau are known to impair cellular transport (including that of mitochondria) and are associated with cell death in cell culture and mouse models of tauopathy.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006810"))
91f607e0-34d4-47cb-b4fc-098dd0d65587	0.65	PubMed	17051677	In contrast, a fragment of tau protein has been shown to induce copper reduction, thus contributing to oxidative stress and initiating copper mediated generation of H 2 O 2 [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:29036))
9c792dc1-aca7-421a-86e5-2e822696c85b	0.94	PubMed	6296995	We have shown previously that TAU directly inhibits dopamine (DA) and (-)-3-(3,4-dihydroxyphenyl)-L-alanine (L-dopa) oxidation.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:18243))
9c792dc1-aca7-421a-86e5-2e822696c85b	0.94	PubMed	18380664	Relative to AAV2 or AAV8, tau expression from AAV9 or AAV10 peaked earlier and caused more dopamine loss.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:18243))
9c792dc1-aca7-421a-86e5-2e822696c85b	0.94	PubMed	9603901	Relative to AAV2 or AAV8, tau expression from AAV9 or AAV10 peaked earlier and caused more dopamine loss.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:18243))
9c792dc1-aca7-421a-86e5-2e822696c85b	0.94	PubMed	7870905	Administration of TAU significantly attenuated MPTP induced depletion of striatal dopamine and loss of tyrosine-hydroxylase-positive neurons in the substantia nigra.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:18243))
3f680833-aa04-4e25-96ae-ab68cde8d9fe	0.65	Other	sparser:Unknown	We find that tau inhibits EB tracking at microtubule ends.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:P23895))
af29903f-5101-4250-84f1-f121c4dc1d49	0.65	Other	sparser:Unknown	Low micromolar tau filament formation inhibition of myricetin was previously reported in vitro as well as for two other members of the flavonoid family the roselle (Hibiscus sabdariffa) -derived gossypetin (8) [ xref ] and the green tea (Camellia sinensis )-derived (−)-epicatechin-3-gallate (9) [ xref ] showing IC 50 values at 1.2, 2.0 and 1.8 µM, respectively [ xref ].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00038))
85a92a72-d0c3-4c19-af31-1a8fe55c788e	0.65	PubMed	20171421	Purported causal mechanisms may include altered glycolysis and depressed neuronal mitochondrial activity, attenuated BDNF, insulin desensitization (also known as type-3 diabetes) possibly as a consequence of depressed adiponectin, exaggerated BACE1 mediated amyloid biogenesis, and tau phosphorylation.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006096"))
aec2fe56-8445-4285-a4b0-e07bfefd8c3f	0.65	PubMed	21236678	Among the amino acids examined, Tau suppressed the release of histamine that was stimulated by C12 on both mucosal and serosal sides most effectively.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:774))
90753fe0-9fd5-4544-829b-fa2f60e9cd9d	0.65	PubMed	13284325	With these effects, Tau protects the cells from oxidative damage, reduces inflammation and promotes regression of pancreatic damage.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006954"))
b4097ada-e4cc-42a7-9684-33b1c6076eba	0.65	PubMed	12349292	In primary neuronal culture, we found loss of tau also causes iron retention, by decreasing surface trafficking of APP.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:23925))
73221363-2667-4b87-b771-eb5ca9fd4bdf	0.86	PubMed	18635222	One major MAP, the tau protein, has been shown to antagonize the microtubule destabilizing activity of XKCM1 (Xenopus kinesin catastrophe modulator-1) 51 and can offer protection against katanin dependent microtubule severing.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q91636))
73221363-2667-4b87-b771-eb5ca9fd4bdf	0.86	PubMed	7826806	Because tau completely suppresses XKCM1 activity, even at low concentrations, the combination of tau and XKCM1 is unable to generate mitotic microtubule dynamics.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q91636))
f787c54a-7be0-47e6-9db5-d42114446f03	0.65	Other	sparser:Unknown	Previous studies have shown that tau inhibits kinesin-1 without markedly affecting dynein xref , xref , posing a transport problem within the axons of neuronal cells (Fig.  xref ).	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q54UC9))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	6249309	Tau inhibits kinesin dependent transport of peroxisomes, neurofilaments, and Golgi derived vesicles into neurites.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	17628373	Overexpressing tau selectively inhibits kinesin driven anterograde mitochondrial transport in N2a and NB2a/d1 neuroblastoma cell lines, primary cortical neurons, and retinal ganglion neurons.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	Other	sparser:Unknown	By demonstrating that MT-bound Tau inhibits the Eg5 kinesin and cell mitosis, our work provides a new framework to consider the role of Tau in neurodegenerative diseases.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	24268156	Although the disease-relevant microtubule associated protein tau is known to severely inhibit kinesin based transport invitro, the potential mechanisms for reversing this detrimental effect to maintain healthy transport in cells remain unknown.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	13856989	Although the disease-relevant microtubule associated protein tau is known to severely inhibit kinesin based transport invitro, the potential mechanisms for reversing this detrimental effect to maintain healthy transport in cells remain unknown.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	Other	sparser:Unknown	In the present study, we have used single molecule imaging techniques to demonstrate that Tau inhibits kinesin's processive run length in an isoform-dependent manner on GDP-microtubules stabilized with either paclitaxel or glycerol/DMSO but not guanosine-5'-((α,β)-methyleno)triphosphate (GMPCPP)-stabilized microtubules.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	20237556	Importantly, kinesin motor mediated axonal transport is impaired in AD, where p-tau is reported to impair kinesin dependent axonal cargo trafficking by blocking transport of the adaptor-molecule c-Jun N-terminal kinase interacting protein 1 from the cell body to axons.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	15147841	who concluded that tau reduces primarily the attachment rate of kinesin, but not directly its capability to walk.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	25468336	In stably transfected cultured cells, overexpression of tau inhibited kinesin dependent trafficking of vesicles ().	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	16846010	Tau sequesters the available kinesin, and thereby limits axonal transport of other cargoes [XREF_BIBR, XREF_BIBR] and regulates the release of cargo vesicles from kinesin chains by activating PP1 and GSK3beta [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	16845805	Previous observations in cultured neurons demonstrated that overexpression of tau inhibits kinesin dependent transport of peroxisomes in neurites [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	18659054	Overexpression of tau in neurons inhibits kinesin dependent transport of neurofilaments, mitochondria, peroxisomes, and Golgi derived vesicles, thus rendering cells vulnerable to oxidative stress and contributing to neurodegeneration [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
0b248acb-0525-48b1-ae23-e3f066ab1db1	0.99	PubMed	17074558	In line of this, overexpression of the microtubule associated protein tau, which inhibits kinesin dependent transport of peroxisomes (and of other organelles, neurofilaments, and vesicles), increases the susceptability of neurons to oxidative stress.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00225))
fd3ddb2b-7841-4572-be38-36b88171b60f	0.95	PubMed	16851298	Hyperphosphorylation of tau disrupts this localization pattern [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0051179"))
fd3ddb2b-7841-4572-be38-36b88171b60f	0.95	PubMed	17709744	Indeed, phosphorylation of tau at N-terminal, but not C-terminal, residues prevents its membrane localization in tau transfected cells, demonstrating that the phosphorylation state of tau directly impacts its positioning at membranes.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0051179"))
fd3ddb2b-7841-4572-be38-36b88171b60f	0.95	PubMed	22920254	These findings overall provide strong evidence that tau blocks DRP1 localization to mitochondria through its influence on the actin cytoskeleton.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0051179"))
fd3ddb2b-7841-4572-be38-36b88171b60f	0.95	PubMed	18547795	A recent study showed that Tau mediated stabilization of actin reduces DRP1 localization to the mitochondrial membrane in drosophila and mouse hippocampal neurons [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0051179"))
fd3ddb2b-7841-4572-be38-36b88171b60f	0.95	PubMed	18946808	These findings overall provide strong evidence that tau blocks DRP1 localization to mitochondria through its influence on the actin cytoskeleton.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0051179"))
fd3ddb2b-7841-4572-be38-36b88171b60f	0.95	PubMed	18340930	Overall these results demonstrate that tau inhibits EB1 localization at microtubule ends.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0051179"))
fd3ddb2b-7841-4572-be38-36b88171b60f	0.95	PubMed	25760044	A recent study showed that Tau mediated stabilization of actin reduces DRP1 localization to the mitochondrial membrane in drosophila and mouse hippocampal neurons [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0051179"))
fd3ddb2b-7841-4572-be38-36b88171b60f	0.95	PubMed	12004523	Tau overexpression in cell culture impairs localization and trafficking of organelles.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0051179"))
11ce3c39-7447-4357-a2a2-711b2c3a6178	0.65	PubMed	17479151	In summary, we have demonstrated that combination of Tau and AZ inhibited melanin production and tyrosinase activity.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:6325610))
81ea0de2-da51-40c3-b74c-e3573023bc02	0.65	PubMed	20155224	Memory impairment is closely associated with tau hyperphosphorylation, we speculated that tau phosphorylation alleviation might underlie the protective effect of melatonin.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:16796))
7eaa96e6-da6c-4988-91d3-a78184ff9f5e	0.86	PubMed	14535315	Hypothesising that tau proteins may exert a detrimental effect on the entire cellular energy metabolism, the negative correlation found between lactate and tau protein levels may allow speculation that tau toxicity, already demonstrated to have affected mitochondria, could also impair glycolytic metabolism with a less evident increase of lactate levels in more severe AD.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008152"))
7eaa96e6-da6c-4988-91d3-a78184ff9f5e	0.86	PubMed	428633	As for NE and DA metabolism, LiCl administered subacutely inhibited the MAPT induced decrease of the deaminated NE metabolites and Ro4-1284-induced decrease of DA metabolism and the Ro4-1284-induced alterations in NE metabolism.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008152"))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	20231021	Abnormal phosphorylation of TAU impairs microtubule binding capacity and leads to microtubule destabilization [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	20235723	Elevated tau phosphorylation decreases its microtubule binding and bundling and increases the number of motile tau particles, which affects the axonal transport 37.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	17409694	Thus, 14-3-3zeta overexpression promotes tau phosphorylation at Ser 262, inhibits tau microtubule binding, and reduces the amount of polymerized microtubules in the neurons.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	24909306	Likewise, phosphorylation of Tau has been shown to decrease its microtubule binding affinity (XREF_BIBR; XREF_BIBR), suggesting that disease related hyperphosphorylation could also result in the loss of normal Tau function (XREF_BIBR).	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	21348938	Abnormal phosphorylation of tau, a prominent feature of AD brain, decreases its microtubule binding ability, which may destabilize microtubules and result in cellular damage [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	14636889	Indeed, hyperphosphorylation of tau protein, which impairs the microtubule binding function of tau, is a critical event in the pathogenesis of Alzheimer 's disease.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	16905971	XREF_BIBR - XREF_BIBR Tau hyperphosphorylation inhibits microtubule binding and thereby contributes to the formation of neurofibrillar tangles in the course of Alzheimer 's disease.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	18605788	Hyperphosphorylation of tau reduces microtubule binding in vitro with loss of microtubule stability and buildup of NFTs [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	26556772	Abnormal tau phosphorylation at Ser396 and Thr 231 contributes to reduced microtubule binding ().	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	18779763	Likewise, phosphorylation of Tau has been shown to decrease its microtubule binding affinity, suggesting that disease related hyperphosphorylation could also result in the loss of normal Tau function.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	24367683	Thus, 14-3-3zeta overexpression promotes tau phosphorylation at Ser 262, inhibits tau microtubule binding, and reduces the amount of polymerized microtubules in the neurons.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	17634135	Abnormal phosphorylation of tau, a prominent feature of AD brain, decreases its microtubule binding ability, which may destabilize microtubules and result in cellular damage [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	24905733	Mono-ubiquitination of tau occurs in the microtubule binding region and impairs microtubule binding.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	17600751	It is known that the phosphorylation of tau reduces its in vitro microtubule binding activity.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	21243369	Hyperphosphorylation of tau reduces microtubule binding in vitro with loss of microtubule stability and buildup of NFTs [XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	13376881	Elevated tau phosphorylation decreased its microtubule binding and bundling, and increased the number of motile tau particles, without affecting axonal transport kinetics.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	17642658	Yet abnormal hyperphosphorylation of Tau reduces its microtubule binding capacity and accelerates aggregation.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
87a11a38-dccf-4991-a0eb-abe6f82229e2	0.95	PubMed	20973857	</ce:given-name> <ce:surname> Mandelkow </ce:surname> </sb:author> <sb:author> <ce:given-name> J. </ce:given-name> <ce:surname> Biernat </ce:surname> </sb:author> <sb:author> <ce:given-name> H.E. </ce:given-name> <ce:surname> Meyer </ce:surname> </sb:author> <sb:author> <ce:given-name> M. </ce:given-name> <ce:surname> Goedert </ce:surname> </sb:author> <sb:author> <ce:given-name> E. </ce:given-name> <ce:surname> Mandelkow </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> The Alzheimer like phosphorylation of tau protein reduces microtubule binding and involves SerPro and ThrPro motifs </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> FEBS Lett.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF16796))
9b3a8f13-f027-4029-a303-6601d26d7c14	0.65	PubMed	19666594	Western blot and immunofluorescence showed Tau can inhibit p38 activation.	p(HGNC:MAPT)	directlyDecreases	act(p(FPLX:p38))
d6e7428e-b378-4545-b913-b43b90bf40a5	0.65	PubMed	15010395	We observed marked elevation in the myeloperoxidase (MPO) activity after 5-FU administration, which was reversed by Tau pretreatment.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:304590))
642f5af8-089f-42ce-8d13-fde8f972a4a0	0.65	PubMed	18950963	The neutral pH of NUT-PAGE ensures that each phosphate group is deprotonated (pKa 1 = ~ 2; pKa 2 = ~ 7), whereas the acidic pH of the widely used TAU gel may restrict phosphate group deprotonation to a minimal.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:1061))
b326c106-d158-4a2b-b479-1e5e1746a54f	0.65	PubMed	18704719	tau Reduces the Pol III Concentration Required for Initiation Complex Formation.	p(HGNC:MAPT)	directlyDecreases	act(p(UP:Q819Y5))
a5e6d1c4-96b9-4390-9980-ef7706202dc9	0.94	PubMed	14705068	Tau could inhibit the hypoxia induced PASMC proliferation, and may regulate it through ERK1/2 pathway.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008283"))
a5e6d1c4-96b9-4390-9980-ef7706202dc9	0.94	PubMed	18867525	These results imply that tau hyperphosphorylation may underlie impaired proliferation and neuronal maturation in APPswe and PS1DeltaE9 mice.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008283"))
a5e6d1c4-96b9-4390-9980-ef7706202dc9	0.94	PubMed	3302487	The type I IFNs, alpha, beta, and tau, inhibited induction of T cell proliferation by several staphylococcal enterotoxin superantigens; the type II IFN, gamma, was without effect.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008283"))
a5e6d1c4-96b9-4390-9980-ef7706202dc9	0.94	PubMed	17595337	A second noticeable effect was that overexpression of tau in CHO cells slowed down proliferation approximately twofold (data not shown), similar to observations with MAP4 transfected cells (Nguyen at al., 1997).	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0008283"))
62b5c13c-769a-416c-9f24-5dab1750a029	0.65	PubMed	19074461	Our analyses support the conclusion that the function of the ubiquitin-proteasome pathway is intact in NPC1 and tau double null mutant mice, and suggest that tau deletion primarily impairs protein degradation through autophagy in NPC1 deficiency.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006508"))
48ad9703-fdd5-4525-9ba2-1147aacf1e6b	0.92	PubMed	13000399	Since tau phosphorylation inhibits its proteolysis, we examined the impact of endogenous phosphatase activities on tau proteolysis by homogenization of cultured cells and 3xTg-AD mouse brain followed by incubation with or without phosphatase inhibitors.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006508"))
48ad9703-fdd5-4525-9ba2-1147aacf1e6b	0.92	PubMed	7530583	They are consistent with the hypothesis that phosphorylation of tau inhibits proteolysis by thrombin or other endogenous proteases, leading to aggregation of tau into insoluble fibrils.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006508"))
48ad9703-fdd5-4525-9ba2-1147aacf1e6b	0.92	PubMed	15542598	They are consistent with the hypothesis that phosphorylation of tau inhibits proteolysis by thrombin or other endogenous proteases, leading to aggregation of tau into insoluble fibrils.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006508"))
f0edee03-d277-4658-b154-54d754897a41	0.65	PubMed	9161599	However, TAU and NAC, despite completely normalizing H (2) DCF-DA (dihydro-dichlorofluorescein diacetate)-measured ROS, did not prevent the increase in superoxide and the decrease in beta-cell function induced by high glucose.	p(HGNC:MAPT)	directlyDecreases	act(a(CHEBI:18421))
519deced-96e7-47a0-8e2d-3380775e8354	0.86	PubMed	18752972	In this model, elevated Tau expression leads to decreased taxane binding to microtubules and in turn, decreased taxane efficacy and suboptimal clinical response to taxane based chemotherapy regimens.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:9548828))
519deced-96e7-47a0-8e2d-3380775e8354	0.86	PubMed	21062914	In this model, elevated Tau expression leads to decreased taxane binding to microtubules and in turn, decreased taxane efficacy and suboptimal clinical response to taxane based chemotherapy regimens.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:9548828))
0d222ed5-ecac-445c-a7eb-bfeb24bbe380	0.65	PubMed	17711696	In vitro, tau prevents DNA replication but not transcription and it may behave like a histone like protein.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006351"))
99003317-61cd-4b34-a139-671baf1a76e7	0.86	PubMed	1421571	Tau increases the rate of polymerization, decreases the rate of transit into the shrinking phase (catastrophe), and inhibits the rate of depolymerization.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:3440))
99003317-61cd-4b34-a139-671baf1a76e7	0.86	PubMed	599580	Tau increases the rate of polymerization, decreases the rate of transit into the shrinking phase (catastrophe), and inhibits the rate of depolymerization.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:3440))
18104109-7620-4c33-8444-42c7f584fa67	0.86	PubMed	19121464	Tau accumulation increased miR92a, which targeted vGAT mRNA 3 ' UTR and inhibited vGAT translation.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006412"))
18104109-7620-4c33-8444-42c7f584fa67	0.86	PubMed	17264032	Lastly, the glutamate induced changes in dendritic tau protein levels were abolished when neurons were co-incubated with cycloheximide (XREF_FIG f, g), indicating that glutamate stimulates rapid local translation of tau mRNA in dendrites.	p(HGNC:MAPT)	directlyDecreases	act(bp(GO:"GO:0006412"))
d5df82ed-02f7-48dc-ae21-9eb374b09509	0.65	PubMed	12151178	In the present study, we have used single molecule imaging techniques to demonstrate that Tau inhibits kinesin 's processive run length in an isoform dependent manner on GDP-microtubules stabilized with either paclitaxel or glycerol and DMSO but not guanosine-5 '-((alpha, beta)-methyleno) triphosphate (GMPCPP)-stabilized microtubules.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:983))
cde0578b-c08d-4eef-90b5-efea8cef4eae	0.92	PubMed	17076777	In pathological conditions, such as the case in AD, not only does abnormal phosphorylation of tau protein decrease its tubulin binding capacity leading to microtubule disorganization, but also this protein self-polymerizes and aggregates in the form of NFTs [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00418))
cde0578b-c08d-4eef-90b5-efea8cef4eae	0.92	PubMed	22303461	Furthermore, we revealed that LRRK2 mediated phosphorylation of tau reduces its tubulin binding ability.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00418))
cde0578b-c08d-4eef-90b5-efea8cef4eae	0.92	PubMed	12387058	Furthermore, we revealed that LRRK2 mediated phosphorylation of tau reduces its tubulin binding ability.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF00418))
246ebbae-2689-4852-8dc1-a235b6783c8b	0.65	PubMed	21109946	TAU Coadministration of BBBA at 30, 60, and 120 mg/kg with TAU (460 mg/kg) increased the C ^ x of plasma uridine (78 | JLM), achieved by TAU alone, by 1.3-, 2.9-, and 2.5-fold, and reduced the C ^ ^ of plasma uracil (265 u, M) by 5.2-, 8.7-, and 12.6-fold, respectively.	p(HGNC:MAPT)	directlyDecreases	act(a(PUBCHEM:1174))
c720fb26-8706-49df-a95a-4123cf357477	0.65	PubMed	3025529	Repetitive injections of morphine (MP), methamphetamine (MAPT) and cocaine (CC) markedly increased motor activity for about 4 hours post-injection, depending on the number of injections and also remarkably increased the state of wakefulness (AW), but decreased the amount of both slow wave sleep (SWS) and fast wave sleep (FWS) in the EEG sleep-wakefulness cycles during the 7-hour observation period.	p(HGNC:MAPT)	directlyDecreases	act(p(PFAM:PF07507))
1844a6c3-2f0c-464b-a3eb-556b85b40cc8	0.65	PubMed	19519311	Recently, we identified the human microtubule associated protein tau (MAP tau), which binds specifically to tubulin and modulates the stability of microtubules, thereby blocking mitosis and presumably vesicular transport.	complex(p(HGNC:MAPT), p(FPLX:Tubulin))	directlyDecreases	act(bp(GO:"GO:0007067"))
71d5548f-1ee6-4ec6-aa50-1d3cd0514d5f	0.99	PubMed	10090741	We have studied the relationship between the phosphorylation of tau by several kinases (MARK, PKA, MAPK, GSK3) and its assembly into PHFs. MARK and PKA phosphorylate several sites within the repeats (notably the KXGS motifs including Ser262, Ser324, and Ser356, plus Ser320). This type of phosphorylation strongly reduces tau's affinity for microtubules, and at the same time inhibits tau's assembly into PHFs.	p(HGNC:MARK1)	directlyDecreases	act(p(HGNC:MAPT))
71d5548f-1ee6-4ec6-aa50-1d3cd0514d5f	0.99	PubMed	10090741	We have studied the relationship between the phosphorylation of tau by several kinases (MARK, PKA, MAPK, GSK3) and its assembly into PHFs. MARK and PKA phosphorylate several sites within the repeats (notably the KXGS motifs including Ser262, Ser324, and Ser356, plus Ser320). This type of phosphorylation strongly reduces tau's affinity for microtubules, and at the same time inhibits tau's assembly into PHFs.	p(HGNC:MARK1)	directlyDecreases	act(p(HGNC:MAPT))
71d5548f-1ee6-4ec6-aa50-1d3cd0514d5f	0.99	PubMed	10090741	We have studied the relationship between the phosphorylation of tau by several kinases (MARK, PKA, MAPK, GSK3) and its assembly into PHFs. MARK and PKA phosphorylate several sites within the repeats (notably the KXGS motifs including Ser262, Ser324, and Ser356, plus Ser320). This type of phosphorylation strongly reduces tau's affinity for microtubules, and at the same time inhibits tau's assembly into PHFs.	p(HGNC:MARK1)	directlyDecreases	act(p(HGNC:MAPT))
71d5548f-1ee6-4ec6-aa50-1d3cd0514d5f	0.99	PubMed	10090741	We have studied the relationship between the phosphorylation of tau by several kinases (MARK, PKA, MAPK, GSK3) and its assembly into PHFs. MARK and PKA phosphorylate several sites within the repeats (notably the KXGS motifs including Ser262, Ser324, and Ser356, plus Ser320). This type of phosphorylation strongly reduces tau's affinity for microtubules, and at the same time inhibits tau's assembly into PHFs.	p(HGNC:MARK1)	directlyDecreases	act(p(HGNC:MAPT))
71d5548f-1ee6-4ec6-aa50-1d3cd0514d5f	0.99	PubMed	21215781	Mark and pka phosphorylate several sites within the repeats (notably the kxgs motifs including ser262, ser324, and ser356, plus ser320)tau pseudophosphorylation at specific sites such as s262, s293, s324 and s356 was reported to induce tau conformational change and attenuate tau binding to microtubules (fischer et al., 2009). Then, newly soluble tau proteins are targeted by post-translational modifications that directly or indirectly alter tau conformation, promoting tau dimerization in an anti-parallel manner. Stable tau dimers form tau oligomers, which continue in the aggregation process	p(HGNC:MARK1)	directlyDecreases	act(p(HGNC:MAPT))
71d5548f-1ee6-4ec6-aa50-1d3cd0514d5f	0.99	PubMed	21215781	Mark and pka phosphorylate several sites within the repeats (notably the kxgs motifs including ser262, ser324, and ser356, plus ser320)tau pseudophosphorylation at specific sites such as s262, s293, s324 and s356 was reported to induce tau conformational change and attenuate tau binding to microtubules (fischer et al., 2009). Then, newly soluble tau proteins are targeted by post-translational modifications that directly or indirectly alter tau conformation, promoting tau dimerization in an anti-parallel manner. Stable tau dimers form tau oligomers, which continue in the aggregation process	p(HGNC:MARK1)	directlyDecreases	act(p(HGNC:MAPT))
71d5548f-1ee6-4ec6-aa50-1d3cd0514d5f	0.99	PubMed	21215781	Mark and pka phosphorylate several sites within the repeats (notably the kxgs motifs including ser262, ser324, and ser356, plus ser320)tau pseudophosphorylation at specific sites such as s262, s293, s324 and s356 was reported to induce tau conformational change and attenuate tau binding to microtubules (fischer et al., 2009). Then, newly soluble tau proteins are targeted by post-translational modifications that directly or indirectly alter tau conformation, promoting tau dimerization in an anti-parallel manner. Stable tau dimers form tau oligomers, which continue in the aggregation process	p(HGNC:MARK1)	directlyDecreases	act(p(HGNC:MAPT))
b9f6b2c7-09d2-49ff-bcfd-e7e27492eaf9	0.94	PubMed	21439371	Surprisingly, Tau exon 10 splicing is not significantly modulated by a loss of MBNL1 expression, in contrast to Tau exon 2.	p(HGNC:MBNL1)	directlyDecreases	act(p(HGNC:MAPT))
b9f6b2c7-09d2-49ff-bcfd-e7e27492eaf9	0.94	PubMed	24440524	This loss of MBNL1 expression significantly promoted Tau exon 2 skipping, regardless of the hTau minigene in which MBNL1 was silenced (A, B, C), suggesting that intronic cis-regulatory elements sensitive to both CUG repeats and the loss of MBNL1 expression are present immediately in close vicinity of Tau exon 2 (A-C).	p(HGNC:MBNL1)	directlyDecreases	act(p(HGNC:MAPT))
b9f6b2c7-09d2-49ff-bcfd-e7e27492eaf9	0.94	PubMed	24440524	In the DM1 condition, however (i.e. in the presence of DT), MBNL2 was only partially effective at reducing the mis splicing of Tau exon 2 induced by the concomitant presence of CUG repeats and silencing of MBNL1 expression (B).	p(HGNC:MBNL1)	directlyDecreases	act(p(HGNC:MAPT))
b9f6b2c7-09d2-49ff-bcfd-e7e27492eaf9	0.94	PubMed	24440524	Surprisingly, in our cell system, the overexpression of MBNL1, up to 10-times its normal levels, concomitantly with DT, does not reverse Tau exon 2 skipping.	p(HGNC:MBNL1)	directlyDecreases	act(p(HGNC:MAPT))
3bafea9b-411b-44ac-a122-2c318780f247	0.65	PubMed	13974236	Intriguingly, the interaction of MBNL1 and MBNL2 is required to fully reverse the mis splicing of Tau exon 2 induced by the trans-dominant effect of long CUG repeats, similar to the DM1 condition.	complex(p(HGNC:MBNL2), p(HGNC:MBNL1))	directlyDecreases	act(p(HGNC:MAPT))
652cc685-f2da-4aa0-aa17-be5ae6372f5e	0.95	PubMed	18922365	To better understand the specific role of Hsp90 in this system, we examined how changes in Hsp90 levels influence MB initiated tau degradation.	p(HGNC:MB)	directlyDecreases	act(p(HGNC:MAPT))
652cc685-f2da-4aa0-aa17-be5ae6372f5e	0.95	PubMed	15293274	Since methylene blue (MB) is able to inhibit Tau aggregation in vitro, we investigated whether MB can prevent or rescue Tau induced cognitive impairments in our mouse models.	p(HGNC:MB)	directlyDecreases	act(p(HGNC:MAPT))
652cc685-f2da-4aa0-aa17-be5ae6372f5e	0.95	PubMed	15277264	Methylene blue (MB) inhibits the aggregation of tau, a main constituent of neurofibrillary tangles.	p(HGNC:MB)	directlyDecreases	act(p(HGNC:MAPT))
652cc685-f2da-4aa0-aa17-be5ae6372f5e	0.95	PubMed	19793966	To test this idea, cells were transiently transfected with myc tagged Hsp70 and tau reductions by AC and MB were quantified (XREF_FIG).	p(HGNC:MB)	directlyDecreases	act(p(HGNC:MAPT))
652cc685-f2da-4aa0-aa17-be5ae6372f5e	0.95	PubMed	18366179	We show that MB is capable of protecting neurons, however, only high dose MB treatment was able to reduce tau and also improve cognition.	p(HGNC:MB)	directlyDecreases	act(p(HGNC:MAPT))
99ca2578-50c9-4a89-9a3b-3ad4d1894282	0.65	PubMed	18616508	It has been postulated that tauopathies result, at least in part, from a loss of tau function caused by reduced MT binding of hyperphosphorylated or mutant tau.	p(HGNC:MCAT)	directlyDecreases	act(p(HGNC:MAPT))
b132a163-00d8-4e67-9b5b-0898416cca19	0.65	PubMed	22890115	Contrary to PK and trypsine, MMP-3 and MMP-9 did not completely degrade tau protein at comparable concentrations (see A and B).	p(HGNC:MMP9)	directlyDecreases	act(p(HGNC:MAPT))
1fc4a848-933d-41ca-b9e0-f3f0c05ed1f0	0.92	PubMed	18894782	Increased mTOR protein expression occurs in select neurons in severe AD, and inhibition of mTOR signaling induces autophagy, reduces tau and Abeta pathology and ameliorates behavioral deficits in young transgenic mice overexpressing Abeta and tau.	p(HGNC:MTOR)	directlyDecreases	act(p(HGNC:MAPT))
1fc4a848-933d-41ca-b9e0-f3f0c05ed1f0	0.92	PubMed	18950918	Supporting this view, it has been shown that rapamycin suppresses the translation of tau, whereas constitutively active p70S6K, a downstream target of mTOR, increases tau translation.	p(HGNC:MTOR)	directlyDecreases	act(p(HGNC:MAPT))
1fc4a848-933d-41ca-b9e0-f3f0c05ed1f0	0.92	PubMed	16937836	For instance, it has been shown that rapamycin mediated mTOR inhibition reduces Abeta and tau accumulation in an autophagy dependent manner and reduces cognitive deficits in two different mouse models of AD [XREF_BIBR, XREF_BIBR].	p(HGNC:MTOR)	directlyDecreases	act(p(HGNC:MAPT))
f8a23b0e-c65c-43c6-9959-5f004d956dac	0.86	PubMed	17319640	Memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is the potential inhibitor of tau protein in neurons.	a(PUBCHEM:4054)	directlyDecreases	act(p(HGNC:MAPT))
f8a23b0e-c65c-43c6-9959-5f004d956dac	0.86	PubMed	19114480	Memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is the potential inhibitor of tau protein in neurons.	a(PUBCHEM:4054)	directlyDecreases	act(p(HGNC:MAPT))
161d6555-1afe-4407-824d-393ae90da098	0.65	PubMed	17285292	Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice.	a(PUBCHEM:6099)	directlyDecreases	act(p(HGNC:MAPT, var(p.Pro301Leu)))
392b78c8-95c3-433b-bdc9-94a9c21803bd	0.65	PubMed	18441440	Methylene blue disrupts the aggregation of Tau, has the ability to inhibit amyloid aggregation, improves the efficiency of mitochondrial electron transport chain, reduces oxidative stress, prevents mitochondrial damage, and is also a modulator of autophagy [XREF_BIBR, XREF_BIBR].	a(PUBCHEM:6099)	directlyDecreases	act(p(HGNC:MAPT))
7c9ff331-b7ea-40d9-b5cb-04fcbd293e11	0.65	PubMed	18340930	Tau inhibitory effect on EB tracking at microtubule ends is mediated by the C-terminal part of EBs.	p(HGNC:NAT9)	directlyDecreases	act(p(HGNC:MAPT))
0095a115-03c6-48ba-9f0b-11211482a02c	0.94	PubMed	17260343	Chronic HFD feeding alone (HFD+VEH) significantly reduced pTau (P < 0.01) and ChAT (P < 0.001) relative to control, whereas early NDEA exposure plus later chronic HFD feeding significantly reduced Tau (P < 0.001), pTau (P < 0.001), ChAT (P < 0.001), and AChE (P < 0.001) relative to control and chronic HFD fed rats.	a(PUBCHEM:5921)	directlyDecreases	act(p(HGNC:MAPT))
0095a115-03c6-48ba-9f0b-11211482a02c	0.94	PubMed	10928005	HFD +/- NDEA caused T2DM, neurodegeneration with impairments in brain insulin, insulin receptor, IGF-2 receptor, or insulin receptor substrate gene expression, and reduced expression of tau and choline acetyltransferase (ChAT), which are regulated by insulin and IGF-1.	a(PUBCHEM:5921)	directlyDecreases	act(p(HGNC:MAPT))
0095a115-03c6-48ba-9f0b-11211482a02c	0.94	PubMed	17260343	Correspondingly, NDEA treatment inhibited tau and ChAT, which are regulated by insulin and IGF [XREF_BIBR], and are reduced in brains with AD [XREF_BIBR].	a(PUBCHEM:5921)	directlyDecreases	act(p(HGNC:MAPT))
0095a115-03c6-48ba-9f0b-11211482a02c	0.94	PubMed	17260343	HFD +/- NDEA caused T2DM, neurodegeneration with impairments in brain insulin, insulin receptor, IGF-2 receptor, or insulin receptor substrate gene expression, and reduced expression of tau and choline acetyltransferase (ChAT), which are regulated by insulin and IGF-1.	a(PUBCHEM:5921)	directlyDecreases	act(p(HGNC:MAPT))
6058d736-c0f3-4515-a0de-867c0b900efa	0.65	PubMed	18557585	Recently, it was found that clearance of tau was slowed in human tau expressing neuroblastoma cells that were treated with the lysosomotropic agents NH 4 Cl or chloroquine XREF_BIBR.	p(IP:IPR000981)	directlyDecreases	act(p(HGNC:MAPT))
e9642770-1b41-449e-b8f7-6d356661613b	0.65	PubMed	3917290	MK-801 pretreatment abolished NMDA induced changes and reduced Tau (26%) and Gly (30%) levels.	a(PUBCHEM:22880)	directlyDecreases	act(p(HGNC:MAPT))
7b1401e6-5ce6-4585-ab8e-7c1aea251f58	0.65	PubMed	15716587	However, NPAS4 over-expression reversed the aggregation of tau that was induced by the inhibition of autophagy.	p(HGNC:NPAS4)	directlyDecreases	act(p(HGNC:MAPT))
a9aa4edd-e8f7-41e8-88c7-fb10a0ae4848	0.65	PubMed	21320871	Puromycin sensitive aminopeptidase (PSA and NPEPPS) impedes development of neuropathology in hPSA and TAU (P301L) double-transgenic mice.	p(HGNC:NPEPPS)	directlyDecreases	act(p(HGNC:MAPT, var(p.Pro301Leu)))
9f89b587-3a45-4a54-b18e-4a9c79eb7773	0.65	PubMed	3192688	Whereas pH (range 5-10) had little effect on r (t), [NaCl] addition (0-150 mM) remarkably decreased tau 1c from 68 to 44 ns.	a(PUBCHEM:5234)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	However, Nilotinib prevented p-Tau accumulation even in the presence of MG132 in Abeta1-42 expressing cells (n = 5, p < 0.036).	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	Nilotinib reduced p-Tau relative to actin (1 st blot, p < 0.05) when Abeta1-42 and Tau were expressed together or separately in the presence or absence of MG132, while Bafilomycin-A1 blocked the effects of Nilotinib on p-Tau reduction.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	No p-Tau was detected in Abeta1-42 expressing Tau -/- neurons, but Nilotinib significantly reduced p-Tau compared to DMSO in Tau alone or with Abeta1-42.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	However, both MG132 and Bafilomycin-A1 blocked Nilotinib induced p-Tau decrease (p < 0.01) in the presence of Tau alone or together with Abeta1-42.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	23737459	p-Tau was also detected in AV10 (211ng/mL) and AV20 (112ng/mL) in lentiviral Abeta 1-42 expressing WT brain (XREF_FIG) and Nilotinib decreased p-Tau in AV10 (49ng/mL, p = 0.02, N = 5) and increased it in lysosomes (17ng/mL) compared to DMSO.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	Further ELISA measurement of Ser396 p-Tau showed significantly high levels of p-Tau in AV10 and AV20 in Abeta1-42 expressing WT mice compared to LacZ (+ DMSO), but Nilotinib reduced p-Tau in AV10 and increased it in the lysosomes.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	Expression of Abeta1-42 together with Tau in WT mice significantly increased p-Tau in AV10 compared to Abeta1-42 alone, but Nilotinib again reduced p-Tau in AV10 (p < 0.03) and increased it in AV20.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	Nilotinib also reduced p-Tau in AV10 and AV20 in Tau expressing WT mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	However, when Tau was co-expressed with Abeta1-42 in Tau -/- mice, Nilotinib significantly decreased p-Tau in AV10 and AV20 and increased it in lysosomes, indicating that exogenous Tau affects Abeta1-42 and p-Tau clearance in Tau -/- mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	However, total Tau (Tau-5) and p-Tau (AT8) were increased in Tau (n = 5, p < 0.05) and Tau and Abeta1-42 (p < 0.05) expressing WT mice, but both parkin and Nilotinib decreased p-Tau (38 and 50%, respectively, p < 0.04) relative to actin.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	Nilotinib significantly decreased p-Tau at Ser262 (44%) and Ser 396 (53%) relative to actin in Abeta1-42 alone or with Tau in WT mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	Nilotinib reduces p-Tau when exogenous Tau is expressed in Tau -/- mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	Abeta1-42 and Tau together increased p-Tau compared to LacZ but Nilotinib decreased p-Tau in WT mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	No p-Tau was observed in the hippocampus of Tau -/- mice but human Tau expression led to p-Tau in Tau -/- mice with DMSO, while Nilotinib reduced p-Tau.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	Injection of lentiviral Tau into the hippocampus also increased p-Tau (AT180) (91%, by stereology) in the cortex in mice treated with DMSO compared to LacZ, but Nilotinib reduced p-Tau (45%, p < 0.05).	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	Abeta1-42 and Tau together increased p-Tau levels (69%, by stereology, p < 0.04) compared to LacZ but Nilotinib decreased p-Tau (62% by stereology, p < 0.04) in WT mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	25384392	In contrast with WT mice, Nilotinib did not reduce Abeta1-42-induced cell death in Tau -/- mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	Nilotinib also reduced p-Tau in AV10 and AV20 in Tau expressing WT mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	However, Nilotinib prevented p-Tau accumulation even in the presence of MG132 in Abeta1-42 expressing cells (n = 5, p < 0.036).	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	Abeta1-42 and Tau together increased p-Tau compared to LacZ but Nilotinib decreased p-Tau in WT mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	Nilotinib significantly decreased p-Tau at Ser262 (44%) and Ser 396 (53%) relative to actin in Abeta1-42 alone or with Tau in WT mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	Expression of Abeta1-42 together with Tau in WT mice significantly increased p-Tau in AV10 compared to Abeta1-42 alone, but Nilotinib again reduced p-Tau in AV10 (p < 0.03) and increased it in AV20.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	However, both MG132 and Bafilomycin-A1 blocked Nilotinib induced p-Tau decrease (p < 0.01) in the presence of Tau alone or together with Abeta1-42.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	Injection of lentiviral Tau into the hippocampus also increased p-Tau (AT180) (91%, by stereology) in the cortex in mice treated with DMSO compared to LacZ, but Nilotinib reduced p-Tau (45%, p < 0.05).	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	No p-Tau was observed in the hippocampus of Tau -/- mice but human Tau expression led to p-Tau in Tau -/- mice with DMSO, while Nilotinib reduced p-Tau.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	Further ELISA measurement of Ser396 p-Tau showed significantly high levels of p-Tau in AV10 and AV20 in Abeta1-42 expressing WT mice compared to LacZ (+ DMSO), but Nilotinib reduced p-Tau in AV10 and increased it in the lysosomes.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	In contrast with WT mice, Nilotinib did not reduce Abeta1-42-induced cell death in Tau -/- mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	No p-Tau was detected in Abeta1-42 expressing Tau -/- neurons, but Nilotinib significantly reduced p-Tau compared to DMSO in Tau alone or with Abeta1-42.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	Abeta1-42 and Tau together increased p-Tau levels (69%, by stereology, p < 0.04) compared to LacZ but Nilotinib decreased p-Tau (62% by stereology, p < 0.04) in WT mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	However, when Tau was co-expressed with Abeta1-42 in Tau -/- mice, Nilotinib significantly decreased p-Tau in AV10 and AV20 and increased it in lysosomes, indicating that exogenous Tau affects Abeta1-42 and p-Tau clearance in Tau -/- mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	Nilotinib reduced p-Tau relative to actin (1 st blot, p < 0.05) when Abeta1-42 and Tau were expressed together or separately in the presence or absence of MG132, while Bafilomycin-A1 blocked the effects of Nilotinib on p-Tau reduction.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	Nilotinib reduces p-Tau when exogenous Tau is expressed in Tau -/- mice.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
6707f541-974f-46f8-aa98-7aa2a5edc239	0.95	PubMed	18363490	However, total Tau (Tau-5) and p-Tau (AT8) were increased in Tau (n = 5, p < 0.05) and Tau and Abeta1-42 (p < 0.05) expressing WT mice, but both parkin and Nilotinib decreased p-Tau (38 and 50%, respectively, p < 0.04) relative to actin.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
c6e2647c-aeb6-4b15-a2a5-edf1fb13a369	0.65	PubMed	20895290	~ Noradrenalinc 1.3 2.1 0.6 blood pressure elicited by noradrenaline enhanced Nitroprusside 0.8 o. ~ I.O release rate of taurinc in the hypothalamus, nitrop side lowered blood pressure and diminished tau release.	a(PUBCHEM:11963622)	directlyDecreases	act(p(HGNC:MAPT))
1388ec10-5a2f-4715-b36d-bcf753cb963b	0.65	PubMed	17595337	Nocodazole and Taxotere Reverse the Effect of Tau on Mitochondrial Distribution.	a(PUBCHEM:4122)	directlyDecreases	act(p(HGNC:MAPT))
94586288-d426-437f-9f08-845cd557ad28	0.86	PubMed	4422983	These results suggest that in MCF7 cells OA selectively inhibits PP2A and TAU predominantly affects PP1, a conclusion supported by their differential effects on cytokeratins in this cell line.	a(CHEBI:44658)	directlyDecreases	act(p(HGNC:MAPT))
94586288-d426-437f-9f08-845cd557ad28	0.86	PubMed	21319843	In contrast, OA treatment decreased WGA mediated detection of Tau 441 in both cytosolic and nuclear extracts.	a(CHEBI:44658)	directlyDecreases	act(p(HGNC:MAPT))
87b9c7d3-b37d-41a4-aad6-16ee0254c37a	0.65	PubMed	16851072	Endogenous Otub1 depletion significantly inhibited Tau aggregation, with the level of inhibition correlating with the level of knockdown efficiency, while use of a control siRNA did not affect levels of Otub1 nor aggregation efficiency.	p(HGNC:OTUB1)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	Because protein disulfide isomerase (PDI) is both an enzyme and a chaperone, and implicated in neuroprotection against Alzheimer disease, we want to know whether PDI can prevent Tau fibrillization.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	As revealed by thioflavin T binding assays, Sarkosyl-insoluble SDS-PAGE, and transmission electron microscopy, full-length human PDI remarkably inhibits both steps of nucleation and elongation of Tau 244-372 fibrillization in a concentration dependent manner.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	Because PDI is both an enzyme and a chaperone, and implicated in neuroprotection against Alzheimer disease as described above, we want to know whether PDI can prevent Tau fibrillization.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	Our biophysical analysis revealed that one full-length PDI bound to one full-length Tau monomer with micromolar affinity at physiological pH. We also found that PDI (especially thioredoxin like catalytic domain a) inhibited nucleation and elongation of Tau 244-372 fibrillization.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	Furthermore, we found that the a-domain of human PDI inhibited both steps of nucleation and elongation of Tau 244-372 fibrillization more strongly than full-length human PDI (XREF_TABLE and XREF_FIG), resulting in a lag time of 253 min in the presence of 20 microM domain a, which is 40% increased compared to that in the absence of PDI, and a rate constant for the growth of fibrils of 17.6 x10 -3 min -1, which is 52% decreased compared to that in the absence of PDI.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	However, 20 microM full-length human PDI strongly inhibited both steps of nucleation and elongation of Tau 244-372 fibrillization in the presence of 100 g/l Ficoll 70, resulting in a lag time of 44.8 min, which is infinite increase compared with that in the absence of PDI (0 min), and a rate constant for the growth of fibrils of 31.4 x10 -3 min -1, which is 43% decreased compared to that in the absence of PDI (54.9 x10 -3 min -1) (XREF_TABLE).	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	These findings further support the observations mentioned above that the addition of 20 microM full-length human PDI did inhibit Tau 244-372 fibrillization at physiological pH, and that the a-domain of human PDI inhibited Tau 244-372 fibrillization more strongly than full-length human PDI.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	These findings once again support the observations that the addition of 10-20 microM full-length human PDI did inhibit Tau 244-372 fibrillization at physiological pH, and that the a-domain of human PDI inhibited Tau 244-372 fibrillization more strongly than full-length human PDI.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	As shown in XREF_FIG, full-length human PDI remarkably inhibited both steps of nucleation and elongation of Tau 244-372 fibrillization under such conditions.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	The reason why PDI reduced Tau seeds fibrillization but not Tau oligomers fibrillization is unknown.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	Therefore, human PDI formed a 1:1 complex with human Tau protein and prevented abnormal Tau aggregation under physiological conditions.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	17485366	In the present study, we found that two molecules of the a-domain of human PDI interacted with one Tau molecule with sub-micromolar affinity, and inhibited both steps of nucleation and elongation of Tau fibrillization more strongly than full-length human PDI.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	Because protein disulfide isomerase (PDI) is both an enzyme and a chaperone, and implicated in neuroprotection against Alzheimer disease, we want to know whether PDI can prevent Tau fibrillization.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	As revealed by thioflavin T binding assays, Sarkosyl-insoluble SDS-PAGE, and transmission electron microscopy, full-length human PDI remarkably inhibits both steps of nucleation and elongation of Tau 244-372 fibrillization in a concentration dependent manner.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	Because PDI is both an enzyme and a chaperone, and implicated in neuroprotection against Alzheimer disease as described above, we want to know whether PDI can prevent Tau fibrillization.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	Our biophysical analysis revealed that one full-length PDI bound to one full-length Tau monomer with micromolar affinity at physiological pH. We also found that PDI (especially thioredoxin like catalytic domain a) inhibited nucleation and elongation of Tau 244-372 fibrillization.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	Furthermore, we found that the a-domain of human PDI inhibited both steps of nucleation and elongation of Tau 244-372 fibrillization more strongly than full-length human PDI (XREF_TABLE and XREF_FIG), resulting in a lag time of 253 min in the presence of 20 microM domain a, which is 40% increased compared to that in the absence of PDI, and a rate constant for the growth of fibrils of 17.6 x10 -3 min -1, which is 52% decreased compared to that in the absence of PDI.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	However, 20 microM full-length human PDI strongly inhibited both steps of nucleation and elongation of Tau 244-372 fibrillization in the presence of 100 g/l Ficoll 70, resulting in a lag time of 44.8 min, which is infinite increase compared with that in the absence of PDI (0 min), and a rate constant for the growth of fibrils of 31.4 x10 -3 min -1, which is 43% decreased compared to that in the absence of PDI (54.9 x10 -3 min -1) (XREF_TABLE).	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	These findings further support the observations mentioned above that the addition of 20 microM full-length human PDI did inhibit Tau 244-372 fibrillization at physiological pH, and that the a-domain of human PDI inhibited Tau 244-372 fibrillization more strongly than full-length human PDI.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	These findings once again support the observations that the addition of 10-20 microM full-length human PDI did inhibit Tau 244-372 fibrillization at physiological pH, and that the a-domain of human PDI inhibited Tau 244-372 fibrillization more strongly than full-length human PDI.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	As shown in XREF_FIG, full-length human PDI remarkably inhibited both steps of nucleation and elongation of Tau 244-372 fibrillization under such conditions.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	The reason why PDI reduced Tau seeds fibrillization but not Tau oligomers fibrillization is unknown.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	Therefore, human PDI formed a 1:1 complex with human Tau protein and prevented abnormal Tau aggregation under physiological conditions.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	24098548	In the present study, we found that two molecules of the a-domain of human PDI interacted with one Tau molecule with sub-micromolar affinity, and inhibited both steps of nucleation and elongation of Tau fibrillization more strongly than full-length human PDI.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
88454b8a-7290-4448-a4bc-bc1a8e97c980	0.95	PubMed	13784695	Because protein disulfide isomerase (PDI) is both an enzyme and a chaperone, and implicated in neuroprotection against Alzheimer disease, we want to know whether PDI can prevent Tau fibrillization.	p(HGNC:P4HB)	directlyDecreases	act(p(HGNC:MAPT))
e448513f-a6ed-40ee-8af6-f2685030886a	0.86	PubMed	21376022	Our animal models expressing intraneuronal Abeta 1-42 or alpha-Synuclein show an increase in Tau phosphorylartion, but lentiviral parkin expression reverses Tau modification in these animals (XREF_BIBR; XREF_BIBR).	p(UP:O60260)	directlyDecreases	act(p(HGNC:MAPT))
e448513f-a6ed-40ee-8af6-f2685030886a	0.86	PubMed	23262240	Expression of human alpha-Synuclein leads to a significant increase (XREF_FIG, 34%, N = 8) in p-Tau in the rat striatum, but co-expression of parkin reverses p-Tau back to control.	p(UP:O60260)	directlyDecreases	act(p(HGNC:MAPT))
b5e35de2-379f-4fbb-8514-49e3d679b240	0.86	PubMed	18594910	Furthermore, the strong binding between R3/wt with disease related DeltaK280 mutant implies a possible toxicity mechanism, as the tight complexes of PHF6 containing Tau and the DeltaK280 mutant could reduce the population of functional Tau available to regulate microtubule dynamics and/or to promote pathological trans-synaptic tau transfer.	p(HGNC:PHF6)	directlyDecreases	act(p(HGNC:MAPT))
b5e35de2-379f-4fbb-8514-49e3d679b240	0.86	PubMed	20347229	However, inhibitors of the PHF6 * motif have been shown to reduce the heparin induced assembly of 4R Tau.	p(HGNC:PHF6)	directlyDecreases	act(p(HGNC:MAPT))
85f29085-776d-4f5e-bec0-1af4ab638617	0.99	PubMed	8999860	Muscle phosphorylase kinase phosphorylates Ser237, Ser262, Ser285, Ser305, and Ser352 of human tau. in vitro phosphorylation of tau on Ser262 alone strongly reduced the ability of tau to bind microtubules whereas the phosphorylation of many Ser/Thr-Pro motif sites of tau showed moderate effects on the binding of tau to microtubules	p(HGNC:PHKG1)	directlyDecreases	act(p(HGNC:MAPT))
85f29085-776d-4f5e-bec0-1af4ab638617	0.99	PubMed	8999860	Muscle phosphorylase kinase phosphorylates Ser237, Ser262, Ser285, Ser305, and Ser352 of human tau. in vitro phosphorylation of tau on Ser262 alone strongly reduced the ability of tau to bind microtubules whereas the phosphorylation of many Ser/Thr-Pro motif sites of tau showed moderate effects on the binding of tau to microtubules	p(HGNC:PHKG1)	directlyDecreases	act(p(HGNC:MAPT))
85f29085-776d-4f5e-bec0-1af4ab638617	0.99	PubMed	8999860	Muscle phosphorylase kinase phosphorylates Ser237, Ser262, Ser285, Ser305, and Ser352 of human tau. in vitro phosphorylation of tau on Ser262 alone strongly reduced the ability of tau to bind microtubules whereas the phosphorylation of many Ser/Thr-Pro motif sites of tau showed moderate effects on the binding of tau to microtubules	p(HGNC:PHKG1)	directlyDecreases	act(p(HGNC:MAPT))
85f29085-776d-4f5e-bec0-1af4ab638617	0.99	PubMed	8999860	Muscle phosphorylase kinase phosphorylates Ser237, Ser262, Ser285, Ser305, and Ser352 of human tau. in vitro phosphorylation of tau on Ser262 alone strongly reduced the ability of tau to bind microtubules whereas the phosphorylation of many Ser/Thr-Pro motif sites of tau showed moderate effects on the binding of tau to microtubules	p(HGNC:PHKG1)	directlyDecreases	act(p(HGNC:MAPT))
85f29085-776d-4f5e-bec0-1af4ab638617	0.99	PubMed	8999860	Muscle phosphorylase kinase phosphorylates Ser237, Ser262, Ser285, Ser305, and Ser352 of human tau. in vitro phosphorylation of tau on Ser262 alone strongly reduced the ability of tau to bind microtubules whereas the phosphorylation of many Ser/Thr-Pro motif sites of tau showed moderate effects on the binding of tau to microtubules	p(HGNC:PHKG1)	directlyDecreases	act(p(HGNC:MAPT))
c22ca0f4-6441-4edc-82c1-6bc7f374d89d	0.94	PubMed	24853415	For example, Pin1 knockdown and/or downregulation in AD neurons increase tau protein stability.	p(HGNC:PIN1)	directlyDecreases	act(p(HGNC:MAPT))
c22ca0f4-6441-4edc-82c1-6bc7f374d89d	0.94	PubMed	18703919	Therefore, deletion of the Pin1 gene alone in mice causes progressive deposition of tau and Abeta, and neuronal degeneration [XREF_BIBR, XREF_BIBR].	p(HGNC:PIN1)	directlyDecreases	act(p(HGNC:MAPT))
c22ca0f4-6441-4edc-82c1-6bc7f374d89d	0.94	PubMed	25576397	Functional inhibition of Pin1 contributes to the development of AD by inducing tau and Abeta pathologies and neurodegeneration in an age dependent manner.	p(HGNC:PIN1)	directlyDecreases	act(p(HGNC:MAPT))
c22ca0f4-6441-4edc-82c1-6bc7f374d89d	0.94	PubMed	17317113	Furthermore, loss of Pin1 function in mice can cause both Tau and Abeta related pathologies in an age dependent manner, resembling many aspects of human Alzheimer 's disease.	p(HGNC:PIN1)	directlyDecreases	act(p(HGNC:MAPT))
f230853a-6ca1-462e-a199-b64e91e52b08	0.94	PubMed	11104762	Phosphorylation of tau is regulated by pknthere is a pkn-specific phosphorylation site, ser-320, in mbdsthus pkn serves as a regulator of microtubules by specific phosphorylation of tau, which leads to disruption of tubulin assembly.	p(HGNC:PKN1)	directlyDecreases	act(p(HGNC:MAPT))
794ebac5-f167-4918-a5f5-bdccfdab7c75	0.94	PubMed	15525651	Galpha12 directly interacts with pp2a: evidence for galpha12-stimulated pp2a phosphatase activity and dephosphorylation of microtubule-associated protein, tau.	p(HGNC:PPP2R1A)	directlyDecreases	act(p(HGNC:MAPT))
ae572aef-36e8-412b-9160-b7303f54c12b	0.99	PubMed	9771888	Tau is phosphorylated by gsk-3 at several sites found in alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by a-kinase.	p(HGNC:PRKACA)	directlyDecreases	act(p(HGNC:MAPT))
ae572aef-36e8-412b-9160-b7303f54c12b	0.99	PubMed	21215781	However, other kinases, such as cdk5, p38 and pka, also phosphorylate tau at t231tau phosphorylation at t231, s235 and s262 also contributes to the dissociation of tau from microtubules	p(HGNC:PRKACA)	directlyDecreases	act(p(HGNC:MAPT))
ae572aef-36e8-412b-9160-b7303f54c12b	0.99	PubMed	9614189	S214 can be rapidly and selectively phosphorylated in vitro by PKA, and this single site strongly affects tau's ability to bind and stabilize microtubules.	p(HGNC:PRKACA)	directlyDecreases	act(p(HGNC:MAPT))
ae572aef-36e8-412b-9160-b7303f54c12b	0.99	PubMed	12435421	Ser214, Ser262, Ser356, and Ser409 of tau441‚ were phosphorylated by PKA. tau in PHF is abnormally hyperphosphorylated and lacks its normal activity to bind to microtubules and to stimulate their assembly	p(HGNC:PRKACA)	directlyDecreases	act(p(HGNC:MAPT))
ae572aef-36e8-412b-9160-b7303f54c12b	0.99	PubMed	12435421	Ser214, Ser262, Ser356, and Ser409 of tau441‚ were phosphorylated by PKA. tau in PHF is abnormally hyperphosphorylated and lacks its normal activity to bind to microtubules and to stimulate their assembly	p(HGNC:PRKACA)	directlyDecreases	act(p(HGNC:MAPT))
ae572aef-36e8-412b-9160-b7303f54c12b	0.99	PubMed	12435421	Ser214, Ser262, Ser356, and Ser409 of tau441‚ were phosphorylated by PKA. tau in PHF is abnormally hyperphosphorylated and lacks its normal activity to bind to microtubules and to stimulate their assembly	p(HGNC:PRKACA)	directlyDecreases	act(p(HGNC:MAPT))
3c60a878-c792-4cfd-93ac-54c03c36279e	0.65	PubMed	18753019	Our animal models expressing intraneuronal Abeta 1-42 or alpha-Synuclein show an increase in Tau phosphorylartion, but lentiviral parkin expression reverses Tau modification in these animals.	p(HGNC:PRKN)	directlyDecreases	act(p(HGNC:MAPT))
a8effc6c-69e9-4453-87fd-f00f8353b4f5	0.86	PubMed	26159201	Overexpression of PSEN1 reduced MAPT promoter activity in an in vitro luciferase study, and led to an increase in methylation of the endogenous MAPT promoter.	p(HGNC:PSEN1)	directlyDecreases	act(p(HGNC:MAPT))
a8effc6c-69e9-4453-87fd-f00f8353b4f5	0.86	PubMed	15427311	Overexpression of PSEN1 reduced MAPT promoter activity in an in vitro luciferase study, and led to an increase in methylation of the endogenous MAPT promoter.	p(HGNC:PSEN1)	directlyDecreases	act(p(HGNC:MAPT))
94b762b0-bcad-4f0c-8816-82a554fbe34a	0.65	PubMed	18616420	The proteasomal subunits Psmb8 and Psmb9 belong to the immunoproteasome which replace catalytic subunits of the proteasome when cells are exposed to pro inflammatory cytokines IFN-gamma or TNF, and can accelerate the degradation of tau.	p(HGNC:PSMB8)	directlyDecreases	act(p(HGNC:MAPT))
dc13a717-e17e-46b4-999a-4f3583182eb8	0.65	PubMed	6803836	HG myocytes exhibited normal PS; decreased +/-dL/dt; and prolonged TPS, TR90, and tau.	a(PUBCHEM:7408258)	directlyDecreases	act(p(HGNC:MAPT))
4e38003c-c37e-4e70-9e94-bae16b477bc2	0.65	PubMed	18913346	Progesterone administration has been shown to decrease tau-P and increase the dephosphorylated form of tau in the hippocampus of ovarectomized rats, but does not affect GSK3 phosphorylation.	a(PUBCHEM:5994)	directlyDecreases	act(p(HGNC:MAPT))
26efe5df-90d3-4817-903d-bb6e578cb918	0.65	PubMed	4509049	If the dimers are formed, however, their clearance is considerably slower than that of the monomers, explaining the remarkable protease resistance of PHF-tau in the affected brains.	p(FPLX:Protease)	directlyDecreases	act(p(HGNC:MAPT))
14e6648f-2d96-44bb-bfa1-d91e47f9a441	0.94	PubMed	17890370	The suppression of Rab1A inducing a fragmentation of the Golgi increased Tau secretion by both HeLa cells and neurons.	p(HGNC:RAB1A)	directlyDecreases	act(p(HGNC:MAPT))
14e6648f-2d96-44bb-bfa1-d91e47f9a441	0.94	PubMed	17890370	The suppression of Rab1A, Rab GTPase associated with the Golgi membranes, known to induce a Golgi fragmentation increased Tau secretion by both neurons and HeLa cells.	p(HGNC:RAB1A)	directlyDecreases	act(p(HGNC:MAPT))
14e6648f-2d96-44bb-bfa1-d91e47f9a441	0.94	PubMed	19425129	The suppression of Rab1A, Rab GTPase associated with the Golgi membranes, known to induce a Golgi fragmentation increased Tau secretion by both neurons and HeLa cells.	p(HGNC:RAB1A)	directlyDecreases	act(p(HGNC:MAPT))
14e6648f-2d96-44bb-bfa1-d91e47f9a441	0.94	PubMed	17890370	Suppression of Rab1A induces a Golgi fragmentation and an increase of Tau secretion by neurons and HeLa cells.	p(HGNC:RAB1A)	directlyDecreases	act(p(HGNC:MAPT))
ad8986b1-9640-4864-b66f-4a8a62413e53	0.65	PubMed	18528543	RARalpha deletion significantly impaired cardiomyocyte relaxation, as evidenced by slowed -dL/dt, increased TR50, TR90 and Tau in adult cardiomyocytes isolated from RARalphaKO mouse hearts.	p(HGNC:RARA)	directlyDecreases	act(p(HGNC:MAPT))
0118c2ec-d1c7-4b5c-81d8-c37d16d04ac5	0.65	PubMed	25930997	Scavenging ROS suppresses neurotoxicity and reduces Tau aggregation, showing positive effects in animal models of neuronal diseases.	p(HGNC:ROS1)	directlyDecreases	act(p(HGNC:MAPT))
c2f304b8-0a4a-41dd-a53f-85c074c9f958	0.65	PubMed	20849811	kinase-I or RSK-2) (61,62) and as such, stimulation of the MAP kinase cascade is predicted to inhibit GSK-3-mediated phosphor- ylation of tau.	p(HGNC:RPS6KA3)	directlyDecreases	act(p(HGNC:MAPT))
5c83d303-1858-4b3e-ba19-b40c6d25bff2	0.94	PubMed	17764056	Rapamycin at the concentrations tested appears to be not toxic for the cells (XREF_FIG) and induces a concentration dependent reduction in TAU aggregation (XREF_FIG).	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
5c83d303-1858-4b3e-ba19-b40c6d25bff2	0.94	PubMed	14854404	Rapamycin has been shown to prevent (and possibly restore in some cases) the deficit in memory observed in the mouse model of Alzheimer 's disease (AD-Tg) as well as reduce Abeta and tau aggregation, restore cerebral blood flow and vascularization, and reduce microglia activation.	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
5c83d303-1858-4b3e-ba19-b40c6d25bff2	0.94	PubMed	17488787	Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice.	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
5c83d303-1858-4b3e-ba19-b40c6d25bff2	0.94	PubMed	16896973	Rapamycin significantly decreased Tau in hippocampus OXYS and Wistar rats (p < 0.001 and p < 0.001, respectively).	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
68d10e07-0a05-4e54-a2b3-88f7d0c8059c	0.65	PubMed	12813043	Replacement of leucine 272 in S1 of HCN4 by the corresponding phenylalanine present in HCN2 decreased tau act of HCN4 to 149 ms. Conversely, activation of the fast channel HCN2 was decreased 3-fold upon the corresponding mutation of F221L in the S1 segment.	p(PFAM:PF00575)	directlyDecreases	act(p(HGNC:MAPT))
2e18188b-abca-4fe3-b682-416cf843e6a7	0.65	PubMed	12167662	SAM supplementation reduced hippocampal intracellular AbetaPP and Abeta and phospho-tau immunoreactivity to a similar extent at both sampling intervals.	a(PUBCHEM:34755)	directlyDecreases	act(p(HGNC:MAPT))
604f9f43-6fb4-4237-95f0-f3a3777c43ff	0.65	PubMed	18291703	The calpain-2 C-terminal peptide did not inhibit the association of tau and c-Abl with PTPN13, indicating that the interaction of tau and c-Abl with PTPN13 does not rely on calpain-2 C-terminal domain.	p(HGNC:SCG5)	directlyDecreases	act(p(HGNC:MAPT))
616f102e-ba34-4329-a4b1-c9c091905015	0.65	PubMed	5286501	Increasing SDS concentrations decreased tau, but then lower V (ss) values were detected because of a possible excess of unfolding and subsequent denaturation of the protein.	p(HGNC:SDS)	directlyDecreases	act(p(HGNC:MAPT))
8164f3f4-e480-4f49-93b9-d7b89cf5eeaa	0.86	PubMed	21881826	PSF Suppresses Tau Exon 10 Inclusion by Interacting with a Stem-Loop Structure Downstream of Exon 10.	p(HGNC:SFPQ)	directlyDecreases	act(p(HGNC:MAPT))
8164f3f4-e480-4f49-93b9-d7b89cf5eeaa	0.86	PubMed	18967205	PSF Suppresses Tau Exon 10 Inclusion by Interacting with a Stem-Loop Structure Downstream of Exon 10.	p(HGNC:SFPQ)	directlyDecreases	act(p(HGNC:MAPT))
32f25233-e6a9-4af2-bb98-675aa59d5c74	0.94	PubMed	16982696	Second, sgk1 indirectly depolymerized mts through the phosphorylation of tau at ser214	p(HGNC:SGK1)	directlyDecreases	act(p(HGNC:MAPT))
e6af1fa2-6232-47ea-a1bc-7b913af1f6b8	0.95	PubMed	22049092	Thus, impaired SIRT1 activity can cause mitochondrial dysfunction and autophagy and mitophagy inhibition, leading to accumulation of damaged mitochondria as well as Abeta plaques and Tau tangles.	p(HGNC:SIRT1)	directlyDecreases	act(p(HGNC:MAPT))
e6af1fa2-6232-47ea-a1bc-7b913af1f6b8	0.95	PubMed	16946814	In mice AD model, studies have found that SIRT1 inhibition can restore cognition by stabilizing tau protein.	p(HGNC:SIRT1)	directlyDecreases	act(p(HGNC:MAPT))
e6af1fa2-6232-47ea-a1bc-7b913af1f6b8	0.95	PubMed	11332794	Deleting SIRT1 enhanced levels of acetylated-tau and pathogenic forms of p-tau, probably by blocking proteasome mediated degradation.	p(HGNC:SIRT1)	directlyDecreases	act(p(HGNC:MAPT))
e6af1fa2-6232-47ea-a1bc-7b913af1f6b8	0.95	PubMed	17750361	Deleting SIRT1 enhanced levels of acetylated-tau and pathogenic forms of p-tau, probably by blocking proteasome mediated degradation.	p(HGNC:SIRT1)	directlyDecreases	act(p(HGNC:MAPT))
e6af1fa2-6232-47ea-a1bc-7b913af1f6b8	0.95	PubMed	20869593	To directly test if enhancing acetylation can block ubiquitination, we transfected HEK293T cells with expression plasmids encoding tau and hemagglutinin (HA)-tagged ubiquitin and then treated with EX527 to inhibit SIRT1 and with MG132 to block the proteasome mediated degradation.	p(HGNC:SIRT1)	directlyDecreases	act(p(HGNC:MAPT))
c4a08914-d758-4b23-ab93-a807c5f9aba5	0.65	PubMed	17861531	In this study no in vitro effect on tubulin polymerization was apparent [XREF_BIBR], but another in vitro system revealed that soluble alpha-synuclein oligomers may inhibit the microtubule polymerizing activity of the tau protein, and additionally impair kinesin motility [XREF_BIBR].	p(HGNC:SNCA)	directlyDecreases	act(p(HGNC:MAPT))
c887ce8f-df8a-4a2b-ac39-8508a4fb3eca	0.65	PubMed	18119229	Under these conditions TAU is degraded by p62 driven macroautophagy and LAMP2A driven chaperone mediated autophagy XREF_BIBR.	p(HGNC:SQSTM1)	directlyDecreases	act(p(HGNC:MAPT))
87931337-476f-47c6-a19e-c32af951d049	0.65	PubMed	28059128	A similar pathway, in which Hsp70 functions as a negative regulator of CHIP, can be found in the CHIP dependent degradation of Tau XREF_BIBR.	p(HGNC:STUB1)	directlyDecreases	act(p(HGNC:MAPT))
b7490fec-47bd-4440-8f7e-169e3cfc625a	0.94	PubMed	18070606	We established that tyrosine 18 was the primary residue in tau phosphorylated by sykphosphorylation of tau by syk could be involved in neurite outgrowth.	p(HGNC:SYK)	directlyDecreases	act(p(HGNC:MAPT))
eabfc36b-e824-43f8-bd13-b9718da53d28	0.86	PubMed	5785840	Staurosporine induced Tau cleavage was blocked by 20 microM z-Asp-Glu-Val-Asp-chloromethylketone, a caspase-3 inhibitor, and in vitro, Tau was selectively cleaved by caspase-3 or calpain, a calcium activated protease, but not by caspases-1, -8, or -9.	a(PUBCHEM:44259)	directlyDecreases	act(p(HGNC:MAPT))
eabfc36b-e824-43f8-bd13-b9718da53d28	0.86	PubMed	11162250	Staurosporine induced Tau cleavage was blocked by 20 microM z-Asp-Glu-Val-Asp-chloromethylketone, a caspase-3 inhibitor, and in vitro, Tau was selectively cleaved by caspase-3 or calpain, a calcium activated protease, but not by caspases-1, -8, or -9.	a(PUBCHEM:44259)	directlyDecreases	act(p(HGNC:MAPT))
d0e482d3-8567-4f17-b473-c0b33004781c	0.86	PubMed	8435248	Treatment of cells with nocodazole revealed that pseudophosphorylation of T4 at both Thr231 and Ser235 and Ser396 and Ser404 diminished the ability of tau to protect against microtubule depolymerization, whereas with T4C3 only pseudophosphorylation at Ser396 and Ser404 attenuated the ability of tau to stabilize the microtubules.	a(PUBCHEM:5819)	directlyDecreases	act(p(HGNC:MAPT))
d0e482d3-8567-4f17-b473-c0b33004781c	0.86	PubMed	16687396	Treatment of cells with nocodazole revealed that pseudophosphorylation of T4 at both Thr231 and Ser235 and Ser396 and Ser404 diminished the ability of tau to protect against microtubule depolymerization, whereas with T4C3 only pseudophosphorylation at Ser396 and Ser404 attenuated the ability of tau to stabilize the microtubules.	a(PUBCHEM:5819)	directlyDecreases	act(p(HGNC:MAPT))
c1702914-94ae-4db5-942f-385bcefbd7d7	0.65	PubMed	26655856	Phosphorylation of selected Ser/Thr residues can influence these functional aspects of Tau, with phosphorylation events in the proline rich region (PRR) having a modulatory effect, whereas phosphorylation of, for example, Ser262 by the MARK kinase abolishes altogether the effect of Tau.	p(HGNC:TAOK1)	directlyDecreases	act(p(HGNC:MAPT))
1fe06f2e-c153-49ed-9774-242ffb5e0134	0.65	PubMed	17569400	Given that the same kinases are implicated in both the polymerization of TDP-43 and Tau filaments, and HSPs can inhibit the polymerization of Tau oligomers and filaments in vitro while also promoting Tau function in vivo XREF_BIBR, XREF_BIBR, XREF_BIBR, the effects of Hsp90 on CKII promoted rTDP-43 polymerization into filaments were examined to determine if they were recognized as abnormal.	p(HGNC:TARDBP)	directlyDecreases	act(p(HGNC:MAPT))
572cbbff-66a0-41f9-bbee-b52692fd3579	0.65	PubMed	14417824	TP4 inhibits Tau aggregation at substoichiometric concentration, demonstrating that it interferes with aggregation nucleation.	p(UP:Q09821)	directlyDecreases	act(p(HGNC:MAPT))
b5d33975-030a-4696-bdef-8b97d8ef0ef3	0.92	PubMed	20194101	TREM2 Deficiency in PS19 Mice Attenuates Tau Mediated Neurodegeneration.	p(HGNC:TREM2)	directlyDecreases	act(p(HGNC:MAPT))
b5d33975-030a-4696-bdef-8b97d8ef0ef3	0.92	PubMed	25732305	TREM2 deficiency reduces astrocytosis and microtubule associated protein tau (MAPT) pathology.	p(HGNC:TREM2)	directlyDecreases	act(p(HGNC:MAPT))
b5d33975-030a-4696-bdef-8b97d8ef0ef3	0.92	PubMed	17824030	TREM2 deficiency reduces astrocytosis and microtubule associated protein tau (MAPT) pathology.	p(HGNC:TREM2)	directlyDecreases	act(p(HGNC:MAPT))
c97db285-e615-4de7-a368-fb98bdbec065	0.99	PubMed	16923168	Direct tau phosphorylation by ttbk1 at ser198, ser199, ser202 and ser422, which are also phosphorylated in phfs. Ttbk1 also induces tau aggregation in human neuronal cells in a dose-dependent manner. We conclude that ttbk1 is a neuron-specific dual kinase involved in tau phosphorylation at ad-related sites and is also associated with tau aggregation.	p(HGNC:TTBK1)	directlyDecreases	act(p(HGNC:MAPT))
c97db285-e615-4de7-a368-fb98bdbec065	0.99	PubMed	16923168	Direct tau phosphorylation by ttbk1 at ser198, ser199, ser202 and ser422, which are also phosphorylated in phfs. Ttbk1 also induces tau aggregation in human neuronal cells in a dose-dependent manner. We conclude that ttbk1 is a neuron-specific dual kinase involved in tau phosphorylation at ad-related sites and is also associated with tau aggregation.	p(HGNC:TTBK1)	directlyDecreases	act(p(HGNC:MAPT))
c97db285-e615-4de7-a368-fb98bdbec065	0.99	PubMed	16923168	Direct tau phosphorylation by ttbk1 at ser198, ser199, ser202 and ser422, which are also phosphorylated in phfs. Ttbk1 also induces tau aggregation in human neuronal cells in a dose-dependent manner. We conclude that ttbk1 is a neuron-specific dual kinase involved in tau phosphorylation at ad-related sites and is also associated with tau aggregation.	p(HGNC:TTBK1)	directlyDecreases	act(p(HGNC:MAPT))
c97db285-e615-4de7-a368-fb98bdbec065	0.99	PubMed	16923168	Direct tau phosphorylation by ttbk1 at ser198, ser199, ser202 and ser422, which are also phosphorylated in phfs. Ttbk1 also induces tau aggregation in human neuronal cells in a dose-dependent manner. We conclude that ttbk1 is a neuron-specific dual kinase involved in tau phosphorylation at ad-related sites and is also associated with tau aggregation.	p(HGNC:TTBK1)	directlyDecreases	act(p(HGNC:MAPT))
2e0682f1-5f7e-4af3-bfe3-ed7bb37c3b4e	0.65	PubMed	811207	Trypsin digestion reduced the maximum width of PHFs by 10%-20%, increased aggregation of filaments, and abolished the binding of Tau 14, but had no effect on the binding of AH-1.	p(PFAM:PF00089)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	16807328	Our results demonstrate that CHIP is a primary component in the ubiquitin dependent degradation of tau.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	20578603	This interaction suggests that tau may normally be degraded by an ubiquitin dependent mechanism and alterations in it may contribute to the formation of neuro-fibrillary pathology.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	820745	This interaction suggests that tau may normally be degraded by an ubiquitin dependent mechanism and alterations in it may contribute to the formation of neuro-fibrillary pathology.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	20578603	Possibly, tau is degraded by the ubiquitin proteolytic pathway, or perhaps tau acts as a stable conjugate of ubiquitin in the cell, as seen in proteins such as histones and some growth factor receptors [25].	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	20578603	This interaction suggests that tau may normally be degraded by an ubiquitin dependent mechanism and alterations in it may contribute to the formation of neuro-f brillary pathology.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	23237806	CHIP, ubiquitin E3 ligase for tau, binds to tau and is thought to promote the degradation of tau by its ubiquitination through ubiquitin-proteasome system.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	1723470	This interaction suggests that tau may normally be degraded by an ubiquitin dependent mechanism and alterations in it may contribute to the formation of neuro-f brillary pathology.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	1723470	Possibly, tau is degraded by the ubiquitin proteolytic pathway, or perhaps tau acts as a stable conjugate of ubiquitin in the cell, as seen in proteins such as histones and some growth factor receptors [25].	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	8486747	Our results demonstrate that CHIP is a primary component in the ubiquitin dependent degradation of tau.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	20478262	These results indicate that tau might be degraded by an ubiquitin independent pathway.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	18643199	These results indicate that tau might be degraded by an ubiquitin independent pathway.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
318a5a9d-2e3e-40a0-be22-d387079eec71	0.95	PubMed	12470988	This fits with the recent finding that tau can be degraded by the proteasome in a ubiquitin independent manner.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:MAPT))
722b5b0d-2cdc-4a3d-98e6-138fc46298f4	0.65	PubMed	22028232	More recently, VHL recruiting peptidic PROTACs were utilized to induce the degradation of Akt 129 and Tau 130.	p(HGNC:VHL)	directlyDecreases	act(p(HGNC:MAPT))
021196e4-7655-4d7f-9300-0167852474a1	0.65	PubMed	20286478	We further examined whether overexpression of wfs1 could suppress tau mediated neurodegeneration.	p(HGNC:WFS1)	directlyDecreases	act(p(HGNC:MAPT))
b67818f5-124f-48d5-bb07-1479eb37c915	0.65	PubMed	22193544	Collectively, our results reveal that WWOX negatively regulates GSK3beta kinase activity on the neuron specific microtubule binding protein Tau in SH-SY5Y cells.	p(HGNC:WWOX)	directlyDecreases	act(p(HGNC:MAPT))
8d396c08-7eae-449d-bf8f-4a8f9b5a6581	0.86	PubMed	13185467	In the response, the regulator factor human X-box-binding protein 1 (XBP1) has been shown to facilitate the refolding and degradation of misfolded proteins, prevent neurotoxicity of amyloid-beta (Abeta) and tau, and play an important role in the survival of neurons.	p(HGNC:XBP1)	directlyDecreases	act(p(HGNC:MAPT))
8d396c08-7eae-449d-bf8f-4a8f9b5a6581	0.86	PubMed	23421912	In the response, the regulator factor human X-box-binding protein 1 (XBP1) has been shown to facilitate the refolding and degradation of misfolded proteins, prevent neurotoxicity of amyloid-beta (Abeta) and tau, and play an important role in the survival of neurons.	p(HGNC:XBP1)	directlyDecreases	act(p(HGNC:MAPT))
b8d16fa4-a277-4813-8a82-6c090afff78b	0.86	PubMed	18416479	Moreover, overexpression of AEP in primary neurons elicited demonstrable tau N368 degradation (XREF_SUPPLEMENTARY).	p(UP:P09230)	directlyDecreases	act(p(HGNC:MAPT))
b8d16fa4-a277-4813-8a82-6c090afff78b	0.86	PubMed	25326800	Moreover, overexpression of AEP in primary neurons elicited demonstrable tau N368 degradation (XREF_SUPPLEMENTARY).	p(UP:P09230)	directlyDecreases	act(p(HGNC:MAPT))
1651cd5b-b69e-473a-b521-439f12982f8b	0.65	PubMed	17409694	Overexpression of 14-3-3zeta Promotes Tau Phosphorylation at Ser 262 and Inhibits Tau Microtubule Binding in Rat Primary Neurons in Culture.	p(HGNC:YWHAZ)	directlyDecreases	act(p(HGNC:MAPT))
05408030-ecf1-4b23-8434-8900e33cb10e	0.65	PubMed	17587127	In contrast to our observations, Zn supplementation in the 3xTg mouse actually improved performance on behavioral tasks, and decreased both Abeta and tau pathology, while decreased dietary Zn elevated plaque volume in APP and PS1 mice.	a(PUBCHEM:23994)	directlyDecreases	act(p(HGNC:MAPT))
198c53c9-148d-4683-97bf-10d26d5acabb	0.86	PubMed	11382183	It was recently reported that Tau can be degraded by an aminopeptidase known as the puromycin sensitive aminopeptidase (PSA).	p(UP:P80474)	directlyDecreases	act(p(HGNC:MAPT))
198c53c9-148d-4683-97bf-10d26d5acabb	0.86	PubMed	18358045	It was recently reported that Tau can be degraded by an aminopeptidase known as the puromycin sensitive aminopeptidase (PSA).	p(UP:P80474)	directlyDecreases	act(p(HGNC:MAPT))
bb1c2635-3b0d-4912-a018-52667885c2b6	0.65	PubMed	17733085	Zwingmann et al. [XREF_BIBR] showed that ammonia exposition on glioma cells could elevate Gln and reduce Tau and Ins.	a(PUBCHEM:222)	directlyDecreases	act(p(HGNC:MAPT))
73a60775-db19-49fb-8045-904760f8d260	0.65	PubMed	10811201	tau increases with the mercury density but is substantially reduced by the argon pressure in quantitative agreement with the theory of Holstein and Walsh and the concept that the initial decay is primarily limited by self-absorption for our range of variables.	p(PFAM:PF16486)	directlyDecreases	act(p(HGNC:MAPT))
ee8cfe4d-6b96-4808-a09c-5febe419cc49	0.86	PubMed	15221002	In this study, we investigated whether atorvastatin could prevent Tau cleavage and hence prevent Abeta1-42 oligomer (AbetaO)-induced neurotoxicity in cultured cortical neurons.	a(PUBCHEM:60823)	directlyDecreases	act(p(HGNC:MAPT))
ee8cfe4d-6b96-4808-a09c-5febe419cc49	0.86	PubMed	25891085	In this study, we investigated whether atorvastatin could prevent Tau cleavage and hence prevent Abeta1-42 oligomer (AbetaO)-induced neurotoxicity in cultured cortical neurons.	a(PUBCHEM:60823)	directlyDecreases	act(p(HGNC:MAPT))
5505c655-fbb3-4242-8fe0-a0775e78256e	0.65	PubMed	23737459	Furthermore, the current findings show that TKI mediated autophagy may reduce p-Tau, indicating that autophagy may clear free unbound p-Tau, which can potentially lead to toxic intracellular inclusions, and spare Tau that may be bound to microtubule.	bp(GO:"GO:0006914")	directlyDecreases	act(p(HGNC:MAPT))
2a69d86b-e5e1-48f3-85fa-20fed1b78345	0.65	PubMed	20461814	Considering the Ca2 ^ dependent release in the con- trol (i.e. in the absence of baclofen) as 100%, baclofen 10 betaM reduced the Ca2 ^ dependent release of Glu (85) and baclofen 100 ft M reduced the Ca2 ^ de- pendent release of Asp (46), Glu (96), Tau (100) and Ala (77) (% of reduction = W * (1 - control release / release in the presence of baclofen)).	a(PUBCHEM:2284)	directlyDecreases	act(p(HGNC:MAPT))
a59c608c-65d5-42cf-941b-0446b88821ca	0.65	PubMed	17241698	XREF_BIBR However, administration of LDME and benserazide loaded nanoparticles prevented the increase of p-tau in dyskinetic rats while reducing the development of dyskinesia.	a(PUBCHEM:2327)	directlyDecreases	act(p(HGNC:MAPT))
ff52e2a1-5423-4082-85c7-1caa2b62bbd2	0.65	PubMed	18461377	In consideration that intracellular Abeta accumulation and the formation of NFTs contribute to a significant oxidative and inflammatory process that generates a vicious cycle, berberine may suppress the Abeta and tau pathologies to lower the progress of oxidative stress.	a(CHEBI:16118)	directlyDecreases	act(p(HGNC:MAPT))
80300612-9803-4f5c-9452-14267fd29904	0.65	PubMed	11770979	Results demonstrate that the beta-carboline compounds (1) potently reduce the expression of all three phosphorylated forms of tau protein, and (2) inhibit the DYRK1A catalyzed direct phosphorylation of tau protein on serine 396.	a(PUBCHEM:64961)	directlyDecreases	act(p(HGNC:MAPT))
aef8cbc6-5e3e-4f86-b24d-50808fde07a9	0.65	PubMed	22668776	In contrast, tau release was not diminished by either brefeldin A or monensin treatment.	a(PUBCHEM:5287620)	directlyDecreases	act(p(HGNC:MAPT))
f6df9e11-6c75-4e29-872a-190b4aeb8fc7	0.86	PubMed	18804306	From this point Abeta increases intracellular calcium levels; the hypothesis states that this loss of calcium homeostasis causes two distinct effects : 1) the hyperphosporylation of tau, resulting in neurofibrillary tangles and 2) neurodegeneration.	a(CHEBI:29108)	directlyDecreases	act(p(HGNC:MAPT))
f6df9e11-6c75-4e29-872a-190b4aeb8fc7	0.86	PubMed	3181821	One day after injury, Western blot analyses revealed a calcium dependent loss of tau protein of approximately 50% of control values.	a(CHEBI:29108)	directlyDecreases	act(p(HGNC:MAPT))
ed011af1-b6c4-4fe6-89c2-e6363c52920a	0.65	PubMed	17769158	The cholesterol lowering action of TAU was attributed to increasing the conversion of cholesterol to bile acid as a result of stimulation of 7-alpha hydroxylase, the rate limiting enzyme of hepatic cholesterol degradation and its conjugation to bile acids lately [XREF_BIBR].	a(CHEBI:16113)	directlyDecreases	act(p(HGNC:MAPT))
8f2b294a-79f9-46a2-a035-e4bc611de094	0.92	PubMed	15382304	Co-administration of crocin significantly attenuated MDA, Abeta and p-tau levels by modulating MAPKs signalling pathways.	a(PUBCHEM:5281233)	directlyDecreases	act(p(HGNC:MAPT))
8f2b294a-79f9-46a2-a035-e4bc611de094	0.92	PubMed	17319954	Herein, we showed that crocin can inhibit the aggregation of human tau protein.	a(PUBCHEM:5281233)	directlyDecreases	act(p(HGNC:MAPT))
8f2b294a-79f9-46a2-a035-e4bc611de094	0.92	PubMed	17319954	In addition, after adding crocin (100 mug/ml) to tau protein under fibril condition, the intensity of ellipticity of [theta] 217 was significantly reduced and crocin impeded the formation of beta-sheet structures of tau protein.	a(PUBCHEM:5281233)	directlyDecreases	act(p(HGNC:MAPT))
25b9a44e-6307-40d5-bb3f-972ac57d5cd1	0.95	PubMed	19790492	Using several complementary techniques, including dynamic light scattering, thioflavin S fluorescence, 90degrees light scattering, electron microscopy, and atomic force microscopy, curcumin was found to inhibit the aggregation of tau.	a(CHEBI:3962)	directlyDecreases	act(p(HGNC:MAPT))
25b9a44e-6307-40d5-bb3f-972ac57d5cd1	0.95	PubMed	19790492	The results indicated that curcumin inhibited the oligomerization of tau and could disaggregate tau filaments.	a(CHEBI:3962)	directlyDecreases	act(p(HGNC:MAPT))
25b9a44e-6307-40d5-bb3f-972ac57d5cd1	0.95	PubMed	19790492	The dynamic light scattering analysis and atomic force microscopic images revealed that curcumin inhibits the oligomerization of tau.	a(CHEBI:3962)	directlyDecreases	act(p(HGNC:MAPT))
25b9a44e-6307-40d5-bb3f-972ac57d5cd1	0.95	PubMed	23264626	In summary, curcumin reduced soluble Tau and elevated HSPs involved in Tau clearance, showing that even after tangles have formed, Tau dependent behavioral and synaptic deficits can be corrected.	a(CHEBI:3962)	directlyDecreases	act(p(HGNC:MAPT))
25b9a44e-6307-40d5-bb3f-972ac57d5cd1	0.95	PubMed	13085231	In summary, curcumin reduced soluble Tau and elevated HSPs involved in Tau clearance, showing that even after tangles have formed, Tau dependent behavioral and synaptic deficits can be corrected.	a(CHEBI:3962)	directlyDecreases	act(p(HGNC:MAPT))
a6391879-25fc-4f4d-977a-18f7ae37305f	0.65	PubMed	18638000	DHA dietary administration reduces Abeta and tau pathology, protects against dendritic pathology, cerebral blood volume alterations and enhances cognitive function in animal models of AD.	a(CHEBI:207229)	directlyDecreases	act(p(HGNC:MAPT))
adb6dbf9-d8bf-42a7-b9d6-363c09c4eac4	0.65	PubMed	3585774	At comparable end-systolic pressures, tau was increased by acute regional ischaemia (36 +/- 2 versus 32 +/- 2 ms, p < 0.01) and reduced by dobutamine infusion (27 +/- 2 versus 32 +/- 2 ms, p < 0.01).	a(PUBCHEM:36811)	directlyDecreases	act(p(HGNC:MAPT))
adab32f6-8601-4d9f-b4c1-694bb1cde7a0	0.65	PubMed	18519819	Since ethanol alters the activity or expression of proteases and regulators of protein degradation [XREF_BIBR, XREF_BIBR], ethanol may impede the turnover of tau, thus increasing tau levels beyond the tolerable window of activity.	a(CHEBI:16236)	directlyDecreases	act(p(HGNC:MAPT))
822e4ff9-dddc-4511-a9a4-fc0b65ff446f	0.65	Other	sparser:Unknown	These studies suggest (i) that in Alzheimer disease tau in PHF is functionally inactive because of abnormal phosphorylation and (ii) that the abnormally phosphorylated site(s) in PHF that inactivates PHF-tau is accessible to enzymatic dephosphorylation in vitro.	p(PFAM:PF00038)	directlyDecreases	act(p(HGNC:MAPT))
2627a7d7-d707-4eea-b177-94d8bf8aa011	0.65	PubMed	20345301	In addition, t-tau and p-tau are degraded by formic acid preparation.	a(PUBCHEM:284)	directlyDecreases	act(p(HGNC:MAPT))
452609a9-5e49-46bd-bf1f-de6f0f29f347	0.65	PubMed	18557492	It has been reported [XREF_BIBR] that E 2 effectively attenuated forskolin induced over-activation of PKA and elevation of cAMP, and thus prevented Tau from hyperphosphorylation.	a(PUBCHEM:47936)	directlyDecreases	act(p(HGNC:MAPT))
163b1fe2-0ca7-4f62-af98-3ef66fb8d1a6	0.65	PubMed	11970033	Regarding chemoresistant factors, Bcl2 and microtubule associated protein tau were downregulated by fulvestrant.	a(PUBCHEM:104741)	directlyDecreases	act(p(HGNC:MAPT))
795c8803-489c-4955-9de3-1f8dd25e79ae	0.65	PubMed	18922607	We showed that GSPE treatment significantly attenuated mutant-tau mediated motor impairment in JNPL3 mice by improving wire hang test scores from 6 seconds to 26 seconds.	p(UP:P45759)	directlyDecreases	act(p(HGNC:MAPT))
93669011-2060-461c-adb4-7555a28450f4	0.92	PubMed	18324451	Such an observation would be surprising, because formation of heparin induced Tau filaments is very slow, taking days to accumulate significant concentrations of filaments, and is normally performed at much higher [Tau] than used in our experiments.	a(PUBCHEM:22833565)	directlyDecreases	act(p(HGNC:MAPT))
93669011-2060-461c-adb4-7555a28450f4	0.92	PubMed	15323472	Antibody independent Tau uptake into BV2 cells was blocked by heparin, consistent with a previously described role for heparan sulfate proteoglycans.	a(PUBCHEM:22833565)	directlyDecreases	act(p(HGNC:MAPT))
93669011-2060-461c-adb4-7555a28450f4	0.92	PubMed	23087208	Such an observation would be surprising, because formation of heparin induced Tau filaments is very slow, taking days to accumulate significant concentrations of filaments, and is normally performed at much higher [Tau] than used in our experiments.	a(PUBCHEM:22833565)	directlyDecreases	act(p(HGNC:MAPT))
fd45beb9-50ac-4e02-b748-9d2f6498babe	0.65	PubMed	2487747	Both ketamine and ditran disrupted the voltage dependence of tau.	a(PUBCHEM:3821)	directlyDecreases	act(p(HGNC:MAPT))
324e0f9e-3ee6-4043-a538-02939cf42f5b	0.65	PubMed	2308978	At the low concentrations of 0.5 to 2 microM, maytansine inhibited Tau catalyzed tubulin assembly more effectively than it did MAP2 catalyzed assembly.	a(PUBCHEM:5281828)	directlyDecreases	act(p(HGNC:MAPT))
13982075-ec27-4282-b099-c998b208a339	0.65	PubMed	8137968	The capacity of melatonin to prevent or ameliorate tau and Abeta pathology further enhances its potential in the prevention or treatment of AD.	a(CHEBI:16796)	directlyDecreases	act(p(HGNC:MAPT))
02821f1f-b99c-42fb-98be-35fc6f0ed267	0.65	PubMed	13185071	Further, daily administration of anticholinergic drug, donepezil (5mg/kg, p.o.), and the NMDA receptor antagonist, memantine (10mg/kg, p.o.) initiated after OKA administration for 13days significantly attenuated OKA induced variation in Tau, Tau-C terminal, Tau-N terminal CaMKII, Calpain, PP2A and GSK3beta.	a(PUBCHEM:4054)	directlyDecreases	act(p(HGNC:MAPT))
ac9a1bfb-c9eb-4f25-8708-7affa739043a	0.65	PubMed	20630035	Increasing methanol and tetrahy- drofuran concentrations and the column temperature decreased the retention times of Ala, Tau, and GABA but gradually impaired clear separation of Ala and Tau (data not shown).	a(PUBCHEM:887)	directlyDecreases	act(p(HGNC:MAPT))
1562636a-2fa6-4ca5-8c56-1f2a85ce4780	0.65	PubMed	17630317	A very recent study indicates that methylene blue reduced Tau protein aggregates in Alzheimer 's disease through inducing macroautophagy.	a(PUBCHEM:6099)	directlyDecreases	act(p(HGNC:MAPT))
a9a9e4f1-1941-4e8f-9d40-dfaa578a4b7f	0.65	PubMed	4554698	After 48 hr treatment morphine sulfate (200 microM) reduced tau protein in the cytoplasmic (supernatant) fraction of undifferentiated cells, and in the cytoplasmic as well as membrane (pellet) fractions of differentiated cells.	a(PUBCHEM:23253564)	directlyDecreases	act(p(HGNC:MAPT))
b44016de-e613-44e7-b3b2-9e6a0c3ee9a7	0.65	PubMed	18049691	The dose of 15 mug and mouse per day induced a marked decrease of tau hyperphosphorylation in cerebellum, while the dose of 2 mug and mouse per day decreased p-tau in subcortical regions, including the SN.	p(IP:IPR003310)	directlyDecreases	act(p(HGNC:MAPT))
6fcb6f29-a394-4d5e-9f2a-290c0cfe149a	0.65	PubMed	20912220	(B) STR (3 nA) blocked the TAU responses with little effect on GABA responses.	a(PUBCHEM:5360545)	directlyDecreases	act(p(HGNC:MAPT))
a28fdfe9-3721-4fff-8aba-7690ef8034c2	0.65	PubMed	17750514	Taken together, the findings revealed that orally administered naringenin ameliorates memory deficits and effectively decreases amyloid plaques, plaque associated PHF-tau and swollen axons in 5XFAD mice, as shown for DR administration.	a(PUBCHEM:439246)	directlyDecreases	act(p(HGNC:MAPT))
991cda31-64ed-45d7-a525-a5c79a412244	0.65	PubMed	18948488	20 Our experiments showed that NR attenuated the progressive changes of Ca transient duration and Tau during IR.	p(UP:P22945)	directlyDecreases	act(p(HGNC:MAPT))
2d4d5803-5916-4a33-8d97-ebb25783811c	0.86	PubMed	17681420	Similarly, p-Tau levels were also significantly increased in muscle, small intestine and blood (XREF_FIG, n = 4, p < 0.05) of 3-4 months old A53T mice compared to WT, and nilotinib and bosutinib reduced p-Tau.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
2d4d5803-5916-4a33-8d97-ebb25783811c	0.86	PubMed	18876496	Similarly, p-Tau levels were also significantly increased in muscle, small intestine and blood (XREF_FIG, n = 4, p < 0.05) of 3-4 months old A53T mice compared to WT, and nilotinib and bosutinib reduced p-Tau.	a(PUBCHEM:644241)	directlyDecreases	act(p(HGNC:MAPT))
e6bb077e-b923-49ca-a6df-1887cbfc72f6	0.65	PubMed	13952418	We sought to determine whether 17-AAG can reduce Abeta and tau pathology in the brains of AD and FTD model mice expressing Abeta or P301L mutant tau, respectively.	a(PUBCHEM:6505803)	directlyDecreases	act(p(HGNC:MAPT))
61e29b23-d9c0-41e5-8ad7-644b1e641ae0	0.92	PubMed	17082661	Thus, highly phosphorylated tau is more likely to be present in the cytosolic compartment of neurons, whereas reduced phosphate burden allows tau to bind to and stabilise the microtubule cytoskeleton.	a(PUBCHEM:1061)	directlyDecreases	act(p(HGNC:MAPT))
61e29b23-d9c0-41e5-8ad7-644b1e641ae0	0.92	PubMed	11955240	Thus, highly phosphorylated tau is more likely to be present in the cytosolic compartment of neurons, whereas reduced phosphate burden allows tau to bind to and stabilise the microtubule cytoskeleton.	a(PUBCHEM:1061)	directlyDecreases	act(p(HGNC:MAPT))
61e29b23-d9c0-41e5-8ad7-644b1e641ae0	0.92	PubMed	26165593	In agreement with previous reports (), we found that introduction of up to four phosphate groups did not abolish binding of the proline rich region of Tau to MTs, but changed the mode of interaction.	a(PUBCHEM:1061)	directlyDecreases	act(p(HGNC:MAPT))
9efc1712-b250-4f5d-bce4-614db20f2838	0.65	PubMed	3181821	We propose that brief potassium depolarization causes degradation of tau protein, possibly due to calpain activation.	a(PUBCHEM:813)	directlyDecreases	act(p(HGNC:MAPT))
de2425ca-d40a-4b86-8e25-ccd1f28d9273	0.65	PubMed	18358045	As a control we showed that the reaction of hPSA Sf with two known PSA substrates, alanine 4-methoxy-2-naphthylamide (Ala-4-MNA) and Leu enkephalin, was completely inhibited by bestatin and puromycin under the same conditions in which these inhibitors failed to inhibit Tau cleavage,.	a(PUBCHEM:7058180)	directlyDecreases	act(p(HGNC:MAPT))
8886d655-3a81-47c7-923c-9ed988792934	0.95	PubMed	18781231	In these mice, rapamycin administered beginning early in life restored mTOR signaling, decreased Abeta and tau pathology, and ameliorated cognitive deficits.	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
8886d655-3a81-47c7-923c-9ed988792934	0.95	PubMed	17199010	In contrast, the mTORC1 inhibitor rapamycin decreased tau synthesis [XREF_BIBR, XREF_BIBR] and increased cognitive functions in animal models of Alzheimer 's disease [XREF_BIBR, XREF_BIBR].	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
8886d655-3a81-47c7-923c-9ed988792934	0.95	PubMed	17293006	Here we show that rapamycin reduces the hyperactive mTOR signaling in the 3xTg-AD mice and decreases Abeta and tau pathology.	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
8886d655-3a81-47c7-923c-9ed988792934	0.95	PubMed	17293006	Furthermore, we showed that rapamycin administration increases autophagy and decreases soluble Abeta and tau in young 3xTg-AD mice XREF_BIBR.	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
8886d655-3a81-47c7-923c-9ed988792934	0.95	PubMed	17293006	The 3xTg-AD 15-18 mice were treated for 3 months based on previous studies showing that in young mice 10-12 weeks of rapamycin administration is sufficient to reduce soluble Abeta and tau XREF_BIBR, XREF_BIBR.	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
8886d655-3a81-47c7-923c-9ed988792934	0.95	PubMed	18861114	Additionally, it is also known that rapamycin suppresses the translation of both tau and collapsing response mediator protein 2 (CRMP2), which play important roles in axon formation from neurites through their interactions with microtubules [XREF_BIBR, XREF_BIBR].	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
8886d655-3a81-47c7-923c-9ed988792934	0.95	PubMed	15910686	Consistent with these findings, rapamycin, a potent inhibitor of mammalian target of rapamycin (mTOR), prevented DHA mediated axon outgrowth and up-regulation of Tau and CRMP2.	a(CHEBI:9168)	directlyDecreases	act(p(HGNC:MAPT))
04a4a834-68de-44fa-b6df-f05154aa689f	0.65	PubMed	15249542	More importantly, gammadelta T cells from HT patients enhanced B cells for antibody production, and all-trans retinoic acid (ATRA) treatment inhibited the effect by inducing apoptosis of gammadelta Tau cells.	a(PUBCHEM:5282379)	directlyDecreases	act(p(HGNC:MAPT))
b6869a03-ee4b-462b-9df1-dc1ff049c37f	0.65	PubMed	16064015	Under cell-free conditions, rifampicin inhibited oligomer formation of amyloid-beta, tau, and alpha-synuclein, indicating its broad spectrum.	a(PUBCHEM:70680287)	directlyDecreases	act(p(HGNC:MAPT))
65be5f1a-1a51-4b94-a337-76042f6dff96	0.92	PubMed	18547795	Tat promotes nucleo cytoplasmic translocation and pathological activation of CDK5, which suggests that Tau reduction or CDK5 inhibition with a new class of compounds, such as roscovitine, may be neuroprotective in preclinical models of HIV neurotoxicity [XREF_BIBR].	a(PUBCHEM:160355)	directlyDecreases	act(p(HGNC:MAPT))
65be5f1a-1a51-4b94-a337-76042f6dff96	0.92	PubMed	17640395	Although ROS production was early enhanced upon DADS treatment in SH-SY5Y cells [XREF_BIBR], an increase of cdk5 phopho-active form was not found and the selective cdk5 inhibitor roscovitine did not impede alteration of Tau state, excluding the involvement of p35 and cdk5 pathway in this process.	a(PUBCHEM:160355)	directlyDecreases	act(p(HGNC:MAPT))
65be5f1a-1a51-4b94-a337-76042f6dff96	0.92	PubMed	25760044	Tat promotes nucleo cytoplasmic translocation and pathological activation of CDK5, which suggests that Tau reduction or CDK5 inhibition with a new class of compounds, such as roscovitine, may be neuroprotective in preclinical models of HIV neurotoxicity [XREF_BIBR].	a(PUBCHEM:160355)	directlyDecreases	act(p(HGNC:MAPT))
b9ccf65f-c878-447f-9636-d65cf585101f	0.65	PubMed	7941169	LLE (TAU) was prevented by scopolamine, a muscarinic antagonist, and significantly suppressed by the nicotinic antagonist mecamylamine.	a(PUBCHEM:3000322)	directlyDecreases	act(p(HGNC:MAPT))
2b2231cb-8ef3-4a63-adf4-f105523ba1ed	0.65	PubMed	17706415	In fact, the PP2A activator sodium selenate that dramatically reduced TAU pathology in several mouse models is currently evaluated in a phase IIa clinical trial in mild to moderate AD (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83952).	a(PUBCHEM:26473)	directlyDecreases	act(p(HGNC:MAPT))
a8fdc052-2353-41cf-b444-c5021b825a8f	0.65	PubMed	21504079	We found that sorafenib reversibly decreased developed force in auxotonically contracting human myocardia (3microM : -25 +/-4%, 10microM : -29 +/-7%, 30microM : -43 +/-12%, p < 0.01), reduced peak cytosolic calcium concentrations in isolated cardiomyocytes (10microM : 52 +/-8.1% of baseline, p < 0.001), and slowed cytosolic calcium removal kinetics (RT50, RT10, Tau, p < 0.05).	a(CHEBI:50924)	directlyDecreases	act(p(HGNC:MAPT))
a1f826d1-bc35-48e7-8554-9572a6800c2c	0.86	PubMed	18653404	The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios.	a(PUBCHEM:996)	directlyDecreases	act(p(HGNC:MAPT))
a1f826d1-bc35-48e7-8554-9572a6800c2c	0.86	PubMed	25436420	The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios.	a(PUBCHEM:996)	directlyDecreases	act(p(HGNC:MAPT))
6aeb7e40-455b-47c3-ab9d-a51547424628	0.65	PubMed	3186764	Increased tau immunolabelling during chronic NMDA toxicity was dramatically attenuated by tetrodotoxin and also by 6-cyano-7-nitroquinoxaline-2,3-dione.	a(PUBCHEM:6324668)	directlyDecreases	act(p(HGNC:MAPT))
e4fcbc46-8663-47ef-bab7-4f2c1cc78b7a	0.65	PubMed	17730742	Biochemical investigation on soluble tau fractions revealed that CP13 lowered p-tau at Thr231 in cortex (* p = 0.0124), with significant reduction of total soluble fraction in the hindbrain region (** p = 0.0039) (Figs XREF_FIG and XREF_FIG).	p(UP:P81347)	directlyDecreases	act(p(HGNC:MAPT))
47d4a75a-de80-4cca-8c1b-f6acf8141d36	0.92	PubMed	26916334	Beyond that, trehalose suppresses Tau aggregation in an inducible N2a cell model of Tau pathology and diminishes cytotoxicity [XREF_BIBR].	a(PUBCHEM:7427)	directlyDecreases	act(p(HGNC:MAPT))
47d4a75a-de80-4cca-8c1b-f6acf8141d36	0.92	PubMed	16853734	Beyond that, trehalose suppresses Tau aggregation in an inducible N2a cell model of Tau pathology and diminishes cytotoxicity [XREF_BIBR].	a(PUBCHEM:7427)	directlyDecreases	act(p(HGNC:MAPT))
47d4a75a-de80-4cca-8c1b-f6acf8141d36	0.92	PubMed	18118518	Although its administration has not been studied in the context of humans and PD, trehalose decreases alpha-synuclein in PC12 cells XREF_BIBR, decreases Tau accumulation in mice XREF_BIBR, and reduces neurodegeneration in amyotrophic lateral sclerosis XREF_BIBR, Huntington 's XREF_BIBR, and Alzheimer 's XREF_BIBR disease models.	a(PUBCHEM:7427)	directlyDecreases	act(p(HGNC:MAPT))
340a649a-a139-407f-981f-38abc000cb11	0.65	PubMed	16848282	The first category comprises cholinesterase inhibitors and the NMDAR antagonist memantine, the second anticonvulsants, antidepressants and atypical antipsychotics such as risperidone, and the third ranges from natural products such as vitamin E, gingko biloba and omega-3 fatty acids, to copper and zinc modulators, beta- and gamma-secretase inhibitors, tau and Abeta aggregation inhibitors and, last but not least, immunotherapies.	a(PUBCHEM:14985)	directlyDecreases	act(p(HGNC:MAPT))
a70afdb9-5fb3-48ee-850b-61bdf5ec76b1	0.65	PubMed	17513150	Consistently, wogonin decreased the expression levels of phospho-Tau and total Tau to 1.3- and 1.5-fold, respectively, than those of AD mice.	a(CHEBI:10043)	directlyDecreases	act(p(HGNC:MAPT))
8f88ba54-9b1f-4db7-8e48-4207c6e96917	0.65	Other	sparser:Unknown	Recent studies have also demonstrated that zinc inactivates the major tau phosphatase, protein phosphatase 2A (PP2A), via an Src-dependent phosphorylation of PP2A to result in the hyperphosphorylation of tau [ xref ].	a(CHEBI:27363)	directlyDecreases	act(p(HGNC:MAPT))
07fd447a-4b0c-4056-a320-dc81ddcfbcaf	0.65	Other	sparser:Unknown	Aberrant CpG methylation in APP , Tau and GSK3 β genes was reported in post-mortem brains (Iwata et al., xref ).	p(HGNC:CXXC1)	directlyIncreases	p(HGNC:MAPT, pmod(Me))
30c5f6ac-95cc-45b0-87f6-2740333eb404	0.94	Other	sparser:Unknown	Histamine N-methyltransferase (HNMT) catalyzes the N tau-methylation of histamine and structurally-related compounds.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:HRH1, pmod(Me))
30c5f6ac-95cc-45b0-87f6-2740333eb404	0.94	PubMed	PMC3608535	Histamine N-methyltransferase (HNMT) catalyzes the N tau-methylation of histamine.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:HRH1, pmod(Me))
30c5f6ac-95cc-45b0-87f6-2740333eb404	0.94	PubMed	PMC3815341	Histamine N-methyltransferase (HNMT) catalyzes the N tau-methylation of histamine and structurally related compounds.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:HRH1, pmod(Me))
30c5f6ac-95cc-45b0-87f6-2740333eb404	0.94	Other	sparser:Unknown	Histamine N-methyltransferase (HNMT) catalyzes the N tau-methylation of histamine.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:HRH1, pmod(Me))
2b01bc99-1920-4d5f-b43f-153d96bf9aa5	0.86	PubMed	13636730	Enhanced methylation of PP2A promotes the association of PP2A and Tau with the plasma membrane.	p(HGNC:MAPT)	directlyIncreases	p(FPLX:PPP2, pmod(Me))
2b01bc99-1920-4d5f-b43f-153d96bf9aa5	0.86	PubMed	23943618	Enhanced methylation of PP2A promotes the association of PP2A and Tau with the plasma membrane.	p(HGNC:MAPT)	directlyIncreases	p(FPLX:PPP2, pmod(Me))
1762534f-0dce-43f5-99c5-c35a41f42b05	0.86	PubMed	26159201	Overexpression of PSEN1 with a deletion of exon 9 mutation (Deltaex9) led to a smaller reduction in MAPT promoter activity relative to wild-type PSEN1 in the luciferase assay, consistent with a decreased ability to modulate endogenous MAPT gene methylation.	p(HGNC:PSEN1)	directlyIncreases	p(HGNC:MAPT, pmod(Me))
1762534f-0dce-43f5-99c5-c35a41f42b05	0.86	PubMed	15427311	Overexpression of PSEN1 with a deletion of exon 9 mutation (Deltaex9) led to a smaller reduction in MAPT promoter activity relative to wild-type PSEN1 in the luciferase assay, consistent with a decreased ability to modulate endogenous MAPT gene methylation.	p(HGNC:PSEN1)	directlyIncreases	p(HGNC:MAPT, pmod(Me))
9cb13978-4f6b-49d7-b696-bd37c8f4c366	0.65	PubMed	24375821	DNA Methylation of MAPT Gene in Parkinson 's Disease Cohorts and Modulation by Vitamin E In Vitro.	a(PUBCHEM:14985)	directlyIncreases	p(HGNC:MAPT, pmod(Me))
e86f44aa-1ed0-4f19-a245-b077c81d33c9	0.65	PubMed	21368377	Both c-Abl and Arg phosphorylate tyrosine 394 of tau, and the kinases are highly homologous, sharing approximately 90% of their sequence in their kinase domains [XREF_BIBR, XREF_BIBR].	p(HGNC:ABL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Arg))
07f0b3a7-15ae-485e-87ba-c2d465ea0f13	1.0	Other	sparser:Unknown	Specifically, Abl phosphorylates Tyr394 of tau and this tau species is found in neurofibrillary tangles ( xref ; xref ).	p(HGNC:ABL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
07f0b3a7-15ae-485e-87ba-c2d465ea0f13	1.0	PubMed	18636973	Specifically, Abl phosphorylates Tyr394 of tau.	p(HGNC:ABL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
07f0b3a7-15ae-485e-87ba-c2d465ea0f13	1.0	Other	sparser:Unknown	Specifically, Abl phosphorylates Tyr394 of tau ( xref ; xref ).	p(HGNC:ABL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
07f0b3a7-15ae-485e-87ba-c2d465ea0f13	1.0	Other	sparser:Unknown	If STH were found to influence the phosphorylation of tau Tyr394 by Abl, this would establish a STH link to neurodegeneration although its exact mechanism would still need to be deciphered.	p(HGNC:ABL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
07f0b3a7-15ae-485e-87ba-c2d465ea0f13	1.0	PubMed	20168965	c-Abl seems to phosphorylate tau primarily at Y394, and pY394 tau has been found in neurofibrillary tangles in AD patient brains [XREF_BIBR].	p(HGNC:ABL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
07f0b3a7-15ae-485e-87ba-c2d465ea0f13	1.0	PubMed	21368377	While the literature suggests that c-Abl primarily phosphorylates tyrosine 394 of tau, the question of which specific tyrosine residues of tau were being phosphorylated in our model could not be addressed due to a lack of antibodies to specific phospho-tyrosine sites on tau.	p(HGNC:ABL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
07f0b3a7-15ae-485e-87ba-c2d465ea0f13	1.0	Other	sparser:Unknown	In addition, Derkinderen et
al [ xref ] demonstrated that Abl phosphorylates tau in Tyr 394;
both phosphorylations are present in PHFs.	p(HGNC:ABL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
07f0b3a7-15ae-485e-87ba-c2d465ea0f13	1.0	Other	sparser:Unknown	A recent in vitro study demonstrated that c-Abl phosphorylated tau at Tyr394 and this specific phosphorylated form of tau was identified in human brain by mass spectrometry [ xref ].	p(HGNC:ABL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
400a96eb-a066-4b86-b4a7-e78739004967	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_86ec18cc6911785ce87c99ba3268b4f0	No evidence text.	p(HGNC:ABL2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 514))
959fe1fb-971d-4f17-8d0b-80134b6a2735	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_0ebe395a13bc55809a170ab4b36297ad	No evidence text.	p(HGNC:ABL2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 627))
c620f119-0c2f-49c3-b2b6-6a40b2ba9f47	0.93	Other	sparser:Unknown	This particular study demonstrates that ARG can phosphorylate tau at tyrosine 394 and confirms the occurrence of phosphotau-394 in AD-related tangles [ xref ].	p(HGNC:ABL2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
c620f119-0c2f-49c3-b2b6-6a40b2ba9f47	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8a59209c630b5f40e9876b8edd1ade75	No evidence text.	p(HGNC:ABL2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 711))
c95f9a6e-d8b6-481d-bf8f-c1e1c5d25507	0.65	PubMed	19793966	MB and AC significantly reduced both total tau and phosphorylated tau (pTau), while treatment with 115-7c or SW02 led to accumulation of these species (XREF_FIG).	p(HGNC:ADCY1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6b789f0a-d9c6-43bf-b893-48712336ea72	0.65	PubMed	7684462	In contrast, PACAP strengthened the polarization of actin at the emergence cone, increased Tau phosphorylation, and abolished C2-ceramide-evoked alterations of the cytoskeletal architecture.	p(HGNC:ADCYAP1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ca3683cc-0748-48ab-965d-33145748725e	0.65	PubMed	22193445	[Suppressing poly (ADP-ribose) polymerase-1 inhibits tau phosphorylation in HEK293 and tau441 cells].	a(PUBCHEM:192)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	23320095	Activated PKR is increased in AD brains XREF_BIBR and PKR activation via Abeta 1-42, can also lead to the phosphorylation of Tau protein and during oxidative stress can modify beta -secretase 1 (BACE1) protein levels, one of the main enzyme implicated in the formation of Abeta peptides XREF_BIBR - XREF_BIBR.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	7076129	The results suggest that Akt may be involved in AD specific phosphorylation of tau at the AT100 epitope in conjunction with other kinases.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	18438800	Our observations from several studies suggest that a down regulation of tau phosphatases in AD brain might trigger the abnormal hyperphosphorylation of tau and other neuronal proteins.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	17706804	In subsequent studies we showed that the cytosolic AD abnormally hyperphosphorylated tau (AD P-tau) sequestered some of the normal tau and sedimented at 200,000 xg, whereas most of the non hyperphosphorylated tau from the same AD brains remained in the 200,000 xg supernatant.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	8813822	We investigated self-assembly and microtubule assembly promoting activities of hyperphosphorylated tau isolated from Alzheimer disease brain cytosol, the AD abnormally hyperphosphorylated tau (AD P-tau) before and after dephosphorylation by phosphoseryl and phosphothreonyl protein phosphatase-2A (PP-2A), and then rephosphorylation by cyclic AMP dependent protein kinase (PKA), calcium, calmodulin dependent protein kinase II (CaMKII), glycogen synthase kinase-3beta (GSK-3beta) and cyclin dependent protein kinase 5 (cdk5) in different kinase combinations.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	17247160	Both AD and non demented PD patients have hyperphosphorylated tau XREF_BIBR - XREF_BIBR, which aggregates in AD and in some cases of PD without dementia XREF_BIBR - XREF_BIBR.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	8257139	We also found by double immunostaining of AD brain tissue that phosphorylated tau and Abeta form separate insoluble complexes within the same neurons and their processes.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	4796788	The AD abnormally phosphorylated tau (AD P-tau) does not promote microtubule assembly, but on dephosphorylation its microtubule promoting activity is restored to approximately that of the normal tau.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	16935975	AD : Alzheimer 's disease; ALS : Amyotrophic lateral sclerosis; Abeta : Beta amyloid; BUADC : Boston University 's alzheimer 's disease center; CTE : Chronic traumatic encephalopathy; FTLD : Frontotemporal lobar degeneration; LBD : Lewy body disease; MND : Motor neuron disease; mTBI : mild traumatic brain injury; NFT : Neurofibrillary tangle; p-tau : phosphorylated tau; TBI : Traumatic brain injury; TDP-43 : 43 kDa TAR DNA binding protein.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	18091297	Whereas AD shows the abundant presence of aggregated Abeta peptides and hyperphosphorylated tau protein in brain, AMD is characterized by deposition of lipids, lipoproteinaceous debris, and oxidized and damaged extracellular matrix (ECM) components within Bruch 's membrane of the eye [XREF_BIBR - XREF_BIBR].	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	10916578	AD patients exhibit augmented accumulation of amyloid-beta (Abeta) and hyperphosphorylated tau protein in specific brain regions.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	4307308	When AD abnormally hyperphosphorylated tau is used as a substrate, PP-2B activity is inhibited by trifluoperazine> chlorpromazine> clozapine.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	20183469	These AD brain extracts induce an elevation in the phosphorylation of TAU in forebrain neurons, and this is dependent upon the Abeta present in these extracts.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	16446437	We also found by double immunostaining of AD brain tissue that phosphorylated tau and Abeta form separate insoluble complexes within the same neurons and their processes.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	20164562	AD patients exhibit augmented accumulation of amyloid-beta (Abeta) and hyperphosphorylated tau protein in specific brain regions.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	12108919	Previously it was reported that Alzheimer 's disease (AD) patients have reduced amyloid (Abeta 1-42) and elevated total tau (t-tau) and phosphorylated tau (p-tau 181p) in the cerebro-spinal fluid (CSF), suggesting that these same measures could be used to detect early AD pathology in healthy elderly (CN) and mild cognitive impairment (MCI).	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	18660386	Previously it was reported that Alzheimer 's disease (AD) patients have reduced amyloid (Abeta 1-42) and elevated total tau (t-tau) and phosphorylated tau (p-tau 181p) in the cerebro-spinal fluid (CSF), suggesting that these same measures could be used to detect early AD pathology in healthy elderly (CN) and mild cognitive impairment (MCI).	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	7615582	A decrease in the activity of protein phosphatase-2A (PP-2A) in AD brain and certain missense mutations seen in frontotemporal dementia promotes the abnormal hyperphosphorylation of tau.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	17586961	Neuropathological AD like hallmarks described in SAMP8 mice include impaired synaptic plasticity in hippocampal newborn slices and hippocampal astrogliosis, Abeta 40 -positive vessels and phosphorylated Tau at 3-4 months old.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	4103613	We now show that in solution normal tau associates with the AD hyperphosphorylated tau (AD P-tau) in a nonsaturable fashion, forming large tangles of filaments 3.3 +/- 0.7 nm in diameter.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	20570401	Previously it was reported that Alzheimer 's disease (AD) patients have reduced amyloid (Abeta 1-42) and elevated total tau (t-tau) and phosphorylated tau (p-tau 181p) in the cerebrospinal fluid (CSF), suggesting that these same measures could be used to detect early AD pathology in healthy elderly (CN) and mild cognitive impairment (MCI).	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	25339173	Highly Phosphorylated Human Tau Expressed in Sf9 Cells Reveals AD like Characteristics.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	18752794	The cytosolic AD abnormally hyperphosphorylated tau (AD P-tau) is sedimentable and oligomeric, and probably causes neurodegeneration by sequestering normal MAPs and disrupting microtubule network.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	18752794	The AD cytosolic abnormally hyperphosphorylated tau (AD P-tau) does not bind to tubulin and promote microtubule assembly, but instead it inhibits assembly and disrupts microtubules XREF_FIG [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	17303106	To identify the kinases that are important in AD relevant pathologic phosphorylation of tau protein, we developed a cell based, high-throughput immunofluorescence assay for the rapid detection and quantitation of both total tau and 12E8 tau (pS262 and pS356) protein expression.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	7212369	Alzheimer 's disease (AD) brains contain neurofibrillary tangles (NFTs) composed of abnormally hyperphosphorylated tau protein.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	14636947	The results suggest that Akt may be involved in AD specific phosphorylation of tau at the AT100 epitope in conjunction with other kinases.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	6971511	Notably, V642I-APP knock-in ES cell derived neurons exhibited significantly increased secretion of Abeta42 without AD related hyperphosphorylation of tau, indicating that the direct output of the AD-causative mutation is increased Abeta42 secretion.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	18433214	Additionally in AD, pathologically phosphorylated tau protein forms intraneuronal inclusions (neurofibrillary tangles) which are postulated a cause of increased p-tau in CSF.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	18615943	Phosphorylation sites that lead to the AD type abnormal hyperphosphorylation of tau are phosphorylated by different combinations of non-proline-directed protein kinases like PKA and CaMKII with the proline directed kinases like glycogen synthase kinase 3beta (GSK-3beta), and cyclin dependent protein kinase 5 (cdk5), and are dephosphorylated largely by protein phosphatase-2A [XREF_BIBR].	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	14638720	Accordingly, we postulate a positive feedback mechanism in which AD risk factors or genes trigger perturbations of intraneuronal signalling leading to enhanced Abetao formation and TAU phosphorylation which in turn further derange signalling.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	20678074	The AD cytosolic abnormally hyperphosphorylated tau (AD P-tau) does not bind to tubulin and promote microtubule assembly, but instead it inhibits assembly and disrupts microtubules XREF_FIG [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a2138982-6d78-4c78-8fec-6e95abbd7b4e	0.95	PubMed	20678074	The cytosolic AD abnormally hyperphosphorylated tau (AD P-tau) is sedimentable and oligomeric, and probably causes neurodegeneration by sequestering normal MAPs and disrupting microtubule network.	p(PFAM:PF09793)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7fd8119c-bf5f-48bf-b2b7-d29b9c685f17	0.65	Other	sparser:Unknown	A recent study demonstrates that injection of AGEs in the rat hippocampus leads to RAGE-dependent tau hyperphosphorylation, spatial memory deficit, and impaired synaptic transmission as demonstrated by inhibition of long-term potentiation (LTP) in AGEs treated rats [ xref ].	p(HGNC:AGER)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
12a833a7-c800-413a-ab9a-f2c2b01a6e7f	0.65	PubMed	19074441	Vice versa, stereotactic inhibition of AT2 oligomers by RNA interference prevented the impairment of Galphaq/11 and delayed Tau phosphorylation.	p(HGNC:AGTR2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7c0f5094-6cdf-42e0-8e1d-d3f9b2dbcec1	0.65	PubMed	11165564	We have found no evidence that AID overexpression induces AD like characteristics, such as activation of GSK-3beta, hyperphosphorylation of Tau and formation of neurofibrillary pathology.	p(HGNC:AICDA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0cc4c08d-1202-463c-bcc3-31d1e098e22a	0.86	PubMed	12467795	Ectopic expression of AK1 alone augments the pathologic phosphorylation of tau at PHF1, CP13 and AT180 epitopes and enhances the formation of tau aggregates.	p(HGNC:AK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0cc4c08d-1202-463c-bcc3-31d1e098e22a	0.86	PubMed	22419736	Ectopic expression of AK1 alone augments the pathologic phosphorylation of tau at PHF1, CP13 and AT180 epitopes and enhances the formation of tau aggregates.	p(HGNC:AK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0efb2f12-6e55-4139-9060-781630161f55	0.65	PubMed	17303106	We provide evidence that the eukaryotic translation initiation factor 2 alpha kinase 2 (EIF2AK2), dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A), and a-kinase anchor protein 13 (AKAP13) proteins contribute to phosphorylation of tau at the 12E8 epitope (pS262 and pS356).	p(HGNC:AKAP13)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
af0d67cd-d87b-4902-8432-4848eb4e3485	0.86	PubMed	PMC4884921	We have found that the phosphorylation of human tau (tau3L) by A-kinase, GSK-3 or CK-1 inhibits its microtubule assembly-promoting and microtubule-binding activities.	p(HGNC:AKAP1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
af0d67cd-d87b-4902-8432-4848eb4e3485	0.86	Other	sparser:Unknown	Tau was phosphorylated  by A-kinase ([]), C-kinase (o), CaM kinase II (A), GSK-3 (z~), and CK-1 (o). (B) Use of different prephosphorylated tau species as substrates for  GSK-3.	p(HGNC:AKAP1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a7f1d726-bc7e-40d8-ba36-08e2b91cb786	0.86	PubMed	19014373	In this study, we show that the phosphorylation of tau by either protein kinase A (PKA) or protein kinase B (PKB) enhances the binding of tau with 14-3-3 in vitro.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a7f1d726-bc7e-40d8-ba36-08e2b91cb786	0.86	PubMed	22019820	GCBE improved cognition, decreased serine phosphorylation of insulin receptor substrate, increased phosphoinositol-3 kinase (PI3K) activity and protein kinase B (Akt) gene expression, decreased glycogen synthase kinase-3beta (GS3Kbeta) gene expression and Tau hyperphosphorylation.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87bb120e-480e-4be0-9956-c7e9d91878d4	0.86	PubMed	17872252	Peripheral injection of supraphysiological insulin is capable of elevating IS in the mouse brain and increases p-tau even though GSK3 is serine phosphorylated by p-AKT to reduce activity and presumably p-tau.	p(FPLX:AKT, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87bb120e-480e-4be0-9956-c7e9d91878d4	0.86	PubMed	7193540	In intact animals, this loss results in markedly reduced phosphorylation of Akt and GSK3 beta, leading to substantially increased phosphorylation of the microtubule associated protein Tau, a hallmark of neurodegenerative diseases.	p(FPLX:AKT, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f50aacdb-f4dc-4c61-ab5a-889ea1cf3ff7	0.99	PubMed	15283964	We also established that Akt phosphorylates tau separately at T212 and S214, two sites previously shown to be phosphorylated by glycogen synthase kinase 3beta (GSK3beta) and protein kinase A (PKA), respectively.	p(FPLX:AKT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
f50aacdb-f4dc-4c61-ab5a-889ea1cf3ff7	0.99	PubMed	7429151	We also established that Akt phosphorylates tau separately at T212 and S214, two sites previously shown to be phosphorylated by glycogen synthase kinase 3beta (GSK3beta) and protein kinase A (PKA), respectively.	p(FPLX:AKT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
f50aacdb-f4dc-4c61-ab5a-889ea1cf3ff7	0.99	Other	sparser:Unknown	In summary, these results strongly suggest that in primary cultures, Akt selectively phosphorylates tau at S214 rather than T212.	p(FPLX:AKT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
f50aacdb-f4dc-4c61-ab5a-889ea1cf3ff7	0.99	Other	sparser:Unknown	We also established that Akt phosphorylates tau separately at T212 and S214, two sites previously shown to be phosphorylated by glycogen synthase kinase 3beta (GSK3beta) and protein kinase A (PKA), respectively.	p(FPLX:AKT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
f50aacdb-f4dc-4c61-ab5a-889ea1cf3ff7	0.99	PubMed	14636947	Akt and PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro.	p(FPLX:AKT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
e30f87cb-5eca-470d-8862-3c882e0e29dc	0.86	PubMed	17200775	In addition, Akt enhances phosphorylation of tau at Ser262 and Ser356, a site that is not recognized by the CHIP and Hsp90 degradation complex.	p(FPLX:AKT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
e30f87cb-5eca-470d-8862-3c882e0e29dc	0.86	PubMed	24646911	In addition, Akt enhances phosphorylation of tau at Ser262 and Ser356, a site that is not recognized by the CHIP and Hsp90 degradation complex.	p(FPLX:AKT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
671ce158-c0f5-4c85-a420-20184567a9d6	0.95	Other	sparser:Unknown	In vitro study confirmed the involvement of this kinase in the 5LO-dependent tau phosphorylation, which was independent of the effect on Aβ.	p(HGNC:ALOX5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
671ce158-c0f5-4c85-a420-20184567a9d6	0.95	Other	sparser:Unknown	Under our experimental conditions, we indeed observed that roscovitine was able to prevent the 5LO‐dependent increase in tau phosphorylation at the same epitopes.	p(HGNC:ALOX5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
671ce158-c0f5-4c85-a420-20184567a9d6	0.95	Other	sparser:Unknown	In vitro data corroborated these findings showing that 5LO‐dependent tau phosphorylation was specifically dependent on the involvement of this kinase.	p(HGNC:ALOX5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
671ce158-c0f5-4c85-a420-20184567a9d6	0.95	Other	sparser:Unknown	In vitro study confirmed the involvement of this kinase in the 5LO-dependent tau phosphorylation, which was independent of the effect on Aβ [ xref ].	p(HGNC:ALOX5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
671ce158-c0f5-4c85-a420-20184567a9d6	0.95	Other	sparser:Unknown	To elucidate the molecular mechanism for the 5LO-induced selective in vivo tau hyperphosphorylation, we assayed several putative tau kinases.	p(HGNC:ALOX5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
671ce158-c0f5-4c85-a420-20184567a9d6	0.95	Other	sparser:Unknown	The functional involvement of this kinase in the 5LO-dependent tau phosphorylation was confirmed in neuronal cells.	p(HGNC:ALOX5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7dc2ee29-6335-48e9-9bd3-8bd0042d12f0	0.65	PubMed	17264032	Local Somatodendritic Translation and Hyperphosphorylation of Tau Protein Triggered by AMPA and NMDA Receptor Stimulation.	a(PUBCHEM:14017)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
27d3e35a-aa81-455a-88e2-69d9074460e9	0.65	PubMed	18751282	AMPK failed to phosphorylate tau on Ser 202, Ser 214, or Ser 235, but triggered efficient phosphorylation on Thr 231 and Ser 396/404, and to a lesser extent on Ser 409 (XREF_FIG).	p(FPLX:AMPK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
7e3044eb-9df2-4191-8f92-4c3a358edadc	0.65	PubMed	11844628	These findings confirm and extend prior studies in which overexpression of the cdk5 activator p35, or GSK3beta, induced phosphorylation, mislocalization and/or aggregation of tau.	p(HGNC:ANXA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c0e429b7-b9a5-4ea4-bf3c-e5fd70a10330	0.65	PubMed	12226093	Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202 and Thr205 of human tau.	p(HGNC:ANXA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
c140b7e3-7653-4589-b5cc-0d4cc44da818	0.65	PubMed	16793187	The modulatory role of apoE on tau phosphorylation is complex; for example, expression of apoE decreased the amount of phosphorylation of a specific serine residue (Ser 413) of the tau protein in double knockout mice lacking Dab 1 and apoE ().	p(HGNC:APOE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
8490c800-6e33-4e55-9219-5b14728e42b9	0.65	PubMed	17285176	Overexpression of the Swedish mutant amyloid precursor protein (APP SWE) has been shown to augment Tau phosphorylation in lines of mice that are sensitized by expression of additional proteins such as Tau and Psen1 XREF_BIBR.	p(HGNC:APP, var(p.?))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5b555117-69b4-4d3d-bd68-5020c7401a45	0.65	PubMed	17711247	Abeta significantly induced the phosphorylation of tau at Thr 212 and Ser 396.	p(HGNC:APP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
b78a8623-833c-442c-a6e5-9bd6bece8c86	0.65	PubMed	12868949	We found that Asp664 cleavage of APP increased tau phosphorylation at Thr212 and Ser262 in N2A cells and primary cultured hippocampal neurons.	p(HGNC:APP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
1eacdfc5-be7a-493f-bb09-8b565aa15084	0.65	Other	sparser:Unknown	Osmotin
treatment significantly attenuated the Aβ 1-42 -induced
hyperphosphorylation of tau at Ser 413 after both 3 and 40 days compared with
Aβ 1-42 treatment alone (p < 0.001, xref ).	p(HGNC:APP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 730))
64fb11ed-5aad-410c-87e4-f437c264a744	0.65	PubMed	10387669	The involvement of protein phosphatase 2A (PP2A) in dephosphorylation of isomerised Tau is shown by the co-treatment of neurons with Abeta (1-42) and okadaic acid, a PP2A inhibitor, leading to Tau (Thr231) hyperphosphorylation.	p(HGNC:APP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
71cec6af-c07d-488e-8a9a-68876860b638	0.65	PubMed	15708437	Abeta also induces the simultaneous tyrosine phosphorylation of tau and FAK.	p(HGNC:APP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr))
1521f3e5-66bf-4930-aea3-7e2199d23b48	0.65	PubMed	20553266	Phosphorylated tau became immunoreactive with the anti-PI-IF tart specific antibodies T3P and ATB, demonstrating phosphorylation of serine 396 and serines-199 and/or -20?	p(UP:Q9ZWC6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5a7e6afe-7beb-46ba-8edb-24f09b206ec6	0.65	PubMed	16420965	The ATP competitive selective GSK-3beta inhibitor, SB-415286 () induced a concentration dependent depression of Ser396 specific phosphorylation of Tau protein.	a(CHEBI:15422)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
87c9b086-4799-43a8-91aa-db68481dcb08	0.94	Other	sparser:Unknown	Melatonin did not only antagonize tau hyperphosphorylation induced by the PI3 kinase inhibitor wortmannin, but also a wortmannin-dependent stimulation of lipid peroxidation [ xref ].	p(HGNC:ATR)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87c9b086-4799-43a8-91aa-db68481dcb08	0.94	Other	sparser:Unknown	In other experiments, tau hyperphosphorylation was induced by wortmannin [ xref ] and isoproterenol [ xref ]; again, melatonin was found to attenuate this process.	p(HGNC:ATR)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87c9b086-4799-43a8-91aa-db68481dcb08	0.94	Other	sparser:Unknown	To investigate the in vivo induction of Alzheimer-like tau phosphorylation by wortmannin and the attenuation by melatonin.	p(HGNC:ATR)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87c9b086-4799-43a8-91aa-db68481dcb08	0.94	Other	sparser:Unknown	Wortmannin induced in vivo Alzheimer-like hyperphosphorylation of tau at Ser396/404, and melatonin inhibited partially the pathological processes.	p(HGNC:ATR)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
279f1d0b-2b4e-46ef-8d74-22c00892741e	0.65	PubMed	17156290	Finally, we and others have shown that the AT 2 receptor can activate the tyrosine kinase Fyn [XREF_BIBR] and the phosphatase PP2A [XREF_BIBR, XREF_BIBR, XREF_BIBR], both of which are key regulators of the phosphorylation of the microtubule associated protein tau.	a(PUBCHEM:5460479)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9771ae3d-62e8-4dbe-bed1-de4830598992	0.65	Other	sparser:Unknown	The results showed first that Aurora A cannot phosphorylate purified Tau–GFP protein that migrated at ∼100 kD ( xref D, lane 1).	p(HGNC:AURKA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f600ea12-0c09-4542-8fce-0f753abe0894	0.95	Other	sparser:Unknown	Heparin also promotes phosphorylation of tau by a number of protein kinases, prevents tau from binding to taxol-stabilized microtubules, and produces rapid disassembly of microtubules assembled from tau and tubulin.	p(HGNC:AZU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f600ea12-0c09-4542-8fce-0f753abe0894	0.95	Other	sparser:Unknown	While phosphorylation of tau is markedly enhanced by heparin, phosphorylation of histone H1 by Nclk is essentially unaffected.	p(HGNC:AZU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f600ea12-0c09-4542-8fce-0f753abe0894	0.95	PubMed	PMC4159794	These findings, with previous studies which show that heparin stimulates tau phosphorylation by a number of protein kinases, indicate that sulphated glycosaminoglycans may be a key factor in the formation of the neurofibrillary lesions of Alzheimer's disease.	p(HGNC:AZU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f600ea12-0c09-4542-8fce-0f753abe0894	0.95	Other	sparser:Unknown	Heparin stimulated tau phosphorylation by neuronal cdc2-like kinase (NCLK) and cAMP-dependent protein kinase.	p(HGNC:AZU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f600ea12-0c09-4542-8fce-0f753abe0894	0.95	Other	sparser:Unknown	These findings, with previous studies which show that heparin stimulates tau phosphorylation by a number of protein kinases, indicate that sulphated glycosaminoglycans may be a key factor in the formation of the neurofibrillary lesions of Alzheimer's disease.	p(HGNC:AZU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f600ea12-0c09-4542-8fce-0f753abe0894	0.95	PubMed	PMC4597200	Heparin also promotes phosphorylation of tau by a number of protein kinases, prevents tau from binding to taxol-stabilized microtubules, and produces rapid disassembly of microtubules assembled from tau and tubulin.	p(HGNC:AZU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f600ea12-0c09-4542-8fce-0f753abe0894	0.95	PubMed	PMC4737806	While phosphorylation of tau is markedly enhanced by heparin, phosphorylation of histone H1 by Nclk is essentially unaffected.	p(HGNC:AZU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9f01a2b6-c6c6-4451-9632-64166d2a61dd	0.65	PubMed	3731231	AlCl3 at 100 microM to 500 microM range induced non enzymatic phosphorylation of tau with gamma-ATP, gamma-GTP, and alpha-GTP.	a(PUBCHEM:24012)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5e50195c-ae72-419f-81a7-975d82754dd8	0.65	PubMed	17973532	Although our previous study demonstrated that the alpha- and beta-Syn isoforms equivalently stimulate GSK-3beta-mediated phosphorylation of tau, the gamma-Syn isoform was found to have no stimulatory effects on tau phosphorylation by GSK-3beta [XREF_BIBR].	p(UP:P10277)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b75033f7-4cdf-49ca-8c3a-1229ad5ee09d	0.86	PubMed	17661501	BACE1 upregulation and hyperphosphorylation of tau.	p(HGNC:BACE1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b75033f7-4cdf-49ca-8c3a-1229ad5ee09d	0.86	PubMed	9838156	BACE1 upregulation and hyperphosphorylation of tau.	p(HGNC:BACE1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7c0b722a-854c-4357-bcf2-d206d482b853	0.95	PubMed	9507617	14-3-3 zeta protein and butyrylcholinesterase (BCHE) are associated with NFT in AD brain and stimulate tau phosphorylation.	p(HGNC:BCHE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7c0b722a-854c-4357-bcf2-d206d482b853	0.95	Other	sparser:Unknown	14-3-3 zeta protein and butyrylcholinesterase (BCHE) are associated with NFT in AD brain and stimulate tau phosphorylation.	p(HGNC:BCHE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7c0b722a-854c-4357-bcf2-d206d482b853	0.95	PubMed	18290843	14-3-3 zeta protein and butyrylcholinesterase (BCHE) are associated with NFT in AD brain and stimulate tau phosphorylation.	p(HGNC:BCHE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d6573f03-8170-466b-9a78-65c68c223858	0.65	PubMed	16045749	BCR kinase phosphorylates 14-3-3 Tau on residue 233.	p(HGNC:BCR)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, 233))
400a3fb3-2531-42e8-a1f1-df520b9bb77a	0.65	Other	sparser:Unknown	These data suggest that GSK-3β inhibition contributes to the reduced tau and APP phosphorylation induced by the TAT-BDNF peptide.	p(HGNC:BDNF)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9d47cafb-5e59-467a-b17e-27cb37501304	0.65	PubMed	14004062	Pretreatment with metabotropic glutamate receptor 5 (mGluR5) and Src antagonists blocked the BMAA induced inhibition of PP2A and the abnormal hyperphosphorylation of tau, indicating the involvement of an Src dependent PP2A pathway.	a(PUBCHEM:105089)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a4af2108-57d1-4e0d-a599-8931bd41d07d	0.95	PubMed	15705853	No evidence text.	p(HGNC:BRSK1, pmod(Ph, Thr, 189))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
a4af2108-57d1-4e0d-a599-8931bd41d07d	0.95	PubMed	17482548	No evidence text.	p(HGNC:BRSK1, pmod(Ph, Thr, 189))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
048d1470-f667-461d-91d2-49c1dfcfe553	0.95	PubMed	15705853	No evidence text.	p(HGNC:BRSK2, pmod(Ph, Thr, 174))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
048d1470-f667-461d-91d2-49c1dfcfe553	0.95	PubMed	17482548	No evidence text.	p(HGNC:BRSK2, pmod(Ph, Thr, 174))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
ed547609-668d-449b-980d-a039cb8a4832	0.65	PubMed	18439393	In summary, our data point to the following model : lysosomal acid ceramidase inhibition leads to ceramide accumulation, resulting in GluN2B receptor phosphorylation and selective enhancement of NMDA mediated responses in CA1 synapses, an event that could eventually increase Tau phosphorylation by a CaMKII dependent pathway (XREF_FIG).	p(HGNC:CA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
70389109-b71a-48b6-b7e3-eed149a9a8a9	0.92	PubMed	20966148	</sb:maintitle> </sb:title> <sb:volume-nr> 34 </sb:volume-nr> </sb:series> <sb:date> 1968 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 43 </sb:first-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB2"> <ce:label> Baudier and Cole, 1988 </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> J. </ce:given-name> <ce:surname> Baudier </ce:surname> </sb:author> <sb:author> <ce:given-name> R.D. </ce:given-name> <ce:surname> Cole </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> Interactions between the microtubule associated tau proteins and S100b regulate tau phosphorylation by the Ca2 +/calmodulin-dependent protein kinase II </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> J. Biol.	p(HGNC:CA2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
70389109-b71a-48b6-b7e3-eed149a9a8a9	0.92	PubMed	20966148	Baudier, J. and R.D. Cole, 1988, Interactions between the mierotubule-as- sociated tau proteins and S100b regulate tau phosphorylation by the Ca2 +/calmodulin-dependent protein kinase II, J. Biol.	p(HGNC:CA2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
70389109-b71a-48b6-b7e3-eed149a9a8a9	0.92	PubMed	787654	We have analyzed the in vitro phosphorylation of tau protein by Ca2 +/calmodulin-dependent protein kinase, casein kinase II, and proline directed serine/threonine protein kinase.	p(HGNC:CA2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6083281b-9c89-4489-9448-114ed36fdfd4	0.65	PubMed	24021800	Tau is dephosphorylated by calcineurin, and the Dyrk1A mediated phosphorylation of RCAN1 at Thr activates its function as a calcineurin inhibitor, which leads to enhanced Tau phosphorylation.	p(HGNC:CABIN1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dd4d6b89-7408-4b57-86a2-ed43cadbec06	0.65	PubMed	12464279	These results suggest that the LC/MS analysis is very sensitive.It has been reported that CaM kinase II phosphorylates tau exclusively at serine 416.	p(FPLX:CALM)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 733))
b2ddc51f-3173-40d2-86c4-685d7465b9d9	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_24ba30603065bb27ff4a610e1b1be804	No evidence text.	p(HGNC:CAMK2A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
c9d10205-a6d0-49c1-907e-fef9e6c84cb2	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d44a5ef52a2673e976beb7ddafd89355	No evidence text.	p(HGNC:CAMK2A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 733))
05f2fabd-0604-4d80-9c51-9786fd136d9d	0.65	Other	sparser:Unknown	This result determined that Ca 2+ -dependent kinases PKC, CamKII, and phosphorylase kinase do not phosphorylate tau in NGF-exposed PC12 cells.	p(HGNC:CAMK2G)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6a72aa98-2b64-4279-b790-b5cc0e431df8	0.86	PubMed	PMC7088939	Recombinant human tau was phosphorylated at Thr212, Ser214, Ser262, and Ser356 by CaMKII.	p(FPLX:"CAMK2_complex")	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
6a72aa98-2b64-4279-b790-b5cc0e431df8	0.86	Other	sparser:Unknown	Recombinant human tau was phosphorylated at Thr212, Ser214, Ser262, and Ser356 by CaMKII.	p(FPLX:"CAMK2_complex")	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
0792c343-a676-4d9f-9de7-f0f6307f27e1	0.65	Other	sparser:Unknown	Accumulating evidence suggests that excessive phosphorylation of tau protein causes production of neurofibrillary tangles, which is one of the main pathological characteristics of Alzheimer's disease, and tau protein can be phosphorylated by calcium/calmodulin dependent protein kinase IV (CAMK4).	p(HGNC:CAMK4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e3a1acd3-e3c0-46d1-8a8e-a40eae751546	0.65	Other	sparser:Unknown	It has been documented that A β 42 oligomers induce dendritic spine loss and microtubule-associated protein tau hyperphosphorylation by the calcium/calmodulin-dependent protein kinase kinase 2, adenosine monophosphate-activated protein kinase (CAMKK2-AMPK) signaling cascade, which is tightly associated with synaptic plasticity alteration in AD progression [ xref , xref ].	p(HGNC:CAMKK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
632f2a5d-c70c-445f-999f-ef00b6f2594d	0.65	PubMed	5017424	Phosphopeptide mapping and phosphopeptide sequencing revealed that tau is phosphorylated by NCLK on Thr212 and Thr231 and by cAMP dependent protein kinase on Ser262 only in the presence of heparin.	a(CHEBI:17489)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
ddd182c9-d22b-4604-bb0e-a32f01f5c9f1	0.86	PubMed	16828627	Tau phosphorylation can be modulated by calpain.	p(FPLX:CAPN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ddd182c9-d22b-4604-bb0e-a32f01f5c9f1	0.86	PubMed	18895604	Studies have reported that calpain mediated p25 accumulation in brains of patients with AD induces prolonged activation and mislocalization of Cdk5 and thus hyperphosphorylation of tau.	p(FPLX:CAPN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5aa49e9c-d2f1-4775-ac2a-1a76905e7307	0.65	Other	sparser:Unknown	Current work, including our own, suggests that Leucine-rich repeat kinase 2 (LRRK2) can also phosphorylate tau either in vitro or in vivo ( xref ; xref ).	p(HGNC:CARMIL2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d7717fc0-a6aa-4de3-b604-50d74fea3025	0.86	PubMed	20595388	We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin dependent protein kinase II promoter in APP and PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.	p(HGNC:CAST)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d7717fc0-a6aa-4de3-b604-50d74fea3025	0.86	PubMed	11136134	We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin dependent protein kinase II promoter in APP and PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.	p(HGNC:CAST)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
45250971-bc31-47dc-a69e-113f16bdf36c	0.65	PubMed	19819512	Here, we report that CCH induced miR-132 deficiency and increased tau phosphorylation at Ser396 while tau expression was not influenced.	p(UP:O82089)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
c4a6e5dd-962a-4d3b-b64c-7598fb4793b7	0.86	PubMed	21980472	Since CCI acutely affects tau phosphorylation in 3xTg-AD mice at several sites, specifically at Serine 199, Serine 396 and Serine 404, as detected with phospho specific tau antibodies pS199 and PHF1, respectively XREF_BIBR, we tested whether CCI increased tau phosphorylation in injured Tau P301L mice by staining with these antibodies.	p(UP:P32954)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c4a6e5dd-962a-4d3b-b64c-7598fb4793b7	0.86	PubMed	18595622	Consequently, in our present study, CCI induces the formation of p25, as well as phosphorylation of the aberrant Cdk5 substrates, Rb protein and tau, thereby indicating the association of Cdk5 and p25 hyper activation in CCI induced neurotoxic insult.	p(UP:P32954)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7560db3e-d175-4d43-98ba-3bc141671e2a	0.65	PubMed	18849422	Cdc37 is important for recruiting kinases to the chaperone network, including CdK5 and Akt, which are both able to phosphorylate tau.	p(HGNC:CDC37)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ab8703d7-b52f-409c-b119-3bc909f37771	0.86	PubMed	16766195	To analyze whether PCTAIRE 3 can phosphorylate tau protein in cell culture, transfections were performed in a CHO cell line stably expressing the longest isoform of tau.	p(HGNC:CDK18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ab8703d7-b52f-409c-b119-3bc909f37771	0.86	PubMed	16766195	While it is likely that PCTAIRE 3 stimulates tau phosphorylation by an indirect mechanism in cell culture, it is unknown whether the protein takes a more active role in endogenous tissue.Because little is known about how to reconstitute PCTAIRE 3 activity in vitro, further experiments will be needed to investigate the role of this protein in neurodegenerative disease and determine whether PCTAIRE 3 can directly phosphorylate tau and other cytoskeletal proteins.While this study is the first report to associate PCTAIRE 3 with Alzheimer 's disease, this protein may be associated with other neurologic diseases.	p(HGNC:CDK18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
14aab4fd-9003-49dc-8d9a-59ea61d28ad3	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_41929a9b3f2d09fb3303f02d8d348a79	No evidence text.	p(HGNC:CDK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
86aa1e85-263a-4c82-b8d2-5ac8f8a5db35	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d0ef8e90dc11a49ca517b55f1f01feb8	No evidence text.	p(HGNC:CDK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
e869e729-f705-4ecf-8c44-67a1abe8fad7	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d11fd487e761e50e88ae56a6c6a2ff5d	No evidence text.	p(HGNC:CDK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
7ee50b7a-9145-4a50-801b-5bc3cba2875f	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_17ad01e93f28bad460dfdda950a403b0	No evidence text.	p(HGNC:CDK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 153))
270ae682-667e-4f33-8fe3-8781a0bd98a5	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_aec07ff2834e6f1ab5b4f535a4b97725	No evidence text.	p(HGNC:CDK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
c665cf6d-a1b7-44c6-96d3-9ced4c4ce841	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9b88d3020ae7e072e77c5bd65a5740eb	No evidence text.	p(HGNC:CDK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
d709e126-e079-446c-b980-1cf1a52b2f0d	0.97	Other	sparser:Unknown	These results confirm the previous findings that phosphorylation of tau on Thr231 by Cdc2 disrupts its ability to promote MT assembly ( xref ), that Pin1 restores the MT function of pT231-tau ( xref ), and that the ability of Pin1 to regulate MT function depends on T231 phosphorylation ( xref ; xref ).	p(HGNC:CDK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
d709e126-e079-446c-b980-1cf1a52b2f0d	0.97	PubMed	PMC18842062	These results confirm the previous findings that phosphorylation of tau on Thr231 by Cdc2 disrupts its ability to promote MT assembly ( xref ), that Pin1 restores the MT function of pT231-tau ( xref ), and that the ability of Pin1 to regulate MT function depends on T231 phosphorylation ( xref ; xref ).	p(HGNC:CDK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
d709e126-e079-446c-b980-1cf1a52b2f0d	0.97	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_4d52c54e5c066563c65cfd27214e7661	No evidence text.	p(HGNC:CDK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
14357b21-df08-4aa6-872a-e2d2025afef9	0.98	PubMed	20974939	Baumann, K.; Mandelkow, E.-M.; Biernat, J.; Piwnica-Worms, H.; Mandelkow, E. Abnormal Alzheimer like phosphorylation of tau- protein by cyclin dependent kinase cdk2 and cdk5.	p(HGNC:CDK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
14357b21-df08-4aa6-872a-e2d2025afef9	0.98	Other	sparser:Unknown	These results demonstrate that Aβ efficiently stimulates the mTORC1 signaling pathway to facilitate HIF1α synthesis and autophagy inhibition to promote the expression of cell cycle regulatory proteins, during which CDK2 uniquely stimulates tau phosphorylation for microtubule destabilization-mediated neuronal apoptosis.	p(HGNC:CDK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
14357b21-df08-4aa6-872a-e2d2025afef9	0.98	PubMed	20909923	The phosphorylation of tau by cdk2 is illustrated in Fig. 2.	p(HGNC:CDK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
14357b21-df08-4aa6-872a-e2d2025afef9	0.98	Other	sparser:Unknown	The phosphorylation of tau by cdk2 is illustrated in  Fig. 2.	p(HGNC:CDK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
487e0121-fc3f-4286-89d9-30b39043e4a1	0.95	Other	sparser:Unknown	Studies have clearly demonstrated that phosphorylation of TAU by GSK3B and cyclin-dependent kinase 5 reduces the affinity of TAU to bind to microtubules [ xref ], whereas phosphorylation of the serines within the KXGS motifs destructively affects TAU-microtubule interactions [ xref ].	p(HGNC:CDK5R1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
487e0121-fc3f-4286-89d9-30b39043e4a1	0.95	Other	sparser:Unknown	In addition, cyclin-dependent kinase 5 (CDK5), which phosphorylates tau, has been shown to be abundantly expressed in neurofibrillary tangles in the hippocampus.	p(HGNC:CDK5R1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
487e0121-fc3f-4286-89d9-30b39043e4a1	0.95	PubMed	PMC6654575	Although tau is phosphorylated by cyclin-dependent kinase 5 (Cdk5) in vitro, its in vivo roles remain unclear.	p(HGNC:CDK5R1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
487e0121-fc3f-4286-89d9-30b39043e4a1	0.95	Other	sparser:Unknown	Although tau is phosphorylated by cyclin-dependent kinase 5 (Cdk5) in vitro, its in vivo roles remain unclear.	p(HGNC:CDK5R1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
487e0121-fc3f-4286-89d9-30b39043e4a1	0.95	Other	sparser:Unknown	Neurofibrillary tangles (NFTs), a major pathological hallmark of AD, are composed of tau protein that is hyperphosphorylated by cyclin-dependent kinase 5 (Cdk5) and glycogen synthase kinase 3β (GSK3β).	p(HGNC:CDK5R1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
487e0121-fc3f-4286-89d9-30b39043e4a1	0.95	PubMed	PMC18439787	Overexpression of 5-LOX by an adeno-associated virus (AAV)-mediated gene transfer evokes γ-secretase-dependent enhancement of Aβ production and plaque formation, as well as cyclin-dependent kinase 5 (Cdk5)-dependent MAPT hyperphosphorylation.	p(HGNC:CDK5R1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
487e0121-fc3f-4286-89d9-30b39043e4a1	0.95	Other	sparser:Unknown	Acute intraneuronal accumulation of PC( O -16:0/2:0) but not PAF species with other sn -1 carbon chains initiates an endoplasmic reticulum stress-dependent signaling cascade culminating in the hyperphosphorylation of tau on Alzheimer Disease-specific epitopes by cyclin-dependent kinase 5 (Ryan et al., xref , xref ).	p(HGNC:CDK5R1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c66d6b04-6047-41c4-b4f8-2fdd0e76fc19	0.92	PubMed	17586722	We reported that a reduction in CDK5 levels can reverse Tau phosphorylationin vitro and in vivo in wild type (WT) mice and triple transgenic AD model.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c66d6b04-6047-41c4-b4f8-2fdd0e76fc19	0.92	PubMed	18510143	IL-1beta over-expression in AD brains was reported earlier, and hippocampal neurons treated with a physiological dose of IL-6 has been shown to induce Tau phosphorylation, possibly mediated by the increased levels of intraneuronal levels of Cdk5 and p35.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c66d6b04-6047-41c4-b4f8-2fdd0e76fc19	0.92	PubMed	21435449	To verify that the increased expression and activation of CDK5 contributes to the abnormal phosphorylation of tau, gp120 Tg mice were cross bred with CDK5 knockdown mice.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4b136491-7ff2-459e-a309-6caa379c7635	0.93	PubMed	PMC6526222	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
4b136491-7ff2-459e-a309-6caa379c7635	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_bf2e3ed784c4f82d5c224915b2e1a254	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
25957ed7-ddff-4e7e-b6d6-2999d41a3367	0.99	Other	sparser:Unknown	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
25957ed7-ddff-4e7e-b6d6-2999d41a3367	0.99	Other	sparser:Unknown	Cdk5 phosphorylated tau at Ser404, Ser235, Thr205 and Ser202 in this order in vitro .	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
25957ed7-ddff-4e7e-b6d6-2999d41a3367	0.99	Other	sparser:Unknown	Here, we found that Cdk5-p25 phosphorylated tau in vitro at Ser404, Ser235, Thr205 and Ser202 in this order.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
25957ed7-ddff-4e7e-b6d6-2999d41a3367	0.99	Other	sparser:Unknown	These results indicate that Cdk5-p25 phosphorylates tau in the order Ser404, Ser235, Thr205 and Ser202.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
25957ed7-ddff-4e7e-b6d6-2999d41a3367	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7f4345c9a50a3283c8250c04837cb9d9	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
7c633f8d-9aea-4522-a947-fab2bace4027	0.99	PubMed	PMC17200775	Additionally, prephosphorylation of tau by PKA slightly promotes tau phosphorylation by cdk5 kinase at Ser396 and inhibits its phosphorylation at Ser202, Thr212, Thr217 and Ser404 [ xref ].	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
7c633f8d-9aea-4522-a947-fab2bace4027	0.99	Other	sparser:Unknown	Additionally, prephosphorylation of tau by PKA slightly promotes tau phosphorylation by cdk5 kinase at Ser396 and inhibits its phosphorylation at Ser202, Thr212, Thr217 and Ser404 [ xref ].	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
7c633f8d-9aea-4522-a947-fab2bace4027	0.99	PubMed	18175478	These results could be explained by a lesser activity of Cdk5 at CP13, AT8 and Tau-1 phosphorylation sites XREF_BIBR since the activation of Cdk5 in neuroblastoma cells leads to a smaller increase of phosphorylation at Ser202 and Thr205 than at Thr231 and Ser235 and does not increase tau phosphorylation at Ser396 and Ser404 XREF_BIBR.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
7c633f8d-9aea-4522-a947-fab2bace4027	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_416d8757af905d0547c19b9485f9c63d	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
ab29640b-ba01-4aad-acf7-cf0fb1446589	0.99	PubMed	18437544	Indeed, we have yet to fully characterize the mechanism by which Cdk5 enhances Tau phosphorylation at Ser199 but, according to the present investigation, this phenomenon appears to be independent of the activation of calpain enzymes, which are known to favour intracellular accumulation of the potent p25 activator of Cdk5 [XREF_BIBR, XREF_BIBR].	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
ab29640b-ba01-4aad-acf7-cf0fb1446589	0.99	Other	sparser:Unknown	Indeed, we have yet to fully characterize the mechanism by which Cdk5 enhances Tau phosphorylation at Ser199 but, according to the present investigation, this phenomenon appears to be independent of the activation of calpain enzymes, which are known to favour intracellular accumulation of the potent p25 activator of Cdk5 [ xref , xref ].	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
ab29640b-ba01-4aad-acf7-cf0fb1446589	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e8f85c0d9c88d1019c50a5e941e7ea15	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
ab29640b-ba01-4aad-acf7-cf0fb1446589	0.99	PubMed	PMC6370717	Recent in vitro studies have shown that cdk5 phosphorylates tau at serine 199, serine 202, and threonine 205 and that p25, an activator of cdk5, is increased in Alzheimer disease (AD).	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
789e4e95-7c08-42fe-9445-f0a0a8aab3dc	0.99	Other	sparser:Unknown	Recent in vitro studies have shown that cdk5 phosphorylates tau at serine 199, serine 202, and threonine 205 and that p25, an activator of cdk5, is increased in Alzheimer disease (AD).	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
789e4e95-7c08-42fe-9445-f0a0a8aab3dc	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_eaa5d97f0695f351f9455e6539da4c42	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
789e4e95-7c08-42fe-9445-f0a0a8aab3dc	0.99	PubMed	22040109	This has important implications, as during brain development, tau is phosphorylated by the Cdk5 and p39 complex at Ser 202 and Thr 205, but not by Cdk5-p35 [XREF_BIBR].	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
789e4e95-7c08-42fe-9445-f0a0a8aab3dc	0.99	PubMed	12071639	Recent in vitro studies have shown that cdk5 phosphorylates tau at serine 199, serine 202, and threonine 205 and that p25, an activator of cdk5, is increased in Alzheimer disease (AD).	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
789e4e95-7c08-42fe-9445-f0a0a8aab3dc	0.99	PubMed	6370717	Recent in vitro studies have shown that cdk5 phosphorylates tau at serine 199, serine 202, and threonine 205 and that p25, an activator of cdk5, is increased in Alzheimer disease (AD).	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
ff58457b-2c4c-4603-8adf-b6476853ce59	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_6ddc0d72f927da10b4f70de30bcfd464	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
ff58457b-2c4c-4603-8adf-b6476853ce59	0.93	Other	sparser:Unknown	Here, we show (i) that GSK-3alpha and neither GSK-3beta nor cdk5 can phosphorylate tau at Ser262 and phosphorylation at Ser235 by cdk5 primes phosphorylation at Thr231 by GSK-3alpha/beta; (ii) that tau isoforms with two N-terminal inserts (tau4L, tau3L) are phosphorylated by cdk5 plus GSK-3 at Thr231 markedly more than isoforms lacking these inserts (tau4, tau3); and (iii) that Thr231 is phosphorylated approximately 50% more in free tau than in microtubule-bound tau, and the phosphorylation at this site results in the dissociation of tau from microtubules.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
21f4ca7a-d28b-42b5-9c24-5e88d2da68a9	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_077d0a1ac904f7baf0dc580e9aaa9491	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
43d3f5f2-bf43-48bf-92ec-8004624b1108	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_0cdf13b7972f4ab3825b610a54854ac8	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 726))
43ff5f31-ae18-492a-8d1d-40ca579422aa	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_fec090283afd0ede0e677c3acded5065	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
10ba9c8f-773b-4354-8ee4-5077dfe81cd8	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d53c5359c6bc67d97dd1c79a04297380	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 153))
6b637e36-2485-470e-a4d4-f3ab6bde98da	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_852e7c5d6dba1336dda17e41476fba5e	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
ed88a36f-d502-4206-8775-fabdd683f0e3	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ceadff71a436d872951999025188c2cc	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
ed88a36f-d502-4206-8775-fabdd683f0e3	0.93	Other	sparser:Unknown	However, different from the in vitro phosphorylation, where Thr205 was phosphorylated in S202A mutant tau by Cdk5, it was not phosphorylated in the 3A mutant, including the S202A mutation, in cells ( xref ).	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
d1a80f5a-f64b-43b7-9feb-1785e6a9a75f	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_236410eb9305faf6ab5a74d8bb7b22ed	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
31c53842-9522-4bf6-bc22-f7ed4a2e574e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_6901b8465c20100ccf8c28b97e3d8f6f	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
647b838b-67fd-4e1d-bf12-e1bb2e1cad38	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e5903f15633afd3e2289f850ea3980d1	No evidence text.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
647b838b-67fd-4e1d-bf12-e1bb2e1cad38	0.99	Other	sparser:Unknown	These findings suggest that the phosphorylation of tau at Thr231 and Ser262 by cdk5 plus GSK-3, which inhibits its normal biological activity, is regulated both by its amino terminal inserts and its physical state.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
647b838b-67fd-4e1d-bf12-e1bb2e1cad38	0.99	Other	sparser:Unknown	Organelle clustering resulted from CDK5-dependent phosphorylation of the microtubule-associated protein tau on threonine 231.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
647b838b-67fd-4e1d-bf12-e1bb2e1cad38	0.99	PubMed	7802275	Organelle clustering resulted from CDK5 dependent phosphorylation of the microtubule associated protein tau on threonine 231.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
e63c5a24-8319-43dd-8146-67ecdcb0de5a	0.86	PubMed	PMC17200775	Tau protein kinase I (TPKI) is a non-PDPK that can phosphorylate native tau isolated from normal brain, which is already phosphorylated to some extent, but it can not phosphorylate completely dephosphorylated tau.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e63c5a24-8319-43dd-8146-67ecdcb0de5a	0.86	Other	sparser:Unknown	Tau protein kinase I (TPKI) is a non-PDPK that can phosphorylate native tau isolated from normal brain, which is already phosphorylated to some extent, but it can not phosphorylate completely dephosphorylated tau.	p(HGNC:CDK5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
52d0d0a5-ff89-4be1-8083-759ca04e9c48	0.99	PubMed	10910881	In vitro kinase assays revealed that human Chk2 and a closely related checkpoint kinase 1 (Chk1) directly phosphorylate human tau at Ser262.	p(HGNC:CHEK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
52d0d0a5-ff89-4be1-8083-759ca04e9c48	0.99	Other	sparser:Unknown	In vitro kinase assays revealed that human Chk2 and a closely related checkpoint kinase 1 (Chk1) directly phosphorylate human tau at Ser262.	p(HGNC:CHEK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
52d0d0a5-ff89-4be1-8083-759ca04e9c48	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2b9e3beddd320dc0dfd627a0a83fdcd5	No evidence text.	p(HGNC:CHEK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
52d0d0a5-ff89-4be1-8083-759ca04e9c48	0.99	PubMed	20159774	In vitro kinase assays revealed that human Chk2 and a closely related checkpoint kinase 1 (Chk1) directly phosphorylate human tau at Ser262.	p(HGNC:CHEK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
872e926d-53a5-4676-b312-955ac472e55e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_52b6491533998932e9c8a541b1e1c654	No evidence text.	p(HGNC:CHEK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
19fdbe69-4933-4467-acbf-c7c38fb8ae67	0.95	Other	sparser:Unknown	It is characterized by the intracellular accumulation of Aβ oligomers and hyperphosphorylated tau and by the extracellular accumulation of high‐molecular‐weight deposits of Aβ peptides in fibrillar forms.	p(HGNC:CHI3L1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
19fdbe69-4933-4467-acbf-c7c38fb8ae67	0.95	Other	sparser:Unknown	Therefore, the involvement of ER Ca(2+) release in GSK-3beta activation and tau phosphorylation induced by Abeta1-42 oligomers was evaluated using dantrolene, an inhibitor of Ca(2+) release through channels associated with ER ryanodine receptors.	p(HGNC:CHI3L1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
19fdbe69-4933-4467-acbf-c7c38fb8ae67	0.95	Other	sparser:Unknown	This finding is important in that tau oligomers and tau hyperphosphorylation for human TBI specimens have been shown to be perivascular in distribution ( xref , xref ).	p(HGNC:CHI3L1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
19fdbe69-4933-4467-acbf-c7c38fb8ae67	0.95	Other	sparser:Unknown	Interestingly, when added to cortical neuronal cultures HEWL oligomers induce tau hyperphosphorylation at epitopes that are characteristically phosphorylated in neurons exposed to soluble oligomers of the amyloid-beta peptide.	p(HGNC:CHI3L1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
19fdbe69-4933-4467-acbf-c7c38fb8ae67	0.95	Other	sparser:Unknown	The human oligomers also induce hyperphosphorylation of tau at AD-relevant epitopes and cause neuritic dystrophy in cultured neurons.	p(HGNC:CHI3L1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
19fdbe69-4933-4467-acbf-c7c38fb8ae67	0.95	Other	sparser:Unknown	The human oligomers also induce hyperphosphorylation of tau atAD‐relevant epitopes and cause neuritic dystrophy in cultured neurons.	p(HGNC:CHI3L1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
19fdbe69-4933-4467-acbf-c7c38fb8ae67	0.95	Other	sparser:Unknown	Moreover, intracerebral administration of amyloid-β oligomers causes hyperphosphorylation of tau, but whether it is involved in the formation of NFTs is still unclear.	p(HGNC:CHI3L1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
19fdbe69-4933-4467-acbf-c7c38fb8ae67	0.95	Other	sparser:Unknown	AD is associated with an increase in amyloid beta (Aβ) oligomers and hyperphosphorylated tau, along with cognitive impairment and neurodegeneration.	p(HGNC:CHI3L1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
cf99ecda-e87f-4958-81c7-c1841537270b	0.65	PubMed	18894975	Indeed, chelating extracellular Ca 2+ in cultured medium with EGTA inhibited the phosphorylation of tau by nicotine and other nAChR agonists.	p(FPLX:CHRN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
891a44b3-b089-4d16-924f-98261802c989	0.86	Other	sparser:Unknown	We previously showed that cis phosphorylated tau ( cis P-tau), but not the trans form, contributes to tau pathology and functional impairment in an animal model of severe TBI.	p(HGNC:CISH)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
891a44b3-b089-4d16-924f-98261802c989	0.86	Other	sparser:Unknown	We previously showed that cis phosphorylated tau (cis P-tau), but not the trans form, contributes to tau pathology and functional impairment in an animal model of severe TBI.	p(HGNC:CISH)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c39092d4-a580-4ca9-a433-4ec3a1d2f2ad	0.98	PubMed	PMC3812531	The in vitro phosphorylation of the microtubule-associated protein tau by casein kinase II was studied.	p(FPLX:CK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c39092d4-a580-4ca9-a433-4ec3a1d2f2ad	0.98	PubMed	PMC3812531	Purified human brain tau was phosphorylated by casein kinase II to a stoichiometry of 0.7 mol of 32P/mol of tau.	p(FPLX:CK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c39092d4-a580-4ca9-a433-4ec3a1d2f2ad	0.98	PubMed	PMC3812531	Phosphopeptide mapping of casein kinase II phosphorylated human tau and recombinant tau isoforms suggested that the isoforms containing an amino-terminal insert constitute the major substrates for casein kinase II within the tau family.	p(FPLX:CK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c39092d4-a580-4ca9-a433-4ec3a1d2f2ad	0.98	PubMed	18237353	CK2 activity increases due to the presence of Abeta peptide and, thus, may accelerate tau phosphorylation.	p(FPLX:CK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c39092d4-a580-4ca9-a433-4ec3a1d2f2ad	0.98	Other	sparser:Unknown	Phosphopeptide mapping of casein kinase II phosphorylated human tau and recombinant tau isoforms suggested that the isoforms containing an amino-terminal insert constitute the major substrates for casein kinase II within the tau family.	p(FPLX:CK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c39092d4-a580-4ca9-a433-4ec3a1d2f2ad	0.98	Other	sparser:Unknown	Purified human brain tau was phosphorylated by casein kinase II to a stoichiometry of 0.7 mol of 32P/mol of tau.	p(FPLX:CK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c39092d4-a580-4ca9-a433-4ec3a1d2f2ad	0.98	Other	sparser:Unknown	The in vitro phosphorylation of the microtubule-associated protein tau by casein kinase II was studied.	p(FPLX:CK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e713d3dc-b7cf-44e1-960d-9b6014b06e37	0.65	Other	sparser:Unknown	In DS brain an increase in 3R:4R ratio combined with an extra copy of Dyrk1A, which can hyperphosphorylate tau, results in tau pathology during the fourth decade of life which is almost two decades earlier than the average age of onset of AD ( xref , xref ).	p(HGNC:CLNS1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a0c1753d-7c42-44f9-ba8d-852485691b20	0.65	PubMed	15635191	CM from high glucose treated WT astrocytes increased tau hyperphosphorylation in cultured primary neurons, an effect absent from Mif (-/-) astrocytes and WT astrocytes treated with the MIF inhibitor ISO-1.	a(PUBCHEM:23979)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a55df269-e2f0-4d5b-a21f-9743244adaed	0.65	PubMed	18543577	In Alzheimer 's disease, cofilin-actin rods and thread like inclusions containing phosphorylated microtubule associated protein tau form in the neuropil of the brain.	p(UP:Q759P0)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4f687b89-563c-49e0-8654-1f8d051fe812	0.65	PubMed	18465183	Our data show that deletion of Crry, the murine orthologue of CR1, gives rise to reduced hippocampal levels of CFH and decreased phosphorylation of tau at one of the key phospho-residues controlling its microtubule binding, serine 235.	p(HGNC:CR1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d0f5fdf-6abf-4147-9b41-5e32c17aff40	0.65	PubMed	19976170	In this study, we explored the effects of long-term noise exposure on the corticotropin releasing factor (CRF) system in the hippocampus and its role in noise induced tau phosphorylation.	p(HGNC:CRH)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0e5155aa-ff58-423e-9588-fda20925ac1a	0.86	Other	sparser:Unknown	They found physical interaction between Drp1 and phosphorylated tau [ xref ].	p(HGNC:CRMP1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0e5155aa-ff58-423e-9588-fda20925ac1a	0.86	Other	sparser:Unknown	AD mice, they also studied physical interaction between Drp1 and phosphorylated tau.	p(HGNC:CRMP1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4749ffc0-60e3-43cf-bb82-58b9061a7ebc	0.65	PubMed	15292343	Western blot analysis showed that CRP, in a time- and concentration dependent manner, induced the phosphorylation of tau at Ser202 and ser396 in SH-SY5Y cells.	p(HGNC:CRP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	13972665	In addition, CSF amyloid beta1-42 (Abeta1-42), total tau (T-tau), and phosphorylated tau (P-tau181P) levels were determined.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	CSF phosphorylated tau (p-tau) 181 and total tau levels and 18F-fluorodeoxyglucose (FDG)-PET are markers of neuronal injury or neurodegeneration xref  xref .	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	17889968	The most frequently used CSF biomarkers include total tau (T-tau) and hyperphosphorylated tau protein (P-tau), which are associated with neuronal damage and intracellular neurofibrillary tangles (NFT); amyloid beta 1-42 (Abeta 42), a predominant component of brain parenchyma amyloid plaques; amyloid beta 1-40 (Abeta 40) found mainly in vascular walls [XREF_BIBR]; and isoprostane (IP), a marker of lipid peroxidation and inflammation [XREF_BIBR, XREF_BIBR].	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Four years of clinical research consistently demonstrate that CSF phosphorylated tau (p-tau) is highly increased in AD compared to healthy controls and may differentiate AD from its most relevant differential diagnoses.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	22057084	The most frequently used CSF panel of biomarkers in AD includes amyloid beta 1-42 (Abeta 42), a predominant component of amyloid plaques; total tau (t-tau) and hyperphosphorylated tau (p-tau), which are associated with neuronal damage and intracellular neurofibrillary tangles [XREF_BIBR].	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	The association between OSA and cerebral spinal fluid (CSF) AD-biomarker changes including elevated CSF phosphorylated tau and β-amyloid 42 in elderly with the APOε3/3 alleles has been demonstrated (Osorio et al., xref ).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Only one patient with AD had increased CSF phosphorylated tau (ptau-181) (more than 61 pg/ml).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Eight patients with non-AD had decreased levels of CSF p-amyloid (1-42), one had increased CSF total tau protein, and none had increased CSF phosphorylated tau (ptau-181) protein.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	It is also noteworthy that mean cortical thickness of AD vulnerable regions, hypothesized to be a marker of neuronal injury, was associated with levels of CSF phosphorylated tau, but not CSF Abeta. xref found an association between mean cortical thickness of AD vulnerable regions and CSF total tau, but not Abeta (cf. xref ), in cognitively normal individuals who were tau positive (though their study did not include measures of p-tau).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	In order to eliminate this confounding effect of heterogeneity of MCI, we classified patients with MCI into either “MCI due to AD” (n = 281) or “MCI not due to AD” (n = 91) based on their biomarker criteria, including positive cortical Aβ and high CSF phosphorylated tau, as suggested by previous studies. xref , xref In each group, there was no relationship between current depressive symptoms, assessed by GDS and NPI-D score, and cortical Aβ deposition in frontal, parietal, cingulate and temporal regions ( xref ).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	CSF Phosphorylated tau (P-tau), which is associated to formation of neurofibrillary tangles in neurodegenerative disorders [ xref ], has not been studied in HD.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	12666522	Voxel-wise image analysis methods were used to test whether baseline CSF Abeta (42), total tau (T-Tau), phosphorylated tau (P-Tau) and neurofilament light protein predicted brain microstructure as indexed by DTI and gray matter volume indexed by T1 weighted imaging.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	A statistically significant reduction of CSF phosphorylated tau at the 1-year follow-up was seen, from median 126 (interquartile range 107-153) to 108 (88-133) ng/l (p = 0.018).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	PMC6939494	To study the combination of CSF phosphorylated tau protein (phospho-tau) and Abeta42 as biochemical markers for AD.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Rs4803758 near APOE showed the most significant associations with levels of CSF phosphorylated
tau 181 (P=3.75×10 −4 ) and CSF
Aβ 42 (P=3.12×10 −5 ),
whereas rs1057233 in the SPI1/CELF1 locus was significantly
associated with CSF Aβ 42 (P=8.24×10 −4 ).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Several previous studies have identified biochemical markers for Alzheimer's disease (AD): cerebrospinal fluid (CSF)-beta-amyloid peptide42 (CSF-Abeta42), CSF-total tau protein (CSF-tau) and CSF-phosphorylated tau protein (CSF-ptau).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	The present study aims to characterize the associations of anosognosia and AD biomarkers based on the recently described amyloid/tau/neurodegeneration construct  xref  in MCI, using [ 18 F]florbetapir, CSF phosphorylated tau (p-tau), and [ 18 F]FDG, respectively.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Decreased CSF Aβ 42 or increased CSF phosphorylated tau 181 (ptau 181 ) were independently associated with reduced DMN integrity, with the most prominent decreases in functional connectivity observed between the posterior cingulate and medial temporal regions.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	16850093	Cerebrospinal fluid (CSF) sample was obtained by lumbar puncture and concentrations of betaeta amyloid protein (Abeta1-42), tau protein (Ttau) and phosphorylate tau protein (P-tau) were determined.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	15989870	The purpose of this study was to investigate whether cerebrospinal fluid (CSF) levels of tau, phosphorylated tau, beta-amyloid42, alpha-synuclein, neurofilament light, and YKL-40 change over time and if changes correlate with motor progression and/or cognitive decline in patients with PD and controls.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	11750139	CSF amyloid-beta (1-42) (Abeta (1-42)), total tau (t-tau) and phosphorylated tau (p-tau (181)) were determined.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	The aim of the study was to assess whether baseline CSF hyperphosphorylated tau (P-tau), total tau (T-tau), amyloid beta 1-42 (Abeta(42)) and neurofilament light (NF-L) in patients with MCI could predict subcortical vascular dementia (SVD) and Alzheimer&apos;s disease (AD) at follow-up.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	In individuals with progressive MCI, low CSF Aβ 1–42 concentration and high concentrations of CSF p -tau 181p and t -tau are associated with higher subsequent rates of hippocampal atrophy [ xref , xref – xref ].	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	For example, amyloid pathology, as evidence by low CSF Aβ levels, was associated with clinical decline and accelerated neurodegeneration only in the presence of elevated CSF phosphorylated tau [ xref , xref ].	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Furthermore, we observed no changes in
the levels of CSF p tau 181 /total tau for PD whereas AD leads to an
increase in this ratio.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	19353789	In the total study population (n = 70), CSF IL-12/23 p40 concentrations correlated positively with CSF concentrations of beta-amyloid1-42 (Abeta1-42) and phosphorylated tau protein (P-tau) whereas in AD patients (n = 30), CSF IL-12/23 p40 only correlated positively with CSF P-Tau (r = 0.46, p = 0.01).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	CSF phosphorylated tau is a promising diagnostic test for AD but this requires replication using pathologically confirmed cases.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	To review the studies that have examined CSF phosphorylated tau as diagnostic test of AD vs clinically representative comparison groups.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	CSF phosphorylated tau is a marker of AD that improves upon the utility of CSF total tau and clinical examination alone.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	PMC6848228	To review the studies that have examined CSF phosphorylated tau as diagnostic test of AD vs clinically representative comparison groups.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	PMC6848228	CSF phosphorylated tau is a marker of AD that improves upon the utility of CSF total tau and clinical examination alone.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	PMC6848228	CSF phosphorylated tau is a promising diagnostic test for AD but this requires replication using pathologically confirmed cases.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Using linear models, we assessed the relationship between APOE ε4 genotype, CSF Complement 3 (C3), CSF amyloid-β (amyloid) and CSF hyperphosphorylated tau (ptau).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Notably, rs7768046 tags the long isoform promoter region and rs1621289 is located within the 3’ UTR region of FYN , suggesting that FYN regulatory region genetic content may play a role in FYN gene regulation, which may in turn contribute to elevated CSF phosphorylated tau in AD.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Significant correlations with BACE1 activity were found for CSF APPβ and total tau in all four groups; and for CSF phosphorylated tau 181 in all groups but the progressive MCI group.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	PMC7337382	Four years of clinical research consistently demonstrate that CSF phosphorylated tau (p-tau) is highly increased in AD compared to healthy controls and may differentiate AD from its most relevant differential diagnoses.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	We developed a prediction model that can accurately predict the probability of AD in a memory clinic population suspected of dementia based on CSF amyloid β42, CSF phosphorylated tau181, and sex.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	The prediction model was developed with logistic regression analysis and included CSF amyloid β42, CSF phosphorylated tau181, and sex.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	In the Aβ42 declining group, suggestive of incipient preclinical AD, CSF phosphorylated tau (p-tau) showed a similar longitudinal pattern of increasing abnormality over time (p = 0.0001).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	18090566	Baseline CSF amyloid-beta 1-42 (Abeta 1-42) and phosphorylated tau (p-tau) levels were measured using the multiplex xMAP Luminex platform (Luminex Corp, Austin, TX) and Innogenetics and Fujirebio AlzBio3 immunoassay kits.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	To study the combination of CSF phosphorylated tau protein (phospho-tau) and Abeta42 as biochemical markers for AD.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	PMC9198431	A statistically significant reduction of CSF phosphorylated tau at the 1-year follow-up was seen, from median 126 (interquartile range 107-153) to 108 (88-133) ng/l (p = 0.018).	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	18891579	For example, cerebrospinal fluid (CSF) biomarkers of AD pathology (e.g., decreased levels of amyloid-beta (Abeta 1-42) and increased levels of total tau (t-tau) and phosphorylated tau (p-tau)) are associated with increased amyloid plaque burden and neurofibrillary tangle load at autopsy.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	15557445	In the total study population (n = 80) as well as in men (n = 40), CSF levels of IGF-II and IGFBP-2 correlated positively with CSF levels of the AD biomarkers total-tau and phosphorylated tau protein.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Using this antibody, Kidins220 was detected in CSF from AD patients where it positively correlated with CSF phosphorylated tau and tau.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	CSF phosphorylated tau (p-tau) and total tau (t-tau) are also established AD biomarkers and both CSF tau and Aβ have recently been added to the clinical diagnostic criteria for mild cognitive impairment (MCI) and AD [ xref , xref , xref ].	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	15428721	CSF biomarkers included soluble amyloid precursor proteins (sAPP, sAPPalpha, sAPPbeta), amyloid beta (Abeta) 1-38, Abeta1-42 and phosphorylated tau (p-tau), lipocalin-type prostaglandin D synthase (L-PGDS)/beta-trace, and cystatin C.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	19904209	To contrast risk of incident AD and mild cognitive impairment (MCI) associated with IICV to risk associated with well established biomarkers : cerebrospinal fluid (CSF) phosphorylated tau protein (p-tau181) and amyloid-beta 42 (Abeta42) peptide.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Higher CSF phosphorylated Tau (pTau) was associated with worse PM.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	Other	sparser:Unknown	Thus, the above-mentioned MEG study xref further reported decreased alpha synchronization in the right PCC associated with increased levels of CSF phosphorylated tau.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
080bbaa0-42a2-41a4-9c35-f452e1400b65	1.0	PubMed	12629835	Several CSF measures are promising, including 42 amino acid beta-amyloid peptide (Abeta42); total tau (T-tau) protein, reflecting axonal damage; and phosphorylated tau (P-tau), reflecting neurofibrillary tangle pathology.	p(HGNC:CSF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5694d765-4a4b-4448-806c-7ab9a440e0c1	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_cdb6c983bf2fdb3cec5977e3022fc89d	No evidence text.	p(HGNC:CSNK1D)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
eaa23f74-6644-4d58-ad43-c2611cc94376	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_1b1a31ca09e18b538b05dab10aac63ac	No evidence text.	p(HGNC:CSNK1D)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
4d958631-9bed-47be-abf8-0c406efd1c9d	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ad44a599721526f218b0ff3dbc92e6d6	No evidence text.	p(HGNC:CSNK1D)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
7c83f833-1dd8-4fa0-8d6f-23dd4a3be21f	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_66f801d30978f2002062ae662015086b	No evidence text.	p(HGNC:CSNK1D)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
1e3520ee-5f0c-49a4-897f-b35a23defefc	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_3a97561956716f48fb55e340941d8603	No evidence text.	p(UP:P68399)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 39))
58df231f-9972-418d-8ae1-1aed9900a78a	0.86	Other	sparser:Unknown	It is conceivable that repression of BAG2 expression or activity by cold-sensitive pathways is a causal factor in the accumulation of cytotoxic hyperphosphorylated tau via restriction of BAG2-mediated clearance of cellular phosphorylated tau [ xref ].	p(HGNC:CTLA4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
58df231f-9972-418d-8ae1-1aed9900a78a	0.86	Other	sparser:Unknown	Our results suggest that repression of BAG2 expression or BAG2 activity by cold-sensitive pathways, as modeled in undifferentiated and differentiated cells, respectively, may be a causal factor in the accumulation of cytotoxic hyperphosphorylated tau protein via restriction of BAG2-mediated clearance of cellular p-tau.	p(HGNC:CTLA4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ba25f1b2-bf61-446b-b388-3c93036e5823	0.65	PubMed	17152488	Further, deficiency of membrane anchored chemokine CX3CL1 (fractalkine) in APP and PS1 tg mice also lead to enhanced TAU phosphorylation, via the p38-MAPK pathway, and reduced Abeta deposition [XREF_BIBR].	p(HGNC:CX3CL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
527f56f7-a2b4-4b85-8a96-f7409b7f4edb	0.92	PubMed	18361674	Additional in vitro experiments demonstrate that microglial activation and CX3CR1 deficiency elevates the level of active p38 MAPK and enhances MAPT hyperphosphorylation within neurons that can be blocked by administration of a specific p38 MAPK inhibitor.	p(HGNC:CX3CR1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
527f56f7-a2b4-4b85-8a96-f7409b7f4edb	0.92	PubMed	18640938	Given our findings that CX3CR1 deficiency promotes phosphorylation of MAPT following peripheral LPS administration in non transgenic mice (XREF_FIG) and that six-month-old hTau mice exhibit elevated levels of cleaved CX3CL1 (XREF_SUPPLEMENTARY), we postulated that a deficiency in CX3CR1 would promote MAPT pathologies in the hTau mice.	p(HGNC:CX3CR1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
527f56f7-a2b4-4b85-8a96-f7409b7f4edb	0.92	PubMed	18640938	Taken together, these results demonstrate that CX3CR1 deficiency promotes MAPT phosphorylation and aggregation as well as behavioral abnormalities in working memory in the hTau mice.	p(HGNC:CX3CR1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d58e3da-66f7-4aa6-8ca7-acb2c037b4b8	0.92	PubMed	17409694	This result determined that Ca 2+ -dependent kinases PKC, CamKII, and phosphorylase kinase do not phosphorylate tau in NGF exposed PC12 cells.	a(CHEBI:29108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d58e3da-66f7-4aa6-8ca7-acb2c037b4b8	0.92	PubMed	24367683	This result determined that Ca 2+ -dependent kinases PKC, CamKII, and phosphorylase kinase do not phosphorylate tau in NGF exposed PC12 cells.	a(CHEBI:29108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d58e3da-66f7-4aa6-8ca7-acb2c037b4b8	0.92	PubMed	21015859	PP-2A and PP-2B have been shown to dephosphorylate tau phosphorylated by Ca ^/calmodulin-dependent protein kinase and cAMP dependent protein kinase (PKA) [20,21].	a(CHEBI:29108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
372e72cb-ee03-490a-b8d6-89712e456f2d	0.65	PubMed	18437544	Role of Calcium and Cdk5 Signalling in NVP Induced Tau Phosphorylation.	a(PUBCHEM:5460341)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
49f143de-1648-4e8b-b431-626eb4b29c8c	0.65	PubMed	18291703	Calpain-2 activation increases tau tyrosine phosphorylation through a PTPN13 and c-Abl pathway.	p(IP:IPR029539)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr))
371f3ff7-37b6-4924-a86c-20bd8cf74eb9	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ee9a97d860f190c059390de6f98b1bc4	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
371f3ff7-37b6-4924-a86c-20bd8cf74eb9	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_12bcf02ec8442cd52ea0e41a710d6c94	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
61736401-e322-4044-874d-91027f9b6736	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ef33be1621d950d46fb867860a929d26	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
d811ddb4-7a2c-4867-861c-3982c02478d8	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_c49918c43cd14470f99a9f809b8a6ca1	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 552))
0c2f175c-96ae-4fe5-b5f3-7e7ec41d1389	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ec74542eebed569a843d96b43b0f6539	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
4aef742b-097f-4d83-bc64-e17430126340	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_833da4fc29c43d02ee980bd21254ebc6	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
4aef742b-097f-4d83-bc64-e17430126340	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_80c72e8a112131110d9e343ea41f897d	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
4aef742b-097f-4d83-bc64-e17430126340	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_3f68965282e275964ba1019a72be1b60	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
850cde37-9e5c-4109-85a8-f5d05a5cdef4	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_75f304df22894ddb1959c5b1e8c06b5d	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
850cde37-9e5c-4109-85a8-f5d05a5cdef4	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_193a3e826b2f006583d962421caafe5d	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
850cde37-9e5c-4109-85a8-f5d05a5cdef4	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7b0d06e6d69ef3c81bf2c41618b90f70	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
850cde37-9e5c-4109-85a8-f5d05a5cdef4	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a5561dd808b582cf3d0b22e28121721f	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
0fa19869-3a75-4644-be06-1b7bcd6f5458	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_4de1041c93d5c4496ca6fb17a4066e59	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 173))
6992b8b0-a689-4372-beae-4976b86a68b8	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a8e58bdbff509687461727d3a9999682	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
6992b8b0-a689-4372-beae-4976b86a68b8	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8331af28cb7b241471c6e972e40ee56d	No evidence text.	p(UP:P11275)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
f5b9770c-dc3c-4640-b2cd-af30b2edb99e	0.65	PubMed	17704504	DHA also triggered inactivation of cell signaling pathways leading to caspase activation and hyperphosphorylation of tau.	p(FPLX:Caspase)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
82a70c6c-35b8-4841-96f6-bae7035c4d50	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ebc2df7f7cfe07a98b596994a9e6c895	No evidence text.	p(UP:P49615)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
16c56fd6-3758-411d-91a0-a355c56a0106	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e8fbdbcc3ea0a30f04cf0ae3318807e6	No evidence text.	p(UP:P49615)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
9dd5c6f7-b828-4a76-84c2-ab0240be3960	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_297115f9bcbc9043a526a7809ca2337f	No evidence text.	p(UP:P49615)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
692ec89c-3a59-4734-ab6f-0df792cdcf65	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_29ea468e5c9d355d0a12e7eab2b49639	No evidence text.	p(UP:P49615)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
5f0f64f5-a349-48d0-b9d5-216a58a1f92f	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b9d00958172676c3e36d12c353e180ca	No evidence text.	p(UP:P49615)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
7c078c7f-03cf-4f3e-add6-8fcf51ad2fe4	0.65	PubMed	9504142	Cisplatin, a G1 phase inhibitor, did not phosphorylate tau.	a(CHEBI:27899)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
29d51e7d-ee3b-4f18-b1a3-bf12f19cb8f4	0.65	PubMed	22071180	The Congo Red, Cresyl Violet staining and immunohistochemistry (IHC) test revealed that VCO improved hippocampus histological changes, reduced Abeta plaques and phosphorylated Tau.	a(PUBCHEM:11313)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
186f7520-6246-40b9-9828-eb9f11c730dc	0.65	PubMed	16850279	We consequently examined whether Abeta deposits (oligomeric or fibrillar Abeta1-42, or Abeta25-35) in the Cx chamber could induce distant post-synaptic Tau phosphorylation in the Hi chamber.	p(PFAM:PF01705)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3e4e726c-5525-4ef4-bc03-04bdd52adb3b	0.65	PubMed	15216390	Hyperphosphorylation of tau on S202 and T205 is mediated by cyclin dependent kinase 5 (Cdk5) in SMA disease condition, because tau phosphorylation at these sites is significantly reduced in Cdk5 knock-out mice; genetic knock-out of Cdk5 activating subunit p35 in an SMA mouse model also leads to reduced tau phosphorylation on S202 and T205 in the SMA; p35 (-/-) compound mutant mice.	p(FPLX:Cyclin)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
18508b52-6db6-460c-8575-5793b799a9a0	0.95	PubMed	17285176	Dab1 gene inactivation in postnatal animals leads to Tau hyperphosphorylation in the hippocampus.	p(HGNC:DAB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
18508b52-6db6-460c-8575-5793b799a9a0	0.95	PubMed	17285176	Tau phosphorylation was significantly increased at P40 by dab1 gene inactivation at P11 in the brains of Cre ERTM transgenic dab1 cKI and cKI animals (XREF_FIG) as compared to the tamoxifen treated control animals.	p(HGNC:DAB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
18508b52-6db6-460c-8575-5793b799a9a0	0.95	PubMed	17285176	We show here that dab1 gene inactivation in healthy animals with relatively normal brain anatomy leads to Tau hyperphosphorylation.	p(HGNC:DAB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
18508b52-6db6-460c-8575-5793b799a9a0	0.95	PubMed	17285176	We show that dab1 gene inactivation after brain development leads to Tau hyperphosphorylation in anatomically normal mice.	p(HGNC:DAB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
18508b52-6db6-460c-8575-5793b799a9a0	0.95	PubMed	12412957	We show that dab1 gene inactivation after brain development leads to Tau hyperphosphorylation in anatomically normal mice.	p(HGNC:DAB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d1bc8e28-d8c8-4dff-8330-638f176a8b57	0.65	PubMed	24853415	Thus, DAPK1 overexpression, but not the kinase deficient mutant K42A, increased tau phosphorylation in cells.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
97f5aa8e-eea2-4bb9-8582-d55cde13048b	0.95	PubMed	24853415	XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR In cell cultures, DAPK1, but not the kinase deficient mutant K42A, increased tau phosphorylation at Thr231, Ser262, and Ser396.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
97f5aa8e-eea2-4bb9-8582-d55cde13048b	0.95	PubMed	PMC13634691	Expression of DAPK1 induced tau hyperphosphorylation at Thr231, Ser262, and Ser396 with no effects on protein phosphatase 2A, glycogen synthase kinase-3β, protein kinase A, calcium/calmodulin dependent protein kinase II, cell division cycle 2, or cyclin dependent protein kinase 5.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
97f5aa8e-eea2-4bb9-8582-d55cde13048b	0.95	PubMed	PMC13634691	These data suggest that tau hyperphosphorylation at Thr231, Ser262, and Ser396 by DAPK1 renders the cells more resistant to the kinase-induced apoptotic cell death, providing new insights into the tau-involved apoptotic abortion in the course of chronic neurodegeneration.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
83dcfea8-9805-4d51-969b-06b7949638f1	0.95	PubMed	15239733	We found that DAPK1 phosphorylates Tau protein at Ser262 (pS (262)) in cortical neurons of stroke mice.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
83dcfea8-9805-4d51-969b-06b7949638f1	0.95	Other	sparser:Unknown	We found that DAPK1 phosphorylates Tau protein at Ser262 (pS(262)) in cortical neurons of stroke mice.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
83dcfea8-9805-4d51-969b-06b7949638f1	0.95	PubMed	24853415	34 It was also shown that the MT-affinity regulating kinase (MARK) 1/2 is activated by DAPK1 to phosphorylate tau on Ser262, regulating its toxicity.	p(HGNC:DAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
1682b7d6-2242-4f83-8eba-4da4a14a4e15	0.86	PubMed	17364473	Perforant path (PP) axon terminals within the dentate gyrus (DG) contained abnormal conformations of tau even in young EC-hTau mice, and phosphorylated tau increased with age in both the EC and PP.	a(PUBCHEM:151148)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1682b7d6-2242-4f83-8eba-4da4a14a4e15	0.86	PubMed	12885796	Perforant path (PP) axon terminals within the dentate gyrus (DG) contained abnormal conformations of tau even in young EC-hTau mice, and phosphorylated tau increased with age in both the EC and PP.	a(PUBCHEM:151148)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
341c59dc-7c71-490d-94d8-81a7a7a7a480	0.65	PubMed	11247310	Treatment of GDX mice with T or E2 but not DHT reduced tau hyperphosphorylation to levels lower than observed in sham animals.	a(CHEBI:2150)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dff1333b-93b5-4e1e-aac5-0c00a5bb9ac8	0.65	PubMed	16919965	We have previously shown that inhibition of GSK3beta by lithium and a specific GSK3beta inhibitor, and of DKK1 expression by antisense oligonucleotides, can decrease Abeta mediated PHF-1 induction in cultured neurons (), consistent with an involvement of DKK1 and of inhibition of Wnt signaling in Abeta mediated Tau phosphorylation.	p(HGNC:DKK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e6b61140-a210-4dc4-b963-ce1de9eaa2cb	0.92	PubMed	19936237	Taken together, STZ induced DM in pR5 mice resulted in an increased phosphorylation of tau, in particular at the pathogenic site pS422.	p(PFAM:PF00751)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e6b61140-a210-4dc4-b963-ce1de9eaa2cb	0.92	PubMed	19316004	In animal models, DM induces or exacerbates the phosphorylation of tau, suggesting that DM may influence the risk at AD by directly facilitating tau pathology.	p(PFAM:PF00751)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e6b61140-a210-4dc4-b963-ce1de9eaa2cb	0.92	PubMed	17208445	Taken together, STZ induced DM in pR5 mice resulted in an increased phosphorylation of tau, in particular at the pathogenic site pS422.	p(PFAM:PF00751)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3a6b6f29-c1d6-4afe-a299-c81b20c27e05	0.94	Other	sparser:Unknown	These data provide the first evidence that escitalopram ameliorates forskolin-induced tau hyperphosphorylation and spatial memory impairment in rats; these effects do not occur via the anti-anxiety activity of escitalopram but may involve the Akt/GSK-3β signaling pathway.	p(HGNC:DUOX1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3a6b6f29-c1d6-4afe-a299-c81b20c27e05	0.94	Other	sparser:Unknown	Interestingly, our previous study showed that escitalopram, one of the SSRIs, attenuated forskolin-induced tau hyperphosphorylation in human embryonic kidney cells that stably express human longest tau isoform tau441 (HEK293/tau441 cells) [ xref ].	p(HGNC:DUOX1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3a6b6f29-c1d6-4afe-a299-c81b20c27e05	0.94	Other	sparser:Unknown	Forskolin can induce tau hyperphosphorylation and spatial memory retentive deficit within a certain period of time.	p(HGNC:DUOX1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3a6b6f29-c1d6-4afe-a299-c81b20c27e05	0.94	Other	sparser:Unknown	To investigate the differential regulatory effect of O -GlcNAc under tau phosphoylation condition, tau-BiFC cells were treated with OGA or OGT inhibitors upon the stimulation of tau phosphorylation by forskolin ( xref a).	p(HGNC:DUOX1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
036a8091-4c53-43f2-a026-70c175841f4c	0.65	PubMed	18039702	Promoter Hypermethylation of the Phosphatase DUSP22 Mediates PKA Dependent TAU Phosphorylation and CREB Activation in Alzheimer 's Disease.	p(HGNC:DUSP22, pmod(Me))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
db72a62b-6010-406a-a280-cc8e416aebc6	0.86	PubMed	9271238	Overexpression of the mouse dishevelled-1 protein inhibits GSK-3beta-mediated phosphorylation of tau in transfected mammalian cells.	p(HGNC:DVL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
db72a62b-6010-406a-a280-cc8e416aebc6	0.86	PubMed	10647780	Therefore, the mode of the interaction of Dvl-1 with Axin is not yet known.Overexpression of Dvl-1 in CHO cells inhibits the phosphorylation of Tau, which is known to be phosphorylated by GSK-3.	p(HGNC:DVL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
cd6229a4-d2ec-4452-924e-30166e61987f	0.65	PubMed	5170242	Furthermore, we showed that mouse Dvl proteins affect downstream components of Drosophila Wg signaling as Dsh does; overexpression of Dvl proteins in clone-8 cells results in elevation of Armadillo (Drosophila homolog of beta-catenin) and Drosophila E-cadherin levels, hyperphosphorylation of Dvl proteins themselves, and inhibition of Zeste-White3 kinase mediated phosphorylation of a microtubule binding protein, Tau.	p(FPLX:DVL, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
348db6c0-19f5-4c3c-8906-fb97b42917b2	0.86	PubMed	18023591	Overexpression of DYRK1A in HEK293 cells caused an increased phosphorylation of tau at Thr212, which was inhibited by 5j with an IC 50 of 2.1 muM.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
348db6c0-19f5-4c3c-8906-fb97b42917b2	0.86	PubMed	17267326	Phosphorylation of Tau at T212 was induced by the overexpression of DYRK1A in 293T cells and then detected by western blotting with an antibody specific for phosphorylated Tau at Thr212.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
a31d0b21-22f0-4234-a492-5a406bc82866	0.86	PubMed	5847941	The DYRK isoforms also phosphorylate human microtubule associated protein tau at Thr (212) in vitro, a residue that is phosphorylated in foetal tau and hyperphosphorylated in filamentous tau from Alzheimer 's-disease brain.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, 212))
a31d0b21-22f0-4234-a492-5a406bc82866	0.86	PubMed	11311121	The DYRK isoforms also phosphorylate human microtubule associated protein tau at Thr (212) in vitro, a residue that is phosphorylated in foetal tau and hyperphosphorylated in filamentous tau from Alzheimer 's-disease brain.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, 212))
2d8aeb7c-6b62-4abd-a846-c049e459dde4	0.97	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_59fd3df0474969bfcc066589eb4ccf11	No evidence text.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
2d8aeb7c-6b62-4abd-a846-c049e459dde4	0.97	PubMed	11770979	Here we test the ability of harmine, and numerous additional beta-carboline compounds, to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
2d8aeb7c-6b62-4abd-a846-c049e459dde4	0.97	Other	sparser:Unknown	Here we test the ability of harmine, and numerous additional β-carboline compounds, to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
cb26927f-3eb0-47a2-a30c-bfaf2dfedf63	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_72d83d213cb03bf856d884dfbd132c54	No evidence text.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
85cc3753-fbb8-48c7-8b23-3dc6166da72c	0.98	Other	sparser:Unknown	Although DYRK1A can phosphorylate tau at serine-202, in vitro, the efficiency of this reaction is low compared with that of Ser212 ( xref ).	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
85cc3753-fbb8-48c7-8b23-3dc6166da72c	0.98	Other	sparser:Unknown	Interestingly, DYRK1A phosphorylates serine 202 of tau protein and this phosphorylation induces a conformational change of tau which is pathological ( xref ).	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
85cc3753-fbb8-48c7-8b23-3dc6166da72c	0.98	Other	sparser:Unknown	We found that Dyrk1A also phosphorylates Tau at Ser-202 and Ser-404 in vitro.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
85cc3753-fbb8-48c7-8b23-3dc6166da72c	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f05c70c3e43b23b9d6db69986f14ddc1	No evidence text.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
65a2fc25-7ae7-4563-ae5b-234226e73a97	0.97	PubMed	9327027	We found that Dyrk1A also phosphorylates Tau at Ser 202 and Ser 404 in vitro.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
65a2fc25-7ae7-4563-ae5b-234226e73a97	0.97	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2256560a65a1ec2fecde9f7cb8fdb350	No evidence text.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
65a2fc25-7ae7-4563-ae5b-234226e73a97	0.97	PubMed	17906291	We found that Dyrk1A also phosphorylates Tau at Ser 202 and Ser 404 in vitro.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
1657abe6-8a7d-488b-ab46-7588d440e20e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e47cfa07b31cbcb580be8f6106c2244b	No evidence text.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
cbaa0055-c3e9-456f-b55f-bc49656d3785	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f06d02c9cbbd4fefd5bc598d00e1ee6d	No evidence text.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
14b5961b-5020-4415-aa2c-305cfda7fd5b	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9d6ead90e40ec1b01af393481d8b61c8	No evidence text.	p(HGNC:DYRK1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
f29f90ec-d9dc-4289-8f98-eefd3248f833	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7a49305d6d67b1d7745213c3c5cf72c3	No evidence text.	p(HGNC:DYRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
7abd35bd-2bd7-42ef-b0fb-874581fe5bca	0.65	PubMed	15371668	Here, we show for the first time that the administration of D-ribose, the most active glycator among monosaccharides, produces high levels of advanced glycation end products (AGEs) and, importantly, triggers hyperphosphorylation of Tau in the brain of C57BL/6 mouse and neuroblastoma N2a cells.	a(PUBCHEM:5779)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
151a2fbe-ff3d-4aa0-9d3b-1d66a4bfaa1a	0.65	PubMed	18914611	Deferoxamine (DFO), a ferric iron chelator used to treat iron overload, has been shown to decrease tau phosphorylation, slow down amyloidogenesis, and improve behavioral impairment in an Alzheimer 's mouse and rabbit models XREF_BIBR - XREF_BIBR.	a(PUBCHEM:2973)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
42882f17-a391-46b4-91ab-c8831fe3c932	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_3c02dc3659d2e1156673306718ed0bad	No evidence text.	p(UP:Q61214)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
de636ecd-b9cd-4c1f-abcf-45187803f36d	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_677333554a47b4e83d5b685002fc4ec1	No evidence text.	p(UP:Q61214)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
4a77c799-918e-4497-885f-00bde5daa589	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9c3d4ce541a51aa1a3e69eac1729b734	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
e385cdaa-8492-432e-a96b-65dc1b40ea2a	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_58618eedddec52aeb88e52e9ce0c9b02	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
ae9e331e-7de1-4aca-8cce-bec0a47000c4	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_acf890a3a80e5044b328caeab49d6593	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
f37e2fc1-6fd6-4568-8dce-939d8e92a31b	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_68b7be0f5b6d263dfb8b9a08a071647d	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
e4cb0cf6-2402-4f25-8cca-000581c92137	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f7c3743745c66bf8e27d3204a4319a2b	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
32d5dba0-fb09-4734-bf9e-0782b399b378	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f2fa65a83621991ec7eda4a63fb88b97	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
ae1977f5-abe5-4485-87b9-b2358c5e1540	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_974cda0bf8960202c0b7ee95f5a6a4d6	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
ac3b9177-46ba-4bca-b573-480b4a3069f0	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2376f874c8162531669b1bb1161cd264	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
4b42a6f4-c57f-4daa-aa3e-1e6058099660	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e2d752ec15b0c3254a918a3f98da7e65	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
f74e6165-110d-42eb-aee9-654a792ec96b	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a307f2a8e43b456e618ea0f2624550df	No evidence text.	p(UP:Q63470)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
4c1de05f-c15a-43c1-a29d-530530a5a517	0.65	PubMed	8070670	Taken together, we concluded that ECS activated MARK1 and subsequently phosphorylated Tau at Ser262.	a(PUBCHEM:247304)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
7c3ab23a-5801-42e8-a3c3-eb3ea40741ba	0.65	PubMed	23320095	The phosphorylation of PKR can indirectly lead to the phosphorylation of Tau protein and in turn could accentuate the toxic consequences of neurofibrillary tangles in affected neurons.	p(HGNC:EIF2AK2, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f309c78c-dd6b-4824-b091-3c65757402f8	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_c986ed8a3f82663324e1cef8e0d8d2b3	No evidence text.	p(HGNC:EIF2AK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
05c8c260-7d6f-4d2f-a2c6-53c8c7e9f377	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_24931cd84550dbc2b56163bc080b5501	No evidence text.	p(HGNC:EIF2AK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
58f7e527-6585-48c2-a900-c911c767d868	0.65	PubMed	14559901	This study aimed to compare the prognostic performances of plasma concentrations of copeptin and other biomarkers like myelin basic protein, glial fibrillary astrocyte protein, S100B, neuron specific enolase, phosphorylated axonal neurofilament subunit H, Tau and ubiquitin carboxyl-terminal hydrolase L1 in severe traumatic brain injury.	p(HGNC:ENO2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
54eeaaeb-3d54-4f95-b757-3d7bd24c69fd	0.92	PubMed	18189986	We found that deletion of PDZ domain did not affect the EphB2 stimulation induced phosphorylation levels of PI3K and GSK-3beta and tau proteins (XREF_FIG), whereas deletion of VM kinase domain almost abolished the EphB2 activation induced alterations of PI3K and GSK-3beta and tau phosphorylation (XREF_FIG).	p(HGNC:EPHB2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
54eeaaeb-3d54-4f95-b757-3d7bd24c69fd	0.92	PubMed	26119563	We found that deletion of PDZ domain did not affect the EphB2 stimulation induced phosphorylation levels of PI3K and GSK-3beta and tau proteins (XREF_FIG), whereas deletion of VM kinase domain almost abolished the EphB2 activation induced alterations of PI3K and GSK-3beta and tau phosphorylation (XREF_FIG).	p(HGNC:EPHB2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
54eeaaeb-3d54-4f95-b757-3d7bd24c69fd	0.92	PubMed	26119563	These in vitro and in vivo data demonstrate that stimulation of EphB2 can attenuate tau phosphorylation.	p(HGNC:EPHB2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3e7d24d5-20d7-422c-84c2-a2003d5020dd	0.65	PubMed	20818790	Tau hyperphosphorylation increased in response to gp120, whereas EPO and/or IGF-I decreased tau hyperphosphorylation, as revealed by immunoblotting (see XREF_FIG).	p(HGNC:EPO)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c9239524-93a5-4498-b851-43967b706d19	0.65	PubMed	17502486	These data suggest that in other brain regions, p-ERK may play an essential role in the hyperphosphorylation of Tau.	p(FPLX:ERK, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6eefe428-445a-4911-93a4-17e4fac3fe61	0.65	Other	sparser:Unknown	GSK-3 is an important serine/threonine protein kinase phosphorylating tau at the majority of AD-related sites xref .	p(HGNC:ERN1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
83dff625-2ad7-481a-bdd9-ecc0a2600bab	0.98	PubMed	20153279	New evidence suggests that endoplasmic reticulum (ER) stress will cause extensive phosphorylation of Tau protein.	p(HGNC:ESR1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
83dff625-2ad7-481a-bdd9-ecc0a2600bab	0.98	PubMed	18654482	The authors propose that Abeta oligomers cause ER stress, which in turn activates GSK-3beta, leading to increased phosphorylation of tau.	p(HGNC:ESR1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
83dff625-2ad7-481a-bdd9-ecc0a2600bab	0.98	PubMed	20143409	The authors propose that Abeta oligomers cause ER stress, which in turn activates GSK-3beta, leading to increased phosphorylation of tau.	p(HGNC:ESR1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
83dff625-2ad7-481a-bdd9-ecc0a2600bab	0.98	Other	sparser:Unknown	Suppressing the increased expression of miR-218 inhibits the ERα-induced tau hyperphosphorylation as well as the PTPα decline.	p(HGNC:ESR1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
83dff625-2ad7-481a-bdd9-ecc0a2600bab	0.98	PubMed	20155224	In parallel with ER stress biomarkers change, tau phosphorylation at Ser199, and Ser396 sites were down-regulated significantly in KA+S al neurons (5 and 10 muM), suggesting that KA induced ER stress modulates tau phosphorylation.	p(HGNC:ESR1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5a8b1456-a13e-4e62-b04b-86ea6b0e70fd	0.65	PubMed	8598097	Estradiol treatment decreased hippocampal injury, inhibited glycogen synthase kinase-3beta and decreased the hyperphosphorylation of Tau and the interaction of Tau with glycogen synthase kinase-3beta and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor.	a(PUBCHEM:5757)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0740c9c4-ba0c-497a-a4ba-96ecf71175c6	0.65	PubMed	18734048	Role of Dickkopf-1 (Dkk1), an Antagonist of the Wnt-beta-Catenin Signaling Pathway, in Estrogen Induced Neuroprotection and Attenuation of Tau Phosphorylation.	a(PUBCHEM:5991)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
057fa617-db02-4f17-ba4d-b69955eb9241	0.65	PubMed	18708763	Ethanol enhances tau phosphorylation.	a(PUBCHEM:702)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3b29eafc-01e7-465e-b048-95374622bbb6	0.99	Other	sparser:Unknown	Genetic suppression of Miro, an adapter protein essential for mitochondrial axonal transport, exacerbates the neurodegenerative phenotype in Drosophila expressing human tau, through a mechanism dependent upon phosphorylation of tau at S262 by PAR-1, the Drosophila homolog of MARK kinase ( xref ).	p(HGNC:F2R)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
3b29eafc-01e7-465e-b048-95374622bbb6	0.99	PubMed	18233622	More importantly, the initial phosphorylation of Tau by PAR1 at S262 and S356 sites is prerequisite for the subsequent multisite phosphorylation of Tau by other kinases, such as GSK-3beta and CDK5 XREF_BIBR.	p(HGNC:F2R)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
3b29eafc-01e7-465e-b048-95374622bbb6	0.99	PubMed	22952452	Blocking tau phosphorylation at Ser262 site by PAR-1 knockdown or by mutating the Ser262 site to unphosphorylatable alanine suppressed the enhancement of tau induced neurodegeneration caused by milton knockdown.	p(HGNC:F2R)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
3b29eafc-01e7-465e-b048-95374622bbb6	0.99	Other	sparser:Unknown	PAR-1 directly phosphorylates tau at S262 and S356.	p(HGNC:F2R)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
3b29eafc-01e7-465e-b048-95374622bbb6	0.99	Other	sparser:Unknown	This study shows that loss of axonal mitochondria promotes detachment tau from microtubules and enhances tau-mediated neurodegeneration, and tau phosphorylation at AD-related Ser262 by PAR-1 plays a critical role in this process.	p(HGNC:F2R)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
3b29eafc-01e7-465e-b048-95374622bbb6	0.99	PubMed	PMC7193149	PAR-1 directly phosphorylates tau at S262 and S356.	p(HGNC:F2R)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
2d0c1c86-465c-4205-bec8-59267c6be8d0	0.65	Other	sparser:Unknown	Recently, we showed in a Drosophila model that tau phosphorylation at Ser262 and Ser356 by PAR-1 stabilizes tau at the initial step of mismetabolism, thereby promoting tau toxicity [ xref ].	p(HGNC:F2R)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
17222607-265d-44d2-b8ad-a94b949e98f0	0.92	Other	sparser:Unknown	Here we report that nanomolar thrombin induced rapid tau hyperphosphorylation and aggregation in murine hippocampal neurons via protease-activated receptors, which was followed by delayed synaptophysin reduction and apoptotic neuronal death.	p(HGNC:F2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
17222607-265d-44d2-b8ad-a94b949e98f0	0.92	PubMed	PMC6824344	Here we report that nanomolar thrombin induced rapid tau hyperphosphorylation and aggregation in murine hippocampal neurons via protease-activated receptors, which was followed by delayed synaptophysin reduction and apoptotic neuronal death.	p(HGNC:F2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
17222607-265d-44d2-b8ad-a94b949e98f0	0.92	Other	sparser:Unknown	For example, thrombin causes Rho-dependent phosphorylation of tau and dephosphorylation of stathmin, leading to disassembly of peripheral MT network [ xref , xref ].	p(HGNC:F2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
80d4b460-6e5a-49a2-aa12-72b4e1550f30	0.65	PubMed	16897463	Moreover limited Tau phosphorylation by Fgf21 dependent AMPK and mTOR signaling, improved cognitive performance upon long-term CR restriction might also be due to maintenance of PSD95 positive cells and thus, neuronal plasticity.	p(HGNC:FGF21)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
51ed0db9-28e7-480a-8054-b6698e38fd57	0.65	PubMed	17706568	FGF-2 levels are increased in AD and it has been shown, in neural progenitor cells and in PC12 cells, that FGF-2 upregulation can increase GSK3 activity and induce the hyperphosphorylation of tau protein in various epitopes including S202, recognized by AT8.	p(HGNC:FGF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
7aac9782-f8ef-41ea-84ed-1f8967c77cf9	0.65	PubMed	20974364	MAP kina,; e, GSK3, and cdk5 all phosphory- late at least some of the hype ~ rphosphorylated sites of tau in vitro (2,19,27,37,41,47,50,53,59).	p(HGNC:FICD)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
915f6b8c-5bf7-4b2e-b7c4-74c53d42ea1e	0.65	PubMed	9696665	Injection of 12.5 nmol FK506 also significantly enhanced the phosphorylation of tau at Ser 262 (12E8 site), Ser 198, Ser 199, and/or Ser 202 (Tau-1 site) and Ser 396 and/or Ser 404 (PHF-1 site), without affecting total tau.	a(PUBCHEM:445643)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
954d732a-8e08-4806-badd-d209aef598c4	0.65	PubMed	11738041	have recently shown that FRAT1 overexpression in PC12 cells is neuroprotective and inhibits phosphorylation of tau and beta-catenin but that FRAT1 overexpression is a less-potent method of neuroprotection than ATP-competitive inhibitors of GSK-3.	p(HGNC:FRAT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6249b9cb-ced0-4d7e-b4e7-995eb127ff2f	0.65	Other	sparser:Unknown	In situ, FRAT-2 significantly increased GSK3 beta-mediated phosphorylation of tau at a primed epitope while not significantly affecting the phosphorylation of unprimed sites.	p(HGNC:FRAT2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1c478dd7-d677-4d13-831f-abb1bed7128b	0.88	Other	sparser:Unknown	Mechanism study demonstrated that FTO activated the phosphorylation of Tau in a mTOR-dependent manner because FTO activated mTOR and its downstream signaling and rapamycin blocked FTO-mediated phosphorylation of Tau.	p(HGNC:FTO)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1c478dd7-d677-4d13-831f-abb1bed7128b	0.88	PubMed	20300289	Lentivirus mediated knockdown of Fto reduced the phosphorylation of Tau protein whereas overexpression of FTO promoted the level of phosphorylated Tau in neurons.	p(HGNC:FTO)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	Fyn phosphorylates tau on tyrosine 18 ( xref ), and associates with phospho-tau (AT8) positive cells ( xref ).	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	PubMed	24646911	Tau phosphorylated by Fyn on Tyr18 [XREF_BIBR, XREF_BIBR] has been detected in the proportion of tangles in early AD brain [XREF_BIBR, XREF_BIBR].	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	PubMed	17200775	Tau phosphorylated by Fyn on Tyr18 [XREF_BIBR, XREF_BIBR] has been detected in the proportion of tangles in early AD brain [XREF_BIBR, XREF_BIBR].	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	PubMed	18612937	Tau is also phosphorylated at Tyr 18 by Fyn, and it has been postulated that tau and Fyn function together to regulate microtubule structure [XREF_BIBR].	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	PubMed	PMC17200775	Tau phosphorylated by Fyn on Tyr18 [ xref , xref ] has been detected in the proportion of tangles in early AD brain [ xref , xref ].	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	Tau is also phosphorylated at Tyr 18 by Fyn, and it has been postulated that tau and Fyn function together to regulate microtubule structure [ xref ].	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	Tau phosphorylated by Fyn on Tyr18 [ xref , xref ] has been detected in the proportion of tangles in early AD brain [ xref , xref ].	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	Studies have determined that human Tau Tyr18 and Tyr29 are phosphorylated by the Src-family tyrosine kinase Fyn (Williamson et al., xref ; Lee et al., xref ).	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	In this study we determined that human tau tyr18 was phosphorylated by the src family tyrosine kinase fyn.	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	Phosphorylation of tau at Y18 by the Fyn kinase was suggested to prevent the activation of the GSK-3β signaling cascade, thereby counteracting tau's inhibitory effect on anterograde fast axonal transport (Kanaan et al., xref ).	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	Taken together, these data suggest that miR-106b inhibits Aβ1-42-induced tau phosphorylation at Tyr18 by targeting Fyn.	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	Notably, Fyn can phosphorylate tau on tyrosine-18, a post-translational modification found only early in development and in a subset of hyperphosphorylated tau species in the AD brain ( xref ).	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	Other potential strategies include blocking protein-protein interactions that are required for Fyn to phosphorylate Y18 in tau, and targeting downstream consequences of this posttranslational modification.	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	PubMed	18364361	The tau dependent enhancement of excitotoxicity requires phosphorylation of tau at its Y18 residue, which is mediated by Fyn, but does not depend on interactions of Fyn with known Fyn binding domains in tau or on GluN2B/2B containing NMDARs.	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	We previously showed that the Src family non-receptor tyrosine kinases (SFKs) Fyn and Src phosphorylate tau on Tyr18 and that phospho-Tyr18-tau was present in AD brain.	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	PubMed	PMC7198215	In this study we determined that human tau tyr18 was phosphorylated by the src family tyrosine kinase fyn.	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	PubMed	25963821	Although tau-Fyn interactions appear to be primarily pathogenic in AD models (XREF_BIBR; XREF_BIBR), Fyn phosphorylation of tau at Y18 prevented anterograde axonal transport deficits caused by filamentous tau and the 6D isoform of tau, most likely by inhibiting the N-terminal phosphatase activating domain of tau (XREF_BIBR).	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	sparser:Unknown	Moreover, Fyn can hyperphosphorylate tau at tyrosine 18 (Y18) which accumulates in brains of AD subjects and of tau-overexpressing mice ( xref , xref , xref , xref ).	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
6b9f81a4-5571-4db4-a10c-71e06e6ac475	1.0	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f45a61aeb94fbb981fbec0d5c65d6fa4	No evidence text.	p(HGNC:FYN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
1c4a60dc-d1ca-4047-9087-46b9e1432604	0.65	PubMed	17236136	Folate deficiency further enhanced tau phosphorylation in both regions.	a(PUBCHEM:6037)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1d04c9ac-9672-4ba7-bdef-d7c1810baf8e	0.65	PubMed	22883624	Gab1 expression also enhances the phosphorylation of the PAR1 substrate TAU (XREF_FIG), indicating that Gab1 activates PAR1 in vivo.	p(HGNC:GAB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a7b665be-e68a-4aa3-bfe1-0178e5fe9eb9	0.86	PubMed	23724096	Based on this finding and along with the fact that Gab2 is the principal activator of the phosphatidylinositol 3-kinase signaling pathway XREF_BIBR, activation of which suppresses glycogen synthase kinase 3 mediated phosphorylation of tau and prevents apoptosis of confluent cells XREF_BIBR, Reiman et al hypothesized that Gab2 might function to protect neurons from neurofibrillary tangle formation and that a loss-of-function GAB2 haplotype would increase tau phosphorylation at sites abnormally phosphorylated in AD brains.	p(HGNC:GAB2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a7b665be-e68a-4aa3-bfe1-0178e5fe9eb9	0.86	PubMed	23525328	GAB2 and GSK3B (rs6438552, AA genotype) have been shown to increase Tau phosphorylation (XREF_BIBR, XREF_BIBR).	p(HGNC:GAB2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6c59254f-4046-4c7a-8eb2-8e2e5342cda2	0.95	PubMed	22235112	GABA (A) receptor activation promoted specific phosphorylation of Tau at the AT8 epitope (Ser-199/Ser-202/Thr-205) in cultures of mature cortical neurons.	a(PUBCHEM:119)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6c59254f-4046-4c7a-8eb2-8e2e5342cda2	0.95	PubMed	22235112	Increased Tau phosphorylation by GABA (A) receptor activity was associated with reduced Tau binding to protein phosphatase 2A and was dependent on Cdk5 but not GSK3beta kinase activity.	a(PUBCHEM:119)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6c59254f-4046-4c7a-8eb2-8e2e5342cda2	0.95	PubMed	17587763	GABA A receptor activation significantly increased tau phosphorylation at AT8 epitope (Ser199/Ser202/Thr205) in cultured cortical neurons.	a(PUBCHEM:119)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6c59254f-4046-4c7a-8eb2-8e2e5342cda2	0.95	PubMed	17587763	Interestingly, with pharmaceutical chemical library screening, several GABA A receptor modulators including anesthetics benzodiazepines and barbiturates were found to increase the interaction between tau and Pin1, but significantly promoted the phosphorylation of tau.	a(PUBCHEM:119)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6c59254f-4046-4c7a-8eb2-8e2e5342cda2	0.95	PubMed	12308552	Increased Tau phosphorylation by GABA (A) receptor activity was associated with reduced Tau binding to protein phosphatase 2A and was dependent on Cdk5 but not GSK3beta kinase activity.	a(PUBCHEM:119)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6c59254f-4046-4c7a-8eb2-8e2e5342cda2	0.95	PubMed	12308552	GABA (A) receptor activation promoted specific phosphorylation of Tau at the AT8 epitope (Ser-199/Ser-202/Thr-205) in cultures of mature cortical neurons.	a(PUBCHEM:119)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6c59254f-4046-4c7a-8eb2-8e2e5342cda2	0.95	PubMed	17237095	Aside from the aforementioned animal studies, Nykanen et al. demonstrated that tau phosphorylation may be modulated directly by the activation of the GABA A R [XREF_BIBR].	a(PUBCHEM:119)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ca8e4c5e-9381-44c0-a92b-20d99e1b8b93	0.65	Other	sparser:Unknown	Activated p38 MAPK polypeptide phosphorylates tau protein, producing a hyperphosphorylated tau response.	p(HGNC:GALNT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
274dd892-ff13-4d03-878b-538876dc452c	0.86	PubMed	15468764	We demonstrate, both by biochemical and ultrastructural analysis, that GC administration led to cytosolic and dendritic Tau accumulation in rat hippocampus, and triggered Tau hyperphosphorylation in epitopes related to its malfunction (Ser396/404) and cytoskeletal pathology (e.g., Thr231 and Ser262).	p(HGNC:GC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
274dd892-ff13-4d03-878b-538876dc452c	0.86	PubMed	11864246	Results from healthy, wild-type, middle aged rats show that chronic stress and GC induce abnormal hyperphosphorylation of TAU in the hippocampus and prefrontal cortex (PFC), with contemporaneous impairments of hippocampus- and PFC dependent behaviors.	p(HGNC:GC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
730d0ac9-cc7c-479e-871a-b4ce3e213ae0	0.65	PubMed	21243498	Dewaxed sections were stained with haematoxylin and eosin, luxol fast blue-Kluver Barrera, or processed for immunohistochemistry to glial fibrillary acidic protein (1:250; GFAP, Dako), phosphorylated neurofilament epitopes of 170 and 200 kDa (1:100 and 1:200, respectively; clones RT97 and BF10, Boehringer-Mannheim), betaA4 amyloid (1:5; Boehringer-Mannheim), tau and ubiquitin (1:50 and 1:200; both from Dako) and alpha-synuclein (1:1000; Chemicon).	p(HGNC:GFAP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
161fde3b-6e22-43a1-8f57-8d973489ca7e	0.86	Other	sparser:Unknown	We also analyzed the early phosphorylation of TAU by immunohistochemistry and western blot for AT180 (Threonine-231 and Serine-235) (Supplementary Fig.  xref ) and AT270 (Threonine-181) (Supplementary Fig.  xref ).	p(HGNC:GKN2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
161fde3b-6e22-43a1-8f57-8d973489ca7e	0.86	Other	sparser:Unknown	Using recombinant human tau phosphorylated by Chk1 and Chk2 in vitro, we first analyzed tau phosphorylation at the AD-related sites by Western blot with phospho-tau-specific antibodies.	p(HGNC:GKN2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5526e5c0-f228-4d0b-bcce-9292e556033c	0.65	Other	sparser:Unknown	Astrocyte-cultured media induce tau phosphorylation in primary murine neurons.	p(HGNC:GLMN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	Other	sparser:Unknown	TMAO is also found to promote tubulin assembly of glycogen synthase kinase-3beta-phosphorylated tau (1.6 mol phosphates/mol).	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	Other	sparser:Unknown	Glycogen synthase kinase-3beta (GSK3beta) is able to phosphorylate tau in a cellular context which could play a role in the formation of these NFT.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	PubMed	PMC9385766	Tau phosphorylation at the C-terminal tail region by glycogen synthase kinase-3beta increased its activity and promoted its self-aggregation markedly.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	PubMed	PMC4691443	Combined tau protein kinase II (TPK II), which consists of CDK5 and its activator (p23), and glycogen synthase kinase-3beta (GSK-3beta) phosphorylate tau to the PHF-form in vitro.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	Other	sparser:Unknown	Interestingly, the reduction of soluble Abeta oligomers, but not insoluble Abeta, significantly correlated with reduced tau phosphorylation by glycogen synthase kinase-3beta (GSK-3beta), a major tau kinase implicated previously in mediating Abeta toxicity.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	PubMed	PMC6177083	Glycogen synthase kinase-3beta (GSK3beta) is able to phosphorylate tau in a cellular context which could play a role in the formation of these NFT.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	Other	sparser:Unknown	When tau was phosphorylated by glycogen synthase kinase-3beta, most of these proteolytic processes were inhibited, except for the first cleavage at the Arg(155)-Gly(156) bond.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	Other	sparser:Unknown	Combined tau protein kinase II (TPK II), which consists of CDK5 and its activator (p23), and glycogen synthase kinase-3beta (GSK-3beta) phosphorylate tau to the PHF-form in vitro.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	Other	sparser:Unknown	Glycogen synthase kinase-3beta (GSK-3B) phosphorylates tau protein, and increased GSK-3B expression has been associated with neurofibrillary tangles.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	PubMed	PMC5198231	TMAO is also found to promote tubulin assembly of glycogen synthase kinase-3beta-phosphorylated tau (1.6 mol phosphates/mol).	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	Other	sparser:Unknown	Tau phosphorylation at the C-terminal tail region by glycogen synthase kinase-3beta increased its activity and promoted its self-aggregation markedly.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ea0ec4a-319c-4d65-ae28-d6c4360f7c83	0.95	Other	sparser:Unknown	We have investigated the effects of tau phosphorylation by glycogen synthase kinase-3beta (GSK-3beta) on tau filaments in an in vitro model system.	bp(GO:0050321)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a80b7292-f0b4-4071-92f4-3190608cf224	0.65	PubMed	18439393	We observed that disruption of ceramidase activity causes a selective rise in NMDA mediated responses in hippocampal slices, likely resulting from higher levels of GluN2B receptor activity, which probably triggers Tau hyperphosphorylation via a CaMKII pathway.	p(HGNC:GRIN2B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b87357ee-73f2-420a-8735-4d32a18445e7	0.98	PubMed	19026996	We also found that the activation of mGluR2 increases the phosphorylation of tau and that the specific activation of mGluR2 reduces oxidative stress mediated cytotoxicity in neuronal cells.	p(HGNC:GRM2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b87357ee-73f2-420a-8735-4d32a18445e7	0.98	PubMed	19026996	In the present study, we found that mGluR2 activation increased tau phosphorylation in primary neurons (XREF_FIG).	p(HGNC:GRM2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b87357ee-73f2-420a-8735-4d32a18445e7	0.98	PubMed	10023190	We also found that the activation of mGluR2 increases the phosphorylation of tau and that the specific activation of mGluR2 reduces oxidative stress mediated cytotoxicity in neuronal cells.	p(HGNC:GRM2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b87357ee-73f2-420a-8735-4d32a18445e7	0.98	Other	sparser:Unknown	This is consistent with our findings in the AD brain showing co-localization of mGluR2 and hyperphosphorylated tau ( xref ).	p(HGNC:GRM2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b87357ee-73f2-420a-8735-4d32a18445e7	0.98	PubMed	18767475	In the present study, we found that mGluR2 activation increased tau phosphorylation in primary neurons (XREF_FIG).	p(HGNC:GRM2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b87357ee-73f2-420a-8735-4d32a18445e7	0.98	PubMed	18767475	We also found that the activation of mGluR2 increases the phosphorylation of tau and that the specific activation of mGluR2 reduces oxidative stress mediated cytotoxicity in neuronal cells.	p(HGNC:GRM2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
54bd833a-bc70-48b4-8ec0-126c20570014	0.65	PubMed	17640395	Tau dephosphorylation is inhibited by the two-electron reductants NAC and GSH ester but not by SOD1.	a(CHEBI:16856)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e1d03f39-83cb-4907-976e-b9701650c115	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9e8c53855b9bae9bcd962103edf061b9	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
e1d03f39-83cb-4907-976e-b9701650c115	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_c14c94011b12606354e40a62e413df28	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
2e524c29-926b-42a8-8b52-fadbbb1cf5ce	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_0a9abf3f4335064040e826a21773385e	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 369))
2c743b78-2f6f-4e13-a8ea-6d504abfaadc	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_24a4af2fccbc2deaddc24901eb2ee027	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
8f3a4d92-0313-4de1-a63c-19461f055cd1	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_23cead063d32f14fda4e74daf24d8b2f	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 501))
abde6a20-7549-4251-b8fc-2406a69d3ebf	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b494940736d49ca8e3e030f6a5b76b64	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 512))
2edb6c8e-347a-4ddb-b7e1-26c0db768b72	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_5cfac0fbf3597717706b32ef0eb47fc5	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 515))
096b3ff1-6af3-4b55-b1a1-0939990a4658	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_339fef55c7857b5a8c35b34f6f6fd8f9	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
f941261d-2349-4b4d-ab06-ef107d75ac81	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_0efd3c14dbb272e229daf210e2d8c24a	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
6c2d244b-a76e-4c2e-b14b-892895c55035	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b72e4cf94478d4b442ec0ecfd52d7e6c	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 552))
447c1767-9a40-458a-a1c3-ad71a546ab8d	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_01107bd514df818e68e027640ea244ff	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
09d6b782-f41b-442d-9fc5-7448cfa22995	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b938f29e0a5f29079e77a8e71e462c84	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
dc937a11-b3a6-4675-a7fe-7fcaf6a42181	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_02bfe64ebe3b283fb2d1f9691f080247	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
dc937a11-b3a6-4675-a7fe-7fcaf6a42181	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_37f93f9e67e54fd13bed233c16b55123	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
dc937a11-b3a6-4675-a7fe-7fcaf6a42181	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_1ee74073d6df5c66fd29ace4aeb1de72	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
3cee3f58-0782-4983-b797-0a07133572aa	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d9296e61c66cefd3300f65a0e0ad508c	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
3cee3f58-0782-4983-b797-0a07133572aa	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a1d54753d18e910192a3d0388d2ca6c2	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
3cee3f58-0782-4983-b797-0a07133572aa	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_027b5e03e544390000a419baaa1b771a	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
3cee3f58-0782-4983-b797-0a07133572aa	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b5562188be1891bee14ef506a8dc0cd6	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
355e21fa-1edf-493a-8a54-09142c3aff88	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_849594f0482bf3c1089733e34bb1cf08	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 173))
cdea193d-bdeb-4b79-bebc-d1a8975cd0c7	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_df740203651ad4ea972ff08c89db3900	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
57ae3214-5402-4a0c-a811-b13edcbc7499	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_4c2d6a7b95f2febef6a9d6843ccc966c	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
eb856d5e-0d00-4862-b6c9-1d360c83711f	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_94e96203f710aff9d08cf203a121156f	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
eb856d5e-0d00-4862-b6c9-1d360c83711f	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_4794cafad61b782461b33620d476fae4	No evidence text.	p(UP:A6QLB8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
5ed906a3-aba9-4e06-9e06-e6f5eb8531e6	0.65	PubMed	17679471	XREF_BIBR, XREF_BIBR Decreased phosphorylation of GSK-3alpha and GSK-3beta, which increase tau phosphorylation, was found, and the extent of this decrease was strongly correlated with the levels of gamma-C-terminal fragment.	p(HGNC:GSK3A, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a437e9d2-221e-453b-beb0-3367554c009e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8e6f1c3367c17fd4662d463a9ac730e3	No evidence text.	p(HGNC:GSK3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
b6e399f5-a586-473d-bb14-c66cb7fcbd20	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b6a6e3c03dc1ee0775aa5f544e6adc0e	No evidence text.	p(HGNC:GSK3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
17cba7a3-47aa-4da8-aabd-3ae6b13b7789	0.97	Other	sparser:Unknown	GSK3α phosphorylates tau at serine 262 while GSK3β phosphorylates tau at threonine 231 after priming by CDK5 ( xref ).	p(HGNC:GSK3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
17cba7a3-47aa-4da8-aabd-3ae6b13b7789	0.97	PubMed	18623547	GSK3alpha phosphorylates tau at serine 262 while GSK3beta phosphorylates tau at threonine 231 after priming by CDK5.	p(HGNC:GSK3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
17cba7a3-47aa-4da8-aabd-3ae6b13b7789	0.97	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_370c2777fc4e66fa94a6abc00fe0d57a	No evidence text.	p(HGNC:GSK3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
f929a597-37e5-43a7-a40b-f85dcf73dc11	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_bf5b86576a573e11f191834996bb67b6	No evidence text.	p(HGNC:GSK3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
500cf632-87cb-472c-8406-1b3670e14af1	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_6a44d00725cdda1ac80282f4643afdf3	No evidence text.	p(HGNC:GSK3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
2b83a418-28cc-4f42-ab23-153be57f3eea	0.86	PubMed	25219467	We found that overexpression of GSK-3beta increased tau phosphorylation at Ser199, Thr205, and Ser396 (A).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
2b83a418-28cc-4f42-ab23-153be57f3eea	0.86	PubMed	16420965	They demonstrated by both sequential immunofluorescence and immunoblotting that over-expression of GSK-3beta had caused increased Tau phosphorylation at Ser396 and Ser404.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
61482e5c-0e17-4882-a32e-0c610e1cd7fc	0.65	PubMed	14636889	We wanted to understand whether dephosphorylation of GSK3beta through down-regulation of Akt and PKB, presumably by the Swedish amyloid precursor protein gene, could activate GSK3beta and subsequently lead to hyperphosphorylation of tau.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
cc22bde2-d4b2-4a9d-a066-d022c03ccae9	0.65	PubMed	20847424	Phosphorylation and inactivation of GSK-3beta, suppresses GSK-3beta-dependent phosphorylation of tau at residues overphosphorylated in AD and prevents apoptosis of confluent cells.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
43aca6a8-3652-403d-bb6b-d8825ac2ee98	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ae94d1ba1d47aa4585df85edb131f3fe	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
d751e4e3-31ec-4350-90d1-f9676a636de6	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2bd39a00ae8748ccee897fc7190fc338	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
c4206ef3-dc23-4e7b-a26a-f51efe438fbb	0.93	Other	sparser:Unknown	GSK-3 β can phosphorylate tau on Ser 199 , Thr 231 , Ser 396 , Ser 400 , Ser 404 , and Ser 413  in vivo and in vitro (numbered according to the longest tau isoform), residues that are mostly phosphorylated in PHF-tau [ xref ].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 400))
c4206ef3-dc23-4e7b-a26a-f51efe438fbb	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2c708cc8e4a91af6231193434f768432	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 400))
87ae1fac-29dc-47a7-8b6b-9f99f7982241	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_4517a075746b5340d45667e19274c836	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 46))
0f7a734d-84fe-49e2-bee3-52a85919d5fc	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_1f96c3f5ffa4664dea2ba2dae90966ab	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 512))
a0571028-4ad0-4559-b95c-86cc9e4d519e	0.97	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_793bb777f7cfe2778138df0bb2711388	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
a0571028-4ad0-4559-b95c-86cc9e4d519e	0.97	PubMed	18828118	Finally, tau can be phosphorylated at serine 199 by GSK3beta and serine 202 by GSK3beta, and Cdk5, 2 putative tau kinases.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
a0571028-4ad0-4559-b95c-86cc9e4d519e	0.97	Other	sparser:Unknown	Finally, tau can be phosphorylated at serine 199 by GSK3β and serine 202 by GSK3β, and Cdk5, 2 putative tau kinases ( xref ).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
404dac56-9454-413d-b590-bafd61eb9b7f	0.97	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_1f9239bbc29d2ebee7f9e7c68a8d1257	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
404dac56-9454-413d-b590-bafd61eb9b7f	0.97	PubMed	18632914	Co-expressing GSK-3b with active JNK induced excessive phosphorylation of tau at Ser199, Ser202, Thr205, Thr212, Ser214, Thr231, Ser396, Ser400, Ser404 and Ser422 sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
404dac56-9454-413d-b590-bafd61eb9b7f	0.97	PubMed	24268883	Finally, tau can be phosphorylated at serine 199 by GSK3beta and serine 202 by GSK3beta, and Cdk5, 2 putative tau kinases (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
23121aa5-43a6-46a9-97b9-6fec51e0b1c2	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e16a0a8a2c7ccdf472880b7205ec8714	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 527))
eb791948-9178-4ab4-acc8-38743e5e98c3	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8069f099d5010ee1ab845124a2aa1c7a	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
eb791948-9178-4ab4-acc8-38743e5e98c3	0.93	PubMed	14241661	The extra GSK3beta activity led to expected increased phosphorylation of protein Tau, particularly at residues S262 and S396, which we must conclude to delay the aggregation of protein Tau in the brainstem of aging biGT mice.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
2d95a5c8-d8ab-463e-a154-37dc7b5826ff	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_762dac6b141b703ccb5f3f7f6f1ca7eb	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
29b0a667-3fdc-407d-813d-692963d42e5c	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e6ba90f66d3c00b86c7bc87fc43717f7	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 726))
1ec8a542-3a6d-4001-ab2b-2c04999d9d8b	0.93	PubMed	18708763	It has been reported that tau phosphorylation at Ser422 is not mediated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
1ec8a542-3a6d-4001-ab2b-2c04999d9d8b	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_be31985a2dfe53150d29b015f4be0c31	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
57597244-33cb-4915-a350-d11f1dff5d63	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_070614f2f2dc5ed7719273339ea7e386	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 153))
0a03f9d0-f750-46d9-8951-4ff14716aa1f	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9b547cd8e98e28118b44a1f5cbe930f3	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 492))
237fe23c-799b-458a-9cd6-e08e481e14c9	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_0b7559244324ee92285c55348f58c413	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
237fe23c-799b-458a-9cd6-e08e481e14c9	0.93	Other	sparser:Unknown	The two kinases GSK3-β and CDK5 phosphorylate tau at T 181 ( xref ).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
8e497541-b1eb-4cca-961e-6a6a120ef93d	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_636b015046e8fcefbf806ac35c9c5099	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 50))
3ec80ee6-cb7f-426a-8c58-2e81a0929dee	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9650998bf9f48b9a224746a4757bcdc2	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
b53498e9-9fb5-4bed-b99a-e0c1130da93b	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_44edfeaabbcfc095c1633ffcbef7712c	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
2933f149-706a-4035-a721-e477745f3a39	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8b40f5da821142f756978ef060c4a293	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
73d611dc-e175-4904-9334-a71d33fec26a	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_6a43a4c7894c631e09fb59edec060d30	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
73d611dc-e175-4904-9334-a71d33fec26a	0.99	PubMed	16846010	GSK3beta phosphorylates tau at Thr231 and primes residues in the C terminus of tau for subsequent phosphorylation, thereby providing a potential mechanism through which pathological tau phosphorylation and aggregation occurs [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
73d611dc-e175-4904-9334-a71d33fec26a	0.99	Other	sparser:Unknown	These results strongly indicate that phosphorylation of Thr231 in tau by GSK3beta plays a critical role in regulating tau's ability to bind and stabilize microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
73d611dc-e175-4904-9334-a71d33fec26a	0.99	PubMed	PMC7110675	These results strongly indicate that phosphorylation of Thr231 in tau by GSK3beta plays a critical role in regulating tau's ability to bind and stabilize microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
28725994-5a9c-4997-b5f8-91ff5c8b685e	0.65	PubMed	20991506	Supportive of this view is the fact that tau phosphorylation at proline directed sites by GSK-3 (upon co-transfection in non neural cells) abolishes the microtubule stabilizing effect which is observed in tau transfected cells <ce:cross-refs refid="BIB33 BIB34"> [33, 34] </ce:cross-refs>.	p(FPLX:GSK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Pro))
50a68866-a00a-4fe6-a085-91a83506cb31	0.65	PubMed	6902800	The treatment of tau by PKA and GSK-3 combination induced phosphorylation of tau at Ser 195, Ser 198, Ser 199, Ser 202, Thr 205, Thr 231, Ser 235, Ser 262, Ser 356, Ser 404, whereas Thr 181, Ser 184, Ser 262, Ser 356 and Ser 400 were phosphorylated by GSK-3 alone under the same condition.	p(FPLX:GSK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 515))
0f0482ae-26f4-4b17-823f-5d1379ae3dbb	0.86	PubMed	27036949	This is not surprising since calpain mediated proteolysis has been implicated in many neurodegenerative pathways including the processing of amyloid precursor protein to generate Abeta species and resulting synaptic dysfunction [XREF_BIBR, XREF_BIBR], cleavage and phosphorylation of tau by cdk5, GSK-3 and dual specificity tyrosine phosphorylation regulated kinase 1A DYRK1A [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR], and altered learning and memory abilities via processing of synaptic proteins and suppression of LTP [XREF_BIBR, XREF_BIBR].	p(FPLX:GSK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr))
0f0482ae-26f4-4b17-823f-5d1379ae3dbb	0.86	PubMed	16846345	This is not surprising since calpain mediated proteolysis has been implicated in many neurodegenerative pathways including the processing of amyloid precursor protein to generate Abeta species and resulting synaptic dysfunction [XREF_BIBR, XREF_BIBR], cleavage and phosphorylation of tau by cdk5, GSK-3 and dual specificity tyrosine phosphorylation regulated kinase 1A DYRK1A [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR], and altered learning and memory abilities via processing of synaptic proteins and suppression of LTP [XREF_BIBR, XREF_BIBR].	p(FPLX:GSK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr))
9b839713-9825-4ad4-af22-24e2faf38599	0.65	PubMed	14912541	Consistent with above studies using cultured neurons, we also observed that systemic GSNO treatment of transgenic mouse model of AD (APPSw and PS1 (dE9)) attenuated calpain mediated p35 proteolysis and Cdk5 and GSK-3beta activities as well as tau hyperphosphorylation.	a(PUBCHEM:104858)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9da267f8-92ca-4a93-94ed-472c4392dc67	0.86	PubMed	23362255	Here, we analyzed the interaction of Pin1 with Tau phosphorylated by Cdk5-p25 using a GST pulldown assay and Biacore approach.	p(FPLX:GST)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9da267f8-92ca-4a93-94ed-472c4392dc67	0.86	PubMed	13145872	Here, we analyzed the interaction of Pin1 with Tau phosphorylated by Cdk5-p25 using a GST pulldown assay and Biacore approach.	p(FPLX:GST)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f87b8399-da6a-424a-ad6a-12e9f9279909	0.65	PubMed	18356949	They found that neurons derived from APP Dp -iPSCs line and sAD2-iPSCs line have significantly higher levels of Abeta 40, increased phosphorylation of tau protein (at Thr 231) together with an elevated level of active glycogen synthase kinase-3beta (aGSK-3beta).	p(FPLX:GYS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
bd70fc7b-a16f-470f-9d59-730ba9543070	0.65	PubMed	20818790	In the mouse brain following transnasal treatment with EPO+IGF-I, in addition to neuroprotection we observed increased phosphorylation and activation of Akt (protein kinase B) and increased phosphorylation and inhibition of glycogen synthase kinase (GSK)-3beta, dramatically decreasing downstream hyperphosphorylation of tau.	p(FPLX:GYS, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2729bb89-074f-42ad-869c-7f88113e5400	0.86	PubMed	18787790	Phosphorylation by DYRK1A primes further phosphorylation of tau by glycogen synthase kinase 3 at Thr181, Ser199, Ser202, Thr205, and Ser208.	p(FPLX:GYS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
2729bb89-074f-42ad-869c-7f88113e5400	0.86	PubMed	21157379	Phosphorylation by DYRK1A primes further phosphorylation of tau by glycogen synthase kinase 3 at Thr181, Ser199, Ser202, Thr205, and Ser208 (XREF_BIBR, XREF_BIBR).	p(FPLX:GYS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
f6ca87af-7e0e-4877-878b-fe468400ad77	0.65	PubMed	20974364	Glycogen syn- thase kinase-3/3 phosphorylates tau protein at multiple sites in in- tact cells.	a(PUBCHEM:439177)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d2bb33de-e1f4-438d-baba-4be4cbfda64a	0.65	PubMed	11005189	PD98059 (2 '-amino-3 '-methoxyflavone) (ERK1 and ERK2 inhibitor) or SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl) 1H-imidazole] (p38 inhibitor) attenuated veratridine induced increased phosphorylation of glycogen synthase kinase-3beta and decreased phosphorylation of tau by approximately 54% and approximately 56%, as partial blockade by Go6976.	a(PUBCHEM:3501)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3ab3f4b6-e457-4283-a48b-1df5b47df4a0	0.65	PubMed	23962722	S1-S3) and HDAC6 expression enhances phosphorylation of tau at S262/356 (12E8 epitope), an effect that is blocked by mutation of K259/353 to mimic constitutive acetylation.	p(HGNC:HDAC6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5c58014e-6e41-4db4-a5a5-528e66c513dc	0.86	PubMed	18518820	Inhibition of HDAC6 attenuated tau phosphorylation at T231, a critical site in regulating tau function.	p(HGNC:HDAC6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
5c58014e-6e41-4db4-a5a5-528e66c513dc	0.86	PubMed	18636984	Inhibition of HDAC6 attenuated tau phosphorylation at T231, a critical site in regulating tau function (XREF_BIBR).	p(HGNC:HDAC6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
7fc51b85-ad03-4463-81b4-cf2fc2070df5	0.65	Other	sparser:Unknown	These results suggest H63D HFE increases tau phosphorylation via GSK-3β activity and iron-mediated oxidative stress.	p(HGNC:HFE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9b6d3b47-27c5-4d87-af71-a0d57e4fee18	0.65	PubMed	17543693	XREF_BIBR, XREF_BIBR It is possible that these abnormally high expressions of MAPT and the disturbed UPS could contribute to the hyperphosphorylation of MAPT in the Hp and eventually in the Cb too.	p(HGNC:HMBS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ee321ac-00a3-4d57-8876-3be903c1b7ab	0.65	PubMed	25959626	As shown in, increasing concentration of HO led to a significant reduction in GSK3beta Ser9 protein level, suggesting elevated GSK3beta activity and increased tau phosphorylation.	p(HGNC:HMOX1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
aedfc182-7d31-47a2-bd26-795e3da369b0	0.65	PubMed	21274924	Interestingly, p25 overexpression causes Tau hyperphosphorylation in cultured neurons and triggers neuritic dystrophy <ce:cross-ref refid="BIB56"> [56] </ce:cross-ref>.	p(HGNC:HRES1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
181fd4b6-b5aa-4480-a814-fac091e8b920	0.65	PubMed	20012499	To observe the effects of celastrol on Tau hyperphosphorylation induced by amyloid-beta peptides (Abeta) in SH-SY5Y neuroblastoma cells, the changes of Tau hyperphosphorylation and the expression of heat shock protein 90 (HSP90), HSP70 and heat shock factor 1 (HSF-1) in SH-SY5Y cells treated with Abeta	p(HGNC:HSF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e1e28811-bb75-4ed7-9f88-d6170a7387b6	0.86	PubMed	PMC17200775	It has been shown that Hsp90 promotes tau phosphorylation by its ability to regulate GSK-3β.	p(FPLX:HSP90)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e1e28811-bb75-4ed7-9f88-d6170a7387b6	0.86	Other	sparser:Unknown	It has been shown that Hsp90 promotes tau phosphorylation by its ability to regulate GSK-3β.	p(FPLX:HSP90)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7c3a2ecc-1858-4fd8-8cdc-98be41c0c1c1	0.86	Other	sparser:Unknown	Then, we transfected Bip-EGFP plasmid into HEK293 cells stably expressing the longest human tau (HEK293/tau) or N2a cells and found that increased Bip induced tau hyperphosphorylation via activating glycogen synthase kinase-3β (GSK-3β), an important tau kinase, and increased the association with tau and GSK-3β.	p(HGNC:HSPA5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7c3a2ecc-1858-4fd8-8cdc-98be41c0c1c1	0.86	Other	sparser:Unknown	In a recent study, it was found that overexpression of GRP78 induced tau hyperphosphorylation via activating glycogen synthase kinase-3β (GSK-3β), an important tau kinase in AD brain, and increased the association with tau and GSK-3β.	p(HGNC:HSPA5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5ce2f430-0cb5-4ff9-bb22-ada50450dfe5	0.99	Other	sparser:Unknown	Pb exposure induced substantial hyperphosphorylation of tau at serine 199/202 by 5 and 10 μg/dL Pb, and Threonine 231 at higher doses.	p(HGNC:HTN3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5ce2f430-0cb5-4ff9-bb22-ada50450dfe5	0.99	Other	sparser:Unknown	Pb exposure induced substantial hyperphosphorylation of tau at serine 199/202 by 5 and 10 μg/dL Pb, and Threonine 231 at higher doses.	p(HGNC:HTN3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5ce2f430-0cb5-4ff9-bb22-ada50450dfe5	0.99	PubMed	18444745	Second, Pb exposure results in hyperphosphorylation of tau which may subsequently result in cytoskeletal disruption in neurons.	p(HGNC:HTN3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5ce2f430-0cb5-4ff9-bb22-ada50450dfe5	0.99	PubMed	18444745	Pb at 5mug/dL substantially increased tau phosphorylation at AT8 and AT-180 sites, whereas, phosphorylation at these sites was not substantially affected by 20mug/dL Pb.	p(HGNC:HTN3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5ce2f430-0cb5-4ff9-bb22-ada50450dfe5	0.99	PubMed	17074941	In our experiments, we supposed that low levels of Pb exposure could induce accumulation of alpha-synuclein and excessive phosphorylation of tau, while promote ER stress, and stimulate apoptosis and autophagy, thereby affect the number and function of hippocampal neurons in rats, and reduce the ability of learning and memory in rats.	p(HGNC:HTN3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5ce2f430-0cb5-4ff9-bb22-ada50450dfe5	0.99	PubMed	17074941	Our results showed that Pb exposure can cause hyperphosphorylation of tau in CA1 in hippocampus.	p(HGNC:HTN3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
486266a1-3689-48f9-b912-f3b1b50276c6	0.65	Other	sparser:Unknown	Taken together, our data suggest that mutant huntingtin can induce abnormal tau hyperphosphorylation in vivo, via the deregulation of calcineurin.	p(HGNC:HTT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2ea7efd8-8668-47ca-887e-3be0a8791561	0.92	Other	sparser:Unknown	Other studies have confirmed that hypoxia could increase tau phosphorylation (Zhang et al., xref ; Yagishita et al., xref ).	p(HGNC:HYOU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2ea7efd8-8668-47ca-887e-3be0a8791561	0.92	Other	sparser:Unknown	We found in our study that hypoxia promoted the phosphorylation of tau protein via ERK pathway, which suggest hypoxia might be involved in the process of tau pathology.	p(HGNC:HYOU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2ea7efd8-8668-47ca-887e-3be0a8791561	0.92	Other	sparser:Unknown	Although acute hypoxia can also promote the phosphorylation of tau ( xref ), we could not find any link to ischemic/hypoxic damage in the fusiform gyrus and frontal cortex.	p(HGNC:HYOU1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
fb0a6b29-883e-45e6-8f84-73981b252835	0.65	PubMed	9339600	These results imply that Hcy may induce hyperphosphorylation of tau with PP-2Ac involved mechanism.	a(PUBCHEM:778)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
73f4a858-d1a0-441f-83c0-65090171b18f	0.65	PubMed	4597200	Heparin also promotes phosphorylation of tau by a number of protein kinases, prevents tau from binding to taxol stabilized microtubules, and produces rapid disassembly of microtubules assembled from tau and tubulin.	a(PUBCHEM:22833565)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
36eda896-5966-4401-b7b8-77c08151810a	0.65	Other	sparser:Unknown	Therefore, inhibition of A β -induced deficits of histone acetylation and hyperphosphorylation of tau is helpful to treat AD.	p(FPLX:Histone)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
634de0db-f5d2-47d4-b7e9-c5eb06fcaf02	0.86	PubMed	25128526	In AD brain, I2 (PP2A) is translocated from neuronal nucleus to cytoplasm, where it inhibits PP2A activity and promotes abnormal phosphorylation of Tau.	a(PUBCHEM:807)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
634de0db-f5d2-47d4-b7e9-c5eb06fcaf02	0.86	PubMed	14536223	In AD brain, I2 (PP2A) is translocated from neuronal nucleus to cytoplasm, where it inhibits PP2A activity and promotes abnormal phosphorylation of Tau.	a(PUBCHEM:807)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e32ef522-5c35-468b-95b2-b534509ac0bb	0.94	Other	sparser:Unknown	3xTgQ-/- mice showed similar amounts of fibrillar amyloid, reactive glia and hyperphosphorylated tau as the C1q-sufficient 3xTg at the ages analyzed.	p(HGNC:IAPP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e32ef522-5c35-468b-95b2-b534509ac0bb	0.94	Other	sparser:Unknown	Aβ and IAPP amyloid co-deposition increased tau phosphorylation, and a reduction in pancreatic β-cell mass was detected in islets.	p(HGNC:IAPP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e32ef522-5c35-468b-95b2-b534509ac0bb	0.94	Other	sparser:Unknown	Alzheimer's disease (AD) is a protein-misfolding disease characterized by accumulation of amyloid β (Aβ) peptides and hyperphosphorylated tau protein into plaques and neurofibrillary tangles, respectively [ xref ].	p(HGNC:IAPP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e32ef522-5c35-468b-95b2-b534509ac0bb	0.94	Other	sparser:Unknown	Alzheimer&apos;s disease (AD) is characterized by accumulation of two misfolded and aggregated proteins, β-amyloid and hyperphosphorylated tau.	p(HGNC:IAPP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
44828cf1-c46b-4f0f-b953-c264de8fdd68	0.65	Other	sparser:Unknown	Moreover, insulin/IGF negatively controls Aβ intracellular deposition, tau phosphorylation and degradation by IDE (Gasparini et al., xref , xref ).	p(HGNC:IDE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0c244d42-516e-4242-b0dc-f3426dd87540	0.99	Other	sparser:Unknown	As mentioned above, p44 +/+ transgenic mice display hyperphosphorylation of tau, synaptic deficits, and memory impairment ( xref ).	p(HGNC:IFI44)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0c244d42-516e-4242-b0dc-f3426dd87540	0.99	Other	sparser:Unknown	Here, we provide evidence that p44 promotes the phosphorylation of tau in the mouse.	p(HGNC:IFI44)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0c244d42-516e-4242-b0dc-f3426dd87540	0.99	Other	sparser:Unknown	In addition to the accelerated aging and reduced lifespan, p44 +/+ mice display hyperphosphorylation of the microtubule-binding protein tau, synaptic impairment, and premature cognitive decline (Pehar et al ., xref ).	p(HGNC:IFI44)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0c244d42-516e-4242-b0dc-f3426dd87540	0.99	PubMed	13936988	Here, we provide evidence that p44 promotes the phosphorylation of tau in the mouse.	p(HGNC:IFI44)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0c244d42-516e-4242-b0dc-f3426dd87540	0.99	PubMed	16901214	Here, we provide evidence that p44 promotes the phosphorylation of tau in the mouse.	p(HGNC:IFI44)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
05b7a836-7061-4d93-ba4c-3f14fd1057f9	0.98	PubMed	17203233	Similarly, levels of IRs, IGF-1R, IRS-1 and IRS-2 are reduced in AD brains [XREF_BIBR], which suggests that reduced insulin and IGF-1 signaling may result in the hyperphosphorylation of Tau by mediating protein phosphatase-2A (PP2A) and glycogen synthase kinase 3beta (GSK-3beta) [XREF_BIBR, XREF_BIBR].	p(HGNC:IGF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
05b7a836-7061-4d93-ba4c-3f14fd1057f9	0.98	PubMed	27061773	Disturbance in insulin or IGF-1 signaling pathways are reported to increase tau phosphorylation.	p(HGNC:IGF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
05b7a836-7061-4d93-ba4c-3f14fd1057f9	0.98	PubMed	27061773	Reduced insulin or IGF-1 signaling leads to the hyperphosphorylation of tau while stimulation by insulin and IGF-1 reduces its phosphorylation and promotes its binding to microtubules.	p(HGNC:IGF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
05b7a836-7061-4d93-ba4c-3f14fd1057f9	0.98	PubMed	18752365	Accordingly, it was previously shown that insulin and IGF-1 reduce tau phosphorylation promoting its binding to microtubules by inhibition of GSK-3beta via the PI3-K pathway.	p(HGNC:IGF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
05b7a836-7061-4d93-ba4c-3f14fd1057f9	0.98	Other	sparser:Unknown	In an Alzheimer’s mouse model, a protein restricted diet was shown to reduce IGF-1 and phosphorylated Tau, resulting in a decline in cognitive impairment and AD-related pathologies ( xref , xref ).	p(HGNC:IGF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
05b7a836-7061-4d93-ba4c-3f14fd1057f9	0.98	PubMed	18739332	On the other hand, impaired insulin or IGF-I signaling may result in hyper-phosphorylation of Tau due to the reduced activation of PI3-kinase and Akt signaling axis, which results in the release of the inhibition of multifunctional serine/threonine kinase GSK3beta.	p(HGNC:IGF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f66539ae-063d-4ad7-b63a-01cf1150ee33	0.86	PubMed	26637371	In AD brain, IGFBP-3 released from astrocytes is supposed to actually induce phosphorylation of tau in neurons.	p(HGNC:IGFBP3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f66539ae-063d-4ad7-b63a-01cf1150ee33	0.86	PubMed	18345764	In AD brain, IGFBP-3 released from astrocytes is supposed to actually induce phosphorylation of tau in neurons.	p(HGNC:IGFBP3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
da986590-f595-47af-a278-9d8c0902d660	0.65	PubMed	17279310	IL-18 has been recently shown to increase glycogen synthase kinase 3-beta (GSK-3b) and tau hyperphosphorylation.	p(HGNC:IL18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
29f17c3f-a9da-43aa-90f8-6e422f1e73b5	0.86	Other	sparser:Unknown	The early tau phosphorylation induced by IL-1alpha might create a plastic environment for morphological changes in astrocytes.	p(HGNC:IL1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
29f17c3f-a9da-43aa-90f8-6e422f1e73b5	0.86	PubMed	PMC6735759	The early tau phosphorylation induced by IL-1alpha might create a plastic environment for morphological changes in astrocytes.	p(HGNC:IL1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a5655242-2788-44c7-b9ff-d10bfa8b8e08	0.98	PubMed	16844413	Although IL-1beta has been shown to increase tau phosphorylation, amyloid has also been reported to promote astrocytic and microglial release of IL-1beta [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:IL1B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a5655242-2788-44c7-b9ff-d10bfa8b8e08	0.98	Other	sparser:Unknown	IL-1β released from microglia also increases Tau phosphorylation through a p38 MAPK pathway [ xref ].	p(HGNC:IL1B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a5655242-2788-44c7-b9ff-d10bfa8b8e08	0.98	PubMed	17081658	Additionally, IL-1beta treatment of microglia and neuron cocultures results in significant hyperphosphorylation of tau protein in the neuron [XREF_BIBR].	p(HGNC:IL1B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a5655242-2788-44c7-b9ff-d10bfa8b8e08	0.98	PubMed	18463245	XREF_BIBR Some studies have also demonstrated that IL-1beta induces Tau protein phosphorylation and triggers the formation of paired-helical filaments, thus aggregating into NFTs.	p(HGNC:IL1B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a5655242-2788-44c7-b9ff-d10bfa8b8e08	0.98	PubMed	17637060	Several studies have demonstrated that IL-1 beta can induce the phosphorylation of tau protein and hence mediate the formation of neurofibrillary tangles [e.g. XREF_BIBR, XREF_BIBR].	p(HGNC:IL1B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a5655242-2788-44c7-b9ff-d10bfa8b8e08	0.98	PubMed	18640938	Several previous in vitro studies demonstrated that microglial derived interleukin 1beta (IL1beta) could induce MAPT phosphorylation in neurons through a p38 MAPK dependent pathway.	p(HGNC:IL1B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
34372cfe-7fa2-4e2e-91f1-db9424860825	0.88	Other	sparser:Unknown	Intracerebral administration of LPS was shown to induce activation of cdk5 in the 3xTgAD mice [ xref ], whereas IL-6 induced tau-hyperphosphorylation through an increase in intraneuronal levels of p35 activator, and in cdk5 activity [ xref ].	p(HGNC:IL6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
34372cfe-7fa2-4e2e-91f1-db9424860825	0.88	PubMed	20245383	47 Moreover, other authors have shown that the application of IL-6 directly to rat hippocampal neurons promoted hyperphosphorylation of Tau protein and that this effect was dependent on cdk5 and p35 complex, one of the main kinases implicated in tau hyperphosphorylation in neurodegenerative diseases.	p(HGNC:IL6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4db41dc3-6a25-4d50-8bf8-db0567e50693	0.94	PubMed	18602180	ILK inactivation resulted in increased GSK3beta activity and hyper-phosphorylation of Tau.	p(HGNC:ILK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4db41dc3-6a25-4d50-8bf8-db0567e50693	0.94	PubMed	18602180	Depletion of ILK by stable transfection of kinase deficient ILK induced aberrant Tau phosphorylation.	p(HGNC:ILK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4db41dc3-6a25-4d50-8bf8-db0567e50693	0.94	PubMed	12629168	Consequently, ILK inhibition resulted in an increase in the hyperphosphorylation of Tau, a substrate of GSK-3.	p(HGNC:ILK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4db41dc3-6a25-4d50-8bf8-db0567e50693	0.94	PubMed	6736794	Consequently, ILK inhibition resulted in an increase in the hyperphosphorylation of Tau, a substrate of GSK-3.	p(HGNC:ILK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
921868bd-ec5b-44ae-b97e-39bb77282064	0.86	PubMed	18273361	It would be interesting in the future studies to perform comparative evaluations in both male and female mice after TBI exposure and determine any sex specific impact on blast induced phospholipid dysregulation development of Tau hyper-phosphorylation in different ApoE groups.	p(HGNC:IMPACT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
921868bd-ec5b-44ae-b97e-39bb77282064	0.86	PubMed	23962722	In agreement with results in transfected cells, pseudoacetylation of K259 and K353 (K259/353Q) completely prevented phosphorylation at the 12E8 epitope, though the K to R mutations on these residues (which mimic constitutive deacetylation) had no impact on the ability of PKA to phosphorylate tau in vitro.	p(HGNC:IMPACT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ebd624e1-1b01-4716-bf77-f14647205caa	0.65	PubMed	18487304	We hypotheses that the mechanism of IR on cognitive function may involve the following factors : 1) IR promotes the metabolism of Abeta and Tau hyperphosphorylation, resulting in sugar, fat, protein, and other metabolic disorders, and neuronal degeneration together with an impaired cognitive function under hyperinsulinemia; XREF_BIBR, XREF_BIBR 2) IR protein is rich in the specific learning and memory regions of the brain.	p(HGNC:INSR)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	17153629	Insulin and IGF-1 have been shown to reduce the phosphorylation of tau protein by inhibiting activity of GSK-3.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18745152	For example, insulin and insulin signaling pathways also inhibit the phosphorylation of tau, the main constituent of neurofibrillary tangles which correlate best with cognition in pathological aging.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18806575	Insulin in the brain can increase the deposition of Abeta and tau protein phosphorylation, which are central to the pathogenesis of LOAD.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	Other	sparser:Unknown	Therefore, we speculate that abnormal PI-3K pathway activation of glycogen synthase kinase-3β in an era of declining insulin caused tau protein phosphorylation to be increased in our model.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	17236136	In the present study, we also found tau hyperphosphorylation at Ser396 in hippocampus after STZ treatment in mice fed with the control diet, which further confirmed that insulin deficiency caused by STZ could increase phosphorylation of tau.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	Other	sparser:Unknown	Interestingly, insulin transiently promotes tau phosphorylation by activating GSK-3β in SH-SY5Y neuroblastoma cells and primary cortical neurons xref , xref .	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18511745	Insulin has been reported to promote hyper-phosphorylation of tau protein by increased activation of GSK-3beta [XREF_BIBR, XREF_BIBR].	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	17245783	Thus, diet induced insulin resistance accelerates beta-amyloid (Abeta) pathology XREF_BIBR, whilst peripheral insulin injection induces tau phosphorylation XREF_BIBR.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	17245783	However, in this study an acute insulin challenge (20 min peripheral injection) was shown to increase tau phosphorylation.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	21347323	Thus, diet induced insulin resistance accelerates beta-amyloid (Abeta) pathology XREF_BIBR, whilst peripheral insulin injection induces tau phosphorylation XREF_BIBR.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	21347323	In the first study, our data shows diet induced insulin resistance reduces tau phosphorylation at 3 epitopes, independent of APOE genotype.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	21347323	However, in this study an acute insulin challenge (20 min peripheral injection) was shown to increase tau phosphorylation.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18674497	Moreover, as insulin treatment prevented learning deficits, GSK3 activation and increased tau phosphorylation in STZ-diabetic mice, these disorders can be attributed to insulin deficiency and its consequences rather than any direct STZ neurotoxicity.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	17731932	Neuronal insulin resistance is associated with impaired amyloid clearance [XREF_BIBR] and increased tau phosphorylation in the human brain [XREF_BIBR] and in mouse models of T2D [XREF_BIBR].	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	27061773	The phosphorylation of tau is inhibited by apolipoprotein E, insulin and insulin like growth factor-1 (IGF-1).	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	17587502	In the present study, we treated 3xTg-AD mice, a commonly used transgenic model of AD which harbors three mutated transgenes (human PS1 M146V, APP SWE, and tau P301L), with propofol, a commonly used intravenous anesthetic in clinical practice, and investigated the effects of intranasal insulin on propofol induced hyperphosphorylation of tau.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	14363849	In addition, insulin signaling modulates phosphorylation of tau protein, an early component in the development of Alzheimer disease.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18362237	In contrast, insulin inhibits the GSK3beta activity to prevent generation of Abeta and hyperphosphorylated Tau [XREF_BIBR, XREF_BIBR].	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	15709063	In this study, we reported that insulin deficiency induced significant increase of tau phosphorylation.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	17587502	In order to investigate the effect of insulin on propofol induced hyperphosphorylation of tau, we delivered insulin intranasally to 3xTg-AD mice for 7 days prior to the administration of propofol.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18437246	Further, insulin deficiency promotes the phosphorylation of tau, leading to deteriorated accumulations of neurofibrillary tangles.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	19446884	The hyperphosphorylation of microtubule associated protein tau (tau) in the hippocampus can be caused by central and peripheral insulin resistance and these alterations are related to the development of tauopathies, such as Alzheimer 's disease.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18838832	Insulin has also been shown to increase tau phosphorylation.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	19931251	Moreover, as insulin treatment prevented learning deficits, GSK3 activation and increased tau phosphorylation in STZ-diabetic mice (XREF_BIBR), these disorders can be attributed to insulin deficiency and its consequences rather than any direct STZ neurotoxicity.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	16990017	Involvement of other factor will be needed to develop AD based on changes in GSK3 activity and hyperphosphorylation of tau protein induced by lack of insulin signaling in the brain.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	Other	sparser:Unknown	Hong et al. (1997) demonstrated a decrease in tau phosphorylation by insulin and IGF-1 and promotes binding of tau to microtubules by inhibition of GSK-3β through phosphoinositide 3-kinase pathway in human neuronal cultures [ xref ].	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	22910909	Hyperphosphorylation of Tau induced by naturally secreted amyloid-beta at nanomolar concentrations is modulated by insulin dependent Akt-GSK3beta signaling pathway.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	22910909	The mechanism underlying the Abeta induced Tau hyperphosphorylation is mediated by the impaired insulin signal transduction because we demonstrated that the phosphorylation of Akt and GSK3beta upon insulin stimulation is less activated under this condition.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18651770	Insulin resistance potentially promotes abnormal phosphorylation of tau in cognitively healthy middle aged APOE epsilon4 carriers.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	15964100	These results suggest that reduced insulin signaIing may increase hyperphosphorylation of tau, one of the neuropathological hallmarks of AD.Low brain insulin may also influence CNS levels of Abeta, a second hallmark of AD.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	17497011	GSK-3beta acts as both the insulin cascade kinase and the primary kinase phosphorylating Tau [XREF_BIBR, XREF_BIBR].	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	Other	sparser:Unknown	GSK-3β acts as both the insulin cascade kinase and the primary kinase phosphorylating Tau [ xref , xref ].	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	19311097	Interestingly, insulin injection 30minutes before sacrifice partially restored tau phosphorylation to control levels in both STZ injected groups.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18253332	Interestingly, insulin injection 30minutes before sacrifice partially restored tau phosphorylation to control levels in both STZ injected groups.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18821413	With regard to tau biology, insulin deficiency has been shown to promote pathological phosphorylation of tau in various models of insulin dysfunction.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18253332	Insulin deprivation induces PP2A inhibition and Tau hyperphosphorylation in hTau mice, a model of Alzheimer 's disease like tau pathology.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18317863	Interestingly, changes in insulin signalling may not only increase the oxidative stress and promote synaptic loss, but also increase the hyperphosphorylation of Tau protein by regulating Tau protein kinases and phosphatases.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	14104854	Overall, most published studies showed that insulin dysfunction can promote Tau hyperphosphorylation and pathology, both directly and indirectly, through hypothermia.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
28a839a8-596a-4a53-9cb3-2ec2f7c77a83	1.0	PubMed	18651517	On the other hand, AbetaPP oligomers and ADDLs inhibit neuronal insulin stimulated signals, blocking PI3 kinase activation of Akt, which leads to impaired survival signaling, increased activation of GSK-3beta, and resultant hyper-phosphorylation of tau.	p(HGNC:INS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
32ad3b93-0532-46a2-9bae-de50dfef07c3	0.65	PubMed	17308813	However, strikingly, one of these candidates, the inositol 1,4,5-trisphosphate 3-kinase B (ITPKB), was recently shown to induce both Abeta aggregation and TAU phosphorylation in 5XFAD mice (APP K670N and M671L (Swedish) + I716V (Florida) + V717I (London), and PS1 M146L+ L286V) (Stygelbout etal, 2014).	p(HGNC:ITPKB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c4d3e6bd-3055-4f1c-991a-ae99f3e62036	0.65	PubMed	8480283	The mitogen activated protein (MAP) kinase SAPK and JNK phosphorylates tau protein at many of its proline directed serine/threonine residues in vitro and is a likely candidate kinase to phosphorylate the pathologically relevant S422 site on tau.	p(FPLX:JNK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Pro))
1343b0d0-bdb2-4507-ae19-431d7b5e95c5	0.65	PubMed	22049801	As reported, KE fed animals showed improvements in behavior and learning and had significantly lower amounts of amyloid-beta (Abeta) and phosphorylated Tau (p-Tau) proteins in regions of the hippocampus.	a(PUBCHEM:7010502)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2dacfa1a-371c-4346-bb51-9a9344e4acc2	0.65	PubMed	22272245	Previous studies in our lab showed that KLC1 reduction in mice leads to altered localization and phosphorylation of Tau while KLC1 heterozygous animals also expressing a human APP transgene exhibit increased brain Abeta, two phenotypes associated with AD XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:KLC1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e831623c-ccaf-4a08-b288-e2282bb7b4c2	0.86	PubMed	20663292	Taken together, we believe that amyloid-beta (Abeta), through its activation of microglia and astrocytes (discussed below), induces the upregulation of the toxic intermediates of the KP that produce further oxidative stress, excitotoxicity, and tau phosphorylation.	a(PUBCHEM:171204)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e831623c-ccaf-4a08-b288-e2282bb7b4c2	0.86	PubMed	18641003	Taken together, we believe that amyloid-beta (Abeta), through its activation of microglia and astrocytes (discussed below), induces the upregulation of the toxic intermediates of the KP that produce further oxidative stress, excitotoxicity, and tau phosphorylation.	a(PUBCHEM:171204)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
76ac0f14-6e11-45c0-97ba-612eb999405f	0.86	PubMed	25950000	TTBK2 is another serine/threonine protein kinase of the CK1 superfamily that is able to phosphorylate both tau and tubulin [XREF_BIBR - XREF_BIBR].	p(HGNC:KRT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
76ac0f14-6e11-45c0-97ba-612eb999405f	0.86	PubMed	18057174	It was previously shown that CK1 phosphorylation of tau initiates a decrease in the fraction of bundled tau bound to microtubules and that tau residue Ser396 is one of the essential phosphorylation sites for this event.	p(HGNC:KRT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0b110b3a-184f-484b-add9-5d31fe05500b	0.86	PubMed	20155224	Melatonin Mitigates Kainic Acid Induced Neuronal Tau Hyperphosphorylation and Memory Deficits through Alleviating ER Stress.	a(PUBCHEM:10255)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0b110b3a-184f-484b-add9-5d31fe05500b	0.86	PubMed	20155224	Melatonin Mitigates Kainic Acid Induced Memory Deficits and Tau Hyperphosphorylation.	a(PUBCHEM:10255)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8d3a4503-c86b-41a5-a9ea-c237800d8279	0.65	PubMed	19783039	Moreover, using double immunofluorescence staining, AD brain displayed an increase in the autophagy SQSTM1 and p62 and LC3 positive vesicles and the lysosomal marker LAMP1 that also co-localized with GMF, Abeta and hyperphosphorylated p-tau.	p(HGNC:LAMP1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
168299f2-66d3-4eff-9b00-c692ffabeee0	0.86	PubMed	13636730	We have reported that altered leucine carboxyl methyltransferase (LCMT1)-dependent PP2A methylation is associated with down-regulation of PP2A holoenzymes containing the Balpha subunit (PP2A and Balpha) and subsequent accumulation of phosphorylated Tau in N2a cells, in vivo and in AD.	p(HGNC:LCMT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
168299f2-66d3-4eff-9b00-c692ffabeee0	0.86	PubMed	23943618	We have reported that altered leucine carboxyl methyltransferase (LCMT1)-dependent PP2A methylation is associated with down-regulation of PP2A holoenzymes containing the Balpha subunit (PP2A and Balpha) and subsequent accumulation of phosphorylated Tau in N2a cells, in vivo and in AD.	p(HGNC:LCMT1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ba3182b8-1a2f-412b-b34d-50b05dd8ed79	0.98	PubMed	18524835	Thus it appears that leptin and insulin can modulate phosphorylation of tau at multiple AD related sites.	p(HGNC:LEP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ba3182b8-1a2f-412b-b34d-50b05dd8ed79	0.98	PubMed	18643563	Leptin Reduces the Accumulation of Abeta and Phosphorylated Tau Induced by 27-Hydroxycholesterol in Rabbit Organotypic Slices.	p(HGNC:LEP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ba3182b8-1a2f-412b-b34d-50b05dd8ed79	0.98	PubMed	18733650	This was based on the following : Leptin and the cell-permeable AMPK activator, 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR), reduced tau phosphorylation at AD-relevant sites similarly to the GSK-3beta inhibitor, lithium chloride (LiCl).	p(HGNC:LEP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ba3182b8-1a2f-412b-b34d-50b05dd8ed79	0.98	PubMed	19429119	Leptin Inhibits Glycogen Synthase Kinase-3beta to Prevent Tau Phosphorylation in Neuronal Cells.	p(HGNC:LEP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ba3182b8-1a2f-412b-b34d-50b05dd8ed79	0.98	PubMed	19429119	This was based on the following : Leptin and the cell-permeable AMPK activator, 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR), reduced tau phosphorylation at AD-relevant sites similarly to the GSK-3beta inhibitor, lithium chloride (LiCl).	p(HGNC:LEP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ba3182b8-1a2f-412b-b34d-50b05dd8ed79	0.98	PubMed	19429119	In summary, the findings of the present study suggest that Leptin and its downstream signaling protein, AMPK (stimulated by AICAR) [XREF_BIBR, XREF_BIBR], reduce phosphorylation of tau by inhibiting GSK-3beta; thereby supporting a putative signaling cascade whereby Leptin modulates tau phosphorylation via AMPK [XREF_BIBR, XREF_BIBR].	p(HGNC:LEP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ba3182b8-1a2f-412b-b34d-50b05dd8ed79	0.98	Other	sparser:Unknown	The reduction of tau phosphorylation by leptin appears to be mediated through AMPK, Akt, and p38 pathways ( xref ; xref ).	p(HGNC:LEP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
831f8a8f-b5f9-414c-a571-51631777eeaf	0.65	PubMed	16872759	LC and LS also reduced tau phosphorylation at several sites, notably p-tau (Ser 396 and Thr 231), albeit less than LP.	p(HGNC:LIAS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5ed73750-68de-4caf-a75b-1a1e89423c6a	0.65	PubMed	PMC18439787	It has also been suggested that Gsk-3β is a mediator of 5-LOX-dependent MAPT phosphorylation in Tg2576 mice [ xref ].	p(HGNC:LOX)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dd096e1-a631-4b73-aa6e-0be3bc2cf51a	0.98	PubMed	6367849	Tau hyperphosphorylation in response to LPA is mediated by the activation of glycogen synthase kinase-3 (GSK-3).	p(HGNC:LPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dd096e1-a631-4b73-aa6e-0be3bc2cf51a	0.98	PubMed	6484877	In addition, LPA induces a GSK-3-mediated hyperphosphorylation of the microtubule associated protein tau.	p(HGNC:LPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dd096e1-a631-4b73-aa6e-0be3bc2cf51a	0.98	PubMed	18966241	LPA increases Tau phosphorylation (a commonly observed characteristic in AD brains) during LPA induced neurite retraction [XREF_BIBR].	p(HGNC:LPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dd096e1-a631-4b73-aa6e-0be3bc2cf51a	0.98	PubMed	21288824	Tau hyperphosphorylation in response to LPA is mediated by the activation of glycogen synthase kinase-3 (GSK-3).	p(HGNC:LPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dd096e1-a631-4b73-aa6e-0be3bc2cf51a	0.98	PubMed	21288824	</ce:para> <ce:para view="all"> To address this possibility, we took a pharmacological approach in which we investigated whether the interference with different elements located in the different putative LPA triggered pathways blocked LPA induced GSK-3 activation and Tau hyperphosphorylation (see <ce:cross-ref refid="FIG1"> Fig. 1 </ce:cross-ref> <ce:float-anchor refid="FIG1"/>).	p(HGNC:LPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dd096e1-a631-4b73-aa6e-0be3bc2cf51a	0.98	PubMed	21288824	The use of distinct signaling pathways by Galpha <ce:inf loc="post"> 12 </ce:inf> and Galpha <ce:inf loc="post"> 13 </ce:inf> to converge in a common effector has already been demonstrated in various other cell systems <ce:cross-refs refid="BIB67 BIB80 BIB81"> [67,80,81] </ce:cross-refs> </ce:para> <ce:para view="all"> Moreover, disorganization of the actin cytoskeleton, using Citochalasin D or latrunculin B, not only blocked neurite retraction but also inhibited Tau hyperphosphorylation and GSK-3 activation induced by LPA (unpublished data).	p(HGNC:LPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dd096e1-a631-4b73-aa6e-0be3bc2cf51a	0.98	PubMed	21288824	Provided that GSK-3 is activated by LPA in neuronal cells, hyperphosphorylation of Tau might be induced by LPA in AD brains <ce:cross-ref refid="FIG3"> </ce:cross-ref>.	p(HGNC:LPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dd096e1-a631-4b73-aa6e-0be3bc2cf51a	0.98	PubMed	21288824	</ce:simple-para> </ce:caption> <ce:link locator="gr1"/> </ce:figure> <ce:figure id="FIG2"> <ce:label> Fig. 2 </ce:label> <ce:caption> <ce:simple-para view="all"> Schematic model of the LPA induced regulation of GSK-3 activity and Tau hyperphosphorylation in neuronal cells.	p(HGNC:LPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dd096e1-a631-4b73-aa6e-0be3bc2cf51a	0.98	Other	sparser:Unknown	Transfection of the dominant-negative CREBs, K-CREB and A-CREB, failed to prevent LPA-induced tau phosphorylation and neurite retraction in differentiated Neuro2a cells.	p(HGNC:LPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
57c3518a-0d06-414d-b7cc-351d32acd7ac	0.95	PubMed	18093249	Conversely, Saa3 deficiency enhanced tau phosphorylation induced by systemic LPS administration.	a(CHEBI:16412)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
57c3518a-0d06-414d-b7cc-351d32acd7ac	0.95	PubMed	16279506	Here we show that 7days of LPS treatment in male C57BL/6J mice, which normally produces elevations in peripheral and central Abeta, also produces hyperphosphorylation of tau.	a(CHEBI:16412)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
57c3518a-0d06-414d-b7cc-351d32acd7ac	0.95	PubMed	12588153	Pentobarbital induced hypothermia or acute systemic LPS treatment in normal mice increased tau phosphorylation in hippocampal CA3 mossy fibers, as measured by immunohistochemistry, whereas acute A-705253 pretreatment prevented the stress induced tau hyperphosphorylation in both models.	a(CHEBI:16412)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
57c3518a-0d06-414d-b7cc-351d32acd7ac	0.95	PubMed	18640938	These findings demonstrate that LPS induces elevated endogenous MAPT phosphorylation that is dependent upon LPS dose and the presence and absence of CX3CR1.	a(CHEBI:16412)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
57c3518a-0d06-414d-b7cc-351d32acd7ac	0.95	PubMed	18640938	The present study demonstrates that a single dose of LPS, administered peripherally, is sufficient to induce MAPT hyperphosphorylation.	a(CHEBI:16412)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3b612e01-5c6b-4e32-9418-5b4933c2b367	0.86	PubMed	18791320	Unexpectedly, we observed robust phosphorylation of tau at T149 and T153 by G2019S LRRK2 when using Mg 2+ as the catalytic ion, but not when using Mn 2+ (XREF_FIG).	p(HGNC:LRRK2, var(p.Gly2019Ser))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 153))
3b612e01-5c6b-4e32-9418-5b4933c2b367	0.86	PubMed	18791320	Herein, we present in vitro evidence that MTs enhance phosphorylation of tau by both WT and G2019S mutant LRRK2 at the T149, T153, and T205 sites.	p(HGNC:LRRK2, var(p.Gly2019Ser))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 153))
0567c1e7-c494-41dd-897b-520a0512ad54	0.65	PubMed	24113872	Immunoblot analysis of cell lysates with total tau and pT149 tau antibodies confirmed that both tagged and untagged full-length WT and G2019S LRRK2 increased phosphorylation of tau at T149 in vivo by 8.4 +/-0.8-fold more (WT; P < 0.0001) and 7.5 +/-0.4-fold more (G2019S; P < 0.0001) than vector transfected control cells when normalized to total tau.	p(HGNC:LRRK2, var(p.Gly2019Ser))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 466))
1069e68e-4f26-4973-a928-cbdb61f32b7c	0.65	PubMed	18791320	In this work we provide in vitro evidence that MTs enhance the phosphorylation of tau at T149, T153 and T205 by both WT and G2019S mutant LRRK2 and show an MT dependent elevation of phosphorylation at the T181 site, but only with G2019S LRRK2.	p(HGNC:LRRK2, var(p.Gly2019Ser))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
1f5ba569-ccd5-4c9f-a438-665192d6afc0	0.94	PubMed	12511003	Additionally, we found LRRK2 I2020T enhanced tau phosphorylation in cultured cells co-expressing LRRK2-I2020T and 3 or 4 repeated tau.	p(HGNC:LRRK2, var(p.Ile2020Thr))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1f5ba569-ccd5-4c9f-a438-665192d6afc0	0.94	PubMed	22303461	In the present study, we demonstrated for the first time that (i) LRRK2 interacts with tau in a tubulin dependent manner; (ii) LRRK2 directly phosphorylates tubulin associated tau, but not free tau; (iii) LRRK2 phosphorylates tau at Thr181 as one of the target sites; and (iv) The PD associated LRRK2 mutations, G2019S and I2020T, elevated the degree of tau phosphorylation.	p(HGNC:LRRK2, var(p.Ile2020Thr))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1f5ba569-ccd5-4c9f-a438-665192d6afc0	0.94	PubMed	18935617	LRRK2 can directly phosphorylate tubulin associated tau directly, and G2019S and I2020T LRRK2 mutations increase tau phosphorylation.	p(HGNC:LRRK2, var(p.Ile2020Thr))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1f5ba569-ccd5-4c9f-a438-665192d6afc0	0.94	PubMed	12387058	In the present study, we demonstrated for the first time that (i) LRRK2 interacts with tau in a tubulin dependent manner; (ii) LRRK2 directly phosphorylates tubulin associated tau, but not free tau; (iii) LRRK2 phosphorylates tau at Thr181 as one of the target sites; and (iv) The PD associated LRRK2 mutations, G2019S and I2020T, elevated the degree of tau phosphorylation.	p(HGNC:LRRK2, var(p.Ile2020Thr))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
fe712c9f-5922-4eaa-9a27-8819fbb93b28	0.65	PubMed	22303461	However, we did not detect LRRK2 phosphorylation of tau at any Ser residues or at Thr205, nor did we observe any increase in the phosphorylation level of tau Thr205 upon overexpression of LRRK2 in SH-SY5Y cells (data not shown).	p(HGNC:LRRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
7925fee6-73c5-4efd-a47c-d4ecdcb950ef	1.0	PubMed	17973532	Another study using cultured cells has demonstrated that phosphorylation of tau at Thr181 and Thr231 is potently enhanced by LRRK2 [XREF_BIBR].	p(HGNC:LRRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
7925fee6-73c5-4efd-a47c-d4ecdcb950ef	1.0	Other	sparser:Unknown	Another study using cultured cells has demonstrated that phosphorylation of tau at Thr181 and Thr231 is potently enhanced by LRRK2 [ xref ].	p(HGNC:LRRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
7925fee6-73c5-4efd-a47c-d4ecdcb950ef	1.0	Other	sparser:Unknown	Kawakami and colleagues have shown that LRRK2 can phosphorylate tau at threonine 181 (T181) in a MT-dependent manner ( xref ); however, we failed to detect an enhanced phosphorylation of tau T181 in transgenic mice expressing human WT LRRK2 as compared to tau transgenic only mice ( xref ).	p(HGNC:LRRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
7925fee6-73c5-4efd-a47c-d4ecdcb950ef	1.0	PubMed	18791320	Concurring with our previous study, in the current study we found that WT LRRK2 was unable to phosphorylate the tau T181 epitope, regardless of the presence of MTs with and without Taxol (XREF_FIG).	p(HGNC:LRRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
7925fee6-73c5-4efd-a47c-d4ecdcb950ef	1.0	PubMed	18791320	The presence of Taxol did not enhance LRRK2 mediated phosphorylation of tau at T181 over the influence of MTs alone.	p(HGNC:LRRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
7925fee6-73c5-4efd-a47c-d4ecdcb950ef	1.0	Other	sparser:Unknown	Additionally, G2019S LRRK2 modestly phosphorylated tau at T181, only in the presence of MTs.	p(HGNC:LRRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
7925fee6-73c5-4efd-a47c-d4ecdcb950ef	1.0	Other	sparser:Unknown	Recent evidence suggests that the interaction of tubulin with LRRK2 and tau may be pivotal for the phosphorylation of tau by LRRK2 at T181 ( xref ); however, the authors provided no details regarding the influence of WT versus mutant LRRK2 on this phosphorylation event and no other phospho-epitopes were identified as targets of LRRK2 kinase activity.	p(HGNC:LRRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
bfdc38f8-07b1-4b63-a736-35197ccf304c	0.65	PubMed	24113872	In Drosophila, LRRK2 has been proposed to increase tau phosphorylation at T212 in a GSK-3beta dependent manner [XREF_BIBR].	p(HGNC:LRRK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
667dbb1b-e85d-4230-9675-fcc38a089d5f	0.65	PubMed	16850767	These studies showed that phosphorylation of tau is promoted by LTD inducing stimuli [XREF_BIBR, XREF_BIBR] and that phosphorylated tau is required for the formation of LTD [XREF_BIBR].	p(PFAM:PF00932)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
09690ebc-c364-4da3-85ad-b9d79d1503c0	0.95	PubMed	22764226	Acute administration of L-dopa induces changes in methylation metabolites, reduced protein phosphatase 2A methylation and hyperphosphorylation of Tau protein in mouse brain.	a(PUBCHEM:6047)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
09690ebc-c364-4da3-85ad-b9d79d1503c0	0.95	PubMed	22764226	In the folate deficient mouse model, L-dopa resulted in a marked depletion of SAM and increase in SAH in various brain regions with parallel down regulation of PP2A methylation and increased Tau phosphorylation.	a(PUBCHEM:6047)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
09690ebc-c364-4da3-85ad-b9d79d1503c0	0.95	PubMed	22764226	These findings reveal a novel mechanism involving methylation dependent pathways in which L-dopa induces PP2A hypomethylation and increases Tau phosphorylation, which may be potentially detrimental to neuronal cells.	a(PUBCHEM:6047)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
09690ebc-c364-4da3-85ad-b9d79d1503c0	0.95	PubMed	22764226	Our findings suggest a novel mechanism in which L-dopa increases phosphorylation of Tau protein, which has major implications for patients with PD or other neurodegenerative diseases.	a(PUBCHEM:6047)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
09690ebc-c364-4da3-85ad-b9d79d1503c0	0.95	PubMed	12687233	In the folate deficient mouse model, L-dopa resulted in a marked depletion of SAM and an increase in SAH in various brain regions with parallel downregulation of PP2A methylation and increased Tau phosphorylation.	a(PUBCHEM:6047)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a11e2d63-4b75-45cd-93fd-4441646fe214	0.65	PubMed	18360852	Furthermore, Li and co-workers observed increased phosphorylation of Tau in a mouse model of mutant LRRK2 [XREF_BIBR].	a(PUBCHEM:7010534)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a9a3c008-4195-4833-a38a-1fe571ef4cd1	0.65	PubMed	15441694	Liraglutide injection reversed the CSF insulin to ~ 1 mIU/L by the end of 8 weeks treatment, and prevented the hyperphosphorylation of tau protein in the hippocampal formation.	a(PUBCHEM:16134956)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1306739a-b8b3-45f9-9d8a-044c42a26f62	0.92	PubMed	5148158	Lithium reversibly reduced tau phosphorylation at therapeutic concentrations, and even at high concentrations did not alter neuronal morphology.	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1306739a-b8b3-45f9-9d8a-044c42a26f62	0.92	PubMed	22415718	Lithium has also been shown to decrease tau phosphorylation in tau transgenic models with advanced neurofibrillary pathology (XREF_BIBR).	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1306739a-b8b3-45f9-9d8a-044c42a26f62	0.92	PubMed	18708763	Lithium, a GSK-3beta inhibitor, which blocks ethanol induced caspase-3 activation, has been shown to reduce phosphorylation and aggregation of tau in a mouse model of Alzheimer 's disease.	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
02071ae5-502e-4a11-a5d1-9fa601b9d5cd	0.65	Other	sparser:Unknown	Tau-tubulin kinase-1 (TTBK1) phosphorylates microtubule-associated protein tau at specific serine/threonine residues found in paired helical filaments (PHFs), and its expression is up-regulated in the brain in Alzheimer disease, suggesting its role in tauopathy pathogenesis.	p(HGNC:MAP2K4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2baf4e98-90c8-4619-94a2-362d3e5ca7d4	0.65	PubMed	18677332	The findings of XREF_FIG suggest that the phosphorylation of MAP2 and Tau by the MAP2 bound PKA affects directly MT-MT interactions.	p(HGNC:MAP2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4ff0772d-c4ab-4267-a86e-392b9ac364d5	0.65	PubMed	20140913	Dimerization of beta-amyloid precursor protein (APP) activates the apoptosis signal regulating kinase1 (ASK1)-mitogen-activated kinase kinase 6 (MKK6)-p38 cascade, which subsequently phosphorylates tau, resulting in neurofibrillary tangles.	p(HGNC:MAP3K5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0323cb7c-a696-49a7-a50d-ebf5c11b0307	0.86	PubMed	21136848	Tau phosphorylated by SAPK2b and SAPK2a also reacted with AT8, whereas AT8 failed to recognise tau phosphorylated by SAPK1gamma.	p(HGNC:MAPK11)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0323cb7c-a696-49a7-a50d-ebf5c11b0307	0.86	PubMed	21136848	In contrast, phosphorylation of tau by SAPK2a and SAPK2b was markedly inhibited by heparin and dextran sulphate.	p(HGNC:MAPK11)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d6429740-7e6b-47f0-99cd-055e85d558bf	0.95	PubMed	9199504	No evidence text.	p(HGNC:MAPK12, pmod(Ph, Thr, 183), pmod(Ph, Tyr, 185))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
d6429740-7e6b-47f0-99cd-055e85d558bf	0.95	PubMed	9202310	No evidence text.	p(HGNC:MAPK12, pmod(Ph, Thr, 183), pmod(Ph, Tyr, 185))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
0cdc5dca-5ef2-4071-abe5-8d5a9bbe9412	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_6fde84acb266c523b4ea73f19e1c4daa	No evidence text.	p(HGNC:MAPK12)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
5ed44025-cbc5-4602-90ed-c874d7efe29a	0.95	PubMed	9199504	No evidence text.	p(HGNC:MAPK13, pmod(Ph, Thr, 180), pmod(Ph, Tyr, 182))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
5ed44025-cbc5-4602-90ed-c874d7efe29a	0.95	PubMed	9202310	No evidence text.	p(HGNC:MAPK13, pmod(Ph, Thr, 180), pmod(Ph, Tyr, 182))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
453d2189-2a76-466f-9f66-1e3402cccab4	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a8ec160c87af9b5a57f04ec034766685	No evidence text.	p(HGNC:MAPK13)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
74a01b14-8488-4e1c-9606-e23e09b01447	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_5c2314665fb7694c4a87b7d768037377	No evidence text.	p(HGNC:MAPK13)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
de24099f-a533-4250-8c69-4d0b6f40f3c2	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_4f08647fe2da38aa65e283c027a94e0a	No evidence text.	p(HGNC:MAPK13)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
651aeb56-bafa-4ad0-9083-36184191ad17	0.65	PubMed	21136848	In contrast, phosphorylation of tau by SAPK2a and SAPK2b was reduced in the presence of heparin (data not shown) and dextran sulphate (<ce:cross-ref refid="FIG3"> Fig. 3 </ce:cross-ref>).	p(HGNC:MAPK14)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a1ad9b45-ddf5-45ab-8654-a5cc08759972	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_39af4a867b0669b5baf83d013238e59b	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
f884df24-addc-4647-a5c5-4eef78d4d59e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_925a66f2c800cfbd0189f4214c540358	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
a04742c9-4cce-4eb7-82cb-be47477d0944	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_fd898f4cd425c1f062c643c962548d33	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 46))
a9789012-c1ce-4994-b334-3084d0033605	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_5197b4fee255b0faad6901c4f3556687	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 508))
15d85941-927c-4548-ac5f-b0507fcbf873	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7e6c963e63e5ce905411b7aa08f9ea95	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
9c4af8dd-2952-435b-a50e-1e723111c048	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_bfb54a375fb9b67815fd3daf05ce0ad6	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
cb1217b4-6ad5-4cce-9841-91a406214841	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7b903b991739849cd981e634a980f542	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
b53c0aeb-216a-4813-a8b9-9f74f05af811	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_49438103778ecf67b2ff16db20c971fe	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
a65e63b5-3e00-469e-9df1-9487065fa918	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_149ef62dd47c0ee9d1c1e20354464683	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 153))
136718ba-afba-4ed6-b500-1dc8a8cfe5a2	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_4254615ec14a1149d366fb7abc5408f8	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 492))
21f15313-d5a4-4d9e-8331-0b5c18c11f2f	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_14082ff52d2e4f59e230de2c7da788ee	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
562cabdc-3f25-4dd7-af93-d5590b517844	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_163156812683bcb5dad9e3fd86a43c72	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 50))
744a2c53-3001-4744-8269-8b7616280845	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_0da3b96cd05a14bac3d87291cc3873cb	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
f3517a3b-003e-4080-9c76-bfcee65647c2	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7dcaf61c28feb254fe88de2565b1ec4b	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
69772f2b-6cfe-4417-9412-60f5fe8c825e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_1ecb8ec1633c5f2dfdff30f9fe869ead	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
2ba9d523-510b-43de-9b53-e49a1c710168	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d34a5444bf770a8dced263cf5890ee0b	No evidence text.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
e9850a53-4630-40d2-8570-1ec4f0cb5ed2	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e4a8e48c95a13058d9f2316cb0a7f453	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
84dd8730-43d5-475b-945d-c60617aff24e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_39df58e2cdc14db8c34d31b168c18197	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
dd325dbd-1ac4-494e-bc36-6b379cbf3298	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_37342294ebae0eeae60bf5ec19449685	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 46))
1f0dc5c3-8a6a-4e08-b2ae-46ac79b347f8	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a710754bdb43f02b0790779b4368d71a	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
3cd5ca23-ad35-4bbd-ac7e-d5c1f15a6d83	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9f0d3088c1d2e13bcfc15bbb0be55355	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
13a28b13-bca5-46d2-975a-4085882caf3e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_62acb73f8d587d5247fb94d8425481ce	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
dc9f9ad5-e2f5-4199-a189-beee0f353c82	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_dec69fadad3af0689526c8e1a3350647	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
6b582b40-7c8d-407d-b841-15065bcd909a	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8aa2e9b0418c2695a316fe357336bf42	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 153))
cf7c75e3-02ba-4a54-9098-f99ab9146ed5	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d77de94e4e9960980fe25d72e86468c6	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 492))
8ef41ffe-4057-44f1-9a49-ea703d973ec7	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_3904eb7c99828864e80a4750d6730359	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
af3a3b0d-86d1-46ae-874b-be7a96dfefc6	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f9fb50564e3cdb1fb1b574802535c8b3	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 50))
f57ae820-0d91-4204-aef7-b02bc12126f8	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_923b3073479f87e6ac1b70e192e30c98	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
9de79933-786b-4c75-bcc4-6a02d799d4ce	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_1f3877eadb7e568dec5d9ee650f19415	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
41c1640d-9bfe-4266-aadd-cd5eace3e689	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_564fc32a11274f22db3906f88c61cbec	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
738cc881-ffcf-499c-817b-87975ca96e94	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9d8baa97a88253dc0746ec68c8e042e8	No evidence text.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
59791a16-ce42-440c-a81a-cc58f8309c92	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f13566b9e81adfb604351012317293ad	No evidence text.	p(HGNC:MAPK8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
b0a35fa5-250e-4e86-a2e6-a9528584931b	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_4bb63a2d471bf93ae3c5ba31d437e019	No evidence text.	p(HGNC:MAPK8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
4acb2e76-b7f5-478f-be0c-63e9d79bb66b	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_58cb635dc864ce9a6e09a630983a9d1a	No evidence text.	p(HGNC:MAPK8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
5e417118-7cfa-4416-82f6-11d12b8ec77c	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f6a37559b9d03d74448dc270cf4d8f02	No evidence text.	p(HGNC:MAPK8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
4e723fd9-e78f-4ca5-8fda-490fe8bac064	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_655d97bf77e35dd34b5968e4eae06c37	No evidence text.	p(HGNC:MAPK9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
c59ea74c-1aec-463a-8b7e-5ed1bb5457c4	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_50110bb49a848e5e7609c93dc720e597	No evidence text.	p(HGNC:MAPK9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
da68e4b5-3027-42d8-8661-e04af8fc7321	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e1e4266db4c7307990211577d6322236	No evidence text.	p(HGNC:MAPK9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
6af7d5f0-cc93-46a8-9ec2-acb637ca5aaa	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a4b1caec564d6d104393a62e05aef757	No evidence text.	p(HGNC:MAPK9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
3fcbf83d-4cc4-44fb-a6f1-f8bbb51442aa	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_48d24fc9adace9bc76203eb20289c78b	No evidence text.	p(HGNC:MAPK9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
523c1e04-8302-48f2-98e5-0c3d4e6f86de	0.86	Other	sparser:Unknown	PK40erk2 is a MAP kinase which phosphorylates recombinant hTau40 up to 14 moles of phosphate/mole, markedly slowing its electrophoretic mobility.	p(FPLX:MAPK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
523c1e04-8302-48f2-98e5-0c3d4e6f86de	0.86	PubMed	PMC3174271	PK40erk2 is a MAP kinase which phosphorylates recombinant hTau40 up to 14 moles of phosphate/mole, markedly slowing its electrophoretic mobility.	p(FPLX:MAPK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9c7f1bf7-d2f8-4443-bc0b-4820040a1da5	0.65	PubMed	18249585	Tau acetylation modulates tau phosphorylation status.	p(HGNC:MAPT, pmod(Ac))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
43faf1ca-eb72-41b4-8cd3-4afd537f32a0	0.65	PubMed	18424056	AD pathological markers exhibited a significant increase for beta amyloid protein (< 0.001), phosphorylated Tau protein and AD2 (< 0.001), phosphorylated neurofilaments and SMI -31 (= 0.019) and glial fibrillary protein GFAP (= 0.011).	p(HGNC:MAPT, pmod(Ph))	directlyIncreases	p(HGNC:GFAP, pmod(Ph))
3b488e2b-a04f-443a-8d0b-0c746d7f5fd3	0.65	PubMed	18057174	However, CK1 kinase often acts as a modulator of GSK-3 phosphorylation by prephosphorylating tau, resulting in a stronger phosphorylation of the same phosphorylation site by GSK-3, supporting our data that CK1 and GSK-3 inhibitors suppress the same sites.	p(HGNC:MAPT, pmod(Ph))	directlyIncreases	p(FPLX:GSK3, pmod(Ph))
85af37c5-2934-4ebd-83c3-c9f50d578e6e	0.65	PubMed	3918581	In vitro phosphorylation of tau by tau protein kinase I, a kinase responsible for abnormal phosphorylation of tau found in paired helical filaments of patients with Alzheimer 's disease, was enhanced by prior phosphorylation of tau by tau protein kinase II.	p(HGNC:MAPT, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9d808b31-6e33-420b-a686-bb0c82e1f3cb	0.65	PubMed	17711126	In addition, sumoylation of Tau protein promotes Tau phosphorylation and inhibits its ubiquitination, contributing to AD associated Tau hyperphosphorylation and accumulation.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a7a94719-c4a6-4dd2-963e-4724032fb2c3	0.65	PubMed	20235173	Therefore, we analyzed CRMP2 phosphorylation induced by TAU P301L (XREF_FIG E) and the possible effect of DMF.	p(HGNC:MAPT, var(p.Pro301Leu))	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
9a384c91-d9a1-4cea-b3bf-6e2b5e91ca63	0.65	PubMed	25331948	In addition, treatment of P301S mutant human Tau transgenic mice (transgenic Tau P301S) with (-)-nilvadipine reduces Tau hyperphosphorylation at several Alzheimer disease (AD) pertinent epitopes.	p(HGNC:MAPT, var(p.Pro301Ser))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a34342bd-dc73-47ab-b4cf-b4007332a010	0.65	PubMed	21319843	The phospho dependent Tau antibodies used in this study were as follows : Tau-1 (1:2000) (Chemicon), a monoclonal antibody specific for Tau sequence 192-204 in the absence of phosphate residues; AD2 (1:10,000), specific for phosphorylated Ser 396, 404 <ce:cross-ref refid="BIB36"> [36] </ce:cross-ref>; AT 180, specific for phosphorylated Thr 231; ADI 294 (1:1000), a monoclonal antibody specific for Tau proteins in their phosphorylated form, generated via collaboration with the Immunotech.	p(HGNC:MAPT)	directlyIncreases	a(PUBCHEM:46906074, pmod(Ph, Thr, 231))
493250ac-5c48-48da-887a-4ec6c1347aa2	0.65	Other	sparser:Unknown	They include isoform specific toxicity, ApoE ε4- mediated amyloid aggregation, ApoE ε4- mediated tau hyperphosphorylation, and isoform-driven ApoE concentration changes ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:APOE, pmod(Ph))
1bb32339-390e-49fa-bd09-1d9368de0bcd	0.86	Other	sparser:Unknown	Furthermore, ginsenoside Rb1 was shown to attenuate amyloid beta (25–35)-induced tau hyperphosphorylation in cortical neurons via inhibition of cyclin-dependent kinase-5 activity and through the c-Jun N-terminal kinase/p38 MAPK pathway (Chen et al., 2008; Song et al., 2008).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:APP, pmod(Ph))
1bb32339-390e-49fa-bd09-1d9368de0bcd	0.86	Other	sparser:Unknown	AZD0530 treatment also reduces microglial activation in APP/PS1 mice, and rescues Tau phosphorylation and deposition abnormalities in APP/PS1/Tau transgenic mice.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:APP, pmod(Ph))
75447640-b72a-4512-a640-4b35df4a9047	0.65	PubMed	17178742	A systematic characterization of Tau phosphorylation sites in Atg7 deficient neurons indicated that the pattern observed was similar to an early ' pre-tangle ' state that does not lead to formation of amyloid or fibrillar structures.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ATG7, pmod(Ph))
848bb1e1-82de-40f8-83a5-b5150dee0c5d	0.65	Other	sparser:Unknown	Previous studies showed that BAG2 overexpression reverses nicotine-induced tau phosphorylation, which is p38-dependent.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:BAG2, pmod(Ph))
3eb3e8da-fd74-4c60-8aa7-82fa9ae1977b	0.86	Other	sparser:Unknown	Interaction between complement cleavage component, C3a and C3a receptor and tau phosphorylation were also attenuated in rhDAF treated animals at 3 and 24 hours after BOP.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:C3, pmod(Ph))
3eb3e8da-fd74-4c60-8aa7-82fa9ae1977b	0.86	Other	sparser:Unknown	Interaction between complement cleavage component, C3a and C3a receptor and tau phosphorylation were also attenuated in rhDAF treated animals at 3 and 24 hours after BOP.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:C3, pmod(Ph))
065ea77b-b800-4e77-8155-b6ea5f1beb69	0.86	Other	sparser:Unknown	LC or LS treatment did not significantly alter tau phosphorylation in CA1 or CA3 as determined by IHC.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CA1, pmod(Ph))
065ea77b-b800-4e77-8155-b6ea5f1beb69	0.86	Other	sparser:Unknown	Our data also suggests an important role for modulation of JNK signaling in the E2 suppression of tau hyperphosphorylation in the hippocampus CA1 following cerebral ischemia.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CA1, pmod(Ph))
1d2499e1-f7e7-44ca-8697-dcb9f118a545	0.92	Other	sparser:Unknown	Alterations in glutamate levels associated with hyperactivation of cyclin dependent kinase 5 (Cdk5) signaling pathway downstream Tau phosphorylation may participate in the genesis of this pathological phenotype.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CDK5, pmod(Ph))
1d2499e1-f7e7-44ca-8697-dcb9f118a545	0.92	PubMed	PMC6643940	We have designed a moderate throughput for tau binding that relies on fluorescence detection in living cells and an in vitro cdk5/p25 tau phosphorylation high throughput screen.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CDK5, pmod(Ph))
1d2499e1-f7e7-44ca-8697-dcb9f118a545	0.92	Other	sparser:Unknown	We have designed a moderate throughput for tau binding that relies on fluorescence detection in living cells and an in vitro cdk5/p25 tau phosphorylation high throughput screen.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CDK5, pmod(Ph))
c14d02ac-ccfe-42fb-a5d1-70f01b9eee3a	0.98	Other	sparser:Unknown	More recently, it has been shown that A β oligomers cause abnormal tau phosphorylation and morphology changes of spines by missorting of endogenous tau into dendrites [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CHI3L1, pmod(Ph))
c14d02ac-ccfe-42fb-a5d1-70f01b9eee3a	0.98	Other	sparser:Unknown	We observed that Abeta1-42 oligomers increase tau phosphorylation and compromises cell survival through a mechanism mediated by GSK-3beta activation.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CHI3L1, pmod(Ph))
c14d02ac-ccfe-42fb-a5d1-70f01b9eee3a	0.98	PubMed	15989870	The levels of CSF alpha-synuclein, tau, phosphorylated tau, neurofilament light, and YKL-40, but not beta-amyloid42, increased in CSF over 2 years in PD.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CHI3L1, pmod(Ph))
c14d02ac-ccfe-42fb-a5d1-70f01b9eee3a	0.98	Other	sparser:Unknown	In fact, increased intracellular Cu availability inhibited the accumulation of Aβ oligomers and protein tau phosphorylation xref .	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CHI3L1, pmod(Ph))
c14d02ac-ccfe-42fb-a5d1-70f01b9eee3a	0.98	Other	sparser:Unknown	Overall, these data show that synaptic stimulation reduces Tau phosphorylation and accumulation of Tau oligomers, and protects synapses in in vivo models of Tau pathology.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CHI3L1, pmod(Ph))
58ecefbb-e58d-4ac6-b490-c8394b1be61e	0.65	PubMed	PMC5205055	In the present study, we examined the effect of PSEN1 1143T and G384A mutations on tau phosphorylation in human SH-SY5Y and mouse Neuro-2a neuroblastoma cell lines that were transiently transfected with wild type (WT) or mutant PSEN1.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CHRNA7, pmod(Ph))
b2ef0f10-627d-469d-b690-24884cac063e	0.65	Other	sparser:Unknown	Statins showed positive effects against Alzheimer-relevant Aβ-induced oxidative stress in mice models of AD [ xref , xref ] as well as a reduction in CSF tau protein phosphorylation in humans [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:CSF2, pmod(Ph))
42e8e8d6-0ed2-44b6-910b-1ee3f047e2e1	0.65	Other	sparser:Unknown	These events cause a further cascade of changes, including tau phosphorylation, and activation of caspases, CDK5/dynamin-related protein 1 (Drp1), calcineurin/protein phosphatase 2B (PP2B), PP2A, GSK3β, Fyn, cofilin, and calcium calmodulin-dependent kinase II (CaMKII). [DE3]These events result in the endocytosis of AMPA receptors (AMPARs) as well as NMDA receptors (NMDARs) [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(FPLX:Caspase, pmod(Ph))
fde9de75-a05a-4c79-9465-2f5992f38978	0.65	PubMed	PMC17748884	Tau phosphorylation in the DG is also temporally and spatially linked to DCX and neuroD expression with activated GSK-β believed to be the main tau kinase in newborn neurons (Fuster-Matanzo et al., xref ; Hong et al., xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:DET1, pmod(Ph))
350cb3fb-f56b-43a2-805e-82b65395fd29	0.65	Other	sparser:Unknown	We also reported a slight but consistent increase of Aβ 1-42 SDS- and PBS-soluble form and tau phosphorylation in DS versus CTR.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:DHPS, pmod(Ph))
14576f6e-8cbc-44b8-84c4-fee44ab94862	0.65	PubMed	17632320	However, tau phosphorylation of DYRK1A is reported to be triggered by GSK3beta.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:DYRK1A, pmod(Ph))
2ae82321-534e-4532-b6b8-bfb63c8c1a43	0.86	PubMed	17479151	Combination of Tau and AZ stimulated the phosphorylation of ERK.	p(HGNC:MAPT)	directlyIncreases	p(FPLX:ERK, pmod(Ph))
2ae82321-534e-4532-b6b8-bfb63c8c1a43	0.86	PubMed	17308813	It has been previously shown that ITPKB has a dual regulatory role in relation to AD pathology : It can affect BACE1 activity leading to more Abeta generation, while at the same time, it promotes TAU phosphorylation via phosphorylation and activation of ERK1/2 (Stygelbout etal, 2014).	p(HGNC:MAPT)	directlyIncreases	p(FPLX:ERK, pmod(Ph))
4eff9993-120a-4a9e-a1e7-97ff692f9057	0.86	Other	sparser:Unknown	The results show that in vivo stimulation of EphB2 also reduces tau phosphorylation in hippocampal CA1, CA3 and dentate gyrus (DG) shown by immunohistochemistry ( xref ) and immunofluorescence staining ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ESR1, pmod(Ph))
4eff9993-120a-4a9e-a1e7-97ff692f9057	0.86	Other	sparser:Unknown	Immunohistochemistry confirmed tau hyperphosphorylation in hippocampus that was most prominent in the dentate gyrus (DG) and CA1 region.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ESR1, pmod(Ph))
dd6d7a5a-d10d-4874-9102-62db43a69b78	0.65	Other	sparser:Unknown	However, it is unknown whether and how ER stress causes tau phosphorylation, and vice versa.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ESR1, pmod(Ph))
8a225596-8215-4f32-a6fd-62dd4acb800c	0.65	Other	sparser:Unknown	PAR-1 kinase-initiated tau phosphorylation may mediate neurite damage xref .	p(HGNC:MAPT)	directlyIncreases	p(HGNC:F2R, pmod(Ph))
3dd0ede3-d920-4e2f-bf44-750c85ecb188	0.65	Other	sparser:Unknown	Based on our experiments, we found significant increase in TLR9 expression in neurons and an increase in tau hyperphosphorylation in high-glucose media.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GLMN, pmod(Ph))
738d212d-095a-41e3-a945-5a446ee5e026	0.65	Other	sparser:Unknown	Finally, we demonstrated that cyclin-dependent kinase-5 and extracellular signal-regulated kinase were activated after golgin-84 knockdown, and simultaneous inhibition of these kinases abolished the golgin-84 deficit-induced tau hyperphosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GOLGA5, pmod(Ph))
a38e67ad-c451-420b-adb0-8e0415356c72	0.65	Other	sparser:Unknown	Taken together, these findings indicate that GRK5 dysfunction accelerated tau hyperphosphorylation in APP(swe) mice by activating GSK3β through impaired cholinergic activity.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GRK5, pmod(Ph))
74a43438-d7ce-492f-a52e-88287157e92a	0.65	Other	sparser:Unknown	Of note, the recent report that PGRN haploinsufficiency increases tau phosphorylation in P301L tau transgenic mice [ xref ], strongly supports our conclusion from AAV studies.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GRN, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	PubMed	6691199	Tau phosphorylation and nuclear translocation of NF-kappaB and GSK-3beta were also observed.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	Other	sparser:Unknown	PI3K/Akt signaling pathway has been suggested to play a pivotal role in GSK-3 β -mediated tau protein hyperphosphorylation and neuronal survival.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	Other	sparser:Unknown	Further protection against AD-related toxicity by APPsα may arise from the inhibition of the tau phosphorylating enzyme GSK3β, thus reducing tau hyperphosphorylation and the subsequent production of NFTs (Deng et al., xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	Other	sparser:Unknown	We have previously shown that pThr 175 tau induces GSK3β phosphorylation and that this in turn leads to Thr 231 tau phosphorylation resulting in tau fibril formation and cell death in vitro [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	Other	sparser:Unknown	Here we show that Aβ1–42 injection in the hindbrain ventricle of 24 hpf zebrafish embryos results in specific cognitive deficits and increased tau phosphorylation in GSK-3β target residues at 5dpf larvae.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	Other	sparser:Unknown	Here we show that Aβ1-42 injection in the hindbrain ventricle of 24 hpf zebrafish embryos results in specific cognitive deficits and increased tau phosphorylation in GSK-3β target residues at 5dpf larvae.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	PubMed	11959122	Modelling Alzheimer specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	Other	sparser:Unknown	Moreover, incubation of organotypic sections with the GSK-3beta inhibitor SB216763 prevented tau phosphorylation but not alterations in levels of Bcl-2, Bax, and caspase-3.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	Other	sparser:Unknown	In an MPTP model and in MPP+ cellular models, α Syn has been shown to induce GSK-3 β -catalyzed tau phosphorylation [ xref – xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	Other	sparser:Unknown	In agreement with the in vitro evidence, mice overexpressing GSK-3 β display prominent tau hyperphosphorylation [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a39e2c46-e00a-43c1-91fd-8f7b345c3ffb	0.99	PubMed	PMC16853176	We have previously shown that pThr 175 tau induces GSK3β phosphorylation and that this in turn leads to Thr 231 tau phosphorylation resulting in tau fibril formation and cell death in vitro [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
bca1f44d-7411-491e-9f42-9c73d6d3cb23	0.65	Other	sparser:Unknown	The result suggests that the removal of O -GlcNAc boosts tau phosphorylation even further, when kinases are activated.	p(HGNC:MAPT)	directlyIncreases	p(PFAM:PF11397, pmod(Ph))
6db15c05-78d4-4492-8c27-75977ca730e3	0.65	Other	sparser:Unknown	These results suggest that tau phosphorylation in hypoxia occur through a GSK-3 β - γ -taxilin signaling pathway.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:HYOU1, pmod(Ph))
36161867-a224-4fae-a6af-70c524fc2193	0.95	Other	sparser:Unknown	We previously found that genetic deletion of iNOS in mice overexpressing the amyloid precursor protein (APP) and presenilin-1 (PS1) reduced mortality, nitrosative stress, amyloid plaque burden, microgliosis, astrocytosis, and peri-plaque tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IAPP, pmod(Ph))
36161867-a224-4fae-a6af-70c524fc2193	0.95	Other	sparser:Unknown	For example, pathologic  changes in AD occur in a consistent distribution, severely affect-  ing certain neuronal populations in limbic areas and association  cortices and are accompanied by neurofibrillary tangles, dystro-  phic neurites, and neuritic plaques associated with the deposi-  tion of amyloid protein and tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IAPP, pmod(Ph))
36161867-a224-4fae-a6af-70c524fc2193	0.95	Other	sparser:Unknown	Inhibition of amyloid β -induced tau hyperphosphorylation was also reported (Shiryaev et al. xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IAPP, pmod(Ph))
36161867-a224-4fae-a6af-70c524fc2193	0.95	Other	sparser:Unknown	Combination of PKCε activation and PTP1B inhibition more sufficiently activated Akt and inactivated GSK-3β than each independent treatment, to suppress amyloid β (Aβ)-induced tau phosphorylation and ameliorate spatial learning and memory impairment in 5xFAD transgenic mice, an animal model of AD.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IAPP, pmod(Ph))
36161867-a224-4fae-a6af-70c524fc2193	0.95	PubMed	PMC5855713	Currently, the important part played by the senile plaque and neurofibrillary tangles puts amyloid protein and tau hyperphosphorylation at the centre of a new direction in the investigation of the molecular biology and treatment of Alzheimer s disease.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IAPP, pmod(Ph))
36161867-a224-4fae-a6af-70c524fc2193	0.95	Other	sparser:Unknown	We found a selective postsynaptic deficiency in those degus who showed elevated amyloid oligomers and tau phosphorylation levels, predominantly in aged, but not in young degus.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IAPP, pmod(Ph))
36161867-a224-4fae-a6af-70c524fc2193	0.95	Other	sparser:Unknown	Somehow, amyloid production increases tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IAPP, pmod(Ph))
36161867-a224-4fae-a6af-70c524fc2193	0.95	Other	sparser:Unknown	Currently, the important part played by the senile plaque and neurofibrillary tangles puts amyloid protein and tau hyperphosphorylation at the centre of a new direction in the investigation of the molecular biology and treatment of Alzheimer s disease.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IAPP, pmod(Ph))
36161867-a224-4fae-a6af-70c524fc2193	0.95	Other	sparser:Unknown	In this article, we review the roles of brain insulin signaling in memory and cognition, the metabolism of amyloid β precursor protein, and tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IAPP, pmod(Ph))
d8d69ed7-cec5-4348-ad65-b68bb687eb13	0.65	PubMed	PMC16894757	Interestingly, the distribution pattern of tau hyperphosphorylation in p44 +/+ ;APP 695/swe double-transgenics was similar to that observed in p44 +/+ single-transgenics ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:IFI44, pmod(Ph))
a9def331-7b8d-4d8b-b10d-903cf99f9b7e	0.65	Other	sparser:Unknown	But decreased IR/IGF-1 signaling causes tau hyperphosphorylation which is neurotoxic at least to certain extend.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:INSR, pmod(Ph))
61481300-fa89-4572-afce-30f3c4a12a2d	0.92	Other	sparser:Unknown	Specifically, insulin transiently regulates tau phosphorylation in cultured neurons [ xref , xref ], while reduced insulin signaling increases tau phosphorylation both in cultured neuronal cells [ xref ] and in vivo models of insulin resistance and T2DM [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:INS, pmod(Ph))
61481300-fa89-4572-afce-30f3c4a12a2d	0.92	Other	sparser:Unknown	Together, these data indicate that insulin dysfunction induced abnormal tau hyperphosphorylation through two distinct mechanisms: one was consequent to hypothermia; the other was temperature-independent, inherent to insulin depletion, and probably caused by inhibition of phosphatase activity.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:INS, pmod(Ph))
61481300-fa89-4572-afce-30f3c4a12a2d	0.92	Other	sparser:Unknown	The relevance of the insulin/PI3K pathway to the development of AD biomarkers has been studied in a mouse model of hyperinsulinemia in which systemic insulin administration promoted tau phosphorylation as shortly as 10 min after insulin administration [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:INS, pmod(Ph))
6fe6b920-6de8-4fd0-af86-7f549a1a54c7	0.65	PubMed	15289074	Phosphorylations of Janus kinase 2 (JAK2) and signal transducer and activator of transcription 5 (STAT5) were increased by Oys and by Tau.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:JAK2, pmod(Ph))
288c09be-f6f6-492c-96ff-04d4da12a8b2	0.65	Other	sparser:Unknown	LRP8 knockout increases tau phosphorylation in mice suggesting a relation to MAPT (see above).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:LRP8, pmod(Ph))
f6050b5b-1504-481b-a0d0-9d750d0e52ce	0.86	PubMed	PMC3509110	Previously, we identified protein kinase FA/glycogen synthase kinase-3 alpha (GSK-3 alpha) as a brain microtubule-associated tau kinase that phosphorylates Ser235 and Ser404 of tau and causes its electrophoretic mobility shift in gels, a unique property characteristic of paired helical filament-associated pathological tau (PHF-tau) in Alzheimer&apos;s disease brains.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
f6050b5b-1504-481b-a0d0-9d750d0e52ce	0.86	Other	sparser:Unknown	Previously, we identified protein kinase FA/glycogen synthase kinase-3 alpha (GSK-3 alpha) as a brain microtubule-associated tau kinase that phosphorylates Ser235 and Ser404 of tau and causes its electrophoretic mobility shift in gels, a unique property characteristic of paired helical filament-associated pathological tau (PHF-tau) in Alzheimer&apos;s disease brains.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
658f2609-24ae-42b1-83f0-5f7e7a297fe0	0.65	PubMed	6904344	(2) The treatment of tau by PKA and GSK-3 combination induced phosphorylation of tau at Ser 195, Ser 198, Ser 199, Ser 202, Thr 205, Thr 231, Ser 235, Ser 262, Ser 356, Ser 404, whereas only Thr 181, Ser 184, Ser 262, Ser 356 and Ser 400 were phosphorylated by GSK-3 alone under the same conditions.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 515))
ce5d77e9-1c98-4167-8dd8-1bbb6ecd5b60	0.86	Other	sparser:Unknown	Moreover, CaMKII is one of the most effective kinases in the phosphorylation of tau at the Ser262 tau MT binding site ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
ce5d77e9-1c98-4167-8dd8-1bbb6ecd5b60	0.86	Other	sparser:Unknown	Western blot analyses for the expression of APP C-terminal protein, human tau-1, and phosphorylated tau at Serine 262 (p(262)) and Serine 396 (pS(396)) were done after treatment of N2A cells with the test compounds.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
05c901c9-9914-43a0-856b-04806f76aa23	0.65	Other	sparser:Unknown	CaMKII has been shown to be the major mammalian kinase to phosphorylate tau at Ser262 ( xref ; xref ) and we show that phosphorylation of this tau MT binding site is essential for Wnt5a induced axon outgrowth through MT reorganization.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MCAT, pmod(Ph))
740f8923-34cb-4c03-a290-f987f5fdb536	0.65	Other	sparser:Unknown	The enhancement of MAPT phosphorylation in the hTau-Cx3cr1 −/− mice required both the hTau transgene and loss of CX3CR1 signaling, as neither 6-month-oldCx3cr1 −/− ( xref and xref ) norCx3cl1 −/− mice (data not shown) exhibited alterations in AT8, AT180 or PHF1 epitopes when compared to non-transgenic controls.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MPV17, pmod(Ph))
0f46ad5d-0960-4785-9071-ba6afe4e9e4a	0.65	PubMed	PMC7108453	Combined biochemical, immunohistochemical and functional studies indicate that active p38 kinase is expressed in a very high percentage of Pick bodies, thus suggesting a critical role of this kinase in enhancing and perpetuating tau hyperphosphorylation in PiD.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:MTA2, pmod(Ph))
357f5de5-82f8-457d-8879-ad92c8753ebd	0.65	Other	sparser:Unknown	Results showed that acute hyperhomocysteinemia increases Akt phosphorylation, cytosolic and nuclear immunocontent of NF-κB/p65 subunit and Tau protein phosphorylation, but reduces GSK-3β phosphorylation at 1h after homocysteine injection.	p(HGNC:MAPT)	directlyIncreases	p(FPLX:NFkappaB, pmod(Ph))
326fe206-ab2d-427e-8732-5fcf84e0b33f	0.65	PubMed	14904817	Abeta is known to act as a scaffold to promote clustering of metabotropic glutamate receptor type 5 (mGluR5) at the synaptic compartment, and tau is also supposed to mediate phosphorylation of N-methyl-D-aspartate (NMDA) receptor at the excitatory postsynapse.	p(HGNC:MAPT)	directlyIncreases	a(PUBCHEM:22880, pmod(Ph))
6f219785-c07c-435d-b4cb-a83825ea5fe7	0.95	Other	sparser:Unknown	First, pretreatment of mouse primary cortical neurons with MW181 completely blocked inflammation-induced p38α MAPK activation and AT8 (pS199/pS202) site tau phosphorylation, with the maximum effect peaking at 60–90 min after stimulation.	p(HGNC:MAPT)	directlyIncreases	p(UP:Q9SI18, pmod(Ph))
6f219785-c07c-435d-b4cb-a83825ea5fe7	0.95	Other	sparser:Unknown	First, pretreatment of mouse primary cortical neurons with MW181 completely blocked inflammation-induced p38α MAPK activation and AT8 (pS199/pS202) site tau phosphorylation, with the maximum effect peaking at 60-90 min after stimulation.	p(HGNC:MAPT)	directlyIncreases	p(UP:Q9SI18, pmod(Ph))
6f219785-c07c-435d-b4cb-a83825ea5fe7	0.95	Other	sparser:Unknown	As reported previously [ xref ], a single injection of LPS led to AT8 and AT180 site tau phosphorylation in nontransgenic mice (Fig.  xref ).	p(HGNC:MAPT)	directlyIncreases	p(UP:Q9SI18, pmod(Ph))
6f219785-c07c-435d-b4cb-a83825ea5fe7	0.95	Other	sparser:Unknown	Unlike nontransgenic mice, MK2 –/– mice did not show an elevation in AT8 or AT180 site tau phosphorylation (Fig.  xref ).	p(HGNC:MAPT)	directlyIncreases	p(UP:Q9SI18, pmod(Ph))
6f219785-c07c-435d-b4cb-a83825ea5fe7	0.95	PubMed	PMC10911898	This suggests that the apoE4 mice are already stressed under nonstimulated conditions and that AT8 tau phosphorylation may contribute to their increased susceptibility to brain insults.	p(HGNC:MAPT)	directlyIncreases	p(UP:Q9SI18, pmod(Ph))
6f219785-c07c-435d-b4cb-a83825ea5fe7	0.95	Other	sparser:Unknown	In the Stk25 knockdown samples, significantly lower AT8 site (pSer202/pThr205) Tau phosphorylation was observed as compared to the EV-control and control Stk25 shRNA-infected neuronal cultures, while total Tau levels were not affected ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(UP:Q9SI18, pmod(Ph))
6f219785-c07c-435d-b4cb-a83825ea5fe7	0.95	Other	sparser:Unknown	The molecular mechanism underlying the presently observed effects of apoE4 on VGlut, Aβ42, AT8 tau phosphorylation as well as the mitochondrial parameters are not known.	p(HGNC:MAPT)	directlyIncreases	p(UP:Q9SI18, pmod(Ph))
15418cf1-661c-44e4-944f-5bcf8682027f	0.65	Other	sparser:Unknown	In insulin deficiency, increased lipid delivery and oxidation suppress skeletal-muscle glucose oxidation by inhibiting pyruvate dehydrogenase complex (PDC) activity via enhanced protein expression of pyruvate dehydrogenase kinase (PDK) isoform 4, which phosphorylates (and inactivates) PDC.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:PDC, pmod(Ph))
93eb79bf-aaaa-4c5a-b968-9cddf3a110d0	0.65	Other	sparser:Unknown	Moreover, these astrocytes display increased Tau phosphorylation and reduce the survival of cocultured hippocampal neurons ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:PEA15, pmod(Ph))
ee714839-1822-49e5-8f24-df8d9675c422	0.95	Other	sparser:Unknown	There was also no significant effect of either LPS or MK2 deficiency on PHF1 site tau phosphorylation (Fig.  xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:PHF1, pmod(Ph))
ee714839-1822-49e5-8f24-df8d9675c422	0.95	Other	sparser:Unknown	In 3-month-old TgCRND8 mice, the lithium-induced reduction in Aβ load was associated with a significant reduction in APP phosphorylation and in 7-month-old TgCRND8 mice with a decrease in PHF-1 tau hyperphosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:PHF1, pmod(Ph))
ee714839-1822-49e5-8f24-df8d9675c422	0.95	PubMed	18360551	Analyses of tau immunoreactivity revealed a substantial decrease of total tau, and tau phosphorylated at positions Thr212, Ser214, Ser396/404 (PHF1), Thr212 and Ser214 (AT100), Thr231 (AT180), Ser202 and Thr205 (AT8) in ipsilateral hemisphere injected with Armanezumab versus the contralateral hemisphere injected with irrelevant human IgG1.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:PHF1, pmod(Ph))
2ab63168-2779-4f8e-959b-6320676f621d	0.65	Other	sparser:Unknown	Interestingly, we also observed that preexposure of hippocampal slices to AP-5 (50  μ M) completely blocked d-NMAPPD-induced Tau phosphorylation at Ser262 epitopes ( xref ), indicating that Tau hyperphosphorylation mainly relies on calcium influx and NMDA receptors.	p(HGNC:MAPT)	directlyIncreases	p(UP:P06595, pmod(Ph))
f04162dc-2ad6-42c0-a44a-aa4f79c657b7	0.65	Other	sparser:Unknown	Coff or Caff, plus Mel inhibited GSK3β, Akt, PI3K p55, and Tau phosphorylation but enhanced PI3K p85 and Erk1/2 phosphorylation in N2a/APP cells.	p(HGNC:MAPT)	directlyIncreases	p(FPLX:PI3K, pmod(Ph))
cca3cc9c-6e39-492a-a6c6-ea0bf1177fa3	0.65	Other	sparser:Unknown	Here, we investigated the effect of escitalopram pretreatment on protein kinase A (PKA)-induced tau hyperphosphorylation and spatial memory deficits in rats using western blot and behavioral tests, respectively.	p(HGNC:MAPT)	directlyIncreases	p(FPLX:PKA, pmod(Ph))
baf9633d-08bc-472b-97b2-76a988fa1267	0.65	Other	sparser:Unknown	Furthermore, we detected the distribution and expression of I 1  PP2A and tau phosphorylation by double immunofluorescent staining in the brain.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:PPP1R1A, pmod(Ph))
1ff383cc-fb6b-480d-895c-9ab4aeae3765	0.65	Other	sparser:Unknown	We found no negative correlation between PP2B truncation/activation and tau phosphorylation ( xref ), which would be otherwise expected if PP2B dephosphorylated tau in the human brain.	p(HGNC:MAPT)	directlyIncreases	p(FPLX:PPP3, pmod(Ph))
f7091a2e-8dd8-4e7b-9dc7-fed38c584a27	0.65	Other	sparser:Unknown	To determine this possibility, we tested the neurofilaments (using SMI antibodies) and tau phosphorylation (AT8 and AT100 epitopes) in 6- and 18 months PS1/APP.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:PSEN1, pmod(Ph))
04fa3158-39bb-458a-a202-48ac16e48853	0.65	Other	sparser:Unknown	Tg601 mice exhibit synapse loss in the nucleus accumbens and axonopathy in the ventral medial prefrontal cortex, as well as increased tau phosphorylation at the PHF1 epitope (phosphorylated Ser296/Ser404) in the striatum [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:PTPN5, pmod(Ph))
1fbe7e15-c9c5-44d4-95c6-215ea90a66e9	0.65	Other	sparser:Unknown	An efficient Reelin signaling cascade controls tau phosphorylation, thus a reduction in Reelin may favor progression of the disease.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:RELN, pmod(Ph))
47285aec-3f80-44a8-bace-5328f743775b	0.65	Other	sparser:Unknown	Previous studies reported pronounced levels of tau phosphorylation at specific sites in pR5 mice at around 6 months of age (Bi et al., 2011).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:RENBP, pmod(Ph))
340b3ff6-0396-45bc-9226-a2567725ad17	0.65	PubMed	16042390	A diagnostic potential has been attributed to CSF proteins such as 14-3-3, but also tau protein, phosphorylated tau (181P) (p-tau) protein, amyloid beta1-42, S100B and neuron specific enolase (NSE).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:S100B, pmod(Ph))
bc6ae04e-282b-40f3-9132-1c85a7f5fe99	0.92	PubMed	17681420	We previously demonstrated that CX3CL1 levels are differentially altered in Tau gene transfer animal models that also over-express murine phosphorylated alpha-Synuclein [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:SNCA, pmod(Ph))
bc6ae04e-282b-40f3-9132-1c85a7f5fe99	0.92	PubMed	18876496	We previously demonstrated that CX3CL1 levels are differentially altered in Tau gene transfer animal models that also over-express murine phosphorylated alpha-Synuclein [XREF_BIBR, XREF_BIBR].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:SNCA, pmod(Ph))
bc6ae04e-282b-40f3-9132-1c85a7f5fe99	0.92	PubMed	21945393	These data indicate that Tau wt and Tau P301L expression differentially increase alpha-Synuclein and phosphorylated alpha-Synuclein, but do not affect betaAPP or TDP-43, in these animal models.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:SNCA, pmod(Ph))
5db15b6a-53be-4e87-b886-261ae937885e	0.65	PubMed	PMC6317254	Stress-responsive MAP kinase pathways were activated in the brain of the Tg2576/PS1(P264L) AD model, and this activation was coincident with the age-dependent increase in amyloid deposition, tau phosphorylation, and loss of synaptophysin.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:SYP, pmod(Ph))
6f5fd794-e47e-4526-8e37-e589734f1701	0.86	Other	sparser:Unknown	TLR4 ligand (LPS)-induced MAPT hyperphosphorylation and exacerbation of tau pathology has been well documented [ xref , xref , xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:TLR4, pmod(Ph))
6f5fd794-e47e-4526-8e37-e589734f1701	0.86	Other	sparser:Unknown	In addition, TLRs can affect tau related pathology; TLR4 ligand (LPS)-induced MAPT hyperphosphorylation and exacerbation of tau pathology has been well documented [ xref – xref ].	p(HGNC:MAPT)	directlyIncreases	p(HGNC:TLR4, pmod(Ph))
2b16f206-1841-4435-aee9-f6b35125bb74	0.92	Other	sparser:Unknown	Okadaic acid inhibits PP2A and PP1, and in rat brain slice cultures increases tau phosphorylation but does not lead to the formation of tangles ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(UP:Q8VHJ4, pmod(Ph))
2b16f206-1841-4435-aee9-f6b35125bb74	0.92	Other	sparser:Unknown	The present study was aimed to investigate the effects of ginsenoside Rb1 on okadaic acid (OA)-induced Tau hyperphosphorylation in hippocampal neurons of Sparague-Dawley rat and to explore its possible mechanism.	p(HGNC:MAPT)	directlyIncreases	p(UP:Q8VHJ4, pmod(Ph))
2b16f206-1841-4435-aee9-f6b35125bb74	0.92	Other	sparser:Unknown	A recent study showed that central infusion of ANGII in normal rat brains induced tau phosphorylation in a dose-dependent manner via activating glycogen synthase kinase 3β.	p(HGNC:MAPT)	directlyIncreases	p(UP:Q8VHJ4, pmod(Ph))
b2e9dd9f-93b9-47c3-aa49-e53f79f1196d	0.65	PubMed	5163074	There were several subsets of neurites that were argyrophilic or immunoreactive against antibodies to either phosphorylated tau protein, phosphorylated neurofilaments, ubiquitin, or synaptophysin.	p(HGNC:MAPT)	directlyIncreases	p(FPLX:Ubiquitin, pmod(Ph))
9d116b8e-5a9f-4a66-8292-7b34b188f696	0.65	Other	sparser:Unknown	Neuron    Polarity    Axonogenesis    Microtubules    Tau    Phosphorylation    THE establishment and maintenance of structural polarity is  fundamental to the cell biology of neurons (reviewed in ref.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:WHAMM, pmod(Ph))
0174f7fc-4cb4-4214-aebb-dbf613773ac4	0.65	Other	sparser:Unknown	Furthermore, replacement with exogenous Dkk1 was able to reinstate tau hyperphosphorylation in E2-treated animals, further suggesting that a reduction of Dkk1 is important for E2 suppression of tau hyperphosphorylation in cerebral ischemia.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:YRDC, pmod(Ph))
3f7b472a-3cc9-4895-873b-1814c53454dd	0.86	Other	sparser:Unknown	Stress and glucocorticoids increase tau phosphorylation in dendrites and synapses commensurate to the intensity of stimuli xref  xref .	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ZFP36L2, pmod(Ph))
3f7b472a-3cc9-4895-873b-1814c53454dd	0.86	Other	sparser:Unknown	Glucocorticoids increase tau phosphorylation in PC12 cells that express human tau, demonstrating a direct effect of glucocorticoids on neurons ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(HGNC:ZFP36L2, pmod(Ph))
3b087d77-e308-4add-b775-28f19719d16f	0.65	Other	sparser:Unknown	The analysis is extended to the action of neuroprotective factors including selective inhibitors of tau phosphorylating protein kinases, estrogens, and antioxidants among other molecules that apparently prevent neuronal degeneration.	p(HGNC:MAPT)	directlyIncreases	a(CHEBI:22586, pmod(Ph))
23f369ef-7f0a-428a-b470-04923ad4996d	0.94	Other	sparser:Unknown	Because hyperphosphorylated tau is a consistent component of neurofibrillary tangles, a pathological hallmark of Alzheimer&apos;s disease, we investigated the signaling molecules involved in A beta 42-induced tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(UP:O73683, pmod(Ph))
23f369ef-7f0a-428a-b470-04923ad4996d	0.94	Other	sparser:Unknown	We show that A beta 42 elicited rapid and reversible tau protein phosphorylation on three proline-directed sites (Ser-202, Thr-181, and Thr-231) in systems enriched in alpha 7 nicotinic acetylcholine receptors (alpha 7nAChR) including serum-deprived human SK-N-MC neuroblastoma cells and hippocampal synaptosomes.	p(HGNC:MAPT)	directlyIncreases	p(UP:O73683, pmod(Ph))
23f369ef-7f0a-428a-b470-04923ad4996d	0.94	PubMed	PMC6894342	Because hyperphosphorylated tau is a consistent component of neurofibrillary tangles, a pathological hallmark of Alzheimer&apos;s disease, we investigated the signaling molecules involved in A beta 42-induced tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(UP:O73683, pmod(Ph))
23f369ef-7f0a-428a-b470-04923ad4996d	0.94	PubMed	PMC6894342	We show that A beta 42 elicited rapid and reversible tau protein phosphorylation on three proline-directed sites (Ser-202, Thr-181, and Thr-231) in systems enriched in alpha 7 nicotinic acetylcholine receptors (alpha 7nAChR) including serum-deprived human SK-N-MC neuroblastoma cells and hippocampal synaptosomes.	p(HGNC:MAPT)	directlyIncreases	p(UP:O73683, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Apart from the Aβ protein, FTIR spectroscopy has also been used to gain a greater understanding of the structural conformation of the tau protein, which is hyperphosphorylated in AD, leading to the formation of NFTs.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	The ERS/JNK/IRS-1 pathway may be involved in Aβ1-42 oligomer-induced Tau hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	The symptoms of this AD pathology included increased tau phosphorylation at multiple sites, increased tau cleavage, and greater neuronal and synaptic damage, even with increased amyloid β protein production.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Tau protein, which is hyperphosphorylated in AD can only account for approximately 4 pmol phosphate/microg protein, suggesting the presence of non-tau hyperphosphorylated proteins in the diseased brain.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	We therefore investigated whether
osmotin, a homolog of the mammalian adiponectin hormone, exerts a neuroprotective effect
against Aβ 1-42 -induced memory impairment, synaptotoxicity, tau
hyperphosphorylation and hippocampal neuronal degeneration in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	ERK is able to phosphorylate tau protein, so the up-regulation of mGluR2 in vulnerable neurons may represent the upstream mediator of abnormal tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	AD type tau hyperphosphorylation ( xref ), redistribution of insulin receptors ( xref ; xref ), spine loss ( xref ) and oxidative stress ( xref ; xref ) are manifest exclusively in neurons showing synapses targeted by oligomers.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC3373831	Amyloid fibril formation may therefore be a cause of abnormal tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	GMPR's product GMPR1 is in the AMPK and adenosine receptor pathways and is thus associated with Tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Numerous studies have focused on the role of tau phosphorylation in AD because neurofibrillary tangles, pathological hallmarks of this disease, are formed mainly by hyperphosphorylated tau isoforms ( xref , xref , xref , xref ; xref , xref , xref ; xref ).	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	While the mechanism and consequence of abnormal tau phosphorylation in AD remains unclear [ xref ], p-tau proteins are richly expressed in the brain during development [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	The latter pathway may serve as a useful model for the putative pathway linking ApoE receptor signaling to tau phosphorylation in AD.</ce:para>
                  <ce:para view="all">Remarkably, Notch also serves as an informative model of βPP proteolytic processing (reviewed by <ce:cross-ref refid="BIB2">Brown et al. 2000</ce:cross-ref>).	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	The identities of both the PDPKs and non-PDPKs involved in AD tau hyperphosphorylation are still to be established.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Given the known importance of tau hyperphosphorylation in AD, one wonders whether the activation of p53 could be linked to the phosphorylation of tau through intracellular Aβ 1–42 induction of kinase activity.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Combined, these and other studies indicate that there may not necessarily be direct associations between Aβ, kinase activation and tau phosphorylation in AD, although Aβ likely plays an indirect or modulatory role.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	We now report that in vitro PK40erk, a candidate for the enzyme responsible for TAU hyperphosphorylation in AD, will further phosphorylate TAU that was previously saturated by protein kinase A, provided that the concentrations of free uncomplexed ATP are low.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	We now report that in vitro PK40<ce:sup loc="post"&gt;erk</ce:sup&gt;, a candidate for the enzyme responsible for TAU hyperphosphorylation in AD, will further phosphorylate TAU that was previously saturated by protein kinase A, provided that the concentrations of free uncomplexed ATP are low.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC5844393	These results demonstrate increased phosphorylated (active) ERK expression in association with early tau deposition in neurones and glial cells in taupathies, and suggest activated Ras as the upstream activator of the MEK/ERK pathway of tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Thus we propose a mechanism to link Aβ toxicity and tau hyperphosphorylation in AD: In our hypothesis, Aβ causes mitochondrial oxidative stress and increases production of reactive oxygen species, which result in an up-regulation of RCAN1 gene expression.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	We also analyzed protein levels and activity of CDK5, another kinase mediating tau phosphorylation in AD ( xref ), following FG01 overexpression and observed little change, suggesting that CDK5 is not involved in FG01-regulated tau phosphorylation ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	In contrast to the C-terminal fragment of PS1, which has been claimed to be present in senile plaques, the N-terminal fragment binds to intracellular and intradendritic pathological structures and may play a role in tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Simulations using this model allowed the observation of the behavior of Tau and p-Tau at different calcium concentrations; however, it is important to describe in more detail the factors involved in the proposed signaling cascade to build a model that better approximates the chronic phenomenon of Tau hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Although a number of tau residues are phosphorylated under physiological conditions, in AD tau phosphorylation increases 3 to 4-fold.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Neurofibrillary tangles are composed of microtubule associated protein tau, normally expressed in axons, which are abnormally hyperphosphorylated in AD and aggregate into abnormal filaments in the neuronal cell body [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC3192015	The identities of both the PDPKs and non-PDPKs involved in AD tau hyperphosphorylation are still to be established.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	A deregulation in the activity of Cdk5 has been postulated to participate in the abnormal tau hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Whether Tau hyperphosphorylation in AD is a cause of aggregation (Alonso et al ., xref ) or whether the two changes occur independently is still controversial.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC7108823	Because amyloid beta peptide, the primary neurotoxic component of amyloid plaques in AD, has been shown to increase the conversion of p35 to p25, aberrant activation of Cdk5 by p25 might be a pathway connecting amyloid beta toxicity to tau hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Thiadiazolidindiones (TDZD’s) represents the first selective GSK3 inhibitor entering phase I clinical trial (Neuropharma) as a new therapeutic agent which inhibits GSK3 and tau phosphorylation in AD ( xref ; xref ).	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	These results suggest that Abeta causes mitotic protein expression in adult brain neurons, which may die through apoptosis or may be affected by AD NFT-related tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC6273683	Key challenges in developing effective therapeutic agents include identification of the relevant kinase(s) responsible for aberrant tau phosphorylation in AD, synthesis of inhibitors selectively targeting those kinases and establishment of appropriate animal models.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	PHFs are composed of the microtubule-associated protein (MAP) tau, which is abnormally phosphorylated in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	This finding is remarkable because the down-regulation of PP2A/Bα and the deregulation of FYN/TAU interactions have been linked to enhanced TAU phosphorylation in AD (Sontag et al., xref ).	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	One of the pathological hallmarks of Alzheimer&apos;s disease (AD) is neurofibrillary tangles (NFTs), which are composed of abnormally hyperphosphorylated tau, but the mechanism of tau hyperphosphorylation in AD is still unclear.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	The exact mechanisms underlying tau hyperphosphorylation in AD are not well understood.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC6553864	To determine the role of tau hyperphosphorylation in AD, pseudohyperphosphorylated tau (PHP-tau) that simulates disease-like permanent, high stoichiometric tau phosphorylation and mimics structural and functional aspects of hyperphosphorylated tau was expressed in neural cells.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC5189436	Thus, tau hyperphosphorylation in AD may result in part from deregulation of Nclk.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Understanding why GSK3β turns from an inhibited into a hyperactive state during ageing of these mice and testing the mutants with drugs that can revert this process seems a promising approach to prevent or treat tau hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Previous studies have shown that Pin1, a peptidylprolyl cis/trans-isomerase, may be actively involved in the regulation of Tau hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Tau protein, which is hyperphosphorylated in AD can only account for ∼4 pmol phosphate/μg protein, suggesting the presence of non-tau hyperphosphorylated proteins in the diseased brain.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Several findings suggest that correcting signal dysregulation for Tau phosphorylation in AD may offer a potential therapeutic approach.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC6776973	These results suggest that Abeta causes mitotic protein expression in adult brain neurons, which may die through apoptosis or may be affected by AD NFT-related tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	To determine the role of tau hyperphosphorylation in AD, pseudohyperphosphorylated tau (PHP-tau) that simulates disease-like permanent, high stoichiometric tau phosphorylation and mimics structural and functional aspects of hyperphosphorylated tau was expressed in neural cells.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Key challenges in developing effective therapeutic agents include identification of the relevant kinase(s) responsible for aberrant tau phosphorylation in AD, synthesis of inhibitors selectively targeting those kinases and establishment of appropriate animal models.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	To investigate whether PP2B activation has any role in counteracting tau hyperphosphorylation in AD, we measured tau phosphorylation levels at individual phosphorylation sites by immuno-dot blots and analyzed the correlation between PP2B truncation and tau phosphorylation in 13 human brains, including both AD and controls.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC7192467	These results support the amyloid cascade of tau phosphorylation in AD regarding phosphorylation of tau dependent on beta-amyloid deposition in neuritic plaques, but not of tau in neurofibrillary tangles and threads.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Comparison of tau phosphorylation during development with AD abnormal tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC6580057	Moreover, phosphorylated TIF 2 alpha immunoreactivity was found in a percentage of neurones expressing phosphorylated SAPK/JNK and p38, which, in turn, are involved in tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	The identities of  both the PDPKs and non-PDPKs involved in AD tau hyper-  phosphorylation are still to be established.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC3195242	Excessive formation of an ERK2 species resistant to inactivation by PP2A might be relevant to the persistent pathological tau hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC4602667	In contrast to the C-terminal fragment of PS1, which has been claimed to be present in senile plaques, the N-terminal fragment binds to intracellular and intradendritic pathological structures and may play a role in tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	In addition, the rs2373115 did not modulate the extent of tau phosphorylation in the brain of 89 AD cases.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	The truncated GSK-3β phosphorylates tau much more efficiently and causes tau hyperphosphorylation and neurofibrillary degeneration in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	These findings suggest that ELF-MF exposure could act as a valid therapeutic strategy for ameliorating cognitive deficits and attenuating tau hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Synapses are sites of early Aβ accumulation and aberrant tau phosphorylation in AD, which alter the synaptic composition at early stages of the disease.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC6143004	Tau protein, which is hyperphosphorylated in AD can only account for approximately 4 pmol phosphate/microg protein, suggesting the presence of non-tau hyperphosphorylated proteins in the diseased brain.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Amyloid fibril formation may therefore be a cause of abnormal tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC3685191	We now report that in vitro PK40erk, a candidate for the enzyme responsible for TAU hyperphosphorylation in AD, will further phosphorylate TAU that was previously saturated by protein kinase A, provided that the concentrations of free uncomplexed ATP are low.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Thus, tau hyperphosphorylation in AD may result in part from deregulation of Nclk.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	As described above, tau hyperphosphorylation and the presence of neurofibrillary tangles is one of the central hallmarks in AD, and the main kinase related to tau hyperphosphorylation in AD is GSK3β.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	A recent study also implicated QUIN, the downstream component of the KP, with tau phosphorylation in AD through reduction of tau phosphatases PP2A, PP1, and PP5 xref .	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	In particular, protein kinases IKBKB, AKT1, CDK5, CSK, MAPK3, PRKCZ and RAF1, whose substrates were enriched in at least three brain regions’ perturbed subnetworks, were also hub genes, suggesting that they may play vital roles in the regulation of signal transduction and tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC4267481	PHFs are composed of the microtubule-associated protein (MAP) tau, which is abnormally phosphorylated in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Taken together, the results of the aforementioned studies seem to indicate a clear role for GABA A R signaling in tau hyperphosphorylation in AD and related disorders, albeit one that needs to be investigated further.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	Overall, our data show that chaperone induction results in the selective clearance of specific phospho-tau and conformationally altered tau species mediated by the proteasome; however, the apparent stability of pS262/S356 tau may also explain why MARK is able to regulate normal tau function yet still be linked to the initiation of pathogenic tau hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	In AD, based on the prevailing amyloid cascade hypothesis, soluble Aβ peptide levels are drastically increased, augmenting synaptic dysfunction, calcium dyshomeostasis, inflammation, oxidative stress as well as tau hyperphosphorylation and the formation of NFTs at specific brain regions in AD [ xref - xref ].	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	It is suggested that nitric oxide may be an upstream element of tau abnormal hyperphosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	While the specific pathways linking glucocorticoid receptor activation to tau phosphorylation in AD still remain poorly defined, others have shown that leukotrienes, downstream metabolites of 5LO, can modulate GSK3β in an Akt-dependent manner (Kim et al., 2018).	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	PubMed	PMC17051380	Quite recently, HRD1 ubiquitin ligase, previously reported to favor APP degradation [ xref ], was also identified as a negative regulator of tau phosphorylation in AD [ xref ].	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
7f719453-8f1e-422b-bdd3-b9060d1936d4	0.95	Other	sparser:Unknown	These results demonstrate increased phosphorylated (active) ERK expression in association with early tau deposition in neurones and glial cells in taupathies, and suggest activated Ras as the upstream activator of the MEK/ERK pathway of tau phosphorylation in AD.	p(HGNC:MAPT)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
fa3809fb-e5f5-4d5e-8259-5a4948415437	0.65	PubMed	PMC6022269	The analysis is extended to the action of neuroprotective factors including selective inhibitors of tau phosphorylating protein kinases, estrogens, and antioxidants among other molecules that apparently prevent neuronal degeneration.	p(HGNC:MAPT)	directlyIncreases	a(CHEBI:50114, pmod(Ph))
69e23766-0e5a-4573-a206-669a3434b554	0.65	Other	sparser:Unknown	Recent investigations utilizing inducible pluripotent stem cell-derived neurons from AD patients further suggested that inhibition of BACE1, but not γ-secretase, decreases glycogen synthase kinase-3 (GSK3β)-mediated Alzheimer-like tau phosphorylation as well ( xref ).	p(HGNC:MAPT)	directlyIncreases	p(UP:Q9U2Q9, pmod(Ph))
ee342f75-be85-4041-a56c-775367c3a747	0.86	Other	sparser:Unknown	We demonstrate that loss of axonal mitochondria caused by milton knockdown increases tau phosphorylation at Ser262 through PAR-1, promotes detachment of tau from microtubules, and enhances tau-mediated neurodegeneration.	p(HGNC:MAPT)	directlyIncreases	p(PFAM:PF12448, pmod(Ph, Ser, 262))
ee342f75-be85-4041-a56c-775367c3a747	0.86	Other	sparser:Unknown	Our data demonstrate that loss of axonal mitochondria caused by knockdown of milton or Miro increases tau phosphorylation at an AD-related site Ser262 through PAR-1, promotes detachment of tau from microtubules, and enhances tau-mediated neurodegeneration.	p(HGNC:MAPT)	directlyIncreases	p(PFAM:PF12448, pmod(Ph, Ser, 262))
0e94422b-0140-4278-b58b-815536858527	0.65	PubMed	17051958	In addition, Tau did not trigger Hpo phosphorylation and Sav dissociation in vitro (XREF_SUPPLEMENTARY), indicating that Par-1 regulated Hpo signaling independent of Tau.	p(HGNC:MAPT)	directlyIncreases	p(UP:Q9VCR6, pmod(Ph))
57061852-9030-4b6c-ac5d-33a772941916	0.94	Other	sparser:Unknown	Experiments with hippocampal cells in culture have indicated a relationship between fibrillary amyloid and the cascade of molecular signals that trigger tau hyperphosphorylations.	p(HGNC:MAPT)	directlyIncreases	p(UP:P0A850, pmod(Ph))
57061852-9030-4b6c-ac5d-33a772941916	0.94	PubMed	PMC6022269	Experiments with hippocampal cells in culture have indicated a relationship between fibrillary amyloid and the cascade of molecular signals that trigger tau hyperphosphorylations.	p(HGNC:MAPT)	directlyIncreases	p(UP:P0A850, pmod(Ph))
57061852-9030-4b6c-ac5d-33a772941916	0.94	Other	sparser:Unknown	The reduction of PHF-1-positive neurons could be a consequence of a decreased accumulation of Aβ and inflammatory response, and also IDN5706 may have effects on the signaling that define to trigger tau phosphorylation.	p(HGNC:MAPT)	directlyIncreases	p(UP:P0A850, pmod(Ph))
57061852-9030-4b6c-ac5d-33a772941916	0.94	Other	sparser:Unknown	Impaired insulin signaling may contribute to dysregulation of downstream pro-survival pathways, including decreased signaling mediated by PI3K, Akt, and Wnt/β-catenin; moreover, disrupted insulin-related signaling may enhance pathogenic pathways such as GSK-3β to trigger tau hyperphosphorylation
[ xref , xref ].	p(HGNC:MAPT)	directlyIncreases	p(UP:P0A850, pmod(Ph))
230886b2-58bb-4506-8b82-06ecd2b04b35	0.65	PubMed	18388390	Overexpression of MARK promotes tau phosphorylation at KXGS motifs and disrupts the microtubule array in vivo [XREF_BIBR].	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3820b5c0-d2d2-4220-bd72-d94d30d4a398	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9f771fd69fe000651ddea67a8ad0fe20	No evidence text.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
c0268b16-004f-49b9-9aeb-c014d0187c8e	0.93	PubMed	17129327	MARK and Par -1 can phosphorylate Tau at serine 262 [XREF_BIBR], which has been shown to be hyperphosphorylated in postmortem Alzheimer 's disease (AD) patient brains [XREF_BIBR] and it has been demonstrated that MARK and Par -1 can function as a " initiator kinase " [XREF_BIBR] for the cascade that hyperphosphorylates Tau.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
c0268b16-004f-49b9-9aeb-c014d0187c8e	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_90eef9aa27f3b25cf37e9f8ae81dda73	No evidence text.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
57a53302-e7e9-409b-9535-3b2e62be54c4	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_bac8ec06f8b2582967f38add778253b0	No evidence text.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
ffd8896c-a8eb-4841-8d35-687c70642429	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_c0acabae2c9ff8584a487e41ad80db1f	No evidence text.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 622))
fafaac16-0c70-4465-acda-bf29cfd91718	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_61ee531fa30eab30b9900cd30843efec	No evidence text.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
3b38dcdc-7fd4-46df-95a1-a4aa74b83b5a	0.97	Other	sparser:Unknown	MARK phosphorylates tau on Ser262 and Ser356 in vitro , both of which are located within the microtubule-binding domain of tau, and this phosphorylation results in the disruption of microtubules [ xref ].	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
3b38dcdc-7fd4-46df-95a1-a4aa74b83b5a	0.97	PubMed	17082661	MARK phosphorylates tau on Ser262 and Ser356 in vitro, both of which are located within the microtubule binding domain of tau, and this phosphorylation results in the disruption of microtubules [XREF_BIBR].	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
3b38dcdc-7fd4-46df-95a1-a4aa74b83b5a	0.97	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a98101807cfe192d09b9350255ee4960	No evidence text.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
efc827c7-dce2-4f13-bbde-953cd3ec7251	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a5adbb76bb3aa2e244eb9b11f16f743e	No evidence text.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 726))
383a1a82-2fc3-4a8f-8ab4-9ce6b8c9f2f7	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8059a599febaa1289ace599b598f43ac	No evidence text.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
4ec0d4ab-166c-4170-af58-a1727f21fda2	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_01daa5db456d7022cb64683bb65560ec	No evidence text.	p(HGNC:MARK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
b96f77ab-eff0-46da-8174-50715a77861a	0.98	PubMed	7706316	No evidence text.	p(HGNC:MARK2, pmod(Ph, Thr, 208))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
b96f77ab-eff0-46da-8174-50715a77861a	0.98	PubMed	17573348	No evidence text.	p(HGNC:MARK2, pmod(Ph, Thr, 208))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
b96f77ab-eff0-46da-8174-50715a77861a	0.98	PubMed	17713250	GSK-3beta was shown to phosphorylate MARK2 at two different sites, the activatory T208 and the inhibitory S212, thereby modulating the phosphorylation of tau, particularly at S262.	p(HGNC:MARK2, pmod(Ph, Thr, 208))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
37c5d4fd-3921-4aff-9d34-96c8aa791fb3	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_5b6a14a20cfcf3d91c19b2e3a3e177fd	No evidence text.	p(HGNC:MARK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
3668a9bb-4d7f-4636-b490-b6969841e021	0.95	Other	sparser:Unknown	Similar results were observed as shown in xref where Tau phosphorylation at S262 by endogenous MARK4 was inhibited by MB in a dose dependent manner.	p(HGNC:MARK4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
3668a9bb-4d7f-4636-b490-b6969841e021	0.95	PubMed	18233622	As shown in XREF_FIG, a low level of Tau S262 was phosphorylated by endogenous MARK4 but no phosphorylated HMW Tau was observed in the absence of HA-MARK4-WT overexpression.	p(HGNC:MARK4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
3668a9bb-4d7f-4636-b490-b6969841e021	0.95	PubMed	18233622	As shown in XREF_SUPPLEMENTARY, immunoprecipitated HA-MARK4-WT effectively phosphorylated Tau at S262 site as shown by WB, while HA-MARK4-KD failed to do so.	p(HGNC:MARK4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
4160b5af-e2f0-4573-8c27-463a6427acbf	0.65	PubMed	15293274	Beside improved learning and memory, MB treated Tau (DeltaK) mice showed a strong decrease of insoluble Tau, a reduction of conformationally changed (MC1) and phosphorylated Tau species (AT180, PHF1) as well as an upregulation of protein degradation systems (autophagy and proteasome).	p(HGNC:MB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
85059ccf-7263-46d1-919f-4c2fb5fd678f	0.92	Other	sparser:Unknown	Taken together these results show that tau phosphorylation at the Ser262 MT binding site is necessary for Wnt5a evoked axon outgrowth and growth cone repulsion.	p(HGNC:MCAT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
85059ccf-7263-46d1-919f-4c2fb5fd678f	0.92	Other	sparser:Unknown	CaMKII, activated by calcium ( xref ; xref ) has been shown to phosphorylate tau at the Ser262 MT binding site ( xref ; xref ; xref ) leading to detachment of tau from MTs and decreased MT stability ( xref ).	p(HGNC:MCAT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
85059ccf-7263-46d1-919f-4c2fb5fd678f	0.92	Other	sparser:Unknown	These results show that phosphorylation of tau at the Ser262 MT binding site is required for Wnt5a induced axon outgrowth mediated by the redistribution of dynamic MTs.	p(HGNC:MCAT)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
df0e0b01-e719-4f7c-b17f-431d1131be7e	0.86	PubMed	PMC17200775	The p25/cdk5 holoenzyme phosphorylates tau and reduces its ability to bind to microtubules.	p(HGNC:MCM3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
df0e0b01-e719-4f7c-b17f-431d1131be7e	0.86	Other	sparser:Unknown	The p25/cdk5 holoenzyme phosphorylates tau and reduces its ability to bind to microtubules.	p(HGNC:MCM3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
07fb9905-9560-47a8-8a84-0653820bfd7a	0.65	PubMed	21288824	</ce:para> <ce:para view="all"> We demonstrated that the blockade of the G <ce:inf loc="post"> i </ce:inf>-PTX sensitive pathway and the inhibition of MEK (proposed to be in the G <ce:inf loc="post"> i </ce:inf>-pathway) abolished Tau dephosphorylation 2 h after LPA addition in SH-SY5Y cells <ce:cross-ref refid="BIB72"> [72] </ce:cross-ref>.	p(FPLX:MEK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d2c65a7b-f509-4761-a5f8-0e2feaa9253b	0.65	PubMed	14695070	Importantly, inhibition of OGA by thiamet-G decreased the phosphorylation of microtubule associated protein Tau and caused alterations of microtubule network in cells.	p(HGNC:MGEA5)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
04d3f6e0-91f5-401c-9e34-7eeb1892ddca	0.65	PubMed	17363766	Our study corroborates these data and in addition, demonstrates that ECM results in aberrant phosphorylation of tau protein leading to conformational changes and accumulation of the unbound protein in neuronal cell bodies of PbA infected mice.	bp(GO:"GO:0031012")	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
063c87af-30d4-433c-a0ad-4c42b5ebad59	0.65	Other	sparser:Unknown	4.5 mTOR-dependent tau phosphorylation at S262 is required for CCR.	p(HGNC:MTOR)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
96b7b124-60aa-4e18-8999-fc7439475739	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2cf56c95579dad2bcab375619dfa3707	No evidence text.	p(UP:O08678)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
8c5c08bf-d55c-45f5-9246-ee6b8c2951d1	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_50b17f88b44766642ebeac44a5c522cb	No evidence text.	p(UP:O08678)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
370255b9-9c7e-4d7b-a8a2-0fd140b663b3	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_12d7a22facf551c9d452c683b10fb966	No evidence text.	p(UP:O08678)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
c995902f-a696-497b-9817-7dca6d24fd43	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_04d33bf63c2e591a329736b0b6a3bc97	No evidence text.	p(UP:O08678)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
4b8588e6-0ce6-418d-a0d0-4f439bf6aaeb	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_67eeb5765c89be9c03bfbcc567f0f01c	No evidence text.	p(UP:O08679)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
837909fd-6a8b-4a50-8b57-dd12cd7e6f9e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b3d39e920854eb35d35c53d58d8e2368	No evidence text.	p(UP:O08679)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
b14b95f6-b434-4372-af28-de5e39cd709d	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b4b296eaf7a5898c0eb2123d7a576443	No evidence text.	p(UP:O08679)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
6bd1ddfb-b51f-4153-b082-bea23bbec9ba	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_13b48368068cce7bbf371eea94e28327	No evidence text.	p(UP:O08679)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
e4e7ec03-87d8-4460-95e1-9b6b81daf430	0.65	PubMed	22952452	Milton knockdown increased the levels of active PAR-1 and tau phosphorylation at Ser262, and promoted detachment of tau from microtubules.	p(PFAM:PF12448)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
78abb44a-7e8a-4ab3-92f7-c4338e42f1eb	0.65	PubMed	18561615	[XREF_BIBR, XREF_BIBR] Morphine also promotes hyperphosphorylation of tau, a key component of neurofibrillary tangles.	a(PUBCHEM:23253564)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
aa3ddd38-1093-4f66-806f-d654c4788f9f	0.65	PubMed	13238296	These findings suggest that the endothelin-1-induced down-regulation of NaV1.7 diminishes NaV1.7-related catecholamine secretion and dephosphorylation of tau.	p(HGNC:NAV1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
07fd9903-c189-4049-aa4f-9da315f50a7b	0.65	Other	sparser:Unknown	These observations and our data together suggest that NGF promotes Ser 262 phosphorylation of tau by PKA in PC12 cells via enhancing intracellular 14-3-3ζ levels.	p(HGNC:NGF)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
2973d636-6eef-4772-bcd2-d37229072541	0.86	PubMed	17640395	The idea that Tau alteration is an H 2 O 2 -mediated process is also confirmed by results obtained in the presence of the more general ROS scavengers NAC and GSH-ester, which completely abolished Tau dephosphorylation.	a(CHEBI:7421)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2973d636-6eef-4772-bcd2-d37229072541	0.86	PubMed	10010223	Tau dephosphorylation is inhibited by the two-electron reductants NAC and GSH ester but not by SOD1.	a(CHEBI:7421)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
16366844-00c0-4654-a17d-520607cd80d5	0.95	PubMed	18439393	XREF_FIG illustrates that the ability of NMDA to induce Tau phosphorylation was totally abrogated in slices preexposed to the GluN2B antagonist RO25-6981 (1muM).	a(PUBCHEM:22880)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
16366844-00c0-4654-a17d-520607cd80d5	0.95	PubMed	18445309	Similarly, we observed that regulation of Tau phosphorylation by NMDA was minimally altered in slices pretreated with the cdk5 inhibitor Roscovitine (10muM).	a(PUBCHEM:22880)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
16366844-00c0-4654-a17d-520607cd80d5	0.95	PubMed	13939887	In the present study, pharmacological inhibitors were deployed to investigate potential processes by which the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors modulates Tau phosphorylation in rat hippocampal slices.	a(PUBCHEM:22880)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
16366844-00c0-4654-a17d-520607cd80d5	0.95	PubMed	18445309	NMDA Induced Regulation of Tau Phosphorylation : Role of Calcium and GSK3beta.	a(PUBCHEM:22880)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
16366844-00c0-4654-a17d-520607cd80d5	0.95	PubMed	17307818	In these structures, it has been shown that activation of NMDA glutamate receptor triggers Tau phosphorylation, thus regulating the interaction of Tau with the actin cytoskeleton, PSD95, and Fyn kinase (Ittner etal, 2010; Mondragon-Rodriguez etal, 2012; Frandemiche etal, 2014).	a(PUBCHEM:22880)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
acd75a25-aa35-4545-a306-d27a6743a122	0.65	PubMed	23579329	Nmnat2 attenuates Tau phosphorylation through activation of PP2A.	p(HGNC:NMNAT2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
41096fcd-ee5c-429f-ab60-b12842e250fe	0.86	Other	sparser:Unknown	Therefore, we performed double immunolabeling with Notch1 and phosphorylated Tau (p-Tau) and counterstaining with Thioflavin T. We observed a nearly complete overlap of Notch1 with p-Tau in plaque-like structures (Fig. xref ).	p(HGNC:NOTCH1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
41096fcd-ee5c-429f-ab60-b12842e250fe	0.86	PubMed	PMC16849885	Therefore, we performed double immunolabeling with Notch1 and phosphorylated Tau (p-Tau) and counterstaining with Thioflavin T. We observed a nearly complete overlap of Notch1 with p-Tau in plaque-like structures (Fig. xref ).	p(HGNC:NOTCH1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d5b568f1-d974-44c9-b4f7-adb7a9a322a4	0.65	PubMed	18771167	Small Molecule p75 NTR Ligands Reduce Pathological Phosphorylation and Misfolding of Tau, Inflammatory Changes, Cholinergic Degeneration, and Cognitive Deficits in AbetaPP L/S Transgenic Mice.	p(PFAM:PF01759)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ce113fe0-badd-4647-b4e7-5112a719d435	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_800430ebdcd13241eea58860af430c9b	No evidence text.	p(HGNC:NUAK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
f63b0076-6401-48ea-a6e7-ff7a08ee147c	0.99	PubMed	17778208	Recent studies have identified another kinase, Nuak1, which also phosphorylates Tau on S356 and hence shares a phospho-target site with MARK kinases.	p(HGNC:NUAK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
f63b0076-6401-48ea-a6e7-ff7a08ee147c	0.99	Other	sparser:Unknown	This last observation holds true in the context of Nuak1, where we showed how tau phosphorylation at Ser356 by Nuak1 primes tau for the subsequent phosphorylation at other pathological sites.	p(HGNC:NUAK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
f63b0076-6401-48ea-a6e7-ff7a08ee147c	0.99	Other	sparser:Unknown	Therefore, we performed an immunoprecipitation assay to test if a similar mechanism occurs when tau is phosphorylated at Ser356 by Nuak1.	p(HGNC:NUAK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
f63b0076-6401-48ea-a6e7-ff7a08ee147c	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d943c7f548ac4fa60e87a4f32a7a28fa	No evidence text.	p(HGNC:NUAK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
4f57c3a2-9e16-44d8-932c-85b345860b41	0.65	Other	sparser:Unknown	Nuak1 did not phosphorylate tau at Thr212, Thr231 Ser214, Ser262 or Ser396, which are known sites for phosphorylation by other AMPK-related kinases ( xref ; xref ; xref ) (data not shown).	p(HGNC:NUAK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
9b1e9b72-404d-4124-83fa-6fecdc1f10a2	0.65	Other	sparser:Unknown	Transgenic mice expressing human ACT alone or ACT along with mutant human amyloid precursor protein (APP) showed a significant increase in tau phosphorylation, suggesting that this inflammatory protein can induce tau hyperphosphorylation.	p(HGNC:NUP214)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
828dbd66-ca4d-4cf3-af6a-3b6257daa916	0.65	PubMed	18437544	In fact, when normalized with Tau-5 (an antibody that recognized phosphate independent epitopes of Tau), it became evident that overtime NVP elevated phosphorylated Tau levels at its Ser199 site, with a maximal increase observed in slices preincubated for a period of 2 hours (n = 5, P <.01).	a(PUBCHEM:4463)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
527cfa9a-ab3f-4936-b2ae-a4a6887668a6	0.86	PubMed	18273520	Thornton et al. provided evidence that Abeta 1-42 activates AMPK via the N-methyl-D-aspartate (NMDA) receptor, which in turn leads to the hyperphosphorylation of tau, a hallmark of AD 48, although the authors did not show changes in autophagy upon the activation of AMPK in response to Abeta.	a(PUBCHEM:22880)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
527cfa9a-ab3f-4936-b2ae-a4a6887668a6	0.86	PubMed	18445309	In the present study, pharmacological inhibitors were deployed to investigate potential processes by which the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors modulates Tau phosphorylation in rat hippocampal slices.	a(PUBCHEM:22880)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7e1c9b3d-49b5-4649-bfa5-ec8d6b542e8a	0.86	PubMed	4704157	OA increased the phosphorylation of tau at Thr-231 and Ser-235 and Ser 3961404, but not at Ser 262/356 or Ser 199/202.	a(CHEBI:44658)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
7e1c9b3d-49b5-4649-bfa5-ec8d6b542e8a	0.86	PubMed	21011048	OA increased the phosphorylation of tau at Thr-231 and Ser-235 and Ser 396/404, but not at Ser 262/356 or Ser 199/202.	a(CHEBI:44658)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
17aa8bdc-d506-4023-abff-a89c090e42f2	0.65	PubMed	16067947	We found that Okadaic acid (OA) induced the hyperphosphorylation of tau protein at Ser199, Ser396, Thr205, and Thr231 and produced oxidative stress to the HT22 cells.	a(CHEBI:44658)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
63113e1a-2832-4ad1-9b09-bded9112979f	0.65	Other	sparser:Unknown	However, in our model, we have not observed any variations of Tau phosphorylation and GSK-3 β activation, suggesting that an AD brain environment might be necessary for TD-dependent phosphorylation of Tau.	p(UP:Q9ZSS6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6f598e82-6f68-4120-89d7-e03e2a3a2afe	0.86	PubMed	16851072	Otub1 increases total Tau concentration and Tau phosphorylation in primary neurons.	p(HGNC:OTUB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6f598e82-6f68-4120-89d7-e03e2a3a2afe	0.86	PubMed	16851072	Otub1 promotes Tau phosphorylation and oligomerization invivo in Tau transgenic mice.	p(HGNC:OTUB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
40164c2e-e892-4331-b5e5-7a5a0116ab60	0.65	PubMed	20553266	98 to this paper we demonstrate that the p42 isoform of MAP kinase phosphorylates tau protein in a simii-ar manner to that observed in Alzheimer 's disease, a : : judged by a large reduction in gel mobility, and the phosphorylation of serine 39G and serines-199 and/or -202, two of the sites that are abnormally phosphorylated in tau from PHFs [2,8].	p(HGNC:PA2G4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	PubMed	21439371	AT8 and AT100 label phosphorylated Tau epitopes : AT8 specifically detects phospho-serine 202 and phospho-threonine 205, while AT100 recognizes the pathological phospho-Tau epitopes at serine 212 and threonine 214.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Over-activation of CDK5 in young transgenic animals does not induce tau hyperphosphorylation at sites recognized by the antibodies AT8, AT100, PHF-1 and TG3, while increased GSK3β activity coincides with tau hyperphosphorylation at the AT8 and PHF-1 sites, which reveales the role of GSK3β as a key mediator of tau hyperphosphorylation, whereas CDK5 acts as a modulator of tau hyperphosphorylation via the inhibitory regulation of GSK3β [ xref ].	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	PubMed	PMC15556754	Tau phosphorylation at the AT8 sites was also increased.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Tau phosphorylation at the AT8 sites was also increased.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Pb at 5 μg/dL substantially increased tau phosphorylation at AT8 and AT-180 sites, whereas, phosphorylation at these sites was not substantially affected by 20 μg/dL Pb (Fig.  xref c, d).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	There was a sharp spike in both p38α MAPK and AT8 site tau phosphorylation at the 40-min time point (Fig.  xref , i).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	In contrast to MW181, SB239063 showed a biphasic effect with an initial drop in the p-p38α MAPK and AT8 site tau phosphorylation at 20 min and then again at 60 min after Cx3cr1  –/– CM treatment (Fig.  xref , i).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Biochemical analysis further confirmed increased AT8-positive Tau by Otub1 expression (Fig.  xref b), with AT8 phosphorylated Tau more robustly increased than total Tau, as reflected by the AT8/total Tau ratio.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	We next determined the relationship between PAD exposure and AT8 phosphorylation in tau since this modification rendered soluble tau monomers toxic to FAT (see above).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	The ability of LM11A-31 to decrease MC-1 signal indicates that its effect on reducing tau phosphorylation at the AT8 site, and possibly at additional tau sites, may be significant in terms of preventing aberrant folding.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Transgenic mice that express both the activator and Tau P301L transgenes show increased levels of Tau phosphorylation at the AT8 site and develop neurofibrillary tangles by 7 months of age xref .	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Weak labeling for AT8-phosphorylated tau was detectable under control conditions primarily in hilar neurons of the dentate gyrus and CA3 pyramidal neurons ( xref ).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Inducing tau phosphorylation at the AT8 site in MAPK-transfected cells required 2-10 times more OKA than CAL, suggesting both PP1 and PP2A helped block the phosphorylation.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Tau phosphorylation at AT8 sites (Ser202 and Thr205), which belongs to our group 1 and group 2 sites, has been reported during this active neurite outgrowth period ( xref ).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	To determine whether sNEP-NSCs can alter tau pathology in aged 3xTg-AD mice we quantified the levels of AT8 phosphorylated tau (ser199/202) within the hippocampus.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	In our study although we observed a pGSK3-β increase in LPS-treated mice which was not associated with increased tau phosphorylation at the AT8 site.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	By contrast, in anti-aggregant animals there was no impairment in basal synaptic transmission or in bouton diameter although endogenous Tau became phosphorylated at AT8 and AT180 site.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Thus, Tau phosphorylation at the AT8 sites may have meaningful effects on mitochondrial movement, likely by controlling microtubule spacing.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	PubMed	PMC4116239	Inducing tau phosphorylation at the AT8 site in MAPK-transfected cells required 2-10 times more OKA than CAL, suggesting both PP1 and PP2A helped block the phosphorylation.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Notably, exposure of primary neurons to CM fromCx3cr1 −/− microglia resulted in enhanced levels of MAPT phosphorylation at both the AT8 and PHF1 sites ( xref ).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	This finding is consistent with our previous data showing that the phosphorylation of 0N4R tau at the AT8 site did not negatively affect its association with Fyn or Src SH3 domain ([ xref ] and unpublished data).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Six-month-old hTau-Cx3cr1 −/− mice exhibited significantly increased MAPT phosphorylation on AT8, AT180 and PHF1 sites when compared to age-matched hTau mice ( xref ), while detergent soluble total MAPT levels remained unchanged ( xref ).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Co-cultures of neurons with wild-type microglia significantly induced MAPT phosphorylation at the AT8 site compared to neurons alone, while co-culture of CX3CR1 deficient microglia with neurons further increased the levels of AT8 MAPT epitopes ( xref ).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	PubMed	18640938	While H-LPS induces AT8 and AT180 site phosphorylation of MAPT in Cx3cr1 +/+ and Cx3cr1 -/- mice, these effects were completely blocked in both Tlr4 -/- (XREF_FIG) and Il1r1 -/- mice (XREF_FIG).	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Numerous disease-associated forms of tau exist in which PAD is expected to be exposed, including tau aggregates, short N-terminal isoforms, AT8 phosphorylated tau and mutant tau.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	PubMed	PMC3253157	Of tau phosphorylated at the mAb AT8 site, only 12% was found to co-sediment with PHFs.	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
64231fd1-3dbf-4b08-9f92-282f741b1d1c	0.99	Other	sparser:Unknown	Intriguingly, tau phosphorylation at the AT8 sites affects mitochondrial movement likely by controlling microtubule spacing [ xref ].	p(UP:Q9SI18)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4a4315d7-6131-4d91-8e9c-f249b0925340	0.86	PubMed	12280045	The results suggest that the inhibition of PARP-1 by 3-AB could decrease tau phosphorylation in HEK293 and tau441 cells probably through decreasing GSK-3 activity.	p(HGNC:PARP1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4a4315d7-6131-4d91-8e9c-f249b0925340	0.86	PubMed	22193445	The results suggest that the inhibition of PARP-1 by 3-AB could decrease tau phosphorylation in HEK293 and tau441 cells probably through decreasing GSK-3 activity.	p(HGNC:PARP1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8a3f9d32-9503-41c1-96f5-31b0e8e9aa3a	0.65	Other	sparser:Unknown	Interestingly, astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons (Saez et al., xref ).	a(PUBCHEM:145068)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
400eece3-ac26-4c3e-a5d7-4908fe5064d8	0.92	Other	sparser:Unknown	Using amyloid precursor protein (APP) and presenilin 1 (PS1) double transgenic mouse brain as a model system, we investigated the effects and potential mechanisms of intranasal administration of DFO on iron induced abnormal tau phosphorylation.	a(PUBCHEM:23925)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
400eece3-ac26-4c3e-a5d7-4908fe5064d8	0.92	Other	sparser:Unknown	Cumulatively, our data show that intranasal DFO treatment exerts its suppressive effects on iron induced tau phosphorylation via CDK5 and GSK3β pathways.	a(PUBCHEM:23925)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
400eece3-ac26-4c3e-a5d7-4908fe5064d8	0.92	Other	sparser:Unknown	Aside from the amyloid based model for AD, iron enhanced phosphorylation of Tau and the formation of the neurofibrillary tangles associated with the AD brain ( xref ).	a(PUBCHEM:23925)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5b35fc0c-52fb-4fbe-b5bf-03fd5e42ceab	0.65	PubMed	20720012	Furthermore, we have demonstrated that p5 reduced Abeta (1-42)-induced Tau hyperphosphorylation and apoptosis in cortical neurons.	p(HGNC:PDIA6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f52e4034-a00c-4da1-9ff1-c7fa65589e10	0.94	PubMed	21127069	PD associated alpha synuclein mutations increase alpha-synuclein binding to Tau and stimulate Tau phosphorylation at Ser (262).	bp(MESH:D010300)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
f52e4034-a00c-4da1-9ff1-c7fa65589e10	0.94	PubMed	21127069	Our results demonstrate that alpha-synuclein is an in vivo regulator of Tau protein phosphorylation at Ser (262) and suggest that PD associated risk factors such as environmental toxins and alpha synuclein mutations promote Tau phosphorylation at Ser (262), causing microtubule instability, which leads to loss of dopaminergic neurons in PD brain.	bp(MESH:D010300)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
f52e4034-a00c-4da1-9ff1-c7fa65589e10	0.94	PubMed	11440755	PD associated alpha synuclein mutations increase alpha-synuclein binding to Tau and stimulate Tau phosphorylation at Ser (262).	bp(MESH:D010300)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
f52e4034-a00c-4da1-9ff1-c7fa65589e10	0.94	PubMed	11440755	Our results demonstrate that alpha-synuclein is an in vivo regulator of Tau protein phosphorylation at Ser (262) and suggest that PD associated risk factors such as environmental toxins and alpha synuclein mutations promote Tau phosphorylation at Ser (262), causing microtubule instability, which leads to loss of dopaminergic neurons in PD brain.	bp(MESH:D010300)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
c4056b4d-51f3-45b8-9c50-b6edb6483760	0.65	PubMed	15126504	Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells.	a(PUBCHEM:4713)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
60a2b763-d2a8-4723-9126-6201545364dd	0.86	Other	sparser:Unknown	It is also possible that tau propagation may be mediated via glial cells, since cytosolic tau accumulations are observed in neurons surrounded by activated microglia ( xref ) and astrocytes promote tau phosphorylation in neighboring neurons ( xref ).	p(HGNC:PEA15)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
60a2b763-d2a8-4723-9126-6201545364dd	0.86	Other	sparser:Unknown	We further demonstrated that IGFBP-3 produced by astrocytes induced tau phosphorylation in neurons.	p(HGNC:PEA15)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4bf5e75d-f024-4912-b20f-011c913901b3	0.65	Other	sparser:Unknown	The tau mutation increases PER1 and PER2 phosphorylation, increasing proteasomal degradation, and shortening the circadian period [ xref ].	p(HGNC:PER1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
82fcc0f4-55f1-4199-a524-429e6861faf0	0.65	PubMed	6129617	PG stimulate the processing and aggregation of amyloid-beta (Abeta), protect the protein from proteolysis, and increase the formation of neurofibrillary tangles by inducing the hyperphosphorylation of tau protein.	a(PUBCHEM:6426709)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	No significant differences in the levels of Tau phosphorylated at 12E8 and PHF1 sites was detected between exosomes from AD and from controls (Fig.  xref , c2, c3).	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	Indeed, incubation of wild-type and S1P-lyase-deficient neurons with cimes and S1P, respectively, results in an enhanced tau phosphorylation at the PHF-1 site (S396 and S404) ( xref ).	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	Cells transfected with mutant G309D PINK1 exhibited a significant increase in the phosphorylation of tau protein at the PHF-1 (ser396/404) site.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	However, in old transgenic animals the inhibition of GSK3 is lost and results in increased GSK3 activity, which coincides with tau hyperphosphorylation at the AT8 and PHF-1 sites.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	In other mouse models of Hsa21 trisomy, Ts65Dn and Ts1Cje, and mouse models of DYRK1A overexpression, significant aberrant phosphorylation of tau at PHF1 and AT8 sites has been observed ( xref ).	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	GSK3β activity is believed to coincide with tau hyperphosphorylation at the AT8 and PHF-1 sites [ xref ].	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	PubMed	PMC8253229	In contrast, c-jun N-terminal kinase (JNK) as activated in the mitotic phase directly hyperphosphorylates R406W tau at the PHF-1 site.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	PubMed	PMC8253229	This was confirmed by PHF-1 hyperphosphorylation of R406W tau in mitotic cells, its association with cytoplasmic JNK activation, and its inhibition by a JNK inhibitor, SP600125.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	PubMed	PMC8253229	These data unveil the unknown mechanisms of physiological tau phosphorylation at the PHF-1 site and suggest that cytoplasmic JNK activation may play an important role in the abnormal tau hyperphosphorylation associated with R406W tau mutation and in AD.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	PubMed	PMC6685379	Whereas the basal phosphorylation of tau protein at the PHF1 site seems to be largely mediated by glycogen synthase kinase-3 (which is also activated in response to Abeta peptide), the acrolein-induced tau hyperphosphorylation at the same site is also due to p38 stress-activated kinase.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	PubMed	16935554	Interestingly, PHF1 site phosphorylation of tau was also completely abolished with MW181 pretreatment.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	Interestingly, PHF1 site phosphorylation of tau was also completely abolished with MW181 pretreatment (Fig.  xref ).	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	Whereas the basal phosphorylation of tau protein at the PHF1 site seems to be largely mediated by glycogen synthase kinase-3 (which is also activated in response to Abeta peptide), the acrolein-induced tau hyperphosphorylation at the same site is also due to p38 stress-activated kinase.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	Taken together the most prominent effect of CDK5 knockdown is on PHF1 hyperphosphorylated Tau in the sarkosyl insoluble fraction.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	This was confirmed by PHF-1 hyperphosphorylation of R406W tau in mitotic cells, its association with cytoplasmic JNK activation, and its inhibition by a JNK inhibitor, SP600125.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	In contrast, c-jun N-terminal kinase (JNK) as activated in the mitotic phase directly hyperphosphorylates R406W tau at the PHF-1 site.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	PubMed	PMC6784404	It is implicated that (1) PP2A and PP1 participate in the in vivo regulation of tau phosphorylation, and down-regulation of the two phosphatases will result in tau hyperphosphorylation; (2) hyperphosphorylation of tau at PHF-1 and 12E8 sites might be crucial to affect spatial memory in AD.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	As shown in xref , the significantly increased PP2Ac-Yp307 levels were observed after PTP1B silencing, in parallel to a significant decrease in PP2A activity (∼50%) and tau phosphorylation at PHF-1 sites.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	In a similar manner to Aβ, up-regulated PP2A phosphorylation (Y307) was found in the brains of ERβ −/– mice, which corresponds to increased tau phosphorylation at PHF-1 sites and decreased tau dephosphorylation at Tau-1 sites.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	Due to high heterogeneity in the level of tau phosphorylation at the PHF-1 phospho-site in this study, the difference between the two groups of animals was not statistically significant.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
95e58c41-eefd-432e-ad5d-febbc8d2b4db	0.98	Other	sparser:Unknown	In addition, the presence of Tau phosphorylated at 12E8 and PHF1 sites in CSF-derived exosomes is in contrast to the absence of such tau species in exosomes derived from cultured neurons.	p(HGNC:PHF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4bbc8a34-bdfd-400c-a468-c20ba2e3cd57	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_47a64927c297f0b694094912b90fcb56	No evidence text.	p(UP:P00518)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
47dd05b8-26e6-4742-ab7e-e4e1bba9a3f0	0.88	Other	sparser:Unknown	It thus appears that Pho85 does not phosphorylate tau directly in yeast.	p(UP:Q751E8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
47dd05b8-26e6-4742-ab7e-e4e1bba9a3f0	0.88	PubMed	17082609	It thus appears that Pho85 does not phosphorylate tau directly in yeast.	p(UP:Q751E8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	From microtubule pro-  tein we have purified a protein kinase phosphorylating  tau into the PHF-like state [1,2].	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	The enzyme is a Ser/Thr protein  kinase phosphorylating tau, l~-tubulin, MAP2 and ~-casein.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	We have shown recently that a novel protein kinase, termed p110 microtubule-affinity regulating kinase (&quot;MARK&quot;), phosphorylates microtubule-associated protein tau at the KXGS motifs in the region of internal repeats and causes the detachment of tau from microtubules (Drewes, G., Trinczek, B., Illenberger, S., Biernat, J., Schmitt-Ulms, G., Meyer, H.E., Mandelkow, E.-M., and Mandelkow, E. (1995) J. Biol.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	The enzyme is a Ser/Thr protein kinase phosphorylating tau, β-tubulin, MAP2 and α-casein.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	The enzyme is a Ser/Thr protein kinase phosphorylating tau, beta-tubulin, MAP2 and alpha-casein.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	We show that the sequential phosphorylation of recombinant tau by cAMP-dependent protein kinase (PKA) and the stress-activated protein kinases SAPK4/p38delta or JNK2 generated the AT100 epitope and that this required phosphorylation of T212, S214 and T217.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	Data from gas phase sequencing, amino acid analysis, and phosphoamino acid analysis suggest that proline-directed protein kinase phosphorylates tau at four sites.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	Comparison of S-100b protein with calmodulin: interaction with melittin and microtubule-  associated tau proteins and inhibition of phosphorylation of tau proteins by protein kinase.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	We have analyzed the in vitro phosphorylation of tau protein by Ca2+/calmodulin-dependent protein kinase, casein kinase II, and proline-directed serine/threonine protein kinase.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	The dual-specificity tyrosine phosphorylation-regulated kinase-1A (Dyrk1a) is a protein kinase that phosphorylates the amyloid precursor protein (APP) and tau and thus represents a link between two key proteins involved in AD pathogenesis.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	The dual‐specificity tyrosine phosphorylation‐regulated kinase‐1A (Dyrk1a) is a protein kinase that phosphorylates the amyloid precursor protein (APP) and tau and thus represents a link between two key proteins involved inADpathogenesis.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	Thus, GSK3 beta is a protein kinase that phosphorylates tau protein in intact cells.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	Tau may also be phosphorylated by cyclin-dependent protein kinase 5 (cdk5), cAMP-dependent protein kinase (PKA), and stress-activated protein kinases [ xref ].	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	PMC5017424	Heparin stimulated tau phosphorylation by neuronal cdc2-like kinase (NCLK) and cAMP-dependent protein kinase.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	PMC3910423	Here we show that recombinant human tau can be phosphorylated by cAMP-dependent protein kinase resulting in decreased electrophoretic mobility.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	PMC3204194	A single protein kinase, glycogen synthase kinase 3 (GSK 3), is able to phosphorylate tau at the flanking regions and, additionally, at the tubulin-binding motifs if heparin or tubulin is present.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	A single protein kinase, glycogen synthase kinase 3 (GSK 3), is able to phosphorylate tau at the flanking regions and, additionally, at the tubulin-binding motifs if heparin or tubulin is present.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	PMC3207259	The enzyme is a Ser/Thr protein kinase phosphorylating tau, beta-tubulin, MAP2 and alpha-casein.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	Phosphorylation of tau by different kinases  We have examined the time course of phosphorylation of  human tau 39 (three tandem C-terminal repeats plus a 58-  amino acid N-terminal insert) by a proline-dependent protein  kinase (PDPK), GSK-3, and several non-PDPKs (A-kinase,  C-kinase, CK-1, CK-2, CaM kinase II) (Fig. 1A).	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	PMC3700508	To study the effect of phosphorylation and substrate modulation on tau&apos;s distinct activities to promote growth of existing microtubules and nucleation of new ones, we phosphorylated bacterially expressed human tau by cAMP-dependent protein kinase in the absence or presence of heparin, an acidic substrate modulator.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	PMC3818706	Phosphorylation of tau by the proline-directed protein kinase completely blocked immunoreactivity with antibody SMI33.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	PMC3818706	Antibody SMI33 recognizes neurofibrillary tangles after treatment with alkaline phosphatase, suggesting that the proline-directed protein kinase may phosphorylate tau at sites that are phosphorylated in Alzheimer's disease.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	PMC3950119	Thus, GSK3 beta is a protein kinase that phosphorylates tau protein in intact cells.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	7931292	Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer 's disease brain.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	To study the effect of phosphorylation and substrate modulation on tau&apos;s distinct activities to promote growth of existing microtubules and nucleation of new ones, we phosphorylated bacterially expressed human tau by cAMP-dependent protein kinase in the absence or presence of heparin, an acidic substrate modulator.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	The protein kinase C-mediated phosphorylation of tau reduced its abilities to promote tubulin polymerization and to cross-link actin filaments.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	PubMed	PMC3984846	We have shown recently that a novel protein kinase, termed p110 microtubule-affinity regulating kinase (&quot;MARK&quot;), phosphorylates microtubule-associated protein tau at the KXGS motifs in the region of internal repeats and causes the detachment of tau from microtubules (Drewes, G., Trinczek, B., Illenberger, S., Biernat, J., Schmitt-Ulms, G., Meyer, H.E., Mandelkow, E.-M., and Mandelkow, E. (1995) J. Biol.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	Antibody SMI33 recognizes neurofibrillary tangles after treatment with alkaline phosphatase, suggesting that the proline-directed protein kinase may phosphorylate tau at sites that are phosphorylated in Alzheimer's disease.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b6bb8262-28cf-4035-ae8d-3786431514fa	0.98	Other	sparser:Unknown	Phosphorylation of tau by the proline-directed protein kinase completely blocked immunoreactivity with antibody SMI33.	p(UP:P25848)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0d70f6fd-fbd6-45a4-bac5-7948983ad293	0.86	PubMed	18360106	Our data suggested that abnormally upregulated PI3K signaling can forcefully increase tau phosphorylation at the two Akt sites that may play a key role in the pathogenesis of tauopathies, a notion that is supported by the observation that a higher Akt activity and loss of PTEN are indeed found in postmortem AD brains [XREF_BIBR, XREF_BIBR].	p(FPLX:PI3K)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0d70f6fd-fbd6-45a4-bac5-7948983ad293	0.86	PubMed	16014629	In addition, it has been documented that PS1 positively regulates, whereas PS1 familial Alzheimer disease mutations suppress, phosphatidylinositol 3-kinase (PI3K)/Akt activation, a pathway known to inactivate glycogen synthase kinase-3 and reduce tau phosphorylation.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
cc27a5cc-8a74-4202-a0b6-2c438e6e9955	0.65	PubMed	21726674	Further studies by Lu et al., showed that overexpression of Pin1 leads to decreased phosphorylation of Tau protein [XREF_BIBR], and suggests that Pin1 might be a promising therapeutic target to delay or combat this devastating disorder.	p(HGNC:PIN1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7b3737b7-0b37-4964-a829-635b1e18c02e	0.65	Other	sparser:Unknown	Notably, we found that mutant G309D PINK1 significantly reduced phosphorylation of GSK3β at serine 9, suggesting that alterations in GSK3β activity play an essential role in mutant G309D PINK1-induced tau phosphorylation at the PHF-1 site.	p(HGNC:PINK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
31a7690f-e07b-49ba-a826-c6655602754a	0.65	PubMed	PMC6902800	The treatment of tau by PKA and GSK-3 combination induced phosphorylation of tau at Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356, Ser-404, whereas Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400 were phosphorylated by GSK-3 alone under the same condition.	p(FPLX:PKA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 512))
62f01e89-1f30-44f6-aeed-3af968309fb1	0.65	PubMed	6902800	Phosphorylation of tau by PKA plus GSK-3 at Thr 205 might play a key role in tau pathology in AD.	p(FPLX:PKA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
a9cf21a9-b44f-4b08-b0b4-8a03963795cf	0.92	PubMed	24436131	In this regard, we studied the glycogen synthase kinase 3 (GSK3beta), p38 mitogen activated protein kinase (p38) and cAMP dependent protein kinase (PKA) proteins which are all able to phosphorylate TAU at the Thr231 site (Wang et al., XREF_BIBR).	p(FPLX:PKA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
a9cf21a9-b44f-4b08-b0b4-8a03963795cf	0.92	PubMed	18039702	In this regard, we studied the glycogen synthase kinase 3 (GSK3beta), p38 mitogen activated protein kinase (p38) and cAMP dependent protein kinase (PKA) proteins which are all able to phosphorylate TAU at the Thr231 site.	p(FPLX:PKA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
a9cf21a9-b44f-4b08-b0b4-8a03963795cf	0.92	PubMed	18039702	A different pattern was observed for PKA, wherein the use of the PKA activator forskolin was able to induce TAU Thr231 phosphorylation in DUSP22 shRNA depleted cells (2.2 +/- 0.5), but not in DUSP22 overexpressing SK-N-BE (2) cells (0.8 +/- 0.3) (XREF_FIG d).	p(FPLX:PKA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
38583865-3839-4d90-8c77-5de88e3e9636	0.65	Other	sparser:Unknown	The mechanism involves Aβ oligomer (AβO) induced activation in parallel of three protein kinases - fyn, protein kinase A (PKA) and calcium/calmodulin-activated kinase II (CaMKII) -which then must respectively phosphorylate tau at Y18, S409 and S416.	p(FPLX:PKA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
ac46dec1-001c-43a9-9b92-c1b44bf14f41	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8e75c2ff786b785a39712c7bb8b7f5ae	No evidence text.	p(HGNC:PKN1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
10e81ee5-d4a9-441d-86aa-46b5d07d445a	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e3d2b53292e49077f966b11937a684c0	No evidence text.	p(HGNC:PKN1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 258))
84dba7d5-8bf0-4e5b-bc95-c00831f5d85a	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_70acb445e5e2919657d399539844be25	No evidence text.	p(HGNC:PKN1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 352))
728be2b9-4edc-4a0f-acb6-a26fd77147cb	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_0b0209852d11c7f0fa68e78c730cc099	No evidence text.	p(HGNC:PKN1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 726))
f6577046-a4ba-4b99-8094-018209080a38	0.65	PubMed	19472218	For comparison, we tested the PLTP effect on levels of pTau Ser356, showing that PLTP reduces phosphorylation of tau at serine 356 as well, but not to the same extent (XREF_FIG).	p(HGNC:PLTP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
9c728a60-ec17-4856-b287-cc5deaa89de1	0.94	PubMed	18813146	We also demonstrated that the full-length isoform (TS1), but not the shorter isoforms (TS2 and TS3) of PLXNA4 increased tau phosphorylation in SH-SY5Y cells stably expressing the P301L tau mutant and in primary rat neurons when stimulated by SEMA3A.	p(HGNC:PLXNA4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9c728a60-ec17-4856-b287-cc5deaa89de1	0.94	PubMed	18813146	PLXNA4 is Associated with Alzheimer Disease and Modulates Tau Phosphorylation.	p(HGNC:PLXNA4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9c728a60-ec17-4856-b287-cc5deaa89de1	0.94	PubMed	25043464	PLXNA4 is Associated with Alzheimer Disease and Modulates Tau Phosphorylation.	p(HGNC:PLXNA4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9c728a60-ec17-4856-b287-cc5deaa89de1	0.94	PubMed	25043464	We also demonstrated that the full-length isoform (TS1), but not the shorter isoforms (TS2 and TS3) of PLXNA4 increased tau phosphorylation in SH-SY5Y cells stably expressing the P301L tau mutant and in primary rat neurons when stimulated by SEMA3A.	p(HGNC:PLXNA4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c1f39633-b1bf-4598-b3cd-fa704539caef	0.65	Other	sparser:Unknown	Memory deficits were associated with a significant increase in pP38 MAPK-dependent tau phosphorylation at specific epitopes as recognized by the AT8 and PHF1 antibodies along with a significant accumulation of tau in its insoluble form.	p(UP:P68347)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
81a1a6f9-bab2-4863-b54c-12550f164dde	0.65	PubMed	21347323	PPARgamma activation has also been shown to reduce the phosphorylation of tau in vitro XREF_BIBR, whilst the overexpression of PPARgamma reduces the accumulation of Abeta XREF_BIBR, XREF_BIBR.	p(HGNC:PPARG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6cb527cc-173d-4cd7-b29c-fea0bb183dfe	0.86	PubMed	6115036	In addition, the expression of PBP increases the phosphorylation of tau in cultured cells.	p(HGNC:PPBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6cb527cc-173d-4cd7-b29c-fea0bb183dfe	0.86	PubMed	11696419	The expression of PBP increases tau phosphorylation in the human HEK293T fibroblast cell line but decreases GSK-3beta activity.	p(HGNC:PPBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
40542496-277b-45e1-ad1d-e251fcbd465c	0.65	PubMed	11696419	PBP specifically increased tau phosphorylation at ser199, and this effect was reversed by alkaline phosphatase treatment ().	p(HGNC:PPBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
857cbf6d-912b-48bd-b952-f5fea399a1a2	0.86	PubMed	21341502	Thus, it is likely that reduced PP-2A activity might not only induce a compromised PHF-tau dephosphorylation, but may also cause PHF-tau accumulation as a result of up-regulated p70 S6 kinase activation.	p(HGNC:PPP2CA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
857cbf6d-912b-48bd-b952-f5fea399a1a2	0.86	PubMed	12875979	It can not be ruled out that in tau transgenic mice the over-loading of beta-amyloid results in a stress to adjacent neurons, and subsequent activation of JNK that may phosphorylate tau to be a better substrate for other kinases such as cdk5, GSK-3, and MAPK.Protein-serine/threonine phosphatase 2A (PP-2A) is thought to be the main candidate phosphatase involved in neurofibrillary degeneration in AD brain.	p(HGNC:PPP2CA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
838597aa-bf7a-4325-a35c-4e003bdbf6c9	0.65	PubMed	16014719	Tyrosine phosphorylation of tau was inhibited by PP2 (4-amino-5-(4-chlorophenyl-7-(t-butyl) pyrazolo [3,4-d] pyrimidine), which is known to inhibit Src family kinases and c-Abl.	p(FPLX:PPP2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr))
1dd59c69-b0c3-4e2f-82c1-7ac9a066f614	0.86	PubMed	PMC2681289	Cyclic AMP dependent protein kinases and casein kinase (type I) phosphorylated tau proteins on different sites.	p(HGNC:PPP3R1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1dd59c69-b0c3-4e2f-82c1-7ac9a066f614	0.86	Other	sparser:Unknown	Cyclic AMP dependent protein kinases and casein kinase (type I) phosphorylated tau proteins on different sites.	p(HGNC:PPP3R1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
98fdd67e-4444-4938-a025-fe0ef2dc7672	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ca6d10b2bc7510b74d608677c138b51d	No evidence text.	p(HGNC:PRKAA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
3937f8cc-a4f6-42eb-bcb2-959606713222	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a09c926f4fe4771b236f911a586d05d9	No evidence text.	p(HGNC:PRKAA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
9000784e-63fd-4b73-8c78-05b59c209bd0	0.97	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_46965ed6b4aa403efbffb6af4c84c4e9	No evidence text.	p(HGNC:PRKAA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
9000784e-63fd-4b73-8c78-05b59c209bd0	0.97	Other	sparser:Unknown	Using HeLa cell lines and in vivo mouse models, Mairet-Coello and colleagues demonstrated that AMPKα1 phosphorylates tau on Serine 262 in response to Aβ42 oligomers.	p(HGNC:PRKAA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
9000784e-63fd-4b73-8c78-05b59c209bd0	0.97	PubMed	22074119	Using HeLa cell lines and in vivo mouse models, Mairet-Coello and colleagues demonstrated that AMPKalpha1 phosphorylates tau on Serine 262 in response to Abeta42 oligomers.	p(HGNC:PRKAA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
2b3871db-f28b-4144-96ee-3ee69599a5fa	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_79cb1189b5ab5a70128a5cbb91a26c18	No evidence text.	p(HGNC:PRKAA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
8ec837b8-23fa-4af9-9623-dc555f31f49c	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2ead378278b0c6da365cc695ea27e444	No evidence text.	p(HGNC:PRKAA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
d94d4958-d50d-4927-a3f6-c643822e08f2	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_3e3f0ac0baac6749452fd47856435a50	No evidence text.	p(HGNC:PRKAA1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
629dfb20-45cd-4c92-8358-e0ae2dc0b13c	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7a31e86d8fcc9a2ba3d66334ab51b30c	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
d8f7a38d-46a3-421f-b6b5-571f5923b2ff	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8a354118081e220b251cb0abb55818bd	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 512))
73a53d70-6b04-49e3-91cf-65195e37dea9	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_32a450bf84cbec9ae8fa06fdeb14d311	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 515))
b5c001ba-023a-44a0-9822-f66f6143971b	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_51a28fa6d40f13507fbee75aef9f7ecc	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
86a62d0c-02ae-4972-bc14-7553f914667f	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b65c18351ff4894b8e9f5cf68e04ba50	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
cda56d77-1896-4044-9962-72c835d95ad8	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_582b686bcd29533c72cd608329e48ed6	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
8241b4bf-3071-416d-81ad-f686f66629bc	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_efe550f3d1cff7400a4d7d9315c47528	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
79390476-6f02-4794-a465-77ba899fc4e5	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9d1e8b863cbac5b9998721392175af24	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
4f6c2a4e-9e98-45c7-ac5b-4b5ba1e2c452	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_076cda61aa9c1f90f3005cc40550890a	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 726))
515d7d07-bd9d-4334-b70f-fb1a84ea610c	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a633aba7c0daad799d3e744a3d743083	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
d004a410-5f20-4e9d-a560-6f338e9008e1	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d4c6162938a12f65e179ae3b5d1c2e3f	No evidence text.	p(UP:P00517)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
cbd80850-3f69-4f52-a46f-20d732822d95	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_e6fb903c3e561c11c0820372676ffaf6	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
9fa43d66-98e3-457b-820e-f38ee91bf73b	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d85e57b5252d2460fe418fdc81f5d692	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 531))
9fa43d66-98e3-457b-820e-f38ee91bf73b	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7f9a2dffe5ad608da03ada0030dcbd82	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 531))
93ea30e6-f1da-44c2-8951-7417876f20c8	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b66c3e4fc20a86980079d5c9169b4f3c	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
93ea30e6-f1da-44c2-8951-7417876f20c8	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_3199a2def2f9d2c466acce87500b53a6	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
7973a7ad-a71b-4a18-9bc0-8df88a1e29b1	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b516b6d4819567484b0bf48a33c86da0	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
c9205f83-45fd-48bc-9b9b-13d128203c1a	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f93def9d7d58b00299172828a2dbf9c0	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 622))
2f7e1c5c-eafe-4065-bf39-f88362516523	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_452b7449420d44bc10af2cb8631fbd0c	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 633))
2741d4d5-1b79-49ab-b52f-67d15e3b3f6e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ff9f2aaef809c4642ad13f5e3b5b3886	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
b5b57359-8152-46a7-b7cb-eab4a7ca1d6f	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_815bab108a89bb5ecb9163348804effa	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
b5b57359-8152-46a7-b7cb-eab4a7ca1d6f	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_748cb2d96e704300ea3e62a4630a5a55	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
b5b57359-8152-46a7-b7cb-eab4a7ca1d6f	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_1db3dfd344083ae74842d8059a640ec1	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 673))
828fb150-a6a3-4cab-bbc4-6320d7012343	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_bcf75dd63d0d1c337aa7dfb9a67e4fc9	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 726))
828fb150-a6a3-4cab-bbc4-6320d7012343	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_02285cea0916eefbe16e07f66b51c32b	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 726))
828fb150-a6a3-4cab-bbc4-6320d7012343	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b3013cc8e17c3d23be36837de2c00db8	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 726))
828fb150-a6a3-4cab-bbc4-6320d7012343	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7f66c968eea7ebfdb5f7689937d51063	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 726))
06e43455-2caa-4647-a06e-3f7fd605e8fa	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a20e6e3898038bd11ae2fd76f8d16fcf	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 733))
8be05f58-3284-44dd-8b18-435124e993dc	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8c728b3e71cb7a554a224ce2e4c99814	No evidence text.	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 245))
d9ac56c2-7564-4cdc-9a5b-7045e92dc2ee	0.92	PubMed	PMC3910423	Phosphorylation of tau by cAMP-dependent protein kinase caused a 92% decrease in the maximum rate of tau-induced microtubule assembly.	p(HGNC:PRKACG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d9ac56c2-7564-4cdc-9a5b-7045e92dc2ee	0.92	PubMed	PMC5231487	The present study demonstrates by immunohistochemical analysis, CP-3 and PG-5 immunoreactivity with neurofibrillary pathology in both early and advanced Alzheimer&apos;s disease, but not in normal brain tissue and demonstrates that cAMP-dependent protein kinase phosphorylations on tau precede or are coincident with the initial appearance of filamentous aggregates of tau.	p(HGNC:PRKACG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d9ac56c2-7564-4cdc-9a5b-7045e92dc2ee	0.92	Other	sparser:Unknown	The present study demonstrates by immunohistochemical analysis, CP-3 and PG-5 immunoreactivity with neurofibrillary pathology in both early and advanced Alzheimer&apos;s disease, but not in normal brain tissue and demonstrates that cAMP-dependent protein kinase phosphorylations on tau precede or are coincident with the initial appearance of filamentous aggregates of tau.	p(HGNC:PRKACG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
cb4813ad-9007-4c15-a13f-7e8c619b90d4	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2442f1ad7d983f4df328ce77f908d942	No evidence text.	p(HGNC:PRKCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 258))
b68c38e6-7fe1-47e2-ba61-346a6e0ebfa5	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_35061051297fcda6b187d2382a6ef8e8	No evidence text.	p(HGNC:PRKCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 352))
26e4b533-cd4a-43d0-bea1-23105b0639c5	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9618e18cc48be5adf0e16d72b747ec97	No evidence text.	p(HGNC:PRKCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
4896d42f-d7e6-45f4-8818-2319587ac5f8	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_5bc8485070ca38d15bd2d5065f1f1393	No evidence text.	p(HGNC:PRKCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 622))
f4fe1465-38d3-4b2c-b5c8-0ba9795d09fe	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_96727a7693a0fa9b44f2c182f8e6a01b	No evidence text.	p(HGNC:PRKCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
bf28bb1b-aa3d-41ef-8427-4820b1db2697	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d5c08cb957c9243c04917e2cae9276ad	No evidence text.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 258))
bf28bb1b-aa3d-41ef-8427-4820b1db2697	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f79fd088d8e1b5722a5c5d084ef26354	No evidence text.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 258))
4e4071e5-3495-4252-a7f9-d09311605f6b	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7f58e65bdd191bd2d1e9f177a570632c	No evidence text.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 352))
4e4071e5-3495-4252-a7f9-d09311605f6b	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7422876249fbf0ec6567eeb1b3323a4f	No evidence text.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 352))
96b67ac5-6833-499c-94d5-ece1fb9747ac	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d038b79bff01948265ac5a0d5065fe75	No evidence text.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
96b67ac5-6833-499c-94d5-ece1fb9747ac	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_5e20678a5a1c1d27f2b9e21d12c27497	No evidence text.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
185d43a4-9610-42e1-814d-06421fa3f8b0	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_98b18589d8baacdd5fd9a076cbd2b582	No evidence text.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
185d43a4-9610-42e1-814d-06421fa3f8b0	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_c2b19f6ff9f64e2965b10fec7221544e	No evidence text.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
d6770e8a-1fb9-4901-8567-98038c34a380	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_3b58829293b5f97b0204c18164d07f70	No evidence text.	p(HGNC:PRKCE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 258))
31babb76-50e3-4f59-a152-bd6f4e11c26e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_24ffa8a783845af96299c2b715f77554	No evidence text.	p(HGNC:PRKCE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 352))
d266dded-f133-4d83-80df-fbb10b1b92de	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_1452d44dc9833468bd6103381b986526	No evidence text.	p(HGNC:PRKCE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
feda28f6-5a4f-4abb-a4f7-8f5244d7d361	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2889301e4fce26dac6b8d64b1b8359b8	No evidence text.	p(HGNC:PRKCE)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
17b9a581-f201-4d3c-988a-396ca9dad497	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_2e980650aa91fe0688c8fe55e4a656bd	No evidence text.	p(HGNC:PRKCG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 258))
cb3d5b3d-ff3f-416f-b99d-2a3f31ad547f	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_5f12ae34efb002c15a2e9f8d38af7fa7	No evidence text.	p(HGNC:PRKCG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 352))
a43318d4-1c6f-4918-bd6c-888987ad110e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8bd5e7e1b58f420efbcbaa6d7405c930	No evidence text.	p(HGNC:PRKCG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
100e0f32-30e8-4eab-89ad-8981e84f853a	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_071bf1b633bdb9b155f683d55105db04	No evidence text.	p(HGNC:PRKCG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
a91ea41b-0e0a-43c7-90ac-bfda3f3bf696	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9f48d231d0d7aa75ed42e12b148e4c72	No evidence text.	p(HGNC:PRKCI)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 258))
3f9860f1-dc43-45d0-9845-ef4591a0947c	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_caf5fa0e9a3c802c2d9dd82960b4d648	No evidence text.	p(HGNC:PRKCI)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 352))
2f101265-c65b-43fd-a33b-cc19b9b9aec9	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_bad8e7aae1aecc674868d827e18e315b	No evidence text.	p(HGNC:PRKCI)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
8c10ab2d-0e40-4586-957d-d4415d08a56c	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_59c3e24151a884328e429cd5b6b8982a	No evidence text.	p(HGNC:PRKCI)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
aa2243a7-0348-4331-840e-025b6431887b	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a7e07be89514b903c933bd68e5dbce5f	No evidence text.	p(HGNC:PRKCZ)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 258))
61fee015-6b3d-47ac-9306-54e001da9cc1	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_62c199a7ad682cf14a235e98ef0b5a09	No evidence text.	p(HGNC:PRKCZ)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 352))
9fce0c8a-aa70-4d70-9eb4-c267f4d338b4	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_256e47b20cd1ca18458b42340eade223	No evidence text.	p(HGNC:PRKCZ)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 610))
83988fca-3deb-49bc-86b0-01d6a0154eb7	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_07a46973e7ce31e5def3f47459393dde	No evidence text.	p(HGNC:PRKCZ)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 641))
9addba84-baf1-4261-8f7a-5050207f2e71	0.65	PubMed	20185013	In addition, we used antibodies directed against phosphorylation sites on cAMP response element binding protein (pSer133-CREB) and the microtubule associated protein, Tau (pSer214-Tau) that are known to be phosphorylated by either PKA or PKG [XREF_BIBR - XREF_BIBR].	p(FPLX:PRKG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9438750d-d902-442a-9073-d88c2c6de9c1	0.65	PubMed	21050448	Parkin expression results in alpha-Synuclein de-phosphorylation at Ser 87 and Ser 129 and attenuates the phosphorylation of Tau at several Ser and Thr residues.	p(HGNC:PRKN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr))
ea3067ee-09f9-463f-b70a-92bd8304e8d9	0.65	PubMed	23175838	In contrast we anticipated that Prnp overexpression would potentiate Fyn and tau phosphorylation in APPPS1 + mice.	p(HGNC:PRNP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a067e4b7-a29a-471b-9af1-531b5c4cea2d	0.65	PubMed	17317113	Importantly, Tau hyperphosphorylation and NFT formation can be induced by Abeta challenge and/or PS1 mutation.	p(HGNC:PSEN1, var(p.?))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
af9c8074-f12c-4a2a-bff2-5841abf1031c	0.65	Other	sparser:Unknown	Tumor suppressor PTEN can alleviate the phosporylation of the mutant FTDP-17 tau at specific sites, and the phosphatase activity null PTEN increases the mutant tau phosphorylation at these sites.	p(HGNC:PTEN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
75f11151-32dd-4001-9d41-a130bf3c8496	0.65	PubMed	19877278	Interestingly, selective phosphatases inhibitors completely abrogated PGE2 induced P38 MAPK and TAU phosphorylation.	p(HGNC:PTGER4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a5d6da36-c7b1-4b15-922c-8e0ad2a3f062	0.65	PubMed	23428800	In contrast, downregulation of PTPA dramatically enhanced tau phosphorylation at the same sites (G and H).	p(HGNC:PTPRA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
eeec3b8a-dc06-4786-9c84-b0317562f9a2	0.65	PubMed	4896375	In this study we compared the phosphorylation of tau at Ser 262 by CaMKII, PhK and PKA in vitro as determined by radioimmunoblots developed by the monoclonal antibody 12E8 which recognizes P-Ser-262 and P-Ser-356; and Ab-262, a polyclonal antibody which is specific to unphosphorylated Ser 262 in tau.	p(FPLX:PhK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
22ce962e-f6a1-4de1-92f9-0503f4139450	0.65	PubMed	24436131	Promoter Hypermethylation of the Phosphatase DUSP22 Mediates PKA Dependent TAU Phosphorylation and CREB Activation in Alzheimer 's Disease.	p(PFAM:PF15698, pmod(Me))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87a18496-e4c2-46e8-b7fc-d84312277566	0.95	PubMed	20995437	Indeed, de- tection by Tau 1 was increased by phosphatase treatment, (not shown) then some of the Tau 1 sites must already be phosphorylated before OA treament.	p(FPLX:Phosphatase)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87a18496-e4c2-46e8-b7fc-d84312277566	0.95	PubMed	12826017	The activity of protein phosphatase (PP) 2A is downregulated and promotes the hyperphosphorylation of tau in the brains of Alzheimer 's disease (AD), but the mechanism for PP2A inactivation has not been elucidated.	p(FPLX:Phosphatase)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87a18496-e4c2-46e8-b7fc-d84312277566	0.95	PubMed	17051677	PP2A contributes to abnormally hyperphosphorylated tau protein and is the most efficient phosphatase.	p(FPLX:Phosphatase)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87a18496-e4c2-46e8-b7fc-d84312277566	0.95	PubMed	8743141	Examination of several kinases that phosphorylate tau indicated that they were unlikely to account for the widespread hyperphosphorylation of tau caused by streptozotocin treatment, but there was a large decrease in mouse brain protein phosphatase 2A activity, which is known to mediate tau phosphorylation.	p(FPLX:Phosphatase)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
87a18496-e4c2-46e8-b7fc-d84312277566	0.95	PubMed	22054838	The studies suggest selenate acts as an agonist for protein phosphatase 2A (PP2A), which targets tau phosphorylation.	p(FPLX:Phosphatase)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d475f0f3-7f49-44ff-97c7-9d5ddb21fdd5	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a68fdb90229b355dead217043fcaa75c	No evidence text.	p(UP:P27791)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
fdf18b43-34ef-4cd5-b7aa-f9150256d91e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_5b5be3823d4070167b91f8c05a0b463a	No evidence text.	p(UP:P27791)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
0cbc497a-68d5-4cc3-af99-c8416961a507	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_b2a6ae728370d337dd07eeb0df7e4d44	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
0cbc497a-68d5-4cc3-af99-c8416961a507	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_88af66b1ade91c9a19ecca8626207af5	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 235))
8c43abea-4daf-4b7a-a878-cd66920c4f38	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_7651481460fef23136ce4380bbc81fb2	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
231af788-2cd5-48ec-bfc3-016ca599bbc6	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_ed110eb38466d91e1a2f1ddc4b986bc5	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 552))
e0b927e8-f2ea-4bd0-9c8b-5d8c07a2ff37	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_bd3db96a417320bfe492e61de6e0035b	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
e0b927e8-f2ea-4bd0-9c8b-5d8c07a2ff37	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_32d50cba6e8e05a96d85b2fc588126f0	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
e0b927e8-f2ea-4bd0-9c8b-5d8c07a2ff37	0.98	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9a12664212f57c67da0e505b7578427b	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
04344047-6033-432f-a973-bdf0e4386768	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_6ca39d6540ac858b6c019b06fdbe0f6b	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
04344047-6033-432f-a973-bdf0e4386768	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_9e42a655effc5af290f5affd1efd55d0	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
04344047-6033-432f-a973-bdf0e4386768	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_dd751c0a5db077eaa7afcafeff80c9e9	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
04344047-6033-432f-a973-bdf0e4386768	0.99	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_bb9c155463d859770b0141d20515c642	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
21812f16-292b-4b44-8fab-d66814703686	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_29a9c2b871657802ace72ea3e81a3c49	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 173))
c80f49af-2bb2-4b07-9167-6ac8a2838d0a	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_a265eb5ef05ac4b06d4e338f1bd9086a	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
c80f49af-2bb2-4b07-9167-6ac8a2838d0a	0.95	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_fe203ec4f69bbb698816653b3c19be07	No evidence text.	p(UP:P05696)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
c41cf021-1d4b-4517-9062-011054c0ac65	0.86	PubMed	15866902	Propofol with hypothermia significantly increased phosphorylation of tau at AT8, AT180, Thr205, and Ser199 in cortex and hippocampus except Ser396.	a(PUBCHEM:4943)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c41cf021-1d4b-4517-9062-011054c0ac65	0.86	PubMed	17854312	Propofol increased Tau phosphorylation, even with normothermia [XREF_BIBR].	a(PUBCHEM:4943)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
24374999-1b1c-46e5-999d-f2eeaf849422	0.65	Other	sparser:Unknown	While total tau protein levels were unmodified in all groups, we found that dexamethasone significantly increased tau phosphorylation at S396, as recognized by the antibody PHF-13, which was specifically associated with an increase in the GSK3β activity.	a(CHEBI:41879)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
87b17e70-1641-472c-ad43-08bca22430b0	0.65	PubMed	18524835	RA induction of the human neuroblastoma cell line, SY5Y, has been reported to increase phosphorylation of tau at AD related sites [XREF_BIBR].	a(CHEBI:26536)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8e97cddb-0e03-4310-bda2-340a3d64d3b5	0.65	PubMed	17336830	Thus it becomes clear that alteration in Rb1 and E2F signaling pathway and therefore overexpression of Rb1 and E2F target genes leads to abnormal CCE and enhanced tau phosphorylation causing apoptotic death of neurons and AD.	p(HGNC:RB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7f0875fb-63bd-4b74-81a0-348d84546cd7	0.86	PubMed	12059334	Phosphorylation of RCAN1 at Thr (192) by Dyrk1A enhances the ability of RCAN1 to inhibit the phosphatase activity of calcineurin (Caln), leading to reduced NFAT transcriptional activity and enhanced Tau phosphorylation.	p(HGNC:RCAN1, pmod(Ph, 192))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7f0875fb-63bd-4b74-81a0-348d84546cd7	0.86	PubMed	21965663	Phosphorylation of RCAN1 at Thr (192) by Dyrk1A enhances the ability of RCAN1 to inhibit the phosphatase activity of calcineurin (Caln), leading to reduced NFAT transcriptional activity and enhanced Tau phosphorylation.	p(HGNC:RCAN1, pmod(Ph, 192))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b53b487b-c189-4692-a401-b4577e8602fe	0.86	PubMed	24021800	The phosphorylation of RCAN1 at Ser primes the protein for GSK3beta mediated phosphorylation of Ser, while the phosphorylation of RCAN1 at Thr by Dyrk1A increases its activity as an inhibitor of calcineurin, which results in reduced NFAT transcriptional activity and enhanced Tau phosphorylation.	p(HGNC:RCAN1, pmod(Ph, Thr))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b53b487b-c189-4692-a401-b4577e8602fe	0.86	PubMed	24021800	On the other hand, the phosphorylation of RCAN1 at Thr by Dyrk1A activates its function as a calcineurin inhibitor, which leads to reduced NFAT transcriptional activity and enhanced Tau phosphorylation.	p(HGNC:RCAN1, pmod(Ph, Thr))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
81fe9077-ae7c-4356-8542-f93cef9e6b14	0.95	PubMed	18804306	Indeed, pharmacological inhibition of GSK3 rescues cells from death in AD mice, and Abeta induced reelin deregulation causes an increase of GSK3 dependent tau phosphorylation.	p(HGNC:RELN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
81fe9077-ae7c-4356-8542-f93cef9e6b14	0.95	PubMed	18043415	Reelin signaling pathways modulate phosphorylation of tau, the major component of NFTs, either directly or through beta-amyloid pathways that influence tau phosphorylation.	p(HGNC:RELN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
81fe9077-ae7c-4356-8542-f93cef9e6b14	0.95	PubMed	23632168	In addition, since hyperphosphorylated filamentous Tau can inhibit kinesin based fast axonal transport (), Reelin may also support axonal transport integrity via GSK3beta kinase mediated suppression of Tau hyperphosphorylation.Importantly, we were recently able to demonstrate that a viral like prenatal immune challenge predisposes the offspring to develop an AD like phenotype, which is induced if the challenge is repeated for a second time during adulthood ().	p(HGNC:RELN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
81fe9077-ae7c-4356-8542-f93cef9e6b14	0.95	PubMed	18648701	Whether Reelin dependent modulation of Tau phosphorylation is involved in axo-dendritic specification remains to be determined.	p(HGNC:RELN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
81fe9077-ae7c-4356-8542-f93cef9e6b14	0.95	PubMed	18236197	These results confirm that Abeta compromises the biological role of Reelin modulating tau phosphorylation.	p(HGNC:RELN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
81fe9077-ae7c-4356-8542-f93cef9e6b14	0.95	PubMed	20452100	Reelin signaling pathways modulate phosphorylation of tau, the major component of NFTs, either directly or through beta-amyloid pathways that influence tau phosphorylation.	p(HGNC:RELN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
81fe9077-ae7c-4356-8542-f93cef9e6b14	0.95	PubMed	11005920	Reelin signaling pathways modulate phosphorylation of tau, the major component of NFTs, either directly or through beta-amyloid pathways that influence tau phosphorylation.	p(HGNC:RELN)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	PubMed	18437330	Age dependent aberrant phosphorylation of tau has also been reported in rodent models.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	Age-dependent aberrant phosphorylation of tau has also been reported in rodent models ( xref ).	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	More recently, LiCl was administered to transgenic mice that overexpress both mutant human tau and GSK-3β, and which develop age-dependent tau hyperphosphorylation accompanied by NFT formation.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	Recently, we have shown that the fluorescent, heterodimeric AChE inhibitor PE154 allows for the histochemical staining of cortical Abeta plaques in triple-transgenic (TTG) mice with age-dependent beta-amyloidosis and tau hyperphosphorylation, an established animal model for aspects of AD.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	Here, we present a novel triple immunofluorescence labelling of amino- and differently carboxy-terminally truncated beta-amyloid peptides in cortical plaques from a case with Alzheimer&apos;s disease, senile macaques and baboons, and triple transgenic mice with age-dependent beta-amyloidosis and tau hyperphosphorylation.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	Db/db mice, a rodent model of T2D, also exhibited age-dependent tau hyperphosphorylation.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	In summary, this study indicates that early GLP-1 analog intervention prevented the age-dependent tau hyperphosphorylation in T2D mice brain, probably by facilitating sequential activation in an insulin signaling pathway reflected in increased basal activation of Akt and basal suppression of glycogen synthase kinase-3 beta.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	Transgenic mice overexpressing AICD show age-dependent tau phosphorylation and aggregation, memory deficits, and neurodegeneration.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	Transgenic mice overexpressing AICD show age-dependent tau phosphorylation and aggregation, memory deficits and neurodegeneration.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	In a &quot;combined&quot; model, expressing both tau(V337M) and the familial amyloid precursor protein AD mutation APP(V717I) in a CT100 fragment, age-dependent tau phosphorylation occurred at the same sites and was significantly augmented compared to &quot;single&quot; tau(V337M) mice.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	To determine whether old age potentiates cold-induced tau phosphorylation, we compared the effects of cold exposure (4 °C, 24 hours) in 6- and 18-month-old mice.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	Rats expressing either Tau 151–391 3R or Tau 151–391 4R exhibit pathological features including age-dependent increases in tau phosphorylation at multiple epitopes, and Gallyas-positive intracellular and extracellular tangles, which were positive for Congo red birefringence and thioflavin S [ xref ].	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0568dfd8-ea0e-4898-bf2b-a059df00ad62	0.98	Other	sparser:Unknown	The htau mice express all six human tau isoforms and show age-dependent tau hyperphosphorylation and aggregation.	p(HGNC:RENBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
73fdd568-c1fb-482e-9266-68ed0eef8235	0.65	Other	sparser:Unknown	We also found that Rho-kinase phosphorylated Tau at Ser262 to some extent.	p(FPLX:RHO)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
e9be33fe-3636-481e-a0b5-1611b2b5ba9d	0.65	PubMed	18364571	Ding et al. [XREF_BIBR] hypothesized that even if HDAC6 up-regulation in AD brains contributes to the sequestration of ubiquitinated protein aggregates and recruitment of autophagic components, it would eventually be deleterious to cell survival in AD, due to decreased tubulin acetylation and increased tau phosphorylation.	p(HGNC:RNF2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e215d4be-d1ed-46f7-90ef-dc520bb38532	0.65	PubMed	15501444	ROCK phosphorylates TAU and MAP2, proteins that regulate microtubule stability.	p(FPLX:ROCK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
bd783467-765a-4306-830e-564ca7243345	0.88	PubMed	13761714	In the present study, we investigated whether ROS might play a critical role in MC-LR-induced hyperphosphorylation of microtubule associated protein tau and the activation of the MAPKs in PC12 cell line.	p(HGNC:ROS1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
bd783467-765a-4306-830e-564ca7243345	0.88	Other	sparser:Unknown	SOD2 deficiency which increases ROS also increases tau phosphorylation [ xref ].	p(HGNC:ROS1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d9c1885d-d21f-4715-a291-2b006eaebb33	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_128c1bfb03e54a8c052e6725fde36de0	No evidence text.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
5597f4c8-9b24-480c-8aa4-4526a9db30d8	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_40aa21e706ca2d457f35a0be1efb984b	No evidence text.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
c11f37ce-6443-4204-95e7-aa8ea11cde8d	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_465df6e0cd501f8f00d1fbbe5f3d1d1d	No evidence text.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
2354574b-d4d6-4372-a7ef-4e3bc4559a40	0.86	PubMed	7792782	Zinc could induce tau hyperphosphorylation in SH-SY5Y and N2a cells, and tau phosphorylation may be mediated by p70 S6 kinase activation.	p(HGNC:RPS6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2354574b-d4d6-4372-a7ef-4e3bc4559a40	0.86	PubMed	15812314	Zinc could induce tau hyperphosphorylation in SH-SY5Y and N2a cells, and tau phosphorylation may be mediated by p70 S6 kinase activation.	p(HGNC:RPS6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e7404358-a15b-45f3-965f-06b162d34245	0.65	PubMed	4691443	Combined tau protein kinase II (TPK II), which consists of CDK5 and its activator (p23), and glycogen synthase kinase-3beta (GSK-3beta) phosphorylate tau to the PHF-form in vitro.	p(HGNC:RRAS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
15ba94e4-020a-4eab-a275-7c72c2b59638	0.65	PubMed	25791428	On the other hand, constitutive silencing of S6K (S6K-KD), the immediate downstream substrate of mTor, significantly decreased the level of tau phosphorylation.	p(UP:Q8BSK8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
df9bfb8f-ce15-4a60-b664-262bd596952e	0.65	PubMed	23666762	In cells, a CagA peptide specifically and significantly inhibited tau phosphorylation at Ser (2) 6 (2) mediated by MARK4 but not other MARK isoforms.	p(HGNC:S100A8)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
6db594f6-de8f-4fbf-a7d0-78efec26d1fd	0.86	PubMed	14188056	This study was designed to compare plasma concentrations of copeptin and other biomarkers like myelin basic protein, glial fibrillary astrocyte protein, S100B, neuron specific enolase, phosphorylated axonal neurofilament subunit H, tau and ubiquitin carboxyl-terminal hydrolase L1 for analysis of their prognostic prediction.	p(HGNC:S100B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6db594f6-de8f-4fbf-a7d0-78efec26d1fd	0.86	PubMed	18494933	S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.	p(HGNC:S100B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
786e5644-40ae-40a2-954d-2bbbde2d6080	0.65	PubMed	15863530	Conversely, Saa3 deficiency enhanced tau phosphorylation induced by systemic LPS administration.	p(UP:P19453)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7827da2c-fecb-459d-a696-947d3add79c6	0.65	PubMed	17533060	Accordingly, the GSK-3beta inhibitor (SB-216763) prevented ASN evoked Tau hyperphosphorylation, but the CDK5 inhibitor had no effect.	a(PUBCHEM:176158)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2a24c31a-d4c8-4ad1-a7be-90efac36d349	0.65	PubMed	22054838	SelS siRNA increased phosphorylation of tau at pT212 (XREF_FIG), but this increase was not further promoted by tunicamycin.	p(HGNC:SELENOS)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0da53bbc-07cf-42cf-a0eb-6b69fbc90d19	0.99	PubMed	18813146	Importantly, the findings that the relative increase of TS1 is much greater than TS3 in AD cases, and TS1 expression is significantly correlated with clinical and neuropathological severity measures of AD, are consistent with our observation of increased phosphorylation of tau by SEMA3A bound specifically to TS1.	p(HGNC:SEMA3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0da53bbc-07cf-42cf-a0eb-6b69fbc90d19	0.99	Other	sparser:Unknown	Importantly, the findings that the relative increase of TS1 is much greater than TS3 in AD cases, and TS1 expression is significantly correlated with clinical and neuropathological severity measures of AD, are consistent with our observation of increased phosphorylation of tau by SEMA3A bound specifically to TS1.	p(HGNC:SEMA3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0da53bbc-07cf-42cf-a0eb-6b69fbc90d19	0.99	Other	sparser:Unknown	Stimulation of neurons with SEMA3A induced phosphorylation of endogenous tau as determined by AT8 + cells ( xref , red staining in Myc − cells).	p(HGNC:SEMA3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0da53bbc-07cf-42cf-a0eb-6b69fbc90d19	0.99	PubMed	18813146	Immunoblotting with AT8 (anti-phospho-Tau at Ser 202 / Thr 205) showed that tau phosphorylation was induced by SEMA3A stimulation, which was enhanced by over-expression of TS1 (XREF_FIG).	p(HGNC:SEMA3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0da53bbc-07cf-42cf-a0eb-6b69fbc90d19	0.99	PubMed	25043464	Immunoblotting with AT8 (anti-phospho-Tau at Ser 202 / Thr 205) showed that tau phosphorylation was induced by SEMA3A stimulation, which was enhanced by over-expression of TS1 (XREF_FIG).	p(HGNC:SEMA3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0da53bbc-07cf-42cf-a0eb-6b69fbc90d19	0.99	PubMed	25043464	Importantly, the findings that the relative increase of TS1 is much greater than TS3 in AD cases, and TS1 expression is significantly correlated with clinical and neuropathological severity measures of AD, are consistent with our observation of increased phosphorylation of tau by SEMA3A bound specifically to TS1.	p(HGNC:SEMA3A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1a8c0d27-6638-429b-954f-9d74b788f4fd	0.95	PubMed	24981783	In these two models, we report that cytoplasmic SET induces the hyperphosphorylation of tau in the absence of detectable cleaved forms of SET.	p(HGNC:SET)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1a8c0d27-6638-429b-954f-9d74b788f4fd	0.95	PubMed	24981783	Uncleaved SET in the cytoplasm induces hyper- and abnormal phosphorylation of tau protein.	p(HGNC:SET)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1a8c0d27-6638-429b-954f-9d74b788f4fd	0.95	PubMed	24981783	The hyper- and/or abnormal phosphorylation of tau protein induced by recombinant SET protein or Jcasp peptide usually involve the same tau protein isoforms as those affected by OA.	p(HGNC:SET)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1a8c0d27-6638-429b-954f-9d74b788f4fd	0.95	PubMed	18426071	Furthermore, cleavage of SET by delta-secretase promotes the phosphorylation of tau and neuronal cell death XREF_BIBR XREF_BIBR.	p(HGNC:SET)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1a8c0d27-6638-429b-954f-9d74b788f4fd	0.95	PubMed	18391849	XREF_BIBR, XREF_BIBR, XREF_BIBR Transfection in PC12 cells 53 demonstrated that SET induces hyperphosphorylation of tau, suggesting that SET may be involved in AD through the regulation of tau hyperphosphorylation.	p(HGNC:SET)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4902b99d-ae70-41f4-9be9-7d854ee0c2f2	1.0	Other	sparser:Unknown	We report here that SGK1 phosphorylates Ser214 of Tau.	p(HGNC:SGK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
4902b99d-ae70-41f4-9be9-7d854ee0c2f2	1.0	PubMed	15650334	We report here that SGK1 phosphorylates Ser214 of Tau.	p(HGNC:SGK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
4902b99d-ae70-41f4-9be9-7d854ee0c2f2	1.0	PubMed	7669801	We report here that SGK1 phosphorylates Ser214 of Tau.	p(HGNC:SGK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
4902b99d-ae70-41f4-9be9-7d854ee0c2f2	1.0	PubMed	PMC7669801	We report here that SGK1 phosphorylates Ser214 of Tau.	p(HGNC:SGK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
4902b99d-ae70-41f4-9be9-7d854ee0c2f2	1.0	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_0f5b44ad5685cac054a825d8d9904620	No evidence text.	p(HGNC:SGK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
06686777-d9d2-4334-bf5c-9e43d0a15ad8	0.95	PubMed	6287970	We previously showed that stress activated protein (SAP) kinases phosphorylate tau protein at many of the hyperphosphorylated sites in vitro.	p(HGNC:SH2D1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
06686777-d9d2-4334-bf5c-9e43d0a15ad8	0.95	PubMed	21136848	Tau phosphorylated by individual SAP kinases showed a variable reduction in gel mobility, as seen by SDS-PAGE and immunoblotting with anti-tau serum 134 which recognises the carboxy-terminus of tau in a non-phosphorylation-dependent manner <ce:cross-ref refid="BIB29"> [29] </ce:cross-ref> (<ce:cross-ref refid="FIG2"> Fig. 2 </ce:cross-ref> <ce:float-anchor refid="FIG2"/>).	p(HGNC:SH2D1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
06686777-d9d2-4334-bf5c-9e43d0a15ad8	0.95	PubMed	21136848	</ce:para> <ce:para id="para160" view="all"> Taken together, the present in vitro findings which indicate that tau is phosphorylated by SAP kinases at many S/T-P sites, suggest a possible role for SAP kinases in the hyperphosphorylation of tau that characterises Alzheimer 's disease and other neurodegenerative disorders.	p(HGNC:SH2D1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
06686777-d9d2-4334-bf5c-9e43d0a15ad8	0.95	PubMed	21136848	Tau phosphorylated by each of the five SAP kinases was strongly immunoreactive with AT270, a phosphorylation dependent monoclonal antibody which recognises tau phosphorylated at T181 <ce:cross-ref refid="BIB30"> [30] </ce:cross-ref> (<ce:cross-ref refid="FIG2"> Fig. 2 </ce:cross-ref>).	p(HGNC:SH2D1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
06686777-d9d2-4334-bf5c-9e43d0a15ad8	0.95	PubMed	21136848	</ce:para> <ce:para id="para120" view="all"> In this paper we show that the SAP kinases SAPK1gamma, SAPK2a, SAPK2b, SAPK3 and SAPK4 phosphorylate tau protein to various extents, as judged by relative initial rates of phosphorylation, incorporation of phosphate after extended periods of incubation, reduced gel mobility of phosphorylated tau and the production of epitopes of phosphorylation dependent anti-tau antibodies.	p(HGNC:SH2D1A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f7723177-aa43-4b86-95f6-c81b9c3c8d00	0.65	Other	sparser:Unknown	We demonstrated that exposure to 0.5 or 2 Gy γ rays causes increased phosphorylation of tau protein at several phosphorylation sites in a time- and dose-dependent manner.	p(HGNC:SH3YL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
726ccc1f-5c0a-402e-94d2-1367a1db899f	0.92	PubMed	18561377	Lack of SIRT6 increases Tau phosphorylation and stability.	p(HGNC:SIRT6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
726ccc1f-5c0a-402e-94d2-1367a1db899f	0.92	PubMed	18561377	Accordingly, we found that SIRT6 depletion in cells led to increased Tau stability and phosphorylation through GSK3 activation and to increased apoptosis, which could be rescued by reducing GSK3 activity.	p(HGNC:SIRT6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
726ccc1f-5c0a-402e-94d2-1367a1db899f	0.92	PubMed	18561377	Our studies indicate that lack of SIRT6 leads to DNA damage signaling, increasing activity of ATM and GSK3, phosphorylating Tau, leaving neurons more vulnerable to genotoxic insults.	p(HGNC:SIRT6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
27bcc893-3fac-4699-b4c8-8c4d6da244d1	0.65	PubMed	18752365	More recently, impaired insulin signaling pathway, overactivation of GSK-3beta, decreased GLUT-1 and GLUT-3, downregulation of protein O GlcNAcylation, increased phosphorylation of tau and NFTs, and decreased microtubule binding activity of tau were found in the brain of the icvSTZ treated rat.	p(HGNC:SLC2A1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c9549f86-89f7-4993-a3e1-ed27013b0ce2	0.92	PubMed	17247160	Furthermore, neuronal overexpression of human alpha-synuclein in transgenic mice causes phosphorylation and aggregation of endogenous tau XREF_BIBR, XREF_BIBR - XREF_BIBR.	p(HGNC:SNCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c9549f86-89f7-4993-a3e1-ed27013b0ce2	0.92	PubMed	21050448	alpha-Synuclein expression increased GSK-3beta activity and Tau phosphorylation.	p(HGNC:SNCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c9549f86-89f7-4993-a3e1-ed27013b0ce2	0.92	PubMed	21050448	These data suggest that alpha-Synuclein over-expression increases kinase activity and leads to Tau and alpha-Synuclein phosphorylation, while parkin increases phosphatase activity to de-phosphorylate proteins and counteract the effects of alpha-Synuclein over-expression.	p(HGNC:SNCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d364fa3-6fa1-4321-a075-33384e1a3258	0.99	Other	sparser:Unknown	α-synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356 (Jensen et al. xref ).	p(HGNC:SNCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
3d364fa3-6fa1-4321-a075-33384e1a3258	0.99	Other	sparser:Unknown	Functionally, alpha-synuclein stimulated the protein kinase A-catalyzed phosphorylation of tau serine residues 262 and 356 as determined using a phospho-epitope-specific antibody.	p(HGNC:SNCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
3d364fa3-6fa1-4321-a075-33384e1a3258	0.99	PubMed	PMC5228334	Functionally, alpha-synuclein stimulated the protein kinase A-catalyzed phosphorylation of tau serine residues 262 and 356 as determined using a phospho-epitope-specific antibody.	p(HGNC:SNCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
3d364fa3-6fa1-4321-a075-33384e1a3258	0.99	PubMed	21127069	In mouse brain, ablation of alpha-synuclein function significantly suppresses Tau phosphorylation at Ser (262).	p(HGNC:SNCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
3d364fa3-6fa1-4321-a075-33384e1a3258	0.99	PubMed	21127069	In vitro, alpha-synuclein binds to phosphorylated Ser (214) of Tau and stimulates PKA catalyzed Tau phosphorylation at Ser (262).	p(HGNC:SNCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
3d364fa3-6fa1-4321-a075-33384e1a3258	0.99	PubMed	11440755	In vitro, alpha-synuclein binds to phosphorylated Ser (214) of Tau and stimulates PKA catalyzed Tau phosphorylation at Ser (262).	p(HGNC:SNCA)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser))
e4c3357f-5e14-43d0-87a5-13f6f753e884	0.65	PubMed	22072713	The Sod1 deletion also caused Tau phosphorylation and the lower levels of synaptophysin.	p(HGNC:SOD1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
713237f3-2f37-404d-82f3-9f78ef290e79	0.92	Other	sparser:Unknown	Here, we characterize phosphorylation of Tau by extracellular-regulated kinase (ERK2), a mitogen-activated kinase (MAPK) that responds to extracellular signals.	p(HGNC:SOD3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
713237f3-2f37-404d-82f3-9f78ef290e79	0.92	Other	sparser:Unknown	Also, it was described that extracellular phosphorylated tau is dephosphorylated by tissue-non-specific alkaline phosphatase (TNAP) and that this phosphatase, promotes the neurotoxic effect of extracellular tau (Diaz-Hernandez et al., xref ).	p(HGNC:SOD3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
713237f3-2f37-404d-82f3-9f78ef290e79	0.92	Other	sparser:Unknown	It has been recently reported that extracellular hyperphosphorylated tau protein coming from damaged neurons must be dephosphorylated to become an agonist of a muscarinic receptor and induce the unbalances of the intracellular calcium homeostasis that finally triggers neuronal death xref .	p(HGNC:SOD3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1fa34d92-c759-457c-bc12-02509f5828f1	0.86	PubMed	18727381	We evaluated in 867 AD subjects the association of AD+P with genes which may modify the pathologic process via effects on the accumulation of amyloid beta (Abeta) protein and/or hyperphosphorylated microtubule associated protein tau (MAPT) : amyloid precursor protein (APP), beta-site amyloid precursor protein cleaving enzyme (BACE1), sortilin related receptor (SORL1), and MAPT.	p(HGNC:SORL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1fa34d92-c759-457c-bc12-02509f5828f1	0.86	PubMed	11406170	We evaluated in 867 AD subjects the association of AD + P with genes which may modify the pathological process via effects on the accumulation of amyloid beta (Abeta) protein and/or hyperphosphorylated microtubule associated protein tau (MAPT) : amyloid precursor protein (APP), beta-site amyloid precursor protein cleaving enzyme (BACE1), sortilin related receptor (SORL1), and MAPT.	p(HGNC:SORL1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
94310886-b2e5-4b65-b65b-4ac4e1a82560	0.65	PubMed	20973705	Paudel, H.; Lew, J.; Ali, Z.; Wang, J. H. Brain proline directed kinase phosphorylates tau on sites that are abnormally phosphor- 268 COMMENTARY ON LEW ET AL..	p(HGNC:SPARC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
bf423453-9f41-464a-9f77-6defab6de365	0.65	PubMed	20736167	Both SPRED1 and SPRED2 inhibit the ability of DYRK1A to phosphorylate its substrates, Tau and STAT3.	p(HGNC:SPRED2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3a2b62d6-d26b-426a-8297-2959134f717c	0.65	PubMed	18356324	Atg7 deficient neurons were defective in the initiation of macroautophagy, and displayed a progressive degeneration with prominent inclusions that harbor ubiquitin, p62, phosphorylated tau and GSK3beta.	p(HGNC:SQSTM1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c684522e-b6e8-43be-85ad-cfabb9106e26	1.0	Other	sparser:Unknown	Bhaskar et al [ xref ] have shown that Src also
phosphorylate tau in Tyr 18 in vitro.	p(HGNC:SRC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
c684522e-b6e8-43be-85ad-cfabb9106e26	1.0	PubMed	18868634	Fyn, Src, and Syk phosphorylate tau at Tyr18 XREF_BIBR; XREF_BIBR, while Abl phosphorylates Tyr394 179.	p(HGNC:SRC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
c684522e-b6e8-43be-85ad-cfabb9106e26	1.0	PubMed	11158064	We previously showed that the Src family non receptor tyrosine kinases (SFKs) Fyn and Src phosphorylate tau on Tyr18 and that phospho-Tyr18-tau was present in AD brain.	p(HGNC:SRC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
c684522e-b6e8-43be-85ad-cfabb9106e26	1.0	PubMed	18644023	We previously showed that the Src family non receptor tyrosine kinases (SFKs) Fyn and Src phosphorylate tau on Tyr18 and that phospho-Tyr18-tau was present in AD brain.	p(HGNC:SRC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
c684522e-b6e8-43be-85ad-cfabb9106e26	1.0	Other	sparser:Unknown	We had previously demonstrated that Src family tyrosine kinases (SFKs) phosphorylate tau at Tyr18 [ xref ] and tau, in turn, could potentiate Fyn and Src activation [ xref ].	p(HGNC:SRC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
c684522e-b6e8-43be-85ad-cfabb9106e26	1.0	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_50cefb6ebe48783878a4091623d00f55	No evidence text.	p(HGNC:SRC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
8b0ad329-3224-4184-8912-06097995c66c	0.88	Other	sparser:Unknown	Here, we show that SRPK2 phosphorylates tau on S214, suppresses tau-dependent microtubule polymerization, and inhibits axonal elongation in neurons.	p(HGNC:SRPK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
8b0ad329-3224-4184-8912-06097995c66c	0.88	PubMed	13045617	Here, we show that SRPK2 phosphorylates tau on S214, suppresses tau dependent microtubule polymerization, and inhibits axonal elongation in neurons.	p(HGNC:SRPK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
07506836-3372-446f-a840-e0add398b55b	0.88	PubMed	9630912	Both somatostatin and cortistatin induce tau phosphorylation at Ser262, a site modified in Alzheimer 's disease, although with different kinetics in cortex.	p(HGNC:SST)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
07506836-3372-446f-a840-e0add398b55b	0.88	Other	sparser:Unknown	Both somatostatin and cortistatin induce tau phosphorylation at Ser262, a site modified in Alzheimer&apos;s disease, although with different kinetics in cortex.	p(HGNC:SST)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
5228c825-ff15-430b-a2a4-03bd34831f28	0.98	PubMed	22052787	For instance, ICV STZ induces progressive neuroinflammation, oxidative stress, and mitochondrial dysfunction, as well as marked Abeta deposition and hyperphosphorylation of tau in the hippocampus; effects that are associated with significant learning and cognitive impairments [XREF_BIBR - XREF_BIBR].	p(HGNC:ST3GAL4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5228c825-ff15-430b-a2a4-03bd34831f28	0.98	PubMed	17137279	STZ causes phosphorylation of the tau protein, amyloid deposits, cognitive impairment, insulin desensitization and neuronal death XREF_BIBR, XREF_BIBR.	p(HGNC:ST3GAL4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5228c825-ff15-430b-a2a4-03bd34831f28	0.98	PubMed	7685911	ICV injection of STZ increases the expression of Abeta and promotes hyerphosphorylation of tau protein.	p(HGNC:ST3GAL4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5228c825-ff15-430b-a2a4-03bd34831f28	0.98	PubMed	19936237	Other studies addressed tau phosphorylation in response to STZ treatment, albeit in non transgenic mice XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:ST3GAL4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5228c825-ff15-430b-a2a4-03bd34831f28	0.98	Other	sparser:Unknown	Planel et al. demonstrated that the peripheral STZ induces tau hyperphosphorylation through two distinct mechanisms—one is consequent to hypothermia and induced by impaired glucose/energy metabolism, and the other is inherent to insulin deficiency and induced by inhibition of protein phosphatase activities [ xref ].	p(HGNC:ST3GAL4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5228c825-ff15-430b-a2a4-03bd34831f28	0.98	PubMed	18809741	Administration of STZ into the brain of WT mice also causes learning and spatial memory deficits, neuroinflammation, altered synaptic proteins and insulin signaling, and hyperphosphorylation of tau in the brain [XREF_BIBR].	p(HGNC:ST3GAL4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5228c825-ff15-430b-a2a4-03bd34831f28	0.98	PubMed	18809741	Furthermore, we found that icv STZ treatment of the 3xTg-AD mice further increased the level of tau phosphorylated at Ser199/202, Ser262/356 (12E8 sites) and Ser422 (XREF_FIG), as well as the net phosphorylation of tau at these sites, the latter of which was calculated after normalization with the total tau level (XREF_FIG).	p(HGNC:ST3GAL4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5228c825-ff15-430b-a2a4-03bd34831f28	0.98	PubMed	17208445	Other studies addressed tau phosphorylation in response to STZ treatment, albeit in non transgenic mice XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:ST3GAL4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5228c825-ff15-430b-a2a4-03bd34831f28	0.98	PubMed	16743590	The majority of AD markers evaluated were found altered at 14days, i.e., the STZ group showed increased amyloid-beta protein and neurofilament expression, increased phosphorylation of Tau protein, and decreased synapsin expression levels compared to controls.	p(HGNC:ST3GAL4)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ab034083-9940-49db-ac18-8842b775ec69	0.65	PubMed	17761446	Recently, it is suggested that the decrease of glucose metabolism in the brain reduces the level of UDP-GlcNAc through hexosamine biosynthetic pathway (HBP), which promotes hyperphosphorylation of tau by decreasing tau O GlcNAcylation [XREF_BIBR].	p(HGNC:STAM2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ccbb916b-e497-49fa-9491-27149a8940bc	0.65	PubMed	22043440	These experiments demonstrated that LKB1 linked NCs indeed phosphorylated Tau at Ser 262 only in lysates that co-expressed SAD-A and STRADalpha together with Tau (XREF_FIG).	p(HGNC:STK11)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
08a7186d-a7be-4b63-832d-bd1c4ed17a4c	0.86	PubMed	17285176	We then assessed whether Stk25 overexpression would augment Tau phosphorylation.	p(HGNC:STK25)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
08a7186d-a7be-4b63-832d-bd1c4ed17a4c	0.86	PubMed	17285176	This suggests that Stk25 overexpression alone is not sufficient to augment Tau phosphorylation.	p(HGNC:STK25)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ddb8c6db-e527-4de1-94d5-5afcc98b6bf4	0.65	PubMed	17195169	Pathologically, PSP patients have abnormal neuronal and glial neurofibrillary tangles and neuropil threads, which are composed of aggregated, hyperphosphorylated microtubule associated protein tau, predominantly in its four-repeat isoform [XREF_BIBR].	p(HGNC:STXBP3)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4be061ba-0476-4a7c-bdf6-a1b8bba18296	0.65	Other	sparser:Unknown	Indeed, previous reports have described an alternative branch of Wnt/GSK-3β signaling, including the prevention of aberrant tau and microtubule-associated protein 1B (MAP1B) phosphorylation mediated by Wnt3a ligand and Wnt7a treatment, respectively [ xref , xref ].	p(HGNC:SULT1B1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
82bd084f-55a5-454e-ba5c-67786b2963f4	0.92	Other	sparser:Unknown	It is known as a selective and potent inhibitor of serine/threonine phosphatases 1 and 2A induces hyperphosphorylation of tau in vitro and in vivo .	p(HGNC:SULT2A1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
82bd084f-55a5-454e-ba5c-67786b2963f4	0.92	Other	sparser:Unknown	It is a selective and potent inhibitor of serine/threonine phosphatases 1 and 2A induces hyperphosphorylation of tau in vitro and in vivo.	p(HGNC:SULT2A1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
82bd084f-55a5-454e-ba5c-67786b2963f4	0.92	PubMed	PMC3443418	In the present study, the site-specific dephosphorylation of this Alzheimer&apos;s disease abnormally phosphorylated tau by protein phosphatase-2A was studied and compared with that by protein phosphatase-2B. The dephosphorylation was detected by its interaction with several phosphorylation-dependent antibodies to various abnormal phosphorylation sites.	p(HGNC:SULT2A1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
81c8c07d-af47-439b-a0cc-40723a2b843b	0.93	PubMed	18070606	We herein report that Syk can phosphorylate Tau on Y18, and that the kinase and its substrate directly interact.	p(HGNC:SYK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
81c8c07d-af47-439b-a0cc-40723a2b843b	0.93	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8c707dcc359c12a2bb2e30c84a06a645	No evidence text.	p(HGNC:SYK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 18))
490076af-ae45-4ea6-913d-1fcef85a9e7a	0.86	PubMed	18273361	Down-regulation of synj1 rescues blast induced phospholipid dysregulation and prevents development of Tau hyper-phosphorylation in ApoE4 carriers.	p(HGNC:SYNJ1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
490076af-ae45-4ea6-913d-1fcef85a9e7a	0.86	PubMed	18273361	In contrast, the ApoE4 genotype blunts any changes in brain PIP 2 and synj1 in response to blast TBI which may contribute to the development of ApoE4 induced Tau hyper-phosphorylation.	p(HGNC:SYNJ1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ea3a0631-8aa4-4d36-99be-51a36fb6e090	0.65	PubMed	22502727	Synaptophysin and phosphorylated tau expression relative to APOE genotype.	p(HGNC:SYP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
05af29b1-8a49-4344-82e6-d7ce90b56706	0.65	Other	sparser:Unknown	Ubiquitination of tau and phosphorylated tau (p-tau) by HRD1 targets these proteins for degradation by the proteasome xref .	p(HGNC:SYVN1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e503f8e8-f913-4b31-a314-ef455efdeff8	0.86	PubMed	10618583	Streptozotocin injection also increased tau phosphorylation; however, the increase was less significant compared with the type 2 mouse model, and more importantly, no tau cleavage was detected.	a(PUBCHEM:29327)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e503f8e8-f913-4b31-a314-ef455efdeff8	0.86	PubMed	16939861	Streptozotocin administration induced the phosphorylation of the tau protein, amyloid deposits, cognitive impairment, insulin desensitization, and neuronal death [XREF_BIBR, XREF_BIBR].	a(PUBCHEM:29327)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
05fb937f-3fca-4089-b731-a49802c48cf8	0.86	PubMed	12786849	Confocal microscopy imaging showed that TDP-43 proteins more often colocalized with OPTN than with FUS and TLS, p62 and phosphorylated Tau.	p(HGNC:TARDBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
05fb937f-3fca-4089-b731-a49802c48cf8	0.86	PubMed	22860700	Confocal microscopy imaging showed that TDP-43 proteins more often colocalized with OPTN than with FUS and TLS, p62 and phosphorylated Tau.	p(HGNC:TARDBP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
79beb197-43d1-43b9-a22c-e89290d8a570	0.65	PubMed	16872060	However, in our model, we have not observed any variations of Tau phosphorylation and GSK-3beta activation, suggesting that an AD brain environment might be necessary for TD dependent phosphorylation of Tau.	a(PUBCHEM:7016067)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5601bfe7-a9b9-4a4c-adf1-dbdf53a62c60	0.65	PubMed	17051677	The generation of a Tg mouse line overexpressing human tau441 via V337M and R406W tau mutations has been shown to accelerate the phosphorylation of human tau, inducing tau pathology and cognitive deficits [XREF_BIBR].	p(HGNC:TG)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a106e09d-a8f8-4656-a4be-b16e4a19c775	0.65	Other	sparser:Unknown	Thrombin induced phosphorylation of MT regulatory protein tau at Ser409 and Ser262 and peripheral MT disassembly, which was linked to increased EC permeability.	p(UP:P84122)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
ff946423-0f3f-4864-8445-72f9807271ed	0.65	PubMed	22038932	Studies showed that TNF-alpha not only increased the expression of PINCH, but also resulted in the hyperphosphorylation of Tau (hpTau).	p(HGNC:TNF)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d02af189-9388-48d9-9ba5-c0cf0a51158e	0.65	PubMed	18359673	TEM analysis of filaments from GSK-3beta phosphorylated tau.	p(HGNC:TNMD)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
23d8f304-bd9b-4307-9f7d-0fa0d992d77f	0.99	PubMed	17051743	Hooper et al. [XREF_BIBR] reported that p53 is upregulated approximately 2-fold in the superior temporal gyrus of AD and that p53 induces Tau indirect phosphorylation.	p(HGNC:TP53)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
23d8f304-bd9b-4307-9f7d-0fa0d992d77f	0.99	PubMed	17051743	Since p53 and GSK3beta are both involved in the apoptotic pathway (GSK3beta overactivity leads to increased levels of plaques and tangles and p53 activity induces Tau phosphorylation), a strong RV effect may be speculated on AD against several molecular targets.	p(HGNC:TP53)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
23d8f304-bd9b-4307-9f7d-0fa0d992d77f	0.99	Other	sparser:Unknown	An interesting observation by Hooper et al (2007) is that p53 induces tau phosphorylation but that the effects are indirect since they observed p53 in the nucleus and tau in the cytoskeletal compartment [ xref ].	p(HGNC:TP53)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
23d8f304-bd9b-4307-9f7d-0fa0d992d77f	0.99	Other	sparser:Unknown	One possibility is that GSK3β is the kinase responsible for the p53-induced tau phosphorylation, since p53 affects GSK3β activity.	p(HGNC:TP53)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
23d8f304-bd9b-4307-9f7d-0fa0d992d77f	0.99	Other	sparser:Unknown	It was observed that p53 could enhance tau phosphorylation in human cells [ xref ] and that tau hyperphosphorylation was associated with neuroblastoma cell death [ xref ].	p(HGNC:TP53)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4cb07d2e-73ab-4f4b-92fd-ab3eb86727c7	0.86	PubMed	18359163	In this system, we also found that transcriptionally active forms of p63 activate tau phosphorylation, while incrementNp63 forms do not (unpublished observations).	p(HGNC:TP63)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4cb07d2e-73ab-4f4b-92fd-ab3eb86727c7	0.86	PubMed	21380933	In this system, we also found that transcriptionally active forms of p63 activate tau phosphorylation, while incrementNp63 forms do not (unpublished observations).	p(HGNC:TP63)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f3d39f6f-fa05-44e1-a83f-d68f37c8030a	0.65	PubMed	11781156	The presence of p24 could inhibit phosphorylation of tau and other cellular substrates of GSK 3 ().	p(HGNC:TPPP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9f4ffcb3-5a1b-4080-a17e-34917f0f1eda	0.86	PubMed	19805732	Here we report that TREM2 deficiency leads to accelerated and exacerbated hyperphosphorylation and aggregation of tau in a humanized mouse model of tauopathy.	p(HGNC:TREM2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9f4ffcb3-5a1b-4080-a17e-34917f0f1eda	0.86	PubMed	25732305	However, TREM2 deficiency not only ameliorated amyloid pathology but also reduced reactive astrocyte accumulation and MAPT hyperphosphorylation.	p(HGNC:TREM2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
042038d3-c1b3-4fea-ae6e-786eaccae7cc	0.86	PubMed	16827932	A decrease of the thyrotrophic releasing hormone (TRH) can enhance the phosphorylation of tau protein and other proteins that are potentially involved in the pathogenesis of AD [XREF_BIBR].	p(HGNC:TRH)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
042038d3-c1b3-4fea-ae6e-786eaccae7cc	0.86	PubMed	6454786	TRH withdrawal was found to enhance the activity of glycogen synthetase kinase-3 (GSK-3beta), a critical enzyme necessary for the phosphorylation of tau, as well as the phosphorylation of the tau protein itself.	p(HGNC:TRH)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2a12b2ae-7dbe-4062-95fd-491ee5e45e58	0.65	PubMed	25043464	In contrast, over-expression of either TS2 or TS3 inhibited tau phosphorylation under stimulation by SEMA3A (XREF_FIG).	p(UP:Q8SRG2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
b60b4aae-1b92-4616-8403-2fc333180da2	0.65	PubMed	21548880	More recently, overexpression of TTBK1 in mouse was reported to enhance phosphorylation and oligomerization of tau in the brain [XREF_BIBR].	p(HGNC:TTBK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a9af55b9-ae86-486e-8368-20e4dd4b9b55	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_c3a5c6967f98b78642917936694b919b	No evidence text.	p(HGNC:TTBK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 515))
51b4899c-63f8-4d94-ace5-e7c006c38a4f	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_8e27f1f3e0f9ac263fe88d4cca2ef527	No evidence text.	p(HGNC:TTBK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
ac127108-f718-4ad3-a647-6fcc2f0282bf	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_65f28971867bc507e334a01e8d717cc7	No evidence text.	p(HGNC:TTBK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
3072fe3f-7ccb-420e-84ba-00221ebdc63e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_4d09a6202f1140d098b951f4c767358f	No evidence text.	p(HGNC:TTBK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 733))
30494593-709f-407b-a322-8a998eda968e	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_f759b98a9a01b004711d0d2523fa2a95	No evidence text.	p(HGNC:TTBK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 739))
64d40814-ffe8-4a0f-974d-60c99200813b	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_1a3aca3d9af8b22369568a7eb6d42dcf	No evidence text.	p(HGNC:TTBK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 744))
ffd6871b-02c9-4629-9262-442a0e8e6ab2	0.79	Other	biopax:http://pathwaycommons.org/pc2/Catalysis_d0775de1b9c72f74bc4dad5af2d9bda6	No evidence text.	p(HGNC:TTBK1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr, 514))
211b7e16-57ed-4314-b0be-6ebbe4508394	0.99	Other	sparser:Unknown	TTBK2 phosphorylates the tau protein and stabilizes Purkinje cells [ xref ].	p(HGNC:TTBK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
211b7e16-57ed-4314-b0be-6ebbe4508394	0.99	PubMed	17007579	TTBK2 phosphorylates the tau protein and stabilizes Purkinje cells [XREF_BIBR].	p(HGNC:TTBK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
211b7e16-57ed-4314-b0be-6ebbe4508394	0.99	PubMed	25950000	Although TTBK2 can phosphorylate two AD associated sites of tau, the major phenotype of mutant TTBK2 is not associated with AD but with autosomal dominant spinocerebellar ataxia type 11 (SCA11), a type of serious neurodegeneration [XREF_BIBR].	p(HGNC:TTBK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
211b7e16-57ed-4314-b0be-6ebbe4508394	0.99	PubMed	18548900	SCA11 is caused by nonsense mutations in tau tubulin kinase (TTBK2), which is expressed abundantly in the brain and phosphorylates the microtubule associated protein tau [XREF_BIBR].	p(HGNC:TTBK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
211b7e16-57ed-4314-b0be-6ebbe4508394	0.99	PubMed	17620722	Expression, purification and crystallization of a human tau-tubulin kinase 2 that phosphorylates tau protein.	p(HGNC:TTBK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
211b7e16-57ed-4314-b0be-6ebbe4508394	0.99	Other	sparser:Unknown	TTBK2 is expressed ubiquitously [ xref ] and can phosphorylate tau at sites identified in paired helical filament tau, a hyperphosphorylated tau variant found in the brains of Alzheimer’s disease (AD) patients [ xref ].	p(HGNC:TTBK2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5e195dca-0e9d-4d16-b697-3340f8872ee8	0.98	PubMed	20968735	Phosphorylation of tau and tubulin by TTK.	p(HGNC:TTK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5e195dca-0e9d-4d16-b697-3340f8872ee8	0.98	Other	sparser:Unknown	Phosphorylation of tau and tubulin by TTK. (A) The phospho-  rylation of tau (e) and tubulin (o) was monitored as a function of time.  (B) Phospho-amino acids of 32p-labeled tau, tubulin and K2 peptide  were hydrolyzed and analyzed with two-dimensional electrophoresis.	p(HGNC:TTK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5e195dca-0e9d-4d16-b697-3340f8872ee8	0.98	PubMed	20968735	Discussion TTK was found in bovine brain and phosphorylates tau, MAP2, tubulin and m-casein.	p(HGNC:TTK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5e195dca-0e9d-4d16-b697-3340f8872ee8	0.98	Other	sparser:Unknown	Discussion    TTK was found in bovine brain and phosphorylates tau,  MAP2, tubulin and m-casein.	p(HGNC:TTK)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
775bd165-6e20-4bba-9fdd-161bdf1a42d9	0.65	Other	sparser:Unknown	Neurotoxin MPTP promotes tau phosphorylation at Ser 262 in human neuroblastoma cells [ xref ].	p(UP:P83108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
bcb8a331-a24a-4bb5-978c-f1d1480b4d14	0.92	Other	sparser:Unknown	In the current report we have expanded upon those findings by showing that SP/TP phosphorylation of tau is necessary for both oligomerized Aβ 1-42 -induced tau mislocalization and synaptic deficits ( xref & xref ).	p(HGNC:TYMP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
bcb8a331-a24a-4bb5-978c-f1d1480b4d14	0.92	Other	sparser:Unknown	Phosphorylation of tau at SP/TP sites has low impact on the tau-MT binding and is observed in AD, dissociating the detachment of tau from MTs from the likability to assemble into PHFs.	p(HGNC:TYMP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
bcb8a331-a24a-4bb5-978c-f1d1480b4d14	0.92	Other	sparser:Unknown	In contrast to PAR-1/MARK, blocking tau phosphorylation at SP/TP sites by knockdown of Sgg/GSK3 did not reduce tau levels, suppress tau mislocalization to the cytosol, or diminish Aβ-mediated augmentation of tau toxicity.	p(HGNC:TYMP)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10e67997-00db-4afd-9cf7-867a80bfa03d	0.65	PubMed	18798360	Thiamine deficiency also increase the phosphorylation of tau.	a(PUBCHEM:1130)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5f10be85-7e9f-4b63-8208-ddbe84e4ad2b	0.99	Other	sparser:Unknown	Although they did not report studies on phosphorylation  of tau by the tubulin kinases, it would be interesting to know  the recognition sites of these enzymes.	p(FPLX:Tubulin)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5f10be85-7e9f-4b63-8208-ddbe84e4ad2b	0.99	PubMed	1142950	The phosphorylation of tau by this enzyme was stimulated by tubulin under the condition of microtubule formation, suggesting that the phosphorylation of tau could occur concomitantly with microtubule formation in the brain.	p(FPLX:Tubulin)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5f10be85-7e9f-4b63-8208-ddbe84e4ad2b	0.99	PubMed	1383690	The phosphorylation of tau was stimulated by tubulin under the condition of microtubule formation.	p(FPLX:Tubulin)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5f10be85-7e9f-4b63-8208-ddbe84e4ad2b	0.99	Other	sparser:Unknown	The phosphorylation of tau was stimulated by tubulin under the condition of microtubule formation.	p(FPLX:Tubulin)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5f10be85-7e9f-4b63-8208-ddbe84e4ad2b	0.99	Other	sparser:Unknown	Additionally, phosphorylation of tau by the purified  GSK3 was also stimulated by tubulin.	p(FPLX:Tubulin)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8bbbb208-d685-4ca7-bf37-699eff660809	0.65	Other	sparser:Unknown	Further, we also studied the interaction between VDAC1 and Aβ (monomers and oligomers) and phosphorylated tau, using cortical issues from AD patients, control subjects, APP, APP/PS1 and 3XTg.	p(HGNC:VDAC1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
cd220037-2b49-404e-beaa-07de63854e2d	0.65	PubMed	17146116	The HDAC inhibitor I-2 decreased expression of beta- and gamma- secretase components and increased mRNA levels of Abeta degradation enzymes while W2 decreased Tau phosphorylation at Thr181, an unknown function among HDAC inhibitors [XREF_BIBR].	p(PFAM:PF02020)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
4c49baf1-44d6-43dc-8d4d-c75c508ae349	0.65	PubMed	17972626	WAVE1 coaggregates with hyperphosphorylated Tau and is found in neurofibrillary tangles and abnormal neurites of Alzheimer 's disease brain [XREF_BIBR].	p(HGNC:WASF1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
13142541-a7a5-4f44-a499-29b9f664e984	0.86	Other	sparser:Unknown	Here we present data suggesting that microtubules enhance LRRK2-mediated tau phosphorylation at 3 different epitopes.	p(HGNC:WHAMM)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
13142541-a7a5-4f44-a499-29b9f664e984	0.86	Other	sparser:Unknown	In vitro phosphorylation of tau by LRRK2 is enhanced by microtubules.	p(HGNC:WHAMM)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3fa42411-0b66-4611-a66e-d2eaea283358	0.65	PubMed	17185331	Taken together these results suggest that Wnt5a promoted axon outgrowth involves the phosphorylation of tau at Ser262 in the growth cone.	p(HGNC:WNT5A)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
60494286-4702-4cbe-a112-bed334c14814	0.86	PubMed	7290354	Remarkably knock-down of WOX1 expression by small interfering RNA in neuroblastoma SK-N-SH cells spontaneously induced Tau phosphorylation at Thr212 and Thr231 and Ser515 and Ser516, enhanced phosphorylation of glycogen synthase kinase 3beta (GSK-3beta) and ERK, and enhanced NFT formation.	p(HGNC:WWOX)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 515))
60494286-4702-4cbe-a112-bed334c14814	0.86	PubMed	15126504	Remarkably knock-down of WOX1 expression by small interfering RNA in neuroblastoma SK-N-SH cells spontaneously induced Tau phosphorylation at Thr212 and Thr231 and Ser515 and Ser516, enhanced phosphorylation of glycogen synthase kinase 3beta (GSK-3beta) and ERK, and enhanced NFT formation.	p(HGNC:WWOX)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 515))
03560815-c0e9-47f2-92e1-dd948a310868	0.94	Other	sparser:Unknown	Ischemic insults also affect tau proteins, which are the main components of neurofibrillary tangles, as indicated by a recent study showing that transient cerebral ischemia induces tau hyperphosphorylation in wildtype mice ( xref ).	p(HGNC:YRDC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
03560815-c0e9-47f2-92e1-dd948a310868	0.94	Other	sparser:Unknown	We and other researchers have found that Tau hyperphosphorylation is increased by focal and global cerebral ischemia, which is closely related to spatial memory impairment ( xref ), implying the alteration of proteins that regulate microtubule assembly, such as glycogen synthase kinase 3 (GSK3; xref ) and CDK5 ( xref ; xref ), and remodeling of the actin cytoskeleton, such as the small GTPases RhoA and Rac (Rho family of GTPase members; xref ).	p(HGNC:YRDC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
03560815-c0e9-47f2-92e1-dd948a310868	0.94	Other	sparser:Unknown	Cerebral ischemia
induces tau hyperphosphorylation [ xref , xref – xref ] and an increase in BACE levels [ xref , xref ].	p(HGNC:YRDC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
03560815-c0e9-47f2-92e1-dd948a310868	0.94	Other	sparser:Unknown	For example, ginsenosides in Panax ginseng C.A.Mey reduced cerebral ischemia-induced tau phosphorylation and attenuated the symptoms of DACD [ xref , xref ].	p(HGNC:YRDC)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
62779df4-9d3c-4efb-89c9-ac8abf003e4e	0.86	PubMed	24367683	Overexpression of 14-3-3zeta in neurons causes phosphorylation of tau at Ser 262, destabilizes microtubules, and reduces intracellular synaptophysin levels (XREF_FIG, XREF_FIG, XREF_FIG and XREF_FIG).	p(HGNC:YWHAZ)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
62779df4-9d3c-4efb-89c9-ac8abf003e4e	0.86	PubMed	17409694	Overexpression of 14-3-3zeta in neurons causes phosphorylation of tau at Ser 262, destabilizes microtubules, and reduces intracellular synaptophysin levels (XREF_FIG, XREF_FIG, XREF_FIG and XREF_FIG).	p(HGNC:YWHAZ)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
2d60c52f-9629-4a30-ae5a-36550292b0c1	0.86	PubMed	20973705	Mawal-Dewan, M.; Sen, P. C.; Abel-Ghany, M.; Shalloway, D.; odc2s Racher, E. Phosphorylation of tau protein by purified p34 and a related protein kinase from neurofilament.	p(HGNC:ZC3H12D)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2d60c52f-9629-4a30-ae5a-36550292b0c1	0.86	PubMed	21218429	Phosphorylation of tau protein by purified p34 cdc28 and a related protein kinase.	p(HGNC:ZC3H12D)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4d0ebe94-c326-4119-9afc-99469f948498	0.65	Other	sparser:Unknown	Glucocorticoids augment tau phosphorylation at several epitopes associated with cytoskeletal pathology, synaptic loss, neuronal atrophy and cognitive impairment xref .	p(HGNC:ZFP36L2)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
aa19fa1a-c003-4845-9c84-1fb974fb3d8e	0.65	PubMed	20211578	Remarkably, authors proved in the fly that Tau phosphorylation was mediated by Zn and that hyperphosphorylation was a cardinal mechanism underlying toxicity.	a(PUBCHEM:23994)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9d1ec7be-cdd3-4d00-b5fd-9d06440850aa	0.65	PubMed	6685379	We have found that acrolein, a peroxidation product from arachidonic acid, increases the phosphorylation of tau at the site recognized by PHF-1 both in human neuroblastoma cells and in primary cultures of mouse embryo cortical neurons.	a(PUBCHEM:7847)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
24f15a52-163d-4f89-a1e6-8eb57b4880b2	0.65	PubMed	18321700	There is considerable in vitro and in vivo evidence demonstrating that aluminium ions inhibit the dephosphorylation of tau, potentiate the development of neurofibrillary tangles (NFTs), cause the accumulation of amyloid beta protein and accelerate the formation of amyloid plaques.	a(PUBCHEM:5359268)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	We observed a significant decrease in presynaptic synaptophysin and an increase in postsynaptic density protein PSD-95, positively correlated with beta amyloid and phosphorylated Tau proteins in Alzheimer cases.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	In this context, there are evidence that Cdk5 is involved in tau hyperphosphorylation promoted by A beta in its fibrillary form.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	In addition, BSA partially prevented the decrease in the expression of GAP-43, MAP-2, and tubulin, and the phosphorylation of tau protein caused by A beta, suggesting that BSA protects against the loss of plasticity caused by the peptide.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	Alzheimer&apos;s disease (AD) is known to be caused by the accumulation of deformed beta amyloid and hyperphosphorylated tau proteins resulting into formation and aggregation of senile plaques and neurofibrillary tangles in the brain.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	PubMed	PMC4110661	Exposure of rat hippocampal neurons to the peptide amyloid beta (A beta) (25-35) as well as A beta (1-40) peptides enhances phosphorylation of tau to a paired helical filament (PHF)-state through activation of tau protein kinase I (TPK I)/glycogen synthase kinase-3 beta (GSK-3 beta) [Busciglio, J., Lorenzo, A., Yeh, J. and Yankner, B.A., Neuron, 14 (1995) 879-888; Takashima, A., Ishiguro, K., Noguchi, K., Michel, G., Hoshi, M., Sato, K., Takahashi, M., Hoshino, T., Uchida, T. and Imahori, K., Neurosci.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	Exposure of rat hippocampal neurons to the peptide amyloid beta (A beta) (25-35) as well as A beta (1-40) peptides enhances phosphorylation of tau to a paired helical filament (PHF)-state through activation of tau protein kinase I (TPK I)/glycogen synthase kinase-3 beta (GSK-3 beta) [Busciglio, J., Lorenzo, A., Yeh, J. and Yankner, B.A., Neuron, 14 (1995) 879-888; Takashima, A., Ishiguro, K., Noguchi, K., Michel, G., Hoshi, M., Sato, K., Takahashi, M., Hoshino, T., Uchida, T. and Imahori, K., Neurosci.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	These studies have shown that androgen depletion results in increased levels of beta amyloid and hyperphosphorylated tau, changes which are thought to be associated with subsequent neuronal death.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	Although alpha 7nAChR agonists induced similar phosphorylation, pretreatment with antisense-alpha 7nAChR oligonucleotides (in cells) or alpha 7nAChR antagonists (in cells and synaptosomes) attenuated A beta-induced tau phosphorylation.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	Western analyses showed that the mitogen-activated kinase cascade proteins, ERKs and c-Jun N-terminal kinase (JNK-1), were concomitantly activated by A beta 42, and their respective kinase inhibitors suppressed A beta-induced tau phosphorylation.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	Thus, the alpha 7nAChR may mediate A beta-induced tau protein phosphorylation via ERKs and JNK-1.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	Lithium compounds might theoretically play a role in preventing dementia by inhibiting formation both of beta amyloid and hyper phosphorylated tau protein.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	Other	sparser:Unknown	Moreover, PCs significantly decreased the levels of beta amyloid and phosphorylated tau in the brains of lead-treated rats, which in turn inhibited endoplasmic reticulum (ER) stress.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
10409553-8c7c-4b6d-884b-50f1ee5c65e9	0.98	PubMed	3428949	Hypotheses are presented regarding the possible cause and significance of abnormally accumulated beta-amyloid protein, two other epitopes of beta-amyloid precursor protein, hyperphosphorylated tau, alpha 1-antichymotrypsin, ubiquitin, and prion protein in sporadic inclusion-body myositis and hereditary inclusion-body myopathy.	p(UP:O73683)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	The high levels of SERPINA3 observed in both the human cortex and cerebellar tissue are consistent with the presence of NFTs, as high levels of SERPINA3 and amyloid precursor protein in transgenic AD mouse models display hyperphosphorylation of TAU and tangle formation xref .	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	Numerous protein kinases, including mitogen-activated protein kinase (MAPK),GSK-3, and cyclin-dependent kinase 5 (Cdk5), have been documented to phosphorylate tau protein at a range of sites that are found in AD hyper-phosphorylated tau [ xref , xref ] whereas its dephosphorylation is mostly catalyzed by protein phosphatase (PP) 1, 2A, 2B and 5, with PP2A as the chief player [ xref , xref ].	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	Phosphorylation of tau at some of the AD abnormal hyperphosphorylation sites was increased in T2DM brain.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	Lower concentrations of copper were ineffective, and phosphorylation of tau at other AD sites was less robust (data not shown).	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	Both I 1  PP2A and I 2  PP2A inhibit PP2A activity toward AD hyperphosphorylated tau ( xref ) and these inhibitors are predominantly localized in the hippocampus and the cerebellum ( xref ).	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	We investigated the isoform-specific interaction of normal tau with AD hyperphosphorylated tau (AD P-tau).	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	In the AD brain hyperphosphorylation of tau causes the formation of NFTs.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	PubMed	PMC4796788	The AD abnormally phosphorylated tau (AD P-tau) does not promote microtubule assembly, but on dephosphorylation its microtubule promoting activity is restored to approximately that of the normal tau.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	Also, in AD hyper-phosphorylated tau and APs co-localized with the autophagosomal markers SQSTM1/p62 and LC3-containing structures and lysosomal marker LAMP1.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	Phosphorylation of tau, on the other hand, results in disruption of microtubule organization and structure, and in AD hyperphosphorylation of tau proteins causes microtubular collapse and results in the formation of neurofibrillary tangles inside neurons.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	PubMed	PMC4307308	When AD abnormally hyperphosphorylated tau is used as a substrate, PP-2B activity is inhibited by trifluoperazine &gt; chlorpromazine &gt; clozapine.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	ALCAR antagonized tau hyperphosphorylation at multiple AD sites and it abated the OA-induced PP2A inhibition and oxidative stress.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	The AD abnormally phosphorylated tau (AD P-tau) does not promote microtubule assembly, but on dephosphorylation its microtubule promoting activity is restored to approximately that of the normal tau.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	In addition, magnesium sulfate markedly decreased tau hyperphosphorylation at multiple AD sites in sAD rats by improving insulin sensitivity, and increasing the inhibitory phosphorylated GSK-3β (ser 9) through the activation of PI3K and Akt.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	When AD abnormally hyperphosphorylated tau is used as a substrate, PP-2B activity is inhibited by trifluoperazine &gt; chlorpromazine &gt; clozapine.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	While normal tau labels the microtubule network, the AD abnormally hyperphosphorylated tau disrupts it in permeabilized cells in vitro [ xref ].	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	The AD abnormally hyperphosphorylated tau probably disrupts the microtubule network and leads to neurodegeneration by sequestration of normal tau as well as microtubule associated proteins MAP1 and MAP2 [ xref ].	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	The cytosolic AD abnormally hyperphosphorylated tau (AD P-tau) is sedimentable/oligomeric, and probably causes neurodegeneration by sequestering normal MAPs and disrupting microtubule network.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	Unlike normal tau, the AD hyperphosphorylated tau is resistant to proteolysis by calpains [ xref ].	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	The AD abnormal hyperphosphorylation of tau (AD P-tau) makes tau resistant to both calcium activated neutral proteases, calpains, and its degradation by the ubiquitin-proteasome pathway.	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	JNK, p38 and ERK have been shown to phosphorylate tau in vitro at AD specific sites and to co-localize with tau in vivo  xref , xref , xref .	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	We also inferred that tau had to be phosphorylated because in vivo tau aggregates are usually hyperphosphorylated ( xref ), and tau phosphorylated at AD sites polymerizes more readily into filaments ( xref ).	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	Other	sparser:Unknown	Phosphorylation sites that lead to the AD type abnormal hyperphosphorylation of tau are phosphorylated by different combinations of non-proline-directed protein kinases like PKA and CaMKII with the proline directed kinases like glycogen synthase kinase 3β (GSK-3β), and cyclin dependent protein kinase 5 (cdk5), and are dephosphorylated largely by protein phosphatase-2A [ xref ].	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
63fb88ec-5a51-4584-be47-f4bd65f3b018	0.95	PubMed	PMC5984275	We investigated the isoform-specific interaction of normal tau with AD hyperphosphorylated tau (AD P-tau).	p(UP:B6EMS7)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
2e1dcec3-fb36-46e7-a8a9-13a90a52bdb8	0.65	PubMed	6610184	Tau phosphorylation induced by arsenite did not involve glycogen synthase kinase-3 or protein phosphatase-1 or -2, but the activity responsible for tau hyperphosphorylation could be inhibited with the protein kinase inhibitor roscovitine.	a(CHEBI:22633)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c01c820f-0552-49ab-9d56-34005c7195e1	0.95	Other	sparser:Unknown	Exosomes have been shown to spread toxic amyloid-beta and hyperphosphorylated tau between cells, and they have been suspected of inducing apoptosis and thereby contributing to neuronal loss.	p(UP:B7I895)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c01c820f-0552-49ab-9d56-34005c7195e1	0.95	Other	sparser:Unknown	Amyloid-beta (Abeta) induces tau hyperphosphorylation, decreases microtubule (MT) stability and induces neuronal death.	p(UP:B7I895)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c01c820f-0552-49ab-9d56-34005c7195e1	0.95	Other	sparser:Unknown	Stimuli as diverse as head injury, inhaled anesthetic agents, stimulant drugs, and both physiological (restraint) and psychological stress (social isolation) have been shown to increase brain expression of amyloid-beta and hyperphosphorylated tau without accompanying neurodegeneration.	p(UP:B7I895)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c01c820f-0552-49ab-9d56-34005c7195e1	0.95	Other	sparser:Unknown	As well as decreased olfactory function, post mortem studies have demonstrated the presence of amyloid-beta (Aβ) and hyperphosphorylated tau (key products in the two major AD pathological hallmarks; Attems et al., xref ) in the olfactory system.	p(UP:B7I895)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c01c820f-0552-49ab-9d56-34005c7195e1	0.95	Other	sparser:Unknown	These aspects can promote the formation and accumulation of insoluble amyloid-beta and hyperphosphorylated tau.	p(UP:B7I895)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c01c820f-0552-49ab-9d56-34005c7195e1	0.95	Other	sparser:Unknown	Alzheimer&apos;s disease (AD) pathology is characterised by aggregation in the brain of amyloid-beta (Abeta) peptide and hyperphosphorylated tau (phospho-tau), although how these proteins interact in disease pathogenesis is unclear.	p(UP:B7I895)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
53d69f84-2c58-499b-9b99-e15e5453fdd7	0.65	Other	sparser:Unknown	Investigation of opiate-abusers brains also demonstrated accumulation of β-APP and hyper-phosphorylated tau in various brain regions [ xref , xref ].	p(PFAM:PF03494)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
899ee142-3dfb-4bd8-ad2d-c75ca6bebf39	0.95	Other	sparser:Unknown	Alzheimer’s disease (AD), the most common cause of dementia, is associated with excessive accumulation of amyloid-β (Aβ) peptides and hyperphosphorylated tau in the brain [ xref ].	a(CHEBI:64645)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
899ee142-3dfb-4bd8-ad2d-c75ca6bebf39	0.95	Other	sparser:Unknown	Despite the demonstration that amyloid-β (Aβ) can trigger increased tau phosphorylation and neurofibrillary tangle (NFT) formation in vivo, the molecular link associating Aβ and tau pathologies remains ill defined.	a(CHEBI:64645)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
899ee142-3dfb-4bd8-ad2d-c75ca6bebf39	0.95	Other	sparser:Unknown	The pathological hallmark of Alzheimer's disease (AD) is accumulation of misfolded amyloid-β peptides and hyperphosphorylated tau protein in the brain.	a(CHEBI:64645)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
899ee142-3dfb-4bd8-ad2d-c75ca6bebf39	0.95	Other	sparser:Unknown	Both amyloid-β and hypoperfusion may increase hyperphosphorylation of tau thereby leading to neurofibrillary tangle formation.	a(CHEBI:64645)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
899ee142-3dfb-4bd8-ad2d-c75ca6bebf39	0.95	Other	sparser:Unknown	Increasing evidence have shown that beta-amyloid (Abeta) induced hyperphosphorylation of tau, which eventually resulted in the disruption of microtubule (MT) integrity.	a(CHEBI:64645)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
80998239-057c-4e65-99ba-17bdb4de2aac	0.86	PubMed	3237224	beta-APP as well as other treatments that activate MAP kinase also enhance phosphorylation of the microtubule associated protein tau in these cells.	p(PFAM:PF03494)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
80998239-057c-4e65-99ba-17bdb4de2aac	0.86	PubMed	3620422	In the ras dominant inhibitory cell line, beta-APP failed to enhance phosphorylation of tau.	p(PFAM:PF03494)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
69a08f33-6edf-4713-8d75-a9d6d47bce35	0.92	Other	sparser:Unknown	We tested the hypothesis that this ExoY-dependent cAMP signal causes phosphorylation of tau, without inducing phosphorylation of membrane effectors that strengthen endothelial barrier function.	a(CHEBI:17489)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
69a08f33-6edf-4713-8d75-a9d6d47bce35	0.92	Other	sparser:Unknown	This cAMP signal is steered toward effectors that promote junctional integrity and is inactivated before it accesses microtubules, where the cAMP signal causes phosphorylation of tau, leading to microtubule disassembly and barrier disruption.	a(CHEBI:17489)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
69a08f33-6edf-4713-8d75-a9d6d47bce35	0.92	Other	sparser:Unknown	Phosphorylation of tau by cAMP-PK significantly inhibited its proteolysis by calpain compared with untreated tau.	a(CHEBI:17489)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
cd96fad1-7096-4cf8-9361-223711717b1c	0.65	PubMed	17491258	Previous studies have shown that Ser 214 of Tau is phosphorylated by cAMP-and/or cGMP dependent kinases XREF_BIBR, XREF_BIBR, and phosphorylation of Tau results in dissociation of Tau from the microtubule lattice.	a(PUBCHEM:24316)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
1b50dd84-83b4-4050-aa62-f5a3750a5384	0.95	PubMed	1889443	The availability of individual tau protein species greatly simplified the analysis for mode II phosphorylation of tau, which was found to be catalyzed by the calcium and phospholipid dependent protein kinase C.	a(CHEBI:29108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1b50dd84-83b4-4050-aa62-f5a3750a5384	0.95	PubMed	8704706	Here we show that, in cultured neurons, membrane depolarization induced a calcium mediated transient phosphorylation of both microtubule associated protein tau and amyloid precursor protein (APP), followed by a dephosphorylation of these proteins.	a(CHEBI:29108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1b50dd84-83b4-4050-aa62-f5a3750a5384	0.95	PubMed	24914767	Increase of ROS results in the dyshomeostasis of calcium, promotes calcium influx, which actives calcium dependent protein kinases (such as PKC) and causes the imbalance between protein phosphatases and protein kinases, thus finally increases the abnormal phosphorylation of Tau [XREF_BIBR].	a(CHEBI:29108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1b50dd84-83b4-4050-aa62-f5a3750a5384	0.95	PubMed	17704947	Phosphorylated tau released into the medium of cultured neuroblastoma cells through muscarinic receptor activation that is dephosphorylated by tissue-non-specific alkaline phosphatase (TNAP) led to excitotoxicity, increasing calcium levels in nearby cells.	a(CHEBI:29108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1b50dd84-83b4-4050-aa62-f5a3750a5384	0.95	PubMed	17200729	Increase of ROS results in the dyshomeostasis of calcium, promotes calcium influx, which actives calcium dependent protein kinases (such as PKC) and causes the imbalance between protein phosphatases and protein kinases, thus finally increases the abnormal phosphorylation of Tau [XREF_BIBR].	a(CHEBI:29108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
1b50dd84-83b4-4050-aa62-f5a3750a5384	0.95	PubMed	8196204	Additional studies indicate that the increase in cytosolic calcium induces tau protein hyperphosphorylation, as revealed by using specific antibodies against Alzheimer phosphoepitopes.	a(CHEBI:29108)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7388a251-f0f3-4aec-8143-7696739b7ee8	0.86	PubMed	19732023	Following TBI, calpain-2 activation cleaved PTPN13, activated c-Abl and triggered tau tyrosine phosphorylation.	p(IP:IPR029539)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr))
7388a251-f0f3-4aec-8143-7696739b7ee8	0.86	PubMed	18291703	Following TBI, calpain-2 activation cleaved PTPN13, activated c-Abl and triggered tau tyrosine phosphorylation.	p(IP:IPR029539)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Tyr))
7ca1aae7-0177-463e-810f-a0cc68c0e038	0.65	PubMed	18291703	GSK-3beta and cdk5 have been shown to directly phosphorylate tau at S202, T205 and T231, while casein kinase 1 (CK1) and protein kinase A (PKA) directly phosphorylate tau at S416 4.	p(PFAM:PF00363)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, 4))
e70582ec-aae5-49ed-8be8-db526a21f90b	0.86	PubMed	10506204	Abnormal tau hyperphosphorylation is one of the central events in the development of neurofibrillary tangles (NFTs) in Alzheimer 's disease (AD), and phosphorylation of tau is accelerated by the increase in the level of neuronal cholesterol.	a(CHEBI:16113)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e70582ec-aae5-49ed-8be8-db526a21f90b	0.86	PubMed	19684401	Abnormal tau hyperphosphorylation is one of the central events in the development of neurofibrillary tangles (NFTs) in Alzheimer 's disease (AD), and phosphorylation of tau is accelerated by the increase in the level of neuronal cholesterol.	a(CHEBI:16113)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9cbd8a23-332b-4290-981e-53b2740f2304	0.65	PubMed	4467923	The treatment of NT2N cells with OK and CL-A increased tau phosphorylation, decreased the binding of tau to MTs, and selectively depolymerized the more stable detyrosinated MTs but not the more labile tyrosinated MTs.	p(UP:P0CL70)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e4bb0615-28ae-46d1-a05a-ffb2d5c9067f	0.86	PubMed	18386601	These studies demonstrate that copper modulates tau phosphorylation in the absence of pathological Abeta.	a(CHEBI:29036)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e4bb0615-28ae-46d1-a05a-ffb2d5c9067f	0.86	PubMed	18386601	We tested the hypothesis that copper modulates tau phosphorylation in the absence of pathological Abeta in a human neuroblastoma cell line (SH-SY5Y) and in a transgenic mouse expressing wild type human tau (hTau).	a(CHEBI:29036)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4f1ea129-1044-4b12-b4ec-c4898ba18a7b	0.65	PubMed	3265077	Previous studies have identified serine and threonine residues phosphorylated in PHF-tau and have shown that tau can be phosphorylated at several of these sites by proline directed protein kinases and cyclic AMP dependent protein kinase.	a(PUBCHEM:6076)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Pro))
940ef9ba-7785-416d-bb4c-f4be252f2011	0.65	PubMed	3430431	In addition, the CCCP induced dephosphorylation of tau was blocked by cyclosporin A, a selective inhibitor of the calcium dependent phosphatase, calcineurin.	a(PUBCHEM:5284373)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4f5034fe-89e4-4165-9b1a-c4dff048e5a5	0.65	PubMed	20173332	High levels of d-ribose also led to the hyperphosphorylation of Tau through the activation of CaMKII.	a(PUBCHEM:5779)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
24879f51-bb27-4f4c-b7fe-17c4ba124308	0.94	PubMed	17241028	With respect to the mechanism of action, OKA is a selective and potent antagonist of serine/threonine phosphatases 1 and 2A [XREF_BIBR, XREF_BIBR], affects short and long-term memory alteration in rats [XREF_BIBR], stimulates hyper-phosphorylation of tau protein, and neuronal cell death in vitro [XREF_BIBR] and in vivo [XREF_BIBR].	bp(GO:"GO:0008219")	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
24879f51-bb27-4f4c-b7fe-17c4ba124308	0.94	PubMed	17332293	SPs and neurofibrillary tangles (NFTs) are caused by the intraneuronal hyperphosphorylation of Tau protein and apoptotic neuronal death XREF_BIBR, XREF_BIBR, XREF_BIBR.	bp(GO:"GO:0008219")	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
24879f51-bb27-4f4c-b7fe-17c4ba124308	0.94	PubMed	9016435	Recent advances in our understanding of neurobiology of Alzheimer 's disease (AD) demonstrate that AD starts with accumulation of amyloid beta protein (Abeta) followed by abnormal phosphorylation of tau protein and a massive neuron death in vulnerable brain areas.	bp(GO:"GO:0008219")	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
24879f51-bb27-4f4c-b7fe-17c4ba124308	0.94	PubMed	7669459	Recent advances in our understanding of neurobiology of AD demonstrate that AD starts with accumulation of amyloid beta protein (A beta) followed by abnormal phosphorylation of tau protein and a massive neuron death in vulnerable brain areas.	bp(GO:"GO:0008219")	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a02680c3-b967-46b1-8313-5e476bd3f4d6	0.86	PubMed	13328024	While total tau protein levels were unmodified in all groups, we found that dexamethasone significantly increased tau phosphorylation at S396, as recognized by the antibody PHF-13, which was specifically associated with an increase in the GSK3beta activity.	a(CHEBI:41879)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
a02680c3-b967-46b1-8313-5e476bd3f4d6	0.86	PubMed	18901070	While total tau protein levels were unmodified in all groups, we found that dexamethasone significantly increased tau phosphorylation at S396, as recognized by the antibody PHF-13, which was specifically associated with an increase in the GSK3beta activity.	a(CHEBI:41879)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
8e833f96-fff3-4b64-95ca-0b575bd7b75b	0.65	PubMed	8093621	Dyrk1 phosphorylates the human microtubule associated protein tau at Thr212 in vitro, a residue that is phosphorylated in fetal tau and hyper-phosphorylated in Alzheimer disease (AD) and tauopathies, including Pick disease (PiD).	p(UP:Q76NV1)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
dd0993bb-87be-4cb7-88ed-d39677de698e	0.86	PubMed	18909716	Moreover, we provide evidence that HAND is associated with hyperphosphorylated tau in the human brain, and that HIV and gp120 can induce hyperphosphorylation of tau.	p(UP:P04578)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dd0993bb-87be-4cb7-88ed-d39677de698e	0.86	PubMed	20818790	Moreover, we provide evidence that HAND is associated with hyperphosphorylated tau in the human brain, and that HIV and gp120 can induce hyperphosphorylation of tau.	p(UP:P04578)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
53fc570d-9c37-4c09-9b2b-3cddb93231d4	0.65	PubMed	26837465	Similarly controversial, while estrogen decreases the hyperphosphorylation of tau in a ER dependent manner XREF_BIBR supporting the observation that females have more affected brain regions with NFTs than males XREF_BIBR and show more severe early tau alterations in the nucleus basalis of Meynert XREF_BIBR, a recent study demonstrated that overexpression of ERalpha caused tau hyperphosphorylation and aggregation XREF_BIBR.	a(CHEBI:50114)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
196351e6-4258-48c3-bbb2-fcf6cd9c9ab3	0.95	Other	sparser:Unknown	Ethanol enhances tau phosphorylation.	a(CHEBI:16236)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
196351e6-4258-48c3-bbb2-fcf6cd9c9ab3	0.95	Other	sparser:Unknown	Because the reduction in phosphorylation at Ser9 suggested that ethanol activated GSK-3β, we tested if ethanol augmented tau phosphorylation at Ser396/Ser404 (substrates of GSK-3β) using the PHF-1 antibody.	a(CHEBI:16236)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
196351e6-4258-48c3-bbb2-fcf6cd9c9ab3	0.95	PubMed	18708763	Because the major epitopes of these antibodies are the sites phosphorylated by GSK-3beta, it is highly probable that ethanol increases tau phosphorylation through GSK-3beta activation although involvement of other protein kinases and/or phosphatases can not be ruled out.	a(CHEBI:16236)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7f1741d0-7296-4ad4-93eb-f531035f5b6d	0.95	PubMed	22637478	The enzymatic activity of ExoY caused phosphorylation of endothelial Tau serine 214, accumulation of insoluble Tau, inter-endothelial cell gap formation, and increased macromolecular permeability.	p(UP:Q02731)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
7f1741d0-7296-4ad4-93eb-f531035f5b6d	0.95	Other	sparser:Unknown	ExoY Induces Tau Ser-214 Phosphorylation Necessary to Impair Microtubule Reassembly.	p(UP:Q02731)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
7f1741d0-7296-4ad4-93eb-f531035f5b6d	0.95	PubMed	12651919	The enzymatic activity of ExoY caused phosphorylation of endothelial Tau serine 214, accumulation of insoluble Tau, inter-endothelial cell gap formation, and increased macromolecular permeability.	p(UP:Q02731)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
ee6c9040-3917-4885-b42c-a47da0df2498	0.86	Other	sparser:Unknown	Soluble non-PHF abnormally phosphorylated tau isolated from AD brain has been previously shown to be dephosphorylated by alkaline phosphatase [23] and phosphoseryl/phosphothreonyl protein phosphatases -1, -2A and -2B [24-26].	p(PFAM:PF00038)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ee6c9040-3917-4885-b42c-a47da0df2498	0.86	Other	sparser:Unknown	Not surprisingly, extensive efforts have been made to identify these molecules to inhibit formation of tau filaments or tau hyperphosphorylation as the mainstream objective in the search for drugs for treatment of tauopathies [ xref , xref ].	p(PFAM:PF00038)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0a2d13d3-bf75-4fbe-8e1b-16e8216d6301	0.65	Other	sparser:Unknown	Similar downregulation of PP2A methylation and concomitant phosphorylation of tau and/or APP in the brain of AD mice caused by dietary folate and B-vitamin deficiency [ xref , xref ] and elevated homocysteine levels [ xref ] have been shown previously.	a(CHEBI:62501)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
96f142f1-2b6a-417a-8617-8f99cd8788e7	0.65	PubMed	17236136	Immunohistochemistry results demonstrated that folate deficiency further enhanced tau phosphorylation at Ser396 in both CA3 and DG hippocampal regions induced by STZ injection.	a(PUBCHEM:6037)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
c4dc4e49-404a-451a-a5f0-e98a6210d7d8	0.65	PubMed	17254830	Furthermore, formaldehyde induces the hyperphosphorylation and aggregation of neuronal Tau protein [XREF_BIBR] and aggregation of Tau protein in vitro and in vivo [XREF_BIBR - XREF_BIBR].	a(PUBCHEM:712)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4957b6f1-fc44-4234-8b16-7fc6dc707a40	0.65	PubMed	24436131	A different pattern was observed for PKA, wherein the use of the PKA activator forskolin was able to induce TAU Thr231 phosphorylation in DUSP22 shRNA depleted cells (2.2 +/- 0.5), but not in DUSP22 overexpressing SK-N-BE (2) cells (0.8 +/- 0.3) (XREF_FIG d).	a(PUBCHEM:47936)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
b94a8f2e-bcae-4ad2-bf39-3741cb0933d5	0.65	PubMed	22235112	gamma-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.	a(PUBCHEM:119)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
0995eb5f-1852-4a0f-b4de-771c08b27062	0.65	PubMed	11022883	After the brain slices in ginsenoside Rg1 groups were administration with ginsenoside Rg1 for 2 h preventively, brain slices in untreated group and ginsenoside Rg1 groups were administrated with okadaic acid (OA) for 3 h to induce hyperphosphorylation of Tau protein to prepare AD models.	a(PUBCHEM:441923)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
40f26b8b-1acc-437b-9fe6-30aef1a477c9	0.65	Other	sparser:Unknown	We show that glutamate increased tau phosphorylation, concomitant with an increased Cdk5 activity achieved by upregulation of Cdk5 and p35 protein levels.	a(CHEBI:29987)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d1114761-52d7-45b7-8c1e-79dd46f6b29d	0.65	PubMed	PMC4280091	Glycogen synthase kinase 3 (GSK3) phosphorylates tau in vitro at several sites also found to be phosphorylated in PHF-tau; tau is phosphorylated at these sites in both AD and normal control (NC) brains, although the extent of phosphorylation is far greater in tau from AD.	p(PFAM:PF05693)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a94d3953-0709-4e10-b365-41e10cf0cb51	0.86	Other	sparser:Unknown	The biochemical mechanism by which sulfated glycosaminoglycans stimulate tau phosphorylation and cause tau aggregation remains unclear.	a(CHEBI:18085)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a94d3953-0709-4e10-b365-41e10cf0cb51	0.86	PubMed	PMC5017424	The biochemical mechanism by which sulfated glycosaminoglycans stimulate tau phosphorylation and cause tau aggregation remains unclear.	a(CHEBI:18085)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d5dc714-a988-4ed6-978d-33b3f7cc242c	0.95	Other	sparser:Unknown	In cultured human neurons, Hong et al. [ xref ] showed that glycogen synthase kinase-3 (GSK-3) phosphorylates the neuronal protein tau.	p(UP:Q9U2Q9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d5dc714-a988-4ed6-978d-33b3f7cc242c	0.95	Other	sparser:Unknown	Glycogen synthase kinase-3 (GSK-3beta) phosphorylates tau and is inhibited via protein kinase C (PKC).	p(UP:Q9U2Q9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d5dc714-a988-4ed6-978d-33b3f7cc242c	0.95	PubMed	PMC5714647	Glycogen synthase kinase-3 (GSK-3beta) phosphorylates tau and is inhibited via protein kinase C (PKC).	p(UP:Q9U2Q9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d5dc714-a988-4ed6-978d-33b3f7cc242c	0.95	Other	sparser:Unknown	It is believed that glycogen synthase kinase-3 hyperphosphorylates tau protein in progressive supranuclear palsy (PSP).	p(UP:Q9U2Q9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d5dc714-a988-4ed6-978d-33b3f7cc242c	0.95	Other	sparser:Unknown	It is believed that glycogen synthase kinase-3 (GSK-3) hyperphosphorylates tau protein in progressive supranuclear palsy (PSP).	p(UP:Q9U2Q9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d5dc714-a988-4ed6-978d-33b3f7cc242c	0.95	Other	sparser:Unknown	It has been known that tau protein can be phosphorylated by glycogen synthase kinase-3 (GSK3) and STZ can increase the activity of GSK3β.	p(UP:Q9U2Q9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d5dc714-a988-4ed6-978d-33b3f7cc242c	0.95	Other	sparser:Unknown	Additonally, tau phosphorylation by glycogen synthase kinase-3 (GSK3) at specific residues appears to modulate long-term depression (LTD) [ xref ].	p(UP:Q9U2Q9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d5dc714-a988-4ed6-978d-33b3f7cc242c	0.95	PubMed	PMC7265456	These findings raise the possibility that the phosphorylation of tau by glycogen synthase kinase-3 might be involved in the regulation of organelle transport.	p(UP:Q9U2Q9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d5dc714-a988-4ed6-978d-33b3f7cc242c	0.95	Other	sparser:Unknown	These findings raise the possibility that the phosphorylation of tau by glycogen synthase kinase-3 might be involved in the regulation of organelle transport.	p(UP:Q9U2Q9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
49e3b397-8eb6-4313-bd66-0a06a1d8329f	0.65	PubMed	21763357	On the other hand, phosphorylation of Tau by PKA and GSK reduces its binding to tubulin as well as its ability to prevent the PrP induced oligomerization.	p(UP:P0AEW6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7a74aabf-aad3-46f4-9830-b4b7e07423a3	0.65	PubMed	7436244	We have found that injection of haloperidol into the lateral ventricle and into peritoneal cavity compromises spatial memory retention of rats and induces hyperphosphorylation of microtubule associated protein tau at tau-1 (Ser199 and Ser202) and PHF-1 (Ser396 and Ser404) epitopes.	a(PUBCHEM:3559)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
3ebe28d5-2a28-4133-b8ce-7ec1e8bf5144	0.95	PubMed	21151866	While phosphorylation of tau is markedly enhanced by heparin, phosphorylation of histone H1 by Nclk is essentially unaffected.	a(PUBCHEM:22833565)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3ebe28d5-2a28-4133-b8ce-7ec1e8bf5144	0.95	PubMed	21151866	Very recently, Hasegawa et al. have shown that Nclk catalyzed phosphorylation of tau can be stimulated by heparin <ce:cross-ref refid="BIB9"> [9] </ce:cross-ref>.	a(PUBCHEM:22833565)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3ebe28d5-2a28-4133-b8ce-7ec1e8bf5144	0.95	PubMed	21136848	Addition of 100 mug/ml heparin (data not shown) or dextran sulphate to the phosphorylation reaction increased tau phosphorylation by SAPK1gamma, SAPK3 and SAPK4 (<ce:cross-ref refid="FIG3"> Fig. 3 </ce:cross-ref> <ce:float-anchor refid="FIG3"/>).	a(PUBCHEM:22833565)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3ebe28d5-2a28-4133-b8ce-7ec1e8bf5144	0.95	PubMed	3700508	We found that heparin increased phosphorylation of tau by a factor of more than 2 and produced tau bands with decreased electrophoretic mobility.	a(PUBCHEM:22833565)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3ebe28d5-2a28-4133-b8ce-7ec1e8bf5144	0.95	PubMed	4737806	While phosphorylation of tau is markedly enhanced by heparin, phosphorylation of histone H1 by Nclk is essentially unaffected.	a(PUBCHEM:22833565)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d57943fa-4cea-42d8-afe8-c9d1ad338a83	0.65	PubMed	18802180	Aside from the amyloid based model for AD, iron enhanced phosphorylation of Tau and the formation of the neurofibrillary tangles associated with the AD brain.	a(PUBCHEM:23925)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5a07e6d7-e2ae-406a-bf83-86e0258321ba	0.94	PubMed	18750496	Recently, Dong et al. 12 observed that isoflurane exposure increases tau phosphorylation at the Ser262 site both in vitro and in vivo.	a(CHEBI:6015)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5a07e6d7-e2ae-406a-bf83-86e0258321ba	0.94	PubMed	18804124	20 Moreover, isoflurane has been shown to promote AD neuropathogenesis, e.g. apoptosis, A-beta accumulation, and tau protein hyperphosphorylation in cultured cells and in the brain tissues of wild-type rats.	a(CHEBI:6015)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5a07e6d7-e2ae-406a-bf83-86e0258321ba	0.94	PubMed	24977637	Recently, Dong et al. 12 observed that isoflurane exposure increases tau phosphorylation at the Ser262 site both in vitro and in vivo.	a(CHEBI:6015)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5a07e6d7-e2ae-406a-bf83-86e0258321ba	0.94	PubMed	22037098	Previous studies have shown that isoflurane, a commonly used inhalation anesthetic, may induce the neurotoxicity associated with Alzheimer 's disease (AD) neuropathogenesis, including accumulation of beta-amyloid protein and phosphorylation of Tau protein [XREF_BIBR - XREF_BIBR], and cause neurobehavior deficits [XREF_BIBR, XREF_BIBR - XREF_BIBR].	a(CHEBI:6015)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8cb2ff6d-f6fc-433b-92af-2257fd67e016	0.86	PubMed	18640938	First, lipopolysaccharide induced microglial activation promotes hyperphosphorylation of endogenous mouse MAPT in non transgenic mice that is further enhanced in mice lacking the microglial specific fractalkine receptor (CX3CR1) and is dependent upon functional toll like receptor 4 and interleukin 1 (IL1) receptors.	a(CHEBI:16412)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8cb2ff6d-f6fc-433b-92af-2257fd67e016	0.86	PubMed	11312538	First, lipopolysaccharide induced microglial activation promotes hyperphosphorylation of endogenous mouse MAPT in nontransgenic mice that is further enhanced in mice lacking the microglial specific fractalkine receptor (CX3CR1) and is dependent upon functional toll like receptor 4 and interleukin-1 (IL-1) receptors.	a(CHEBI:16412)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
075db5b4-15ba-423f-a7c8-7607d7c22986	0.65	PubMed	16420965	Our results are in a good agreement with other studies showing that lithium reduces GSK-3-induced Tau phosphorylation at Ser202 and Ser396 in transfected cells () and in primary cultures of neurons ().	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
979a8469-7e72-41e9-a1ee-0bd6a32fb786	0.65	PubMed	18443194	Thus, lithium chloride not only inhibited dephosphorylation of tau in brain ischemia, but also inhibited the rephosphorylation of tau in reperfusion.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f8de0093-da2e-4a61-820d-37ad944f6ba2	0.65	PubMed	16491390	Pretreatment with rapamycin, an mTOR inhibitor, restored the abnormal mTOR and p70S6K signaling induced by surgery, attenuated the accumulation of Abeta and reduced the phosphorylation of tau protein.	a(CHEBI:68481)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e79b0f30-c4b6-462f-9adb-85c8842eea49	0.65	Other	sparser:Unknown	Additionally, different reports have shown that specifically in brain tissue, iAs and its metabolites induce hyper-phosphorylation of the tau protein and over-regulation of the amyloid precursor protein, impaired neurotransmitters synthesis and synaptic transmission, increased glutamate receptors activation, and decreased glutamate transporters expression.	a(CHEBI:25212)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
346b43ef-a89f-4eea-8fb4-003f95a27bca	0.65	PubMed	23684085	The antidiabetic drug metformin reduces tau phosphorylation through an increase in PP2A activity.	a(CHEBI:6801)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7a54b3ef-ced8-4ef0-b6a3-c193381e6941	0.65	PubMed	15496074	Oral administration of methanol (the metabolic precursor of FA) triggers formation of senile plaques (SPs) and Tau hyperphosphorylation in the brains of monkeys with memory decline.	a(PUBCHEM:887)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
58f7af50-fdf4-4c12-9fb2-cc8b06effd16	0.65	PubMed	18438111	De-Paula and collaborators recently showed that injection of the dual cPLA 2 and iPLA 2 inhibitor methyl arachidonyl fluorophosphonate (MAFP) induced Tau phosphorylation at Ser214 [XREF_BIBR].	a(PUBCHEM:3034819)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
c0d085f9-71fd-4084-a42e-8ffebd3cda4a	0.65	PubMed	21133479	</sb:maintitle> </sb:title> <sb:volume-nr> 48 </sb:volume-nr> </sb:series> <sb:date> 1988 </sb:date> </sb:issue> <sb:pages> <sb:first-page> 2265 </sb:first-page> <sb:last-page> 2272 </sb:last-page> </sb:pages> </sb:host> </sb:reference> </ce:bib-reference> <ce:bib-reference id="BIB34"> <ce:label> 34 </ce:label> <sb:reference> <sb:contribution langtype="en"> <sb:authors> <sb:author> <ce:given-name> U. </ce:given-name> <ce:surname> Preuss </ce:surname> </sb:author> <sb:author> <ce:given-name> F. </ce:given-name> <ce:surname> Doring </ce:surname> </sb:author> <sb:author> <ce:given-name> S. </ce:given-name> <ce:surname> Illenberger </ce:surname> </sb:author> <sb:author> <ce:given-name> E.M. </ce:given-name> <ce:surname> Mandelkow </ce:surname> </sb:author> </sb:authors> <sb:title> <sb:maintitle> Cell cycle dependent phosphorylation and microtubule binding of tau protein stably transfected into chinese hamster ovary cells </sb:maintitle> </sb:title> </sb:contribution> <sb:host> <sb:issue> <sb:series> <sb:title> <sb:maintitle> Mol.	p(PFAM:PF16796)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
72aabdaa-7333-4153-874d-af5770bd5b40	0.65	PubMed	22952452	In the PAR-1 knockdown background, milton knockdown did not increase tau phosphorylation levels at Ser262 (XREF_FIG), indicating that PAR-1 mediates the increase in tau phosphorylation at Ser262 caused by milton knockdown.	p(PFAM:PF12448)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9a8990dd-df65-4b5c-9f43-6672523d0c5b	0.65	PubMed	16107670	In the hypoxia treated rats, minocycline down-regulated Iba-1, IL-1beta, TNF-alpha and EAAT2 protein expressions significantly, but did not affect total Tau and phosphorylated Tau protein expressions.	a(PUBCHEM:51537604)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
400cdbc9-0353-4338-8f50-36b6edd09382	0.86	Other	sparser:Unknown	This aberrant tau phosphorylation can be induced in the human neuroblastoma cell line TR14 by a hyperstimulating mixture, consisting of nerve growth factor (NGF), db-cAMP, gangliosides and sodium butyrate (NaBut) [20,23].	a(CHEBI:60004)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
400cdbc9-0353-4338-8f50-36b6edd09382	0.86	PubMed	PMC4024093	This aberrant tau phosphorylation can be induced in the human neuroblastoma cell line TR14 by a hyperstimulating mixture, consisting of nerve growth factor (NGF), db-cAMP, gangliosides and sodium butyrate (NaBut) [20,23].	a(CHEBI:60004)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
008fc651-2954-420c-be55-a9879c08af4d	0.65	PubMed	19876027	Brain tissues examined for dopamine content, tyrosine hydroxylase, inducible nitric oxide synthase (iNOS), glutathione peroxidase, phosphorylated tau and alpha-synuclein protein.	a(PUBCHEM:145068)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
61666204-d8f0-46e9-8422-1fe547df87b0	0.65	PubMed	11145449	Reactive oxygen species produce cytoskeletal collapse and an excessive phosphorylation of tau, a microtubule associated protein that plays a key role in microtubule stabilization, and in growth cone and neurite formation, which are cytoskeletal phenotypes that participate in neurodevelopment.	a(CHEBI:25806)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f419c68d-a6ee-4f5f-9a33-7a77b227ddca	0.86	PubMed	23951306	The 14-3-3 protein enhances tau phosphorylation by GSK3beta favoring that GSK3beta phosphorylated at serine 9 remains active and phosphorylates tau [XREF_BIBR, XREF_BIBR].	p(PFAM:PF00244)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f419c68d-a6ee-4f5f-9a33-7a77b227ddca	0.86	PubMed	15650334	14-3-3 Protein mediates phosphorylation of microtubule associated protein tau by serum- and glucocorticoid induced protein kinase 1.	p(PFAM:PF00244)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
964b71e0-e512-4183-ad59-dead54d3fc76	0.86	PubMed	24367683	However, Myc-14-3-3zeta promoted tau phosphorylation at Ser 262 but not at Ser 214 (XREF_FIG, lanes 4-6).	p(UP:Q1HR36)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
964b71e0-e512-4183-ad59-dead54d3fc76	0.86	PubMed	17409694	However, Myc-14-3-3zeta promoted tau phosphorylation at Ser 262 but not at Ser 214 (XREF_FIG, lanes 4-6).	p(UP:Q1HR36)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
f80084b8-2042-444b-b160-c47bc881716f	0.65	PubMed	10418963	Our results suggest that the decrease of glutamate induced Tau hyperphosphorylation by 17beta-estradiol requires SphK.	a(PUBCHEM:5757)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
038ff053-018e-44a2-b913-92abd0c697b4	0.65	PubMed	7617646	Seven and a half hours after injection of 2-deoxyglucose a significant increase in brain cortex beta-APP expression, increased tau phosphorylation, and a marked relative expansion of the trans- part of the Golgi intracellular secretory pathway in cortical neurons has been found.	a(PUBCHEM:9062)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3b238964-d053-4a62-85d0-4cbd15768cff	0.65	PubMed	20849811	In the second system, the ability of p42 MAP and p44 MAP kinases, glycogen synthase kinases 3a and 3beta (GSK-3a and GSK-3beta) to phosphorylate tau in transfected COS cells was investigated.	p(PFAM:PF00803)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
9706a392-a50c-4c65-8a1e-cfd28d69df40	0.65	PubMed	20153023	Furthermore, carbonyl-4-hydroxy-2-nonenal (4-HNE) facilitates aggregation of p-tau in vitro and induces hyperphosphorylation of tau.	a(PUBCHEM:5283344)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
78af7509-0d72-4ecf-90c2-ff8a7e7f1992	0.86	Other	sparser:Unknown	Taking into account that in vivo evidence showed that peroxynitrite induces Alzheimer-like tau hyperphosphorylation, nitration, and accumulation [ xref ], it was reported that curcumin mediates the direct detoxification of reactive nitrogen species such as peroxynitrite, thus exerting an antioxidant activity [ xref ].	a(CHEBI:25941)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
78af7509-0d72-4ecf-90c2-ff8a7e7f1992	0.86	Other	sparser:Unknown	Furthermore, peroxynitrite can also induce AD-like Tau hyperphosphorylation via activation of both glycogen synthase kinase-3beta (GSK3beta) and p38 MAPKs [ xref ].	a(CHEBI:25941)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
c27472ce-6a10-4bc5-a7fa-de433fae9a24	0.65	PubMed	9504142	Cyclophosphamide and phosphoramide mustard, DNA cross linking agents, decreased tau phosphorylation at Ser 396/404 site, but increased phosphorylation at Ser 202.	a(PUBCHEM:96356)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
b210a8d5-01bc-4d3f-b661-7d2a94373819	0.65	PubMed	8999860	The regulatory Ser262 of microtubule associated protein tau is phosphorylated by phosphorylase kinase.	p(PFAM:PF00343)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
b50f1541-873c-47c6-bd73-97134fd9c1cc	0.65	PubMed	21347323	The lowering of tau phosphorylation by pioglitazone treatment in insulin resistant animals indicates that human APOEepsilon3 is the isoform most responsive to treatment.	a(PUBCHEM:4829)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f5a00572-2d76-43c1-b115-37ed93f219bd	0.65	PubMed	16766195	pKA phosphorylation of tau was performed in 50mM Tris-HCl, 10mM MgCl, at pH 7.5 and 25degreesC overnight.	p(UP:Q90Z06)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
bb08906a-413f-46bb-a0e2-8d1f69e5c1a4	0.65	PubMed	11114068	Previous studies have shown that progesterone modulates the activity of different kinases and the phosphorylation of Tau in the brain.	a(CHEBI:17026)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
20b0f8ca-a276-4e93-a6d2-f11b07ea641d	0.65	PubMed	15866902	These findings indicated that propofol increased tau phosphorylation under both normothermic and hypothermic conditions, and temperature control could partially attenuate the hyperphosphorylation of tau.	a(PUBCHEM:4943)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4f5b4e14-4bd6-4b19-9ae0-d43ce9015692	0.95	Other	sparser:Unknown	Two-dimensional phosphopeptide mapping revealed that most of the sites on tau phosphorylated in brain slices in response to increased cAMP levels were the same as those phosphorylated on isolated tau by purified cAMP-PK.	p(UP:P57404)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4f5b4e14-4bd6-4b19-9ae0-d43ce9015692	0.95	PubMed	PMC3261170	Two-dimensional phosphopeptide mapping revealed that most of the sites on tau phosphorylated in brain slices in response to increased cAMP levels were the same as those phosphorylated on isolated tau by purified cAMP-PK.	p(UP:P57404)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4f5b4e14-4bd6-4b19-9ae0-d43ce9015692	0.95	Other	sparser:Unknown	Two-dimensional phosphopeptide maps indicate that cAMP-PK phosphorylates a site or sites on tau that are phosphorylated by CaMKII, as well as a unique site or sites that are not phosphorylated by CaMKII.	p(UP:P57404)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4f5b4e14-4bd6-4b19-9ae0-d43ce9015692	0.95	Other	sparser:Unknown	Phosphorylation of tau by cAMP-PK significantly decreased tubulin binding and, as previously reported, also inhibited the calpain-induced degradation of tau.	p(UP:P57404)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4f5b4e14-4bd6-4b19-9ae0-d43ce9015692	0.95	Other	sparser:Unknown	However, cAMP-PK phosphorylated tau to a significantly greater extent than CaMKII (1.5 and 0.9 mol of 32P/mol of tau, respectively), and phosphorylation of tau by cAMP-PK resulted in a greater shift to a more acidic, less heterogeneous pattern on two-dimensional nonequilibrium pH gradient gels compared with CaMKII phosphorylation.	p(UP:P57404)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
4f5b4e14-4bd6-4b19-9ae0-d43ce9015692	0.95	Other	sparser:Unknown	Purified bovine brain tau that had been phosphorylated by cAMP-PK had a slower migration pattern on sodium dodecyl sulfate-polyacrylamide gels and a more acidic, less heterogeneous pattern on two-dimensional, nonequilibrium pH gradient electrophoresis (NEPHGE) gels compared with untreated tau.	p(UP:P57404)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d15da262-ccf4-4c6d-89f6-15297d6a8b05	0.65	PubMed	18648555	Treatment with leptin alleviated the increase in phosphorylation of tau induced by rapamycin at Ser 202 and Thr 205 residues not at Ser 396 and Ser 404 residues.	a(CHEBI:9168)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
67d481b5-ea2a-4acb-a439-1585ed0fe7a3	0.65	PubMed	18798620	In a cellular model where retinoic acid induced the phosphorylation of tau at the key amino acid residues Ser 202, Ser 396, and Ser 404, exogenous leptin treatment led to a decrease in hyperphosphorylation of tau that was approximately 300-fold more potent than insulin, another metabolic hormone that has been suggested as a neuroprotective agent against AD pathology.	a(PUBCHEM:5282379)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
92f6738d-64de-472c-9318-34c0308b668b	0.65	PubMed	21435449	In these models, roscovitine also reduced abnormal phosphorylation of tau.	a(PUBCHEM:160355)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
538b0817-2922-49d3-bd4b-01248da56bcf	0.65	PubMed	10421054	In addition, BSA partially prevented the decrease in the expression of GAP-43, MAP-2, and tubulin, and the phosphorylation of tau protein caused by A beta, suggesting that BSA protects against the loss of plasticity caused by the peptide.	p(UP:P12878)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7a65c0df-b230-4c69-b5c8-ea26526b2fb6	0.86	PubMed	24914767	Previously, van Eersel reported sodium selenate reduced Tau phosphorylation, completely abrogated NFT formation in Tau transgenic mouse, improved its contextual memory and motor performance, and finally prevented its neurodegeneration [XREF_BIBR].	a(PUBCHEM:26473)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
7a65c0df-b230-4c69-b5c8-ea26526b2fb6	0.86	PubMed	23684085	Similarly, chronic low doses of sodium selenate increased PP2A activity and reduced tau phosphorylation in mouse models of tauopathy.	a(PUBCHEM:26473)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
f1bee926-299a-4315-b0a8-20ff6437f408	0.65	PubMed	17237095	For instance, sevoflurane, an anesthetic thought to act as both a positive allosteric modulator and antagonist at allosteric and orthosteric sites on the GABA A R [XREF_BIBR], has been found to increase tau phosphorylation in C57B16/J mice, which was reversible with chronic administration and persistent with clear memory impairment after repeated administration [XREF_BIBR].	a(PUBCHEM:5206)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
882030f8-ce94-4c1e-bf9f-211988e177d5	0.65	PubMed	27023670	In line with these reports, we found that RNAi mediated knockdown of GSK3 and Sgg significantly reduced tau phosphorylation at these SP/TP sites (XREF_SUPPLEMENTARY); as a result, tau is detected as a single band with faster migration speed than tau lower (XREF_FIG, input, asterisk).	p(UP:P18431)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e700989a-6a78-4d7d-94c7-a416f33a5977	0.65	PubMed	17434621	Furthermore, sitagliptin has been reported to increase MAPT phosphorylation, eventually leading to NFTs [XREF_BIBR].	a(PUBCHEM:4369359)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
092a6ef5-80a8-4f9a-815b-b18b458b712b	0.65	PubMed	17200729	Previously, van Eersel reported sodium selenate reduced Tau phosphorylation, completely abrogated NFT formation in Tau transgenic mouse, improved its contextual memory and motor performance, and finally prevented its neurodegeneration [XREF_BIBR].	a(PUBCHEM:923)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
88d2fe65-6ce5-4e71-ac2a-ddd1ebef360b	0.86	PubMed	18958247	Cells expressing a tau-K18 fragment containing the pathogenic P301L mutation (K18-PL) were treated with the autophagy inhibitor 3-methyladenine (3MA), which impairs K18-PL degradation 17, as well as with the oxidative stressor sodium arsenite, previously shown to increase tau phosphorylation 18.	a(PUBCHEM:443495)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
88d2fe65-6ce5-4e71-ac2a-ddd1ebef360b	0.86	PubMed	23624859	Cells expressing a tau-K18 fragment containing the pathogenic P301L mutation (K18-PL) were treated with the autophagy inhibitor 3-methyladenine (3MA), which impairs K18-PL degradation 17, as well as with the oxidative stressor sodium arsenite, previously shown to increase tau phosphorylation 18.	a(PUBCHEM:443495)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
a755cd03-6c2e-4624-904b-0a0dcc1977ed	0.65	PubMed	18953621	In the current report we have expanded upon those findings by showing that SP/TP phosphorylation of tau is necessary for both oligomerized Abeta 1-42 -induced tau mislocalization and synaptic deficits (XREF_FIG & XREF_FIG).	p(UP:Q5PEA9)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ae1d4d5f-cb49-4c31-b6b7-9c86aebd3e18	0.86	PubMed	5431394	Previously, it was demonstrated that in SH-SY5Y human neuroblastoma cells and rat primary cortical cultures tau is phosphorylated at Ser262/356, within its microtubule binding domain, by a staurosporine sensitive protein kinase in response to the vicinal thiol directed agent phenylarsine oxide.	a(PUBCHEM:44259)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ae1d4d5f-cb49-4c31-b6b7-9c86aebd3e18	0.86	PubMed	11027949	Furthermore, tau was spontaneously hyperphosphorylated upon overexpression and by staurosporine treatment.	a(PUBCHEM:44259)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6cab3800-4563-4909-a30f-7d0aa98572fa	0.65	PubMed	20168797	XREF_BIBR, XREF_BIBR, XREF_BIBR Injecting streptozotocin, a glucosaminenitrosourea toxic to pancreatic beta cells, into rat brain induced the phosphorylation of the tau protein, amyloid deposits and other SAD symptoms.	a(PUBCHEM:29327)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
52872e0c-5564-436f-827a-5122ff896b42	0.65	PubMed	14538346	In glial fibrillary acidic protein-gp120 transgenic (tg) mice, sunitinib reduced levels of pCDK5, p35 and p25 and phosphorylated tau protein, along with amelioration of the neurodegenerative pathology.	a(PUBCHEM:5329102)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
5f3bae8d-742c-4c32-bd78-3dea141a0cec	0.65	PubMed	21127069	Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro.	p(PFAM:PF01387, var(p.?))	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
214184b0-6bd2-4f55-aba5-7f07873c112c	0.86	PubMed	24367683	In addition, taxol reduced tau phosphorylation at Ser 262 by 2.1-fold in Ln-14-3-3zeta infected neurons (lane 4).	a(PUBCHEM:36314)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
214184b0-6bd2-4f55-aba5-7f07873c112c	0.86	PubMed	24367683	Thus, taxol treatment reduced tau phosphorylation at Ser 262 and provided significant protection against downregulation of synaptophysin induced by 14-3-3zeta overexpression.	a(PUBCHEM:36314)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
92208f97-01cf-4dce-875f-a98a5f26f4a3	0.65	PubMed	12227074	On the other hand, thapsigargin as an ER-stress inducer stimulated phosphorylation of tau at Thr231, Ser262 and Ser396.	a(CHEBI:9516)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
ebaa193d-a433-4043-83d9-cf20b16a1b37	0.65	PubMed	17850192	Previous studies have demonstrated that thiamine deficiency can induce or aggravate AD like pathologies, such as neuritic plaques, and hyperphosphorylation of tau, finally memory deficits [XREF_BIBR].	a(PUBCHEM:1130)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8dbaf96a-2a9b-4562-9afb-1bc451e8f117	0.65	PubMed	12234383	These results indicate that chronic administration of gonadal hormones and tibolone modulates tau and GSK3beta phosphorylation in hippocampus and cerebellum of the rat and may exert a neuroprotective effect in these tissues.	a(PUBCHEM:444008)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d2b8b4b0-ba83-4b00-b14f-03007fcd0580	0.95	Other	sparser:Unknown	In SH-SY5Y cell cultures, tunicamycin and Aβ(1-42) activate PKR, GSK-3β and induce tau phosphorylation and all these processes are attenuated by PKR inhibitors or PKR siRNA.	a(CHEBI:29699)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d2b8b4b0-ba83-4b00-b14f-03007fcd0580	0.95	PubMed	16166216	The combination of vitamin D & resveratrol completely reversed tunicamycin and Abeta25-35 induced cytotoxicity in SH-SY5Y cells, as well as elevation in ER stress markers (i.e.GRP78, p-eIF2alpha and CHOP), insulin signaling disruption (i.e. elevation in p-IRS-1serine307 and reduction in p-Akt serine473) and tau phosphorylation (i.e. reduction in p-GSK3beta serine9, and elevation in p-Tau serine396 & 404).	a(CHEBI:29699)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
d2b8b4b0-ba83-4b00-b14f-03007fcd0580	0.95	PubMed	22054838	However, combined tunicamycin treatment and knockdown of SelS together significantly increased phosphorylation of tau at the pS214 site (XREF_FIG).	a(CHEBI:29699)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
cbf7e29b-44d4-43e4-a0a3-05ed993d7620	0.65	PubMed	1176469	Calcium/calmodulin dependent protein kinase type II (CaM kinase II), the most abundant kinase in the brain, phosphorylates tau in vitro.	p(UP:A8WXF6)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3734dab3-02bc-4cd5-b3eb-dd0867c46b0b	0.65	PubMed	17711239	Lithium and valproate, besides other modes of action, could reduce hyperphosphorylation of tau, but various clinical studies have shown conflicting results.	a(PUBCHEM:3121)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
ecc93504-e97a-4057-b8b5-81646367cb8e	0.65	PubMed	11775766	Furthermore, the intake of vitamin C restored the declined synaptophysin and the phosphorylation of tau at Ser396.	a(PUBCHEM:54670067)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
86d02e05-c7bc-4c45-9c29-9293848221bd	0.65	PubMed	17513150	These results strongly suggested that wogonin profoundly suppressed the amyloidogenic pathway, as well as Tau and phosphorylated Tau protein, in the cerebra of AD mice.	a(CHEBI:10043)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
710f7a94-2e6c-476c-8f17-98c9f02a96a8	0.65	PubMed	17303106	Protein kinase A has been reported to increase tau phosphorylation in vitro on the 12E8 epitope under some conditions, such as in response to the binding of alpha-synuclein to tau protein [XREF_BIBR].	p(UP:Q9RI12)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
3d0dad83-807c-4130-ad8c-a82ebde7d06f	0.65	Other	sparser:Unknown	They conclude that zinc induces tau Ser214 phosphorylation through the Ras-Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (ERK) pathway, which interferes with microtubule polymerization.	a(CHEBI:27363)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 214))
f50da9eb-2d27-4dbf-9389-38bee63b5792	0.92	Other	sparser:Unknown	Interestingly, p62-KO mice display adult onset neurodegeneration with elevated level of K63-ubiquitinated Tau in the brain xref , xref , reminiscent of the brain degeneration observed upon reduced Htt expression or Htt postnatal deletion xref , xref .	p(UP:D2IE16)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
f50da9eb-2d27-4dbf-9389-38bee63b5792	0.92	Other	sparser:Unknown	Interestingly, a mechanism for K63-linked ubiquitylation has been proposed for tau involving the E3 ligase TRAF6 [ xref ]; the authors describe binding of K63-ubiquitylated tau to the shuttling factor p62, which has been linked to both the proteasome and autophagy [ xref ].	p(UP:D2IE16)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
f50da9eb-2d27-4dbf-9389-38bee63b5792	0.92	Other	sparser:Unknown	Biochemical fractionation of p62(-/-) brain led to recovery of aggregated K63-ubiquitinated tau.	p(UP:D2IE16)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
992aafbe-6a14-469b-8350-038bb2faec81	0.97	Other	sparser:Unknown	Tau co‐immunoprecipitates with CHIP, an E3 ubiquitin ligase that ubiquitinates tau before the proteasome degrades it.	p(FPLX:"E3_Ub_ligase")	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
992aafbe-6a14-469b-8350-038bb2faec81	0.97	PubMed	18362272	It has been shown that Tau co-immunoprecipitates with CHIP, an E3 ubiquitin ligase, that ubiquitinates Tau for subsequent degradation via the proteasome and soluble phosphorylated Tau accumulates in brains of CHIP knockout mice [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(FPLX:"E3_Ub_ligase")	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
992aafbe-6a14-469b-8350-038bb2faec81	0.97	PubMed	16851072	Different Tau forms can be ubiquitinated by E3 ligases CHIP [XREF_BIBR, XREF_BIBR], TRAF6 [XREF_BIBR], and MARCH7 [XREF_BIBR], with particularly CHIP and Hsp70 dependent polyubiquitination characterized in detail invitro and invivo.	p(FPLX:"E3_Ub_ligase")	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
992aafbe-6a14-469b-8350-038bb2faec81	0.97	PubMed	24905733	3.3 E3 ubiquitin ligase activity of axotrophin RING-variant domain leads to ubiquitination of tau in vitro.	p(FPLX:"E3_Ub_ligase")	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
be14492a-f1e0-4feb-8a9c-1330b4a9a265	0.65	PubMed	28059128	In this case, CHIP mediated ubiquitylation of Tau is suppressed by Hsp70.	p(FPLX:HSPA)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
65439ced-f4fa-4df7-8983-7af24f778c35	0.95	PubMed	24905733	Axotrophin and MARCH7 acts as an E3 ubiquitin ligase and ubiquitinates tau protein in vitro impairing microtubule binding.	p(HGNC:MARCH7)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
65439ced-f4fa-4df7-8983-7af24f778c35	0.95	PubMed	24905733	The observation that tau and axotrophin RING-variant domain interact led us ask, whether the E3 ubiquitin ligase activity of the axotrophin RING-variant domain can induce ubiquitination of tau.	p(HGNC:MARCH7)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
65439ced-f4fa-4df7-8983-7af24f778c35	0.95	PubMed	24905733	3.4 Multiple mono-ubiquitination of tau by axotrophin leads to a decreased microtubule binding capacity of tau.	p(HGNC:MARCH7)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
65439ced-f4fa-4df7-8983-7af24f778c35	0.95	PubMed	24905733	We have identified and characterized axotrophin, a protein that binds and preferentially mono-ubiquitinates tau protein.	p(HGNC:MARCH7)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
65439ced-f4fa-4df7-8983-7af24f778c35	0.95	PubMed	24905733	Whereas multiple mono-ubiquitination of tau by axotrophin could be a physiological event regulating microtubule binding affinity of tau it may also provide the basis for ubiquitin chain elongation by so called E4-ligases.	p(HGNC:MARCH7)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
9488fa49-2089-4690-b318-66bcc7f466fa	0.88	PubMed	17878407	Moreover, NGF induces ubiquitination of Tau in cultured cells, indicating that NGF may regulate Tau protein levels by inducing proteasomal degradation of Tau.	p(HGNC:NGF)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
9488fa49-2089-4690-b318-66bcc7f466fa	0.88	Other	sparser:Unknown	Moreover, NGF induces ubiquitination of Tau in cultured cells ( xref ), indicating that NGF may regulate Tau protein levels by inducing proteasomal degradation of Tau.	p(HGNC:NGF)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
fe1990b8-d611-4565-a35c-efe792d3ff02	0.86	PubMed	17707627	For example, if HEK cells are transfected with tau and ubiquitin, tau is readily ubiquitylated and degraded by the proteasome.	p(FPLX:Proteasome)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
fe1990b8-d611-4565-a35c-efe792d3ff02	0.86	PubMed	17607945	Ubiquitination of tau and phosphorylated tau (p-tau) by HRD1 targets these proteins for degradation by the proteasome XREF_BIBR.	p(FPLX:Proteasome)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
7723c9fc-66c0-4c94-a98e-900c1210f45a	0.65	PubMed	24905733	The multiple mono-ubiquitination of tau by the RING-variant domain of axotrophin suggests that the microtubule binding affinity of tau is affected by tau ubiquitination.	p(PFAM:PF12906)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
041fae0e-5bbf-4901-8cbb-2ded02dff6ac	0.86	PubMed	21348938	In fact, a recent study provided evidence that tau and tau truncated at D421 were not ubiquitylated by CHIP in situ, despite evidence of CHIP mediated ubiquitylation in an in vitro reaction [XREF_BIBR].	p(HGNC:STUB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ub, Asp, 421))
041fae0e-5bbf-4901-8cbb-2ded02dff6ac	0.86	PubMed	17634135	In fact, a recent study provided evidence that tau and tau truncated at D421 were not ubiquitylated by CHIP in situ, despite evidence of CHIP mediated ubiquitylation in an in vitro reaction [XREF_BIBR].	p(HGNC:STUB1)	directlyIncreases	p(HGNC:MAPT, pmod(Ub, Asp, 421))
1dac745f-550b-4b9e-b1ff-32d69a9ef4fa	0.65	PubMed	17710070	Interestingly, genetic studies have shown that the disruption of p62, VCP, and 19S particle in the brain leads to ubiquitylated inclusions of tau, TAR-DNA binding protein (TDP-43), and alpha-synuclein, respectively.	p(HGNC:VCP)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
6096794c-1258-40fd-bce2-f448c1a64255	0.65	PubMed	16846010	Notably, tau is ubiquitylated through Lys48 linkages by the action of CHIP or tumour necrosis factor receptor associated factor 6 (TRAF6), leading to proteasomal degradation of tau [XREF_BIBR].	p(IP:IPR006053)	directlyIncreases	p(HGNC:MAPT, pmod(Ub))
